activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	45892	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	45892	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	48475	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1cccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)c1		CHEMBL143370	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	uM	2.1
	52375	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	IC50	nM	4000.0	CHEMBL260	Homo sapiens	IC50	uM	4.0
	52380	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	Oc1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL143007	=	IC50	nM	5700.0	CHEMBL260	Homo sapiens	IC50	uM	5.7
	52383	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(CCCSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL359380	=	IC50	nM	750.0	CHEMBL260	Homo sapiens	IC50	uM	0.75
	54923	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	CSc1cc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)ccc1O		CHEMBL142891	=	IC50	nM	3800.0	CHEMBL260	Homo sapiens	IC50	uM	3.8
	56127	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(Br)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL356983	=	IC50	nM	3800.0	CHEMBL260	Homo sapiens	IC50	uM	3.8
	59854	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(Cl)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL358042	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	59857	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	Fc1ccc(-c2[nH]c(CCc3ccccc3)nc2-c2ccncc2)cc1		CHEMBL87858	=	IC50	nM	690.0	CHEMBL260	Homo sapiens	IC50	uM	0.69
	61302	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL113419	=	IC50	nM	630.0	CHEMBL260	Homo sapiens	IC50	uM	0.63
	63956	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	Fc1ccc(-c2[nH]c(SCc3ccccc3)nc2-c2ccncc2)cc1		CHEMBL142751	=	IC50	nM	35000.0	CHEMBL260	Homo sapiens	IC50	uM	35.0
	66546	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	CSc1cccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)c1		CHEMBL357648	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	67658	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccccc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL143480	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	uM	12.0
	69004	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1cc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)ccc1O		CHEMBL142841	=	IC50	nM	3400.0	CHEMBL260	Homo sapiens	IC50	uM	3.4
	70418	CHEMBL732625	Inhibition of Mitogen-activated protein kinase p38 (P38 MAPK)	B	C[S+]([O-])c1ccc(CCSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL356485	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	105380	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(C4CC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96565	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	106518	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(C4CCC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL419140	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	107707	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccc(C)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL97579	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	107708	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96763	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	108802	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COc1cc(-c2ccc(F)cc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94770	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	111583	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94547	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	112995	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(NC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327987	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	114288	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccc(Cl)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL330358	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	115404	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2cccc(C(F)(F)F)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328752	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	nM	170.0
	118054	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL328614	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	118061	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(CN3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327746	=	IC50	nM	0.13	CHEMBL260	Homo sapiens	IC50	nM	0.13
	119277	CHEMBL811036	Inhibition of Stress activated protein kinase 2a at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	Inhibition	%	9.0
	119286	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2c(F)cccc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL316337	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	119287	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(CN3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL97227	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	120508	CHEMBL733326	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	COC(=O)c1cc(Br)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL420438	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	120509	CHEMBL733326	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	COC(=O)c1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94547	=	Inhibition	%	48.0	CHEMBL260	Homo sapiens	Inhibition	%	48.0
	121688	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccccc2C)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94377	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	121689	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL94417	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	124149	CHEMBL733327	Inhibition of Mitogen-activated protein kinase p38 alpha at 890 nM	B	COC(=O)c1cc(-c2ccccc2C(F)(F)F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL327923	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	Inhibition	%	50.0
	125509	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccccc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94495	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	125510	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C(c1cc(-c2ccc(F)cc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL96225	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	125512	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CN1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL96653	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	127009	CHEMBL733326	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	COC(=O)c1ccc2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421383	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	127010	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CC(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL328242	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	128147	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccc(F)cc2C)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94783	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	129344	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2cccc(C)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328274	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	nM	320.0
	129345	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	130737	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C(c1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL327217	=	IC50	nM	2.4	CHEMBL260	Homo sapiens	IC50	nM	2.4
	130744	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(CC4CC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL419134	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	133236	CHEMBL811036	Inhibition of Stress activated protein kinase 2a at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	41.0	CHEMBL260	Homo sapiens	Inhibition	%	41.0
	133243	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COc1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL96091	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	134413	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(OC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL94825	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	134420	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(CC4CCC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL264627	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	135685	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL96632	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	135686	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(NC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96432	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	138061	CHEMBL811036	Inhibition of Stress activated protein kinase 2a at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	79.0	CHEMBL260	Homo sapiens	Inhibition	%	79.0
	138080	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94556	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	138081	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCN1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL96345	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	139333	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2cccc(F)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94852	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	139334	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccc(C(F)(F)F)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94719	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	141558	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccc(F)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328252	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	141559	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96487	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	141566	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CC(C1CC1)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL318934	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
	141573	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL316604	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	142830	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2ccccc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421194	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	142831	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(-c2cccc(Cl)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421566	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
	142832	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C(c1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL94444	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	144079	CHEMBL811036	Inhibition of Stress activated protein kinase 2a at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%	15.0	CHEMBL260	Homo sapiens	Inhibition	%	15.0
	144090	CHEMBL734090	Inhibitory activity against mitogen-activated protein kinase p38 alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(OC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327959	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	177497	CHEMBL812936	Inhibition of Stress activated protein kinase 2a	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	81.0	CHEMBL260	Homo sapiens	Activity	%	81.0
	178810	CHEMBL812936	Inhibition of Stress activated protein kinase 2a	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	84.0	CHEMBL260	Homo sapiens	Activity	%	84.0
	182557	CHEMBL812936	Inhibition of Stress activated protein kinase 2a	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	109.0	CHEMBL260	Homo sapiens	Activity	%	109.0
	281887	CHEMBL801121	Inhibition of protein kinase SAPK2A (p38-alpha)	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	>	Ki	nM	1000.0	CHEMBL260	Homo sapiens	Ki	nM	1000.0
	345872	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340687	=	IC50	nM	515.0	CHEMBL260	Homo sapiens	IC50	nM	515.0
	345874	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C(O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL128414	=	IC50	nM	96.0	CHEMBL260	Homo sapiens	IC50	nM	96.0
	347250	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(C)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129375	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	348503	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL443285	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	348505	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	CC(=O)c1cc(C)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL128686	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	348507	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(F)cccc1Cl		CHEMBL128781	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	349857	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	COc1ccccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL339095	=	IC50	nM	1990.0	CHEMBL260	Homo sapiens	IC50	nM	1990.0
	349859	CHEMBL731492	Inhibition of Mitogen-activated protein kinase p38 alpha at 10000 nM	B	O=C1NCc2nc(Sc3cccc(Sc4ccc(F)cc4)c3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL131026	=	Inhibition	%	-6.0	CHEMBL260	Homo sapiens	Inhibition	%	-6.0
	349861	CHEMBL731492	Inhibition of Mitogen-activated protein kinase p38 alpha at 10000 nM	B	O=C1NCc2nc(NCc3ccc(Cl)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL338949	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	Inhibition	%	9.0
	349863	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Cc1cc([N+](=O)[O-])cc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL127275	=	IC50	nM	66.0	CHEMBL260	Homo sapiens	IC50	nM	66.0
	349865	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	CN(C)CCNC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL434434	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	nM	80.0
	351335	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Cc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL128756	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	nM	54.0
	351337	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Cc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL128756	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	352679	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1N1C(=O)NCc2nc(Sc3ccc(F)cc3Cl)ccc21		CHEMBL128516	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
	354237	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Nc1cc(F)ccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL128239	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	354239	CHEMBL731492	Inhibition of Mitogen-activated protein kinase p38 alpha at 10000 nM	B	COc1ccc(CSc2ccc3c(n2)CNC(=O)N3c2c(Cl)cccc2Cl)cc1		CHEMBL129508	=	Inhibition	%	-8.0	CHEMBL260	Homo sapiens	Inhibition	%	-8.0
	354241	CHEMBL731493	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(Cl)cccc1CO		CHEMBL129057	=	Inhibition	%	46.0	CHEMBL260	Homo sapiens	Inhibition	%	46.0
	355679	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(Cl)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128440	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	355681	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccccc3C(F)(F)F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340742	=	IC50	nM	1850.0	CHEMBL260	Homo sapiens	IC50	nM	1850.0
	357125	CHEMBL731492	Inhibition of Mitogen-activated protein kinase p38 alpha at 10000 nM	B	O=C1NCc2nc(SCc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL419987	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	Inhibition	%	21.0
	357127	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1ccccc1		CHEMBL129380	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	nM	600.0
	359979	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340687	=	IC50	nM	94.0	CHEMBL260	Homo sapiens	IC50	nM	94.0
	359981	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Cc1cccc(C)c1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL129174	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	nM	260.0
	359983	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	COc1cccc(C)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL341364	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	nM	100.0
	361114	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(NCc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL423517	=	IC50	nM	340.0	CHEMBL260	Homo sapiens	IC50	nM	340.0
	361116	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL129112	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	nM	80.0
	362413	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129628	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	362415	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	COC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129628	<	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	364070	CHEMBL731492	Inhibition of Mitogen-activated protein kinase p38 alpha at 10000 nM	B	O=C1NCc2nc(NCc3ccc(Cl)cc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128042	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	Inhibition	%	14.0
	364072	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(Cl)cccc1C(F)(F)F		CHEMBL129305	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	365559	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3cccc(C(F)(F)F)c3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL129446	=	IC50	nM	1815.0	CHEMBL260	Homo sapiens	IC50	nM	1815.0
	365561	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	CCc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL129704	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	365563	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL92788	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	365565	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL92788	<	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	367089	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccccc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL340377	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	nM	450.0
	368415	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	NC(=O)Oc1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129720	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	368417	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	NC(=O)Oc1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129720	<	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	369855	CHEMBL731493	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	NC(=O)Oc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL262983	=	Inhibition	%	46.0	CHEMBL260	Homo sapiens	Inhibition	%	46.0
	369857	CHEMBL731493	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	Cc1cccc(O)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL335945	=	Inhibition	%	20.0	CHEMBL260	Homo sapiens	Inhibition	%	20.0
	369859	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128813	<	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	372581	CHEMBL731492	Inhibition of Mitogen-activated protein kinase p38 alpha at 10000 nM	B	O=C1NCc2nc(Sc3ccc(C(F)(F)F)cc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL129576	=	Inhibition	%	51.0	CHEMBL260	Homo sapiens	Inhibition	%	51.0
	372583	CHEMBL731493	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	O=C(O)c1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL335292	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	Inhibition	%	14.0
	374117	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1ccccc1Cl		CHEMBL338612	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	nM	69.0
	375440	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	Nc1ccccc1Sc1ccc2c(n1)CNC(=O)N2c1c(Cl)cccc1Cl		CHEMBL128257	=	IC50	nM	1420.0	CHEMBL260	Homo sapiens	IC50	nM	1420.0
	376838	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(NCc3ccccc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL335878	=	IC50	nM	113.0	CHEMBL260	Homo sapiens	IC50	nM	113.0
	376840	CHEMBL731493	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1ccccc1-c1ccccc1		CHEMBL340069	=	Inhibition	%	28.0	CHEMBL260	Homo sapiens	Inhibition	%	28.0
	378236	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128813	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	378238	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL128813	<	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	378239	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccccc3Br)ccc2N1c1c(Cl)cccc1Cl		CHEMBL131194	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	378241	CHEMBL731493	Inhibition of Mitogen-activated protein kinase p38 alpha at 1000 nM	B	Nc1cccc(Cl)c1N1C(=O)NCc2nc(Sc3ccc(F)cc3)ccc21		CHEMBL131399	=	Inhibition	%	29.0	CHEMBL260	Homo sapiens	Inhibition	%	29.0
	379609	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3)ccc2N1c1c(Cl)cc(C(F)(F)F)cc1Cl		CHEMBL128515	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	nM	230.0
	381081	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccc(F)cc3F)ccc2N1c1c(Cl)cccc1Cl		CHEMBL92788	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	381083	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3cc(Cl)ccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL129659	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	nM	350.0
	382528	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3cccc(Cl)c3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL130076	=	IC50	nM	2190.0	CHEMBL260	Homo sapiens	IC50	nM	2190.0
	383943	CHEMBL731492	Inhibition of Mitogen-activated protein kinase p38 alpha at 10000 nM	B	O=C1NCc2nc(SCc3ccccc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL130077	=	Inhibition	%	42.0	CHEMBL260	Homo sapiens	Inhibition	%	42.0
	385353	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3c(Cl)cccc3Cl)ccc2N1c1c(Cl)cccc1Cl		CHEMBL341029	=	IC50	nM	49.0	CHEMBL260	Homo sapiens	IC50	nM	49.0
	385355	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	CC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129775	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	385357	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	CC(=O)c1cc(Cl)c(N2C(=O)NCc3nc(Sc4ccc(F)cc4)ccc32)c(Cl)c1		CHEMBL129775	<	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	389863	CHEMBL735052	Inhibitory activity against Mitogen-activated protein kinase p38 alpha	B	O=C1NCc2nc(Sc3ccccc3)ccc2N1c1c(Cl)cccc1Cl		CHEMBL131176	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	nM	270.0
	391062	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3ccc(F)cc3)nc21		CHEMBL275367	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	392406	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1cc(F)ccc1-c1nc(N(C(N)=O)c2ccccc2)c2ncn(C)c2n1		CHEMBL18657	>	IC50	nM	16700.0	CHEMBL260	Homo sapiens	IC50	uM	16.7
	392443	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CC(C)N1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95206	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	nM	170.0
	393571	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1cc(F)ccc1-c1nc(N(C(N)=O)c2c(F)cc(F)cc2F)c2ncn(C)c2n1		CHEMBL18304	=	IC50	nM	163.0	CHEMBL260	Homo sapiens	IC50	uM	0.163
	393600	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CNc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(C)CC2)n1		CHEMBL329447	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	nM	100.0
	393601	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CNc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(C)CC2)n1		CHEMBL329447	=	ED50	mg.kg-1	2.4	CHEMBL260	Homo sapiens	ED50	mg kg-1	2.4
	394766	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1ccccc1-c1nc(N(C(N)=O)c2c(F)cccc2F)c2ncn(C)c2n1		CHEMBL18392	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	394835	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCS(=O)(=O)CC2)n1		CHEMBL97451	=	IC50	nM	390.0	CHEMBL260	Homo sapiens	IC50	nM	390.0
	394837	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CCOC(=O)N1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95931	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	394902	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	394903	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	ED50	mg.kg-1	2.6	CHEMBL260	Homo sapiens	ED50	mg kg-1	2.6
	396242	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1cc(F)ccc1-c1nc(N(C(N)=O)c2c(F)cccc2F)c2ncn(C)c2n1		CHEMBL18803	=	IC50	nM	128.0	CHEMBL260	Homo sapiens	IC50	uM	0.128
	396243	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3cccc(F)c3)nc21		CHEMBL275162	=	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	396285	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCOCC2)n1		CHEMBL330196	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	nM	230.0
	396332	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccncc3)n2)CC1		CHEMBL329469	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	nM	610.0
	398684	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CNc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL319716	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	398685	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CNc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL319716	=	ED50	mg.kg-1	6.5	CHEMBL260	Homo sapiens	ED50	mg kg-1	6.5
	399870	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CNc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL419149	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	399871	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CNc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL419149	=	ED50	mg.kg-1	3.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	3.0
	402728	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	O[C@H]1CC[C@H](n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL408876	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	404166	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	nM	480.0
	404167	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	ED50	mg.kg-1	5.2	CHEMBL260	Homo sapiens	ED50	mg kg-1	5.2
	404168	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCc3ccccc3)n2)CC1		CHEMBL95365	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	404169	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCc3ccccc3)n2)CC1		CHEMBL95365	=	ED50	mg.kg-1	10.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	10.0
	404170	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	O[C@H]1CC[C@H](n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Oc3ccccc3)n2)CC1		CHEMBL329080	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	404171	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	O[C@H]1CC[C@H](n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Oc3ccccc3)n2)CC1		CHEMBL329080	=	ED50	mg.kg-1	4.2	CHEMBL260	Homo sapiens	ED50	mg kg-1	4.2
	405576	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	405577	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	ED50	mg.kg-1	0.42	CHEMBL260	Homo sapiens	ED50	mg kg-1	0.42
	406730	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(CC(F)(F)F)CC2)n1		CHEMBL95521	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	407985	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1cc(F)ccc1-c1nc(N(C(N)=O)c2ccc(Cl)cc2)c2ncn(C)c2n1		CHEMBL280280	=	IC50	nM	9800.0	CHEMBL260	Homo sapiens	IC50	uM	9.8
	409180	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1cc(F)ccc1-c1nc(N(C(N)=O)c2ccccc2Cl)c2ncn(C)c2n1		CHEMBL18573	=	IC50	nM	123.0	CHEMBL260	Homo sapiens	IC50	uM	0.123
	409181	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3ccc(F)cc3F)nc21		CHEMBL18782	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	uM	0.026
	410414	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1cc(F)ccc1-c1nc(N(C(N)=O)c2ccc(F)cc2)c2ncn(C)c2n1		CHEMBL18382	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	411572	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	COc1ccccc1N(C(N)=O)c1nc(-c2ccc(F)cc2C)nc2c1ncn2C		CHEMBL277312	>	IC50	nM	16700.0	CHEMBL260	Homo sapiens	IC50	uM	16.7
	411651	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL97550	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	411652	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL97550	=	ED50	mg.kg-1	0.6	CHEMBL260	Homo sapiens	ED50	mg kg-1	0.6
	413962	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	NC(=O)N(c1c(F)cccc1F)c1nc(-c2ccccc2F)nc2c1ncn2Cc1ccccc1		CHEMBL17131	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	uM	0.016
	413973	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL319988	=	IC50	nM	83.0	CHEMBL260	Homo sapiens	IC50	nM	83.0
	413974	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL319988	=	ED50	mg.kg-1	7.3	CHEMBL260	Homo sapiens	ED50	mg kg-1	7.3
	413975	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(Cc3ccccc3)CC2)n1		CHEMBL329049	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	nM	8.5
	413976	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(Cc3ccccc3)CC2)n1		CHEMBL329049	=	ED50	mg.kg-1	17.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	17.0
	416449	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1cccc(-c2nc(N(C(N)=O)c3c(F)cccc3F)c3ncn(C)c3n2)c1		CHEMBL18200	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	uM	0.35
	417735	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3ccccc3)nc21		CHEMBL18617	=	IC50	nM	510.0	CHEMBL260	Homo sapiens	IC50	uM	0.51
	417748	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	417749	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	ED50	mg.kg-1	8.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	8.0
	417750	CHEMBL842192	Inhibition of p38 alpha kinase	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	417752	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	nM	86.0
	417753	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	ED50	mg.kg-1	4.4	CHEMBL260	Homo sapiens	ED50	mg kg-1	4.4
	418881	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	418882	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	ED50	mg.kg-1	16.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	16.0
	418883	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	418884	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	ED50	mg.kg-1	5.8	CHEMBL260	Homo sapiens	ED50	mg kg-1	5.8
	420053	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3ccccc3F)nc21		CHEMBL279311	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	420083	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CC(C)n1cnc(-c2ccc(F)cc2)c1-c1ccnc(N)n1		CHEMBL316917	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	nM	170.0
	420119	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	420120	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	ED50	mg.kg-1	0.84	CHEMBL260	Homo sapiens	ED50	mg kg-1	0.84
	421414	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(=O)CC2)n1		CHEMBL97604	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	421415	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(=O)CC2)n1		CHEMBL97604	=	ED50	mg.kg-1	13.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	13.0
	421478	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CC(C)Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95797	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	421479	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CC(C)Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95797	=	ED50	mg.kg-1	1.2	CHEMBL260	Homo sapiens	ED50	mg kg-1	1.2
	422904	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3cccc(Cl)c3)nc21		CHEMBL277599	=	IC50	nM	550.0	CHEMBL260	Homo sapiens	IC50	uM	0.55
	422905	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cc1ccc(-c2nc(N(C(N)=O)c3c(F)cccc3F)c3ncn(C)c3n2)cc1		CHEMBL18189	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	uM	2.1
	422906	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	CN(C)CCn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3ccccc3F)nc21		CHEMBL278179	=	IC50	nM	82.0	CHEMBL260	Homo sapiens	IC50	uM	0.082
	422951	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	IC50	nM	58.0	CHEMBL260	Homo sapiens	IC50	nM	58.0
	422952	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	ED50	mg.kg-1	9.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	9.0
	424152	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3cc(F)cc(F)c3)nc21		CHEMBL18210	>	IC50	nM	16700.0	CHEMBL260	Homo sapiens	IC50	uM	16.7
	424194	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CCNc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(C)CC2)n1		CHEMBL420081	=	IC50	nM	9.6	CHEMBL260	Homo sapiens	IC50	nM	9.6
	424195	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CCNc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(C)CC2)n1		CHEMBL420081	=	ED50	mg.kg-1	11.0	CHEMBL260	Homo sapiens	ED50	mg kg-1	11.0
	426755	CHEMBL735050	Inhibition against Mitogen-activated protein kinase p38 alpha	B	CCOc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL327949	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	426756	CHEMBL736654	Inhibition against murine TNF synthesis induced by lipopolysaccharide (LPS)	F	CCOc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL327949	=	ED50	mg.kg-1	0.25	CHEMBL260	Homo sapiens	ED50	mg kg-1	0.25
	427912	CHEMBL731491	Inhibition of human MAP p38-alpha kinase in vitro.	B	Cn1cnc2c(N(C(N)=O)c3c(F)cccc3F)nc(-c3ccccc3Cl)nc21		CHEMBL416170	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	431291	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3cccc(C(F)(F)F)c3)ccc21		CHEMBL366639	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	431292	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3cc(-c4cccnc4)[nH]c3-c3cccc(C)c3)ccc21		CHEMBL171392	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	432681	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3c[nH]nc3-c3ccccc3)ccc21		CHEMBL170830	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	432682	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3ocnc3-c3cccc(C)c3)ccc21		CHEMBL369668	=	IC50	nM	800.0	CHEMBL260	Homo sapiens	IC50	uM	0.8
	434009	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3cccc(Cl)c3)ccc21		CHEMBL435669	=	IC50	nM	380.0	CHEMBL260	Homo sapiens	IC50	uM	0.38
	434010	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3c[nH]nc3-c3ccccc3)ccc21		CHEMBL427114	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	434011	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	C[C@H](Nc1cc(-c2c(-c3cccc(C(F)(F)F)c3)nc(C3CCNCC3)n2C)ccn1)c1ccccc1		CHEMBL303144	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	435233	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3[nH]cnc3-c3ccc(F)cc3)ccc21		CHEMBL368200	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	435234	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3ccccc3)ccc21		CHEMBL172882	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	435235	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CC(C)c1cccc(-c2[nH]c(-c3cccs3)nc2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL353254	>	IC50	nM	32000.0	CHEMBL260	Homo sapiens	IC50	uM	32.0
	436565	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3[nH]ncc3-c3cccc(C)c3)ccc21		CHEMBL354901	=	IC50	nM	730.0	CHEMBL260	Homo sapiens	IC50	uM	0.73
	437746	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3ccccc3Cl)ccc21		CHEMBL366605	=	IC50	nM	540.0	CHEMBL260	Homo sapiens	IC50	uM	0.54
	437747	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1ccccc1-c1nc(-c2cccs2)[nH]c1-c1ccc2c(c1)n(C)c(=O)n2C		CHEMBL170947	=	IC50	nM	6200.0	CHEMBL260	Homo sapiens	IC50	uM	6.2
	437748	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-n3nnnc3-c3ccc(F)c(C)c3)ccc21		CHEMBL368350	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	439199	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3c[nH]cn3)ccc21		CHEMBL174122	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	439200	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3cccc(F)c3)ccc21		CHEMBL170535	=	IC50	nM	390.0	CHEMBL260	Homo sapiens	IC50	uM	0.39
	439201	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	uM	0.052
	439202	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)ccc21		CHEMBL355790	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	440435	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3ccc(F)cc3)ccc21		CHEMBL174257	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	uM	0.27
	440436	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1cccc(-c2[nH]c3nc(N)ccc3c2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL368455	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	441739	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3c[nH]nc3-c3ccc(F)c(C)c3)ccc21		CHEMBL353427	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	441740	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3c(-c4cccc(C)c4)nc(C4CCNCC4)n3C)ccc21		CHEMBL369404	=	IC50	nM	1250.0	CHEMBL260	Homo sapiens	IC50	uM	1.25
	443119	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3ccccc3F)ccc21		CHEMBL368397	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	uM	0.37
	443120	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3[nH]c(-c4cccnc4)nc3-c3cccc(C)c3)ccc21		CHEMBL172286	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	444506	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3cccc(OC(F)(F)F)c3)ccc21		CHEMBL368653	=	IC50	nM	15800.0	CHEMBL260	Homo sapiens	IC50	uM	15.8
	445861	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCc1cccc(-c2[nH]c(-c3cccs3)nc2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL173908	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	445862	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3[nH]ncc3-c3ccccc3)ccc21		CHEMBL367111	=	IC50	nM	680.0	CHEMBL260	Homo sapiens	IC50	uM	0.68
	447284	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]cnc3-c3ccc(F)cc3)ccc21		CHEMBL355528	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	449809	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]ncc3-c3ccccc3)ccc21		CHEMBL367872	=	IC50	nM	2500.0	CHEMBL260	Homo sapiens	IC50	uM	2.5
	451063	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1cccc(-c2nc[nH]c2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL355529	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	452395	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1ccc(-c2nc(-c3cccs3)[nH]c2-c2ccc3c(c2)n(C)c(=O)n3C)cc1		CHEMBL174461	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	uM	1.8
	452396	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4ccc([S+](C)[O-])cc4)nc3-c3ccc(F)cc3)ccc21		CHEMBL367957	=	IC50	nM	4000.0	CHEMBL260	Homo sapiens	IC50	uM	4.0
	452397	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	455073	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]cnc3-c3ccccc3)ccc21		CHEMBL366533	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	455074	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1cccc(-c2nncn2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL367242	=	IC50	nM	12500.0	CHEMBL260	Homo sapiens	IC50	uM	12.5
	455075	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3cccnc3-c3cccc(C)c3)ccc21		CHEMBL170836	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	458987	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3[nH]cnc3-c3cccc(C)c3)ccc21		CHEMBL170631	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	458988	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cn1c(=O)n(C)c2cc(-c3[nH]c(-c4cccs4)nc3-c3ccc(Cl)cc3)ccc21		CHEMBL368543	=	IC50	nM	680.0	CHEMBL260	Homo sapiens	IC50	uM	0.68
	458989	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3nnnn3-c3ccc(F)c(C)c3)ccc21		CHEMBL173787	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	458990	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1cccc(-n2cncc2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL354380	=	IC50	nM	14400.0	CHEMBL260	Homo sapiens	IC50	uM	14.4
	461547	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3[nH]cnc3-c3ccccc3)ccc21		CHEMBL368345	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	461548	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3c[nH]nc3-c3cccc(C)c3)ccc21		CHEMBL355703	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	462727	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3c[nH]nc3-c3cccc(C(F)(F)F)c3)ccc21		CHEMBL172689	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	462728	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCn1c(=O)n(CC)c2cc(-c3ccnn3-c3cccc(C)c3)ccc21		CHEMBL171242	=	IC50	nM	690.0	CHEMBL260	Homo sapiens	IC50	uM	0.69
	462729	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	466732	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1cccc(-c2nc(C3CCNCC3)[nH]c2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL172232	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	468027	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1cccc(-c2nc(-c3cccnc3)[nH]c2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL353440	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	469509	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	CCc1ccc(-c2[nH]c(-c3cccs3)nc2-c2ccc3c(c2)n(C)c(=O)n3C)cc1		CHEMBL366976	=	IC50	nM	8000.0	CHEMBL260	Homo sapiens	IC50	uM	8.0
	472296	CHEMBL734272	Inhibitory activity against mitogen activated protein (MAP) kinase p38 alpha.	B	Cc1cccc(-c2nc(-c3cccs3)[nH]c2-c2ccc3c(c2)n(C)c(=O)n3C)c1		CHEMBL173857	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	514193	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Nc1ccccc1Nc1ccc(C(=O)c2ccccc2)cc1		CHEMBL152596	=	IC50	nM	145.0	CHEMBL260	Homo sapiens	IC50	nM	145.0
	516661	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	COc1ccccc1C(=O)c1ccc(Nc2ccccc2N)cc1Cl		CHEMBL356455	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	517902	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	C=C(c1ccccc1C)c1ccc(Nc2ccccc2N)cc1Cl		CHEMBL152403	=	IC50	nM	1550.0	CHEMBL260	Homo sapiens	IC50	nM	1550.0
	519264	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2[N+](=O)[O-])cc1Cl		CHEMBL347576	=	IC50	nM	437.0	CHEMBL260	Homo sapiens	IC50	nM	437.0
	519267	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1cccc(C(=O)c2ccc(Nc3ccccc3N)cc2)c1		CHEMBL152209	=	IC50	nM	574.0	CHEMBL260	Homo sapiens	IC50	nM	574.0
	521892	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2)cc1Cl		CHEMBL155567	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	523176	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1Cc1ccc(Nc2ccc(F)cc2N)cc1Cl		CHEMBL153795	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
	524486	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1Nc1ccc(C(=O)c2ccccc2C)c(Cl)c1		CHEMBL153265	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	527047	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2N)cc1		CHEMBL357732	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	527050	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1cc(C(=O)c2ccccc2C)ccc1Nc1ccccc1N		CHEMBL356157	=	IC50	nM	143.0	CHEMBL260	Homo sapiens	IC50	nM	143.0
	528421	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1cc(F)ccc1Nc1ccc(C(=O)c2ccccc2C)c(Cl)c1		CHEMBL152208	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	528422	CHEMBL733325	Inhibition of Mitogen-activated protein kinase p38 alpha at 1 uM	B	Cc1cc(F)ccc1Nc1ccc(C(=O)c2ccccc2C)c(Cl)c1		CHEMBL152208	=	Inhibition	%	88.0	CHEMBL260	Homo sapiens	Inhibition	%	88.0
	529872	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl		CHEMBL347496	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	nM	39.0
	529873	CHEMBL733325	Inhibition of Mitogen-activated protein kinase p38 alpha at 1 uM	B	Cc1ccccc1C(=O)c1ccc(Nc2ccc(Br)cc2N)cc1Cl		CHEMBL347496	=	Inhibition	%	82.0	CHEMBL260	Homo sapiens	Inhibition	%	82.0
	532524	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccncc2)cc1		CHEMBL279416	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	532525	CHEMBL733325	Inhibition of Mitogen-activated protein kinase p38 alpha at 1 uM	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccncc2)cc1		CHEMBL279416	=	Inhibition	%	73.0	CHEMBL260	Homo sapiens	Inhibition	%	73.0
	535188	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Nc1ccccc1Nc1ccc(C(=O)c2ccccc2-c2ccccc2)cc1		CHEMBL356809	=	IC50	nM	811.0	CHEMBL260	Homo sapiens	IC50	nM	811.0
	535197	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2N)cc1Cl		CHEMBL152767	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	535198	CHEMBL733325	Inhibition of Mitogen-activated protein kinase p38 alpha at 1 uM	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2N)cc1Cl		CHEMBL152767	=	Inhibition	%	88.0	CHEMBL260	Homo sapiens	Inhibition	%	88.0
	536521	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	539065	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	O=C(c1ccccc1)c1ccc(Nc2ccccc2)cc1		CHEMBL152349	=	IC50	nM	193.0	CHEMBL260	Homo sapiens	IC50	nM	193.0
	541701	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1C(=O)c1ccc(N(C)c2ccccc2N)cc1Cl		CHEMBL347770	=	IC50	nM	101.0	CHEMBL260	Homo sapiens	IC50	nM	101.0
	543119	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1ccccc1Nc1ccc(C(=O)c2ccccc2C)c(Cl)c1		CHEMBL422510	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	nM	63.0
	544292	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Nc1ccccc1Nc1ccc(C(=O)c2ccccc2Br)cc1		CHEMBL152440	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	nM	54.0
	545571	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2N)cc1C		CHEMBL152820	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	547126	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	CCNC(=O)Nc1ccccc1Nc1ccc(C(=O)c2ccccc2C)c(Cl)c1		CHEMBL155508	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	550399	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	CCOC(=O)Nc1ccccc1Nc1ccc(C(=O)c2ccccc2C)c(Cl)c1		CHEMBL153012	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	552970	CHEMBL732094	In vitro inhibitory activity determined against human mitogen-activated protein kinase p38 alpha	B	Nc1ccccc1Nc1ccc(C(=O)c2ccccc2)c(Cl)c1		CHEMBL155448	=	IC50	nM	139.0	CHEMBL260	Homo sapiens	IC50	nM	139.0
	554906	CHEMBL812937	Inhibition of SAPK2a in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	558956	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Nc1ncnc2c1cc(-c1ccncc1)n2-c1ccc(F)cc1		CHEMBL142682	=	IC50	nM	3300.0	CHEMBL260	Homo sapiens	IC50	nM	3300.0
	559750	CHEMBL812938	Inhibition of SAPK2a in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	560175	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	COn1c(-c2ccncc2)c(-c2ccc(F)cc2)c2ncccc21		CHEMBL358548	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	nM	68.0
	561062	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	CCn1c(-c2ccncc2)c(-c2ccc(F)cc2)c2ncccc21		CHEMBL342503	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	561064	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)n(CCN3CCOCC3)c3cccnc23)cc1		CHEMBL141999	=	IC50	nM	185.0	CHEMBL260	Homo sapiens	IC50	nM	185.0
	561066	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)n(CCN3CCCC3)c3cccnc23)cc1		CHEMBL143389	=	IC50	nM	217.0	CHEMBL260	Homo sapiens	IC50	nM	217.0
	564672	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)n(CCN3CCCCC3)c3cccnc23)cc1		CHEMBL358718	=	IC50	nM	1970.0	CHEMBL260	Homo sapiens	IC50	nM	1970.0
	566994	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	OCCCCNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL142753	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	569602	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)[nH]c3ccncc23)cc1		CHEMBL343873	=	IC50	nM	3100.0	CHEMBL260	Homo sapiens	IC50	nM	3100.0
	570938	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	OCCn1c(-c2ccncc2)c(-c2ccc(F)cc2)c2ncccc21		CHEMBL356355	=	IC50	nM	172.0	CHEMBL260	Homo sapiens	IC50	nM	172.0
	572993	CHEMBL812938	Inhibition of SAPK2a in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	Inhibition	%	12.0
	573407	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Cn1c(-c2ccncc2)c(-c2ccc(F)cc2)c2ncccc21		CHEMBL336002	=	IC50	nM	98.0	CHEMBL260	Homo sapiens	IC50	nM	98.0
	574556	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)[nH]c3cncnc23)cc1		CHEMBL142381	=	IC50	nM	895.0	CHEMBL260	Homo sapiens	IC50	nM	895.0
	578247	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	C[C@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL142425	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	578259	CHEMBL734077	Inhibition of Mitogen-activated protein kinase p38 alpha	B	C[C@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL142425	=	IC50	nM	1.29	CHEMBL260	Homo sapiens	IC50	nM	1.29
	579494	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	OCCNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL143476	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	580678	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)[nH]c3nccnc23)cc1		CHEMBL143307	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	580680	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	C[C@@H](O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL358537	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	580692	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	581836	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	O=C(O)Cn1c(-c2ccncc2)c(-c2ccc(F)cc2)c2ncccc21		CHEMBL343481	=	IC50	nM	23600.0	CHEMBL260	Homo sapiens	IC50	nM	23600.0
	585598	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)[nH]c3cccnc23)cc1		CHEMBL344955	=	IC50	nM	6.5	CHEMBL260	Homo sapiens	IC50	nM	6.5
	585600	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)oc3cccnc23)cc1		CHEMBL142523	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	nM	86.0
	586384	CHEMBL812937	Inhibition of SAPK2a in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	Inhibition	%	1.0
	588032	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	COCCn1c(-c2ccncc2)c(-c2ccc(F)cc2)c2ncccc21		CHEMBL356756	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	589337	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)[nH]c3ccccc23)cc1		CHEMBL345095	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	nM	1800.0
	589338	CHEMBL732624	In vitro inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	CCC(O)CNc1cc(-c2[nH]c3cccnc3c2-c2ccc(F)cc2)ccn1		CHEMBL142367	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	590222	CHEMBL812939	Inhibition of SAPK2a in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	616603	CHEMBL735051	Inhibition of Mitogen-activated protein kinase p38 alpha	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	IC50	nM	20200.0	CHEMBL260	Homo sapiens	IC50	uM	20.2
	676041	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)no1		CHEMBL302379	=	Inhibition	%	88.0	CHEMBL260	Homo sapiens	Inhibition	%	88.0
	676042	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)no1		CHEMBL302379	=	IC50	nM	58.0	CHEMBL260	Homo sapiens	IC50	nM	58.0
	676044	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	Cc1c(C(C)(C)C)noc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL62120	=	Inhibition	%	18.0	CHEMBL260	Homo sapiens	Inhibition	%	18.0
	678607	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CCCCc1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL63101	=	Inhibition	%	33.0	CHEMBL260	Homo sapiens	Inhibition	%	33.0
	678608	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CCCCc1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL63101	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	679719	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	O=C(Nc1cc(C2CCC2)no1)Nc1cccc(Cl)c1Cl		CHEMBL291413	=	Inhibition	%	57.0	CHEMBL260	Homo sapiens	Inhibition	%	57.0
	679720	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	O=C(Nc1cc(C2CCC2)no1)Nc1cccc(Cl)c1Cl		CHEMBL291413	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	nM	370.0
	681140	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)Cc1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL62008	=	Inhibition	%	81.0	CHEMBL260	Homo sapiens	Inhibition	%	81.0
	681141	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)Cc1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL62008	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	682770	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(=O)Nc1cccc(NC(=O)Nc2cc(C(C)(C)C)no2)c1		CHEMBL2114474	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	Inhibition	%	11.0
	684089	CHEMBL735049	Inhibition of Mitogen-activated protein kinase p38 alpha	B	C[S+]([O-])c1ccc(-c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1		CHEMBL88486	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	684184	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1nnc(NC(=O)Nc2cccc(Cl)c2Cl)s1		CHEMBL65775	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	Inhibition	%	1.0
	686711	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)on1		CHEMBL62009	=	Inhibition	%	41.0	CHEMBL260	Homo sapiens	Inhibition	%	41.0
	688096	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1ccc(NC(=O)Nc2cccc(Cl)c2Cl)s1		CHEMBL64510	=	Inhibition	%	82.0	CHEMBL260	Homo sapiens	Inhibition	%	82.0
	688097	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1ccc(NC(=O)Nc2cccc(Cl)c2Cl)s1		CHEMBL64510	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	688098	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CCC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL304936	=	Inhibition	%	83.0	CHEMBL260	Homo sapiens	Inhibition	%	83.0
	688099	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CCC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL304936	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	689540	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	Cc1c(C(C)C)noc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL64644	=	Inhibition	%	34.0	CHEMBL260	Homo sapiens	Inhibition	%	34.0
	689541	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	Cc1c(C(C)C)noc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL64644	=	IC50	nM	920.0	CHEMBL260	Homo sapiens	IC50	nM	920.0
	690752	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)on1		CHEMBL61510	=	Inhibition	%	68.0	CHEMBL260	Homo sapiens	Inhibition	%	68.0
	690753	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)on1		CHEMBL61510	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	nM	260.0
	692053	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL61628	=	Inhibition	%	62.0	CHEMBL260	Homo sapiens	Inhibition	%	62.0
	692054	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL61628	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	nM	290.0
	694378	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2C(F)(F)F)no1		CHEMBL293429	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	Inhibition	%	9.0
	694379	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(=O)Nc1cccc(NC(=O)Nc2cc(C(C)(C)C)on2)c1		CHEMBL62484	=	Inhibition	%	18.0	CHEMBL260	Homo sapiens	Inhibition	%	18.0
	697431	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	Cc1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL65193	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	Inhibition	%	4.0
	698967	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(C(F)(F)F)cc2)no1		CHEMBL63115	=	Inhibition	%	39.0	CHEMBL260	Homo sapiens	Inhibition	%	39.0
	698968	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	Cc1cccc(NC(=O)Nc2cc(C(C)(C)C)no2)c1C		CHEMBL62891	=	Inhibition	%	49.0	CHEMBL260	Homo sapiens	Inhibition	%	49.0
	700253	CHEMBL735049	Inhibition of Mitogen-activated protein kinase p38 alpha	B	CS(=O)(=O)c1ccc(-c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1		CHEMBL316275	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	702714	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL292482	=	Inhibition	%	93.0	CHEMBL260	Homo sapiens	Inhibition	%	93.0
	702715	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)on1		CHEMBL292482	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	704131	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(=O)Nc1ccc(NC(=O)Nc2cc(C(C)(C)C)no2)cc1		CHEMBL2114473	=	Inhibition	%	20.0	CHEMBL260	Homo sapiens	Inhibition	%	20.0
	705345	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)cs1		CHEMBL64075	=	Inhibition	%	76.0	CHEMBL260	Homo sapiens	Inhibition	%	76.0
	705346	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)cs1		CHEMBL64075	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	705347	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(C(F)(F)F)cc2)on1		CHEMBL62946	=	Inhibition	%	77.0	CHEMBL260	Homo sapiens	Inhibition	%	77.0
	705348	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(C(F)(F)F)cc2)on1		CHEMBL62946	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	706787	CHEMBL735049	Inhibition of Mitogen-activated protein kinase p38 alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	706847	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	33.0	CHEMBL260	Homo sapiens	Inhibition	%	33.0
	706848	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)no1		CHEMBL59652	=	Inhibition	%	74.0	CHEMBL260	Homo sapiens	Inhibition	%	74.0
	706849	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)no1		CHEMBL59652	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	nM	190.0
	706850	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	Cc1cc(F)ccc1-c1cc(N(C(N)=O)c2c(Cl)cccc2Cl)ccc1CO		CHEMBL62794	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	708012	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	O=C(Nc1cc(C23CC4CC(CC(C4)C2)C3)no1)Nc1cccc(Cl)c1Cl		CHEMBL305314	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	Inhibition	%	9.0
	708013	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2cc(Br)cc(Br)c2)no1		CHEMBL62665	=	IC50	nM	710.0	CHEMBL260	Homo sapiens	IC50	nM	710.0
	708014	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(=O)Nc1ccc(NC(=O)Nc2cc(C(C)(C)C)on2)cc1		CHEMBL293607	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	Inhibition	%	14.0
	708015	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	NC(=O)c1ccccc1NC(=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL62788	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	nM	100.0
	709334	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)c(Cl)c2)on1		CHEMBL65671	=	Inhibition	%	62.0	CHEMBL260	Homo sapiens	Inhibition	%	62.0
	709335	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)c(Cl)c2)on1		CHEMBL65671	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	nM	220.0
	709368	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	710690	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2C(F)(F)F)no1		CHEMBL59651	=	Inhibition	%	36.0	CHEMBL260	Homo sapiens	Inhibition	%	36.0
	711935	CHEMBL732963	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 expressed in Escherichia coli.	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL41653	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	713226	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	CCC(C)(C)c1noc(NC(=O)Nc2cccc(Cl)c2Cl)c1C		CHEMBL293246	=	Inhibition	%	18.0	CHEMBL260	Homo sapiens	Inhibition	%	18.0
	713227	CHEMBL731908	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2 (expressed Escherichia coli) at concentration of 500 nM	B	Cc1cccc(NC(=O)Nc2cc(C(C)(C)C)on2)c1C		CHEMBL62893	=	Inhibition	%	54.0	CHEMBL260	Homo sapiens	Inhibition	%	54.0
	750650	CHEMBL731490	Inhibition of Mitogen-activated protein kinase p38 alpha	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	753744	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Sc2ccc(O)cc2)cc1		CHEMBL290971	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	756949	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CC(=O)Nc1ccc(Cc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL416425	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	nM	70.0
	758191	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cc1ccc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL39251	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	759156	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Sc2ccncc2)cc1		CHEMBL41723	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	759162	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(SCc2ccncc2)cc1		CHEMBL37353	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	nM	140.0
	759163	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Nc2ccncc2)cc1		CHEMBL289357	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	nM	420.0
	760239	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ccccc2)cc1		CHEMBL41970	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	nM	270.0
	761371	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CC(C)CC(=O)Nc1ccc(Cc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL415679	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	nM	37.0
	762379	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ccc(C(C)(C)C)cc2)cc1		CHEMBL289056	=	IC50	nM	183.0	CHEMBL260	Homo sapiens	IC50	nM	183.0
	763488	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ccc(N)cc2)cc1		CHEMBL41266	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	nM	310.0
	763489	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cc2ccncc2)cc1		CHEMBL288812	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	764537	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CC(C)OC(=O)Nc1ccc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL288663	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	nM	54.0
	765699	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ccc(OCc3ccccc3)cc2)cc1		CHEMBL38084	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	765700	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CC(=O)Nc1ccc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL289155	=	IC50	nM	235.0	CHEMBL260	Homo sapiens	IC50	nM	235.0
	765701	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CCCCOc1ccc(Sc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL38548	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	nM	69.0
	767769	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	767778	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CCC(=O)Nc1ccc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL288889	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	nM	69.0
	769044	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cc2ccc(NC(=O)CCC(=O)O)cc2)cc1		CHEMBL40020	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	769046	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(CSc2ccncc2)cc1		CHEMBL40138	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	770006	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cc2ccc(N)cc2)cc1		CHEMBL39931	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	nM	290.0
	771159	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL41653	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	773601	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CC(C)CC(=O)Nc1ccc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL40166	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	774707	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(CCc2ccncc2)cc1		CHEMBL38648	=	IC50	nM	430.0	CHEMBL260	Homo sapiens	IC50	nM	430.0
	775883	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CCOC(=O)Nc1ccc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL41310	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	782474	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CCC(=O)Nc1ccc(Cc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL290982	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	783615	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cc2ccc(NC(=O)OC(C)(C)C)cc2)cc1		CHEMBL38625	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	nM	87.0
	784691	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	CCCOc1ccc(Sc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3C)cc2)cc1		CHEMBL288891	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	nM	57.0
	785918	CHEMBL731497	Inhibitory activity against Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCc2ccncc2)cc1		CHEMBL39136	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	nM	260.0
	789005	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CNC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL18520	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
	790227	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL278737	=	Inhibition	%	76.0	CHEMBL260	Homo sapiens	Inhibition	%	76.0
	790228	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL278737	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	nM	220.0
	791705	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL279377	=	Inhibition	%	94.0	CHEMBL260	Homo sapiens	Inhibition	%	94.0
	791706	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL279377	=	IC50	nM	413.0	CHEMBL260	Homo sapiens	IC50	nM	413.0
	791707	CHEMBL754534	Inhibition of p38 alpha-2 kinase	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL279377	=	IC50	nM	248.0	CHEMBL260	Homo sapiens	IC50	nM	248.0
	791710	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc([N+](=O)[O-])cc1		CHEMBL18798	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	Inhibition	%	16.0
	792922	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1		CHEMBL19045	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	Inhibition	%	95.0
	792923	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1		CHEMBL19045	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	793992	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)sc2C(=O)OCCCO)cc1		CHEMBL18282	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
	794960	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C(C)C)cc1		CHEMBL18789	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	Inhibition	%	10.0
	794961	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccccc1		CHEMBL429973	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	796244	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	CNC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL279128	=	Inhibition	%	80.0	CHEMBL260	Homo sapiens	Inhibition	%	80.0
	796245	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CNC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL279128	=	IC50	nM	88.0	CHEMBL260	Homo sapiens	IC50	nM	88.0
	796246	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(O)cc1		CHEMBL279560	=	Inhibition	%	44.0	CHEMBL260	Homo sapiens	Inhibition	%	44.0
	796247	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(O)cc1		CHEMBL279560	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	nM	610.0
	797361	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CCOC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL275580	=	IC50	nM	3020.0	CHEMBL260	Homo sapiens	IC50	nM	3020.0
	797362	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CCCOC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL278275	=	IC50	nM	482.0	CHEMBL260	Homo sapiens	IC50	nM	482.0
	798452	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL278506	=	Inhibition	%	79.0	CHEMBL260	Homo sapiens	Inhibition	%	79.0
	798453	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL278506	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
	798454	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL18743	=	Inhibition	%	92.0	CHEMBL260	Homo sapiens	Inhibition	%	92.0
	798455	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL18743	=	IC50	nM	43.0	CHEMBL260	Homo sapiens	IC50	nM	43.0
	798456	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	CNC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc2ccccc12		CHEMBL18103	=	Inhibition	%	96.0	CHEMBL260	Homo sapiens	Inhibition	%	96.0
	798457	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CNC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc2ccccc12		CHEMBL18103	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	799754	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1c(NC(=O)Nc2ccccc2)cc(C(C)(C)C)n1C		CHEMBL279342	=	Inhibition	%	32.0	CHEMBL260	Homo sapiens	Inhibition	%	32.0
	799755	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1c(NC(=O)Nc2ccccc2)cc(C(C)(C)C)n1C		CHEMBL279342	=	IC50	nM	947.0	CHEMBL260	Homo sapiens	IC50	nM	947.0
	800811	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)sc2C(=O)OC(C)C)cc1		CHEMBL19086	=	IC50	nM	741.0	CHEMBL260	Homo sapiens	IC50	nM	741.0
	800812	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(N)cc1		CHEMBL18942	=	Inhibition	%	40.0	CHEMBL260	Homo sapiens	Inhibition	%	40.0
	800813	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(N)cc1		CHEMBL18942	=	IC50	nM	750.0	CHEMBL260	Homo sapiens	IC50	nM	750.0
	800814	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1c(NC(=O)Nc2cccc(Cl)c2Cl)cc(C(C)(C)C)n1C		CHEMBL19057	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	Inhibition	%	50.0
	800815	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1c(NC(=O)Nc2cccc(Cl)c2Cl)cc(C(C)(C)C)n1C		CHEMBL19057	=	IC50	nM	387.0	CHEMBL260	Homo sapiens	IC50	nM	387.0
	802167	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(CCC(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL18510	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	Inhibition	%	8.0
	803329	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	CCc1ccc(NC(=O)Nc2cc(C(C)(C)C)sc2C(=O)NC)cc1		CHEMBL18752	=	Inhibition	%	70.0	CHEMBL260	Homo sapiens	Inhibition	%	70.0
	803330	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CCc1ccc(NC(=O)Nc2cc(C(C)(C)C)sc2C(=O)NC)cc1		CHEMBL18752	=	IC50	nM	119.0	CHEMBL260	Homo sapiens	IC50	nM	119.0
	804573	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	CCc1ccc(NC(=O)Nc2cc(C(C)(C)C)sc2C(=O)OC)cc1		CHEMBL18763	=	Inhibition	%	40.0	CHEMBL260	Homo sapiens	Inhibition	%	40.0
	804574	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CCc1ccc(NC(=O)Nc2cc(C(C)(C)C)sc2C(=O)OC)cc1		CHEMBL18763	=	IC50	nM	660.0	CHEMBL260	Homo sapiens	IC50	nM	660.0
	805954	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccccc2)cc1		CHEMBL428515	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	Inhibition	%	6.0
	805955	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL18286	=	Inhibition	%	67.0	CHEMBL260	Homo sapiens	Inhibition	%	67.0
	805956	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL18286	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	nM	210.0
	807295	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL278719	=	IC50	nM	73.0	CHEMBL260	Homo sapiens	IC50	nM	73.0
	807298	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL18764	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	807301	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL18525	=	Inhibition	%	97.0	CHEMBL260	Homo sapiens	Inhibition	%	97.0
	807302	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL18525	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	808622	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(NC(C)=O)cc1		CHEMBL19156	=	Inhibition	%	23.0	CHEMBL260	Homo sapiens	Inhibition	%	23.0
	808623	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL278057	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	nM	1200.0
	808624	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc2ccccc12		CHEMBL278924	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	808627	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1c(NC(=O)Nc2cccc3ccccc23)cc(C(C)(C)C)n1C		CHEMBL417819	=	Inhibition	%	67.0	CHEMBL260	Homo sapiens	Inhibition	%	67.0
	808628	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1c(NC(=O)Nc2cccc3ccccc23)cc(C(C)(C)C)n1C		CHEMBL417819	=	IC50	nM	253.0	CHEMBL260	Homo sapiens	IC50	nM	253.0
	809884	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(-c2ccccc2)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL18991	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	811134	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	COC(=O)COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL278668	=	IC50	nM	5310.0	CHEMBL260	Homo sapiens	IC50	nM	5310.0
	811135	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CNC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL18754	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	811138	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL18950	=	Inhibition	%	99.0	CHEMBL260	Homo sapiens	Inhibition	%	99.0
	811139	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL18950	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	812356	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(N)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL280059	=	Inhibition	%	90.0	CHEMBL260	Homo sapiens	Inhibition	%	90.0
	812357	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	COC(=O)c1sc(N)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL280059	=	IC50	nM	441.0	CHEMBL260	Homo sapiens	IC50	nM	441.0
	812358	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccccc1		CHEMBL19148	=	Inhibition	%	68.0	CHEMBL260	Homo sapiens	Inhibition	%	68.0
	812359	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccccc1		CHEMBL19148	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	nM	290.0
	812360	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	813651	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	CNC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C(C)C)cc1		CHEMBL19040	=	Inhibition	%	63.0	CHEMBL260	Homo sapiens	Inhibition	%	63.0
	813652	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CNC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C(C)C)cc1		CHEMBL19040	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	nM	270.0
	814846	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)sc2C(=O)OCCO)cc1		CHEMBL277806	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	nM	57.0
	814847	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL18541	=	Inhibition	%	35.0	CHEMBL260	Homo sapiens	Inhibition	%	35.0
	814848	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL18541	=	IC50	nM	830.0	CHEMBL260	Homo sapiens	IC50	nM	830.0
	814849	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C(=O)O)cc1		CHEMBL274234	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	Inhibition	%	4.0
	814850	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C(C)=O)cc1		CHEMBL18633	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	Inhibition	%	21.0
	815990	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL18848	=	Inhibition	%	37.0	CHEMBL260	Homo sapiens	Inhibition	%	37.0
	815991	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CNC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL416543	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	815992	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1c(NC(=O)Nc2ccc(F)cc2)cc(C(C)(C)C)n1C		CHEMBL18709	=	Inhibition	%	42.0	CHEMBL260	Homo sapiens	Inhibition	%	42.0
	815993	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1c(NC(=O)Nc2ccc(F)cc2)cc(C(C)(C)C)n1C		CHEMBL18709	=	IC50	nM	663.0	CHEMBL260	Homo sapiens	IC50	nM	663.0
	818476	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL18771	=	Inhibition	%	89.0	CHEMBL260	Homo sapiens	Inhibition	%	89.0
	818477	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccc(F)cc1		CHEMBL18771	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	818480	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	CNC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL18908	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	Inhibition	%	95.0
	818481	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	CNC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL18908	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	819655	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1c(NC(=O)Nc2ccc(C)cc2)cc(C(C)(C)C)n1C		CHEMBL18852	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	820740	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(OC)cc1		CHEMBL278976	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	Inhibition	%	8.0
	821759	CHEMBL731495	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	COCCOC(=O)c1sc(C(C)(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL278646	=	IC50	nM	464.0	CHEMBL260	Homo sapiens	IC50	nM	464.0
	822971	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(C(C)(C)O)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL276369	=	Inhibition	%	34.0	CHEMBL260	Homo sapiens	Inhibition	%	34.0
	825433	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(CC(C)C)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL18619	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	825434	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc(CCc2ccccc2)cc1NC(=O)Nc1ccc(C)cc1		CHEMBL273554	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	Inhibition	%	17.0
	825435	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccccc1Cl		CHEMBL18770	=	Inhibition	%	85.0	CHEMBL260	Homo sapiens	Inhibition	%	85.0
	825436	CHEMBL731494	In vitro inhibition of mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli	B	COC(=O)c1[nH]c(C(C)(C)C)cc1NC(=O)Nc1ccccc1Cl		CHEMBL18770	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	nM	60.0
	826693	CHEMBL731496	Percent inhibition determined in vitro against mitogen-activated protein kinase p38 alpha 2 derived from Escherichia coli at 5 uM	B	COC(=O)c1sc([N+](=O)[O-])cc1NC(=O)Nc1ccc(C)cc1		CHEMBL416171	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	829603	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL129677	=	IC50	nM	78.0	CHEMBL260	Homo sapiens	IC50	uM	0.078
	829607	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2n[nH]cc2-c2ccc(O)cc2)n1		CHEMBL118928	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	uM	0.56
	831893	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2[nH]ncc2-c2ccc(F)c(F)c2)n1		CHEMBL126789	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	831897	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	COc1ccc(-c2cn(C)nc2-c2cccc(C)n2)cc1		CHEMBL129760	=	IC50	nM	5400.0	CHEMBL260	Homo sapiens	IC50	uM	5.4
	832940	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Brc1cccc(-c2[nH]ncc2-c2ccnc3ccccc23)n1		CHEMBL341280	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	834148	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Clc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL341534	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	837828	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2[nH]nc(C)c2-c2ccnc3ccccc23)n1		CHEMBL129153	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	837832	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2[nH]ncc2-c2ccccc2)n1		CHEMBL129553	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	840230	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	FC(F)(F)c1cccc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL129678	=	IC50	nM	6.8	CHEMBL260	Homo sapiens	IC50	uM	0.0068
	840234	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(Cn2cc(-c3ccnc4ccccc34)c(-c3ccccn3)n2)cc1		CHEMBL126180	=	IC50	nM	510.0	CHEMBL260	Homo sapiens	IC50	uM	0.51
	842728	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Fc1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL337978	=	IC50	nM	6800.0	CHEMBL260	Homo sapiens	IC50	uM	6.8
	848687	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(-c2c[nH]nc2-c2ccccn2)cc1		CHEMBL129280	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	848691	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2[nH]ncc2-c2ccc(F)cc2)n1		CHEMBL125846	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	850974	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2[nH]ncc2-c2ccc(Cl)cc2)n1		CHEMBL125738	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	852088	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)cc1		CHEMBL126676	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	856561	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	Fc1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL340203	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	857658	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(-c2n[nH]c(C3CC3)c2-c2ccnc3ccccc23)nc1		CHEMBL338196	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	860103	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(-c2c[nH]nc2-c2ccnc3ccccc23)nc1		CHEMBL338713	=	IC50	nM	7700.0	CHEMBL260	Homo sapiens	IC50	uM	7.7
	863495	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	c1csc(-c2n[nH]cc2-c2ccnc3ccccc23)c1		CHEMBL130025	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	864845	CHEMBL732623	In vitro inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	740.0	CHEMBL260	Homo sapiens	IC50	uM	0.74
	987530	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	COc1cc2[nH]ccc2cc1C(=O)N1C[C@H](C)N(Cc2ccccc2)C[C@H]1C		CHEMBL105082	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	989879	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	O=C(c1cccc2cc[nH]c12)N1CCN(Cc2ccccc2)CC1		CHEMBL104704	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	991031	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	C[C@H]1CN(C(=O)c2ccc3[nH]ccc3c2)[C@H](C)CN1Cc1ccccc1		CHEMBL106118	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	993248	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	COc1cc2[nH]ccc2cc1C(=O)N1CCN(Cc2ccccc2)CC1		CHEMBL106328	=	IC50	nM	950.0	CHEMBL260	Homo sapiens	IC50	uM	0.95
	995854	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	O=C(c1ccc2[nH]ccc2c1)N1CCN(Cc2ccccc2)CC1		CHEMBL320069	=	IC50	nM	4360.0	CHEMBL260	Homo sapiens	IC50	uM	4.36
	997111	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	O=C(c1cccc2[nH]ccc12)N1CCN(Cc2ccccc2)CC1		CHEMBL105802	=	IC50	nM	1540.0	CHEMBL260	Homo sapiens	IC50	uM	1.54
	1000688	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	O=C(c1ccc2cc[nH]c2c1)N1CCN(Cc2ccccc2)CC1		CHEMBL419355	=	IC50	nM	5520.0	CHEMBL260	Homo sapiens	IC50	uM	5.52
	1003173	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	COc1cc2[nH]ccc2cc1C(=O)N1C[C@H](C)N(Cc2ccccc2)C[C@H]1C		CHEMBL105082	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	1006298	CHEMBL842208	Inhibition of p38-alpha ser/thr kinase.	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1021138	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	COc1cc2[nH]ccc2cc1C(=O)N1C[C@@H](C)N(Cc2ccccc2)C[C@@H]1C		CHEMBL106120	=	IC50	nM	1650.0	CHEMBL260	Homo sapiens	IC50	uM	1.65
	1024862	CHEMBL734089	Inhibition of Mitogen-activated protein kinase p38 alpha	B	O=C(c1c[nH]c2ccccc12)N1CCN(Cc2ccccc2)CC1		CHEMBL318990	=	IC50	nM	4740.0	CHEMBL260	Homo sapiens	IC50	uM	4.74
	1027300	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Fc1ccc(-c2cc[nH]c2-c2ccncc2)cc1		CHEMBL160314	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	1027306	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Fc1ccc(-c2cc(-c3ccc(Cl)cc3)[nH]c2-c2ccncc2)cc1		CHEMBL328126	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	1027312	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Fc1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL157529	=	IC50	nM	340.0	CHEMBL260	Homo sapiens	IC50	uM	0.34
	1032312	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Clc1ccc(-c2cc(C3CCCCC3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160735	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1032318	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CC(C)COc1ccccc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL347663	=	IC50	nM	3760.0	CHEMBL260	Homo sapiens	IC50	uM	3.76
	1033472	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	IC50	nM	117.0	CHEMBL260	Homo sapiens	IC50	uM	0.117
	1033477	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	N#Cc1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL158989	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1034760	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Clc1ccc(-c2cc(-c3ccccc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160550	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	1034892	CHEMBL812940	Inhibition of Stress activated protein kinase 2a, p38-alpha at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	Inhibition	%	11.0
	1036173	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Cc1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160289	=	IC50	nM	1690.0	CHEMBL260	Homo sapiens	IC50	uM	1.69
	1036179	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Clc1ccc(-c2cc(-c3ccc(Cl)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160490	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	1036287	CHEMBL812940	Inhibition of Stress activated protein kinase 2a, p38-alpha at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	Inhibition	%	5.0
	1037227	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Nc1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL159163	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	1038401	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	C=CCOc1ccccc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL158535	=	IC50	nM	4740.0	CHEMBL260	Homo sapiens	IC50	uM	4.74
	1038877	CHEMBL734091	Inhibition of Mitogen-activated protein kinase p38 alpha	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	1039490	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Fc1ccc(-c2cc(-c3ccc(Cl)cc3Cl)[nH]c2-c2ccncc2)cc1		CHEMBL160638	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	uM	0.42
	1039496	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	COc1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160401	=	IC50	nM	2800.0	CHEMBL260	Homo sapiens	IC50	uM	2.8
	1039502	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	O=[N+]([O-])c1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160525	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1040747	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	COc1ccc(-c2cc(-c3ccc(Cl)cc3)[nH]c2-c2ccncc2)cc1		CHEMBL155694	=	IC50	nM	1150.0	CHEMBL260	Homo sapiens	IC50	uM	1.15
	1041953	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	O=C(O)c1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL423781	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	1044611	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Clc1ccc(-c2ccc(-c3ccncc3)[nH]2)cc1		CHEMBL160372	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1045787	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CC(C)(C)c1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL350237	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1045799	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Clc1ccc(-c2cc(-c3ccccc3Br)c(-c3ccncc3)[nH]2)cc1		CHEMBL436022	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	1047002	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Cc1cc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL160627	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	1048353	CHEMBL812940	Inhibition of Stress activated protein kinase 2a, p38-alpha at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	Inhibition	%	5.0
	1049327	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CCc1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160238	=	IC50	nM	1360.0	CHEMBL260	Homo sapiens	IC50	uM	1.36
	1050608	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	C[S+]([O-])c1ccc(-c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1		CHEMBL88486	=	IC50	nM	5.3	CHEMBL260	Homo sapiens	IC50	uM	0.0053
	1050610	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	C[S+]([O-])c1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL155687	=	IC50	nM	670.0	CHEMBL260	Homo sapiens	IC50	uM	0.67
	1051797	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Fc1ccc(-c2cc(-c3ccccc3)[nH]c2-c2ccncc2)cc1		CHEMBL158671	=	IC50	nM	800.0	CHEMBL260	Homo sapiens	IC50	uM	0.8
	1051803	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CCOC(=O)c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL345863	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	1053038	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CN1CCC(c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)CC1		CHEMBL160618	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1053044	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	COc1cccc(-c2cc(-c3ccc(Cl)cc3)[nH]c2-c2ccncc2)c1		CHEMBL158477	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	uM	0.42
	1053050	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CCCOc1ccc(Br)cc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL351772	=	IC50	nM	1440.0	CHEMBL260	Homo sapiens	IC50	uM	1.44
	1054183	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CSc1ccc(-c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1		CHEMBL91652	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	1054185	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CSc1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL156207	=	IC50	nM	1230.0	CHEMBL260	Homo sapiens	IC50	uM	1.23
	1055599	CHEMBL812940	Inhibition of Stress activated protein kinase 2a, p38-alpha at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	Inhibition	%	10.0
	1056809	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Clc1ccc(-c2cc(-c3ccc(Br)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL159198	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	1058094	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Clc1ccc(-c2cc(-c3cccc(Br)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL350255	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	1058100	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CCCCCCOc1ccccc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL345834	=	IC50	nM	2680.0	CHEMBL260	Homo sapiens	IC50	uM	2.68
	1058285	CHEMBL812940	Inhibition of Stress activated protein kinase 2a, p38-alpha at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	1059200	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	COc1ccccc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL160380	=	IC50	nM	2650.0	CHEMBL260	Homo sapiens	IC50	uM	2.65
	1060463	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Fc1ccc(-c2cc(-c3cccc(Cl)c3)[nH]c2-c2ccncc2)cc1		CHEMBL160281	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	uM	0.42
	1060469	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CC(C)c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL158548	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1061827	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	O=C(O)c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL156961	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	1063139	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	Fc1ccc(-c2cc(C3CCCCC3)[nH]c2-c2ccncc2)cc1		CHEMBL348401	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	1063145	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CCOC(=O)c1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL160690	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	1063151	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CC(C)Oc1ccccc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL160561	=	IC50	nM	5540.0	CHEMBL260	Homo sapiens	IC50	uM	5.54
	1064359	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CCCOc1ccccc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL156458	=	IC50	nM	2840.0	CHEMBL260	Homo sapiens	IC50	uM	2.84
	1065642	CHEMBL842195	Inhibitory activity against p38-alpha kinase	B	CCOc1ccccc1-c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL346698	=	IC50	nM	14200.0	CHEMBL260	Homo sapiens	IC50	uM	14.2
	1079151	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccncc3)c3ccccc23)cc1		CHEMBL143134	=	Kd	nM	2.4	CHEMBL260	Homo sapiens	Kd	nM	2.4
	1079152	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccncc3)c3ccccc23)cc1		CHEMBL143134	=	Kd	nM	0.104	CHEMBL260	Homo sapiens	Kd	nM	0.104
	1079153	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccncc3)c3ccccc23)cc1		CHEMBL143134	=	Kd	nM	0.5	CHEMBL260	Homo sapiens	Kd	nM	0.5
	1082643	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	CC(C)(CO)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL444613	=	Kd	nM	493.0	CHEMBL260	Homo sapiens	Kd	nM	493.0
	1082644	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	CC(C)(CO)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL444613	=	Kd	nM	56.4	CHEMBL260	Homo sapiens	Kd	nM	56.4
	1082645	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	CC(C)(CO)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL444613	=	Kd	nM	36.0	CHEMBL260	Homo sapiens	Kd	nM	36.0
	1082646	CHEMBL734086	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (constant fit)	B	CC(C)(CO)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL444613	=	Kd	nM	20.0	CHEMBL260	Homo sapiens	Kd	nM	20.0
	1082647	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)cc1		CHEMBL315100	=	Kd	nM	177.0	CHEMBL260	Homo sapiens	Kd	nM	177.0
	1082648	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)cc1		CHEMBL315100	=	Kd	nM	16.8	CHEMBL260	Homo sapiens	Kd	nM	16.8
	1082649	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)cc1		CHEMBL315100	=	Kd	nM	21.0	CHEMBL260	Homo sapiens	Kd	nM	21.0
	1082650	CHEMBL734086	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (constant fit)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)cc1		CHEMBL315100	=	Kd	nM	5.0	CHEMBL260	Homo sapiens	Kd	nM	5.0
	1085849	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	Kd	nM	118.0	CHEMBL260	Homo sapiens	Kd	nM	118.0
	1085850	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	Kd	nM	10.6	CHEMBL260	Homo sapiens	Kd	nM	10.6
	1085851	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	Kd	nM	1.0	CHEMBL260	Homo sapiens	Kd	nM	1.0
	1085852	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	CC(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL105248	=	Kd	nM	62.8	CHEMBL260	Homo sapiens	Kd	nM	62.8
	1085853	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	CC(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL105248	=	Kd	nM	3.4	CHEMBL260	Homo sapiens	Kd	nM	3.4
	1085854	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	CC(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL105248	=	Kd	nM	6.0	CHEMBL260	Homo sapiens	Kd	nM	6.0
	1089157	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	Kd	nM	210.0	CHEMBL260	Homo sapiens	Kd	nM	210.0
	1089158	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	Kd	nM	25.7	CHEMBL260	Homo sapiens	Kd	nM	25.7
	1089159	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	Kd	nM	23.0	CHEMBL260	Homo sapiens	Kd	nM	23.0
	1089160	CHEMBL734086	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (constant fit)	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	Kd	nM	10.0	CHEMBL260	Homo sapiens	Kd	nM	10.0
	1094768	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)Nc1ccnn1-c1ccccc1		CHEMBL104119	=	Kd	nM	6070.0	CHEMBL260	Homo sapiens	Kd	nM	6070.0
	1094769	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)Nc1ccnn1-c1ccccc1		CHEMBL104119	=	Kd	nM	2400.0	CHEMBL260	Homo sapiens	Kd	nM	2400.0
	1094770	CHEMBL734086	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (constant fit)	B	O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)Nc1ccnn1-c1ccccc1		CHEMBL104119	=	Kd	nM	1181.0	CHEMBL260	Homo sapiens	Kd	nM	1181.0
	1100382	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	Kd	nM	5850.0	CHEMBL260	Homo sapiens	Kd	nM	5850.0
	1100383	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	Kd	nM	1950.0	CHEMBL260	Homo sapiens	Kd	nM	1950.0
	1100384	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	Kd	nM	1160.0	CHEMBL260	Homo sapiens	Kd	nM	1160.0
	1100385	CHEMBL734086	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (constant fit)	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	Kd	nM	1152.0	CHEMBL260	Homo sapiens	Kd	nM	1152.0
	1101467	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL318810	=	Kd	nM	5.3	CHEMBL260	Homo sapiens	Kd	nM	5.3
	1101468	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL318810	=	Kd	nM	0.231	CHEMBL260	Homo sapiens	Kd	nM	0.231
	1101469	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL318810	=	Kd	nM	0.09	CHEMBL260	Homo sapiens	Kd	nM	0.09
	1102613	CHEMBL734085	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1.3	CHEMBL260	Homo sapiens	Kd	nM	1.3
	1102614	CHEMBL734088	Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.046	CHEMBL260	Homo sapiens	Kd	nM	0.046
	1102615	CHEMBL734087	Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.1	CHEMBL260	Homo sapiens	Kd	nM	0.1
	1105880	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cn1		CHEMBL104991	=	k_on	M-1.s-1	21500.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	21500.0
	1105881	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cn1		CHEMBL104991	=	k_off	s-1	0.000023	CHEMBL260	Homo sapiens	Koff	s-1	0.000023
	1105882	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cn1		CHEMBL104991	=	Kd	nM	1.1	CHEMBL260	Homo sapiens	Kd	nM	1.1
	1109306	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	k_on	M-1.s-1	84900.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	84900.0
	1109307	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	k_off	s-1	0.0000083	CHEMBL260	Homo sapiens	Koff	s-1	0.0000083
	1109308	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.098	CHEMBL260	Homo sapiens	Kd	nM	0.098
	1109309	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL318810	=	k_on	M-1.s-1	154000.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	154000.0
	1109310	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL318810	=	k_off	s-1	0.000015	CHEMBL260	Homo sapiens	Koff	s-1	0.000015
	1109311	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL318810	=	Kd	nM	0.097	CHEMBL260	Homo sapiens	Kd	nM	0.097
	1112909	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)cc1		CHEMBL315100	=	k_on	M-1.s-1	73300.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	73300.0
	1112910	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)cc1		CHEMBL315100	=	k_off	s-1	0.0016	CHEMBL260	Homo sapiens	Koff	s-1	0.0016
	1112911	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)cc1		CHEMBL315100	=	Kd	nM	22.0	CHEMBL260	Homo sapiens	Kd	nM	22.0
	1117680	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	CC(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL105248	=	k_on	M-1.s-1	64800.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	64800.0
	1117681	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	CC(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL105248	=	k_off	s-1	0.00038	CHEMBL260	Homo sapiens	Koff	s-1	0.00038
	1117682	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	CC(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2ccccc2)n1		CHEMBL105248	=	Kd	nM	5.9	CHEMBL260	Homo sapiens	Kd	nM	5.9
	1118916	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	k_on	M-1.s-1	145000.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	145000.0
	1118917	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	k_off	s-1	0.0033	CHEMBL260	Homo sapiens	Koff	s-1	0.0033
	1118918	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	Kd	nM	23.0	CHEMBL260	Homo sapiens	Kd	nM	23.0
	1122382	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc2c1		CHEMBL107161	=	k_on	M-1.s-1	36100.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	36100.0
	1122383	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc2c1		CHEMBL107161	=	k_off	s-1	0.00034	CHEMBL260	Homo sapiens	Koff	s-1	0.00034
	1122384	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc2c1		CHEMBL107161	=	Kd	nM	9.4	CHEMBL260	Homo sapiens	Kd	nM	9.4
	1123630	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1CN(C)C		CHEMBL106115	=	k_on	M-1.s-1	7900.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	7900.0
	1123631	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1CN(C)C		CHEMBL106115	=	k_off	s-1	0.000038	CHEMBL260	Homo sapiens	Koff	s-1	0.000038
	1123632	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1CN(C)C		CHEMBL106115	=	Kd	nM	4.8	CHEMBL260	Homo sapiens	Kd	nM	4.8
	1123633	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	k_on	M-1.s-1	118000.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	118000.0
	1123634	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	k_off	s-1	0.14	CHEMBL260	Homo sapiens	Koff	s-1	0.14
	1123635	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	Kd	nM	1190.0	CHEMBL260	Homo sapiens	Kd	nM	1190.0
	1124824	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	O=C(Nc1ccc(OCCN2CCOCC2)c2ccccc12)Nc1ccnn1-c1ccccc1		CHEMBL104119	=	Kd	nM	2000.0	CHEMBL260	Homo sapiens	Kd	nM	2000.0
	1124825	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)cc2)cc1		CHEMBL101035	=	k_on	M-1.s-1	13000.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	13000.0
	1124826	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)cc2)cc1		CHEMBL101035	=	k_off	s-1	0.0039	CHEMBL260	Homo sapiens	Koff	s-1	0.0039
	1124827	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)cc2)cc1		CHEMBL101035	=	Kd	nM	300.0	CHEMBL260	Homo sapiens	Kd	nM	300.0
	1132004	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	CN(C)Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL318806	=	k_on	M-1.s-1	1600.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	1600.0
	1132005	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	CN(C)Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL318806	=	k_off	s-1	0.000026	CHEMBL260	Homo sapiens	Koff	s-1	0.000026
	1132006	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	CN(C)Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL318806	=	Kd	nM	16.0	CHEMBL260	Homo sapiens	Kd	nM	16.0
	1137114	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	k_on	M-1.s-1	113000.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	113000.0
	1137115	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	k_off	s-1	0.00012	CHEMBL260	Homo sapiens	Koff	s-1	0.00012
	1137116	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1		CHEMBL420047	=	Kd	nM	1.1	CHEMBL260	Homo sapiens	Kd	nM	1.1
	1137117	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc2c1OCCN1CCOCC1		CHEMBL104973	=	k_on	M-1.s-1	10700.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	10700.0
	1137118	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc2c1OCCN1CCOCC1		CHEMBL104973	=	k_off	s-1	0.00015	CHEMBL260	Homo sapiens	Koff	s-1	0.00015
	1137119	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	COc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc2c1OCCN1CCOCC1		CHEMBL104973	=	Kd	nM	14.0	CHEMBL260	Homo sapiens	Kd	nM	14.0
	1138440	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)CO)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL107850	=	k_on	M-1.s-1	25400.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	25400.0
	1138441	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)CO)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL107850	=	k_off	s-1	0.0004	CHEMBL260	Homo sapiens	Koff	s-1	0.0004
	1138442	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)CO)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL107850	=	Kd	nM	16.0	CHEMBL260	Homo sapiens	Kd	nM	16.0
	1139858	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(CCCN3CCOCC3)c3ccccc23)cc1		CHEMBL320950	=	k_on	M-1.s-1	18700.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	18700.0
	1139859	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(CCCN3CCOCC3)c3ccccc23)cc1		CHEMBL320950	=	k_off	s-1	0.000023	CHEMBL260	Homo sapiens	Koff	s-1	0.000023
	1139860	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(CCCN3CCOCC3)c3ccccc23)cc1		CHEMBL320950	=	Kd	nM	1.2	CHEMBL260	Homo sapiens	Kd	nM	1.2
	1141100	CHEMBL733330	Rate of association to Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1C(=O)O		CHEMBL420474	=	k_on	M-1.s-1	25200.0	CHEMBL260	Homo sapiens	Kon	M-1 s-1	25200.0
	1141101	CHEMBL733329	Rate of dissociation from Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1C(=O)O		CHEMBL420474	=	k_off	s-1	0.000062	CHEMBL260	Homo sapiens	Koff	s-1	0.000062
	1141102	CHEMBL733328	Binding affinity for Mitogen-activated protein kinase p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1C(=O)O		CHEMBL420474	=	Kd	nM	2.5	CHEMBL260	Homo sapiens	Kd	nM	2.5
	1142244	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	1142245	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	IC50	nM	650.0	CHEMBL260	Homo sapiens	IC50	nM	650.0
	1143442	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	1143443	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(C(F)(F)F)cc3)n2)cc1		CHEMBL264227	=	IC50	nM	215.0	CHEMBL260	Homo sapiens	IC50	nM	215.0
	1144762	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CC(F)(F)F)n1		CHEMBL304227	=	Inhibition	%	91.0	CHEMBL260	Homo sapiens	Inhibition	%	91.0
	1144763	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CC(F)(F)F)n1		CHEMBL304227	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	nM	87.0
	1144778	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	1144779	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	IC50	nM	132.0	CHEMBL260	Homo sapiens	IC50	nM	132.0
	1144780	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CN(C)C(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14170	=	IC50	nM	312.0	CHEMBL260	Homo sapiens	IC50	nM	312.0
	1146057	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	COc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL64031	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	1147506	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)[nH]n1		CHEMBL62459	=	Inhibition	%	91.0	CHEMBL260	Homo sapiens	Inhibition	%	91.0
	1147507	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)[nH]n1		CHEMBL62459	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	1147509	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Cl)c2Cl)cc1		CHEMBL291826	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	1147511	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(F)c2)n1		CHEMBL291835	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	1147523	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CC(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL417079	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	1147524	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)c(Cl)c3)n2)cc1		CHEMBL275271	=	IC50	nM	165.0	CHEMBL260	Homo sapiens	IC50	nM	165.0
	1147525	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cc(F)cc(F)c3)n2)cc1		CHEMBL14339	=	IC50	nM	209.0	CHEMBL260	Homo sapiens	IC50	nM	209.0
	1148710	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CCCCOC(=O)c1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2C)cc1		CHEMBL61326	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	nM	290.0
	1148725	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	1148726	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL14318	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	1148727	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	IC50	nM	7.4	CHEMBL260	Homo sapiens	IC50	nM	7.4
	1149945	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Oc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14125	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	1149946	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	O=C(O)Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL273525	=	IC50	nM	119.0	CHEMBL260	Homo sapiens	IC50	nM	119.0
	1151184	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL64538	=	Inhibition	%	47.0	CHEMBL260	Homo sapiens	Inhibition	%	47.0
	1151185	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	Cc1ccccc1-n1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL303798	=	IC50	nM	43.0	CHEMBL260	Homo sapiens	IC50	nM	43.0
	1151202	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c(C)c1		CHEMBL13850	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	1151203	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL13836	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	1152299	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CCC#N)n1		CHEMBL61846	=	Inhibition	%	81.0	CHEMBL260	Homo sapiens	Inhibition	%	81.0
	1152300	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CCC#N)n1		CHEMBL61846	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
	1152302	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccc(Cl)cc2)n1		CHEMBL65073	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	1152316	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	1152317	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	IC50	nM	114.0	CHEMBL260	Homo sapiens	IC50	nM	114.0
	1153595	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccccc2)n1		CHEMBL63071	=	Inhibition	%	97.0	CHEMBL260	Homo sapiens	Inhibition	%	97.0
	1153596	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccccc2)n1		CHEMBL63071	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	1153600	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)c1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Cl)c2Cl)cc1		CHEMBL64820	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	1153617	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	1154925	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Oc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL273432	=	IC50	nM	6.6	CHEMBL260	Homo sapiens	IC50	nM	6.6
	1156340	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	COc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14300	=	IC50	nM	18.7	CHEMBL260	Homo sapiens	IC50	nM	18.7
	1157566	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccccn2)n1		CHEMBL64432	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	1157574	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL41653	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	1157578	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14682	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	1158849	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL418657	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	1158861	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	1158862	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(C)c1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL277521	=	IC50	nM	34.3	CHEMBL260	Homo sapiens	IC50	nM	34.3
	1158863	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	IC50	nM	89.7	CHEMBL260	Homo sapiens	IC50	nM	89.7
	1158864	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	nM	95.0
	1158865	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	O=C(NN1CCNCC1)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL13830	=	IC50	nM	406.0	CHEMBL260	Homo sapiens	IC50	nM	406.0
	1158866	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	O=C(Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1)NN1CCCCC1		CHEMBL276014	=	IC50	nM	453.0	CHEMBL260	Homo sapiens	IC50	nM	453.0
	1160166	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	NC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL268946	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
	1160167	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	O=C(O)CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14026	=	IC50	nM	85.4	CHEMBL260	Homo sapiens	IC50	nM	85.4
	1161527	CHEMBL732965	Inhibition of Mitogen-activated protein kinase p38 alpha 2 at 5 uM	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2C)cc1		CHEMBL63599	=	Inhibition	%	22.0	CHEMBL260	Homo sapiens	Inhibition	%	22.0
	1163031	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccc(N)cc2)n1		CHEMBL62943	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	1163044	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	IC50	nM	177.0	CHEMBL260	Homo sapiens	IC50	nM	177.0
	1164384	CHEMBL732965	Inhibition of Mitogen-activated protein kinase p38 alpha 2 at 5 uM	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccccc1		CHEMBL61229	=	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1164385	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CCOC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL304256	=	Inhibition	%	76.0	CHEMBL260	Homo sapiens	Inhibition	%	76.0
	1164386	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CCOC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL304256	=	IC50	nM	105.0	CHEMBL260	Homo sapiens	IC50	nM	105.0
	1164417	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1cc(C)cc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL417255	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	1165648	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL441793	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	nM	39.0
	1167127	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CNC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL61735	=	Inhibition	%	61.0	CHEMBL260	Homo sapiens	Inhibition	%	61.0
	1167128	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CNC(=O)Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Cl)c1Cl		CHEMBL61735	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	nM	250.0
	1167161	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C		CHEMBL14212	=	IC50	nM	15.2	CHEMBL260	Homo sapiens	IC50	nM	15.2
	1167162	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	O=C(O)CCCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13950	=	IC50	nM	174.0	CHEMBL260	Homo sapiens	IC50	nM	174.0
	1168387	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(=O)Nc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL59876	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	nM	500.0
	1168397	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1ccc(C)c(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL276576	=	IC50	nM	10.7	CHEMBL260	Homo sapiens	IC50	nM	10.7
	1168398	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	O=C(O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14233	=	IC50	nM	82.0	CHEMBL260	Homo sapiens	IC50	nM	82.0
	1169745	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CCC(=O)Nc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL278498	=	IC50	nM	151.0	CHEMBL260	Homo sapiens	IC50	nM	151.0
	1170935	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	1170936	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1172120	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL64041	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	1172143	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccncc2)cc1		CHEMBL279416	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	1172144	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(OCc4ccccc4)cc3)n2)cc1		CHEMBL14228	=	IC50	nM	317.0	CHEMBL260	Homo sapiens	IC50	nM	317.0
	1173524	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(-c2ccccc2)c1		CHEMBL293644	=	IC50	nM	797.0	CHEMBL260	Homo sapiens	IC50	nM	797.0
	1173540	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncn2)cc1		CHEMBL279587	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	1173541	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3F)n2)cc1		CHEMBL14329	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1173542	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(-c4ccccc4)cc3)n2)cc1		CHEMBL14187	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	nM	60.0
	1173543	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CNC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14697	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	nM	75.0
	1173544	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	O=C(NN1CCCCC1)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14252	=	IC50	nM	599.0	CHEMBL260	Homo sapiens	IC50	nM	599.0
	1174776	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Oc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14763	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	1174777	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	COc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14478	=	IC50	nM	15.7	CHEMBL260	Homo sapiens	IC50	nM	15.7
	1176150	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(Br)cc(Br)c1		CHEMBL62859	=	IC50	nM	325.0	CHEMBL260	Homo sapiens	IC50	nM	325.0
	1176151	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL304640	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	Inhibition	%	10.0
	1176152	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)c(-c2ccccc2)s1		CHEMBL303562	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	1176162	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CC(C)NC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL276094	=	IC50	nM	189.0	CHEMBL260	Homo sapiens	IC50	nM	189.0
	1176163	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	nM	300.0
	1177496	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cc1cccc(NC(=O)Nc2cc(C(C)(C)C)nn2C)c1C		CHEMBL64876	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	Inhibition	%	24.0
	1177497	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Br)c1		CHEMBL61069	=	Inhibition	%	33.0	CHEMBL260	Homo sapiens	Inhibition	%	33.0
	1179980	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(N)c2)n1		CHEMBL64040	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1179988	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(C(F)(F)F)c2)n1		CHEMBL64192	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
	1181414	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CCO)n1		CHEMBL62927	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	Inhibition	%	75.0
	1181415	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CCO)n1		CHEMBL62927	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	1181421	CHEMBL731498	Inhibition of mitogen-activated protein kinase p38 alpha 2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	1181431	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL14565	=	IC50	nM	134.0	CHEMBL260	Homo sapiens	IC50	nM	134.0
	1182657	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccccc1C(F)(F)F		CHEMBL304649	=	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1182658	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CC(=O)O)n1		CHEMBL303201	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	1182659	CHEMBL732964	Inhibition of Mitogen-activated protein kinase p38 alpha 2	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(CC(N)=O)n1		CHEMBL291577	=	Inhibition	%	48.0	CHEMBL260	Homo sapiens	Inhibition	%	48.0
	1182678	CHEMBL874040	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1C		CHEMBL13880	=	IC50	nM	21.6	CHEMBL260	Homo sapiens	IC50	nM	21.6
	1190409	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2n[nH]cc2-c2ccc(O)cc2)n1		CHEMBL118928	=	IC50	nM	31000.0	CHEMBL260	Homo sapiens	IC50	uM	31.0
	1191669	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Fc1ccc(-c2c(-c3ccccn3)nn3c2CCC3)cc1		CHEMBL120799	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1191673	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2nn3c(c2-c2ccc(F)c(F)c2)CCC3)n1		CHEMBL120718	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1192834	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Fc1ccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)nc1		CHEMBL325405	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	uM	11.0
	1195419	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1ccc(-c2c(-c3cccc(C)n3)nn3c2CCC3)cc1		CHEMBL118339	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1195423	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2nn3c(c2-c2ccc(F)cc2)CCC3)n1		CHEMBL121790	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1197947	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2nn3c(c2-c2ccnc4cc(Cl)ccc24)CCC3)n1		CHEMBL332344	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	uM	0.44
	1204777	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)nc1		CHEMBL121795	=	IC50	nM	7900.0	CHEMBL260	Homo sapiens	IC50	uM	7.9
	1204781	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)n1		CHEMBL119976	=	IC50	nM	680.0	CHEMBL260	Homo sapiens	IC50	uM	0.68
	1207371	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	IC50	nM	51000.0	CHEMBL260	Homo sapiens	IC50	uM	51.0
	1209957	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	CCSc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL119936	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	1212634	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	COc1ccc(-c2c(-c3ccccn3)nn3c2CCC3)cc1		CHEMBL120907	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1212638	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	COc1ccc(-c2c(-c3cccc(C)n3)nn3c2CCC3)cc1		CHEMBL120211	=	IC50	nM	4600.0	CHEMBL260	Homo sapiens	IC50	uM	4.6
	1213864	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Clc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL121554	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	uM	1.8
	1216498	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	CCS(=O)(=O)c1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL331703	=	IC50	nM	9800.0	CHEMBL260	Homo sapiens	IC50	uM	9.8
	1219285	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	CC(C)c1cccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)n1		CHEMBL120245	=	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	1219289	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	CCOc1ccc2c(-c3c(-c4cccc(C)n4)nn4c3CCC4)ccnc2c1		CHEMBL120587	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	1219293	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Fc1ccc(-c2c(-c3cccc(C(F)(F)F)n3)nn3c2CCC3)cc1		CHEMBL333798	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1221781	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	OCc1cccc(-c2nn3c(c2-c2ccc(F)cc2)CCC3)n1		CHEMBL122414	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1222985	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	CCc1cccc(-c2nn3c(c2-c2ccnc4ccccc24)CCC3)n1		CHEMBL122583	=	IC50	nM	620.0	CHEMBL260	Homo sapiens	IC50	uM	0.62
	1222989	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2nn3c(c2-c2ccc(S(C)(=O)=O)cc2)CCC3)n1		CHEMBL122524	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1222993	CHEMBL734081	Inhibitory activity against Mitogen-activated protein kinase p38	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)CCC3)n1		CHEMBL330814	=	IC50	nM	4300.0	CHEMBL260	Homo sapiens	IC50	uM	4.3
	1406050	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(-c3ccccc3)ncnc21		CHEMBL179217	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	Inhibition	%	16.0
	1406065	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(-c3ccc(F)cc3)ncnc21		CHEMBL539424	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	Inhibition	%	16.0
	1406080	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(-c2ccccc2)nc2c(-c3ccc(F)cc3)ncnc21		CHEMBL368896	=	Inhibition	%	23.0	CHEMBL260	Homo sapiens	Inhibition	%	23.0
	1406201	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(-c2ccccc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL367389	=	Inhibition	%	44.0	CHEMBL260	Homo sapiens	Inhibition	%	44.0
	1406216	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(-c2ccccc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175541	=	Inhibition	%	29.0	CHEMBL260	Homo sapiens	Inhibition	%	29.0
	1406341	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	CSc1ccc(-c2nc3c(Sc4ccccc4)ncnc3n2C)cc1		CHEMBL175868	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	Inhibition	%	11.0
	1406356	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	CSc1ccc(-c2nc3c(Sc4ccc(F)cc4)ncnc3n2C)cc1		CHEMBL175619	=	Inhibition	%	15.0	CHEMBL260	Homo sapiens	Inhibition	%	15.0
	1406459	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(Nc2ncnc3[nH]cnc23)cc1		CHEMBL359730	=	Inhibition	%	34.0	CHEMBL260	Homo sapiens	Inhibition	%	34.0
	1406474	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Nc2[nH]cnc3ncnc2-3)cc1		CHEMBL361227	=	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1406488	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL353740	=	Inhibition	%	27.0	CHEMBL260	Homo sapiens	Inhibition	%	27.0
	1406503	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL180373	=	Inhibition	%	44.0	CHEMBL260	Homo sapiens	Inhibition	%	44.0
	1406518	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL177060	=	Inhibition	%	36.0	CHEMBL260	Homo sapiens	Inhibition	%	36.0
	1406606	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(Oc2ncnc3[nH]cnc23)cc1		CHEMBL366984	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	Inhibition	%	12.0
	1406621	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Oc2[nH]cnc3ncnc2-3)cc1		CHEMBL367695	=	Inhibition	%	18.0	CHEMBL260	Homo sapiens	Inhibition	%	18.0
	1406636	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(Nc3ccccc3)ncnc21		CHEMBL321749	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	1406650	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL367018	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	Inhibition	%	19.0
	1406665	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(Br)nc2c(Sc3ccccc3)ncnc21		CHEMBL177289	=	Inhibition	%	23.0	CHEMBL260	Homo sapiens	Inhibition	%	23.0
	1406771	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(Nc3ccc(F)cc3)ncnc21		CHEMBL362629	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	Inhibition	%	13.0
	1406786	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175600	=	Inhibition	%	54.0	CHEMBL260	Homo sapiens	Inhibition	%	54.0
	1406904	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175603	=	Inhibition	%	72.0	CHEMBL260	Homo sapiens	Inhibition	%	72.0
	1406919	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL360302	=	Inhibition	%	56.0	CHEMBL260	Homo sapiens	Inhibition	%	56.0
	1407030	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL367533	=	Inhibition	%	79.0	CHEMBL260	Homo sapiens	Inhibition	%	79.0
	1407045	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(Sc3ccccc3)ncnc21		CHEMBL179751	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	Inhibition	%	17.0
	1407060	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175622	=	Inhibition	%	38.0	CHEMBL260	Homo sapiens	Inhibition	%	38.0
	1407165	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	Inhibition	%	50.0
	1407180	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(CSc2[nH]cnc3ncnc2-3)cc1		CHEMBL175451	=	Inhibition	%	29.0	CHEMBL260	Homo sapiens	Inhibition	%	29.0
	1407291	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(SCc3ccccc3)ncnc21		CHEMBL176384	=	Inhibition	%	22.0	CHEMBL260	Homo sapiens	Inhibition	%	22.0
	1407306	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(SCc3ccc(F)cc3)ncnc21		CHEMBL175730	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	Inhibition	%	21.0
	1407422	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175816	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	1407437	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175817	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	1407453	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL369622	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	Inhibition	%	6.0
	1407568	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL179515	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	Inhibition	%	5.0
	1407583	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Clc1ncnc2c1ncn2Cc1ccccc1		CHEMBL7944	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	Inhibition	%	11.0
	1407694	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Clc1ncnc2ncn(Cc3ccccc3)c12		CHEMBL368715	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	Inhibition	%	7.0
	1407709	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Cn2cnc3c(Cl)ncnc32)cc1		CHEMBL369181	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	Inhibition	%	10.0
	1407817	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Cn2cnc3ncnc(Cl)c32)cc1		CHEMBL175528	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	Inhibition	%	17.0
	1407832	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Nc1ncnc2c1ncn2Cc1ccccc1		CHEMBL266094	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	Inhibition	%	7.0
	1407847	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Nc1ncnc2c1ncn2Cc1ccc(F)cc1		CHEMBL426037	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	Inhibition	%	8.0
	1407960	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Nc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL180422	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	Inhibition	%	8.0
	1407975	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	COc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL368714	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	Inhibition	%	8.0
	1408090	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL367930	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	Inhibition	%	8.0
	1408105	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL179158	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	Inhibition	%	1.0
	1408219	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(/C=C/c2[nH]cnc3ncnc2-3)cc1		CHEMBL367470	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	Inhibition	%	17.0
	1408234	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1cnc2c(/C=C/c3ccccc3)ncnc21		CHEMBL176186	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	Inhibition	%	12.0
	1408885	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Cn1c(C#CCCO)nc2c(Sc3ccccc3)ncnc21		CHEMBL177784	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	Inhibition	%	3.0
	1408900	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	c1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL180020	=	Inhibition	%	64.0	CHEMBL260	Homo sapiens	Inhibition	%	64.0
	1409010	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Sc2ncnc3c2ncn3Cc2ccccc2)cc1		CHEMBL179768	=	Inhibition	%	64.0	CHEMBL260	Homo sapiens	Inhibition	%	64.0
	1409025	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL176245	=	Inhibition	%	67.0	CHEMBL260	Homo sapiens	Inhibition	%	67.0
	1409040	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Fc1ccc(Cn2cnc3c(Sc4ccc(F)cc4)ncnc32)cc1		CHEMBL175665	=	Inhibition	%	27.0	CHEMBL260	Homo sapiens	Inhibition	%	27.0
	1409151	CHEMBL830639	Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	Inhibition	%	7.0
	1441913	CHEMBL830662	Inhibition of Stress activated protein kinase 2a at 10 uM with 100 uM ATP	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	1448331	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccnc(Oc4ccccc4)n3)nn3c2OCC3)cc1		CHEMBL184733	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	1448333	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	C[C@@H](Nc1nccc(-c2nn3c(c2-c2ccc(F)cc2)OCC3)n1)c1ccccc1		CHEMBL187538	=	IC50	nM	11200.0	CHEMBL260	Homo sapiens	IC50	uM	11.2
	1448335	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	COC[C@@H](C)Nc1nccc(-c2nn3c(c2-c2ccc(F)cc2)OCC3)n1		CHEMBL187961	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	1448337	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	CC[C@@H](C)Nc1nccc(-c2nn3c(c2-c2ccc(F)cc2)OCC3)n1		CHEMBL441119	=	IC50	nM	360.0	CHEMBL260	Homo sapiens	IC50	uM	0.36
	1449508	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	Outside typical range	CHEMBL10	=	IC50	nM	136000.0	CHEMBL260	Homo sapiens	IC50	uM	136.0
	1449510	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	CCOCn1nnc(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL297885	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	uM	0.31
	1449512	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	Oc1[nH]nc(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL362562	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	1449514	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccncc3)nn3c2OCCC3)cc1		CHEMBL364340	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	uM	0.46
	1449516	CHEMBL830116	Inhibition of human Mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2c(-c3ccnc(Oc4ccccc4)n3)nn3c2OCCC3)cc1		CHEMBL184067	=	IC50	nM	6600.0	CHEMBL260	Homo sapiens	IC50	uM	6.6
	1453092	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cccc(NC(=O)c4ccccc4)c3)c2cc1OC		CHEMBL186802	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	1453198	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)c2cc1OC		CHEMBL186580	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1453201	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccccc4)ccc3Cl)c2cc1OC		CHEMBL185327	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	1453204	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccccc4)ccc3C)c2cc1OC		CHEMBL184555	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	1453207	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccccc4)c(Cl)cc3F)c2cc1OC		CHEMBL184685	=	IC50	nM	510.0	CHEMBL260	Homo sapiens	IC50	uM	0.51
	1453210	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3ccc(C)c(NC(=O)c4ccccc4)c3)c2cc1OC		CHEMBL186747	=	IC50	nM	2090.0	CHEMBL260	Homo sapiens	IC50	uM	2.09
	1453213	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cccc(NC(=O)c4ccccc4)c3F)c2cc1OC		CHEMBL182397	=	IC50	nM	690.0	CHEMBL260	Homo sapiens	IC50	uM	0.69
	1453216	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3ccc(Cl)c(NC(=O)c4ccccc4)c3)c2cc1OC		CHEMBL360209	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	uM	0.61
	1453219	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cccc(NC(=O)c4cccc(N(C)C)c4)c3)c2cc1OC		CHEMBL365830	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	1453222	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4cccc(N(C)C)c4)ccc3Cl)c2cc1OC		CHEMBL187007	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	1453441	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	1453447	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc1		CHEMBL184011	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	1453449	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)c(OC)c1		CHEMBL187327	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	1453451	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc1OC		CHEMBL413558	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	1453453	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1cc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc(OC)c1OC		CHEMBL186542	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	1453455	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2cccc(NC(=O)c3cccc(N(C)C)c3)c2)cc1OC		CHEMBL183843	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1453456	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2F)cc1OC		CHEMBL188122	=	IC50	nM	1900.0	CHEMBL260	Homo sapiens	IC50	uM	1.9
	1453458	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2Cl)cc1OC		CHEMBL183100	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	1453622	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4cccc(N(C)C)c4)ccc3C)c2cc1OC		CHEMBL364576	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1453625	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3ccc(Cl)c(NC(=O)c4cccc(N(C)C)c4)c3)c2cc1OC		CHEMBL184682	=	IC50	nM	1690.0	CHEMBL260	Homo sapiens	IC50	uM	1.69
	1453628	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4cccc(N5CCOCC5)c4)ccc3C)c2cc1OC		CHEMBL184052	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1453733	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2cc1OCCN(C(C)C)C(C)C		CHEMBL363462	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1453738	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2cc1OCCN1CCOCC1		CHEMBL184271	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1453740	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2cc1OCCN1CCCC1		CHEMBL184659	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1453742	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2cc1OCCN(C)C		CHEMBL188114	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1453744	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2cc1OCCN1CCCCC1		CHEMBL188167	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1453746	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1cc(Cl)ncn1		CHEMBL185567	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	1453748	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccncn1		CHEMBL185162	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	1453751	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	CCN(CC)CCCNc1cc(Nc2cc(NC(=O)c3ccnc(N4CCOCC4)c3)ccc2C)ncn1		CHEMBL188126	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	1453844	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2Br)cc1OC		CHEMBL184347	=	IC50	nM	340.0	CHEMBL260	Homo sapiens	IC50	uM	0.34
	1453846	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	CCOc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc1OCC		CHEMBL187378	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1453848	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	CCOc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc1		CHEMBL185448	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	1453850	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(OC(C)C)cc1		CHEMBL365472	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	1453852	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COCCOc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc1		CHEMBL184189	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	uM	0.27
	1453854	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	CCOCCOc1ccc(C(=O)Nc2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc1		CHEMBL185086	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	uM	0.31
	1453856	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL366255	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1453956	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1453964	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL184721	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1453967	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL184012	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1454136	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1cc(NCCCN2CCCC2)ncn1		CHEMBL186852	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	1454138	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1cc(N2CCCN(C)CC2)ncn1		CHEMBL184257	=	IC50	nM	1220.0	CHEMBL260	Homo sapiens	IC50	uM	1.22
	1454140	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(Cl)n1		CHEMBL185328	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1454142	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(NCCCN2CCOCC2)n1		CHEMBL359797	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	1454144	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(NCCCN2CCCC2)n1		CHEMBL426969	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1454146	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(N(C)C2CCN(C)CC2)n1		CHEMBL366080	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	1454148	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	C=CCN(C)c1nccc(Nc2cc(NC(=O)c3ccnc(N4CCOCC4)c3)ccc2C)n1		CHEMBL182772	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	1454150	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(OCC(C)(C)CN(C)C)n1		CHEMBL362902	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	1454152	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(OCCCN(C)C)n1		CHEMBL186665	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1454154	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(OCC2CCCN(C)C2)n1		CHEMBL365614	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1454156	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ccnc(OC2CCN(C)CC2)n1		CHEMBL185315	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	1454158	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	CCCN1CCC(Oc2nccc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)n2)CC1		CHEMBL184725	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	1454160	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	CCCN1CCC(Oc2nccc(Nc3cc(NC(=O)c4cccc(N5CCOCC5)c4)ccc3C)n2)CC1		CHEMBL361431	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	1454162	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	CSc1nccc(Nc2cc(NC(=O)c3cc(F)cc(N4CCOCC4)c3)ccc2C)n1		CHEMBL187857	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1454268	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL186531	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	1454372	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cc(N3CCOCC3)cc(C(F)(F)F)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL365688	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1454377	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCCC3)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL184712	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1454382	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2ccccc2)cc1		CHEMBL365929	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1454384	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cccnc2)cc1		CHEMBL182396	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	1454391	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2ccncc2)cc1		CHEMBL186791	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1454392	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2ccncc2)cc1		CHEMBL183999	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1454807	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL183630	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1454813	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL184387	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1454818	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1nc(COc2ccc(C(=O)Nc3cc(NC(=O)c4cccc(N5CCOCC5)c4)ccc3C)cc2)cs1		CHEMBL264502	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	1454824	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	Cc1nc(COc2ccc(C(=O)Nc3cc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)ccc3C)cc2)cs1		CHEMBL445920	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	1454924	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	1454927	CHEMBL874544	Inhibitory concentration against alpha mitogen activated protein kinase p38 activity	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	uM	0.56
	1461157	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)N(C)c2cc(NC(=O)c3cccc(N(C)C)c3)ccc2C)cc1OC		CHEMBL187055	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1461158	CHEMBL829582	Concentration required to inhibit human mitogen activated protein kinase p38 activity 	B	COc1ccc(C(=O)Nc2ccc(C)c(NC(=O)c3cccc(N(C)C)c3)c2)cc1OC		CHEMBL186956	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1474739	CHEMBL832994	Inhibitory concentration against p38 alpha MAP kinase calculated by CoMFA model; FlexX score = -22.2kcal/mol 	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	uM	0.072
	1474873	CHEMBL829450	Inhibitory concentration against p38 alpha MAP kinase (Experimental value)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	uM	0.048
	1474874	CHEMBL832993	Inhibitory concentration against p38 alpha MAP kinase calculated by CoMFA model; FlexX score = -18.6kcal/mol 	B	Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1		CHEMBL416146	=	IC50	nM	530.0	CHEMBL260	Homo sapiens	IC50	uM	0.53
	1474875	CHEMBL833533	Inhibitory concentration against p38 alpha MAP kinase calculated by CoMFA model; FlexX score=-12.4 kcal/mol	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118	=	IC50	nM	810.0	CHEMBL260	Homo sapiens	IC50	uM	0.81
	1475826	CHEMBL830717	Percent inhibition against p38-alpha at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	-7.0	CHEMBL260	Homo sapiens	Inhibition	%	-7.0
	1489994	CHEMBL877307	Inhibition of MAP kinase p38 alpha	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	=	IC50	nM	4800.0	CHEMBL260	Homo sapiens	IC50	uM	4.8
	1497908	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)cc21		CHEMBL434957	=	IC50	nM	125.0	CHEMBL260	Homo sapiens	IC50	nM	125.0
	1498767	CHEMBL827915	Inhibition of Stress activated protein kinase 2a	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n(C2CCCC2)c1=O		CHEMBL365847	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1499698	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc21		CHEMBL364572	=	IC50	nM	4.9	CHEMBL260	Homo sapiens	IC50	nM	4.9
	1499807	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]cnc3-c3ccccc3)cc21		CHEMBL192848	=	IC50	nM	4.2	CHEMBL260	Homo sapiens	IC50	nM	4.2
	1499812	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]cnc3-c3ccc(F)cc3)cc21.CS(=O)(=O)O.CS(=O)(=O)O		CHEMBL192850	=	IC50	nM	4.3	CHEMBL260	Homo sapiens	IC50	nM	4.3
	1499817	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccc3nc(N)n(S(=O)(=O)C(C)C)c3c2)[nH]1.CS(=O)(=O)O		CHEMBL191053	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
	1499822	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)c1nc(-c2ccc(F)cc2)c(-c2ccc3nc(N)n(S(=O)(=O)C(C)C)c3c2)[nH]1.CS(=O)(=O)O		CHEMBL364925	=	IC50	nM	4.5	CHEMBL260	Homo sapiens	IC50	nM	4.5
	1499827	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)cc21.CS(=O)(=O)O.CS(=O)(=O)O		CHEMBL193055	=	IC50	nM	15.9	CHEMBL260	Homo sapiens	IC50	nM	15.9
	1499832	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3F)cc21.CS(=O)(=O)O		CHEMBL363831	=	IC50	nM	4.4	CHEMBL260	Homo sapiens	IC50	nM	4.4
	1499947	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)(C)c1nc(-c2ccc(F)cc2F)c(-c2ccc3nc(N)n(S(=O)(=O)C(C)(C)C)c3c2)[nH]1.CS(=O)(=O)O		CHEMBL190514	=	IC50	nM	4.8	CHEMBL260	Homo sapiens	IC50	nM	4.8
	1499955	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(Cl)cccc4Cl)nc3-c3ccccc3)cc21.CS(=O)(=O)O		CHEMBL192889	=	IC50	nM	15.3	CHEMBL260	Homo sapiens	IC50	nM	15.3
	1499961	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(C4CCNCC4)nc3-c3ccccc3)cc21		CHEMBL191113	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	1499966	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)CN1CCC(c2nc(-c3ccc4nc(N)n(S(=O)(=O)C(C)C)c4c3)c(-c3ccccc3)[nH]2)CC1		CHEMBL371145	=	IC50	nM	5.5	CHEMBL260	Homo sapiens	IC50	nM	5.5
	1499971	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CS(=O)(=O)O.CS(=O)(=O)O.Nc1nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc2n1S(=O)(=O)C1CCCC1		CHEMBL193247	=	IC50	nM	19.9	CHEMBL260	Homo sapiens	IC50	nM	19.9
	1499976	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CN(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc21.CS(=O)(=O)O.CS(=O)(=O)O		CHEMBL363852	=	IC50	nM	22.8	CHEMBL260	Homo sapiens	IC50	nM	22.8
	1499981	CHEMBL832299	Inhibition of human recombinant Mitogen activated protein kinase p38 alpha activity using ATP[gamma-33P] and EGFR 21mer-peptide	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)ncn3C)cc21		CHEMBL193305	=	IC50	nM	20.7	CHEMBL260	Homo sapiens	IC50	nM	20.7
	1512985	CHEMBL827996	Inhibition of Mitogen-activated protein kinase 14 (P38 alpha) at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	1520955	CHEMBL833059	Inhibition of mitogen-activated protein kinase p38 alpha	B	CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(Oc2ccccc2O)n1		CHEMBL371491	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	nM	460.0
	1520974	CHEMBL833059	Inhibition of mitogen-activated protein kinase p38 alpha	B	CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(Oc2cccc(O)c2)n1		CHEMBL197399	=	IC50	nM	520.0	CHEMBL260	Homo sapiens	IC50	nM	520.0
	1521102	CHEMBL833059	Inhibition of mitogen-activated protein kinase p38 alpha	B	CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL436102	=	IC50	nM	84.0	CHEMBL260	Homo sapiens	IC50	nM	84.0
	1521107	CHEMBL833059	Inhibition of mitogen-activated protein kinase p38 alpha	B	CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(N[C@H](C)c2ccccc2)n1		CHEMBL366003	=	IC50	nM	1700.0	CHEMBL260	Homo sapiens	IC50	nM	1700.0
	1521113	CHEMBL833059	Inhibition of mitogen-activated protein kinase p38 alpha	B	O=CCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(Oc2ccccc2)n1		CHEMBL196369	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	1601167	CHEMBL880634	Inhibitory concentration against p38 cytoplasmic sequence; Reported as mean (variability <15%)	B	CCc1c(NC(=O)OCCn2ccnc2)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12		CHEMBL412367	>	IC50	nM	25000.0	CHEMBL260	Homo sapiens	IC50	uM	25.0
	1606450	CHEMBL881761	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	Fc1ccc(-c2ncoc2-c2ccncc2)cc1		CHEMBL366007	=	IC50	nM	1460.0	CHEMBL260	Homo sapiens	IC50	nM	1460.0
	1606451	CHEMBL881761	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CC(C)n1c(=O)n(C)c2cc(-c3ocnc3-c3ccc(F)cc3)ccc21		CHEMBL195016	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	1606452	CHEMBL881761	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CC(C)n1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cc21		CHEMBL196210	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	1606453	CHEMBL881761	Inhibitory concentration against mitogen-activated protein kinase p38 alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL194322	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	1606845	CHEMBL882931	Inhibitory concentration against p38 alpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc(NC2CCCC2)c1C#N		CHEMBL383172	=	IC50	nM	4.1	CHEMBL260	Homo sapiens	IC50	uM	0.0041
	1608328	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccncc2)s1		CHEMBL198334	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	1608331	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(C)c2)s1		CHEMBL371209	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	1608334	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(F)c2)s1		CHEMBL198922	=	IC50	nM	94.0	CHEMBL260	Homo sapiens	IC50	nM	94.0
	1608337	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(N)c2)s1		CHEMBL197983	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	1608340	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(Cl)c2)s1		CHEMBL197776	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	nM	240.0
	1608343	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(C)=O)c2)s1		CHEMBL371920	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	nM	26.0
	1608349	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCC(=O)Nc1cc(-c2sc(CC)nc2-c2cccc(C)c2)ccn1		CHEMBL199160	=	IC50	nM	8.8	CHEMBL260	Homo sapiens	IC50	nM	8.8
	1608355	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCCC(=O)Nc1cc(-c2sc(CC)nc2-c2cccc(C)c2)ccn1		CHEMBL197772	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1608358	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)C3CCCCC3)c2)s1		CHEMBL198383	=	IC50	nM	7.9	CHEMBL260	Homo sapiens	IC50	nM	7.9
	1608364	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)Cc3ccccc3)c2)s1		CHEMBL197581	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
	1608370	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)CCc3ccccc3)c2)s1		CHEMBL194201	=	IC50	nM	8.1	CHEMBL260	Homo sapiens	IC50	nM	8.1
	1608376	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	IC50	nM	7.1	CHEMBL260	Homo sapiens	IC50	nM	7.1
	1608396	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(Cl)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL194595	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	1608402	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2ccccc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL371188	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	1608408	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL425909	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	1608414	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL197517	=	IC50	nM	91.0	CHEMBL260	Homo sapiens	IC50	nM	91.0
	1608420	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2ccccc2C)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL196386	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	1608423	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2ccc(C)cc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL196247	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	nM	210.0
	1608426	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(OC)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL369936	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	1608429	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2ccc(OC)cc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL197753	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	1608435	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(-c2nc(C)sc2-c2ccnc(NC(=O)c3ccccc3)c2)c1		CHEMBL383569	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1608441	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL197545	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1608444	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NCc3ccccc3)c2)s1		CHEMBL196576	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
	1608449	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NCCc3ccccc3)c2)s1		CHEMBL196575	=	IC50	nM	5.1	CHEMBL260	Homo sapiens	IC50	nM	5.1
	1608452	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NCCCc3ccccc3)c2)s1		CHEMBL381864	=	IC50	nM	8.1	CHEMBL260	Homo sapiens	IC50	nM	8.1
	1608455	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(N(C)C(=O)c3ccccc3)c2)s1		CHEMBL372384	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	1608458	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC3CCCC3)c2)s1		CHEMBL197912	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	1608464	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(N3CCCC3)c2)s1		CHEMBL370405	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	1608467	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(-c2nc(-c3ccc(S(C)(=O)=O)cc3)sc2-c2ccncc2)c1		CHEMBL195942	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	1608470	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(-c2nc(-c3ccc(S(C)(=O)=O)cc3)sc2-c2ccnc(C)c2)c1		CHEMBL364441	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	nM	26.0
	1608479	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(-c2nc(-c3ccc(S(C)(=O)=O)cc3)sc2-c2ccnc(NC(=O)c3ccccc3)c2)c1		CHEMBL371716	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	nM	37.0
	1608485	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(-c2nc(-c3ccc(S(C)(=O)=O)cc3)sc2-c2ccnc(NC(=O)Cc3ccccc3)c2)c1		CHEMBL197799	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	1608488	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(-c2nc(-c3ccc(S(C)(=O)=O)cc3)sc2-c2ccnc(NCc3ccccc3)c2)c1		CHEMBL198323	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	1608491	CHEMBL880637	In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha	B	Cc1cccc(-c2nc(-c3ccc(S(C)(=O)=O)cc3)sc2-c2ccnc(NCCc3ccccc3)c2)c1		CHEMBL382103	=	IC50	nM	9.1	CHEMBL260	Homo sapiens	IC50	nM	9.1
	1610379	CHEMBL881485	Inhibitory activity against Mitogen-activated protein kinase 14, p38-alpha	B	Fc1ccc(-c2cc(-c3ccc(Cl)cc3)[nH]c2-c2ccncc2)cc1		CHEMBL328126	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	nM	1400.0
	1610381	CHEMBL881485	Inhibitory activity against Mitogen-activated protein kinase 14, p38-alpha	B	O=C(O)c1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL423781	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	nM	90.0
Not Active	1610383	CHEMBL880625	Inhibitory activity against Mitogen-activated protein kinase 14, p38-alpha; No activity	B	CC(C)c1cc(-c2ccc(Cl)cc2)[nH]c1-c1ccncc1		CHEMBL158548		IC50	nM		CHEMBL260	Homo sapiens	IC50	nM	
	1615457	CHEMBL880234	Inhibitory activity against p38 at a concentration of 1.0 uM 	B	COc1ccc(COC[C@@H]2CCc3nc(-c4ccc(F)cc4)c(-c4ccnc(N)n4)n32)cc1		CHEMBL372082	=	IC50	nM	295.0	CHEMBL260	Homo sapiens	IC50	nM	295.0
	1615466	CHEMBL880234	Inhibitory activity against p38 at a concentration of 1.0 uM 	B	COc1ccc(COC[C@H]2CCc3nc(-c4ccc(F)cc4)c(-c4ccnc(N)n4)n32)cc1		CHEMBL198427	=	IC50	nM	116.0	CHEMBL260	Homo sapiens	IC50	nM	116.0
	1615469	CHEMBL880234	Inhibitory activity against p38 at a concentration of 1.0 uM 	B	CCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3n2[C@H](COCc2ccc(OC)cc2)CC3)n1		CHEMBL383348	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	nM	54.0
	1615472	CHEMBL880234	Inhibitory activity against p38 at a concentration of 1.0 uM 	B	CCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3n2[C@@H](COCc2ccc(OC)cc2)CC3)n1		CHEMBL198261	=	IC50	nM	217.0	CHEMBL260	Homo sapiens	IC50	nM	217.0
	1615475	CHEMBL880234	Inhibitory activity against p38 at a concentration of 1.0 uM 	B	CCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3n2[C@H](CO)CC3)n1		CHEMBL198756	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	1615478	CHEMBL880234	Inhibitory activity against p38 at a concentration of 1.0 uM 	B	CCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3n2[C@@H](CO)CC3)n1		CHEMBL383799	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	1615480	CHEMBL881781	Inhibitory concentration against p38 at a concentration of 1.0 uM 	B	[N-]=[N+]=Nc1cccc(-c2ncn(CCCNC(=O)c3ccc(I)cc3)c2-c2ccncc2)c1		CHEMBL371720	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	1617402	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	c1ccc(Nc2ccc3c(-c4ccccc4)n[nH]c3c2)cc1		CHEMBL383177	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	1617405	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	Clc1ccccc1Nc1ccc2c(-c3ccccc3)[nH]nc2c1		CHEMBL440566	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	1617408	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	COc1ccccc1Nc1ccc2c(-c3ccccc3)n[nH]c2c1		CHEMBL254443	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	nM	46.0
	1617411	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	O=C(O)c1ccc(-c2[nH]nc3cc(Nc4ccccc4Cl)ccc23)cc1		CHEMBL197698	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1617416	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	CN(C)CCNC(=O)c1ccc(-c2n[nH]c3cc(Nc4ccccc4Cl)ccc23)cc1		CHEMBL399167	=	IC50	nM	8.7	CHEMBL260	Homo sapiens	IC50	nM	8.7
	1617419	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	NC(=O)c1cccc(-c2[nH]nc3cc(Nc4ccccc4Cl)ccc23)c1		CHEMBL199136	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	1617422	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	O=C(O)c1cccc(-c2[nH]nc3cc(Nc4ccccc4Cl)ccc23)c1		CHEMBL197613	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	1617425	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	O=C(NCCCN1CCOCC1)c1cccc(-c2[nH]nc3cc(Nc4ccccc4Cl)ccc23)c1		CHEMBL198687	=	IC50	nM	3.7	CHEMBL260	Homo sapiens	IC50	nM	3.7
	1617428	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	CN(C)CCNC(=O)c1cccc(-c2[nH]nc3cc(Nc4ccccc4Cl)ccc23)c1		CHEMBL198821	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	1617431	CHEMBL881763	Inhibitory concentration against Mitogen-activated protein kinase p38 alpha	B	O=C(NC1CCNCC1)c1cccc(-c2n[nH]c3cc(Nc4ccccc4Cl)ccc23)c1		CHEMBL194806	=	IC50	nM	4.4	CHEMBL260	Homo sapiens	IC50	nM	4.4
Not Active	1650333	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1650334	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1650335	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1650336	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1650337	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1650338	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL260	Homo sapiens	Kd		
	1650339	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	260.0	CHEMBL260	Homo sapiens	Kd	uM	0.26
Not Active	1650340	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1650341	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1652050	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Kd			CHEMBL260	Homo sapiens	Kd		
	1652051	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	13.0	CHEMBL260	Homo sapiens	Kd	uM	0.013
	1652052	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	17.0	CHEMBL260	Homo sapiens	Kd	uM	0.017
	1652053	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	3.2	CHEMBL260	Homo sapiens	Kd	uM	0.0032
	1652054	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.24	CHEMBL260	Homo sapiens	Kd	uM	0.00024
Not Active	1652055	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1652056	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1652057	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1652058	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1652059	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	1652060	CHEMBL860914	Average Binding Constant for p38-alpha; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL260	Homo sapiens	Kd		
	1658801	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	1658802	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	CC(C)(CO)c1ccc(CNC(=O)c2ccc(Oc3ccccc3)cc2)cc1O		CHEMBL199229	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	1658803	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Nc1cccc(Oc2ccccc2)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL197336	=	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	1658804	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Nc1cccc(Oc2ccc(F)cc2F)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL198917	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1658805	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Nc1cccc(Oc2ccc(F)cc2)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL197277	=	IC50	nM	6000.0	CHEMBL260	Homo sapiens	IC50	uM	6.0
	1658806	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	CC(C)(CO)c1ccc(CNC(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)cc1O		CHEMBL198470	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	1658807	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=C(NCc1cccc(C(F)(F)F)c1)c1ccc(Oc2ccccc2)cc1		CHEMBL198563	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	1658808	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=C(NCc1cccc(OC(F)(F)F)c1)c1ccc(Oc2ccccc2)cc1		CHEMBL198832	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	1658809	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=C(NCc1ccc2c(c1)CCC2)c1ccc(Oc2ccccc2)cc1		CHEMBL197228	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	1658810	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=C(NCc1ccc(C(F)(F)F)cc1)c1ccc(Oc2ccccc2)cc1		CHEMBL199074	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	1658811	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	Cc1ccc(CNC(=O)c2ccc(Oc3ccccc3)cc2)cc1		CHEMBL199174	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	1658812	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=C(NCc1ccccn1)c1ccc(Oc2ccccc2)cc1		CHEMBL199237	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	1658813	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Nc1cccc(Oc2ccccc2Cl)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL197385	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1658814	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Cc1cccc(Oc2ccccc2)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL198567	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1658816	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Nc1cccc(Oc2ccccc2)c1)N1CCC(NCc2ccccc2)CC1		CHEMBL200648	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1658817	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Nc1cccc(Oc2cccc(C(F)(F)F)c2)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL200647	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1658818	CHEMBL860118	Inhibitory activity against p38alpha MAPK at 10 uM	B	O=S(=O)(Nc1cccc(Oc2ccccc2Cl)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL197385	=	Inhibition	%	37.0	CHEMBL260	Homo sapiens	Inhibition	%	37.0
Not Active	1658819	CHEMBL860118	Inhibitory activity against p38alpha MAPK at 10 uM	B	O=S(=O)(Cc1cccc(Oc2ccccc2)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL198567		Inhibition	%		CHEMBL260	Homo sapiens	Inhibition		
	1658820	CHEMBL860118	Inhibitory activity against p38alpha MAPK at 10 uM	B	O=S(=O)(Nc1cccc(Oc2ccccc2)c1)N1CCC(NCc2cccc3ccccc23)CC1		CHEMBL372145	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	Inhibition	%	24.0
	1658821	CHEMBL860118	Inhibitory activity against p38alpha MAPK at 10 uM	B	O=S(=O)(Nc1cccc(Oc2ccccc2)c1)N1CCC(NCc2ccccc2)CC1		CHEMBL200648	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	Inhibition	%	21.0
	1658822	CHEMBL860118	Inhibitory activity against p38alpha MAPK at 10 uM	B	O=S(=O)(Nc1cccc(Oc2cccc(C(F)(F)F)c2)c1)N1CCC(NCc2ccccc2O)CC1		CHEMBL200647	=	Inhibition	%	27.0	CHEMBL260	Homo sapiens	Inhibition	%	27.0
	1658824	CHEMBL860117	Inhibitory activity against p38-alpha MAPK	B	O=S(=O)(Nc1cccc(Oc2ccccc2)c1)N1CCC(NCc2cccc3ccccc23)CC1		CHEMBL372145	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
Not Determined	1662616	CHEMBL864557	Inhibitory activity against p38alpha	B	Cc1n[nH]c2sc(C(N)=O)cc12		CHEMBL198022		IC50			CHEMBL260	Homo sapiens	IC50		
	1662629	CHEMBL864557	Inhibitory activity against p38alpha	B	CN1CCN(C(=O)c2cc3c(-c4ccccc4)[nH]nc3s2)CC1		CHEMBL371239	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1662630	CHEMBL864557	Inhibitory activity against p38alpha	B	COc1ccc(CNC(=O)c2cc3c(-c4ccccc4)[nH]nc3s2)cc1		CHEMBL199383	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1662631	CHEMBL864557	Inhibitory activity against p38alpha	B	O=C(NCCc1ccccc1)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL197923	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
Not Determined	1662632	CHEMBL864557	Inhibitory activity against p38alpha	B	O=C(NCc1ccccc1)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL200499		IC50			CHEMBL260	Homo sapiens	IC50		
	1662633	CHEMBL864557	Inhibitory activity against p38alpha	B	O=C(NC1CCCCC1)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL199755	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	1662634	CHEMBL864557	Inhibitory activity against p38alpha	B	CCCCN(C)C(=O)c1cc2c(-c3ccccc3)[nH]nc2s1		CHEMBL199528	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
Not Determined	1662635	CHEMBL864557	Inhibitory activity against p38alpha	B	Cc1n[nH]c2sc(C(=O)NCc3ccccc3)cc12		CHEMBL373001		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	1662636	CHEMBL864557	Inhibitory activity against p38alpha	B	Cc1n[nH]c2sc(C(=O)NC3CCCCC3)cc12		CHEMBL199951		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	1662637	CHEMBL864557	Inhibitory activity against p38alpha	B	CCCCN(C)C(=O)c1cc2c(C)n[nH]c2s1		CHEMBL200657		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	1662638	CHEMBL864557	Inhibitory activity against p38alpha	B	CCCCNC(=O)c1cc2c(C)n[nH]c2s1		CHEMBL371242		IC50			CHEMBL260	Homo sapiens	IC50		
	1662763	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC1(C)C=C(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC(C)(C)N1		CHEMBL369989	=	IC50	nM	0.26	CHEMBL260	Homo sapiens	IC50	nM	0.26
	1662764	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199435	=	IC50	nM	1.87	CHEMBL260	Homo sapiens	IC50	nM	1.87
	1662765	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(Oc2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199707	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	1662766	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(F)cccc4F)c3c2)CC1		CHEMBL200534	=	IC50	nM	10.5	CHEMBL260	Homo sapiens	IC50	nM	10.5
	1662767	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL381201	=	IC50	nM	7.1	CHEMBL260	Homo sapiens	IC50	nM	7.1
	1662768	CHEMBL863917	Inhibition of P38 alpha MAPK	B	C[C@@H](C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199565	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	1662769	CHEMBL863917	Inhibition of P38 alpha MAPK	B	C[C@H](C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL200018	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	1662770	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL200047	=	IC50	nM	0.84	CHEMBL260	Homo sapiens	IC50	nM	0.84
	1662771	CHEMBL863917	Inhibition of P38 alpha MAPK	B	COC(=O)C(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199632	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
	1662772	CHEMBL863917	Inhibition of P38 alpha MAPK	B	COC(=O)C(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199316	=	IC50	nM	8.1	CHEMBL260	Homo sapiens	IC50	nM	8.1
	1662773	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccccc3Cl)n2)CC1		CHEMBL424666	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	1662774	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccc(F)cc3F)n2)CC1		CHEMBL199625	=	IC50	nM	0.51	CHEMBL260	Homo sapiens	IC50	nM	0.51
	1662775	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccc(F)cc3Cl)n2)CC1		CHEMBL199291	=	IC50	nM	0.38	CHEMBL260	Homo sapiens	IC50	nM	0.38
	1662776	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(F)cccc4F)c3c2)CC1		CHEMBL199484	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
	1662777	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(c2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199680	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	1662778	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199679	=	IC50	nM	0.14	CHEMBL260	Homo sapiens	IC50	nM	0.14
	1662779	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL381632	=	IC50	nM	0.31	CHEMBL260	Homo sapiens	IC50	nM	0.31
	1662780	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)(C)N1CC=C(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199593	=	IC50	nM	1.15	CHEMBL260	Homo sapiens	IC50	nM	1.15
	1662781	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CC(C)N1C2CCC1CC(c1cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c1)C2		CHEMBL380806	=	IC50	nM	0.51	CHEMBL260	Homo sapiens	IC50	nM	0.51
	1662782	CHEMBL863917	Inhibition of P38 alpha MAPK	B	CN1C2CCC1CC(c1cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c1)C2		CHEMBL200093	=	IC50	nM	0.61	CHEMBL260	Homo sapiens	IC50	nM	0.61
	1662783	CHEMBL863917	Inhibition of P38 alpha MAPK	B	O=c1ccc2c(-c3ccc(F)cc3Cl)cc(C3CC4CCC(C3)N4)cc2n1-c1c(Cl)cccc1Cl		CHEMBL199701	=	IC50	nM	0.45	CHEMBL260	Homo sapiens	IC50	nM	0.45
	1662784	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC1(C)C=C(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC(C)(C)N1		CHEMBL369989	=	IC50	nM	3.32	CHEMBL260	Homo sapiens	IC50	nM	3.32
	1662785	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199435	=	IC50	nM	0.77	CHEMBL260	Homo sapiens	IC50	nM	0.77
	1662786	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(Oc2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199707	=	IC50	nM	1.8	CHEMBL260	Homo sapiens	IC50	nM	1.8
	1662787	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(F)cccc4F)c3c2)CC1		CHEMBL200534	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	1662788	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL381201	=	IC50	nM	2.4	CHEMBL260	Homo sapiens	IC50	nM	2.4
	1662789	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	C[C@@H](C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199565	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	1662790	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	C[C@H](C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL200018	=	IC50	nM	3.8	CHEMBL260	Homo sapiens	IC50	nM	3.8
	1662791	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL200047	=	IC50	nM	3.75	CHEMBL260	Homo sapiens	IC50	nM	3.75
	1662792	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	COC(=O)C(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199632	=	IC50	nM	2.59	CHEMBL260	Homo sapiens	IC50	nM	2.59
	1662793	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	COC(=O)C(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199316	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	1662794	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccc(F)cc3F)n2)CC1		CHEMBL199625	=	IC50	nM	0.69	CHEMBL260	Homo sapiens	IC50	nM	0.69
	1662795	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccc(F)cc3Cl)n2)CC1		CHEMBL199291	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	1662796	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(F)cccc4F)c3c2)CC1		CHEMBL199484	=	IC50	nM	0.42	CHEMBL260	Homo sapiens	IC50	nM	0.42
	1662797	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(c2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199680	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	1662798	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199679	=	IC50	nM	1.7	CHEMBL260	Homo sapiens	IC50	nM	1.7
	1662799	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL381632	=	IC50	nM	0.27	CHEMBL260	Homo sapiens	IC50	nM	0.27
	1662800	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)(C)N1CC=C(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199593	=	IC50	nM	0.74	CHEMBL260	Homo sapiens	IC50	nM	0.74
	1662801	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CC(C)N1C2CCC1CC(c1cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c1)C2		CHEMBL380806	=	IC50	nM	0.99	CHEMBL260	Homo sapiens	IC50	nM	0.99
	1662802	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	CN1C2CCC1CC(c1cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c1)C2		CHEMBL200093	=	IC50	nM	0.82	CHEMBL260	Homo sapiens	IC50	nM	0.82
	1662803	CHEMBL863945	Inhibition of TNF alpha release in THP1 cells	F	O=c1ccc2c(-c3ccc(F)cc3Cl)cc(C3CC4CCC(C3)N4)cc2n1-c1c(Cl)cccc1Cl		CHEMBL199701	=	IC50	nM	0.89	CHEMBL260	Homo sapiens	IC50	nM	0.89
	1662804	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC1(C)C=C(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC(C)(C)N1		CHEMBL369989	=	IC50	nM	24.2	CHEMBL260	Homo sapiens	IC50	nM	24.2
	1662805	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(Oc2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199707	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1662806	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(F)cccc4F)c3c2)CC1		CHEMBL200534	=	IC50	nM	18.4	CHEMBL260	Homo sapiens	IC50	nM	18.4
	1662807	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(Oc2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL381201	=	IC50	nM	16.2	CHEMBL260	Homo sapiens	IC50	nM	16.2
	1662808	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	C[C@@H](C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199565	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	1662809	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	C[C@H](C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL200018	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	1662810	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C(=O)O)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL200047	=	IC50	nM	79.1	CHEMBL260	Homo sapiens	IC50	nM	79.1
	1662811	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	COC(=O)C(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199632	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	1662812	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	COC(=O)C(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199316	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	1662813	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccccc3Cl)n2)CC1		CHEMBL424666	=	IC50	nM	6.8	CHEMBL260	Homo sapiens	IC50	nM	6.8
	1662814	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccc(F)cc3F)n2)CC1		CHEMBL199625	=	IC50	nM	5.2	CHEMBL260	Homo sapiens	IC50	nM	5.2
	1662815	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(c2cc3c(ccc(=O)n3-c3c(Cl)cccc3Cl)c(-c3ccc(F)cc3Cl)n2)CC1		CHEMBL199291	=	IC50	nM	5.3	CHEMBL260	Homo sapiens	IC50	nM	5.3
	1662816	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(F)cccc4F)c3c2)CC1		CHEMBL199484	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	1662817	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(c2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199680	=	IC50	nM	6.4	CHEMBL260	Homo sapiens	IC50	nM	6.4
	1662818	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199679	=	IC50	nM	2.4	CHEMBL260	Homo sapiens	IC50	nM	2.4
	1662819	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL381632	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	1662820	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)(C)N1CC=C(c2cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199593	=	IC50	nM	50.8	CHEMBL260	Homo sapiens	IC50	nM	50.8
	1662821	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CC(C)N1C2CCC1CC(c1cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c1)C2		CHEMBL380806	=	IC50	nM	8.51	CHEMBL260	Homo sapiens	IC50	nM	8.51
	1662822	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	CN1C2CCC1CC(c1cc(-c3ccc(F)cc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c1)C2		CHEMBL200093	=	IC50	nM	7.71	CHEMBL260	Homo sapiens	IC50	nM	7.71
	1662823	CHEMBL863946	Inhibition of LPS stimulated TNF alpha release in whole blood	F	O=c1ccc2c(-c3ccc(F)cc3Cl)cc(C3CC4CCC(C3)N4)cc2n1-c1c(Cl)cccc1Cl		CHEMBL199701	=	IC50	nM	14.5	CHEMBL260	Homo sapiens	IC50	nM	14.5
	1665732	CHEMBL860230	Inhibition of SAPK2a at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	1666388	CHEMBL865778	Inhibition of p38-alpha MAPK activity at 10 uM	B	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl		CHEMBL373011	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	Inhibition	%	95.0
	1666389	CHEMBL865778	Inhibition of p38-alpha MAPK activity at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	46.0	CHEMBL260	Homo sapiens	Inhibition	%	46.0
	1671487	CHEMBL858540	Inhibition of SAPK2a/p38 at 10 uM	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	Inhibition	%	20.0	CHEMBL260	Homo sapiens	Inhibition	%	20.0
	1671516	CHEMBL858540	Inhibition of SAPK2a/p38 at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	Inhibition	%	10.0
	1671540	CHEMBL858540	Inhibition of SAPK2a/p38 at 10 uM	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	Inhibition	%	3.0
	1671632	CHEMBL858540	Inhibition of SAPK2a/p38 at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	Inhibition	%	-3.0	CHEMBL260	Homo sapiens	Inhibition	%	-3.0
	1678211	CHEMBL862114	Inhibitory activity against p38-alpha MAPK	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	1688903	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccccc2)cnn1-c1ccccc1		CHEMBL203333	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	1688961	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2ccccc2)cnn1-c1ccccc1		CHEMBL203333	=	IC50	nM	570.0	CHEMBL260	Homo sapiens	IC50	uM	0.57
	1688962	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	COc1ccccc1-n1ncc(C(=O)c2ccccc2)c1N		CHEMBL383024	=	IC50	nM	530.0	CHEMBL260	Homo sapiens	IC50	uM	0.53
	1688963	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	COc1ccc(-n2ncc(C(=O)c3ccccc3)c2N)cc1		CHEMBL203864	=	IC50	nM	640.0	CHEMBL260	Homo sapiens	IC50	uM	0.64
	1688964	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2ccccc2)cnn1-c1ccccc1F		CHEMBL204345	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	uM	0.56
	1688965	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2ccccc2)cnn1-c1cccc(F)c1		CHEMBL204901	=	IC50	nM	1590.0	CHEMBL260	Homo sapiens	IC50	uM	1.59
	1688966	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2ccccc2)cnn1-c1ccc(F)cc1		CHEMBL424677	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	1688967	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2ccccc2)cnn1-c1cccc([N+](=O)[O-])c1		CHEMBL202684	>	IC50	nM	56000.0	CHEMBL260	Homo sapiens	IC50	uM	56.0
	1688968	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Cc1ccccc1-n1ncc(C(=O)c2ccccc2)c1N		CHEMBL408417	=	IC50	nM	510.0	CHEMBL260	Homo sapiens	IC50	uM	0.51
	1688969	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(/C(=N/O)c2ccccc2)cnn1-c1ccccc1		CHEMBL202863	>	IC50	nM	18000.0	CHEMBL260	Homo sapiens	IC50	uM	18.0
	1688972	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	COc1ccccc1-n1ncc(C(=O)c2ccccc2)c1N		CHEMBL383024	=	IC50	nM	8380.0	CHEMBL260	Homo sapiens	IC50	uM	8.38
	1688973	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	COc1ccc(-n2ncc(C(=O)c3ccccc3)c2N)cc1		CHEMBL203864	=	IC50	nM	7060.0	CHEMBL260	Homo sapiens	IC50	uM	7.06
	1688974	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccccc2)cnn1-c1ccccc1F		CHEMBL204345	=	IC50	nM	2860.0	CHEMBL260	Homo sapiens	IC50	uM	2.86
	1688975	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccccc2)cnn1-c1cccc(F)c1		CHEMBL204901	=	IC50	nM	6700.0	CHEMBL260	Homo sapiens	IC50	uM	6.7
	1688976	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccccc2)cnn1-c1ccc(F)cc1		CHEMBL424677	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	uM	1.1
	1688977	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccccc2)cnn1-c1cccc([N+](=O)[O-])c1		CHEMBL202684	=	IC50	nM	64200.0	CHEMBL260	Homo sapiens	IC50	uM	64.2
	1688978	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Cc1ccccc1-n1ncc(C(=O)c2ccccc2)c1N		CHEMBL408417	=	IC50	nM	1080.0	CHEMBL260	Homo sapiens	IC50	uM	1.08
	1688979	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(/C(=N/O)c2ccccc2)cnn1-c1ccccc1		CHEMBL202863	=	IC50	nM	51000.0	CHEMBL260	Homo sapiens	IC50	uM	51.0
	1688980	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Cc1[nH]n(-c2ccccc2)c(=O)c1C(=O)c1ccccc1		CHEMBL3144705	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	1688981	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	N#Cc1c(C(=O)c2ccccc2)cnn1-c1ccccc1		CHEMBL203735	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	1689016	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	700.0	CHEMBL260	Homo sapiens	IC50	uM	0.7
	1689017	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(OC[C@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL205133	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	1689018	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(C(O)(CO)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL205024	=	IC50	nM	9540.0	CHEMBL260	Homo sapiens	IC50	uM	9.54
	1689019	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(C(O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203508	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	uM	3.5
	1689020	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	CC(C)(O)CCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL438628	=	IC50	nM	590.0	CHEMBL260	Homo sapiens	IC50	uM	0.59
	1689021	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(CCC3(O)CCCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL203908	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	1689022	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	CS(=O)(=O)CCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL202851	=	IC50	nM	790.0	CHEMBL260	Homo sapiens	IC50	uM	0.79
	1689023	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(CCS(N)(=O)=O)c2)cnn1-c1ccc(F)cc1		CHEMBL380850	=	IC50	nM	1250.0	CHEMBL260	Homo sapiens	IC50	uM	1.25
	1689024	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(CCO)c2)cnn1-c1ccc(F)cc1		CHEMBL380849	=	IC50	nM	850.0	CHEMBL260	Homo sapiens	IC50	uM	0.85
	1689025	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(-c3ccc[n+]([O-])c3)c2)cnn1-c1ccc(F)cc1F		CHEMBL380755	=	IC50	nM	340.0	CHEMBL260	Homo sapiens	IC50	uM	0.34
	1689026	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(-c3cccnc3)c2)cnn1-c1ccc(F)cc1F		CHEMBL203926	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	1689027	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(-c3ccncc3)c2)cnn1-c1ccc(F)cc1F		CHEMBL206187	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	uM	0.31
	1689028	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(-c3ccncc3)c2)cnn1-c1ccc(F)cc1		CHEMBL203344	=	IC50	nM	1280.0	CHEMBL260	Homo sapiens	IC50	uM	1.28
	1689029	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccc(-c3cccnc3)cc2)cnn1-c1ccc(F)cc1		CHEMBL203978	=	IC50	nM	980.0	CHEMBL260	Homo sapiens	IC50	uM	0.98
	1689030	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(-c3cccnc3)c2)cnn1-c1ccc(F)cc1		CHEMBL206339	=	IC50	nM	780.0	CHEMBL260	Homo sapiens	IC50	uM	0.78
	1689031	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(OCCN3CCCCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL274506	=	IC50	nM	1840.0	CHEMBL260	Homo sapiens	IC50	uM	1.84
	1689032	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(CCCN3CCOCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL203932	=	IC50	nM	1740.0	CHEMBL260	Homo sapiens	IC50	uM	1.74
	1689033	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccc(C#CCN3CCOCC3)cc2)cnn1-c1ccc(F)cc1		CHEMBL204600	=	IC50	nM	3130.0	CHEMBL260	Homo sapiens	IC50	uM	3.13
	1689034	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(C#CCN3CCOCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL383844	=	IC50	nM	1720.0	CHEMBL260	Homo sapiens	IC50	uM	1.72
	1689035	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(C#CCN3CCCCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL382175	=	IC50	nM	1320.0	CHEMBL260	Homo sapiens	IC50	uM	1.32
	1689036	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	CN1CCN(c2cccc(C(=O)c3cnn(-c4ccc(F)cc4)c3N)c2)CC1		CHEMBL426122	=	IC50	nM	2650.0	CHEMBL260	Homo sapiens	IC50	uM	2.65
	1689037	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	CN(C)CC#Cc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL203133	=	IC50	nM	2280.0	CHEMBL260	Homo sapiens	IC50	uM	2.28
	1689038	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(C#CCO)c2)cnn1-c1ccc(F)cc1		CHEMBL202737	=	IC50	nM	4040.0	CHEMBL260	Homo sapiens	IC50	uM	4.04
	1689039	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	N#Cc1ccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)cc1		CHEMBL205922	=	IC50	nM	8380.0	CHEMBL260	Homo sapiens	IC50	uM	8.38
	1689040	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	N#Cc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL203721	=	IC50	nM	4760.0	CHEMBL260	Homo sapiens	IC50	uM	4.76
	1689041	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	CN1CCN(CCc2cccc(C(=O)c3cnn(-c4ccc(F)cc4)c3N)c2)CC1		CHEMBL425401	=	IC50	nM	1640.0	CHEMBL260	Homo sapiens	IC50	uM	1.64
	1689042	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	NCCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL380531	=	IC50	nM	2440.0	CHEMBL260	Homo sapiens	IC50	uM	2.44
	1689043	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	CN1CCN(c2cccc(C(=O)c3cnn(-c4ccc(F)cc4)c3N)c2)CC1		CHEMBL426122	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	uM	2.0
	1689044	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2cccc(OCCN3CCOCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL203770	=	IC50	nM	1270.0	CHEMBL260	Homo sapiens	IC50	uM	1.27
	1689045	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	1689046	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(OC[C@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL205133	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	1689047	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(C(O)(CO)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL205024	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1689048	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(C(O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203508	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	1689049	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	CC(C)(O)CCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL438628	=	IC50	nM	6590.0	CHEMBL260	Homo sapiens	IC50	uM	6.59
	1689050	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(CCC3(O)CCCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL203908	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	1689051	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	CS(=O)(=O)CCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL202851	=	IC50	nM	520.0	CHEMBL260	Homo sapiens	IC50	uM	0.52
	1689052	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(CCS(N)(=O)=O)c2)cnn1-c1ccc(F)cc1		CHEMBL380850	=	IC50	nM	510.0	CHEMBL260	Homo sapiens	IC50	uM	0.51
	1689053	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(CCO)c2)cnn1-c1ccc(F)cc1		CHEMBL380849	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	1689054	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(-c3ccc[n+]([O-])c3)c2)cnn1-c1ccc(F)cc1F		CHEMBL380755	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	1689055	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(-c3cccnc3)c2)cnn1-c1ccc(F)cc1F		CHEMBL203926	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	1689056	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(-c3ccncc3)c2)cnn1-c1ccc(F)cc1F		CHEMBL206187	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1689057	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(-c3ccncc3)c2)cnn1-c1ccc(F)cc1		CHEMBL203344	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1689058	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2ccc(-c3cccnc3)cc2)cnn1-c1ccc(F)cc1		CHEMBL203978	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	1689059	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(-c3cccnc3)c2)cnn1-c1ccc(F)cc1		CHEMBL206339	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	uM	0.047
	1689060	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(OCCN3CCCCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL274506	=	IC50	nM	1410.0	CHEMBL260	Homo sapiens	IC50	uM	1.41
	1689061	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(CCCN3CCOCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL203932	=	IC50	nM	1040.0	CHEMBL260	Homo sapiens	IC50	uM	1.04
	1689062	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2ccc(C#CCN3CCOCC3)cc2)cnn1-c1ccc(F)cc1		CHEMBL204600	=	IC50	nM	11220.0	CHEMBL260	Homo sapiens	IC50	uM	11.22
	1689063	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(C#CCN3CCOCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL383844	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	1689064	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(C#CCN3CCCCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL382175	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	1689065	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	CN1CCN(c2cccc(C(=O)c3cnn(-c4ccc(F)cc4)c3N)c2)CC1		CHEMBL426122	=	IC50	nM	780.0	CHEMBL260	Homo sapiens	IC50	uM	0.78
	1689066	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	CN(C)CC#Cc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL203133	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	1689067	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(C#CCO)c2)cnn1-c1ccc(F)cc1		CHEMBL202737	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	1689068	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	N#Cc1ccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)cc1		CHEMBL205922	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	1689069	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	N#Cc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL203721	=	IC50	nM	2780.0	CHEMBL260	Homo sapiens	IC50	uM	2.78
	1689070	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	CN1CCN(CCc2cccc(C(=O)c3cnn(-c4ccc(F)cc4)c3N)c2)CC1		CHEMBL425401	=	IC50	nM	360.0	CHEMBL260	Homo sapiens	IC50	uM	0.36
	1689071	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	NCCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL380531	=	IC50	nM	520.0	CHEMBL260	Homo sapiens	IC50	uM	0.52
	1689072	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	CN1CCN(c2cccc(C(=O)c3cnn(-c4ccc(F)cc4)c3N)c2)CC1		CHEMBL426122	=	IC50	nM	1210.0	CHEMBL260	Homo sapiens	IC50	uM	1.21
	1689073	CHEMBL859668	Inhibition of LPS-induced TNFalpha production in THP1 cells	F	Nc1c(C(=O)c2cccc(OCCN3CCOCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL203770	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	uM	0.37
	1689129	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	Nc1c(C(=O)c2cccc(CCO)c2)cnn1-c1ccc(F)cc1		CHEMBL380849	=	IC50	nM	690.0	CHEMBL260	Homo sapiens	IC50	uM	0.69
	1689130	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	570.0	CHEMBL260	Homo sapiens	IC50	uM	0.57
	1689133	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Nc1c(C(=O)c2ccc(CCCN3CCOCC3)cc2)cnn1-c1ccc(F)cc1		CHEMBL204311	=	IC50	nM	22300.0	CHEMBL260	Homo sapiens	IC50	uM	22.3
	1689136	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	Nc1c(C(=O)c2cccc(OC[C@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL205133	=	IC50	nM	760.0	CHEMBL260	Homo sapiens	IC50	uM	0.76
	1689137	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	Nc1c(C(=O)c2cccc(C(O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203508	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	1689138	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	CC(C)(O)CCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL438628	=	IC50	nM	920.0	CHEMBL260	Homo sapiens	IC50	uM	0.92
	1689139	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	Nc1c(C(=O)c2cccc(CCC3(O)CCCC3)c2)cnn1-c1ccc(F)cc1		CHEMBL203908	=	IC50	nM	4640.0	CHEMBL260	Homo sapiens	IC50	uM	4.64
	1689140	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	CS(=O)(=O)CCc1cccc(C(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL202851	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	1689141	CHEMBL859670	Inhibition of LPS-induced IL1-beta production in human whole blood	F	Nc1c(C(=O)c2cccc(CCS(N)(=O)=O)c2)cnn1-c1ccc(F)cc1		CHEMBL380850	=	IC50	nM	3600.0	CHEMBL260	Homo sapiens	IC50	uM	3.6
	1689241	CHEMBL859283	Displacement of [33P] ATP from human recombinant active p38alpha	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1689297	CHEMBL862332	Inhibition of LPS-induced TNFalpha production in human whole blood	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	1970.0	CHEMBL260	Homo sapiens	IC50	uM	1.97
	1689298	CHEMBL862333	Inhibition of LPS-induced TNFalpha production in human PBMC	F	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	1689299	CHEMBL862334	Inhibition of LPS-induced IL1-beta production in human PBMC	F	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	1689333	CHEMBL862346	Inhibition of p38-alpha at 10 uM	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	Kd	nM	200.0	CHEMBL260	Homo sapiens	Kd	uM	0.2
Active	1690606	CHEMBL861432	Ability to bind to phosphorylated p38alpha	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567		Activity			CHEMBL260	Homo sapiens	Activity		
Active	1690607	CHEMBL861433	Ability to bind to unphosphorylated p38alpha	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567		Activity			CHEMBL260	Homo sapiens	Activity		
	1693546	CHEMBL862178	Inhibition of p38alpha	B	CO[C@H]1CC[C@@H](C(=O)Nc2cc(-c3ccnc(Nc4ccc(F)cc4)c3)ccn2)CC1		CHEMBL202676	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	1693567	CHEMBL862178	Inhibition of p38alpha	B	O=C(Nc1cc(-c2ccnc(Nc3ccc(F)cc3)c2)ccn1)C1CCOCC1		CHEMBL205078	=	IC50	nM	199.0	CHEMBL260	Homo sapiens	IC50	nM	199.0
	1693568	CHEMBL862178	Inhibition of p38alpha	B	O=C(Nc1cc(-c2ccnc(Nc3ccccc3)c2)ccn1)C1CCOCC1		CHEMBL203059	=	IC50	nM	251.0	CHEMBL260	Homo sapiens	IC50	nM	251.0
	1693569	CHEMBL862178	Inhibition of p38alpha	B	O=C(Nc1cc(-c2ccnc(Nc3ccc(F)cc3)c2)ccn1)C1CCOC1		CHEMBL203839	=	IC50	nM	581.0	CHEMBL260	Homo sapiens	IC50	nM	581.0
	1693570	CHEMBL862178	Inhibition of p38alpha	B	O=C(Nc1cc(-c2ccnc(Nc3ccccc3)c2)ccn1)C1CCOC1		CHEMBL203535	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
	1693571	CHEMBL862178	Inhibition of p38alpha	B	CC(=O)N1CCC[C@H](C(=O)Nc2cc(-c3ccnc(Nc4ccc(F)cc4)c3)ccn2)C1		CHEMBL202666	=	IC50	nM	162.0	CHEMBL260	Homo sapiens	IC50	nM	162.0
	1693572	CHEMBL862178	Inhibition of p38alpha	B	CC(=O)N1CCC[C@@H](C(=O)Nc2cc(-c3ccnc(Nc4ccc(F)cc4)c3)ccn2)C1		CHEMBL202639	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	1693573	CHEMBL862178	Inhibition of p38alpha	B	CC(=O)N1CCCC(C(=O)Nc2cc(-c3ccnc(Nc4ccc(F)cc4)c3)ccn2)C1		CHEMBL206466	=	IC50	nM	171.0	CHEMBL260	Homo sapiens	IC50	nM	171.0
Not Determined	1693574	CHEMBL862178	Inhibition of p38alpha	B	CC(=O)N1CCCCC1C(=O)Nc1cc(-c2ccnc(Nc3ccccc3)c2)ccn1		CHEMBL383678		IC50			CHEMBL260	Homo sapiens	IC50		
	1693575	CHEMBL862178	Inhibition of p38alpha	B	CC(=O)N1CCCC(C(=O)Nc2cc(-c3ccnc(Nc4ccccc4)c3)ccn2)C1		CHEMBL203225	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	nM	37.0
Not Determined	1693576	CHEMBL862178	Inhibition of p38alpha	B	CO[C@H]1CC[C@H](C(=O)Nc2cc(-c3ccnc(Nc4ccc(F)cc4)c3)ccn2)CC1		CHEMBL203631		IC50			CHEMBL260	Homo sapiens	IC50		
	1693647	CHEMBL862178	Inhibition of p38alpha	B	O=C(Nc1cc(-c2ccnc(Nc3ccc(F)cc3)c2)ccn1)C1CCOC1		CHEMBL203839	=	IC50	nM	421.0	CHEMBL260	Homo sapiens	IC50	nM	421.0
Not Determined	1699046	CHEMBL862178	Inhibition of p38alpha	B	CC(=O)N1CCC(C(=O)Nc2cc(-c3ccnc(Nc4ccccc4)c3)ccn2)CC1		CHEMBL204757		IC50			CHEMBL260	Homo sapiens	IC50		
	1699572	CHEMBL861581	Inhibition of P38-alpha at 10 uM in presence of 100 uM ATP	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	Inhibition	%	73.0	CHEMBL260	Homo sapiens	Inhibition	%	73.0
	1699575	CHEMBL860674	Displacement of rhodamine green fluorescently labeled ATP from recombinant GST-p38alpha	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	IC50	nM	7280.0	CHEMBL260	Homo sapiens	IC50	uM	7.28
	1734081	CHEMBL862835	Residual activity at human SAPK2a at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	84.0	CHEMBL260	Homo sapiens	Activity	%	84.0
	1735021	CHEMBL854498	Activity against SAPK2-alpha at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cc(/C=C2\C(=O)NN(c3ccc(Cl)c(Cl)c3)C2=O)ccc1O		CHEMBL380093	=	Activity	%	112.0	CHEMBL260	Homo sapiens	Activity	%	112.0
	1735040	CHEMBL854498	Activity against SAPK2-alpha at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cccc(NC(=O)Nc2nnc(-c3ccncc3)s2)c1		CHEMBL377430	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	1742897	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(C)C(=O)Nc2ccccc2C)n1		CHEMBL210589	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742899	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(N)C(=O)Nc2ccccc2Cl)n1		CHEMBL378853	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742901	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	C[C@H](Nc1nccc(N(C(=O)Nc2ccccc2Cl)c2cccc(F)c2)n1)c1ccccc1		CHEMBL208932	=	IC50	nM	6160.0	CHEMBL260	Homo sapiens	IC50	uM	6.16
	1742903	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	Cc1ccccc1NC(=O)N(c1ccc(N(C)C)cc1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL427403	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742905	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(C(=O)Nc2ccccc2Cl)c2ccc(N(C)C)cc2)n1		CHEMBL438058	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742907	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(C(=O)Nc2ccccc2C)c2ccccc2)n1		CHEMBL212148	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	1742909	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	C[C@H](Nc1nccc(N(C(=O)Nc2ccccc2Cl)c2ccccc2)n1)C(C)(C)O		CHEMBL378315	=	IC50	nM	718.0	CHEMBL260	Homo sapiens	IC50	uM	0.718
	1742910	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COc1ccc(N(C(=O)Nc2ccccc2C)c2ccnc(N[C@@H](C)C(C)(C)O)n2)cc1		CHEMBL211109	=	IC50	nM	135.0	CHEMBL260	Homo sapiens	IC50	uM	0.135
	1742912	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COc1ccc(N(C(=O)Nc2ccccc2Cl)c2ccnc(N[C@@H](C)C(C)(C)O)n2)cc1		CHEMBL379760	=	IC50	nM	92.0	CHEMBL260	Homo sapiens	IC50	uM	0.092
	1742914	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	O=C(Nc1ccccc1Cl)N(c1ccc(F)cc1)c1ccnc(N2CCOCC2)n1		CHEMBL208737	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742916	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	CN1CCN(c2nccc(N(C(=O)Nc3ccccc3Cl)c3ccc(F)cc3)n2)CC1		CHEMBL208736	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742918	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	CCCS(=O)(=O)N1CCC(Nc2nccc(N(C(=O)Nc3ccccc3Cl)c3ccc(F)cc3)n2)CC1		CHEMBL212150	=	IC50	nM	1420.0	CHEMBL260	Homo sapiens	IC50	uM	1.42
	1742920	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	CCOC(=O)N1CCC(Nc2nccc(N(C(=O)Nc3ccccc3Cl)c3ccc(F)cc3)n2)CC1		CHEMBL212099	=	IC50	nM	3160.0	CHEMBL260	Homo sapiens	IC50	uM	3.16
	1742922	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	O=C(Nc1ccccc1Cl)N(c1ccc(F)cc1)c1ccnc(NC2CCOCC2)n1		CHEMBL209260	=	IC50	nM	539.0	CHEMBL260	Homo sapiens	IC50	uM	0.539
	1742924	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	C[C@H](Nc1nccc(N(C(=O)Nc2ccccc2Cl)c2ccc(F)cc2)n1)c1ccccc1		CHEMBL211944	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742926	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	C[C@H](Nc1nccc(N(C(=O)Nc2ccccc2Cl)c2ccc(F)cc2)n1)c1ccccc1		CHEMBL211944	=	IC50	nM	843.0	CHEMBL260	Homo sapiens	IC50	uM	0.843
	1742927	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccc(F)cc2)n1		CHEMBL378776	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	1742929	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(C(=O)Nc2ccccc2F)c2ccc(F)cc2)n1		CHEMBL209612	=	IC50	nM	2880.0	CHEMBL260	Homo sapiens	IC50	uM	2.88
	1742932	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(C(=O)Nc2ccccc2C)c2ccc(F)cc2)n1		CHEMBL212636	=	IC50	nM	3650.0	CHEMBL260	Homo sapiens	IC50	uM	3.65
	1742933	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	COC[C@H](C)Nc1nccc(N(C(=O)Nc2ccccc2Cl)c2ccc(F)cc2)n1		CHEMBL385138	=	IC50	nM	3100.0	CHEMBL260	Homo sapiens	IC50	uM	3.1
	1742934	CHEMBL868680	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells at 1 uM	F	C[C@H](Nc1nccc(N(C(=O)Nc2c(Cl)cccc2Cl)c2ccc(F)cc2)n1)C(C)(C)O		CHEMBL380154	=	Inhibition	%	63.0	CHEMBL260	Homo sapiens	Inhibition	%	63.0
	1742935	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	Cc1ccccc1NC(=O)N(c1ccc(F)cc1)c1ccnc(N[C@@H](C)C(C)(C)O)n1		CHEMBL211741	=	IC50	nM	176.0	CHEMBL260	Homo sapiens	IC50	uM	0.176
	1742937	CHEMBL868679	Inhibition of LPS-stimulated TNFalpha production in human THP1 cells	F	C[C@H](Nc1nccc(N(C(=O)Nc2ccccc2Cl)c2ccc(F)cc2)n1)C(C)(C)O		CHEMBL211282	=	IC50	nM	122.0	CHEMBL260	Homo sapiens	IC50	uM	0.122
	1748814	CHEMBL870979	Inhibition of p38alpha	B	COc1ccccc1N(C(=O)Oc1c(C)cccc1C)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL211460	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	uM	0.42
	1748815	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)cc1		CHEMBL215847	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	1748816	CHEMBL870979	Inhibition of p38alpha	B	Cc1cccc(C)c1OC(=O)N(c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1)c1ccc(F)cc1OC(C)C		CHEMBL263769	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	1748817	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1		CHEMBL213100	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	1748818	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(OC)c(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1		CHEMBL442485	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	1748819	CHEMBL870979	Inhibition of p38alpha	B	Cc1cccc(C)c1OC(=O)N(c1ccc2ccccc2c1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL377481	=	IC50	nM	740.0	CHEMBL260	Homo sapiens	IC50	uM	0.74
	1748820	CHEMBL870979	Inhibition of p38alpha	B	Cc1cccc(C)c1OC(=O)N(c1ccc(-c2ccccc2)cc1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL209908	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	uM	1.8
	1748821	CHEMBL870979	Inhibition of p38alpha	B	Cc1cccc(C)c1OC(=O)N(c1cccc(-c2ccccc2)c1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL215726	=	IC50	nM	8000.0	CHEMBL260	Homo sapiens	IC50	uM	8.0
	1748822	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL215730	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	uM	0.44
	1748823	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(N4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL385898	=	IC50	nM	430.0	CHEMBL260	Homo sapiens	IC50	uM	0.43
	1748824	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)c(F)c3)n2)c(OC)c1		CHEMBL211845	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	1748825	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCN(C)C)cc3)n2)c(OC)c1		CHEMBL212721	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	uM	2.1
	1748826	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN(C)C)cc3)n2)c(OC)c1		CHEMBL214775	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	uM	2.1
	1748827	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCN4CCN(C)CC4)cc3)n2)c(OC)c1		CHEMBL212668	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	1748828	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL212143	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	1748829	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCN4CCOCC4)c(OC)c3)n2)c(OC)c1		CHEMBL264803	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	1748830	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCN4CCCCC4)cc3)n2)c(OC)c1		CHEMBL379733	=	IC50	nM	3200.0	CHEMBL260	Homo sapiens	IC50	uM	3.2
	1748831	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL379080	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	1748832	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3cc(OC)c(OCCCN4CCN(C)CC4)c(OC)c3)n2)c(OC)c1		CHEMBL386760	=	IC50	nM	530.0	CHEMBL260	Homo sapiens	IC50	uM	0.53
	1748833	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN4CCN(C)CC4)c(F)c3)n2)c(OC)c1		CHEMBL215289	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	1748834	CHEMBL870979	Inhibition of p38alpha	B	COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(OCCCN4CCCCC4)c(F)c3)n2)c(OC)c1		CHEMBL215411	=	IC50	nM	6800.0	CHEMBL260	Homo sapiens	IC50	uM	6.8
	1751763	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3cnoc3-c3cc(F)ccc3F)cn12		CHEMBL386033	=	IC50	nM	33.2	CHEMBL260	Homo sapiens	IC50	nM	33.2
	1751800	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	=	IC50	nM	2.8	CHEMBL260	Homo sapiens	IC50	nM	2.8
	1751841	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(N4CCCC4)n3c2)cc1		CHEMBL386807	=	IC50	nM	15.4	CHEMBL260	Homo sapiens	IC50	nM	15.4
	1751894	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3[nH]cnc3-c3cc(F)ccc3F)cn12		CHEMBL214152	=	IC50	nM	6.2	CHEMBL260	Homo sapiens	IC50	nM	6.2
	1751901	CHEMBL868607	Inhibition of p38alpha	B	Cc1cccc(-c2ncoc2-c2ccc3nnc(C(C)C)n3c2)c1		CHEMBL377875	=	IC50	nM	18.3	CHEMBL260	Homo sapiens	IC50	nM	18.3
	1751902	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL194322	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	1751903	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cccc(F)c3)cn12		CHEMBL384117	=	IC50	nM	37.8	CHEMBL260	Homo sapiens	IC50	nM	37.8
	1751904	CHEMBL868607	Inhibition of p38alpha	B	Cc1cc(-c2ncoc2-c2ccc3nnc(C(C)C)n3c2)ccc1F		CHEMBL215858	=	IC50	nM	6.6	CHEMBL260	Homo sapiens	IC50	nM	6.6
	1751905	CHEMBL868607	Inhibition of p38alpha	B	Cc1ccc(F)c(-c2ncoc2-c2ccc3nnc(C(C)C)n3c2)c1		CHEMBL213258	=	IC50	nM	4.3	CHEMBL260	Homo sapiens	IC50	nM	4.3
	1751906	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(Cl)cc3)cn12		CHEMBL378328	=	IC50	nM	17.7	CHEMBL260	Homo sapiens	IC50	nM	17.7
	1751907	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cccc(Cl)c3)cn12		CHEMBL212239	=	IC50	nM	13.5	CHEMBL260	Homo sapiens	IC50	nM	13.5
	1751908	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3Cl)cn12		CHEMBL212294	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	1751909	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL380030	=	IC50	nM	4.6	CHEMBL260	Homo sapiens	IC50	nM	4.6
	1751910	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)ccc3F)cn12		CHEMBL379866	=	IC50	nM	5.8	CHEMBL260	Homo sapiens	IC50	nM	5.8
	1751911	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3c(F)cccc3F)cn12		CHEMBL212038	=	IC50	nM	14.6	CHEMBL260	Homo sapiens	IC50	nM	14.6
	1751912	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)c(F)c3)cn12		CHEMBL378752	=	IC50	nM	22.3	CHEMBL260	Homo sapiens	IC50	nM	22.3
	1751913	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)c(Cl)c3)cn12		CHEMBL378934	=	IC50	nM	12.4	CHEMBL260	Homo sapiens	IC50	nM	12.4
	1751914	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(Cl)cc3F)cn12		CHEMBL379590	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	1751915	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(Cl)ccc3F)cn12		CHEMBL212238	=	IC50	nM	5.1	CHEMBL260	Homo sapiens	IC50	nM	5.1
	1751916	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	=	IC50	nM	2.5	CHEMBL260	Homo sapiens	IC50	nM	2.5
	1751917	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(Cl)c(F)c3)cn12		CHEMBL384967	=	IC50	nM	43.2	CHEMBL260	Homo sapiens	IC50	nM	43.2
	1751918	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)c(F)c3)cn12		CHEMBL213374	=	IC50	nM	4.1	CHEMBL260	Homo sapiens	IC50	nM	4.1
	1751919	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	1751920	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3c(F)cc(F)cc3F)cn12		CHEMBL210060	=	IC50	nM	7.2	CHEMBL260	Homo sapiens	IC50	nM	7.2
	1751921	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)cc(F)c3F)cn12		CHEMBL379112	=	IC50	nM	83.3	CHEMBL260	Homo sapiens	IC50	nM	83.3
	1751922	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)c(F)c3F)cn12		CHEMBL385352	=	IC50	nM	11.1	CHEMBL260	Homo sapiens	IC50	nM	11.1
	1751923	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(Cl)c(Cl)c3)cn12		CHEMBL211151	=	IC50	nM	26.4	CHEMBL260	Homo sapiens	IC50	nM	26.4
	1751924	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(Cl)cc3Cl)cn12		CHEMBL211362	=	IC50	nM	8.3	CHEMBL260	Homo sapiens	IC50	nM	8.3
	1751925	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cccc(Cl)c3Cl)cn12		CHEMBL378697	=	IC50	nM	14.5	CHEMBL260	Homo sapiens	IC50	nM	14.5
	1751926	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(Cl)cc3F)cn12		CHEMBL378920	=	IC50	nM	24.5	CHEMBL260	Homo sapiens	IC50	nM	24.5
	1751927	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3Cl)cn12		CHEMBL213598	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
	1751928	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)c(Br)c3)cn12		CHEMBL439540	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	1751929	CHEMBL868607	Inhibition of p38alpha	B	CCc1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL215680	=	IC50	nM	54.5	CHEMBL260	Homo sapiens	IC50	nM	54.5
	1751930	CHEMBL868607	Inhibition of p38alpha	B	c1ccc(-c2ncoc2-c2ccc3nnc(C4CCC4)n3c2)cc1		CHEMBL377538	=	IC50	nM	16.6	CHEMBL260	Homo sapiens	IC50	nM	16.6
	1751931	CHEMBL868607	Inhibition of p38alpha	B	c1ccc(-c2ncoc2-c2ccc3nnc(C4CC4)n3c2)cc1		CHEMBL386869	=	IC50	nM	47.2	CHEMBL260	Homo sapiens	IC50	nM	47.2
	1751932	CHEMBL868607	Inhibition of p38alpha	B	CCNc1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL211735	=	IC50	nM	5.4	CHEMBL260	Homo sapiens	IC50	nM	5.4
	1751933	CHEMBL868607	Inhibition of p38alpha	B	CCN(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL377841	=	IC50	nM	9.2	CHEMBL260	Homo sapiens	IC50	nM	9.2
	1751934	CHEMBL868607	Inhibition of p38alpha	B	FC(F)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL213055	=	IC50	nM	544.0	CHEMBL260	Homo sapiens	IC50	nM	544.0
	1751935	CHEMBL868607	Inhibition of p38alpha	B	FC(F)(F)Cc1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL212795	=	IC50	nM	83.2	CHEMBL260	Homo sapiens	IC50	nM	83.2
	1751936	CHEMBL868607	Inhibition of p38alpha	B	c1ccc(-c2ncoc2-c2ccc3nnc(-c4ccno4)n3c2)cc1		CHEMBL213521	=	IC50	nM	285.0	CHEMBL260	Homo sapiens	IC50	nM	285.0
	1751937	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nncn3c2)cc1		CHEMBL386742	=	IC50	nM	19.5	CHEMBL260	Homo sapiens	IC50	nM	19.5
	1751938	CHEMBL868607	Inhibition of p38alpha	B	CCc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213522	=	IC50	nM	21.6	CHEMBL260	Homo sapiens	IC50	nM	21.6
	1751939	CHEMBL868607	Inhibition of p38alpha	B	CN(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL386904	=	IC50	nM	15.3	CHEMBL260	Homo sapiens	IC50	nM	15.3
	1751940	CHEMBL868607	Inhibition of p38alpha	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	=	IC50	nM	7.6	CHEMBL260	Homo sapiens	IC50	nM	7.6
	1751941	CHEMBL868607	Inhibition of p38alpha	B	CCOc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL384990	=	IC50	nM	55.5	CHEMBL260	Homo sapiens	IC50	nM	55.5
	1751942	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(C4CCC4)n3c2)cc1		CHEMBL211678	=	IC50	nM	17.7	CHEMBL260	Homo sapiens	IC50	nM	17.7
	1751943	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(C4CC4)n3c2)cc1		CHEMBL211679	=	IC50	nM	10.9	CHEMBL260	Homo sapiens	IC50	nM	10.9
	1751944	CHEMBL868607	Inhibition of p38alpha	B	CC(C)Cc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL212655	=	IC50	nM	8.8	CHEMBL260	Homo sapiens	IC50	nM	8.8
	1751945	CHEMBL868607	Inhibition of p38alpha	B	CC(C)Nc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL212849	=	IC50	nM	5.5	CHEMBL260	Homo sapiens	IC50	nM	5.5
	1751946	CHEMBL868607	Inhibition of p38alpha	B	CCCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL378922	=	IC50	nM	198.0	CHEMBL260	Homo sapiens	IC50	nM	198.0
	1751947	CHEMBL868607	Inhibition of p38alpha	B	CCN(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL211919	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
	1751948	CHEMBL868607	Inhibition of p38alpha	B	CC(C)Oc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213501	=	IC50	nM	17.9	CHEMBL260	Homo sapiens	IC50	nM	17.9
	1751949	CHEMBL868607	Inhibition of p38alpha	B	CC1(c2nnc3ccc(-c4ocnc4-c4ccc(F)cc4)cn23)CCC1		CHEMBL386360	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	1751950	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(-c4ccccc4)n3c2)cc1		CHEMBL379783	=	IC50	nM	12.3	CHEMBL260	Homo sapiens	IC50	nM	12.3
	1751951	CHEMBL868607	Inhibition of p38alpha	B	COc1ccccc1-c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL378919	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	1751952	CHEMBL868607	Inhibition of p38alpha	B	CCOc1ccccc1-c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL209644	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	1751953	CHEMBL868607	Inhibition of p38alpha	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL379394	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
	1751954	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(N4CCOCC4)n3c2)cc1		CHEMBL213002	=	IC50	nM	11.8	CHEMBL260	Homo sapiens	IC50	nM	11.8
	1751955	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(Cc4ccccc4)n3c2)cc1		CHEMBL377165	=	IC50	nM	19.9	CHEMBL260	Homo sapiens	IC50	nM	19.9
	1751956	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(C4CC4)n3c2)c(F)c1		CHEMBL212898	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
	1751957	CHEMBL868607	Inhibition of p38alpha	B	CC1(c2nnc3ccc(-c4ocnc4-c4ccc(F)cc4F)cn23)CC1		CHEMBL211628	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	nM	0.7
	1751958	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(-c2ncoc2-c2ccc3nnc(C4CCC4)n3c2)c(F)c1		CHEMBL379374	=	IC50	nM	3.75	CHEMBL260	Homo sapiens	IC50	nM	3.75
	1751959	CHEMBL868607	Inhibition of p38alpha	B	CC1(c2nnc3ccc(-c4ocnc4-c4ccc(F)cc4F)cn23)CCC1		CHEMBL384795	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	1751960	CHEMBL868607	Inhibition of p38alpha	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	1751961	CHEMBL868607	Inhibition of p38alpha	B	CC(C)(O)c1nnc2ccc(-c3ocnc3-c3cc(F)ccc3F)cn12		CHEMBL377606	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	1751962	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(F)c(-c2ncoc2-c2ccc3nnc(C4CC4)n3c2)c1		CHEMBL214114	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	1751963	CHEMBL868607	Inhibition of p38alpha	B	CC1(c2nnc3ccc(-c4ocnc4-c4cc(F)ccc4F)cn23)CC1		CHEMBL377319	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	1751964	CHEMBL868607	Inhibition of p38alpha	B	Fc1ccc(F)c(-c2ncoc2-c2ccc3nnc(C4CCC4)n3c2)c1		CHEMBL214310	=	IC50	nM	9.7	CHEMBL260	Homo sapiens	IC50	nM	9.7
	1751965	CHEMBL868607	Inhibition of p38alpha	B	CC1(c2nnc3ccc(-c4ocnc4-c4cc(F)ccc4F)cn23)CCC1		CHEMBL439321	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	1751977	CHEMBL867362	Inhibition of p38alpha	B	COc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL96632	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	1751978	CHEMBL867362	Inhibition of p38alpha	B	Nc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL425422	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	1752021	CHEMBL867362	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94556	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1752024	CHEMBL867362	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(O)cc2N1c1c(Cl)cccc1Cl		CHEMBL210110	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1752032	CHEMBL867362	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	1752033	CHEMBL867362	Inhibition of p38alpha	B	CC(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL212549	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	1752058	CHEMBL867362	Inhibition of p38alpha	B	CS(=O)(=O)c1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL212937	=	IC50	nM	4.2	CHEMBL260	Homo sapiens	IC50	nM	4.2
	1752059	CHEMBL867362	Inhibition of p38alpha	B	Nc1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL212821	=	IC50	nM	5.3	CHEMBL260	Homo sapiens	IC50	nM	5.3
	1752060	CHEMBL867362	Inhibition of p38alpha	B	CNc1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL425785	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1752061	CHEMBL867362	Inhibition of p38alpha	B	CN(C)c1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL441853	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	1752062	CHEMBL867362	Inhibition of p38alpha	B	CC(C)Nc1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL213895	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	1752063	CHEMBL867362	Inhibition of p38alpha	B	CC(C)(C)CNc1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL214138	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	1752064	CHEMBL867362	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)nc(N3CCc4n[nH]cc4C3)nc2N1c1c(Cl)cccc1Cl		CHEMBL213986	=	IC50	nM	1.9	CHEMBL260	Homo sapiens	IC50	nM	1.9
	1752065	CHEMBL867362	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)nc(O)nc2N1c1c(Cl)cccc1Cl		CHEMBL213846	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	1752066	CHEMBL867362	Inhibition of p38alpha	B	COCCNc1nc(-c2ccc(Cl)cc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL213836	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1752067	CHEMBL867362	Inhibition of p38alpha	B	CN(C)CCNc1nc(-c2ccc(Cl)cc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL213190	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
	1752068	CHEMBL867362	Inhibition of p38alpha	B	CN(C)CCOc1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL211426	=	IC50	nM	4.2	CHEMBL260	Homo sapiens	IC50	nM	4.2
	1752069	CHEMBL867362	Inhibition of p38alpha	B	CN(C)CCN1CCN(c2nc(-c3ccccc3Cl)c3c(n2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL211795	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	1752070	CHEMBL867362	Inhibition of p38alpha	B	CN(C)CCN1CCN(c2nc(-c3ccc(Cl)cc3Cl)c3c(n2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL213142	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	1752071	CHEMBL867362	Inhibition of p38alpha	B	CC(C)N1CCN(c2nc(-c3ccc(Cl)cc3Cl)c3c(n2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL425265	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	1752072	CHEMBL867362	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)nc(NN3CCOCC3)nc2N1c1c(Cl)cccc1Cl		CHEMBL215651	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	1752073	CHEMBL867362	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)nc(N3CCOCC3)nc2N1c1c(Cl)cccc1Cl		CHEMBL378717	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1752074	CHEMBL867362	Inhibition of p38alpha	B	C[C@H]1CN(c2nc(-c3ccc(Cl)cc3Cl)c3c(n2)N(c2c(Cl)cccc2Cl)C(=O)NC3)C[C@@H](C)O1		CHEMBL211303	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1752075	CHEMBL867362	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)nc(NC3CN4CCC3CC4)nc2N1c1c(Cl)cccc1Cl		CHEMBL212091	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	1752076	CHEMBL867362	Inhibition of p38alpha	B	CN1C2CCC1CC(Nc1nc(-c3ccccc3Cl)c3c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC3)C2		CHEMBL212803	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	1752077	CHEMBL867362	Inhibition of p38alpha	B	CC(C)N1CCC(Nc2nc(-c3ccccc3Cl)c3c(n2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL377979	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	1752078	CHEMBL867362	Inhibition of p38alpha	B	CC1(C)CC(Nc2nc(-c3ccccc3Cl)c3c(n2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC(C)(C)N1		CHEMBL209442	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	nM	0.7
	1753501	CHEMBL868607	Inhibition of p38alpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	=	IC50	nM	9.6	CHEMBL260	Homo sapiens	IC50	nM	9.6
	1753504	CHEMBL868607	Inhibition of p38alpha	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	=	IC50	nM	1.8	CHEMBL260	Homo sapiens	IC50	nM	1.8
	1753505	CHEMBL868607	Inhibition of p38alpha	B	CC1(c2nnc3ccc(-c4ocnc4-c4cc(F)c(F)cc4F)cn23)CCC1		CHEMBL213159	=	IC50	nM	2.5	CHEMBL260	Homo sapiens	IC50	nM	2.5
	1753506	CHEMBL868607	Inhibition of p38alpha	B	Fc1cc(F)c(-c2ncoc2-c2ccc3nnc(C4CCC4)n3c2)cc1F		CHEMBL377757	=	IC50	nM	9.1	CHEMBL260	Homo sapiens	IC50	nM	9.1
	1753507	CHEMBL868607	Inhibition of p38alpha	B	CC1(c2nnc3ccc(-c4ocnc4-c4cc(F)c(F)cc4F)cn23)CC1		CHEMBL215899	=	IC50	nM	2.3	CHEMBL260	Homo sapiens	IC50	nM	2.3
	1753508	CHEMBL868607	Inhibition of p38alpha	B	Fc1cc(F)c(-c2ncoc2-c2ccc3nnc(C4CC4)n3c2)cc1F		CHEMBL212341	=	IC50	nM	7.8	CHEMBL260	Homo sapiens	IC50	nM	7.8
	1753509	CHEMBL868607	Inhibition of p38alpha	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)ccc3F)cn12		CHEMBL212708	=	IC50	nM	8.8	CHEMBL260	Homo sapiens	IC50	nM	8.8
	1758453	CHEMBL867362	Inhibition of p38alpha	B	CSc1nc(-c2ccccc2Cl)c2c(n1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL212753	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	1758735	CHEMBL870979	Inhibition of p38alpha	B	Cc1cccc(C)c1OC(=O)N(c1ccccc1)c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL427047	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	1765194	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL212964	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1765195	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NC3CC3)ncc2c1		CHEMBL212181	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1765196	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(Nc3ccccc3)ncc2c1		CHEMBL215863	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	nM	57.0
	1765197	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NC3CCN(C)CC3)ncc2c1		CHEMBL215691	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	1765198	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCN3CCCC3)ncc2c1		CHEMBL214556	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	1765199	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCN3CCCCC3)ncc2c1		CHEMBL384942	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	1765200	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(N(C)CCCN3CCOCC3)ncc2c1		CHEMBL212195	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	nM	65.0
	1765201	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCCN3CCOCC3)ncc2c1		CHEMBL214530	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	1765202	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL213290	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	1765203	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL215943	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	1765204	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2C)cc1-c1ccc2nc(N)ncc2c1		CHEMBL215813	=	IC50	nM	109.0	CHEMBL260	Homo sapiens	IC50	nM	109.0
	1765205	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	1765206	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	Cc1ccccc1-c1ccc2nc(N)ncc2c1		CHEMBL215952	=	IC50	nM	3903.0	CHEMBL260	Homo sapiens	IC50	nM	3903.0
	1765207	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(Nc4nc5cc(C(F)(F)F)ccc5[nH]4)ccc3C)ccc2n1		CHEMBL213478	=	IC50	nM	277.0	CHEMBL260	Homo sapiens	IC50	nM	277.0
	1765208	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(NC(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL424719	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	1765209	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL212128	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	1765210	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4N4CC(C)(C)C4=O)ccc3C)ccc2n1		CHEMBL385055	=	IC50	nM	172.0	CHEMBL260	Homo sapiens	IC50	nM	172.0
	1765211	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CCN(CC)CC(=O)Nc1ccc(C(F)(F)F)cc1NC(=O)c1ccc(C)c(-c2ccc3nc(NC)ncc3c2)c1		CHEMBL212953	=	IC50	nM	76.0	CHEMBL260	Homo sapiens	IC50	nM	76.0
	1765212	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4NC(=O)NCCN4CCOCC4)ccc3C)ccc2n1		CHEMBL213831	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	1765213	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4N4CCN(C)C4=O)ccc3C)ccc2n1		CHEMBL385598	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	1765214	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4N4CCCCC4)ccc3C)ccc2n1		CHEMBL214495	=	IC50	nM	168.0	CHEMBL260	Homo sapiens	IC50	nM	168.0
	1765215	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1		CHEMBL386661	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	1765216	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4ccc(Cl)c(C(F)(F)F)c4C)ccc3C)ccc2n1		CHEMBL212183	=	IC50	nM	139.0	CHEMBL260	Homo sapiens	IC50	nM	139.0
	1765217	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL215019	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	1765218	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4ccc(OC5CCN(C)CC5)cc4)ccc3C)ccc2n1		CHEMBL427226	=	IC50	nM	93.0	CHEMBL260	Homo sapiens	IC50	nM	93.0
	1765219	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc5c4CCC5)ccc3C)ccc2n1		CHEMBL427233	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	1765220	CHEMBL853498	Inhibition of p38-alpha by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc(C(F)(F)F)c4C)ccc3C)ccc2n1		CHEMBL215969	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	1769450	CHEMBL910950	Inhibition of SAPK2alpha	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	1780424	CHEMBL911814	Activity of SAPK2-alpha at 10 uM	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Inhibition	%	82.0	CHEMBL260	Homo sapiens	Inhibition	%	82.0
	1782045	CHEMBL911852	Inhibition of P38alpha	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1790005	CHEMBL853552	Percentage activity of human SAPK2a in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	77.0	CHEMBL260	Homo sapiens	Activity	%	77.0
	1790322	CHEMBL873762	Percent residual activity, relative to control, of SAPK2a/p38 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	76.0	CHEMBL260	Homo sapiens	Activity	%	76.0
	1790376	CHEMBL873762	Percent residual activity, relative to control, of SAPK2a/p38 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	79.0	CHEMBL260	Homo sapiens	Activity	%	79.0
	1790557	CHEMBL856415	Inhibition of human recombinant P38A	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Ki	nM	10000.0	CHEMBL260	Homo sapiens	Ki	uM	10.0
	1800069	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccccc1Nc1ccc2c(c1)SCc1ccccc1C2=O		CHEMBL220074	=	IC50	nM	196.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.196
	1800070	CHEMBL910448	Inhibition of p38 alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	89.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.089
	1800071	CHEMBL910448	Inhibition of p38 alpha	B	Cc1ccccc1C(=O)c1ccc(Nc2ccccc2)cc1Cl		CHEMBL155567	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.19
	1800072	CHEMBL910448	Inhibition of p38 alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.068
	1800073	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccccc1Nc1ccc2c(=O)c3ccccc3ccc2c1		CHEMBL220022	=	IC50	nM	1056.0	CHEMBL260	Homo sapiens	IC50	umol/L	1.056
	1800074	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)cc1		CHEMBL219692	=	IC50	nM	1171.0	CHEMBL260	Homo sapiens	IC50	umol/L	1.171
	1800075	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccccc1C2=O		CHEMBL218962	=	IC50	nM	104.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.104
	1800076	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccccc1Nc1ccc2c(c1)COc1ccccc1C2=O		CHEMBL219259	=	IC50	nM	3060.0	CHEMBL260	Homo sapiens	IC50	umol/L	3.06
	1800077	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c(N)c1		CHEMBL219476	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	umol/L	5.0
	1800078	CHEMBL910448	Inhibition of p38 alpha	B	Nc1cc(F)ccc1Nc1ccc2c(c1)OCc1ccccc1C2=O		CHEMBL218961	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.038
	1800079	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c(F)c1		CHEMBL219424	=	IC50	nM	1316.0	CHEMBL260	Homo sapiens	IC50	umol/L	1.316
	1800080	CHEMBL910448	Inhibition of p38 alpha	B	Nc1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1		CHEMBL373775	=	IC50	nM	1219.0	CHEMBL260	Homo sapiens	IC50	umol/L	1.219
	1800081	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)cc1		CHEMBL219965	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	umol/L	5.0
	1800082	CHEMBL910448	Inhibition of p38 alpha	B	Nc1ccccc1Nc1ccc2c(c1)OCc1ccccc1C2=O		CHEMBL375978	=	IC50	nM	303.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.303
	1800083	CHEMBL910448	Inhibition of p38 alpha	B	O=C1c2ccccc2COc2cc(Nc3ccc(Br)cc3Br)ccc21		CHEMBL220349	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	umol/L	5.0
	1800084	CHEMBL910448	Inhibition of p38 alpha	B	O=C1c2ccccc2COc2cc(Nc3ccc(Cl)cc3Cl)ccc21		CHEMBL375350	=	IC50	nM	3021.0	CHEMBL260	Homo sapiens	IC50	umol/L	3.021
	1800085	CHEMBL910448	Inhibition of p38 alpha	B	O=C1c2ccccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL376855	=	IC50	nM	239.0	CHEMBL260	Homo sapiens	IC50	umol/L	0.239
	1808470	CHEMBL911323	Inhibition of p38alpha	B	O=c1ccc(Nc2ccccc2Cl)nn1-c1ccccc1Cl		CHEMBL222109	=	IC50	nM	790.0	CHEMBL260	Homo sapiens	IC50	nM	790.0
	1808474	CHEMBL911323	Inhibition of p38alpha	B	Cc1ccccc1CNc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL374312	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	nM	3500.0
	1808475	CHEMBL911323	Inhibition of p38alpha	B	Cc1cc(Cl)ccc1-n1nc(Sc2ccc(Cl)cc2)ccc1=O		CHEMBL221072	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	nM	2000.0
	1808476	CHEMBL911323	Inhibition of p38alpha	B	Cc1cc(Cl)ccc1-n1nc(Sc2ccc(F)cc2F)ccc1=O		CHEMBL221071	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	nM	310.0
	1808477	CHEMBL911323	Inhibition of p38alpha	B	O=c1ccc(Sc2ccccc2F)nn1-c1ccccc1Cl		CHEMBL373934	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	nM	140.0
	1808478	CHEMBL911323	Inhibition of p38alpha	B	COc1ccccc1Nc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL373767	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	nM	2400.0
	1808479	CHEMBL911323	Inhibition of p38alpha	B	Cc1ccccc1Nc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL221791	=	IC50	nM	760.0	CHEMBL260	Homo sapiens	IC50	nM	760.0
Not Active	1808484	CHEMBL911324	Inhibition of p38-alpha at 20 uM	B	O=c1ccc(Nc2ccccc2-c2ccccc2)nn1-c1ccccc1Cl		CHEMBL375138		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1808486	CHEMBL911324	Inhibition of p38-alpha at 20 uM	B	Cc1cc(Cl)ccc1-n1nc(OCc2ccccc2C(F)(F)F)ccc1=O		CHEMBL221311		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1808487	CHEMBL911324	Inhibition of p38-alpha at 20 uM	B	O=c1ccc(Oc2ccc(F)cc2F)nn1-c1ccccc1Cl		CHEMBL221494		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1808488	CHEMBL911324	Inhibition of p38-alpha at 20 uM	B	O=c1ccc(Oc2ccc(F)cc2Cl)nn1-c1ccccc1Cl		CHEMBL555838		Activity			CHEMBL260	Homo sapiens	Activity		
	1808495	CHEMBL911323	Inhibition of p38alpha	B	CCc1ccccc1Nc1ccc(=O)n(-c2ccccc2Cl)n1		CHEMBL373545	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	nM	560.0
	1808496	CHEMBL911323	Inhibition of p38alpha	B	O=C(NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl)C1CCC(C(F)(F)F)CC1		CHEMBL221700	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	1808497	CHEMBL911323	Inhibition of p38alpha	B	O=C(NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl)C1CCNCC1		CHEMBL221648	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	1808498	CHEMBL911323	Inhibition of p38alpha	B	O=C(CC1CCCN1)NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL218661	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	1808499	CHEMBL911323	Inhibition of p38alpha	B	CNCC(=O)NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL221246	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	1808500	CHEMBL911323	Inhibition of p38alpha	B	NCC(=O)NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL376045	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	1808501	CHEMBL911323	Inhibition of p38alpha	B	O=C1c2ccccc2C(=O)N1CCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccc(F)cc1Cl		CHEMBL221595	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	1808502	CHEMBL911323	Inhibition of p38alpha	B	O=C1c2ccccc2C(=O)N1CCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL221547	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	1808503	CHEMBL911323	Inhibition of p38alpha	B	COc1ccc(CNCCCN(c2ccc(=O)n(-c3ccccc3Cl)n2)c2ccccc2Cl)c(OC)c1OC		CHEMBL374216	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	nM	490.0
	1808504	CHEMBL911323	Inhibition of p38alpha	B	NCCCN(c1ccc(=O)n(-c2ccccc2Cl)n1)c1ccccc1Cl		CHEMBL221546	=	IC50	nM	197.0	CHEMBL260	Homo sapiens	IC50	nM	197.0
	1808505	CHEMBL911323	Inhibition of p38alpha	B	O=c1ccc(N(CCO)c2ccc(F)cc2Cl)nn1-c1ccccc1Cl		CHEMBL221312	=	IC50	nM	168.0	CHEMBL260	Homo sapiens	IC50	nM	168.0
Not Active	1808556	CHEMBL911324	Inhibition of p38-alpha at 20 uM	B	O=c1ccc(-c2cccc(F)c2)nn1-c1ccccc1Cl		CHEMBL220918		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1808558	CHEMBL911324	Inhibition of p38-alpha at 20 uM	B	O=c1ccc(-c2cccc(Cl)c2)nn1-c1ccccc1Cl		CHEMBL375431		Activity			CHEMBL260	Homo sapiens	Activity		
	1809965	CHEMBL853937	Binding affinity to p38alpha	B	CC(=O)N1CCN(c2c(-c3ccncc3)c(-c3ccc(F)cc3)c(C#N)n2C)CC1		CHEMBL220862	=	Kd	nM	100.0	CHEMBL260	Homo sapiens	Kd	nM	100.0
	1812468	CHEMBL911351	Inhibition of p38alpha	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
Not Active	1812707	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	Clc1ccc(N/N=C/c2cccc(I)c2)nn1		CHEMBL374088		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812708	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	NC(=O)COc1ccc(C=C2C(=O)NC(=S)NC2=O)cc1		CHEMBL220169		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812709	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	O=C(CN1CCSCC1)N/N=C/c1ccc(Br)s1		CHEMBL220168		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812710	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	COc1ccc(C(=O)Nc2ccc(OCC(=O)O)cc2)cc1		CHEMBL221097		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812711	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	COc1cc(/C=C2/NC(=O)NC2=O)ccc1OCc1ccc(Br)cc1		CHEMBL221096		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812712	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	Cc1cc(C)c(C#N)c(SCC(=O)c2ccc(Cl)c(Cl)c2)n1		CHEMBL223217		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812713	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	Cc1ccc(-c2nc(-c3cccc([N+](=O)[O-])c3)no2)c(Cl)c1		CHEMBL374884		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812714	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	O=C(CSc1nnc(-c2ccco2)[nH]1)c1ccc(Br)cc1		CHEMBL222841		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812715	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	CC(Oc1ccc(/C=C2/NC(=S)NC2=O)cc1)C(=O)O		CHEMBL220167		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812716	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	CCOC(=O)c1ccc(NC(=S)NCCN2CCOCC2)cc1		CHEMBL221103		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812717	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812718	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	CCOC(=O)c1ccc(/C=N\O)[n+]([O-])c1		CHEMBL219924		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1812719	CHEMBL909652	Inhibition of ATF2 phosphorylation	B	C#CCOC(=O)CCCC(=O)Nc1ccc([N+](=O)[O-])cc1Cl		CHEMBL220166		Activity			CHEMBL260	Homo sapiens	Activity		
	1815190	CHEMBL908528	Inhibition of p38alpha	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	3700.0	CHEMBL260	Homo sapiens	IC50	nM	3700.0
	1815238	CHEMBL908528	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL385956	<	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	1815358	CHEMBL910191	Inhibition of p38alpha	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	>	IC50	nM	8300.0	CHEMBL260	Homo sapiens	IC50	nM	8300.0
	1816522	CHEMBL911992	Inhibition of p38-alpha at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)Cc1ccccc1-3		CHEMBL148471	<	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1816546	CHEMBL911992	Inhibition of p38-alpha at 1 uM	B	O=C1NCc2c1c1c3ccccc3sc1c1[nH]c3ccccc3c21		CHEMBL221536	<	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1816547	CHEMBL911992	Inhibition of p38-alpha at 1 uM	B	O=C1NCc2c1c1c(c3[nH]c4ccccc4c23)Cc2ccccc2-1		CHEMBL357490	<	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1816548	CHEMBL911992	Inhibition of p38-alpha at 1 uM	B	O=C1NCc2c3c(c4[nH]c5ccccc5c4c21)CCc1ccccc1-3		CHEMBL374581	<	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1816549	CHEMBL911992	Inhibition of p38-alpha at 1 uM	B	O=C1NC(=O)c2c1c1c(c3[nH]c4ccccc4c23)CCc2ccccc2-1		CHEMBL386636	<	Inhibition	%	30.0	CHEMBL260	Homo sapiens	Inhibition	%	30.0
	1820577	CHEMBL917091	Inhibition of p38 alpha kinase	B	O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1		CHEMBL387385	>	Ki	nM	4000.0	CHEMBL260	Homo sapiens	Ki	uM	4.0
	1820880	CHEMBL919883	Inhibition of p38-alpha MAPK by non-radioactive immunosorbent assay	B	C[S+]([O-])c1ccccc1CSc1ncc(-c2ccc(F)cc2)c(-c2ccncc2)n1		CHEMBL441811	=	IC50	nM	5100.0	CHEMBL260	Homo sapiens	IC50	uM	5.1
	1820918	CHEMBL919883	Inhibition of p38-alpha MAPK by non-radioactive immunosorbent assay	B	O=c1[nH]c2ccccc2c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL434737	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	uM	1.8
	1820919	CHEMBL919883	Inhibition of p38-alpha MAPK by non-radioactive immunosorbent assay	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	1820921	CHEMBL919883	Inhibition of p38-alpha MAPK by non-radioactive immunosorbent assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	1821052	CHEMBL919883	Inhibition of p38-alpha MAPK by non-radioactive immunosorbent assay	B	Fc1ccc(-c2ncn(CC3CC3)c2-c2ccncc2)cc1		CHEMBL96741	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	1821054	CHEMBL919883	Inhibition of p38-alpha MAPK by non-radioactive immunosorbent assay	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	1821055	CHEMBL919883	Inhibition of p38-alpha MAPK by non-radioactive immunosorbent assay	B	O=c1[nH]c2ccccc2c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL221164	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1837906	CHEMBL920489	Inhibition of SAPK2a/p38 at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	85.0	CHEMBL260	Homo sapiens	Inhibition	%	85.0
	1837945	CHEMBL920489	Inhibition of SAPK2a/p38 at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	107.0	CHEMBL260	Homo sapiens	Inhibition	%	107.0
	1838259	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(NC[C@@H]2CC[C@H]3C[C@@H]2C3(C)C)nc(N2CCCNCC2)n1		CHEMBL222304	=	IC50	nM	1360.0	CHEMBL260	Homo sapiens	IC50	nM	1360.0
	1838261	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCCNCC3)n2)c1		CHEMBL225089	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	nM	52.0
	1838262	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCCN(C)CC3)n2)c1		CHEMBL225088	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	1838263	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCNCC3)n2)c1		CHEMBL376506	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	1838264	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCN(C)CC3)n2)c1		CHEMBL222098	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	nM	57.0
	1838265	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(=O)NC(C)C)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC(C)(C)C)n1		CHEMBL221563	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	nM	51.0
	1838266	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(=O)NO)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC(C)(C)C)n1		CHEMBL225419	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	1838267	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	CONC(=O)c1ccc(C)c(Nc2nc(N[C@H]3CCNC3)nc(N(C)CC(C)(C)C)n2)c1		CHEMBL225418	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	1838268	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(=O)NC2CCCC2)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC(C)(C)C)n1		CHEMBL222050	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	nM	100.0
	1838269	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	COC(=O)c1ccc(C)c(Nc2nc(N[C@H]3CCNC3)nc(N(C)CC(C)(C)C)n2)c1		CHEMBL222268	=	IC50	nM	346.0	CHEMBL260	Homo sapiens	IC50	nM	346.0
	1838270	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(=O)NCc2ccccc2)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC(C)(C)C)n1		CHEMBL415169	=	IC50	nM	64.0	CHEMBL260	Homo sapiens	IC50	nM	64.0
	1838271	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	COCCNC(=O)c1ccc(C)c(Nc2nc(N[C@H]3CCNC3)nc(N(C)CC(C)(C)C)n2)c1		CHEMBL221358	=	IC50	nM	264.0	CHEMBL260	Homo sapiens	IC50	nM	264.0
	1838272	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	CCNC(=O)c1ccc(C)c(Nc2nc(N[C@H]3CCNC3)nc(N(C)CC(C)(C)C)n2)c1		CHEMBL222267	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	1838273	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC2CCCCC2)n1		CHEMBL221824	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	nM	250.0
	1838274	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC(C)(C)C)n1		CHEMBL221771	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	1838275	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC(C)C)n1		CHEMBL426902	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	1838276	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(NCC(C)C)nc(N[C@H]2CCNC2)n1		CHEMBL413783	=	IC50	nM	73.0	CHEMBL260	Homo sapiens	IC50	nM	73.0
	1838277	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(N[C@H]2CCNC2)nc(N(C)CC(C)c2ccccc2)n1		CHEMBL441557	=	IC50	nM	84.0	CHEMBL260	Homo sapiens	IC50	nM	84.0
	1838278	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(NCCc2ccc(F)cc2)nc(N[C@H]2CCNC2)n1		CHEMBL224957	=	IC50	nM	227.0	CHEMBL260	Homo sapiens	IC50	nM	227.0
	1838279	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(NC[C@@H]2CC[C@H]3C[C@@H]2C3(C)C)nc(N[C@H]2CCNC2)n1		CHEMBL224956	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	1838280	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(N)nc(NC[C@@H]2CC[C@H]3C[C@@H]2C3(C)C)n1		CHEMBL222785	=	IC50	nM	5900.0	CHEMBL260	Homo sapiens	IC50	nM	5900.0
	1838281	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(N)=O)cc1Nc1nc(NC[C@@H]2CC[C@H]3C[C@@H]2C3(C)C)nc(N2CCCN(C)CC2)n1		CHEMBL375011	=	IC50	nM	1420.0	CHEMBL260	Homo sapiens	IC50	nM	1420.0
	1838326	CHEMBL904269	Inhibition of human p38-alpha expressed in Escherichia coli	B	Cc1ccc(C(=O)O)cc1Nc1nc(N(C)CC(C)(C)C)nc(N2CCCN(C)CC2)n1		CHEMBL387153	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	1838524	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCO		CHEMBL373807	=	IC50	nM	398.0	CHEMBL260	Homo sapiens	IC50	uM	0.398
	1838527	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	COCCCn1c(SCCC(=O)N2CCOCC2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL221825	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838528	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	COCCn1c(SCCC(=O)N2CCOCC2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL221985	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	uM	0.46
	1838529	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCCC(=O)N3CCOCC3)n2CCCO)ccn1		CHEMBL374485	=	IC50	nM	9501.0	CHEMBL260	Homo sapiens	IC50	uM	9.501
	1838530	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCCCC(=O)N3CCOCC3)n2CCO)ccn1		CHEMBL389266	=	IC50	nM	2001.0	CHEMBL260	Homo sapiens	IC50	uM	2.001
	1838531	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCCC(=O)N3CCOCC3)n2CCO)ccn1		CHEMBL225548	=	IC50	nM	2512.0	CHEMBL260	Homo sapiens	IC50	uM	2.512
	1838532	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCc3ccc([S+](C)[O-])cc3)n2CCN2CCCCC2)ccn1		CHEMBL225231	=	IC50	nM	4435.0	CHEMBL260	Homo sapiens	IC50	uM	4.435
	1838533	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCc3ccc([S+](C)[O-])cc3)n2CCCN2CCOCC2)ccn1		CHEMBL443839	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838534	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCc3ccc([S+](C)[O-])cc3)n2C2CC(C)(C)NC(C)(C)C2)ccn1		CHEMBL387358	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838535	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSCCn1c(SCc2ccc([S+](C)[O-])cc2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL222051	=	IC50	nM	2377.0	CHEMBL260	Homo sapiens	IC50	uM	2.377
	1838536	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	C#CCOCCn1c(SCc2ccc([S+](C)[O-])cc2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL225101	=	IC50	nM	4974.0	CHEMBL260	Homo sapiens	IC50	uM	4.974
	1838537	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	C=CCOCCn1c(SCc2ccc([S+](C)[O-])cc2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL222869	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838538	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)NCCn1c(SCc2ccc([S+](C)[O-])cc2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL225100	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838539	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCc3ccc([S+](C)[O-])cc3)n2CC(C)O)ccn1		CHEMBL374530	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838540	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCc3ccc([S+](C)[O-])cc3)n2CCOCCO)ccn1		CHEMBL388755	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838541	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	COCCCn1c(SCc2ccc([S+](C)[O-])cc2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL222339	=	IC50	nM	1306.0	CHEMBL260	Homo sapiens	IC50	uM	1.306
	1838542	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	COCCn1c(SCc2ccc([S+](C)[O-])cc2)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL374762	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	1838543	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCc3ccc([S+](C)[O-])cc3)n2CCO)ccn1		CHEMBL373913	=	IC50	nM	2236.0	CHEMBL260	Homo sapiens	IC50	uM	2.236
	1838544	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCc3ccc([S+](C)[O-])cc3)n2C)ccn1		CHEMBL387154	=	IC50	nM	5849.0	CHEMBL260	Homo sapiens	IC50	uM	5.849
	1838545	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	462.0	CHEMBL260	Homo sapiens	IC50	uM	0.462
	1838546	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CCOC(=O)N1CCC(n2c(SC)nc(-c3ccc(F)cc3)c2-c2ccnc(NC(C)=O)c2)CC1		CHEMBL224972	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	1838547	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCN1CCCCC1		CHEMBL221568	=	IC50	nM	1343.0	CHEMBL260	Homo sapiens	IC50	uM	1.343
	1838548	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCN1CCOCC1		CHEMBL376486	=	IC50	nM	6279.0	CHEMBL260	Homo sapiens	IC50	uM	6.279
	1838549	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCN1CCOCC1		CHEMBL387551	=	IC50	nM	2029.0	CHEMBL260	Homo sapiens	IC50	uM	2.029
	1838550	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CC1COC(C)(C)O1		CHEMBL225458	=	IC50	nM	3732.0	CHEMBL260	Homo sapiens	IC50	uM	3.732
	1838551	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	COC(Cn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL374756	=	IC50	nM	4099.0	CHEMBL260	Homo sapiens	IC50	uM	4.099
	1838552	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL376608	=	IC50	nM	431.0	CHEMBL260	Homo sapiens	IC50	uM	0.431
	1838553	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	C#CCOCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL221508	=	IC50	nM	666.0	CHEMBL260	Homo sapiens	IC50	uM	0.666
	1838554	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	C=CCOCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL223645	=	IC50	nM	1850.0	CHEMBL260	Homo sapiens	IC50	uM	1.85
	1838555	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCN(C)C		CHEMBL373808	=	IC50	nM	2409.0	CHEMBL260	Homo sapiens	IC50	uM	2.409
	1838556	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCNC(C)=O		CHEMBL222227	=	IC50	nM	7290.0	CHEMBL260	Homo sapiens	IC50	uM	7.29
	1838557	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CC(C)O		CHEMBL225174	=	IC50	nM	8692.0	CHEMBL260	Homo sapiens	IC50	uM	8.692
	1838558	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCOCCO		CHEMBL427104	=	IC50	nM	8479.0	CHEMBL260	Homo sapiens	IC50	uM	8.479
	1838559	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	COCCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL222920	=	IC50	nM	205.0	CHEMBL260	Homo sapiens	IC50	uM	0.205
	1838560	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCO		CHEMBL374531	=	IC50	nM	813.0	CHEMBL260	Homo sapiens	IC50	uM	0.813
	1838561	CHEMBL914443	Inhibition of mitogen-activated protein kinase p38 alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL426183	=	IC50	nM	218.0	CHEMBL260	Homo sapiens	IC50	uM	0.218
	1857002	CHEMBL920659	Inhibition of SAPK2a	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br	Outside typical range	CHEMBL228043	>	IC50	nM	500000.0	CHEMBL260	Homo sapiens	IC50	uM	500.0
	1881834	CHEMBL904798	Inhibition of p38alpha	B	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	1881844	CHEMBL904798	Inhibition of p38alpha	B	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	IC50	nM	87000.0	CHEMBL260	Homo sapiens	IC50	uM	87.0
	1904610	CHEMBL889566	Inhibition of p38alpha	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	IC50	nM	1030.0	CHEMBL260	Homo sapiens	IC50	uM	1.03
Not Active	1912287	CHEMBL889664	Binding affinity to p38alpha	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NC(C)C		CHEMBL450013		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1912302	CHEMBL889664	Binding affinity to p38alpha	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)Nc1ccccc1		CHEMBL226939		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	1912303	CHEMBL889664	Binding affinity to p38alpha	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NCc1ccccc1		CHEMBL226836		Activity			CHEMBL260	Homo sapiens	Activity		
	1913362	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1c(F)cccc1F)N1CCc2c(cnn2-c2ccc(F)cc2Cl)C1		CHEMBL390447	=	IC50	nM	97.0	CHEMBL260	Homo sapiens	IC50	nM	97.0
	1913363	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	CN(C)C(=O)C(=O)c1cn(C)c2cc(Cl)c(C(=O)N3CCc4c(ncnc4-c4ccc(F)cc4F)C3)cc12		CHEMBL243980	=	IC50	nM	195.0	CHEMBL260	Homo sapiens	IC50	nM	195.0
	1913364	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	CN(C)C(=O)C(=O)c1c[nH]c2ccc(C(=O)N3CCc4c(cnn4-c4ccccc4Cl)C3)cc12		CHEMBL243979	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	nM	37.0
	1913365	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	CN(C)C(=O)C(=O)c1cn(C)c2cc(Cl)c(C(=O)N3CCc4c(cnn4-c4ccccc4Cl)C3)cc12		CHEMBL428042	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	1913366	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1nc2[nH]cc(C(=O)C(=O)N(C)C)c2cc1C(=O)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL394599	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	1913367	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1nc2c(cc1C(=O)N1CCn3c(cnc3-c3ccc(F)cc3F)C1)c(C(=O)C(=O)N1CCC(O)C1)cn2C		CHEMBL245224	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	1913368	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1nc2[nH]cc(C(=O)C(=O)N3CCC(O)C3)c2cc1C(=O)N1CCn2c(cnc2-c2ccc(F)cc2F)C1		CHEMBL244172	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1913369	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1nc2[nH]cc(C(=O)C(=O)N(C)C)c2cc1C(=O)N1CCn2c(cnc2-c2ccc(F)cc2F)C1		CHEMBL397975	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	1913370	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	CN(C)C(=O)C(=O)c1cn(C)c2cc(Cl)c(C(=O)N3CCn4c(cnc4-c4ccc(F)cc4F)C3)cc12		CHEMBL243963	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	1913371	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	CN(C)C(=O)C(=O)c1c[nH]c2cc(Cl)c(C(=O)N3CCn4c(cnc4-c4ccc(F)cc4F)C3)cc12		CHEMBL428041	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	1913372	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1cc2c(cc1C(=O)N1CCn3c(cnc3-c3ccc(F)cc3F)C1)c(C(=O)C(=O)N(C)C)cn2C		CHEMBL396768	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	1913373	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1nc2[nH]ccc2cc1C(=O)N1CCn2c(cnc2-c2ccc(F)cc2F)C1		CHEMBL388230	=	IC50	nM	164.0	CHEMBL260	Homo sapiens	IC50	nM	164.0
	1913374	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	Cn1ccc2cc(C(=O)N3CCn4c(cnc4-c4ccc(F)cc4F)C3)c(Cl)cc21		CHEMBL243097	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	1913375	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1cc2c(ccn2C)cc1C(=O)N1CCn2c(cnc2-c2ccc(F)cc2F)C1		CHEMBL244164	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	1913376	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1c(F)cccc1F)N1CCn2c(cnc2-c2ccc(F)cc2F)C1		CHEMBL395030	=	IC50	nM	167.0	CHEMBL260	Homo sapiens	IC50	nM	167.0
	1913377	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1ccc(F)cc1F)N1CCn2c(cnc2-c2ccc(F)cc2F)C1		CHEMBL243957	=	IC50	nM	593.0	CHEMBL260	Homo sapiens	IC50	nM	593.0
	1913378	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	COc1nc2[nH]ccc2cc1C(=O)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL397727	=	IC50	nM	137.0	CHEMBL260	Homo sapiens	IC50	nM	137.0
	1913379	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	CC(C)n1ccc2cc(C(=O)N3CCc4c(cnn4-c4ccccc4Cl)C3)ccc21		CHEMBL242001	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	nM	39.0
	1913380	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	Cn1ccc2cc(C(=O)N3CCc4c(cnn4-c4ccccc4Cl)C3)c(Cl)cc21		CHEMBL396522	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	nM	26.0
	1913381	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	Cn1ccc2cc(C(=O)N3CCc4c(cnn4-c4ccccc4Cl)C3)ccc21		CHEMBL242909	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	1913382	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1ccc2cc[nH]c2c1)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL242908	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	1913383	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1cccc2[nH]ccc12)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL388252	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	nM	37.0
	1913384	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	Cn1cc(C(=O)N2CCc3c(cnn3-c3ccccc3Cl)C2)c2ccccc21		CHEMBL242697	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	1913385	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1c[nH]c2ccccc12)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL388251	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	nM	55.0
	1913386	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1cc2ccccc2[nH]1)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL242695	=	IC50	nM	154.0	CHEMBL260	Homo sapiens	IC50	nM	154.0
	1913387	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1c(Cl)cccc1Cl)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL438109	=	IC50	nM	112.0	CHEMBL260	Homo sapiens	IC50	nM	112.0
	1913388	CHEMBL889782	Inhibition of p38-alpha MAP kinase	B	O=C(c1c(F)cccc1F)N1CCc2c(cnn2-c2ccccc2Cl)C1		CHEMBL242482	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	nM	68.0
	1922422	CHEMBL895923	Inhibition of p38alpha	B	CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1		CHEMBL231568	>	IC50	nM	40000.0	CHEMBL260	Homo sapiens	IC50	uM	40.0
	1923165	CHEMBL896197	Inhibition of p38alpha	B	N#Cc1cnc2c(F)cc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL245212	>	IC50	nM	40000.0	CHEMBL260	Homo sapiens	IC50	uM	40.0
	1923173	CHEMBL896197	Inhibition of p38alpha	B	Cn1cnc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)c1		CHEMBL230761	>	IC50	nM	40000.0	CHEMBL260	Homo sapiens	IC50	uM	40.0
	1923174	CHEMBL896197	Inhibition of p38alpha	B	CCCc1[nH]cnc1CNc1cc(Cl)c2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL230654	>	IC50	nM	40000.0	CHEMBL260	Homo sapiens	IC50	uM	40.0
	1923175	CHEMBL896197	Inhibition of p38alpha	B	CN(C)CCCn1cc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1		CHEMBL425834	>	IC50	nM	40000.0	CHEMBL260	Homo sapiens	IC50	uM	40.0
	1923176	CHEMBL896197	Inhibition of p38alpha	B	N#Cc1cnc2c(Br)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL230232	=	IC50	nM	3600.0	CHEMBL260	Homo sapiens	IC50	uM	3.6
	1923177	CHEMBL896197	Inhibition of p38alpha	B	N#Cc1cnc2c(Cl)cc(NCc3cccc[n+]3[O-])cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL395573	>	IC50	nM	40000.0	CHEMBL260	Homo sapiens	IC50	uM	40.0
	1923178	CHEMBL896197	Inhibition of p38alpha	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	=	IC50	nM	11200.0	CHEMBL260	Homo sapiens	IC50	uM	11.2
	1964160	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2ccsc2)sc2c1CCCC2		CHEMBL397356	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964205	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964206	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2S(=O)(=O)c1ccccc1		CHEMBL233794	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964207	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2Cc1cccnc1		CHEMBL391656	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964208	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	CS(=O)(=O)c1ccc(CN2CCCc3c2sc(NC(=O)c2cccc4ccccc24)c3C#N)cc1		CHEMBL391655	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964209	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)c1cc[nH]n1		CHEMBL232610	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964210	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964211	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCN(S(=O)(=O)c1ccccc1)C2		CHEMBL398601	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964212	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	CN(C)CC(=O)N1CCc2c(sc(NC(=O)c3cccc4ccccc34)c2C#N)C1		CHEMBL232600	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964213	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCN(C(=O)CCN1CCCCC1)C2		CHEMBL232599	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964214	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	Cc1cccc(S(=O)(=O)Nc2sc3c(c2C#N)CCCC3)c1		CHEMBL232598	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964215	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)NC2CCCC2)sc2c1CCCC2		CHEMBL391198	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964216	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)Nc2cccc3ccccc23)sc2c1CCCC2		CHEMBL234687	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964217	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NS(=O)(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL232406	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964218	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)C2CCCCC2)sc2c1CCCC2		CHEMBL396627	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964219	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2		CHEMBL232405	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964220	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)Cc2ccccc2Br)sc2c1CCCC2		CHEMBL234840	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964221	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)Cc2ccccc2)sc2c1CCCC2		CHEMBL397167	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964222	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2ccccc2Br)sc2c1CCCC2		CHEMBL234839	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964223	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964224	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964225	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1964226	CHEMBL897069	Inhibition of mitogen-activated protein kinase p38alpha	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	1969317	CHEMBL896523	Inhibition of P38alpha	B	O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Oc1ccccc1)N2		CHEMBL399203	=	IC50	nM	25000.0	CHEMBL260	Homo sapiens	IC50	uM	25.0
Active	1980666	CHEMBL896824	Inhibition of anisomycin-induced P38alpha activation in human HCA2 cells assessed as HSP27 phosphorylation after 2 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Activity			CHEMBL260	Homo sapiens	Activity		
Active	1980667	CHEMBL896825	Inhibition of anisomycin-induced P38-alpha activation in human HCA2 cells assessed as p-HSP27/HSP27 ratio after 2 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Activity			CHEMBL260	Homo sapiens	Activity		
Active	1980668	CHEMBL896827	Inhibition of anisomycin-induced P38alpha activation in human HCA2 cells assessed as HSP27 phosphorylation at 500 nM after 2 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Activity			CHEMBL260	Homo sapiens	Activity		
Active	1980669	CHEMBL896828	Activation of anisomycin-induced P38alpha activation in human HCA2 cells assessed as HSP27 phosphorylation at 50 nM after 2 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Activity			CHEMBL260	Homo sapiens	Activity		
Active	1980672	CHEMBL896826	Inhibition of anisomycin-induced P38-alpha activation in human HCA2 cells assessed as p-HSP27/HSP27 ratio at 500 nM after 2 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Activity			CHEMBL260	Homo sapiens	Activity		
Active	1980673	CHEMBL897988	Inhibition of anisomycin-induced P38-alpha activation in human human TERT-immortalised WS cells assessed as HSP27 phosphorylation at 1 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Activity			CHEMBL260	Homo sapiens	Activity		
Active	1980674	CHEMBL897989	Inhibition of anisomycin-induced P38-alpha activation in human human TERT-immortalised WS cells assessed as HSP27 phosphorylation at 2.5 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Activity			CHEMBL260	Homo sapiens	Activity		
	1981617	CHEMBL899220	Inhibition of human p38 alpha	B	O=C1Nc2ccccc2CN1c1csc(-c2ccncc2)n1		CHEMBL240799	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	1981618	CHEMBL899220	Inhibition of human p38 alpha	B	O=C1Nc2cc(CN3CCOCC3)ccc2CN1c1csc(-c2ccncc2)n1		CHEMBL400630	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	1981619	CHEMBL899220	Inhibition of human p38 alpha	B	O=C1Nc2cc(F)ccc2CN1c1csc(-c2ccncc2)n1		CHEMBL393041	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2025197	CHEMBL887025	Inhibition of human SAPK2a at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	92.0	CHEMBL260	Homo sapiens	Inhibition	%	92.0
	2025483	CHEMBL887025	Inhibition of human SAPK2a at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	108.0	CHEMBL260	Homo sapiens	Inhibition	%	108.0
	2025484	CHEMBL887025	Inhibition of human SAPK2a at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	93.0	CHEMBL260	Homo sapiens	Inhibition	%	93.0
	2025485	CHEMBL887025	Inhibition of human SAPK2a at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	92.0	CHEMBL260	Homo sapiens	Inhibition	%	92.0
	2025978	CHEMBL887083	Inhibition of p38-alpha by radioactive filtration assay	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1		CHEMBL246356	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	2026000	CHEMBL887103	Inhibition of p38-alpha in THP1 cells assessed as TNFalpha levels	B	CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1		CHEMBL246356	=	IC50	nM	194.0	CHEMBL260	Homo sapiens	IC50	nM	194.0
	2036348	CHEMBL922894	Inhibition of p38alpha	B	COc1ccc2[nH]c3c(c2c1)CCNC3C(=O)O		CHEMBL395157	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2036402	CHEMBL922894	Inhibition of p38alpha	B	COc1ccc2[nH]c3c(c2c1)C1CCN(C1)C3C(=O)O		CHEMBL392876	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2063990	CHEMBL926123	Inhibition of p38alpha	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)OC)c(C)c23)c1		CHEMBL252126	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	nM	220.0
	2063992	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NCCN4CCOCC4)c(C)c23)c1		CHEMBL252944	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	2063993	CHEMBL926122	Inhibition of p38-alpha at 1 uM	B	CCOC(=O)c1cn2ncnc(N(C)c3cc(C(=O)NOC)ccc3C)c2c1CC		CHEMBL251929	=	Inhibition	%	61.0	CHEMBL260	Homo sapiens	Inhibition	%	61.0
	2063994	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)OC)cc23)c1		CHEMBL400996	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	2063995	CHEMBL926123	Inhibition of p38alpha	B	CCONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)OC)c(C)c23)c1		CHEMBL251928	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2063996	CHEMBL926123	Inhibition of p38alpha	B	COC(=O)c1cn2ncnc(Nc3cc(C(N)=O)ccc3C)c2c1C		CHEMBL255042	=	IC50	nM	78.0	CHEMBL260	Homo sapiens	IC50	nM	78.0
	2063997	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)OC)c(C)c23)c1		CHEMBL252127	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	2064002	CHEMBL926123	Inhibition of p38alpha	B	COC(=O)c1cn2ncnc(-c3c(O)[nH]c4cc(Br)ccc34)c2c1C		CHEMBL252125	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	nM	80.0
	2064003	CHEMBL926123	Inhibition of p38alpha	B	COC(=O)c1cn2ncnc(-c3c(O)[nH]c4cc(F)ccc34)c2c1C		CHEMBL400486	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	nM	60.0
	2064006	CHEMBL926122	Inhibition of p38-alpha at 1 uM	B	CCNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)OC)c(C)c23)c1		CHEMBL399575	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	Inhibition	%	24.0
	2064008	CHEMBL926123	Inhibition of p38alpha	B	CCOC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL402489	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	2064009	CHEMBL926122	Inhibition of p38-alpha at 1 uM	B	CCOC(=O)c1cn2ncnc(N(C)c3cc(C(=O)NOC)ccc3C)c2c1C(C)C		CHEMBL400997	=	Inhibition	%	63.0	CHEMBL260	Homo sapiens	Inhibition	%	63.0
	2064010	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)N[C@H](C)c4ccccc4)c(C)c23)c1		CHEMBL252739	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
	2064011	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)N[C@@H](C)c4ccccc4)c(C)c23)c1		CHEMBL252535	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	2064012	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NCc4ccccn4)c(C)c23)c1		CHEMBL252533	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	2064013	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NCc4ccccc4)c(C)c23)c1		CHEMBL437971	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	2064014	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NC4CCCC4)c(C)c23)c1		CHEMBL252337	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	2064015	CHEMBL926123	Inhibition of p38alpha	B	COCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL252336	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	2064016	CHEMBL926123	Inhibition of p38alpha	B	CC[C@H](C)NC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL401210	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	2064017	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NC(C)C)c(C)c23)c1		CHEMBL401209	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2064018	CHEMBL926123	Inhibition of p38alpha	B	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL401164	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	2064019	CHEMBL926123	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL252128	=	IC50	nM	3.1	CHEMBL260	Homo sapiens	IC50	nM	3.1
	2064020	CHEMBL926123	Inhibition of p38alpha	B	CNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL251930	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	2064033	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(NC(=O)OC(C)C)c(C)c23)c1		CHEMBL254453	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	2064034	CHEMBL926123	Inhibition of p38alpha	B	CCOC(=O)Nc1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL254452	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	2064035	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(NC(=O)OC)c(C)c23)c1		CHEMBL252569	=	IC50	nM	3.3	CHEMBL260	Homo sapiens	IC50	nM	3.3
	2064036	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(NC(=O)NC(C)C)c(C)c23)c1		CHEMBL253389	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	2064037	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(NC(=O)C(C)C)c(C)c23)c1		CHEMBL253149	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	2064038	CHEMBL926123	Inhibition of p38alpha	B	CCC(=O)Nc1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL253148	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	2064039	CHEMBL926123	Inhibition of p38alpha	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(NC(C)=O)c(C)c23)c1		CHEMBL252946	=	IC50	nM	3.6	CHEMBL260	Homo sapiens	IC50	nM	3.6
	2064047	CHEMBL926123	Inhibition of p38alpha	B	CCOC(=O)Nc1ccc(C)c(Nc2ncnn3cc(C(=O)N[C@@H](C)CC)c(C)c23)c1		CHEMBL252373	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
	2064048	CHEMBL926123	Inhibition of p38alpha	B	CCOC(=O)Nc1ccc(C)c(Nc2ncnn3cc(C(=O)NC(C)C)c(C)c23)c1		CHEMBL252168	=	IC50	nM	7.7	CHEMBL260	Homo sapiens	IC50	nM	7.7
	2064049	CHEMBL926123	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)OCC)ccc3C)c2c1C		CHEMBL251972	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
	2064050	CHEMBL926123	Inhibition of p38alpha	B	CCCNC(=O)c1cn2ncnc(Nc3cc(NC(C)=O)ccc3C)c2c1C		CHEMBL255084	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	nM	230.0
	2064051	CHEMBL926123	Inhibition of p38alpha	B	CCCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)COC)ccc3C)c2c1C		CHEMBL255083	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	2064052	CHEMBL926123	Inhibition of p38alpha	B	CCCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)OC(C)C)ccc3C)c2c1C		CHEMBL254661	=	IC50	nM	680.0	CHEMBL260	Homo sapiens	IC50	nM	680.0
	2064053	CHEMBL926123	Inhibition of p38alpha	B	CCCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)OCC)ccc3C)c2c1C		CHEMBL254660	=	IC50	nM	5.5	CHEMBL260	Homo sapiens	IC50	nM	5.5
	2064054	CHEMBL926123	Inhibition of p38alpha	B	CCCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)OC)ccc3C)c2c1C		CHEMBL254659	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	2064059	CHEMBL926122	Inhibition of p38-alpha at 1 uM	B	CCCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)Oc4ccccc4)ccc3C)c2c1C		CHEMBL400185	=	Inhibition	%	32.0	CHEMBL260	Homo sapiens	Inhibition	%	32.0
	2077616	CHEMBL944993	Inhibition of p38alpha	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	2077617	CHEMBL944993	Inhibition of p38alpha	B	O=c1[nH]c2ccccc2c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL434737	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	uM	1.8
	2077619	CHEMBL944993	Inhibition of p38alpha	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	2077643	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	O=c1cc(-c2ccncc2)c2ccccc2[nH]1		CHEMBL399305	=	Activity	%	78.0	CHEMBL260	Homo sapiens	Activity	%	78.0
	2077644	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	O=c1[nH]c2ccccc2c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL434737	=	Activity	%	53.0	CHEMBL260	Homo sapiens	Activity	%	53.0
	2077645	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	20.0	CHEMBL260	Homo sapiens	Activity	%	20.0
	2077646	CHEMBL944993	Inhibition of p38alpha	B	CC#Cn1c(=O)c(-c2ccc(F)cc2)c(-c2ccncc2)c2ccccc21		CHEMBL398264	=	IC50	nM	3100.0	CHEMBL260	Homo sapiens	IC50	uM	3.1
	2077647	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	50.0	CHEMBL260	Homo sapiens	Activity	%	50.0
	2077657	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	CCOc1nc2ccccc2c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL253208	=	Activity	%	66.0	CHEMBL260	Homo sapiens	Activity	%	66.0
	2077659	CHEMBL944993	Inhibition of p38alpha	B	Cn1c(=O)c(-c2ccc(F)cc2)c(-c2ccncc2)c2ccccc21		CHEMBL253891	=	IC50	nM	5200.0	CHEMBL260	Homo sapiens	IC50	uM	5.2
	2077660	CHEMBL944993	Inhibition of p38alpha	B	CCn1c(=O)c(-c2ccc(F)cc2)c(-c2ccncc2)c2ccccc21		CHEMBL254717	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	2077663	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	CC#COc1nc2ccccc2c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL254056	=	Activity	%	79.0	CHEMBL260	Homo sapiens	Activity	%	79.0
	2077664	CHEMBL944993	Inhibition of p38alpha	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)c2ccccc2n1CCc1ccccc1	Non standard unit for type	CHEMBL398464	=	IC50	ucm	8.2	CHEMBL260	Homo sapiens	IC50	ucm	8.2
	2077665	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	CC1(C)OCC(Cn2c(=O)c(-c3ccc(F)cc3)c(-c3ccncc3)c3ccccc32)O1		CHEMBL252027	=	Activity	%	55.0	CHEMBL260	Homo sapiens	Activity	%	55.0
	2077666	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	CCC(O)C(O)n1c(=O)c(-c2ccc(F)cc2)c(-c2ccncc2)c2ccccc21		CHEMBL252997	=	Activity	%	57.0	CHEMBL260	Homo sapiens	Activity	%	57.0
	2077667	CHEMBL944993	Inhibition of p38alpha	B	Cc1ccccc1-c1c(-c2ccncc2)c2ccccc2[nH]c1=O		CHEMBL253852	=	IC50	nM	9700.0	CHEMBL260	Homo sapiens	IC50	uM	9.7
Not Determined	2077668	CHEMBL944993	Inhibition of p38alpha	B	Cc1ccccc1-c1c(-c2ccncc2)c2ccccc2n(CC2COC(C)(C)O2)c1=O		CHEMBL400317		Activity			CHEMBL260	Homo sapiens	Activity		
Not Determined	2077669	CHEMBL944993	Inhibition of p38alpha	B	Cc1ccccc1-c1c(OCC2COC(C)(C)O2)nc2ccccc2c1-c1ccncc1		CHEMBL251788		Activity			CHEMBL260	Homo sapiens	Activity		
	2077670	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	CCC(O)C(O)n1c(=O)c(-c2ccccc2C)c(-c2ccncc2)c2ccccc21		CHEMBL437200	=	Activity	%	80.0	CHEMBL260	Homo sapiens	Activity	%	80.0
	2077671	CHEMBL945007	Inhibition of p38alpha assessed as residual activity at 10 uM relative to control	B	O=c1[nH]c2ccccc2c(-c2ccccc2)c1-c1ccccc1		CHEMBL254684	=	Activity	%	64.0	CHEMBL260	Homo sapiens	Activity	%	64.0
	2081719	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ccnn3-c3ccccc3)cc2s1		CHEMBL402537	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	2081721	CHEMBL928788	Inhibition of p38alpha	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)nn(CC)c3N)cc2s1		CHEMBL258002	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	2081722	CHEMBL928788	Inhibition of p38alpha	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)nn(C)c3N)cc2s1		CHEMBL402905	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	2081723	CHEMBL928788	Inhibition of p38alpha	B	CC[C@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL257585	=	IC50	nM	5.5	CHEMBL260	Homo sapiens	IC50	nM	5.5
	2081724	CHEMBL928788	Inhibition of p38alpha	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	2081725	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL255470	=	IC50	nM	3.7	CHEMBL260	Homo sapiens	IC50	nM	3.7
	2081726	CHEMBL928788	Inhibition of p38alpha	B	CC[C@H](C)Nc1nc2ccc(-c3[nH]cnc3-c3ccccc3F)cc2s1		CHEMBL255469	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	2081727	CHEMBL928788	Inhibition of p38alpha	B	CC[C@@H](C)Nc1nc2ccc(-c3[nH]cnc3-c3ccccc3F)cc2s1		CHEMBL439238	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	2081728	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3[nH]cnc3-c3ccccc3F)cc2s1		CHEMBL403942	=	IC50	nM	3.3	CHEMBL260	Homo sapiens	IC50	nM	3.3
	2081729	CHEMBL928788	Inhibition of p38alpha	B	CC[C@H](C)Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1		CHEMBL255269	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2081730	CHEMBL928788	Inhibition of p38alpha	B	CC[C@@H](C)Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1		CHEMBL255268	=	IC50	nM	6.5	CHEMBL260	Homo sapiens	IC50	nM	6.5
	2081731	CHEMBL928788	Inhibition of p38alpha	B	CCNc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1		CHEMBL255464	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	2081732	CHEMBL928788	Inhibition of p38alpha	B	Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1		CHEMBL403943	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	2081733	CHEMBL928788	Inhibition of p38alpha	B	Fc1ccccc1-c1ncoc1-c1ccc2ncsc2c1		CHEMBL257342	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	2081734	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3[nH]cnc3-c3ccccc3F)cc2s1		CHEMBL403942	=	IC50	nM	3.3	CHEMBL260	Homo sapiens	IC50	nM	3.3
	2081735	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ocnc3-c3ccccc3F)cc2s1		CHEMBL257341	=	IC50	nM	6.4	CHEMBL260	Homo sapiens	IC50	nM	6.4
	2081736	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ccnn3-c3ccccc3F)cc2s1		CHEMBL403941	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	2081737	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ccnn3-c3cccc(F)c3)cc2s1		CHEMBL257340	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	2081738	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ccnn3-c3ccc(F)cc3)cc2s1		CHEMBL257132	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	2081739	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ccnn3-c3ccccc3Cl)cc2s1		CHEMBL402861	=	IC50	nM	175.0	CHEMBL260	Homo sapiens	IC50	nM	175.0
	2081740	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ccnn3-c3cccc(Cl)c3)cc2s1		CHEMBL442454	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	nM	72.0
	2081741	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ccnn3-c3ccc(Cl)cc3)cc2s1		CHEMBL402655	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2081742	CHEMBL928788	Inhibition of p38alpha	B	Cc1ccccc1-n1nccc1-c1ccc2nc(NC(C)C)sc2c1		CHEMBL257131	=	IC50	nM	146.0	CHEMBL260	Homo sapiens	IC50	nM	146.0
	2081743	CHEMBL928788	Inhibition of p38alpha	B	Cc1cccc(-n2nccc2-c2ccc3nc(NC(C)C)sc3c2)c1		CHEMBL256926	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	2081744	CHEMBL928788	Inhibition of p38alpha	B	Cc1ccc(-n2nccc2-c2ccc3nc(NC(C)C)sc3c2)cc1		CHEMBL402654	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2081745	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3[nH]cnc3-c3ccccc3)cc2s1		CHEMBL256925	=	IC50	nM	7.1	CHEMBL260	Homo sapiens	IC50	nM	7.1
	2081746	CHEMBL928788	Inhibition of p38alpha	B	CC(C)Nc1nc2ccc(-c3ocnc3-c3ccccc3)cc2s1		CHEMBL256924	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	2082219	CHEMBL929947	Inhibition of human p38alpha	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC2CC2)s1		CHEMBL258403	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	nM	39.0
	2082222	CHEMBL929947	Inhibition of human p38alpha	B	CCCNc1nc(C)c(C(=O)Nc2cc(C(=O)NCC)ccc2C)s1		CHEMBL404446	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	2082223	CHEMBL929947	Inhibition of human p38alpha	B	CCNC(=O)c1ccc(C)c(NC(=O)c2sc(NCC)nc2C)c1		CHEMBL402943	=	IC50	nM	330.0	CHEMBL260	Homo sapiens	IC50	nM	330.0
	2082224	CHEMBL929947	Inhibition of human p38alpha	B	CCNC(=O)c1ccc(C)c(N2CC3N=C(NC4CCCC4)SC3C2=O)c1		CHEMBL254365	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	nM	53.0
	2082225	CHEMBL929947	Inhibition of human p38alpha	B	CCNC(=O)c1ccc(C)c(N2Cc3nc(NC(C)C)sc3C2=O)c1		CHEMBL254169	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	2082226	CHEMBL929947	Inhibition of human p38alpha	B	CCCNc1nc2c(s1)C(=O)N(c1cc(C(=O)NCC)ccc1C)C2		CHEMBL254168	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	2082227	CHEMBL929947	Inhibition of human p38alpha	B	CNC(=O)c1ccc(C)c(N2Cc3nc(NC4CCCC4)sc3C2=O)c1		CHEMBL258247	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	2082228	CHEMBL929947	Inhibition of human p38alpha	B	CNC(=O)c1ccc(C)c(N2Cc3nc(NC(C)C)sc3C2=O)c1		CHEMBL255931	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	2082229	CHEMBL929947	Inhibition of human p38alpha	B	CCCNc1nc2c(s1)C(=O)N(c1cc(C(=O)NC)ccc1C)C2		CHEMBL255719	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	nM	270.0
	2082230	CHEMBL929947	Inhibition of human p38alpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnc(NC(C)C)s1		CHEMBL403200	=	IC50	nM	3.8	CHEMBL260	Homo sapiens	IC50	nM	3.8
	2082231	CHEMBL929947	Inhibition of human p38alpha	B	Cc1ccc(C(=O)Nc2ccnn2C)cc1NC(=O)c1cnc(NC(C)C)s1		CHEMBL258223	=	IC50	nM	5.4	CHEMBL260	Homo sapiens	IC50	nM	5.4
	2082232	CHEMBL929947	Inhibition of human p38alpha	B	Cc1ccc(C(=O)Nc2ccn[nH]2)cc1NC(=O)c1cnc(NC(C)C)s1		CHEMBL255288	=	IC50	nM	4.2	CHEMBL260	Homo sapiens	IC50	nM	4.2
	2082233	CHEMBL929947	Inhibition of human p38alpha	B	CCNC(=O)c1ccc(C)c(NC(=O)c2cnc(NC(C)C)s2)c1		CHEMBL255698	=	IC50	nM	3.4	CHEMBL260	Homo sapiens	IC50	nM	3.4
	2082234	CHEMBL929947	Inhibition of human p38alpha	B	CCCNc1ncc(C(=O)Nc2cc(C(=O)NCC)ccc2C)s1		CHEMBL255482	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2082235	CHEMBL929947	Inhibition of human p38alpha	B	CNC(=O)c1ccc(C)c(NC(=O)c2cnc(NCCOC)s2)c1		CHEMBL258418	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	2082236	CHEMBL929947	Inhibition of human p38alpha	B	CC[C@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258203	=	IC50	nM	2.3	CHEMBL260	Homo sapiens	IC50	nM	2.3
	2082237	CHEMBL929947	Inhibition of human p38alpha	B	CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258202	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
	2082238	CHEMBL929947	Inhibition of human p38alpha	B	CNC(=O)c1ccc(C)c(NC(=O)c2cnc(NC(C)C)s2)c1		CHEMBL258201	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
	2082239	CHEMBL929947	Inhibition of human p38alpha	B	CCCNc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL257996	=	IC50	nM	4.5	CHEMBL260	Homo sapiens	IC50	nM	4.5
	2082240	CHEMBL929947	Inhibition of human p38alpha	B	Cc1ccc(C(N)=O)cc1NC(=O)c1cnc(NC(C)C)s1		CHEMBL257995	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	2082241	CHEMBL929947	Inhibition of human p38alpha	B	CCCNc1ncc(C(=O)Nc2cc(C(N)=O)ccc2C)s1		CHEMBL257994	=	IC50	nM	4.1	CHEMBL260	Homo sapiens	IC50	nM	4.1
	2082242	CHEMBL929947	Inhibition of human p38alpha	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC2CCC2)s1		CHEMBL255428	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	2082243	CHEMBL929947	Inhibition of human p38alpha	B	Cc1cccc(Cl)c1NC(=O)c1cnc(Nc2ccccc2)s1		CHEMBL186177	=	IC50	nM	62.0	CHEMBL260	Homo sapiens	IC50	nM	62.0
	2082244	CHEMBL929947	Inhibition of human p38alpha	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC(C)C)s1		CHEMBL403141	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	2082245	CHEMBL929947	Inhibition of human p38alpha	B	CCCNc1ncc(C(=O)Nc2c(C)cccc2Cl)s1		CHEMBL255254	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	2082246	CHEMBL929947	Inhibition of human p38alpha	B	CCNc1ncc(C(=O)Nc2c(C)cccc2Cl)s1		CHEMBL403140	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	nM	140.0
	2086244	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1N1CCN(C)CC1		CHEMBL270608	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2086245	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1N1CCN(C)CC1		CHEMBL270608	=	Ki	nM	1600.0	CHEMBL260	Homo sapiens	Ki	uM	1.6
	2086246	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3C)c2)o1		CHEMBL444543	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	2086247	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3C)c2)o1		CHEMBL444543	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	uM	2.5
	2086248	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	2086249	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	uM	2.5
	2086250	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)[nH]1		CHEMBL257303	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	2086251	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)[nH]1		CHEMBL257303	=	Ki	nM	220.0	CHEMBL260	Homo sapiens	Ki	uM	0.22
	2086252	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1ccc(-c2ncc[nH]2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL401530	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	uM	11.0
	2086253	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1ccc(-c2ncc[nH]2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL401530	=	Ki	nM	1700.0	CHEMBL260	Homo sapiens	Ki	uM	1.7
	2086254	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)no1		CHEMBL272308	=	IC50	nM	14000.0	CHEMBL260	Homo sapiens	IC50	uM	14.0
	2086255	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)no1		CHEMBL272308	=	Ki	nM	2000.0	CHEMBL260	Homo sapiens	Ki	uM	2.0
	2086256	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CCCCc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257918	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	2086257	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CCCCc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257918	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	uM	2.5
	2086258	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CCCc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL404913	=	IC50	nM	9700.0	CHEMBL260	Homo sapiens	IC50	uM	9.7
	2086259	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CCCc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL404913	=	Ki	nM	1500.0	CHEMBL260	Homo sapiens	Ki	uM	1.5
	2086260	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CCc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL272519	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2086261	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CCc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL272519	=	Ki	nM	1600.0	CHEMBL260	Homo sapiens	Ki	uM	1.6
	2086262	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1ccc(-c2nnco2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL403860	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	2086263	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1ccc(-c2nnco2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL403860	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	uM	2.5
	2086264	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)N4CCCCC4)cc3)c2)o1		CHEMBL256045	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2086265	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)N4CCCCC4)cc3)c2)o1		CHEMBL256045	=	Ki	nM	1600.0	CHEMBL260	Homo sapiens	Ki	uM	1.6
	2086266	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCCN4CCOCC4)cc3)c2)o1		CHEMBL401518	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	2086267	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCCN4CCOCC4)cc3)c2)o1		CHEMBL401518	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	uM	2.5
	2086268	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCCCO)cc3)c2)o1		CHEMBL401517	=	IC50	nM	7100.0	CHEMBL260	Homo sapiens	IC50	uM	7.1
	2086269	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCCCO)cc3)c2)o1		CHEMBL401517	=	Ki	nM	1100.0	CHEMBL260	Homo sapiens	Ki	uM	1.1
	2086270	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	2086271	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	Ki	nM	480.0	CHEMBL260	Homo sapiens	Ki	uM	0.48
	2086272	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)O)cc3)c2)o1		CHEMBL272750	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	2086273	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)O)cc3)c2)o1		CHEMBL272750	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	uM	2.5
	2086274	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)N(C)c4cccc(C#N)c4)cc3)c2)o1		CHEMBL267281	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	uM	12.0
	2086275	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)N(C)c4cccc(C#N)c4)cc3)c2)o1		CHEMBL267281	=	Ki	nM	1900.0	CHEMBL260	Homo sapiens	Ki	uM	1.9
	2086276	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)N(C)Cc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL401674	=	IC50	nM	890.0	CHEMBL260	Homo sapiens	IC50	uM	0.89
	2086277	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)N(C)Cc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL401674	=	Ki	nM	140.0	CHEMBL260	Homo sapiens	Ki	uM	0.14
	2086278	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4cccc(CN5CCOCC5)c4)cc3)c2)o1		CHEMBL269983	=	IC50	nM	870.0	CHEMBL260	Homo sapiens	IC50	uM	0.87
	2086279	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4cccc(CN5CCOCC5)c4)cc3)c2)o1		CHEMBL269983	=	Ki	nM	140.0	CHEMBL260	Homo sapiens	Ki	uM	0.14
	2086280	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	2086281	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	Ki	uM	0.1
	2086282	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	IC50	nM	520.0	CHEMBL260	Homo sapiens	IC50	uM	0.52
	2086283	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Ki	nM	80.0	CHEMBL260	Homo sapiens	Ki	uM	0.08
	2086284	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1cccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL271271	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	uM	0.37
	2086285	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1cccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL271271	=	Ki	nM	60.0	CHEMBL260	Homo sapiens	Ki	uM	0.06
	2086286	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccccc4)cc3)c2)o1		CHEMBL270219	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	uM	0.61
	2086287	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccccc4)cc3)c2)o1		CHEMBL270219	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	Ki	uM	0.1
	2086288	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(NS(C)(=O)=O)cc4)cc3)c2)o1		CHEMBL271272	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	2086289	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(NS(C)(=O)=O)cc4)cc3)c2)o1		CHEMBL271272	=	Ki	nM	40.0	CHEMBL260	Homo sapiens	Ki	uM	0.04
	2086290	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4ccc(NS(C)(=O)=O)cc4)cc3)c2)o1		CHEMBL408476	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	2086291	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4ccc(NS(C)(=O)=O)cc4)cc3)c2)o1		CHEMBL408476	=	Ki	nM	40.0	CHEMBL260	Homo sapiens	Ki	uM	0.04
	2086292	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CNC(=O)c1cccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL272566	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	2086293	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	CNC(=O)c1cccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL272566	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	Ki	uM	0.1
	2086294	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccccc1NC(=O)c1ccc(-c2cc(-c3nnc(C)o3)ccc2C)cc1		CHEMBL272565	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	2086295	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccccc1NC(=O)c1ccc(-c2cc(-c3nnc(C)o3)ccc2C)cc1		CHEMBL272565	=	Ki	nM	250.0	CHEMBL260	Homo sapiens	Ki	uM	0.25
	2086296	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL411661	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	2086297	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	COc1ccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL411661	=	Ki	nM	360.0	CHEMBL260	Homo sapiens	Ki	uM	0.36
	2086298	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	2086299	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Ki	nM	240.0	CHEMBL260	Homo sapiens	Ki	uM	0.24
	2086300	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(N5CCN(C)CC5)c4)cc3)c2)o1		CHEMBL401538	=	IC50	nM	3100.0	CHEMBL260	Homo sapiens	IC50	uM	3.1
	2086301	CHEMBL946927	Inhibition of p38alpha by fluorescence polarization assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(N5CCN(C)CC5)c4)cc3)c2)o1		CHEMBL401538	=	Ki	nM	490.0	CHEMBL260	Homo sapiens	Ki	uM	0.49
	2087628	CHEMBL929902	Inhibition of purified human p38alpha	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	2087629	CHEMBL929902	Inhibition of purified human p38alpha	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	Ki	nM	480.0	CHEMBL260	Homo sapiens	Ki	uM	0.48
	2087646	CHEMBL929902	Inhibition of purified human p38alpha	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	2087647	CHEMBL929902	Inhibition of purified human p38alpha	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Ki	nM	240.0	CHEMBL260	Homo sapiens	Ki	uM	0.24
	2087648	CHEMBL929902	Inhibition of purified human p38alpha	B	COc1ccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1N1CCN(C)CC1		CHEMBL270608	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2087649	CHEMBL929902	Inhibition of purified human p38alpha	B	COc1ccc(NC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1N1CCN(C)CC1		CHEMBL270608	=	Ki	nM	1600.0	CHEMBL260	Homo sapiens	Ki	uM	1.6
	2087650	CHEMBL929902	Inhibition of purified human p38alpha	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12		CHEMBL237127	=	IC50	nM	2500.0	CHEMBL260	Homo sapiens	IC50	uM	2.5
	2087651	CHEMBL929902	Inhibition of purified human p38alpha	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12		CHEMBL237127	=	Ki	nM	400.0	CHEMBL260	Homo sapiens	Ki	uM	0.4
	2087654	CHEMBL929902	Inhibition of purified human p38alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	18.0	CHEMBL260	Homo sapiens	Ki	nM	18.0
	2090629	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc21		CHEMBL364572	=	IC50	nM	4.9	CHEMBL260	Homo sapiens	IC50	nM	4.9
	2090630	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)(C)Cn1cnc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3F)nc21.CS(=O)(=O)O		CHEMBL270657	=	IC50	nM	2.3	CHEMBL260	Homo sapiens	IC50	nM	2.3
	2090631	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)(C)Cn1cnc2ccc(-c3[nH]c(-c4c(Cl)cccc4Cl)nc3-c3ccc(F)cc3)nc21.CS(=O)(=O)O		CHEMBL274201	=	IC50	nM	3.6	CHEMBL260	Homo sapiens	IC50	nM	3.6
	2090632	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)(C)Cn1cnc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccc(F)cc3)nc21.CS(=O)(=O)O		CHEMBL404118	=	IC50	nM	7.2	CHEMBL260	Homo sapiens	IC50	nM	7.2
	2090633	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)(C)Cn1cnc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21.CS(=O)(=O)O		CHEMBL411291	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	2090634	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)(C)Cn1cnc2ccc(-c3[nH]c(-c4c(F)cccc4Cl)nc3-c3ccccc3)nc21.CS(=O)(=O)O		CHEMBL409698	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	2090635	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1cnc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3F)nc21.CS(=O)(=O)O		CHEMBL271505	=	IC50	nM	3.9	CHEMBL260	Homo sapiens	IC50	nM	3.9
	2090636	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1cnc2ccc(-c3[nH]c(-c4c(Cl)cccc4Cl)nc3-c3ccc(F)cc3F)nc21.CS(=O)(=O)O		CHEMBL272731	=	IC50	nM	3.9	CHEMBL260	Homo sapiens	IC50	nM	3.9
	2090637	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1cnc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccccc3)nc21.CS(=O)(=O)O		CHEMBL402188	=	IC50	nM	5.1	CHEMBL260	Homo sapiens	IC50	nM	5.1
	2090638	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1cnc2ccc(-c3[nH]c(-c4c(Cl)cccc4Cl)nc3-c3ccccc3)nc21.CS(=O)(=O)O		CHEMBL429422	=	IC50	nM	3.7	CHEMBL260	Homo sapiens	IC50	nM	3.7
	2090639	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CS(=O)(=O)O.Cc1nc(-c2ccc(F)cc2F)c(-c2ccc3nc(N)n(S(=O)(=O)C(C)C)c3c2)[nH]1		CHEMBL270842	=	IC50	nM	8.8	CHEMBL260	Homo sapiens	IC50	nM	8.8
	2090640	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CS(=O)(=O)O.Cc1nc(-c2ccc(F)cc2)c(-c2ccc3nc(N)n(S(=O)(=O)C(C)C)c3c2)[nH]1		CHEMBL271059	=	IC50	nM	7.1	CHEMBL260	Homo sapiens	IC50	nM	7.1
	2090641	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CS(=O)(=O)O.Cc1nc(-c2ccccc2)c(-c2ccc3nc(N)n(S(=O)(=O)C(C)C)c3c2)[nH]1		CHEMBL258150	=	IC50	nM	20.4	CHEMBL260	Homo sapiens	IC50	nM	20.4
	2090642	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(Cl)cccc4Cl)nc3-c3ccc(F)cc3)cc21.CS(=O)(=O)O		CHEMBL402399	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
	2090643	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(Cl)cccc4Cl)nc3-c3ccccc3)cc21.CS(=O)(=O)O		CHEMBL192889	=	IC50	nM	15.3	CHEMBL260	Homo sapiens	IC50	nM	15.3
	2090644	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(Cl)cccc4C(F)(F)F)nc3-c3ccccc3)cc21.CS(=O)(=O)O		CHEMBL270002	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	nM	8.5
	2090645	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4Cl)nc3-c3ccccc3)cc21.CS(=O)(=O)O		CHEMBL272142	=	IC50	nM	14.5	CHEMBL260	Homo sapiens	IC50	nM	14.5
	2090646	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4ccccc4C(F)(F)F)nc3-c3ccccc3)cc21		CHEMBL271443	=	IC50	nM	26.1	CHEMBL260	Homo sapiens	IC50	nM	26.1
	2090647	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4ccc(Cl)cc4)nc3-c3ccccc3)cc21		CHEMBL403737	=	IC50	nM	34.7	CHEMBL260	Homo sapiens	IC50	nM	34.7
	2090648	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4ccncc4)nc3-c3ccccc3)cc21		CHEMBL437030	=	IC50	nM	6.1	CHEMBL260	Homo sapiens	IC50	nM	6.1
	2090649	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]cnc3-c3ccccc3)cc21		CHEMBL192848	=	IC50	nM	4.2	CHEMBL260	Homo sapiens	IC50	nM	4.2
	2090650	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3F)cc21		CHEMBL404377	=	IC50	nM	4.4	CHEMBL260	Homo sapiens	IC50	nM	4.4
	2090651	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)nc21.CS(=O)(=O)O		CHEMBL403294	=	IC50	nM	6.4	CHEMBL260	Homo sapiens	IC50	nM	6.4
	2090652	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1cnc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)nc21.CS(=O)(=O)O		CHEMBL272989	=	IC50	nM	4.5	CHEMBL260	Homo sapiens	IC50	nM	4.5
	2090653	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)nc21.CS(=O)(=O)O		CHEMBL442972	=	IC50	nM	2.5	CHEMBL260	Homo sapiens	IC50	nM	2.5
	2090654	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)nc21.CS(=O)(=O)O		CHEMBL272108	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
	2090655	CHEMBL932042	Inhibition of human recombinant p38alpha	B	Nc1nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc2n1-c1ccccc1		CHEMBL404547	=	IC50	nM	158.0	CHEMBL260	Homo sapiens	IC50	nM	158.0
	2090656	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc21.CS(=O)(=O)O		CHEMBL402219	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2090657	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CS(=O)(=O)O.Cc1nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc2n1CC(C)C		CHEMBL256684	=	IC50	nM	11.2	CHEMBL260	Homo sapiens	IC50	nM	11.2
	2090658	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1c(N)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc21.CS(=O)(=O)O		CHEMBL444636	=	IC50	nM	9.9	CHEMBL260	Homo sapiens	IC50	nM	9.9
	2090659	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)Cn1cnc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc21		CHEMBL404645	=	IC50	nM	16.2	CHEMBL260	Homo sapiens	IC50	nM	16.2
	2090660	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CCNc1nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc2[nH]1		CHEMBL403851	=	IC50	nM	56.4	CHEMBL260	Homo sapiens	IC50	nM	56.4
	2090661	CHEMBL932042	Inhibition of human recombinant p38alpha	B	Nc1nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc2[nH]1		CHEMBL272735	=	IC50	nM	131.0	CHEMBL260	Homo sapiens	IC50	nM	131.0
	2090662	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CS(=O)(=O)O.Fc1cccc(F)c1-c1nc(-c2ccccc2)c(-c2ccc3nc[nH]c3c2)[nH]1		CHEMBL272535	=	IC50	nM	88.4	CHEMBL260	Homo sapiens	IC50	nM	88.4
	2090663	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CC(C)S(=O)(=O)n1c(N(C)Cc2ccccc2)nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc21		CHEMBL272537	=	IC50	nM	2489.0	CHEMBL260	Homo sapiens	IC50	nM	2489.0
	2090664	CHEMBL932042	Inhibition of human recombinant p38alpha	B	CCNc1nc2ccc(-c3[nH]c(-c4c(F)cccc4F)nc3-c3ccccc3)cc2n1S(=O)(=O)C(C)C		CHEMBL402617	=	IC50	nM	156.0	CHEMBL260	Homo sapiens	IC50	nM	156.0
	2096359	CHEMBL948990	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2096378	CHEMBL948990	Inhibition of p38alpha	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3F)ccc2C)c(NC)n1		CHEMBL269936	=	IC50	nM	2.4	CHEMBL260	Homo sapiens	IC50	nM	2.4
	2096379	CHEMBL948990	Inhibition of p38alpha	B	COc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2F)ccc1C		CHEMBL257858	=	IC50	nM	856.0	CHEMBL260	Homo sapiens	IC50	nM	856.0
	2096380	CHEMBL948990	Inhibition of p38alpha	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3F)ccc2C)c(OC)n1		CHEMBL255533	=	IC50	nM	254.0	CHEMBL260	Homo sapiens	IC50	nM	254.0
	2096381	CHEMBL948990	Inhibition of p38alpha	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c(OC)n1		CHEMBL271018	=	IC50	nM	2720.0	CHEMBL260	Homo sapiens	IC50	nM	2720.0
	2096415	CHEMBL948990	Inhibition of p38alpha	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3C)ccc2C)c(OC)n1		CHEMBL271101	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
Not Determined	2096416	CHEMBL948990	Inhibition of p38alpha	B	CNc1ncc(C(=O)Nc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)c(Oc2ccccc2)n1		CHEMBL271099		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	2096417	CHEMBL948990	Inhibition of p38alpha	B	COc1nc(NCCCCN(C)C)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2C)ccc1C		CHEMBL255132		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	2096418	CHEMBL948990	Inhibition of p38alpha	B	COc1nc(NCCCN2CCN(C)CC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2C)ccc1C		CHEMBL255989		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	2096419	CHEMBL948990	Inhibition of p38alpha	B	COc1nc(NCCN2CCOCC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1C		CHEMBL270793		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	2096420	CHEMBL948990	Inhibition of p38alpha	B	COc1nc(NC2CCN(C)CC2)ncc1C(=O)Nc1cc(C(=O)Nc2cccc(C(F)(F)F)c2)ccc1C		CHEMBL271650		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	2096421	CHEMBL948990	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc(NCCN2CCOCC2)nc1Oc1ccccc1		CHEMBL408292		IC50			CHEMBL260	Homo sapiens	IC50		
	2099511	CHEMBL948225	Inhibition of SAPK2a/p38 at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	87.0	CHEMBL260	Homo sapiens	Inhibition	%	87.0
	2099551	CHEMBL948225	Inhibition of SAPK2a/p38 at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	72.0	CHEMBL260	Homo sapiens	Inhibition	%	72.0
	2099552	CHEMBL948225	Inhibition of SAPK2a/p38 at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	68.0	CHEMBL260	Homo sapiens	Inhibition	%	68.0
	2099553	CHEMBL948225	Inhibition of SAPK2a/p38 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	Inhibition	%	75.0
	2099554	CHEMBL948225	Inhibition of SAPK2a/p38 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	87.0	CHEMBL260	Homo sapiens	Inhibition	%	87.0
	2099555	CHEMBL948225	Inhibition of SAPK2a/p38 at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	55.0	CHEMBL260	Homo sapiens	Inhibition	%	55.0
	2111019	CHEMBL952123	Inhibition of p38alpha at 1000 nM	B	COC(=O)c1ccc2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421383	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	2111020	CHEMBL952123	Inhibition of p38alpha at 1000 nM	B	COC(=O)c1cc(Sc2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL259683	=	Inhibition	%	48.0	CHEMBL260	Homo sapiens	Inhibition	%	48.0
	2111021	CHEMBL952123	Inhibition of p38alpha at 1000 nM	B	COC(=O)c1cc(Br)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL420438	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	Inhibition	%	0.0
	2111022	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccccc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421194	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	2111023	CHEMBL952122	Inhibition of p38alpha	B	O=C(c1cc(-c2ccc(F)cc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL96225	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	2111024	CHEMBL952122	Inhibition of p38alpha	B	O=C(c1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL327217	=	IC50	nM	2.4	CHEMBL260	Homo sapiens	IC50	nM	2.4
	2111025	CHEMBL952122	Inhibition of p38alpha	B	O=C(c1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL94444	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	2111026	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(CN3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327746	=	IC50	nM	0.13	CHEMBL260	Homo sapiens	IC50	nM	0.13
	2111027	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(CN3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL97227	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	2111028	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(NC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96432	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	2111029	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(NC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327987	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	2111030	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(OC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327959	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	2111031	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(OC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL94825	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	2111032	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL94417	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	2111033	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96487	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	2111034	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL328614	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	2111035	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	2111036	CHEMBL952122	Inhibition of p38alpha	B	O=C1NCc2c(-c3ccccc3Cl)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96763	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	2111037	CHEMBL952122	Inhibition of p38alpha	B	COc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL96632	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2111038	CHEMBL952122	Inhibition of p38alpha	B	COc1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL96091	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	2111039	CHEMBL952122	Inhibition of p38alpha	B	COc1cc(-c2ccc(F)cc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94770	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	2111040	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccc(F)cc2C)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94783	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	2111041	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2c(F)cccc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL316337	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	2111042	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94547	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	2111043	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccc(C)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL97579	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	2111044	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2cccc(C)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328274	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	nM	320.0
	2111045	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccccc2C)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94377	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	2111046	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccc(C(F)(F)F)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94719	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	2111047	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2cccc(C(F)(F)F)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328752	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	nM	170.0
	2111048	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccc(Cl)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL330358	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	2111049	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2cccc(Cl)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421566	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
	2111050	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94556	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	2111051	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccc(F)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328252	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	2111052	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2cccc(F)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94852	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	2111053	CHEMBL952122	Inhibition of p38alpha	B	COC(=O)c1cc(-c2ccccc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94495	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	2111054	CHEMBL952124	Inhibition of p38alpha at 890 nM	B	COC(=O)c1cc(-c2ccccc2C(F)(F)F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL327923	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	Inhibition	%	50.0
	2111933	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OC		CHEMBL270777	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111973	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc4c(=O)n(-c5c(Cl)cc(Cl)cc5Cl)c5nc6ccccc6n5c4n3)cc2)CC1		CHEMBL254674	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111974	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OCCCN1CCN(C)CC1		CHEMBL260306	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111975	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)ccc1OCCCN1CCN(C)CC1		CHEMBL405430	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111976	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCCN4CCCCC4)cc3)nc2n2c3ccccc3nc12		CHEMBL408030	=	IC50	nM	4300.0	CHEMBL260	Homo sapiens	IC50	uM	4.3
	2111977	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OCCN1CCOCC1		CHEMBL406804	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111978	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCN4CCN(C)CC4)c(F)c3)nc2n2c3ccccc3nc12		CHEMBL407516	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111979	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)cc(OC)c1OCCN1CCN(C)CC1		CHEMBL260956	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111980	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)ccc1OCCN1CCN(C)CC1		CHEMBL407279	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111981	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCCN(C)C)cc3)nc2n2c3ccccc3nc12		CHEMBL261174	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111982	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(OCCN(C)C)cc3)nc2n2c3ccccc3nc12		CHEMBL410892	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2111983	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncc3c(=O)n(-c4c(C)cccc4C)c4nc5ccccc5n4c3n2)ccc1N1CCN(C)CC1		CHEMBL403522	=	IC50	nM	7500.0	CHEMBL260	Homo sapiens	IC50	uM	7.5
	2111984	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12		CHEMBL410295	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2112036	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncnc(-n3c(Nc4c(C)cccc4C)nc4ccccc43)n2)cc(OC)c1OC		CHEMBL270692	=	IC50	nM	78.0	CHEMBL260	Homo sapiens	IC50	uM	0.078
	2112037	CHEMBL934189	Inhibition of p38-alpha by HTRF assay	B	COc1cc(Nc2ncnc(-n3c(Nc4ccccc4)nc4ccccc43)n2)cc(OC)c1OC		CHEMBL271131	=	IC50	nM	463.0	CHEMBL260	Homo sapiens	IC50	uM	0.463
	2119766	CHEMBL935072	Inhibition of p38alpha	B	O=C(NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1)[C@@H]1CCCN1		CHEMBL409901	=	IC50	nM	0.75	CHEMBL260	Homo sapiens	IC50	nM	0.75
	2119767	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	O=C(NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1)[C@@H]1CCCN1		CHEMBL409901	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	nM	87.0
	2119768	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	NCCC(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL403389	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	2119769	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	C[C@@H](N)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL255403	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	2119770	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	C[C@H](N)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL269792	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	2119771	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	CC(C)(N)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL270004	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	2119772	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	NC(CO)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL257697	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	2119773	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	NCC(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL437024	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	nM	80.0
	2119774	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	NC1(C(=O)NCCOc2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL270611	=	IC50	nM	1010.0	CHEMBL260	Homo sapiens	IC50	nM	1010.0
	2119775	CHEMBL935076	Inhibition of p38-alpha by whole blood assay	B	O=C(NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1)[C@H]1CCCN1		CHEMBL256421	=	IC50	nM	73.0	CHEMBL260	Homo sapiens	IC50	nM	73.0
	2119776	CHEMBL935072	Inhibition of p38alpha	B	NCCC(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL403389	=	IC50	nM	0.57	CHEMBL260	Homo sapiens	IC50	nM	0.57
	2119777	CHEMBL935072	Inhibition of p38alpha	B	C[C@@H](N)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL255403	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	2119778	CHEMBL935072	Inhibition of p38alpha	B	C[C@H](N)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL269792	=	IC50	nM	0.16	CHEMBL260	Homo sapiens	IC50	nM	0.16
	2119779	CHEMBL935072	Inhibition of p38alpha	B	CC(C)(N)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL270004	=	IC50	nM	0.12	CHEMBL260	Homo sapiens	IC50	nM	0.12
	2119780	CHEMBL935072	Inhibition of p38alpha	B	NC(CO)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL257697	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	2119781	CHEMBL935072	Inhibition of p38alpha	B	NCC(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL437024	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
	2119782	CHEMBL935072	Inhibition of p38alpha	B	NC1(C(=O)NCCOc2cc(-c3ccccc3Cl)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL270611	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	2119783	CHEMBL935072	Inhibition of p38alpha	B	O=C(NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1)[C@H]1CCCN1		CHEMBL256421	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	2119784	CHEMBL935075	Inhibition of p38-alpha at 1000 nM	B	O=c1ccc2c(-c3ccncc3)cccc2n1-c1c(Cl)cccc1Cl		CHEMBL272801	=	Inhibition	%	58.0	CHEMBL260	Homo sapiens	Inhibition	%	58.0
	2119785	CHEMBL935072	Inhibition of p38alpha	B	O=c1ccc2c(-c3cccnc3)cccc2n1-c1c(Cl)cccc1Cl		CHEMBL401754	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	nM	460.0
	2119786	CHEMBL935072	Inhibition of p38alpha	B	O=c1ccc2c(-c3ccccn3)cccc2n1-c1c(Cl)cccc1Cl		CHEMBL401957	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	nM	350.0
	2119787	CHEMBL935072	Inhibition of p38alpha	B	O=c1ccc2c(-c3ccccc3)cccc2n1-c1c(Cl)cccc1Cl		CHEMBL271639	=	IC50	nM	13.4	CHEMBL260	Homo sapiens	IC50	nM	13.4
	2119788	CHEMBL935072	Inhibition of p38alpha	B	O=c1c(O)cc2c(-c3ccccc3Cl)cc(O)cc2n1-c1c(Cl)cccc1Cl		CHEMBL271850	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2119789	CHEMBL935072	Inhibition of p38alpha	B	COc1cc(-c2ccccc2Cl)c2cc(O)c(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL401774	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	2119790	CHEMBL935072	Inhibition of p38alpha	B	O=c1ccc2c(-c3ccccc3Cl)cc(O)cc2n1-c1c(Cl)cccc1Cl		CHEMBL257236	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	nM	0.7
	2119791	CHEMBL935072	Inhibition of p38alpha	B	O=C1C(O)Cc2c(-c3ccccc3Cl)cc(O)cc2N1c1c(Cl)cccc1Cl		CHEMBL270599	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2119792	CHEMBL935072	Inhibition of p38alpha	B	COc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL403925	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	2119793	CHEMBL935072	Inhibition of p38alpha	B	COc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)C(O)C2		CHEMBL270812	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
Not Active	2119794	CHEMBL935072	Inhibition of p38alpha	B	NC1Cc2c(-c3ccccc3Cl)cccc2N(c2c(Cl)cccc2Cl)C1=O		CHEMBL272133		IC50			CHEMBL260	Homo sapiens	IC50		
	2119795	CHEMBL935072	Inhibition of p38alpha	B	O=c1ccc2c(-c3ccccc3Cl)cccc2n1-c1c(Cl)cccc1Cl		CHEMBL405713	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2119796	CHEMBL935072	Inhibition of p38alpha	B	O=C1C(O)Cc2c(-c3ccccc3Cl)cccc2N1c1c(Cl)cccc1Cl		CHEMBL404023	=	IC50	nM	27.5	CHEMBL260	Homo sapiens	IC50	nM	27.5
Not Active	2119797	CHEMBL935072	Inhibition of p38alpha	B	COC1Cc2c(-c3ccccc3Cl)cccc2N(c2c(Cl)cccc2Cl)C1=O		CHEMBL271064		IC50			CHEMBL260	Homo sapiens	IC50		
	2119798	CHEMBL935073	Inhibition of p38-alpha at 100 nM	B	[N-]=[N+]=NC1Cc2c(-c3ccccc3Cl)cccc2N(c2c(Cl)cccc2Cl)C1=O		CHEMBL255608	=	Inhibition	%	15.0	CHEMBL260	Homo sapiens	Inhibition	%	15.0
	2119799	CHEMBL935074	Inhibition of p38-alpha at 1250 nM	B	COc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)C(OC)C2		CHEMBL271884	=	Inhibition	%	63.0	CHEMBL260	Homo sapiens	Inhibition	%	63.0
	2119800	CHEMBL935073	Inhibition of p38-alpha at 100 nM	B	COc1cc(-c2ccccc2Cl)c2cc(OC)c(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL402889	=	Inhibition	%	29.0	CHEMBL260	Homo sapiens	Inhibition	%	29.0
	2119801	CHEMBL935077	Inhibition of p38-alpha at 10 uM by whole blood assay	B	COc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1		CHEMBL403925	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	Inhibition	%	75.0
	2120249	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL385937	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2120303	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc(NC(=O)c4c(Cl)cccc4Cl)cn3)cc2)CC1		CHEMBL541726	=	IC50	nM	1070.0	CHEMBL260	Homo sapiens	IC50	nM	1070.0
	2120304	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)c(C)c1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL438016	=	IC50	nM	103.0	CHEMBL260	Homo sapiens	IC50	nM	103.0
	2120305	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	CCc1ccc(NC(=O)c2ccc3c(c2)OC(F)(F)O3)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL270765	=	IC50	nM	233.0	CHEMBL260	Homo sapiens	IC50	nM	233.0
	2120306	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	CN1CCN(c2ccc(Nc3ncc(NC(=O)c4cc(NC(=O)c5ccc6c(c5)OC(F)(F)O6)ccc4Cl)cn3)cc2)CC1		CHEMBL271154	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2120307	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	COc1cc(OC)cc(C(=O)Nc2ccc(C)c(C(=O)Nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3)c2)c1		CHEMBL272850	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2120308	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)cc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL405401	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	2120309	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2ccc3c(c2)OC(F)(F)O3)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271141	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2120310	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271140	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	2120311	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cc(F)cc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL407063	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	2120312	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	COc1ccccc1C(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2)c1		CHEMBL409734	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	2120313	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2ccccc2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL271760	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	2120314	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cnoc2C)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL411050	=	IC50	nM	179.0	CHEMBL260	Homo sapiens	IC50	nM	179.0
	2120315	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	CC(=O)Nc1ccc(C)c(C(=O)Nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2)c1		CHEMBL271201	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	nM	63.0
	2120316	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NC2CCN(C)CC2)nc1		CHEMBL271372	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2120317	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NCCN2CCOCC2)nc1		CHEMBL272673	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2120318	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(NCCCN2CCOCC2)nc1		CHEMBL259465	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2120319	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cncnc1		CHEMBL259247	=	IC50	nM	199.0	CHEMBL260	Homo sapiens	IC50	nM	199.0
	2120320	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL405666	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2120321	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL409914	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	2120322	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL272888	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2120323	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL411632	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	2120324	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1		CHEMBL429582	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	2120325	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL408070	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2120326	CHEMBL951934	Inhibition of p38alpha by HTRF assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL272902	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	nM	87.0
	2121275	CHEMBL933319	Inhibition of human p38-alpha kinase	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)/C(=N\O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL255410	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	2121276	CHEMBL933319	Inhibition of human p38-alpha kinase	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	2121277	CHEMBL933318	Inhibition of human p38-alpha kinase phosphorylation	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	2121295	CHEMBL933319	Inhibition of human p38-alpha kinase	B	Cn1nc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL404722	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	2121296	CHEMBL933319	Inhibition of human p38-alpha kinase	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL270617	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	2121297	CHEMBL933319	Inhibition of human p38-alpha kinase	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	2121298	CHEMBL933319	Inhibition of human p38-alpha kinase	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	2121299	CHEMBL933318	Inhibition of human p38-alpha kinase phosphorylation	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)/C(=N\O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL255410	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	2121300	CHEMBL933318	Inhibition of human p38-alpha kinase phosphorylation	B	Cn1nc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL404722	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	2121301	CHEMBL933318	Inhibition of human p38-alpha kinase phosphorylation	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL270617	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	uM	0.31
	2121302	CHEMBL933318	Inhibition of human p38-alpha kinase phosphorylation	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	6000.0	CHEMBL260	Homo sapiens	IC50	uM	6.0
	2121303	CHEMBL933318	Inhibition of human p38-alpha kinase phosphorylation	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	5300.0	CHEMBL260	Homo sapiens	IC50	uM	5.3
	2136861	CHEMBL939357	Inhibition of p38alpha	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	nM	12000.0
	2136953	CHEMBL939357	Inhibition of p38alpha	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Ki	nM	310.0	CHEMBL260	Homo sapiens	Ki	nM	310.0
	2137144	CHEMBL939357	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	IC50	nM	380.0	CHEMBL260	Homo sapiens	IC50	nM	380.0
	2137213	CHEMBL921080	Inhibition of SAPK2a/p38-alpha	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	nM	2000.0
	2137323	CHEMBL939357	Inhibition of p38alpha	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	2137337	CHEMBL939357	Inhibition of p38alpha	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	2144677	CHEMBL939933	Inhibition of p38 alpha	B	O=c1c2ccc(Br)cc2c(-c2ccccc2)c(CO)n1CC1CCCCC1		CHEMBL406971	>	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2144685	CHEMBL939933	Inhibition of p38 alpha	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1CCCc1ccccc1		CHEMBL409429	>	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2144686	CHEMBL939933	Inhibition of p38 alpha	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1CCc1ccccc1		CHEMBL258457	>	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2144687	CHEMBL939933	Inhibition of p38 alpha	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccccc1		CHEMBL258676	>	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2144688	CHEMBL939933	Inhibition of p38 alpha	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1CC1CCCCC1		CHEMBL259934	>	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2144689	CHEMBL939933	Inhibition of p38 alpha	B	O=C(O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1CC1CCCCC1		CHEMBL259544	>	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2144706	CHEMBL939933	Inhibition of p38 alpha	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccc(S(C)(=O)=O)cc1		CHEMBL259060	>	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	nM	11000.0
	2144708	CHEMBL934578	Inhibition of p38-alpha at 10 uM	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccc(S(C)(=O)=O)cc1		CHEMBL259060	=	Inhibition	%	18.0	CHEMBL260	Homo sapiens	Inhibition	%	18.0
	2147384	CHEMBL922169	Activity of human SAPK2a kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	2147385	CHEMBL922170	Activity of human SAPK2a T106M mutant kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	130.0	CHEMBL260	Homo sapiens	Activity	%	130.0
Active	2149462	CHEMBL937549	Inhibition of human p38-alpha phosphorylation in DLD1 cells at 2.5 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Activity			CHEMBL260	Homo sapiens	Activity		
Active	2149463	CHEMBL937550	Inhibition of human p38-alpha phosphorylation in DLD1 KD cells carrying inactive MET kinase at 2.5 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2149598	CHEMBL931295	Inhibition of human p38alpha	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL260	Homo sapiens	Activity		
	2153669	CHEMBL928265	Inhibition of Sapk2-alpha at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	=	Inhibition	%	87.0	CHEMBL260	Homo sapiens	Inhibition	%	87.0
	2153675	CHEMBL928265	Inhibition of Sapk2-alpha at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	=	Inhibition	%	89.0	CHEMBL260	Homo sapiens	Inhibition	%	89.0
	2158711	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(N)nc3c2cnn3-c2ccccc2)c1		CHEMBL261021	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	2158713	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CCn1ccc(NC(=O)c2ccc(C)c(Nc3ncnc4c3cnn4-c3ccccc3)c2)n1		CHEMBL258974	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	2158714	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	Cc1ccc(C(=O)Nc2cc[nH]n2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL410136	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	2158715	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2158716	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CCCCNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2)c1		CHEMBL410667	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	2158717	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	Cc1ccc(C(=O)Nc2cccnc2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL261235	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	nM	240.0
	2158718	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	Cc1ccc(C(=O)NCc2ccccc2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL260383	=	IC50	nM	184.0	CHEMBL260	Homo sapiens	IC50	nM	184.0
	2158719	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CONC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2)c1		CHEMBL259007	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2158720	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	Cc1ccc(C(N)=O)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL439267	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	2158721	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccc(F)cc2)c1		CHEMBL259212	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	2158722	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2c(C)cc(C)cc2C)c1		CHEMBL409328	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	2158723	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2c(Cl)cccc2Cl)c1		CHEMBL260134	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2158724	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2F)c1		CHEMBL409329	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	2158725	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccn2)c1		CHEMBL258653	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
	2158726	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3Cc2ccccc2)c1		CHEMBL440406	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	2158727	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3C(C)(C)C)c1		CHEMBL407046	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	2158728	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3C)c1		CHEMBL407047	=	IC50	nM	253.0	CHEMBL260	Homo sapiens	IC50	nM	253.0
	2158729	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(N3CCCC3)nc3c2cnn3-c2ccccc2)c1		CHEMBL258851	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	2158730	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(OCCN3CCCC3)nc3c2cnn3-c2ccccc2)c1		CHEMBL429863	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2158731	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(NCCN3CCCC3)nc3c2cnn3-c2ccccc2)c1		CHEMBL409916	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2158732	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(C)nc3c2cnn3-c2ccccc2)c1		CHEMBL261075	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	2158733	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(OC)nc3c2cnn3-c2ccccc2)c1		CHEMBL412265	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	2158734	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2)c1		CHEMBL410668	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2158735	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(N3CCCN(C)CC3)nc3c2cnn3-c2ccccc2)c1		CHEMBL265710	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	2158736	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(N(C)CCC#N)nc3c2cnn3-c2ccccc2)c1		CHEMBL260807	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2158737	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	CNC(=O)c1ccc(C)c(Nc2nc(NC)nc3c2cnn3-c2ccccc2)c1		CHEMBL412281	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	2158793	CHEMBL934611	Inhibition of human recombinant p38alpha-mediated myelin basic protein phosphorylation	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	=	Ki	nM	0.2	CHEMBL260	Homo sapiens	Ki	nM	0.2
	2160633	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2ccc(C)c12		CHEMBL262097	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	2160635	CHEMBL933483	Inhibition of p38alpha	B	COC[C@H](C)NC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4ccc(C#N)cc4)ccc3C)c2c1C		CHEMBL262095	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	2160636	CHEMBL933483	Inhibition of p38alpha	B	COC[C@H](C)NC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL260411	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2160637	CHEMBL933483	Inhibition of p38alpha	B	COC[C@H](C)NC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cccc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL409116	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	2160638	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4ccc(C#N)cc4)ccc3C)c2c1C		CHEMBL261061	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	2160639	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL262608	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2160640	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cccc(N5CCCC5=O)c4)ccc3C)c2c1C		CHEMBL262866	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	2160641	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cccc(-n5ccnc5)c4)ccc3C)c2c1C		CHEMBL262867	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	2160642	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cccc(-n5cccn5)c4)ccc3C)c2c1C		CHEMBL409545	=	IC50	nM	123.0	CHEMBL260	Homo sapiens	IC50	nM	123.0
	2160643	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cccc(N5CCN(C)CC5)c4)ccc3C)c2c1C		CHEMBL258747	=	IC50	nM	924.0	CHEMBL260	Homo sapiens	IC50	nM	924.0
	2160644	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2ccncc2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL411257	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	2160645	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2c(Cl)cccc2Cl)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL259597	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2160646	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL262625	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2160647	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL265956	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	2160648	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2ccc(C)c(Nc3ncnn4cc(C(=O)N[C@@H](C)c5ccccc5)c(C)c34)c2)cc1		CHEMBL262624	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	2160649	CHEMBL933483	Inhibition of p38alpha	B	Cc1cccc(C(=O)Nc2ccc(C)c(Nc3ncnn4cc(C(=O)N[C@@H](C)c5ccccc5)c(C)c34)c2)c1		CHEMBL264697	=	IC50	nM	94.0	CHEMBL260	Homo sapiens	IC50	nM	94.0
	2160650	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL261285	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	2160651	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)NCCN(C)C)c(C)c12		CHEMBL258794	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2160652	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)N(C)C)c(C)c12		CHEMBL260759	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	nM	63.0
	2160653	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)N[C@H](C)c3ccccc3)c(C)c12		CHEMBL445574	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	2160654	CHEMBL933483	Inhibition of p38alpha	B	COC[C@H](C)NC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL260411	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2160655	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)NC(C)C)c(C)c12		CHEMBL261755	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2160656	CHEMBL933483	Inhibition of p38alpha	B	CCCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL442462	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2160657	CHEMBL933483	Inhibition of p38alpha	B	CNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL261005	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2160658	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(N)=O)c(C)c12		CHEMBL261006	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	2160659	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)O)c(C)c12		CHEMBL261007	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	2160660	CHEMBL933483	Inhibition of p38alpha	B	CCOC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL260447	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2160689	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cc(F)cc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL262592	=	Ki	nM	0.42	CHEMBL260	Homo sapiens	Ki	nM	0.42
	2160690	CHEMBL933483	Inhibition of p38alpha	B	CCNC(=O)c1cn2ncnc(Nc3cc(NC(=O)c4cccc(N5CCOCC5)c4)ccc3C)c2c1C		CHEMBL258748	=	Ki	nM	0.98	CHEMBL260	Homo sapiens	Ki	nM	0.98
	2160691	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL258895	=	Ki	nM	0.44	CHEMBL260	Homo sapiens	Ki	nM	0.44
	2160692	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL408150	=	Ki	nM	0.46	CHEMBL260	Homo sapiens	Ki	nM	0.46
	2160693	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL259596	=	Ki	nM	3.4	CHEMBL260	Homo sapiens	Ki	nM	3.4
	2160694	CHEMBL933483	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL261845	=	Ki	nM	0.54	CHEMBL260	Homo sapiens	Ki	nM	0.54
	2162105	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	COc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL409838	=	Inhibition	%	26.5	CHEMBL260	Homo sapiens	Inhibition	%	26.5
	2162106	CHEMBL924741	Inhibition of p38-alpha MAPK	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
	2162107	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	CC(c1ccccc1)n1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL410305	=	Inhibition	%	27.5	CHEMBL260	Homo sapiens	Inhibition	%	27.5
	2162108	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	O=C1c2ccccc2C(=O)N1CCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL261250	=	Inhibition	%	41.86	CHEMBL260	Homo sapiens	Inhibition	%	41.86
	2162109	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	O=c1on(CCN2CCCCC2)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL408972	=	Inhibition	%	38.3	CHEMBL260	Homo sapiens	Inhibition	%	38.3
	2162110	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	CC(C)n1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL410223	=	Inhibition	%	42.2	CHEMBL260	Homo sapiens	Inhibition	%	42.2
	2162111	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	CC(C)Oc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL409837	=	Inhibition	%	11.9	CHEMBL260	Homo sapiens	Inhibition	%	11.9
	2162112	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	OCCOc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL259926	=	Inhibition	%	14.7	CHEMBL260	Homo sapiens	Inhibition	%	14.7
	2162113	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	OCCCOc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL404777	=	Inhibition	%	9.8	CHEMBL260	Homo sapiens	Inhibition	%	9.8
	2162114	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	COCCOc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL260242	=	Inhibition	%	14.4	CHEMBL260	Homo sapiens	Inhibition	%	14.4
	2162115	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	COCOc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL408635	=	Inhibition	%	27.8	CHEMBL260	Homo sapiens	Inhibition	%	27.8
	2162116	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	Fc1ccc(-c2noc(OCC3CC3)c2-c2ccncc2)cc1		CHEMBL261658	=	Inhibition	%	26.4	CHEMBL260	Homo sapiens	Inhibition	%	26.4
	2162117	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	Fc1ccc(-c2noc(OCC3CO3)c2-c2ccncc2)cc1		CHEMBL260454	=	Inhibition	%	23.7	CHEMBL260	Homo sapiens	Inhibition	%	23.7
	2162118	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	CCOc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL260661	=	Inhibition	%	13.6	CHEMBL260	Homo sapiens	Inhibition	%	13.6
	2162119	CHEMBL924741	Inhibition of p38-alpha MAPK	B	CCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL411134	=	IC50	nM	1630.0	CHEMBL260	Homo sapiens	IC50	uM	1.63
	2162120	CHEMBL924741	Inhibition of p38-alpha MAPK	B	Oc1onc(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL383356	=	IC50	nM	390.0	CHEMBL260	Homo sapiens	IC50	uM	0.39
	2162121	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=c1o[nH]c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL261080	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	2162122	CHEMBL924741	Inhibition of p38-alpha MAPK	B	CCOC(=O)CCNC(=O)n1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL261287	=	IC50	nM	970.0	CHEMBL260	Homo sapiens	IC50	uM	0.97
	2162123	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=c1on(C(=S)Nc2ccc(F)cc2)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL411093	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	uM	0.35
	2162124	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=C(Nc1ccc(F)cc1)n1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL260837	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	2162125	CHEMBL924741	Inhibition of p38-alpha MAPK	B	CCNC(=O)n1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL411094	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	2162126	CHEMBL924741	Inhibition of p38-alpha MAPK	B	CC(=O)n1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL263648	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	2162127	CHEMBL924741	Inhibition of p38-alpha MAPK	B	Cc1ccc(S(=O)(=O)n2oc(=O)c(-c3ccc(F)cc3)c2-c2ccncc2)cc1		CHEMBL408196	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	2162128	CHEMBL924741	Inhibition of p38-alpha MAPK	B	COCCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL195518	=	IC50	nM	3830.0	CHEMBL260	Homo sapiens	IC50	uM	3.83
	2162129	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=c1on(CCCO)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL407001	=	IC50	nM	1150.0	CHEMBL260	Homo sapiens	IC50	uM	1.15
	2162130	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=c1on(CCO)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL411727	=	IC50	nM	2500.0	CHEMBL260	Homo sapiens	IC50	uM	2.5
	2162131	CHEMBL924741	Inhibition of p38-alpha MAPK	B	CSCCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL410506	=	IC50	nM	3900.0	CHEMBL260	Homo sapiens	IC50	uM	3.9
	2162132	CHEMBL924741	Inhibition of p38-alpha MAPK	B	CCOCCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL259637	=	IC50	nM	1320.0	CHEMBL260	Homo sapiens	IC50	uM	1.32
	2162133	CHEMBL924741	Inhibition of p38-alpha MAPK	B	COCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL414666	=	IC50	nM	2130.0	CHEMBL260	Homo sapiens	IC50	uM	2.13
	2162134	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=c1on(CC2CO2)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL428259	=	IC50	nM	3830.0	CHEMBL260	Homo sapiens	IC50	uM	3.83
	2162135	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=c1on(CC2CC2)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL264178	=	IC50	nM	2130.0	CHEMBL260	Homo sapiens	IC50	uM	2.13
	2162136	CHEMBL924741	Inhibition of p38-alpha MAPK	B	O=c1on(CCCO)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL407001	=	IC50	nM	1150.0	CHEMBL260	Homo sapiens	IC50	uM	1.15
	2162137	CHEMBL924741	Inhibition of p38-alpha MAPK	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCO		CHEMBL263647	=	IC50	nM	813.0	CHEMBL260	Homo sapiens	IC50	uM	0.813
	2162138	CHEMBL924742	Inhibition of p38-alpha MAPK at 10 uM	B	OCCOc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL259926	=	Inhibition	%	14.7	CHEMBL260	Homo sapiens	Inhibition	%	14.7
Not Active	2170330	CHEMBL927884	Activity at MAPK p38-alpha at 3 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL260	Homo sapiens	Activity		
	2182821	CHEMBL941447	Inhibition of MAPK14 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	INH	%	17.0
	2186733	CHEMBL966655	Inhibition of human p38alpha by ELISA	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2186791	CHEMBL969396	Inhibition of wild type p38alpha	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199679	=	IC50	nM	0.08	CHEMBL260	Homo sapiens	IC50	nM	0.08
	2186792	CHEMBL969397	Inhibition of p38alpha T106M mutant	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3F)c3ccc(=O)n(-c4c(Cl)cccc4Cl)c3c2)CC1		CHEMBL199679	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	2186795	CHEMBL969396	Inhibition of wild type p38alpha	B	C[C@H](Nc1cc(-c2c(-c3cccc(C(F)(F)F)c3)nc(C3CCNCC3)n2C)ccn1)c1ccccc1		CHEMBL303144	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	2186796	CHEMBL969397	Inhibition of p38alpha T106M mutant	B	C[C@H](Nc1cc(-c2c(-c3cccc(C(F)(F)F)c3)nc(C3CCNCC3)n2C)ccn1)c1ccccc1		CHEMBL303144	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	2206784	CHEMBL990555	Inhibition of p38alpha	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2206920	CHEMBL990555	Inhibition of p38alpha	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	260.0	CHEMBL260	Homo sapiens	Kd	nM	260.0
	2210888	CHEMBL976991	Inhibition of MAPK14	B	Fc1ccc(CNc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)cc1		CHEMBL512632	=	Activity	nM	90.9	CHEMBL260	Homo sapiens	Activity	nM	90.9
	2232196	CHEMBL973639	Inhibition of p38alpha	B	COc1cc2nccc(Oc3ccc4c(NC(=O)c5cccc(C(F)(F)F)c5)nn(C)c4c3)c2cc1OC		CHEMBL462168	=	IC50	nM	1650.0	CHEMBL260	Homo sapiens	IC50	uM	1.65
	2239709	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	87.0	CHEMBL260	Homo sapiens	INH	%	87.0
	2239737	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	83.0	CHEMBL260	Homo sapiens	INH	%	83.0
	2239765	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	111.0	CHEMBL260	Homo sapiens	INH	%	111.0
	2239793	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	73.0	CHEMBL260	Homo sapiens	INH	%	73.0
	2239821	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	81.0	CHEMBL260	Homo sapiens	INH	%	81.0
	2239849	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	25.0	CHEMBL260	Homo sapiens	INH	%	25.0
	2239877	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	2239904	CHEMBL996938	Inhibition of SAPK2a/p38 at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	52.0	CHEMBL260	Homo sapiens	INH	%	52.0
	2248263	CHEMBL1012706	Inhibition of p38alpha at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	-2.0	CHEMBL260	Homo sapiens	INH	%	-2.0
	2248264	CHEMBL1012706	Inhibition of p38alpha at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2256923	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	2256924	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3cccc(F)c3c2-c2ccncc2)cc1		CHEMBL509189	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	2256925	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3cc(F)ccc3c2-c2ccncc2)cc1		CHEMBL518917	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	2256926	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Cc1cccn2nc(-c3ccc(F)cc3)c(-c3ccncc3)c12		CHEMBL487577	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	2256927	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Cc1ccn2nc(-c3ccc(F)cc3)c(-c3ccncc3)c2c1		CHEMBL524530	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	2256928	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Cc1ccc2c(-c3ccncc3)c(-c3ccc(F)cc3)nn2c1		CHEMBL487581	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	2256929	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Cc1cccc2c(-c3ccncc3)c(-c3ccc(F)cc3)nn12		CHEMBL487780	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	2256930	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3cc(C(F)(F)F)ccc3c2-c2ccncc2)cc1		CHEMBL487781	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	2256931	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	N#Cc1ccc2c(-c3ccncc3)c(-c3ccc(F)cc3)nn2c1		CHEMBL488183	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	2256932	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3cc(Cl)ccc3c2-c2ccncc2)cc1		CHEMBL501070	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	2256933	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3c(Cl)cccc3c2-c2ccncc2)cc1		CHEMBL520563	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	2256934	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3c(OC4CCCC4)cccc3c2-c2ccncc2)cc1		CHEMBL488184	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	2256935	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	CCOc1cccc2c(-c3ccncc3)c(-c3ccc(F)cc3)nn12		CHEMBL520564	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	2256936	CHEMBL998555	Inhibition of GST-fused p38alpha expressed in Escherichia coli	B	Fc1ccc(-c2nn3c(OCC(F)(F)F)cccc3c2-c2ccncc2)cc1		CHEMBL518890	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	2261749	CHEMBL997719	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1I		CHEMBL523065	>	Ki	nM	2000.0	CHEMBL260	Homo sapiens	Ki	uM	2.0
	2261750	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	CC(=O)Nc1cc(-c2ccc(-c3cc(NC(=O)c4ccnc(N5CCCC5)c4)ccc3C)cc2)[nH]n1		CHEMBL1964268	=	Ki	nM	14.0	CHEMBL260	Homo sapiens	Ki	nM	14.0
	2261751	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(-c2csc(N)n2)cc1		CHEMBL498386	=	Ki	nM	130.0	CHEMBL260	Homo sapiens	Ki	nM	130.0
	2261752	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc(-c2csc(N)n2)cc1		CHEMBL525916	=	Ki	nM	20.0	CHEMBL260	Homo sapiens	Ki	nM	20.0
	2261753	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(-c2csc(N)n2)cc1		CHEMBL526452	=	Ki	nM	6.7	CHEMBL260	Homo sapiens	Ki	nM	6.7
	2261754	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc(-c2csc(N)n2)cc1		CHEMBL496129	>	Ki	nM	850.0	CHEMBL260	Homo sapiens	Ki	nM	850.0
	2261755	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)cc2)no1		CHEMBL496130	=	Ki	nM	98.0	CHEMBL260	Homo sapiens	Ki	nM	98.0
	2261756	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nc(-c2ccc(-c3cc(C(=O)Nc4cccc(N5CCOCC5)c4)ccc3C)cc2)no1		CHEMBL496334	=	Ki	nM	17.0	CHEMBL260	Homo sapiens	Ki	nM	17.0
	2261757	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nc(-c2ccc(-c3cc(NC(=O)c4ccnc(N5CCCC5)c4)ccc3C)cc2)no1		CHEMBL521722	=	Ki	nM	1.1	CHEMBL260	Homo sapiens	Ki	nM	1.1
	2261758	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nc(-c2ccc(-c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cc2)no1		CHEMBL496756	>	Ki	nM	850.0	CHEMBL260	Homo sapiens	Ki	nM	850.0
	2261759	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1		CHEMBL522579	=	Ki	nM	10.0	CHEMBL260	Homo sapiens	Ki	nM	10.0
	2261760	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nnc(-c2ccc(-c3cc(C(=O)Nc4cccc(N5CCOCC5)c4)ccc3C)c(C)c2)o1		CHEMBL523559	=	Ki	nM	2.8	CHEMBL260	Homo sapiens	Ki	nM	2.8
	2261761	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nnc(-c2ccc(-c3cc(NC(=O)c4ccnc(N5CCCC5)c4)ccc3C)c(C)c2)o1		CHEMBL495729	=	Ki	nM	1.7	CHEMBL260	Homo sapiens	Ki	nM	1.7
	2261762	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1nnc(-c2ccc(-c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)c(C)c2)o1		CHEMBL497350	=	Ki	nM	1400.0	CHEMBL260	Homo sapiens	Ki	nM	1400.0
	2261763	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2nc(N)[nH]c(=O)c2c1		CHEMBL496313	=	Ki	nM	49.0	CHEMBL260	Homo sapiens	Ki	nM	49.0
	2261764	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2nc(N)[nH]c(=O)c2c1		CHEMBL496312	=	Ki	nM	4.7	CHEMBL260	Homo sapiens	Ki	nM	4.7
	2261765	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2nc(N)[nH]c(=O)c2c1		CHEMBL521548	=	Ki	nM	6.8	CHEMBL260	Homo sapiens	Ki	nM	6.8
	2261766	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(=O)[nH]c(-c3cccs3)nc2c1		CHEMBL525727	=	Ki	nM	2.9	CHEMBL260	Homo sapiens	Ki	nM	2.9
	2261767	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	CCCCn1c(=O)[nH]c2cc(-c3cc(C(=O)NC4CC4)ccc3C)ccc2c1=O		CHEMBL497976	=	Ki	nM	18.0	CHEMBL260	Homo sapiens	Ki	nM	18.0
	2261768	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	CCCCn1c(=O)[nH]c2cc(-c3cc(C(=O)Nc4cccc(N5CCOCC5)c4)ccc3C)ccc2c1=O		CHEMBL497977	=	Ki	nM	19.0	CHEMBL260	Homo sapiens	Ki	nM	19.0
	2261769	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	CCCCn1c(=O)[nH]c2cc(-c3cc(NC(=O)c4ccnc(N5CCCC5)c4)ccc3C)ccc2c1=O		CHEMBL496943	=	Ki	nM	11.0	CHEMBL260	Homo sapiens	Ki	nM	11.0
	2261770	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	CCCCn1c(=O)[nH]c2cc(-c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)ccc2c1=O		CHEMBL501431	=	Ki	nM	2000.0	CHEMBL260	Homo sapiens	Ki	nM	2000.0
	2261771	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(=O)n(CC3CC3)nnc2c1		CHEMBL521734	=	Ki	nM	6.0	CHEMBL260	Homo sapiens	Ki	nM	6.0
	2261772	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(=O)cc(-c3cccs3)oc2c1		CHEMBL496528	=	Ki	nM	6.7	CHEMBL260	Homo sapiens	Ki	nM	6.7
	2261773	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2[nH]c(=O)ccc2c1		CHEMBL496736	=	Ki	nM	290.0	CHEMBL260	Homo sapiens	Ki	nM	290.0
	2261774	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2[nH]c(=O)ccc2c1		CHEMBL495917	=	Ki	nM	49.0	CHEMBL260	Homo sapiens	Ki	nM	49.0
	2261775	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2[nH]c(=O)ccc2c1		CHEMBL497986	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	nM	2500.0
	2261776	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2cc[nH]c(=O)c2c1		CHEMBL497987	=	Ki	nM	420.0	CHEMBL260	Homo sapiens	Ki	nM	420.0
	2261777	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2cc[nH]c(=O)c2c1		CHEMBL498183	=	Ki	nM	18.0	CHEMBL260	Homo sapiens	Ki	nM	18.0
	2261778	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2cc[nH]c(=O)c2c1		CHEMBL498390	=	Ki	nM	2.4	CHEMBL260	Homo sapiens	Ki	nM	2.4
	2261779	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2cc[nH]c(=O)c2c1		CHEMBL498391	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	nM	2500.0
	2261780	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2ccncc2c1		CHEMBL526639	=	Ki	nM	11.0	CHEMBL260	Homo sapiens	Ki	nM	11.0
	2261781	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2ccncc2c1		CHEMBL497375	=	Ki	nM	4.5	CHEMBL260	Homo sapiens	Ki	nM	4.5
	2261782	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2ccncc2c1		CHEMBL521887	=	Ki	nM	830.0	CHEMBL260	Homo sapiens	Ki	nM	830.0
	2261783	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2cccnc2c1		CHEMBL496338	=	Ki	nM	490.0	CHEMBL260	Homo sapiens	Ki	nM	490.0
	2261784	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2cccnc2c1		CHEMBL496339	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	nM	2500.0
	2261785	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2onc(C)c2c1		CHEMBL526101	=	Ki	nM	1100.0	CHEMBL260	Homo sapiens	Ki	nM	1100.0
	2261786	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2onc(C)c2c1		CHEMBL495901	=	Ki	nM	380.0	CHEMBL260	Homo sapiens	Ki	nM	380.0
	2261787	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2onc(C)c2c1		CHEMBL522893	=	Ki	nM	160.0	CHEMBL260	Homo sapiens	Ki	nM	160.0
	2261788	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Ki	nM	87.0	CHEMBL260	Homo sapiens	Ki	nM	87.0
	2261789	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2[nH]ncc2c1		CHEMBL496104	=	Ki	nM	110.0	CHEMBL260	Homo sapiens	Ki	nM	110.0
	2261790	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(N)noc2c1		CHEMBL498369	=	Ki	nM	110.0	CHEMBL260	Homo sapiens	Ki	nM	110.0
	2261791	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2c(N)noc2c1		CHEMBL526078	=	Ki	nM	19.0	CHEMBL260	Homo sapiens	Ki	nM	19.0
	2261792	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2c(N)noc2c1		CHEMBL497352	=	Ki	nM	12.0	CHEMBL260	Homo sapiens	Ki	nM	12.0
	2261793	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2c(N)noc2c1		CHEMBL497353	>	Ki	nM	850.0	CHEMBL260	Homo sapiens	Ki	nM	850.0
	2261794	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL497563	=	Ki	nM	4.0	CHEMBL260	Homo sapiens	Ki	nM	4.0
	2261795	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(C(=O)Nc2cccc(N3CCOCC3)c2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL485285	=	Ki	nM	1.4	CHEMBL260	Homo sapiens	Ki	nM	1.4
	2261796	CHEMBL997720	Displacement of fluorescent ATP competitive ligand from p38alpha	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc2c(C3CCNCC3)noc2c1		CHEMBL485286	=	Ki	nM	0.8	CHEMBL260	Homo sapiens	Ki	nM	0.8
	2279730	CHEMBL958295	Inhibition of p38alpha at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	2281628	CHEMBL1012732	Inhibition of p38alpha MAP kinase	B	Fc1ccc(C2=C(c3ccncc3)CCC2)cc1		CHEMBL507086	=	IC50	nM	4050.0	CHEMBL260	Homo sapiens	IC50	uM	4.05
	2281629	CHEMBL1012732	Inhibition of p38alpha MAP kinase	B	Fc1ccc(-c2cc(-c3ccc(Cl)cc3)oc2-c2ccncc2)cc1		CHEMBL88925	=	IC50	nM	530.0	CHEMBL260	Homo sapiens	IC50	nM	530.0
	2281630	CHEMBL1012732	Inhibition of p38alpha MAP kinase	B	C[S+]([O-])c1ccc(-c2cc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL155687	=	IC50	nM	670.0	CHEMBL260	Homo sapiens	IC50	nM	670.0
	2281631	CHEMBL1012732	Inhibition of p38alpha MAP kinase	B	Fc1ccc(-c2nc[nH]c2-c2ccncc2)cc1		CHEMBL63135	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	uM	0.079
	2281632	CHEMBL1012732	Inhibition of p38alpha MAP kinase	B	Fc1ccc(-c2occc2-c2ccncc2)cc1		CHEMBL483614	=	IC50	nM	740.0	CHEMBL260	Homo sapiens	IC50	uM	0.74
	2281633	CHEMBL1012732	Inhibition of p38alpha MAP kinase	B	Fc1ccc(-c2[nH]ccc2-c2ccncc2)cc1		CHEMBL66802	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	uM	0.42
Active	2281634	CHEMBL1012733	Binding affinity to ATP binding site of p38alpha MAP kinase	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Activity			CHEMBL260	Homo sapiens	Activity		
	2282298	CHEMBL957582	Inhibition of p38alpha	B	COc1ccc2sc(Sc3ncc([N+](=O)[O-])s3)nc2c1		CHEMBL474804	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2282302	CHEMBL957582	Inhibition of p38alpha	B	O=[N+]([O-])c1cnc(Sc2nc3ccccc3s2)s1		CHEMBL493539	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
Not Active	2298924	CHEMBL1020719	Inhibition of human SAPK2A/P38 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	2298954	CHEMBL1020719	Inhibition of human SAPK2A/P38 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	2298955	CHEMBL1020719	Inhibition of human SAPK2A/P38 at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	2302148	CHEMBL950817	Inhibition of SAPK2a at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	2341414	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	2341454	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	23.0	CHEMBL260	Homo sapiens	INH	%	23.0
	2341495	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	2341536	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	2341577	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	2341618	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	2341659	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	2341700	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	2341741	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2341782	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	57.0	CHEMBL260	Homo sapiens	INH	%	57.0
	2341823	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	2341864	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2341905	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2341946	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2341987	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	2342028	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	2342069	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	2342110	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	37.0	CHEMBL260	Homo sapiens	INH	%	37.0
	2342151	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	2342192	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	20.0	CHEMBL260	Homo sapiens	INH	%	20.0
	2342234	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	2342274	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	2342315	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	2342356	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	2342397	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	2342438	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	2342479	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2342520	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	2342793	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	2342826	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	2343101	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	2343125	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	2343147	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	2343171	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	2343195	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343219	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	2343243	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343267	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343628	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	2343689	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	2343710	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343732	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	2343754	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343776	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343798	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	2343819	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	2343841	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	2343863	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	2343885	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343907	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343929	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343951	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343972	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2343994	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	2344017	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	2344724	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	2344747	CHEMBL953374	Inhibition of p38alpha at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
Not Active	2350719	CHEMBL964731	Inhibition of MAPK p38alpha upto 100 uM	B	CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1		CHEMBL509847		Activity			CHEMBL260	Homo sapiens	Activity		
	2356941	CHEMBL955840	Inhibition of p38alpha at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	2361598	CHEMBL980900	Inhibition of p38alpha	B	Cc1cc(C2CCN(CCCF)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12		CHEMBL459729	=	IC50	nM	30970.0	CHEMBL260	Homo sapiens	IC50	uM	30.97
	2361725	CHEMBL972711	Inhibition of p38alpha	B	OCC(O)CSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL516468	=	IC50	nM	392.0	CHEMBL260	Homo sapiens	IC50	uM	0.392
	2361727	CHEMBL972711	Inhibition of p38alpha	B	COC(=O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C)c2)[nH]1		CHEMBL522486	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	2361728	CHEMBL972711	Inhibition of p38alpha	B	CCOP(=O)(CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1)OCC		CHEMBL492463	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	2361729	CHEMBL972711	Inhibition of p38alpha	B	CC(Nc1cc(-c2[nH]c(SCC(=O)O)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL523494	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	uM	0.037
	2361730	CHEMBL972711	Inhibition of p38alpha	B	COC(=O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL492264	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	2361731	CHEMBL972711	Inhibition of p38alpha	B	OCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H]3CC[C@H](O)CC3)c2)[nH]1		CHEMBL492255	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	2361732	CHEMBL972711	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL480962	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	2361733	CHEMBL972711	Inhibition of p38alpha	B	OCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL492296	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	2361734	CHEMBL972711	Inhibition of p38alpha	B	CC(C)Nc1cc(-c2[nH]c(SCCO)nc2-c2ccc(F)cc2)ccn1		CHEMBL521637	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	2361735	CHEMBL972711	Inhibition of p38alpha	B	COC(=O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C(C)C)c2)[nH]1		CHEMBL492295	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	2361736	CHEMBL972711	Inhibition of p38alpha	B	CC(C)C(C)Nc1cc(-c2[nH]c(SCCO)nc2-c2ccc(F)cc2)ccn1		CHEMBL524174	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	2361737	CHEMBL972711	Inhibition of p38alpha	B	CC(C)C(C)Nc1cc(-c2[nH]c(SCCCO)nc2-c2ccc(F)cc2)ccn1		CHEMBL462476	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	2361738	CHEMBL972711	Inhibition of p38alpha	B	CC(C)Nc1cc(-c2[nH]c(SC[C@@H](O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL462265	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	2361739	CHEMBL972711	Inhibition of p38alpha	B	CC(C)Nc1cc(-c2[nH]c(SC[C@H](O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL517287	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	2361740	CHEMBL972711	Inhibition of p38alpha	B	CC(C)C(C)Nc1cc(-c2[nH]c(SC[C@@H](O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL462477	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	2361741	CHEMBL972711	Inhibition of p38alpha	B	CC(C)C(C)Nc1cc(-c2[nH]c(SC[C@H](O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL459934	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	2361742	CHEMBL972711	Inhibition of p38alpha	B	OCC(O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL459926	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	2361743	CHEMBL972711	Inhibition of p38alpha	B	CC(C)Nc1cc(-c2[nH]c(SCC(O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL459716	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	2361744	CHEMBL972711	Inhibition of p38alpha	B	CCC(C)Nc1cc(-c2[nH]c(SCC(O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL518628	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	2361745	CHEMBL972711	Inhibition of p38alpha	B	CC(C)C(C)Nc1cc(-c2[nH]c(SCC(O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL460773	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	2361746	CHEMBL972711	Inhibition of p38alpha	B	CNc1cc(-c2[nH]c(SCC(O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL518492	=	IC50	nM	102.0	CHEMBL260	Homo sapiens	IC50	uM	0.102
	2361747	CHEMBL972711	Inhibition of p38alpha	B	CCNc1cc(-c2[nH]c(SCC(O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL518367	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	2361748	CHEMBL972711	Inhibition of p38alpha	B	CC(C)CNc1cc(-c2[nH]c(SCC(O)CO)nc2-c2ccc(F)cc2)ccn1		CHEMBL462679	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	2361749	CHEMBL972711	Inhibition of p38alpha	B	OCC(O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccccc3)c2)[nH]1		CHEMBL462463	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	uM	0.087
	2361750	CHEMBL972711	Inhibition of p38alpha	B	CC(Nc1cc(-c2[nH]c(SCC(O)CO)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL462462	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	uM	0.041
	2361751	CHEMBL972711	Inhibition of p38alpha	B	Cn1c(SCC(O)CO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL462494	=	IC50	nM	1220.0	CHEMBL260	Homo sapiens	IC50	uM	1.22
	2361752	CHEMBL972711	Inhibition of p38alpha	B	COC(=O)CSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL505334	=	IC50	nM	158.0	CHEMBL260	Homo sapiens	IC50	uM	0.158
	2361753	CHEMBL972711	Inhibition of p38alpha	B	COC(=O)CCCSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL516620	=	IC50	nM	487.0	CHEMBL260	Homo sapiens	IC50	uM	0.487
	2361754	CHEMBL972711	Inhibition of p38alpha	B	OCCSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL446739	=	IC50	nM	184.0	CHEMBL260	Homo sapiens	IC50	uM	0.184
	2361755	CHEMBL972711	Inhibition of p38alpha	B	OCCCSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL459737	=	IC50	nM	215.0	CHEMBL260	Homo sapiens	IC50	uM	0.215
	2361756	CHEMBL972711	Inhibition of p38alpha	B	CCOC(=O)C(Sc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1)C(=O)OCC		CHEMBL518798	=	IC50	nM	2240.0	CHEMBL260	Homo sapiens	IC50	uM	2.24
	2366618	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	Cc1ccccc1-c1nncc2cc(-c3c(C)ccc4c(NC5CC5)noc34)ccc12		CHEMBL495084	=	Ki	nM	0.4	CHEMBL260	Homo sapiens	Ki	nM	0.4
	2366619	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	Cc1ccc2c(N)nsc2c1-c1ccc2c(N3CCOC[C@@H]3C)nncc2c1		CHEMBL524054	=	Ki	nM	2.0	CHEMBL260	Homo sapiens	Ki	nM	2.0
	2366620	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	Cc1ccc2c(N)n[nH]c2c1-c1ccc2c(N3CCOC[C@@H]3C)nncc2c1		CHEMBL493707	=	Ki	nM	16.0	CHEMBL260	Homo sapiens	Ki	nM	16.0
	2366621	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CNc1noc2c(-c3ccc4c(C(C)C)nncc4c3)c(C)ccc12		CHEMBL492661	=	Ki	nM	1.1	CHEMBL260	Homo sapiens	Ki	nM	1.1
	2366622	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CNc1noc2c(-c3ccc4c(OC(C)C)nncc4c3)c(C)ccc12		CHEMBL494917	=	Ki	nM	0.4	CHEMBL260	Homo sapiens	Ki	nM	0.4
	2366623	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CC[C@H](C)Nc1nncc2cc(-c3c(C)ccc4c(NC)noc34)ccc12		CHEMBL522689	=	Ki	nM	0.2	CHEMBL260	Homo sapiens	Ki	nM	0.2
	2366624	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CNc1noc2c(-c3ccc4c(NC(C)C)nncc4c3)c(C)ccc12		CHEMBL494305	=	Ki	nM	0.5	CHEMBL260	Homo sapiens	Ki	nM	0.5
	2366625	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@H]5C)nncc4c3)c(C)ccc12		CHEMBL493496	=	Ki	nM	0.3	CHEMBL260	Homo sapiens	Ki	nM	0.3
	2366626	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CC(C)Nc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(Cl)ccc12		CHEMBL523516	=	Ki	nM	0.4	CHEMBL260	Homo sapiens	Ki	nM	0.4
	2366627	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(Cl)ccc12		CHEMBL495118	=	Ki	nM	0.2	CHEMBL260	Homo sapiens	Ki	nM	0.2
	2366628	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CC(=O)Nc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL521860	=	Ki	nM	0.6	CHEMBL260	Homo sapiens	Ki	nM	0.6
	2366629	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	Cc1ccc2c(N)noc2c1-c1ccc2c(N3CCOC[C@@H]3C)nncc2c1		CHEMBL494916	=	Ki	nM	0.3	CHEMBL260	Homo sapiens	Ki	nM	0.3
	2366630	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Ki	nM	0.4	CHEMBL260	Homo sapiens	Ki	nM	0.4
	2366631	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CCNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL495493	=	Ki	nM	0.3	CHEMBL260	Homo sapiens	Ki	nM	0.3
	2366632	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	Cc1ccc2c(NC3CC3)noc2c1-c1ccc2c(NC(C)C)nncc2c1		CHEMBL495492	=	Ki	nM	0.5	CHEMBL260	Homo sapiens	Ki	nM	0.5
	2366633	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	CC(=O)N1CCN(c2nncc3cc(-c4c(C)ccc5c(NC6CC6)noc45)ccc23)[C@@H](C)C1		CHEMBL495290	=	Ki	nM	0.8	CHEMBL260	Homo sapiens	Ki	nM	0.8
	2366634	CHEMBL1035784	Inhibition of human recombinant GST-tagged p38alphaMAPK-induced ATF2 phosphorylation	B	Cc1ccc2c(NC3CC3)noc2c1-c1ccc2c(N3CCOC[C@@H]3C)nncc2c1		CHEMBL522877	=	Ki	nM	0.7	CHEMBL260	Homo sapiens	Ki	nM	0.7
	2366697	CHEMBL1035800	Inhibition of p38alpha at 1 uM relative to control	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	2367429	CHEMBL1024840	Activity of human recombinant p38alpha ATP binding site assessed as ratio/min at 6 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Vmax		11.26	CHEMBL260	Homo sapiens	Vmax		11.26
	2367430	CHEMBL1024841	Activity of human recombinant p38alpha ATP binding site assessed as ratio/min at 9 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Vmax		11.6	CHEMBL260	Homo sapiens	Vmax		11.6
	2367431	CHEMBL1024842	Activity of human recombinant p38alpha ATP binding site assessed as ratio/min at 13 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Vmax		12.41	CHEMBL260	Homo sapiens	Vmax		12.41
	2367432	CHEMBL1024843	Activity of human recombinant p38alpha ATP binding site assessed as ratio/min at 19 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Vmax		13.28	CHEMBL260	Homo sapiens	Vmax		13.28
	2367433	CHEMBL1024844	Activity of human recombinant p38alpha ATP binding site at 6 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Km	nM	229200.0	CHEMBL260	Homo sapiens	Km	uM	229.2
	2367434	CHEMBL1024845	Activity of human recombinant p38alpha ATP binding site at 9 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Km	nM	319400.0	CHEMBL260	Homo sapiens	Km	uM	319.4
	2367435	CHEMBL1024846	Activity of human recombinant p38alpha ATP binding site at 13 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Km	nM	451900.0	CHEMBL260	Homo sapiens	Km	uM	451.9
	2367436	CHEMBL1024847	Activity of human recombinant p38alpha ATP binding site at 19 nM	B	CNc1noc2c(-c3ccc4c(N5CCOC[C@@H]5C)nncc4c3)c(C)ccc12		CHEMBL523374	=	Km	nM	769900.0	CHEMBL260	Homo sapiens	Km	uM	769.9
	2367457	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL494072	=	IC50	nM	2.4	CHEMBL260	Homo sapiens	IC50	nM	2.4
	2367464	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3C)nncc2c1		CHEMBL492265	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	2367465	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3)nncc2c1		CHEMBL495330	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2367466	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(O[C@H](C)C(F)(F)F)nncc2c1		CHEMBL493708	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	2367467	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(O[C@@H](C)C(F)(F)F)nncc2c1		CHEMBL493671	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	2367468	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(OC(C)C)nncc2c1		CHEMBL493670	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	2367469	CHEMBL1024853	Inhibition of p38alpha	B	O=C(NC1CC1)c1cccc(-c2ccc3c(N4CCOCC4)nncc3c2)c1		CHEMBL494470	=	IC50	nM	182.0	CHEMBL260	Homo sapiens	IC50	nM	182.0
	2367470	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(N3CCOC[C@@H]3C)nncc2c1		CHEMBL494469	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	2367471	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(N3CCOCC3)nncc2c1		CHEMBL494272	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	2367472	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(NCCN3CCOCC3)nncc2c1		CHEMBL494270	=	IC50	nM	1.9	CHEMBL260	Homo sapiens	IC50	nM	1.9
	2367545	CHEMBL1024853	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(OC(C)C)cncc2c1		CHEMBL492266	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	2379764	CHEMBL996115	Inhibition of human P38alpha expressed in baculovirus insect cell system	B	COc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460989	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2379774	CHEMBL996115	Inhibition of human P38alpha expressed in baculovirus insect cell system	B	CC(C)Oc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460990	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2395415	CHEMBL957081	Inhibition of p38alpha	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	nM	2000.0
	2396078	CHEMBL1006317	Inhibition of MAPK14 at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	2397909	CHEMBL939462	Inhibition of p38-alpha at 100 uM	B	O=C1/C(=C/c2ccc(O)cc2)SC(=S)N1Cc1ccccc1		CHEMBL520882	=	Inhibition	%	16.7	CHEMBL260	Homo sapiens	INH	%	16.7
	2397912	CHEMBL939462	Inhibition of p38-alpha at 100 uM	B	Cc1ccc(COc2ccc(-c3n[nH]cc3-c3ccccc3)c(O)c2)cc1		CHEMBL520871	=	Inhibition	%	12.3	CHEMBL260	Homo sapiens	INH	%	12.3
	2397913	CHEMBL939462	Inhibition of p38-alpha at 100 uM	B	O=C(Nc1nc(NC(=O)c2ccccc2)n(-c2ccccc2)n1)c1ccccc1		CHEMBL487154	=	Inhibition	%	24.5	CHEMBL260	Homo sapiens	INH	%	24.5
	2403463	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	NS(=O)(=O)c1ccc(Cc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)[nH]2)cc1		CHEMBL477657	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	2403464	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	Cc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477451	=	Activity	%	89.0	CHEMBL260	Homo sapiens	Activity	%	89.0
	2403465	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514542	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	2403466	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CCCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477661	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	2403467	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CC(C)c1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL515486	=	Activity	%	98.0	CHEMBL260	Homo sapiens	Activity	%	98.0
	2403468	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CCCCc1cccc(-c2[nH]c(Cc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477663	=	Activity	%	104.0	CHEMBL260	Homo sapiens	Activity	%	104.0
	2403469	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	NS(=O)(=O)c1ccc(CCc2nc(-c3ccc4nccnc4c3)c(-c3ccccn3)[nH]2)cc1		CHEMBL477664	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	2403470	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	Cc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514700	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	2403471	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477453	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
	2403472	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CCCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477454	=	Activity	%	103.0	CHEMBL260	Homo sapiens	Activity	%	103.0
	2403473	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CC(C)c1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL477866	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	2403474	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	CCCCc1cccc(-c2[nH]c(CCc3ccc(S(N)(=O)=O)cc3)nc2-c2ccc3nccnc3c2)n1		CHEMBL514539	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	2403475	CHEMBL963233	Inhibition of p38alpha MAP kinase at 10 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Activity	%	49.0	CHEMBL260	Homo sapiens	Activity	%	49.0
	2409518	CHEMBL959253	Inhibition of P38alpha	B	NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1		CHEMBL523586	=	IC50	nM	25000.0	CHEMBL260	Homo sapiens	IC50	nM	25000.0
Active	2409852	CHEMBL955957	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201		Activity			CHEMBL260	Homo sapiens	Activity		
	2413392	CHEMBL959158	Inhibition of p38alpha	B	O=[N+]([O-])c1ccc(-n2c(O)nnc2Sc2ncc([N+](=O)[O-])s2)cc1		CHEMBL448771	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2413393	CHEMBL959158	Inhibition of p38alpha	B	Cn1cccc1-c1nnc(Sc2ncc([N+](=O)[O-])s2)n1-c1ccc(Cl)cc1Cl		CHEMBL472074	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2413394	CHEMBL959158	Inhibition of p38alpha	B	O=[N+]([O-])c1cnc(Sc2nnc(Sc3ncc([N+](=O)[O-])s3)s2)s1		CHEMBL503022	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2413395	CHEMBL959158	Inhibition of p38alpha	B	Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1		CHEMBL510038	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	2419137	CHEMBL1019625	Inhibition of MAPK14 at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	49.0	CHEMBL260	Homo sapiens	INH	%	49.0
	2449688	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cccnc1		CHEMBL469883	=	IC50	nM	219.0	CHEMBL260	Homo sapiens	IC50	uM	0.219
	2449689	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(N)nc1		CHEMBL272902	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	uM	0.087
	2449690	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL470483	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	2449691	CHEMBL946387	Inhibition of p38alpha	B	CC(=O)Nc1ncc(NC(=O)c2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)cn1		CHEMBL487863	=	IC50	nM	1730.0	CHEMBL260	Homo sapiens	IC50	uM	1.73
	2449692	CHEMBL946387	Inhibition of p38alpha	B	CC(=O)Nc1ccc(NC(=O)c2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)cn1		CHEMBL487864	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
Not Active	2449693	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2ccc(C(F)(F)F)cc2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL487865		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	2449694	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)NC2CCCCC2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL443902		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	2449695	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)NCC2CCCCC2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL488833		Activity			CHEMBL260	Homo sapiens	Activity		
	2449696	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)NCCC2CCCCC2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL488834	=	IC50	nM	181.0	CHEMBL260	Homo sapiens	IC50	uM	0.181
	2449697	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)NCCCC2CCCCC2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL520718	=	IC50	nM	57.8	CHEMBL260	Homo sapiens	IC50	uM	0.0578
Not Active	2449698	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)NCCN2CCCC2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL505394		Activity			CHEMBL260	Homo sapiens	Activity		
	2449699	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)NCCC2CCCC2)cc1C(=O)Nc1ccc(N)nc1		CHEMBL487431	=	IC50	nM	998.0	CHEMBL260	Homo sapiens	IC50	uM	0.998
	2449726	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cncnc1		CHEMBL512840	=	IC50	nM	1750.0	CHEMBL260	Homo sapiens	IC50	uM	1.75
	2449742	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cncnc1		CHEMBL259247	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	2449751	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	13700.0	CHEMBL260	Homo sapiens	IC50	uM	13.7
	2449754	CHEMBL946387	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1NC(=O)c1cncnc1		CHEMBL469882	=	IC50	nM	455.0	CHEMBL260	Homo sapiens	IC50	uM	0.455
	2451153	CHEMBL1013888	Inhibition of p38alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	62.0	CHEMBL260	Homo sapiens	IC50	uM	0.062
	2451154	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NCC(C)O)c1		CHEMBL481950	=	IC50	nM	146.0	CHEMBL260	Homo sapiens	IC50	uM	0.146
Not Determined	2451155	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(N[C@@H](C)CO)c1		CHEMBL481301		IC50			CHEMBL260	Homo sapiens	IC50		
	2451156	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(N[C@H](C)CO)c1		CHEMBL519107	=	IC50	nM	485.0	CHEMBL260	Homo sapiens	IC50	uM	0.485
	2451157	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)CO)c1		CHEMBL480981	=	IC50	nM	292.0	CHEMBL260	Homo sapiens	IC50	uM	0.292
	2451158	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCC[C@H]2O)c1		CHEMBL519791	=	IC50	nM	211.0	CHEMBL260	Homo sapiens	IC50	uM	0.211
	2451159	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(N[C@H]2CC[C@H](O)CC2)c1		CHEMBL481952	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	2451160	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCOCC2)c1		CHEMBL481944	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	2451161	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC[C@H]2CCCC[C@@H]2O)c1		CHEMBL521111	=	IC50	nM	235.0	CHEMBL260	Homo sapiens	IC50	uM	0.235
	2451162	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCCC2)c1		CHEMBL481943	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	uM	0.042
	2451163	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(N[C@H](C)C2CCCCC2)c1		CHEMBL481951	=	IC50	nM	359.0	CHEMBL260	Homo sapiens	IC50	uM	0.359
	2451164	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(Nc2ccccc2)c1		CHEMBL521435	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	uM	0.051
	2451165	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(N[C@@H](C)c2ccccc2)c1		CHEMBL516460	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	2451166	CHEMBL1013888	Inhibition of p38alpha	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(N[C@H](C)c2ccccc2)c1		CHEMBL479998	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	uM	0.61
	2451167	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)c3ccccc3)c2)n1C		CHEMBL479991	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	2451168	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)c3ccccc3)c2)n1C		CHEMBL479990	=	IC50	nM	960.0	CHEMBL260	Homo sapiens	IC50	uM	0.96
	2451169	CHEMBL1013888	Inhibition of p38alpha	B	CCSc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1		CHEMBL516761	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	uM	0.087
Not Determined	2451170	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Sc3ccccc3)c2)[nH]1		CHEMBL481945		IC50			CHEMBL260	Homo sapiens	IC50		
	2451171	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OC(C)CCCC(C)C)c2)[nH]1		CHEMBL454698	=	IC50	nM	641.0	CHEMBL260	Homo sapiens	IC50	uM	0.641
Not Determined	2451172	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OCC3CCCCO3)c2)[nH]1		CHEMBL480964		IC50			CHEMBL260	Homo sapiens	IC50		
	2451173	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OCC3CCCO3)c2)[nH]1		CHEMBL480963	=	IC50	nM	542.0	CHEMBL260	Homo sapiens	IC50	uM	0.542
	2451174	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OCc3cccs3)c2)[nH]1		CHEMBL521417	=	IC50	nM	424.0	CHEMBL260	Homo sapiens	IC50	uM	0.424
	2451175	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Oc3ccc(C)cc3)c2)[nH]1		CHEMBL480957	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	uM	0.033
	2451176	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OC(C)c3ccccc3)c2)[nH]1		CHEMBL480956	=	IC50	nM	639.0	CHEMBL260	Homo sapiens	IC50	uM	0.639
	2451177	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(OCc3ccccc3)c2)[nH]1		CHEMBL479985	=	IC50	nM	436.0	CHEMBL260	Homo sapiens	IC50	uM	0.436
	2451178	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H]3CC[C@H](O)CC3)c2)[nH]1		CHEMBL516607	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	2451179	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL480962	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	2451180	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCCO)c2)[nH]1		CHEMBL481100	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	2451181	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(CO)C(C)C)c2)[nH]1		CHEMBL481116	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	2451182	CHEMBL1013888	Inhibition of p38alpha	B	CCC(CO)Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1		CHEMBL480958	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	2451183	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CO)c2)[nH]1		CHEMBL521250	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	2451184	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCO3)c2)[nH]1		CHEMBL480952	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	uM	0.035
	2451185	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC(C)O)c2)[nH]1		CHEMBL521091	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	uM	0.021
	2451186	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCO)c2)[nH]1		CHEMBL480951	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
	2451187	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCCC(C)C)c2)[nH]1		CHEMBL518964	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	2451188	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CC(C)C)c2)[nH]1		CHEMBL481766	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	uM	0.026
	2451189	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C(C)(C)C)c2)[nH]1		CHEMBL519621	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	2451190	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C(C)C)c2)[nH]1		CHEMBL481765	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	2451191	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCC(C)(C)C)c2)[nH]1		CHEMBL481926	=	IC50	nM	126.0	CHEMBL260	Homo sapiens	IC50	uM	0.126
	2451192	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCC(C)C)c2)[nH]1		CHEMBL479810	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	2451193	CHEMBL1013888	Inhibition of p38alpha	B	CCC(C)CNc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1		CHEMBL481919	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	2451194	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCC(C)CC3)c2)[nH]1		CHEMBL481918	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	2451195	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H]3CC[C@H](C)CC3)c2)[nH]1		CHEMBL481751	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	2451196	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H]3CC[C@@H](C)CC3)c2)[nH]1		CHEMBL481750	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	uM	0.031
	2451197	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3C)c2)[nH]1		CHEMBL482087	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	2451198	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL482086	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	2451199	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)C3CCCCC3)c2)[nH]1		CHEMBL506001	=	IC50	nM	153.0	CHEMBL260	Homo sapiens	IC50	uM	0.153
	2451200	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)C3CCCCC3)c2)[nH]1		CHEMBL481913	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	2451201	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCCC3)c2)[nH]1		CHEMBL481912	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	2451202	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(N[C@H]3CC[C@H](O)CC3)c2)[nH]1		CHEMBL481749	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	2451203	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NCCCO)c2)[nH]1		CHEMBL519628	=	IC50	nM	61.0	CHEMBL260	Homo sapiens	IC50	uM	0.061
	2451204	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NC(C)C(C)C)c2)[nH]1		CHEMBL482111	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	2451205	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(N[C@H](C)C3CCCCC3)c2)[nH]1		CHEMBL481942	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	2451206	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NCc3ccco3)c2)[nH]1		CHEMBL520280	=	IC50	nM	191.0	CHEMBL260	Homo sapiens	IC50	uM	0.191
	2451207	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NCc3cccs3)c2)[nH]1		CHEMBL481911	=	IC50	nM	239.0	CHEMBL260	Homo sapiens	IC50	uM	0.239
	2451208	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL482279	=	IC50	nM	49.0	CHEMBL260	Homo sapiens	IC50	uM	0.049
	2451209	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NCC(C)c3ccccc3)c2)[nH]1		CHEMBL482113	=	IC50	nM	93.0	CHEMBL260	Homo sapiens	IC50	uM	0.093
	2451210	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NC3CCCc4ccccc43)c2)[nH]1		CHEMBL481706	=	IC50	nM	248.0	CHEMBL260	Homo sapiens	IC50	uM	0.248
	2451211	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL481705	=	IC50	nM	199.0	CHEMBL260	Homo sapiens	IC50	uM	0.199
	2451212	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(NCc3ccccc3)c2)[nH]1		CHEMBL521265	=	IC50	nM	282.0	CHEMBL260	Homo sapiens	IC50	uM	0.282
	2451213	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccncc3)c2)[nH]1		CHEMBL506320	=	IC50	nM	119.0	CHEMBL260	Homo sapiens	IC50	uM	0.119
	2451214	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3cccnc3)c2)[nH]1		CHEMBL482112	=	IC50	nM	98.0	CHEMBL260	Homo sapiens	IC50	uM	0.098
	2451215	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccccn3)c2)[nH]1		CHEMBL481883	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	2451216	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccc(C)o3)c2)[nH]1		CHEMBL519624	=	IC50	nM	113.0	CHEMBL260	Homo sapiens	IC50	uM	0.113
	2451217	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccco3)c2)[nH]1		CHEMBL481882	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	2451218	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3cc4ccccc4s3)c2)[nH]1		CHEMBL481698	=	IC50	nM	314.0	CHEMBL260	Homo sapiens	IC50	uM	0.314
	2451219	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cccs3)c2)[nH]1		CHEMBL519617	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	2451220	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3cccs3)c2)[nH]1		CHEMBL452471	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	2451221	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3cccc4ccccc34)c2)[nH]1		CHEMBL479416	=	IC50	nM	171.0	CHEMBL260	Homo sapiens	IC50	uM	0.171
	2451222	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cc(C)ccc3C)c2)[nH]1		CHEMBL481965	=	IC50	nM	82.0	CHEMBL260	Homo sapiens	IC50	uM	0.082
	2451223	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccc(F)cc3)c2)[nH]1		CHEMBL481316	=	IC50	nM	173.0	CHEMBL260	Homo sapiens	IC50	uM	0.173
	2451224	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccc(C(C)(C)C)cc3)c2)[nH]1		CHEMBL481315	=	IC50	nM	1340.0	CHEMBL260	Homo sapiens	IC50	uM	1.34
	2451225	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(Cc3ccccc3)Cc3ccccc3)c2)[nH]1		CHEMBL518962	=	IC50	nM	2150.0	CHEMBL260	Homo sapiens	IC50	uM	2.15
	2451226	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(Cc3ccccc3)c3ccccc3)c2)[nH]1		CHEMBL493870	=	IC50	nM	348.0	CHEMBL260	Homo sapiens	IC50	uM	0.348
	2451227	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL493669	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	2451228	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC(C)c3ccccc3)c2)[nH]1		CHEMBL523880	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	2451229	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCc4ccccc43)c2)[nH]1		CHEMBL494879	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	uM	0.047
	2451230	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCc4ccccc43)c2)[nH]1		CHEMBL494871	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	uM	0.028
	2451231	CHEMBL1013888	Inhibition of p38alpha	B	CCC(Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL494666	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	uM	0.068
	2451232	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccccc3)c2)[nH]1		CHEMBL109028	=	IC50	nM	139.0	CHEMBL260	Homo sapiens	IC50	uM	0.139
	2451233	CHEMBL1013888	Inhibition of p38alpha	B	Fc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2cccc(C(F)(F)F)c2)ccn1		CHEMBL522362	=	IC50	nM	1950.0	CHEMBL260	Homo sapiens	IC50	uM	1.95
	2451234	CHEMBL1013888	Inhibition of p38alpha	B	CCSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(F)c2)[nH]1		CHEMBL494665	=	IC50	nM	657.0	CHEMBL260	Homo sapiens	IC50	uM	0.657
	2451235	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2cccc(C(F)(F)F)c2)c(-c2ccnc(F)c2)[nH]1		CHEMBL524015	=	IC50	nM	1090.0	CHEMBL260	Homo sapiens	IC50	uM	1.09
	2451236	CHEMBL1013888	Inhibition of p38alpha	B	Fc1ccc(-c2nc(SCc3ccccc3)[nH]c2-c2ccnc(Cl)c2)cc1		CHEMBL109383	=	IC50	nM	2900.0	CHEMBL260	Homo sapiens	IC50	uM	2.9
	2451237	CHEMBL1013888	Inhibition of p38alpha	B	CCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Cl)c2)[nH]1		CHEMBL521692	=	IC50	nM	372.0	CHEMBL260	Homo sapiens	IC50	uM	0.372
	2451238	CHEMBL1013888	Inhibition of p38alpha	B	Fc1ccc(-c2nc(SCc3ccccc3)[nH]c2-c2ccnc(F)c2)cc1		CHEMBL110262	=	IC50	nM	258.0	CHEMBL260	Homo sapiens	IC50	uM	0.258
	2451239	CHEMBL1013888	Inhibition of p38alpha	B	CCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(F)c2)[nH]1		CHEMBL494902	=	IC50	nM	213.0	CHEMBL260	Homo sapiens	IC50	uM	0.213
	2451240	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc3ccccc23)[nH]1		CHEMBL494901	=	IC50	nM	411.0	CHEMBL260	Homo sapiens	IC50	uM	0.411
Not Determined	2451241	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccncc2)[nH]1		CHEMBL113419		IC50			CHEMBL260	Homo sapiens	IC50		
	2451242	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Cl)c2)[nH]1		CHEMBL113060	=	IC50	nM	1040.0	CHEMBL260	Homo sapiens	IC50	uM	1.04
	2451243	CHEMBL1013888	Inhibition of p38alpha	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(F)c2)[nH]1		CHEMBL111403	=	IC50	nM	559.0	CHEMBL260	Homo sapiens	IC50	uM	0.559
	2451254	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	CCC(Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL494666	=	Inhibition	%	99.0	CHEMBL260	Homo sapiens	INH	%	99.0
	2451326	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Inhibition	%	97.0	CHEMBL260	Homo sapiens	INH	%	97.0
	2451327	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	2451328	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	98.0	CHEMBL260	Homo sapiens	INH	%	98.0
	2451329	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCCC2)c1		CHEMBL481943	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	2451330	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCO3)c2)[nH]1		CHEMBL480952	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	2451331	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCCC(C)C)c2)[nH]1		CHEMBL518964	=	Inhibition	%	94.0	CHEMBL260	Homo sapiens	INH	%	94.0
	2451332	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cccs3)c2)[nH]1		CHEMBL519617	=	Inhibition	%	99.0	CHEMBL260	Homo sapiens	INH	%	99.0
	2451333	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL493669	=	Inhibition	%	97.0	CHEMBL260	Homo sapiens	INH	%	97.0
	2451334	CHEMBL1013126	Inhibition of human SAPK2a/p38-alpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCc4ccccc43)c2)[nH]1		CHEMBL494871	=	Inhibition	%	98.0	CHEMBL260	Homo sapiens	INH	%	98.0
	2452935	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL387748	=	IC50	nM	1030.0	CHEMBL260	Homo sapiens	IC50	uM	1.03
	2452937	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	4300.0	CHEMBL260	Homo sapiens	IC50	uM	4.3
	2452938	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1ccc(CNc2nccc(-c3ncn(Cc4cccc(C#N)c4)c3-c3ccc(F)cc3)n2)cc1		CHEMBL492848	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452973	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3ccc(C(N)=O)cc3)c2-c2ccc(F)cc2)n1		CHEMBL481764	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452974	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3ccc(C(N)=O)cc3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL481917	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452975	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3cccc(C(N)=O)c3)c2-c2ccc(F)cc2)n1		CHEMBL481757	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452976	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccnc(NC4CC4)n3)c2-c2ccc(F)cc2)c1		CHEMBL520919	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452977	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3cccc(C(N)=O)c3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL480936	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452978	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccnc(N)n3)c2-c2ccc(F)cc2)c1		CHEMBL492858	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452979	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3ccc(C#N)cc3)c2-c2ccc(F)cc2)n1		CHEMBL493686	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452980	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3ccc(C#N)cc3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL493685	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452981	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2ncn(Cc3cccc(C#N)c3)c2-c2ccc(F)cc2)n1		CHEMBL522003	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452982	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccnc(NC4CC4)n3)c2-c2ccc(F)cc2)c1		CHEMBL495301	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452983	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2ncn(Cc3cccc(C#N)c3)c2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL493055	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452984	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccnc(N)n3)c2-c2ccc(F)cc2)c1		CHEMBL492849	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2452985	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1ccc(CNc2nccc(-c3c(-c4ccc(F)cc4)ncn3Cc3cccc(C#N)c3)n2)cc1		CHEMBL482129	=	IC50	nM	191.0	CHEMBL260	Homo sapiens	IC50	uM	0.191
	2452986	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	NC(=O)N(c1nc(-c2ccc(F)cc2)cs1)c1c(Cl)cccc1Cl		CHEMBL516760	=	IC50	nM	822.0	CHEMBL260	Homo sapiens	IC50	uM	0.822
	2452987	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc(F)cc2)n1		CHEMBL479987	=	IC50	nM	48.5	CHEMBL260	Homo sapiens	IC50	uM	0.0485
	2452988	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cc2nc(-c3ccc(F)cc3)c(-c3ccnc(NC4CC4)n3)[nH]2)c1		CHEMBL519620	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	uM	0.031
	2452989	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL481761	=	IC50	nM	78.0	CHEMBL260	Homo sapiens	IC50	uM	0.078
	2452990	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc(F)cc2)n1		CHEMBL480787	=	IC50	nM	62.8	CHEMBL260	Homo sapiens	IC50	uM	0.0628
	2452991	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	N#Cc1cccc(Cc2nc(-c3ccc(F)cc3)c(-c3ccnc(NC4CC4)n3)[nH]2)c1		CHEMBL520437	=	IC50	nM	54.4	CHEMBL260	Homo sapiens	IC50	uM	0.0544
	2452992	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2[nH]c(Cc3cccc(C#N)c3)nc2-c2ccc(F)cc2)n1)c1ccccc1		CHEMBL481752	=	IC50	nM	95.4	CHEMBL260	Homo sapiens	IC50	uM	0.0954
	2452993	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	N#Cc1cccc(Cc2nc(-c3ccc(F)cc3)c(-c3ccnc(N)n3)[nH]2)c1		CHEMBL519294	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	uM	0.028
	2452994	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1ccc(CNc2nccc(-c3[nH]c(Cc4cccc(C#N)c4)nc3-c3ccc(F)cc3)n2)cc1		CHEMBL480940	=	IC50	nM	148.0	CHEMBL260	Homo sapiens	IC50	uM	0.148
	2452995	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C(N)=O)cc2)n1		CHEMBL480933	=	IC50	nM	916.0	CHEMBL260	Homo sapiens	IC50	uM	0.916
	2452996	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C(N)=O)cc2)n1)c1ccccc1		CHEMBL480945	=	IC50	nM	55.6	CHEMBL260	Homo sapiens	IC50	uM	0.0556
	2452997	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C(N)=O)c2)n1		CHEMBL480944	=	IC50	nM	225.0	CHEMBL260	Homo sapiens	IC50	uM	0.225
	2452998	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(NC3CC3)n2)c1		CHEMBL521424	=	IC50	nM	27.6	CHEMBL260	Homo sapiens	IC50	uM	0.0276
	2452999	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C(N)=O)c2)n1)c1ccccc1		CHEMBL481354	=	IC50	nM	55.1	CHEMBL260	Homo sapiens	IC50	uM	0.0551
	2453000	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	NC(=O)c1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)c1		CHEMBL481347	=	IC50	nM	344.0	CHEMBL260	Homo sapiens	IC50	uM	0.344
	2453001	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C#N)cc2)n1		CHEMBL481513	=	IC50	nM	859.0	CHEMBL260	Homo sapiens	IC50	uM	0.859
	2453002	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2ccc(C#N)cc2)n1)c1ccccc1		CHEMBL481339	=	IC50	nM	87.1	CHEMBL260	Homo sapiens	IC50	uM	0.0871
	2453003	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C#N)c2)n1		CHEMBL481338	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	2453004	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(NC3CC3)n2)c1		CHEMBL482301	=	IC50	nM	62.6	CHEMBL260	Homo sapiens	IC50	uM	0.0626
	2453005	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2Cc2cccc(C#N)c2)n1)c1ccccc1		CHEMBL482300	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	2453006	CHEMBL1013160	Inhibition of human recombinant p38alpha MAPK expressed in Escherichia coli by radioisotopic protein kinase assay	B	N#Cc1cccc(Cn2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)c1		CHEMBL520949	=	IC50	nM	101.0	CHEMBL260	Homo sapiens	IC50	uM	0.101
Active	2462697	CHEMBL945201	Inhibition of p38alpha	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567		Activity			CHEMBL260	Homo sapiens	Activity		
Active	2462698	CHEMBL945200	Inhibition of p38alpha in hTERT-immortalized human AG03141 werner syndrome cells assessed as reduced phosphorylated HSP27 level by Western blot in presence of anisomycin	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567		Activity			CHEMBL260	Homo sapiens	Activity		
Active	2462699	CHEMBL945199	Inhibition of p38alpha in hTERT-immortalized human AG03141 werner syndrome cells assessed as reduced MK2 level by Western blot in presence of anisomycin	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567		Activity			CHEMBL260	Homo sapiens	Activity		
	2462702	CHEMBL945196	Inhibition of p38alpha-induced TNFalpha production in human THP1 cells	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	nM	250.0
	2462703	CHEMBL945194	Inhibition of p38alpha-mediated TNFalpha production in peripheral mononucleocytes	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	nM	500.0
	2462704	CHEMBL945195	Inhibition of p38alpha-mediated IL1-beta production in peripheral mononucleocytes	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	2462705	CHEMBL945193	Inhibition of p38alpha in hTERT-immortalized human HCA2 cells assessed as decrease in phosphorylated HSP27 level by ELISA in presence of anisomycin	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
Active	2462706	CHEMBL945192	Inhibition of p38alpha in hTERT-immortalized human HCA2 cells assessed as decrease in phosphorylated HSP27 level at 2.5 to 10.0 uM by ELISA in presence of anisomycin	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567		Activity			CHEMBL260	Homo sapiens	Activity		
	2470299	CHEMBL987219	Inhibition of p38-alpha at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	2471235	CHEMBL984550	Inhibition of human p38alpha	B	Cc1cccc(-n2nc(C(C)(C)C)cc2/C(=N/O)C(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL450809	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	2471236	CHEMBL984551	Inhibition of human p38alpha phosphorylation	B	Cc1cccc(-n2nc(C(C)(C)C)cc2/C(=N/O)C(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL450809	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	2471237	CHEMBL984550	Inhibition of human p38alpha	B	Cc1oc(C(C)(C)C)cc1C(=O)C(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL484550	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	2471238	CHEMBL984550	Inhibition of human p38alpha	B	Cc1oc(C(C)(C)C)cc1C(=O)C(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL483192	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	2471239	CHEMBL984550	Inhibition of human p38alpha	B	Cn1nc(C(C)(C)C)cc1C(=O)C(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL520967	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	2471240	CHEMBL984551	Inhibition of human p38alpha phosphorylation	B	Cc1oc(C(C)(C)C)cc1C(=O)C(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL484550	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	2471241	CHEMBL984551	Inhibition of human p38alpha phosphorylation	B	Cc1oc(C(C)(C)C)cc1C(=O)C(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL483192	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	uM	0.27
	2471242	CHEMBL984551	Inhibition of human p38alpha phosphorylation	B	Cn1nc(C(C)(C)C)cc1C(=O)C(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL520967	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
Not Evaluated	2476753	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2478592	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2478795	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2479650	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2479853	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2480650	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2480852	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL260	Homo sapiens	Activity		
	2488256	CHEMBL946775	Inhibition of p38alpha	B	COc1cc(N2CCC(N3CCN(S(C)(=O)=O)CC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1		CHEMBL507714	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	nM	440.0
	2488266	CHEMBL946775	Inhibition of p38alpha	B	CCc1cc(Nc2nccc(-c3c(-c4cccc(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1		CHEMBL448929	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	nM	1800.0
	2488274	CHEMBL946775	Inhibition of p38alpha	B	CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1		CHEMBL466397	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	nM	11000.0
	2488281	CHEMBL946775	Inhibition of p38alpha	B	O=C(Nc1c(F)cccc1F)c1cccc(-c2nc3ccccn3c2-c2ccnc(Nc3ccc(N4CCC(N5CCCCC5)CC4)cc3)n2)c1		CHEMBL453438	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	2488282	CHEMBL946775	Inhibition of p38alpha	B	COc1cc(N2CCC(N3CCCCC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1		CHEMBL506862	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	2500628	CHEMBL985078	Inhibition of p38alpha	B	Cc1nc(-c2nc(N3CCN(C)CC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL480581	=	EC50	nM	10900.0	CHEMBL260	Homo sapiens	EC50	uM	10.9
	2500629	CHEMBL985078	Inhibition of p38alpha	B	Cc1nc(-c2nc(N)[nH]c2-c2ccc3nccnc3c2)ccc1F		CHEMBL480742	=	IC50	nM	12500.0	CHEMBL260	Homo sapiens	IC50	uM	12.5
	2500631	CHEMBL985078	Inhibition of p38alpha	B	CCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL521441	=	EC50	nM	13530.0	CHEMBL260	Homo sapiens	EC50	uM	13.53
	2500632	CHEMBL985078	Inhibition of p38alpha	B	CC(=O)N1CCN(c2nc(-c3ccc(F)c(C)n3)c(-c3ccc4ncnn4c3)[nH]2)CC1		CHEMBL480582	=	EC50	nM	14200.0	CHEMBL260	Homo sapiens	EC50	uM	14.2
	2500633	CHEMBL985078	Inhibition of p38alpha	B	CC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL519939	=	EC50	nM	14800.0	CHEMBL260	Homo sapiens	EC50	uM	14.8
	2500634	CHEMBL985078	Inhibition of p38alpha	B	COCCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL480731	=	EC50	nM	14830.0	CHEMBL260	Homo sapiens	EC50	uM	14.83
	2500636	CHEMBL985078	Inhibition of p38alpha	B	COCC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3nccnc3c2)[nH]1		CHEMBL479262	=	EC50	nM	15000.0	CHEMBL260	Homo sapiens	EC50	uM	15.0
	2500640	CHEMBL985078	Inhibition of p38alpha	B	Cc1cccc(-c2nc(N)sc2-c2ccc3nccnc3c2)n1		CHEMBL519948	=	EC50	nM	22000.0	CHEMBL260	Homo sapiens	EC50	uM	22.0
	2500643	CHEMBL985078	Inhibition of p38alpha	B	CC(=O)Nc1nc(-c2ccc(F)c(C)n2)c(-c2ccc3ncnn3c2)[nH]1		CHEMBL517068	=	EC50	nM	28100.0	CHEMBL260	Homo sapiens	EC50	uM	28.1
	2500646	CHEMBL985078	Inhibition of p38alpha	B	Cc1nc(-c2nc(N3CCN(S(C)(=O)=O)CC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL480583	=	EC50	nM	41200.0	CHEMBL260	Homo sapiens	EC50	uM	41.2
	2500647	CHEMBL985078	Inhibition of p38alpha	B	Cc1nc(-c2nc(N3CCOCC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL520104	=	EC50	nM	46300.0	CHEMBL260	Homo sapiens	EC50	uM	46.3
	2500649	CHEMBL985078	Inhibition of p38alpha	B	CC(=O)Nc1nc(-c2cccc(C)n2)c(-c2ccc3ncnn3c2)[nH]1		CHEMBL450161	=	EC50	nM	57800.0	CHEMBL260	Homo sapiens	EC50	uM	57.8
Not Determined	2500667	CHEMBL985078	Inhibition of p38alpha	B	Cc1nc(-c2nc(NC(=O)C(C)C)[nH]c2-c2ccc3nccnc3c2)ccc1F		CHEMBL482207		EC50			CHEMBL260	Homo sapiens	EC50		
Not Determined	2500668	CHEMBL985078	Inhibition of p38alpha	B	Cc1nc(-c2nc(N3CCCCC3)[nH]c2-c2ccc3ncnn3c2)ccc1F		CHEMBL481546		EC50			CHEMBL260	Homo sapiens	EC50		
	2505612	CHEMBL941571	Inhibition of p38alpha	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	>	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	nM	15000.0
	2507001	CHEMBL947771	Inhibition of p38alpha	B	Nc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)cc1Cl		CHEMBL475817	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
Not Active	2511597	CHEMBL973451	Inhibition of p38-alpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL260	Homo sapiens	IC50		
	2511992	CHEMBL973477	Inhibition of P38alpha at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	28.0	CHEMBL260	Homo sapiens	INH	%	28.0
	2527116	CHEMBL984137	Binding affinity to p38alpha by exchange curve binding kinetic analysis	B	COc1ccc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL523978	=	Kd	nM	1.8	CHEMBL260	Homo sapiens	Kd	nM	1.8
	2527117	CHEMBL984138	Binding affinity to p38alpha assessed as half life dissociation	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	T1/2	hr	24.0	CHEMBL260	Homo sapiens	t1/2	hr	24.0
	2527118	CHEMBL984137	Binding affinity to p38alpha by exchange curve binding kinetic analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.1	CHEMBL260	Homo sapiens	Kd	nM	0.1
	2527161	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(=O)c2cc3ccccc3s2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL242005	=	Tm	degrees C	51.4	CHEMBL260	Homo sapiens	Tm	degrees C	51.4
	2527162	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1ccc(C(C)(C)C)cc1NC(=O)c1cc2ccccc2s1		CHEMBL519511	=	Tm	degrees C	46.9	CHEMBL260	Homo sapiens	Tm	degrees C	46.9
	2527163	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(=O)c2cc3ccccc3o2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL390254	=	Tm	degrees C	48.8	CHEMBL260	Homo sapiens	Tm	degrees C	48.8
	2527164	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1ccc(C(C)(C)C)cc1NC(=O)c1cc2ccccc2o1		CHEMBL484405	=	Tm	degrees C	46.2	CHEMBL260	Homo sapiens	Tm	degrees C	46.2
	2527165	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(=O)Nc2cccc3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL245230	=	Tm	degrees C	56.3	CHEMBL260	Homo sapiens	Tm	degrees C	56.3
	2527166	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1ccc(C(C)(C)C)cc1NC(=O)Nc1cccc2ccccc12		CHEMBL482969	=	Tm	degrees C	50.3	CHEMBL260	Homo sapiens	Tm	degrees C	50.3
	2527167	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1C(=O)N(C)C		CHEMBL448568	=	Tm	degrees C	56.2	CHEMBL260	Homo sapiens	Tm	degrees C	56.2
	2527168	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	CNC(=O)c1cc(C(C)(C)C)cc(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)c1OC		CHEMBL453999	=	Tm	degrees C	65.6	CHEMBL260	Homo sapiens	Tm	degrees C	65.6
	2527169	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1C(N)=O		CHEMBL451104	=	Tm	degrees C	65.5	CHEMBL260	Homo sapiens	Tm	degrees C	65.5
	2527170	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523	=	Tm	degrees C	63.3	CHEMBL260	Homo sapiens	Tm	degrees C	63.3
	2527171	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1N(C)C(C)=O		CHEMBL504583	=	Tm	degrees C	64.9	CHEMBL260	Homo sapiens	Tm	degrees C	64.9
	2527172	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(N)=O)cc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL453729	=	Tm	degrees C	56.7	CHEMBL260	Homo sapiens	Tm	degrees C	56.7
	2527173	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COC(=O)Nc1cc(C(C)(C)C)cc(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)c1OC		CHEMBL454833	=	Tm	degrees C	58.1	CHEMBL260	Homo sapiens	Tm	degrees C	58.1
	2527174	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	CCC(=O)Nc1cc(C(C)(C)C)cc(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)c1OC		CHEMBL505951	=	Tm	degrees C	58.7	CHEMBL260	Homo sapiens	Tm	degrees C	58.7
	2527175	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(NC(C)=O)cc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL510740	=	Tm	degrees C	63.6	CHEMBL260	Homo sapiens	Tm	degrees C	63.6
	2527176	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1c(N)cc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL491462	=	Tm	degrees C	61.5	CHEMBL260	Homo sapiens	Tm	degrees C	61.5
	2527177	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cc1ccc(C(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL519161	=	Tm	degrees C	52.3	CHEMBL260	Homo sapiens	Tm	degrees C	52.3
	2527178	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	COc1ccc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL523978	=	Tm	degrees C	57.9	CHEMBL260	Homo sapiens	Tm	degrees C	57.9
	2527179	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	CCc1ccc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL518150	=	Tm	degrees C	53.9	CHEMBL260	Homo sapiens	Tm	degrees C	53.9
	2527180	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cc1ncc(-c2ccc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cn1		CHEMBL499149	=	Tm	degrees C	56.6	CHEMBL260	Homo sapiens	Tm	degrees C	56.6
	2527181	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cc1ccc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL470859	=	Tm	degrees C	54.6	CHEMBL260	Homo sapiens	Tm	degrees C	54.6
	2527182	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cc1ccc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL473880	=	Tm	degrees C	52.7	CHEMBL260	Homo sapiens	Tm	degrees C	52.7
	2527183	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(-c2ccc(CN3CCOCC3)nc2)c2ccccc12		CHEMBL410761	=	Tm	degrees C	57.9	CHEMBL260	Homo sapiens	Tm	degrees C	57.9
	2527184	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL104749	=	Tm	degrees C	54.5	CHEMBL260	Homo sapiens	Tm	degrees C	54.5
	2527185	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc1		CHEMBL381743	=	Tm	degrees C	63.6	CHEMBL260	Homo sapiens	Tm	degrees C	63.6
	2527186	CHEMBL984132	Binding affinity to p38alpha assessed as melting temperature of enzyme-inhibitor complex by thermal denaturation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Tm	degrees C	63.7	CHEMBL260	Homo sapiens	Tm	degrees C	63.7
	2527204	CHEMBL984139	Binding affinity to p38alpha assessed as inhibition of ATF2 phosphorylation preincubated for 4 hrs	B	COc1ccc(C(C)(C)C)cc1NC(=O)Nc1cccc2ccccc12		CHEMBL482969	=	IC50	nM	3900.0	CHEMBL260	Homo sapiens	IC50	nM	3900.0
	2527205	CHEMBL984139	Binding affinity to p38alpha assessed as inhibition of ATF2 phosphorylation preincubated for 4 hrs	B	COc1c(NC(=O)c2cc3ccccc3s2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL242005	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	nM	2700.0
	2527206	CHEMBL984139	Binding affinity to p38alpha assessed as inhibition of ATF2 phosphorylation preincubated for 4 hrs	B	COc1ccc(C(C)(C)C)cc1NC(=O)c1cc2ccccc2s1		CHEMBL519511	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2527207	CHEMBL984139	Binding affinity to p38alpha assessed as inhibition of ATF2 phosphorylation preincubated for 4 hrs	B	COc1c(NC(=O)c2cc3ccccc3o2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL390254	=	IC50	nM	4100.0	CHEMBL260	Homo sapiens	IC50	nM	4100.0
	2527208	CHEMBL984139	Binding affinity to p38alpha assessed as inhibition of ATF2 phosphorylation preincubated for 4 hrs	B	COc1ccc(C(C)(C)C)cc1NC(=O)c1cc2ccccc2o1		CHEMBL484405	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2527209	CHEMBL984139	Binding affinity to p38alpha assessed as inhibition of ATF2 phosphorylation preincubated for 4 hrs	B	COc1c(NC(=O)Nc2cccc3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL245230	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	2528145	CHEMBL985026	Inhibition of p38alpha	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL519693	<	IC50	nM	25118.86	CHEMBL260	Homo sapiens	pIC50		4.6
	2528146	CHEMBL985026	Inhibition of p38alpha	B	NCc1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL484967	<	IC50	nM	25118.86	CHEMBL260	Homo sapiens	pIC50		4.6
	2528147	CHEMBL985026	Inhibition of p38alpha	B	c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL484968	<	IC50	nM	25118.86	CHEMBL260	Homo sapiens	pIC50		4.6
	2528952	CHEMBL985887	Inhibition of SAPK2b	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	=	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	2528960	CHEMBL985895	Inhibition of SAPK2a	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
Active	2558359	CHEMBL989969	Binding affinity to human unphosphorylated p38alpha by surface plasmon resonance	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351		Activity			CHEMBL260	Homo sapiens	Activity		
Active	2558360	CHEMBL989969	Binding affinity to human unphosphorylated p38alpha by surface plasmon resonance	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Activity			CHEMBL260	Homo sapiens	Activity		
Active	2558361	CHEMBL989969	Binding affinity to human unphosphorylated p38alpha by surface plasmon resonance	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL260	Homo sapiens	Activity		
	2558362	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	COc1ccc(NC(=O)c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)cc1		CHEMBL476111	=	Ki	nM	730.0	CHEMBL260	Homo sapiens	Ki	nM	730.0
	2558363	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	CC(=O)Nc1cccc(NC(=O)c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)c1		CHEMBL476752	=	Ki	nM	79.0	CHEMBL260	Homo sapiens	Ki	nM	79.0
	2558364	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(C(=O)Nc2cccc(-c3ccccn3)c2)cc1-c1ccc(C(=O)Nc2cccc(C#N)c2)cc1		CHEMBL514509	=	Ki	nM	11.0	CHEMBL260	Homo sapiens	Ki	nM	11.0
	2558365	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Ki	nM	1.9	CHEMBL260	Homo sapiens	Ki	nM	1.9
	2558366	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516264	=	Ki	nM	73.0	CHEMBL260	Homo sapiens	Ki	nM	73.0
	2558367	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2cccc(-c3ccoc3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476996	=	Ki	nM	1.6	CHEMBL260	Homo sapiens	Ki	nM	1.6
	2558368	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2cccc(-n3c(C)ccc3C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476995	=	Ki	nM	2.1	CHEMBL260	Homo sapiens	Ki	nM	2.1
	2558369	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(C(=O)Nc2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)cc1		CHEMBL477620	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	Ki	nM	100.0
	2558370	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Ki	nM	15.0	CHEMBL260	Homo sapiens	Ki	nM	15.0
	2558371	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(N3CCN(C)CC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476552	=	Ki	nM	300.0	CHEMBL260	Homo sapiens	Ki	nM	300.0
	2558372	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(NC3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477191	=	Ki	nM	3.0	CHEMBL260	Homo sapiens	Ki	nM	3.0
	2558373	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(NC3CCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477190	=	Ki	nM	0.6	CHEMBL260	Homo sapiens	Ki	nM	0.6
	2558374	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(NCC(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478234	=	Ki	nM	4.6	CHEMBL260	Homo sapiens	Ki	nM	4.6
	2558375	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(NCC3CC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478031	=	Ki	nM	6.3	CHEMBL260	Homo sapiens	Ki	nM	6.3
	2558376	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(NC3CC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478656	=	Ki	nM	5.2	CHEMBL260	Homo sapiens	Ki	nM	5.2
	2558377	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(N3CCC(C)CC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL514207	=	Ki	nM	15.0	CHEMBL260	Homo sapiens	Ki	nM	15.0
	2558378	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Ki	nM	4.4	CHEMBL260	Homo sapiens	Ki	nM	4.4
	2558379	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	=	Ki	nM	2.5	CHEMBL260	Homo sapiens	Ki	nM	2.5
	2558380	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Ki	nM	1.9	CHEMBL260	Homo sapiens	Ki	nM	1.9
	2558381	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(N(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515318	=	Ki	nM	14.0	CHEMBL260	Homo sapiens	Ki	nM	14.0
	2558382	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccnc(Cl)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478225	=	Ki	nM	150.0	CHEMBL260	Homo sapiens	Ki	nM	150.0
	2558383	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(NC(=O)c2ccccc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478421	=	Ki	nM	12.0	CHEMBL260	Homo sapiens	Ki	nM	12.0
	2558384	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Ki	nM	12.0	CHEMBL260	Homo sapiens	Ki	nM	12.0
	2558385	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	Ki	nM	36.0	CHEMBL260	Homo sapiens	Ki	nM	36.0
	2558386	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	6.4	CHEMBL260	Homo sapiens	Ki	nM	6.4
Not Determined	2558387	CHEMBL987299	Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692		Ki			CHEMBL260	Homo sapiens	Ki		
	2558388	CHEMBL987299	Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Ki	nM	9.0	CHEMBL260	Homo sapiens	Ki	nM	9.0
	2558389	CHEMBL987299	Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	46.0	CHEMBL260	Homo sapiens	Ki	nM	46.0
	2558390	CHEMBL987299	Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Ki	nM	6.0	CHEMBL260	Homo sapiens	Ki	nM	6.0
	2558391	CHEMBL987299	Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Ki	nM	6.0	CHEMBL260	Homo sapiens	Ki	nM	6.0
	2558392	CHEMBL987299	Inhibition of human recombinant p38alpha-mediated ATF2 phosphorylation by TR-FRET assay	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	=	Ki	nM	9.0	CHEMBL260	Homo sapiens	Ki	nM	9.0
	2558399	CHEMBL987301	Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	2558400	CHEMBL987301	Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	2558401	CHEMBL987301	Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	2558402	CHEMBL987301	Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	2558403	CHEMBL987301	Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	2558404	CHEMBL987301	Inhibition of p38alpha phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	2558443	CHEMBL987298	Displacement of rhodamine-green labeled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human p38alpha by fluorescence polarization	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Ki	nM	240.0	CHEMBL260	Homo sapiens	Ki	nM	240.0
	2559680	CHEMBL982985	Inhibition of P38alpha	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	nM	50000.0
	2560637	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	nM	3000.0
	2560638	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	Ki	nM	480.0	CHEMBL260	Homo sapiens	Ki	nM	480.0
	2560639	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CN(C)c1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478838	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	nM	16000.0
	2560640	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CN(C)c1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478838	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	nM	2500.0
	2560641	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478837	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	nM	16000.0
	2560642	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478837	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	nM	2500.0
	2560643	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cc(NC(=O)c3ccoc3)ccc2Cl)cc1		CHEMBL478626	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	nM	63.0
	2560644	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cc(NC(=O)c3ccoc3)ccc2Cl)cc1		CHEMBL478626	=	Ki	nM	10.0	CHEMBL260	Homo sapiens	Ki	nM	10.0
	2560645	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cccc(NC(=O)c3ccoc3)c2)cc1		CHEMBL516287	=	IC50	nM	5900.0	CHEMBL260	Homo sapiens	IC50	nM	5900.0
	2560646	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cccc(NC(=O)c3ccoc3)c2)cc1		CHEMBL516287	=	Ki	nM	940.0	CHEMBL260	Homo sapiens	Ki	nM	940.0
	2560647	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cc(C(=O)NC3CC3)ccc2F)cc1		CHEMBL479245	=	IC50	nM	2900.0	CHEMBL260	Homo sapiens	IC50	nM	2900.0
	2560648	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cc(C(=O)NC3CC3)ccc2F)cc1		CHEMBL479245	=	Ki	nM	460.0	CHEMBL260	Homo sapiens	Ki	nM	460.0
	2560649	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL479244	=	IC50	nM	3300.0	CHEMBL260	Homo sapiens	IC50	nM	3300.0
	2560650	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL479244	=	Ki	nM	520.0	CHEMBL260	Homo sapiens	Ki	nM	520.0
	2560651	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cc(C(=O)NC3CC3)ccc2Cl)cc1		CHEMBL479039	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	2560652	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cc(C(=O)NC3CC3)ccc2Cl)cc1		CHEMBL479039	=	Ki	nM	25.0	CHEMBL260	Homo sapiens	Ki	nM	25.0
	2560653	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	>	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	nM	16000.0
	2560654	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	>	Ki	nM	2500.0	CHEMBL260	Homo sapiens	Ki	nM	2500.0
	2560655	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCCCN(C)C)cc1		CHEMBL477558	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	nM	230.0
	2560656	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCCCN(C)C)cc1		CHEMBL477558	=	Ki	nM	370.0	CHEMBL260	Homo sapiens	Ki	nM	370.0
	2560657	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCCCN2CCOCC2)cc1		CHEMBL477557	=	IC50	nM	650.0	CHEMBL260	Homo sapiens	IC50	nM	650.0
	2560658	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCCCN2CCOCC2)cc1		CHEMBL477557	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	Ki	nM	100.0
	2560659	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCCCO)cc1		CHEMBL477348	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	nM	270.0
	2560660	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCCCO)cc1		CHEMBL477348	=	Ki	nM	43.0	CHEMBL260	Homo sapiens	Ki	nM	43.0
	2560661	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NN)cc1		CHEMBL517205	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	nM	610.0
	2560662	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NN)cc1		CHEMBL517205	=	Ki	nM	97.0	CHEMBL260	Homo sapiens	Ki	nM	97.0
	2560663	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCc2ccc(N3CCN(C)CC3)cc2)cc1		CHEMBL516127	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	2560664	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCc2ccc(N3CCN(C)CC3)cc2)cc1		CHEMBL516127	=	Ki	nM	3.0	CHEMBL260	Homo sapiens	Ki	nM	3.0
	2560665	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCc2cccc(NS(C)(=O)=O)c2)cc1		CHEMBL479028	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2560666	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCc2cccc(NS(C)(=O)=O)c2)cc1		CHEMBL479028	=	Ki	nM	2.0	CHEMBL260	Homo sapiens	Ki	nM	2.0
	2560667	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1cccc(CNC(=O)c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)cc2)c1		CHEMBL517671	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	2560668	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1cccc(CNC(=O)c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)cc2)c1		CHEMBL517671	=	Ki	nM	4.0	CHEMBL260	Homo sapiens	Ki	nM	4.0
	2560669	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1ccc(NC(=O)c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)cc2)cc1		CHEMBL478819	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	2560670	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	COc1ccc(NC(=O)c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)cc2)cc1		CHEMBL478819	=	Ki	nM	7.0	CHEMBL260	Homo sapiens	Ki	nM	7.0
	2560671	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)Nc2cccc(C#N)c2)cc1		CHEMBL476507	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	2560672	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)Nc2cccc(C#N)c2)cc1		CHEMBL476507	=	Ki	nM	5.0	CHEMBL260	Homo sapiens	Ki	nM	5.0
	2560673	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccno2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476543	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	2560674	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccno2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476543	=	Ki	nM	6.0	CHEMBL260	Homo sapiens	Ki	nM	6.0
	2560675	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccsc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476542	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	2560676	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccsc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476542	=	Ki	nM	5.0	CHEMBL260	Homo sapiens	Ki	nM	5.0
	2560677	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2cccs2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477791	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	2560678	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2cccs2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477791	=	Ki	nM	32.0	CHEMBL260	Homo sapiens	Ki	nM	32.0
	2560679	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	IC50	nM	96.0	CHEMBL260	Homo sapiens	IC50	nM	96.0
	2560680	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Ki	nM	15.0	CHEMBL260	Homo sapiens	Ki	nM	15.0
	2560681	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccco2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477582	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	2560682	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccco2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477582	=	Ki	nM	25.0	CHEMBL260	Homo sapiens	Ki	nM	25.0
	2560683	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccccc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478421	=	IC50	nM	76.0	CHEMBL260	Homo sapiens	IC50	nM	76.0
	2560684	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)c2ccccc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478421	=	Ki	nM	12.0	CHEMBL260	Homo sapiens	Ki	nM	12.0
	2560685	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478420	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	nM	12000.0
	2560686	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478420	=	Ki	nM	1900.0	CHEMBL260	Homo sapiens	Ki	nM	1900.0
	2560687	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL479258	=	IC50	nM	7000.0	CHEMBL260	Homo sapiens	IC50	nM	7000.0
	2560688	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL479258	=	Ki	nM	1100.0	CHEMBL260	Homo sapiens	Ki	nM	1100.0
	2560689	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)CC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL479257	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	nM	2100.0
	2560690	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)CC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL479257	=	Ki	nM	330.0	CHEMBL260	Homo sapiens	Ki	nM	330.0
	2560691	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	nM	450.0
	2560692	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Ki	nM	70.0	CHEMBL260	Homo sapiens	Ki	nM	70.0
	2560693	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476534	=	IC50	nM	1700.0	CHEMBL260	Homo sapiens	IC50	nM	1700.0
	2560694	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476534	=	Ki	nM	270.0	CHEMBL260	Homo sapiens	Ki	nM	270.0
	2560695	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL476533	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	nM	240.0
	2560696	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL476533	=	Ki	nM	40.0	CHEMBL260	Homo sapiens	Ki	nM	40.0
	2560697	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476532	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	nM	2300.0
	2560698	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(NC(=O)C2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476532	=	Ki	nM	350.0	CHEMBL260	Homo sapiens	Ki	nM	350.0
	2560699	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2560700	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Ki	nM	170.0	CHEMBL260	Homo sapiens	Ki	nM	170.0
	2560701	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL477997	=	IC50	nM	4000.0	CHEMBL260	Homo sapiens	IC50	nM	4000.0
	2560702	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL477997	=	Ki	nM	630.0	CHEMBL260	Homo sapiens	Ki	nM	630.0
	2560703	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)Nc2nncs2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478650	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	nM	150.0
	2560704	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)Nc2nncs2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478650	=	Ki	nM	20.0	CHEMBL260	Homo sapiens	Ki	nM	20.0
	2560705	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)Nc2nccs2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478614	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	nM	86.0
	2560706	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)Nc2nccs2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478614	=	Ki	nM	14.0	CHEMBL260	Homo sapiens	Ki	nM	14.0
	2560707	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516264	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	nM	460.0
	2560708	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516264	=	Ki	nM	70.0	CHEMBL260	Homo sapiens	Ki	nM	70.0
	2560709	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	IC50	nM	850.0	CHEMBL260	Homo sapiens	IC50	nM	850.0
	2560710	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Ki	nM	130.0	CHEMBL260	Homo sapiens	Ki	nM	130.0
	2560711	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	IC50	nM	2500.0	CHEMBL260	Homo sapiens	IC50	nM	2500.0
	2560712	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Ki	nM	400.0	CHEMBL260	Homo sapiens	Ki	nM	400.0
	2560713	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	IC50	nM	8800.0	CHEMBL260	Homo sapiens	IC50	nM	8800.0
	2560714	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Ki	nM	1400.0	CHEMBL260	Homo sapiens	Ki	nM	1400.0
	2560715	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477977	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	nM	2700.0
	2560716	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477977	=	Ki	nM	430.0	CHEMBL260	Homo sapiens	Ki	nM	430.0
	2560717	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NCC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517346	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	nM	11000.0
	2560718	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NCC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517346	=	Ki	nM	1600.0	CHEMBL260	Homo sapiens	Ki	nM	1600.0
	2560719	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NCC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476978	=	IC50	nM	550.0	CHEMBL260	Homo sapiens	IC50	nM	550.0
	2560720	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NCC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476978	=	Ki	nM	90.0	CHEMBL260	Homo sapiens	Ki	nM	90.0
	2560721	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCCNC(=O)c1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL476770	=	IC50	nM	970.0	CHEMBL260	Homo sapiens	IC50	nM	970.0
	2560722	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCCNC(=O)c1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL476770	=	Ki	nM	150.0	CHEMBL260	Homo sapiens	Ki	nM	150.0
	2560723	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	nM	75.0
	2560724	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Ki	nM	12.0	CHEMBL260	Homo sapiens	Ki	nM	12.0
	2560725	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCNC(=O)c1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL476768	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	nM	610.0
	2560726	CHEMBL983811	Displacement of rhodamine-green labelled (2-(6-amino-3-imino-3H-xanthen-9-yl)-5-{[({4-[4-(4-Cl-3-hydroxyphenyl)-5-(4-pyridinyl)-1H-imidazol-2yl]phenyl}methyl)amino]carbonyl}benzoic acid from human GST-tagged p38alpha by fluorescence polarisation assay	B	CCNC(=O)c1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL476768	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	Ki	nM	100.0
	2560752	CHEMBL983837	Inhibition of human recombinant His-tagged p38alpha-mediated ATF2 phosphorylation by TR-FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Ki	nM	10.0	CHEMBL260	Homo sapiens	Ki	nM	10.0
	2562287	CHEMBL984700	Inhibition of human p38alpha at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	46.0	CHEMBL260	Homo sapiens	INH	%	46.0
	2562309	CHEMBL984700	Inhibition of human p38alpha at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	2565237	CHEMBL967081	Inhibition of p38alpha MAPK	B	COc1ccc(C(=O)NN2CCOCC2)cc1-c1n[nH]c2nc(Nc3ccc(F)cc3F)ccc12		CHEMBL512255	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	nM	0.7
	2567281	CHEMBL975468	Inhibition of human SAPK2a kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	124.0	CHEMBL260	Homo sapiens	Activity	%	124.0
	2571602	CHEMBL1001359	Inhibition of SAPK2a at 10 uM	B	Cn1cc(-c2ccc3c(c2)N(c2nc4c(s2)C(=O)NC(C)(C)C4)CCO3)cn1		CHEMBL512440	>	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
Not Evaluated	2577271	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2577474	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL260	Homo sapiens	Activity		
Not Determined	2592636	CHEMBL1020481	Inhibition of p38 alpha	B	COc1cc(Nc2nc(NCc3ccccc3)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL520608		IC50			CHEMBL260	Homo sapiens	IC50		
	2592642	CHEMBL1020481	Inhibition of p38 alpha	B	CCOC(=O)/C=C/c1ccc(CNc2nc(Nc3cc(OC)cc(OC)c3)c(C(N)=O)c3nccn23)cc1		CHEMBL480014	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2592650	CHEMBL1020481	Inhibition of p38 alpha	B	COc1cc(Nc2nc(NCc3ccc(/C=C/C(=O)O)cc3)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL511829	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2593679	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	22.2	CHEMBL260	Homo sapiens	Activity	%	22.2
	2593945	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	28.2	CHEMBL260	Homo sapiens	Activity	%	28.2
Active	2594148	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL260	Homo sapiens	Activity		
Active	2594888	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL260	Homo sapiens	Activity		
Active	2595091	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2596288	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2596491	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL260	Homo sapiens	Activity		
Not Evaluated	2597760	CHEMBL983551	Binding affinity to human P38A at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL260	Homo sapiens	Activity		
	2605989	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccccc1C2=O		CHEMBL218962	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	2605990	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1cc(F)ccc1Nc1ccc2c(c1)CCc1ccccc1C2=O		CHEMBL473581	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	2605991	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	O=C1c2ccccc2CCc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL515407	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	2605992	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(=O)c3ccccc3ccc2c1		CHEMBL220022	=	IC50	nM	1060.0	CHEMBL260	Homo sapiens	IC50	uM	1.06
	2605993	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	O=c1c2ccccc2ccc2cc(Nc3ccc(F)cc3F)ccc12		CHEMBL515727	=	IC50	nM	2530.0	CHEMBL260	Homo sapiens	IC50	uM	2.53
	2605994	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(=O)c3cccnc3ccc2c1		CHEMBL473984	=	IC50	nM	1080.0	CHEMBL260	Homo sapiens	IC50	uM	1.08
	2605995	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	O=c1c2ccc(Nc3ccc(F)cc3F)cc2ccc2ncccc12		CHEMBL474177	=	IC50	nM	330.0	CHEMBL260	Homo sapiens	IC50	uM	0.33
	2605996	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ncccc1C2=O		CHEMBL474178	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	uM	0.31
	2605997	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1cc(F)ccc1Nc1ccc2c(c1)CCc1ncccc1C2=O		CHEMBL514321	=	IC50	nM	1190.0	CHEMBL260	Homo sapiens	IC50	uM	1.19
	2605998	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ncccc21		CHEMBL515721	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	2605999	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(=O)c3cnccc3ccc2c1		CHEMBL473597	=	IC50	nM	1950.0	CHEMBL260	Homo sapiens	IC50	uM	1.95
	2606000	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(c1)CCc1cccnc1C2=O		CHEMBL473598	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	uM	0.44
	2606001	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(c1)OCc1ccccc1C2=O		CHEMBL375978	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	2606002	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1cc(F)ccc1Nc1ccc2c(c1)OCc1ccccc1C2=O		CHEMBL218961	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	2606003	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	O=C1c2ccccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL376855	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	2606004	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1ccccc1Nc1ccc2c(c1)OCc1ncccc1C2=O		CHEMBL475360	=	IC50	nM	2680.0	CHEMBL260	Homo sapiens	IC50	uM	2.68
	2606005	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	Nc1cc(F)ccc1Nc1ccc2c(c1)OCc1ncccc1C2=O		CHEMBL475361	=	IC50	nM	2730.0	CHEMBL260	Homo sapiens	IC50	uM	2.73
	2606006	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2ncccc21		CHEMBL515758	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	2606007	CHEMBL1022155	Inhibition of p38alpha MAPK by cell-free enzyme immunosorbent assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	2613326	CHEMBL1016944	Inhibition of SAPK2a/p38	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2613492	CHEMBL1031534	Inhibition of p38alpha	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2626875	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	Kd	nM	55.0	CHEMBL260	Homo sapiens	Kd	uM	0.055
	2626876	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	Kd	nM	12.0	CHEMBL260	Homo sapiens	Kd	uM	0.012
Not Determined	2626877	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762		Kd			CHEMBL260	Homo sapiens	Kd		
	2626878	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	495.0	CHEMBL260	Homo sapiens	Kd	uM	0.495
	2626879	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc([N+](=O)[O-])cc34)cc2)c1		CHEMBL526930	=	Kd	nM	127.0	CHEMBL260	Homo sapiens	Kd	uM	0.127
	2626880	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Kd	nM	342.0	CHEMBL260	Homo sapiens	Kd	uM	0.342
	2626881	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516	=	Kd	nM	245.0	CHEMBL260	Homo sapiens	Kd	uM	0.245
	2626882	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc([N+](=O)[O-])cc34)c2)c1		CHEMBL526560	=	Kd	nM	50.0	CHEMBL260	Homo sapiens	Kd	uM	0.05
	2626883	CHEMBL997164	Activity of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 (DE3)	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Kd	nM	74.0	CHEMBL260	Homo sapiens	Kd	uM	0.074
	2626887	CHEMBL997186	Binding affinity to human p38alpha at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	12.0	CHEMBL260	Homo sapiens	Activity	%	12.0
	2626914	CHEMBL997186	Binding affinity to human p38alpha at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	0.0	CHEMBL260	Homo sapiens	Activity	%	0.0
	2635185	CHEMBL1000623	Inhibition of p38alpha at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	<	Residual_activity	%	25.0	CHEMBL260	Homo sapiens	Residual_activity	%	25.0
	2635928	CHEMBL1000623	Inhibition of p38alpha at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL260	Homo sapiens	Residual_activity	%	100.0
	2635996	CHEMBL1000623	Inhibition of p38alpha at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	<	Residual_activity	%	25.0	CHEMBL260	Homo sapiens	Residual_activity	%	25.0
	2638313	CHEMBL1011432	Inhibition of p38alpha	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL466496	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	2638314	CHEMBL1011432	Inhibition of p38alpha	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467079	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	2638315	CHEMBL1011432	Inhibition of p38alpha	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL511410	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	2638316	CHEMBL1011432	Inhibition of p38alpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3F)c2)c(=O)c1=O)c1ccccc1		CHEMBL468125	=	IC50	nM	21660.0	CHEMBL260	Homo sapiens	IC50	uM	21.66
	2638317	CHEMBL1011432	Inhibition of p38alpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccco3)c2)c(=O)c1=O)c1ccccc1		CHEMBL519113	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	2638318	CHEMBL1011432	Inhibition of p38alpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccsc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481248	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	2639165	CHEMBL1025477	Inhibition of p38alpha	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221	>	Ki	nM	4000.0	CHEMBL260	Homo sapiens	Ki	nM	4000.0
	2639166	CHEMBL1025477	Inhibition of p38alpha	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169	>	Ki	nM	4000.0	CHEMBL260	Homo sapiens	Ki	nM	4000.0
	2651580	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	c1ccc(-c2nc(Nc3ccncc3)c3ccccc3n2)cc1		CHEMBL564660	=	IC50	nM	1270.0	CHEMBL260	Homo sapiens	IC50	uM	1.27
	2651581	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Clc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)c1		CHEMBL571451	>	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	2651582	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1csc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL541777	>	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	2651583	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL570533	=	IC50	nM	6720.0	CHEMBL260	Homo sapiens	IC50	uM	6.72
	2651619	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cc(Nc2nc(-c3cccc(C)n3)nc3ccccc23)ccn1		CHEMBL560415	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2651620	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cccc(-c2nc(Nc3ccc4nn[nH]c4c3)c3ccccc3n2)n1		CHEMBL563207	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2651621	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cccc(-c2nc(Nc3ccc4ncsc4c3)c3ccccc3n2)n1		CHEMBL550483	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2651622	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cccc(-c2nc(Nc3ccc4c(cnn4C)c3)c3ccccc3n2)n1		CHEMBL550482	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2651623	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)n1		CHEMBL537968	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2651624	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cccc(-c2nc(Nc3ccncn3)c3ccccc3n2)n1		CHEMBL571452	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2651625	CHEMBL1030215	Inhibition of GST-fused p38alpha	B	Cc1cccc(-c2nc(Nc3cccc(C(N)=O)c3)c3ccccc3n2)n1		CHEMBL563421	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2661426	CHEMBL1058632	Inhibition of P38alpha	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	2661593	CHEMBL1060457	Inhibition of p38alpha after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	2681434	CHEMBL1058804	Inhibition of human recombinant p38alpha assessed as [gamma33P]ATP utilization by microplate scintillation counting	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	2681438	CHEMBL1058804	Inhibition of human recombinant p38alpha assessed as [gamma33P]ATP utilization by microplate scintillation counting	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	7000.0	CHEMBL260	Homo sapiens	IC50	uM	7.0
	2681442	CHEMBL1058804	Inhibition of human recombinant p38alpha assessed as [gamma33P]ATP utilization by microplate scintillation counting	B	OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1		CHEMBL190333	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	2691361	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccccc2)cc[n+]([O-])c1-c1ccccc1		CHEMBL561314	=	IC50	nM	967.0	CHEMBL260	Homo sapiens	IC50	nM	967.0
	2691364	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccccc2)cc[n+]([O-])c1-c1ccccc1Cl		CHEMBL562178	=	IC50	nM	174.0	CHEMBL260	Homo sapiens	IC50	nM	174.0
	2691367	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccccc2)cc[n+]1[O-]		CHEMBL551512	=	IC50	nM	411.0	CHEMBL260	Homo sapiens	IC50	nM	411.0
	2691370	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccccc2)cc[n+]([O-])c1-c1ccc(Cl)cc1		CHEMBL550555	=	IC50	nM	2530.0	CHEMBL260	Homo sapiens	IC50	nM	2530.0
	2691373	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccccc2Cl)cc[n+]([O-])c1-c1ccccc1Cl		CHEMBL569143	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	2691376	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	COc1ccccc1C(=O)c1cc[n+]([O-])c(-c2ccccc2Cl)c1N		CHEMBL563249	=	IC50	nM	149.0	CHEMBL260	Homo sapiens	IC50	nM	149.0
	2691379	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccccc2C(F)(F)F)cc[n+]([O-])c1-c1ccccc1Cl		CHEMBL563749	=	IC50	nM	1655.0	CHEMBL260	Homo sapiens	IC50	nM	1655.0
	2691382	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccc(F)cc2F)cc[n+]([O-])c1-c1ccccc1Cl		CHEMBL559391	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	nM	39.0
	2691385	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccc(F)cc2F)cc[n+]([O-])c1-c1cccc(Cl)c1		CHEMBL539988	=	IC50	nM	228.0	CHEMBL260	Homo sapiens	IC50	nM	228.0
	2691388	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccc(F)cc2F)cc[n+]([O-])c1-c1ccc(Cl)cc1		CHEMBL550561	=	IC50	nM	802.0	CHEMBL260	Homo sapiens	IC50	nM	802.0
	2691391	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	COc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551716	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	2691394	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	2691397	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	CC(C)c1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL549424	=	IC50	nM	208.0	CHEMBL260	Homo sapiens	IC50	nM	208.0
	2691400	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccc(F)cc2F)cc[n+]([O-])c1-c1c(Cl)cccc1Cl		CHEMBL559783	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	2691403	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccc(F)cc2F)cc[n+]([O-])c1-c1c(F)cccc1F		CHEMBL550566	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	2691406	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1cccc(C)c1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL554485	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	2691409	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	COc1cccc(OC)c1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL552113	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	2691412	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	COc1cccc(-c2c(N)c(C(=O)c3ccc(F)cc3F)cc[n+]2[O-])c1OC		CHEMBL557912	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	nM	37.0
	2691415	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccc(F)cc2F)cc[n+]([O-])c1-c1cccc2c1OCO2		CHEMBL552375	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	2691418	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Nc1c(C(=O)c2ccc(F)cc2F)cc[n+]([O-])c1-c1ccc(F)cc1F		CHEMBL549629	=	IC50	nM	126.0	CHEMBL260	Homo sapiens	IC50	nM	126.0
	2691421	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1cc(Cl)ccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL549630	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	2691424	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	COc1cc(F)c(-c2c(N)c(C(=O)c3ccc(F)cc3F)cc[n+]2[O-])c(F)c1		CHEMBL551189	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	2691427	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1cc(O)ccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL552164	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	2691430	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1cc(C(=O)O)ccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL563235	=	IC50	nM	491.0	CHEMBL260	Homo sapiens	IC50	nM	491.0
	2691433	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1cc(OCCN2CCOCC2)ccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL562451	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	2691436	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	Cc1cc(C(=O)NCCN2CCOCC2)ccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL559462	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	2691439	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	COCCOc1ccc(-c2c(N)c(C(=O)c3ccc(F)cc3F)cc[n+]2[O-])c(C)c1		CHEMBL550701	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	2691442	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	COCCNC(=O)c1ccc(-c2c(N)c(C(=O)c3ccc(F)cc3F)cc[n+]2[O-])c(C)c1		CHEMBL564731	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	nM	70.0
	2691832	CHEMBL1063098	Inhibition of human p38alpha by FRET assay	B	O=C1CCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL564912	=	IC50	nM	0.74	CHEMBL260	Homo sapiens	IC50	nM	0.74
	2691871	CHEMBL1054695	Inhibition of human p38alpha assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	0.0	CHEMBL260	Homo sapiens	Activity	%	0.0
	2704995	CHEMBL1054882	Inhibition of p38-alpha at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	5.27	CHEMBL260	Homo sapiens	INH	%	5.27
	2711303	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(NC2CCOCC2)c2cnn(-c3cccc(F)c3)c21		CHEMBL556212	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2711304	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2ccc(F)cc2)c2cnn(-c3c(F)cccc3F)c21		CHEMBL550596	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2711305	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2ccc(F)cc2F)c2cnn(-c3ccc(F)cc3F)c21		CHEMBL562736	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2711306	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccncc1Nc1cc(=O)n(C)c2c1cnn2-c1cc(F)ccc1F		CHEMBL563091	=	IC50	nM	444.0	CHEMBL260	Homo sapiens	IC50	nM	444.0
	2711307	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(N)=O)cc1Nc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL552271	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	2711308	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(N)=O)cc1Nc1cc(=O)n(C)c2c1cnn2-c1cc(F)ccc1F		CHEMBL550798	=	IC50	nM	3.7	CHEMBL260	Homo sapiens	IC50	nM	3.7
	2711309	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	CONC(=O)c1ccc(C)c(Nc2cc(=O)n(C)c3c2cnn3-c2ccc(F)cc2F)c1		CHEMBL563097	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	2711310	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL559401	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	2711311	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC(C)(C)C)cc1Nc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL557515	=	IC50	nM	269.0	CHEMBL260	Homo sapiens	IC50	nM	269.0
	2711312	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)O)cc1Nc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL563326	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2711313	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1cc(=O)n(C)c2c1cnn2-c1cccc(F)c1		CHEMBL559403	=	IC50	nM	3.3	CHEMBL260	Homo sapiens	IC50	nM	3.3
	2711314	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1cc(=O)n(C)c2c1cnn2-c1cccc(F)c1		CHEMBL564121	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	nM	8.5
	2711315	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3)c21		CHEMBL561932	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
	2711316	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	CCn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2C)c2cnn(-c3ccc(F)cc3)c21		CHEMBL559597	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2711317	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	CCn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3)c21		CHEMBL562527	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	2711318	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	CCn1c(=O)cc(Oc2cc(C(=O)NC3CC3)ccc2C)c2cnn(-c3ccc(F)cc3)c21		CHEMBL562528	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	2711319	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3F)c21		CHEMBL558448	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	2711320	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	CCn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3F)c21		CHEMBL550519	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	2711321	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2F)c2cnn(-c3ccc(F)cc3F)c21		CHEMBL559935	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	2711322	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL563284	=	IC50	nM	7.8	CHEMBL260	Homo sapiens	IC50	nM	7.8
	2711323	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1cc(=O)n(C)c2c1cnn2-c1cc(F)ccc1F		CHEMBL563941	=	IC50	nM	2.9	CHEMBL260	Homo sapiens	IC50	nM	2.9
	2711324	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3cc(F)ccc3F)c21		CHEMBL560390	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	2711325	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1cc(=O)n(C)c2c1cnn2-c1cc(F)ccc1F		CHEMBL561468	=	IC50	nM	6.1	CHEMBL260	Homo sapiens	IC50	nM	6.1
	2711326	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Oc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3cc(F)ccc3F)c21		CHEMBL558711	=	IC50	nM	3.3	CHEMBL260	Homo sapiens	IC50	nM	3.3
	2711327	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1cc(=O)n(C)c2c1cnn2-c1c(F)cccc1F		CHEMBL558912	=	IC50	nM	1.9	CHEMBL260	Homo sapiens	IC50	nM	1.9
	2711328	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3c(F)cccc3F)c21		CHEMBL564054	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	2711329	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2F)c2cnn(-c3c(F)cccc3F)c21		CHEMBL559242	=	IC50	nM	1.9	CHEMBL260	Homo sapiens	IC50	nM	1.9
	2711330	CHEMBL1053415	Inhibition of human recombinant p38alpha assessed as phosphorylation of ATF2 by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1cc(=O)n(C)c2c1cnn2-c1c(F)cccc1F		CHEMBL560730	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
Active	2719546	CHEMBL1059996	Inhibition of p38alpha at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	2721717	CHEMBL1055121	Inhibition of SAPK2a at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	2721718	CHEMBL1055122	Inhibition of SAPK2a T106M mutant at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	2722213	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	O=C1/C(=N\O)c2c(CCc3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2		CHEMBL559885	=	Ki	nM	30.0	CHEMBL260	Homo sapiens	Ki	uM	0.03
	2722221	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	O=C1/C(=N\O)c2c(/C=C/c3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2		CHEMBL561540	=	Ki	nM	230.0	CHEMBL260	Homo sapiens	Ki	uM	0.23
	2722246	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	O=C1/C(=N\O)c2c(-c3ccc(F)cc3)cccc2N1Cc1cc(F)cc2c1OCOC2		CHEMBL564447	=	Ki	nM	3400.0	CHEMBL260	Homo sapiens	Ki	uM	3.4
	2722254	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	O=C1/C(=N\O)c2c(-c3cccc(F)c3)cccc2N1Cc1cc(F)cc2c1OCOC2		CHEMBL557003	=	Ki	nM	7400.0	CHEMBL260	Homo sapiens	Ki	uM	7.4
	2722255	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	C=Cc1cccc2c1/C(=N/O)C(=O)N2Cc1cc(F)cc2c1OCOC2		CHEMBL564389	=	Ki	nM	8000.0	CHEMBL260	Homo sapiens	Ki	uM	8.0
	2722259	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	O=C1/C(=N\O)c2c(-c3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2		CHEMBL549385	=	Ki	nM	9500.0	CHEMBL260	Homo sapiens	Ki	uM	9.5
	2722264	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	Cc1ccc2c(c1)N(Cc1cc(F)cc3c1OCOC3)C(=O)/C2=N\O		CHEMBL551140	>	Ki	nM	20000.0	CHEMBL260	Homo sapiens	Ki	uM	20.0
	2722283	CHEMBL1063580	Inhibition of p38alpha by spectrophotometric coupled enzyme assay	B	O=C1/C(=N\O)c2c(Br)cccc2N1Cc1cc(F)cc2c1OCOC2		CHEMBL563057	>	Ki	nM	10000.0	CHEMBL260	Homo sapiens	Ki	uM	10.0
	2892468	CHEMBL1051357	Selectivity for p38-alpha as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Selectivity		0.0035	CHEMBL260	Homo sapiens	Selectivity		0.0035
	2892469	CHEMBL1051357	Selectivity for p38-alpha as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Selectivity		0.0173	CHEMBL260	Homo sapiens	Selectivity		0.0173
	2892470	CHEMBL1051357	Selectivity for p38-alpha as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Selectivity		0.0242	CHEMBL260	Homo sapiens	Selectivity		0.0242
	2892471	CHEMBL1051357	Selectivity for p38-alpha as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Selectivity		0.0	CHEMBL260	Homo sapiens	Selectivity		0.0
	2895033	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895034	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895035	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	73.0	CHEMBL260	Homo sapiens	Kd	nM	73.0
	2895036	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895037	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.37	CHEMBL260	Homo sapiens	Kd	nM	0.37
	2895038	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895039	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895040	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895041	CHEMBL1061091	Binding constant for full-length p38-alpha	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895042	CHEMBL1061091	Binding constant for full-length p38-alpha	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895043	CHEMBL1061091	Binding constant for full-length p38-alpha	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895044	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	27.0	CHEMBL260	Homo sapiens	Kd	nM	27.0
	2895045	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895046	CHEMBL1061091	Binding constant for full-length p38-alpha	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895047	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895048	CHEMBL1061091	Binding constant for full-length p38-alpha	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895049	CHEMBL1061091	Binding constant for full-length p38-alpha	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895050	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895051	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895052	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895053	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895054	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895055	CHEMBL1061091	Binding constant for full-length p38-alpha	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895056	CHEMBL1061091	Binding constant for full-length p38-alpha	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895057	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895058	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895059	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895060	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895061	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	9.8	CHEMBL260	Homo sapiens	Kd	nM	9.8
	2895062	CHEMBL1061091	Binding constant for full-length p38-alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	12.0	CHEMBL260	Homo sapiens	Kd	nM	12.0
	2895063	CHEMBL1061091	Binding constant for full-length p38-alpha	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895064	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	370.0	CHEMBL260	Homo sapiens	Kd	nM	370.0
	2895065	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895066	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895067	CHEMBL1061091	Binding constant for full-length p38-alpha	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895068	CHEMBL1061091	Binding constant for full-length p38-alpha	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2895069	CHEMBL1061091	Binding constant for full-length p38-alpha	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	2.8	CHEMBL260	Homo sapiens	Kd	nM	2.8
	2895070	CHEMBL1061091	Binding constant for full-length p38-alpha	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	2897144	CHEMBL1063691	Percent residual p38alpha activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	2897145	CHEMBL1063691	Percent residual p38alpha activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	2897146	CHEMBL1063691	Percent residual p38alpha activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
Antagonist	2897321	CHEMBL1051326	Inhibition of p38-alpha MAPK in the presence of 100uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	3200.0	CHEMBL260	Homo sapiens	IC50	uM	3.2
Antagonist	2897322	CHEMBL1051361	Inhibition of p38-alpha MAPK in the presence of 50uM ATP	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	5800.0	CHEMBL260	Homo sapiens	IC50	uM	5.8
	2903357	CHEMBL1052110	Percentage p38alpha activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	86.0	CHEMBL260	Homo sapiens	Activity	%	86.0
	2903358	CHEMBL1052110	Percentage p38alpha activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	131.0	CHEMBL260	Homo sapiens	Activity	%	131.0
	2903359	CHEMBL1052110	Percentage p38alpha activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	2903360	CHEMBL1060211	Percentage p38alpha activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	88.0	CHEMBL260	Homo sapiens	Activity	%	88.0
	2903361	CHEMBL1060211	Percentage p38alpha activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	87.0	CHEMBL260	Homo sapiens	Activity	%	87.0
	2903362	CHEMBL1060211	Percentage p38alpha activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	2903363	CHEMBL1060211	Percentage p38alpha activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	2903364	CHEMBL1060211	Percentage p38alpha activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	2903365	CHEMBL1060211	Percentage p38alpha activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	2903366	CHEMBL1060211	Percentage p38alpha activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
	2903367	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	86.0	CHEMBL260	Homo sapiens	Activity	%	86.0
	2903368	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	2903369	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	110.0	CHEMBL260	Homo sapiens	Activity	%	110.0
	2903370	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
Antagonist	2903371	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	38.0	CHEMBL260	Homo sapiens	Activity	%	38.0
	2903372	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	2903373	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	2903374	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	63.0	CHEMBL260	Homo sapiens	Activity	%	63.0
	2903375	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	110.0	CHEMBL260	Homo sapiens	Activity	%	110.0
	2903376	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	85.0	CHEMBL260	Homo sapiens	Activity	%	85.0
	2903377	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	72.0	CHEMBL260	Homo sapiens	Activity	%	72.0
	2903378	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	103.0	CHEMBL260	Homo sapiens	Activity	%	103.0
	2903379	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	2903380	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	2903381	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
Antagonist	2903382	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	17.0	CHEMBL260	Homo sapiens	Activity	%	17.0
Antagonist	2903383	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	8.0	CHEMBL260	Homo sapiens	Activity	%	8.0
Antagonist	2903384	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	8.0	CHEMBL260	Homo sapiens	Activity	%	8.0
Antagonist	2903385	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	14.0	CHEMBL260	Homo sapiens	Activity	%	14.0
	2903386	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	94.0	CHEMBL260	Homo sapiens	Activity	%	94.0
	2903387	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	89.0	CHEMBL260	Homo sapiens	Activity	%	89.0
	2903388	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	2903389	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	77.0	CHEMBL260	Homo sapiens	Activity	%	77.0
	2903390	CHEMBL1062824	Percentage p38alpha activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	99.0	CHEMBL260	Homo sapiens	Activity	%	99.0
	2903391	CHEMBL1063766	Percentage p38alpha activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	2903392	CHEMBL1063766	Percentage p38alpha activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	103.0	CHEMBL260	Homo sapiens	Activity	%	103.0
	2903393	CHEMBL1060212	Percentage p38alpha activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	77.0	CHEMBL260	Homo sapiens	Activity	%	77.0
	2903394	CHEMBL1062770	Percentage p38alpha activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	72.0	CHEMBL260	Homo sapiens	Activity	%	72.0
Antagonist	2903395	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	4.0	CHEMBL260	Homo sapiens	Activity	%	4.0
	2903396	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	82.0	CHEMBL260	Homo sapiens	Activity	%	82.0
	2903397	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	2903398	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	107.0	CHEMBL260	Homo sapiens	Activity	%	107.0
	2903399	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	104.0	CHEMBL260	Homo sapiens	Activity	%	104.0
	2903400	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	2903401	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	82.0	CHEMBL260	Homo sapiens	Activity	%	82.0
Antagonist	2903402	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	9.0	CHEMBL260	Homo sapiens	Activity	%	9.0
Antagonist	2903403	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	3.0	CHEMBL260	Homo sapiens	Activity	%	3.0
	2903404	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	117.0	CHEMBL260	Homo sapiens	Activity	%	117.0
	2903405	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
	2903406	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	109.0	CHEMBL260	Homo sapiens	Activity	%	109.0
	2903407	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	94.0	CHEMBL260	Homo sapiens	Activity	%	94.0
	2903408	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	2903409	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	110.0	CHEMBL260	Homo sapiens	Activity	%	110.0
	2903410	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	72.0	CHEMBL260	Homo sapiens	Activity	%	72.0
	2903411	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	2903412	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
	2903413	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	74.0	CHEMBL260	Homo sapiens	Activity	%	74.0
	2903414	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	88.0	CHEMBL260	Homo sapiens	Activity	%	88.0
	2903415	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	77.0	CHEMBL260	Homo sapiens	Activity	%	77.0
	2903416	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	99.0	CHEMBL260	Homo sapiens	Activity	%	99.0
	2903417	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	2903418	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
Antagonist	2903419	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	49.0	CHEMBL260	Homo sapiens	Activity	%	49.0
Antagonist	2903420	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	49.0	CHEMBL260	Homo sapiens	Activity	%	49.0
Antagonist	2903421	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	41.0	CHEMBL260	Homo sapiens	Activity	%	41.0
	2903422	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	75.0	CHEMBL260	Homo sapiens	Activity	%	75.0
	2903423	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	85.0	CHEMBL260	Homo sapiens	Activity	%	85.0
	2903424	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	2903425	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	83.0	CHEMBL260	Homo sapiens	Activity	%	83.0
	2903426	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
Antagonist	2903427	CHEMBL1063767	Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	43.0	CHEMBL260	Homo sapiens	Activity	%	43.0
	2921238	CHEMBL1048300	Inhibition of p38alpha assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	2921931	CHEMBL1047419	Inhibition of p38alpha	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	>	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	2921932	CHEMBL1047419	Inhibition of p38alpha	B	CNc1ncc2cc(-c3c(C)ccc4c(Nc5ccc6c(c5)NC(=O)C6(C)C)nccc34)ccc2n1		CHEMBL576985	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	nM	51.0
	2921933	CHEMBL1047419	Inhibition of p38alpha	B	CNc1ncc2cc(-c3c(C)ccc4c(Nc5cc(C(C)(C)C)nn5C)nccc34)ccc2n1		CHEMBL569882	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	2921934	CHEMBL1047419	Inhibition of p38alpha	B	CNc1ncc2cc(-c3c(C)ccc4c(Nc5ccc(Cl)cc5)nccc34)ccc2n1		CHEMBL576787	>	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	2921935	CHEMBL1047419	Inhibition of p38alpha	B	CNc1cc(-c2cccnc2Nc2c(C)ccc3c(Nc4ccc5sc(C)nc5c4)nccc23)ncn1		CHEMBL570573	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	nM	350.0
	2921936	CHEMBL1047419	Inhibition of p38alpha	B	C#Cc1cccc(Nc2nccc3c(Nc4ncccc4-c4cc(NC)ncn4)c(C)ccc23)c1		CHEMBL571278	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	nM	450.0
	2921937	CHEMBL1047419	Inhibition of p38alpha	B	CNc1cc(-c2cccnc2Nc2c(C)ccc3c(Nc4ccc(C#N)cc4)nccc23)ncn1		CHEMBL570567	>	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	2921938	CHEMBL1047419	Inhibition of p38alpha	B	CNc1cc(-c2cccnc2Nc2c(C)ccc3c(Nc4ccc(Cl)cc4)nccc23)ncn1		CHEMBL565885	>	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	2921939	CHEMBL1047419	Inhibition of p38alpha	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ccncn1		CHEMBL565884	>	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	2921940	CHEMBL1047419	Inhibition of p38alpha	B	Cc1ccc2c(Nc3cccc(C(F)(F)F)c3)nccc2c1Nc1ncccc1-c1ccncn1		CHEMBL571703	>	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	2921941	CHEMBL1047419	Inhibition of p38alpha	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL212964	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
	2921942	CHEMBL1047419	Inhibition of p38alpha	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL385956	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	2924038	CHEMBL1038778	Inhibition of N-terminal FLAG-tagged p38alpha by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2924039	CHEMBL1038778	Inhibition of N-terminal FLAG-tagged p38alpha by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2924685	CHEMBL1047332	Inhibition of p38alpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	115.0	CHEMBL260	Homo sapiens	Activity	%	115.0
	2924686	CHEMBL1047332	Inhibition of p38alpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	108.0	CHEMBL260	Homo sapiens	Activity	%	108.0
	2924687	CHEMBL1047332	Inhibition of p38alpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	108.0	CHEMBL260	Homo sapiens	Activity	%	108.0
	2924688	CHEMBL1047332	Inhibition of p38alpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	2926192	CHEMBL1046785	Inhibition of p38alpha assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	87.0	CHEMBL260	Homo sapiens	Activity	%	87.0
	2926286	CHEMBL1057670	Inhibition of p38alpha assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	2938408	CHEMBL1038683	Inhibition of P38alpha	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	>	Ki	nM	4000.0	CHEMBL260	Homo sapiens	Ki	uM	4.0
Not Active	2938605	CHEMBL1040618	Inhibition of p38alpha at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	2981296	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)Nc1cc(-c2nc3cccnc3nc2-c2ccc(F)cc2)ccn1		CHEMBL576242	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	2981297	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	Cc1cc2nc(-c3ccc(F)cc3)c(-c3ccnc(NC(C)C)c3)nc2cc1C		CHEMBL584280	=	IC50	nM	238.0	CHEMBL260	Homo sapiens	IC50	uM	0.238
	2981298	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CCC(C)Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1		CHEMBL567260	=	IC50	nM	114.0	CHEMBL260	Homo sapiens	IC50	uM	0.114
	2981299	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)Nc1cc(-c2nc3ncccc3nc2-c2ccc(F)cc2)ccn1		CHEMBL567268	=	IC50	nM	333.0	CHEMBL260	Homo sapiens	IC50	uM	0.333
	2981300	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)[C@H](C)Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1		CHEMBL566615	=	IC50	nM	576.0	CHEMBL260	Homo sapiens	IC50	uM	0.576
	2981301	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	O[C@H]1CC[C@H](Nc2cc(-c3nc4ccccc4nc3-c3ccc(F)cc3)ccn2)CC1		CHEMBL566841	=	IC50	nM	211.0	CHEMBL260	Homo sapiens	IC50	uM	0.211
	2981302	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)Nc1cc(-c2nc3cc(Cl)c(Cl)cc3nc2-c2ccc(F)cc2)ccn1		CHEMBL585280	=	IC50	nM	412.0	CHEMBL260	Homo sapiens	IC50	uM	0.412
	2981303	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	C[C@H](Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL566858	=	IC50	nM	431.0	CHEMBL260	Homo sapiens	IC50	uM	0.431
	2981304	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1		CHEMBL565564	=	IC50	nM	81.0	CHEMBL260	Homo sapiens	IC50	uM	0.081
	2981306	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	Cc1cc2nc(-c3ccc(F)cc3)c(-c3ccnc(N[C@H]4CC[C@H](O)CC4)c3)nc2cc1C		CHEMBL585287	=	IC50	nM	259.0	CHEMBL260	Homo sapiens	IC50	uM	0.259
	2981307	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	O[C@H]1CC[C@H](Nc2cc(-c3nc4cc(Cl)c(Cl)cc4nc3-c3ccc(F)cc3)ccn2)CC1		CHEMBL565792	=	IC50	nM	608.0	CHEMBL260	Homo sapiens	IC50	uM	0.608
	2981308	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)C(C)Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1		CHEMBL566405	=	IC50	nM	790.0	CHEMBL260	Homo sapiens	IC50	uM	0.79
	2981309	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	C[C@@H](Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL568110	=	IC50	nM	4790.0	CHEMBL260	Homo sapiens	IC50	uM	4.79
	2981310	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL566214	=	IC50	nM	720.0	CHEMBL260	Homo sapiens	IC50	uM	0.72
	2981311	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	Cc1cc2nc(-c3ccc(F)cc3)c(-c3ccnc(NC(C)C(C)C)c3)nc2cc1C		CHEMBL584057	=	IC50	nM	1380.0	CHEMBL260	Homo sapiens	IC50	uM	1.38
	2981313	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CCC(C)Nc1cc(-c2nc3cc(C)c(C)cc3nc2-c2ccc(F)cc2)ccn1		CHEMBL566205	=	IC50	nM	595.0	CHEMBL260	Homo sapiens	IC50	uM	0.595
	2981314	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	Cc1cc2nc(-c3ccc(F)cc3)c(-c3ccnc(NCc4ccccc4)c3)nc2cc1C		CHEMBL565385	=	IC50	nM	1530.0	CHEMBL260	Homo sapiens	IC50	uM	1.53
	2981315	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	Fc1ccc(-c2nc3ncccc3nc2-c2ccncc2)cc1		CHEMBL566417	=	IC50	nM	3190.0	CHEMBL260	Homo sapiens	IC50	uM	3.19
	2981316	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)[C@@H](C)Nc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1		CHEMBL566408	=	IC50	nM	1590.0	CHEMBL260	Homo sapiens	IC50	uM	1.59
	2981317	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	Fc1ccc(-c2nc3ccccc3nc2-c2ccncc2)cc1		CHEMBL565381	=	IC50	nM	3150.0	CHEMBL260	Homo sapiens	IC50	uM	3.15
	2981318	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	Cc1cc2nc(-c3ccncc3)c(-c3ccc(F)cc3)nc2cc1C		CHEMBL567899	=	IC50	nM	3700.0	CHEMBL260	Homo sapiens	IC50	uM	3.7
	2981319	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	COc1ccc2nc(-c3ccncc3)c(-c3ccc(F)cc3)nc2c1		CHEMBL566640	=	IC50	nM	6140.0	CHEMBL260	Homo sapiens	IC50	uM	6.14
	2981320	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)C(C)Nc1cc(-c2nc3cc(Cl)c(Cl)cc3nc2-c2ccc(F)cc2)ccn1		CHEMBL584277	=	IC50	nM	9460.0	CHEMBL260	Homo sapiens	IC50	uM	9.46
	2981321	CHEMBL1040072	Inhibition of p38alpha-mediated ATF2 phosphorylation in presence of ATP	B	CC(C)CNc1cc(-c2nc3ccccc3nc2-c2ccc(F)cc2)ccn1		CHEMBL566840	=	IC50	nM	642.0	CHEMBL260	Homo sapiens	IC50	uM	0.642
	2981323	CHEMBL1040074	Inhibition of p38alpha-mediated ATF2 phosphorylation at 10 uM in presence of ATP	B	Fc1ccc(-c2nc3cc(Cl)c(Cl)cc3nc2-c2ccncc2)cc1		CHEMBL579218	=	Inhibition	%	39.0	CHEMBL260	Homo sapiens	INH	%	39.0
	2981324	CHEMBL1040074	Inhibition of p38alpha-mediated ATF2 phosphorylation at 10 uM in presence of ATP	B	COc1ccc2nc(-c3ccc(F)cc3)c(-c3ccncc3)nc2c1		CHEMBL568331	=	Inhibition	%	33.0	CHEMBL260	Homo sapiens	INH	%	33.0
	2981325	CHEMBL1040074	Inhibition of p38alpha-mediated ATF2 phosphorylation at 10 uM in presence of ATP	B	Fc1ccc(-c2nc3ccccc3nc2-c2ccnc(NCc3ccccc3)c2)cc1		CHEMBL566401	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	2981326	CHEMBL1040074	Inhibition of p38alpha-mediated ATF2 phosphorylation at 10 uM in presence of ATP	B	Fc1ccc(-c2nc3cc(Cl)c(Cl)cc3nc2-c2ccnc(NCc3ccccc3)c2)cc1		CHEMBL566191	=	Inhibition	%	37.0	CHEMBL260	Homo sapiens	INH	%	37.0
	2981327	CHEMBL1040074	Inhibition of p38alpha-mediated ATF2 phosphorylation at 10 uM in presence of ATP	B	Fc1ccc(-c2nc3cccnc3nc2-c2ccncc2)cc1		CHEMBL577993	=	Inhibition	%	46.0	CHEMBL260	Homo sapiens	INH	%	46.0
	2983218	CHEMBL1046251	Inhibition of p38alpha	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	2983795	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	IC50	nM	16800.0	CHEMBL260	Homo sapiens	IC50	nM	16800.0
	2983796	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	nM	440.0
	2983797	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2983798	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	nM	170.0
	2983799	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL585549	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	nM	220.0
	2983800	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL583263	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	nM	220.0
	2983801	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	2983802	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)c1		CHEMBL568875	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	nM	1300.0
	2983803	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)cc1		CHEMBL568776	=	IC50	nM	680.0	CHEMBL260	Homo sapiens	IC50	nM	680.0
Not Active	2983804	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL260	Homo sapiens	IC50		
	2983805	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	nM	220.0
	2983806	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)cc2)cc1		CHEMBL101035	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	nM	2300.0
	2983807	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc([N+](=O)[O-])cc34)cc2)c1		CHEMBL526930	=	IC50	nM	760.0	CHEMBL260	Homo sapiens	IC50	nM	760.0
	2983808	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	nM	1400.0
	2983809	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2983810	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)cc1		CHEMBL569531	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2983811	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	nM	420.0
	2983812	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)cc1		CHEMBL569943	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	nM	370.0
	2983813	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ccnc4ccc(N)cc34)cc2)c1		CHEMBL570904	=	IC50	nM	470.0	CHEMBL260	Homo sapiens	IC50	nM	470.0
	2983814	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CCC(=O)Nc1ccc2nccc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL568756	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	nM	420.0
	2983815	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccc(N)cc34)c2)cc1		CHEMBL570427	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	nM	310.0
	2983816	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccc([N+](=O)[O-])cc34)c2)cc1		CHEMBL568874	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	nM	95.0
	2983817	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccccc34)c2)cc1		CHEMBL571544	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	nM	230.0
	2983818	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CCC(=O)Nc1ccc2nccc(Nc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c3)c2c1		CHEMBL566100	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	nM	250.0
	2983819	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	2983820	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	IC50	nM	96.0	CHEMBL260	Homo sapiens	IC50	nM	96.0
	2983821	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	nM	75.0
	2983822	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	IC50	nM	820.0	CHEMBL260	Homo sapiens	IC50	nM	820.0
	2983823	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	2983824	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	IC50	nM	21000.0	CHEMBL260	Homo sapiens	IC50	nM	21000.0
	2983825	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2983826	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	nM	2000.0
	2983827	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	nM	90.0
	2983828	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL585549	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	nM	100.0
	2983829	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL583263	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	2983830	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	nM	150.0
	2983831	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)c1		CHEMBL568875	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	nM	1200.0
	2983832	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)cc1		CHEMBL568776	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
Not Active	2983833	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2c(Cl)cc(C(F)(F)F)cc2Cl)n1		CHEMBL584726		IC50			CHEMBL260	Homo sapiens	IC50		
	2983834	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	nM	250.0
	2983835	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)cc2)cc1		CHEMBL101035	=	IC50	nM	5500.0	CHEMBL260	Homo sapiens	IC50	nM	5500.0
	2983836	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc([N+](=O)[O-])cc34)cc2)c1		CHEMBL526930	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	nM	1800.0
	2983837	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	IC50	nM	800.0	CHEMBL260	Homo sapiens	IC50	nM	800.0
	2983838	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CCC(=O)Nc1ccc2ncnc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL510516	=	IC50	nM	6000.0	CHEMBL260	Homo sapiens	IC50	nM	6000.0
	2983839	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)cc1		CHEMBL569531	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	nM	1500.0
	2983840	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	nM	320.0
	2983841	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)cc1		CHEMBL569943	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	nM	460.0
	2983842	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ccnc4ccc(N)cc34)cc2)c1		CHEMBL570904	=	IC50	nM	900.0	CHEMBL260	Homo sapiens	IC50	nM	900.0
	2983843	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CCC(=O)Nc1ccc2nccc(Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(C)c4)cc3)c2c1		CHEMBL568756	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	nM	2400.0
	2983844	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccc(N)cc34)c2)cc1		CHEMBL570427	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	nM	290.0
	2983845	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccc([N+](=O)[O-])cc34)c2)cc1		CHEMBL568874	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	nM	150.0
	2983846	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ccnc4ccccc34)c2)cc1		CHEMBL571544	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	nM	290.0
	2983847	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CCC(=O)Nc1ccc2nccc(Nc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(C)cc4)c3)c2c1		CHEMBL566100	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	nM	140.0
	2983848	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	nM	1100.0
	2983849	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	2983850	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	2983851	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	2983852	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	2800.0	CHEMBL260	Homo sapiens	IC50	nM	2800.0
Not Active	2983853	CHEMBL1050682	Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL260	Homo sapiens	IC50		
	2983875	CHEMBL1050680	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	=	Kd	nM	197.0	CHEMBL260	Homo sapiens	Kd	nM	197.0
	2983876	CHEMBL1050680	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	Kd	nM	55.0	CHEMBL260	Homo sapiens	Kd	nM	55.0
	2983877	CHEMBL1050680	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	Kd	nM	12.0	CHEMBL260	Homo sapiens	Kd	nM	12.0
Not Active	2983878	CHEMBL1050681	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL21(DE3) cells by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2c(Cl)cc(C(F)(F)F)cc2Cl)n1		CHEMBL584726		IC50			CHEMBL260	Homo sapiens	IC50		
	2988719	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	CN1CCN(C(=O)c2ccc(Nc3ncc4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL565366	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	2988720	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NC(=O)CCNC(=O)OC(C)(C)C)cc3)nc21		CHEMBL565609	=	IC50	nM	299.0	CHEMBL260	Homo sapiens	IC50	nM	299.0
	2988721	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NCC(O)CO)cc3)nc21		CHEMBL567068	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	2988722	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NC(=O)CCN)cc3)nc21		CHEMBL566635	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	2988723	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(O)c3)nc21		CHEMBL321193	=	IC50	nM	187.0	CHEMBL260	Homo sapiens	IC50	nM	187.0
	2988724	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21		CHEMBL327127	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	nM	140.0
	2988725	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	CCc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL565372	=	IC50	nM	752.0	CHEMBL260	Homo sapiens	IC50	nM	752.0
	2988726	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(COCC(O)CO)c3)nc21		CHEMBL566834	=	IC50	nM	330.0	CHEMBL260	Homo sapiens	IC50	nM	330.0
	2988727	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(N)c3)nc21		CHEMBL577269	=	IC50	nM	133.0	CHEMBL260	Homo sapiens	IC50	nM	133.0
	2988728	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	CC(=O)Nc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL565801	=	IC50	nM	251.0	CHEMBL260	Homo sapiens	IC50	nM	251.0
	2988729	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(O)cc3)nc21		CHEMBL323405	=	IC50	nM	105.0	CHEMBL260	Homo sapiens	IC50	nM	105.0
	2988730	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(OC4OC(CO)C(O)C(O)C4O)cc3)nc21		CHEMBL585666	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	2988731	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(I)cc3)nc21		CHEMBL570175	=	IC50	nM	224.0	CHEMBL260	Homo sapiens	IC50	nM	224.0
	2988732	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(F)cc3)nc21		CHEMBL574059	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	2988733	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL111339	=	IC50	nM	488.0	CHEMBL260	Homo sapiens	IC50	nM	488.0
	2988734	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CCO)cc3)nc21		CHEMBL576218	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	2988735	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(N)cc3)nc21		CHEMBL566636	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	nM	51.0
	2988736	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	CC(=O)Nc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL566850	=	IC50	nM	108.0	CHEMBL260	Homo sapiens	IC50	nM	108.0
	2988737	CHEMBL1050609	Inhibition of human recombinant P38alpha	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(NC(=O)CCl)cc3)nc21		CHEMBL565587	=	IC50	nM	135.0	CHEMBL260	Homo sapiens	IC50	nM	135.0
	2992182	CHEMBL1044495	Inhibition of p38alpha at 10 uM by FRET assay	B	C#Cc1nc(-c2ccncc2)c(-c2ccc(F)cc2)n1C#Cc1ccccc1		CHEMBL567055	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	2992183	CHEMBL1044495	Inhibition of p38alpha at 10 uM by FRET assay	B	C#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1C#Cc1ccccc1		CHEMBL565387	=	Inhibition	%	28.0	CHEMBL260	Homo sapiens	INH	%	28.0
	2992184	CHEMBL1044495	Inhibition of p38alpha at 10 uM by FRET assay	B	OCC#Cc1nc(-c2ccncc2)c(-c2ccc(F)cc2)n1C#Cc1ccccc1		CHEMBL584925	=	Inhibition	%	63.0	CHEMBL260	Homo sapiens	INH	%	63.0
	2992185	CHEMBL1044495	Inhibition of p38alpha at 10 uM by FRET assay	B	OCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1C#Cc1ccccc1		CHEMBL565398	=	Inhibition	%	83.0	CHEMBL260	Homo sapiens	INH	%	83.0
	2992186	CHEMBL1044495	Inhibition of p38alpha at 10 uM by FRET assay	B	OCCC#Cc1nc(-c2ccncc2)c(-c2ccc(F)cc2)n1C#Cc1ccccc1		CHEMBL565399	=	Inhibition	%	53.0	CHEMBL260	Homo sapiens	INH	%	53.0
	2992187	CHEMBL1044495	Inhibition of p38alpha at 10 uM by FRET assay	B	OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1C#Cc1ccccc1		CHEMBL565367	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	INH	%	75.0
	2992188	CHEMBL1044495	Inhibition of p38alpha at 10 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	2992189	CHEMBL1044493	Inhibition of p38alpha by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	2992193	CHEMBL1044493	Inhibition of p38alpha by FRET assay	B	OCCc1cc(Cl)n2c(-c3ccncc3)c(-c3ccc(F)cc3)nc2c1		CHEMBL584064	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	nM	370.0
	2993570	CHEMBL1040945	Inhibition of human recombinant p38alpha	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	2998984	CHEMBL1048074	Inhibition of p38alpha assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	20.0	CHEMBL260	Homo sapiens	Activity	%	20.0
	2999774	CHEMBL1048074	Inhibition of p38alpha assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	50.0	CHEMBL260	Homo sapiens	Activity	%	50.0
	2999851	CHEMBL1047252	Inhibition of p38alpha assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	3.0	CHEMBL260	Homo sapiens	Activity	%	3.0
	2999927	CHEMBL1047252	Inhibition of p38alpha assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	5.0	CHEMBL260	Homo sapiens	Activity	%	5.0
	2999998	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	2999999	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	3000008	CHEMBL1045456	Inhibition of p38alpha at 10 uM by Cherenkov counting	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Inhibition	%	62.0	CHEMBL260	Homo sapiens	INH	%	62.0
	3000010	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	3000012	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
Not Active	3000014	CHEMBL1045458	Inhibition of GST-fused human full length p38alpha expressed in Escherichia coli at 25 uM	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3000016	CHEMBL1045458	Inhibition of GST-fused human full length p38alpha expressed in Escherichia coli at 25 uM	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	3000019	CHEMBL1045463	Inhibition of GST-fused human p38alpha expressed in Escherichia coli	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	uM	12.0
	3000020	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	3000021	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CCC(C)Nc1cc(-c2c(-c3ccc(F)cc3)noc2C(C)C)ccn1		CHEMBL569551	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	3000022	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCOCC2)c1		CHEMBL569552	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	3000023	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccnc(N[C@H](C)c2ccccc2)c1		CHEMBL571356	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	3000024	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccnc(N[C@@H](C)c2ccccc2)c1		CHEMBL571357	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	3000025	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)noc2C(C)C)ccn1		CHEMBL585533	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	3000026	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1		CHEMBL569151	=	IC50	nM	1560.0	CHEMBL260	Homo sapiens	IC50	uM	1.56
	3000027	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	CC(Oc1ccccc1)C(=O)Nc1cc(-c2c(-c3ccc(F)cc3)noc2C(C)C)ccn1		CHEMBL566058	=	IC50	nM	890.0	CHEMBL260	Homo sapiens	IC50	uM	0.89
	3000028	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3c(-c4ccc(F)cc4)noc3C(C)C)ccn2)c(OC)c1		CHEMBL571142	=	IC50	nM	2520.0	CHEMBL260	Homo sapiens	IC50	uM	2.52
	3000049	CHEMBL1045448	Inhibition of p38alpha by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	uM	0.041
Not Active	3006219	CHEMBL1047294	Inhibition of p38alpha at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	3006220	CHEMBL1047294	Inhibition of p38alpha at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	3006221	CHEMBL1047294	Inhibition of p38alpha at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	3006222	CHEMBL1047294	Inhibition of p38alpha at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL260	Homo sapiens	Activity		
	3052424	CHEMBL1069805	Residual activity of p38alpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	101.0	CHEMBL260	Homo sapiens	Residual activity	%	101.0
	3052676	CHEMBL1041163	Residual activity of p38alpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	148.0	CHEMBL260	Homo sapiens	Residual activity	%	148.0
	3053985	CHEMBL1050316	Residual activity of p38alpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	320.0	CHEMBL260	Homo sapiens	Residual activity	%	320.0
	3054237	CHEMBL1069805	Residual activity of p38alpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL260	Homo sapiens	Residual activity	%	93.0
	3055524	CHEMBL1041163	Residual activity of p38alpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	145.0	CHEMBL260	Homo sapiens	Residual activity	%	145.0
	3056829	CHEMBL1050316	Residual activity of p38alpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	327.0	CHEMBL260	Homo sapiens	Residual activity	%	327.0
	3057081	CHEMBL1069805	Residual activity of p38alpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	100.0	CHEMBL260	Homo sapiens	Residual activity	%	100.0
	3058401	CHEMBL1041163	Residual activity of p38alpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	143.0	CHEMBL260	Homo sapiens	Residual activity	%	143.0
	3059685	CHEMBL1050316	Residual activity of p38alpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	325.0	CHEMBL260	Homo sapiens	Residual activity	%	325.0
	3062490	CHEMBL1037977	Binding affinity to human p38alpha at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	89.0	CHEMBL260	Homo sapiens	Activity	%	89.0
	3063625	CHEMBL1074891	Binding affinity to human p38alpha at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	3063715	CHEMBL1042477	Binding affinity to human p38alpha at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	3066870	CHEMBL1066076	Inhibition of p38alpha at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3066960	CHEMBL1066076	Inhibition of p38alpha at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	3082894	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL593422	=	IC50	nM	79.3	CHEMBL260	Homo sapiens	IC50	nM	79.3
	3082895	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)(C)c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL609275	=	IC50	nM	4.8	CHEMBL260	Homo sapiens	IC50	nM	4.8
	3082896	CHEMBL1071905	Inhibition of p38 alpha	B	CC1(c2nnc3ccc(Sc4ccc(F)cc4F)cn23)CC1.Cl		CHEMBL593423	=	IC50	nM	24.9	CHEMBL260	Homo sapiens	IC50	nM	24.9
	3082897	CHEMBL1071905	Inhibition of p38 alpha	B	C=CCC(C)(C)c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL611945	=	IC50	nM	16.3	CHEMBL260	Homo sapiens	IC50	nM	16.3
	3082898	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)(CC(O)CO)c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL604581	=	IC50	nM	1740.0	CHEMBL260	Homo sapiens	IC50	nM	1740.0
	3082899	CHEMBL1071905	Inhibition of p38 alpha	B	Cl.Fc1ccc(Sc2ccc3nnc(-c4ccc(F)cc4F)n3c2)c(F)c1		CHEMBL592978	=	IC50	nM	7.2	CHEMBL260	Homo sapiens	IC50	nM	7.2
	3082900	CHEMBL1071905	Inhibition of p38 alpha	B	Cc1cc(Br)ccc1-c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL595106	=	IC50	nM	141.0	CHEMBL260	Homo sapiens	IC50	nM	141.0
	3082901	CHEMBL1071905	Inhibition of p38 alpha	B	C=Cc1ccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)c(C)c1.Cl		CHEMBL595557	=	IC50	nM	106.0	CHEMBL260	Homo sapiens	IC50	nM	106.0
	3082902	CHEMBL1071905	Inhibition of p38 alpha	B	Cc1cc(C(O)CO)ccc1-c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL594601	=	IC50	nM	28.3	CHEMBL260	Homo sapiens	IC50	nM	28.3
	3082903	CHEMBL1071905	Inhibition of p38 alpha	B	Cc1cc(CNCCO)ccc1-c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL594168	=	IC50	nM	33.3	CHEMBL260	Homo sapiens	IC50	nM	33.3
	3082904	CHEMBL1071905	Inhibition of p38 alpha	B	COC(=O)c1cccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)c1.Cl		CHEMBL593218	=	IC50	nM	181.0	CHEMBL260	Homo sapiens	IC50	nM	181.0
	3082905	CHEMBL1071905	Inhibition of p38 alpha	B	Cl.O=C(O)c1cccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)c1		CHEMBL605924	=	IC50	nM	7420.0	CHEMBL260	Homo sapiens	IC50	nM	7420.0
	3082906	CHEMBL1071905	Inhibition of p38 alpha	B	Cl.NC(=O)c1cccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)c1		CHEMBL607143	=	IC50	nM	241.0	CHEMBL260	Homo sapiens	IC50	nM	241.0
	3082907	CHEMBL1071905	Inhibition of p38 alpha	B	COC(=O)c1ccc(C)c(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)c1.Cl		CHEMBL595338	=	IC50	nM	7.8	CHEMBL260	Homo sapiens	IC50	nM	7.8
	3082908	CHEMBL1071905	Inhibition of p38 alpha	B	Cc1ccc(C(=O)O)cc1-c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL592990	=	IC50	nM	2920.0	CHEMBL260	Homo sapiens	IC50	nM	2920.0
	3082909	CHEMBL1071905	Inhibition of p38 alpha	B	Cc1ccc(C(N)=O)cc1-c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL606158	=	IC50	nM	60.8	CHEMBL260	Homo sapiens	IC50	nM	60.8
	3082910	CHEMBL1071905	Inhibition of p38 alpha	B	CNC(=O)c1ccc(C)c(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)c1.Cl		CHEMBL593459	=	IC50	nM	39.9	CHEMBL260	Homo sapiens	IC50	nM	39.9
	3082911	CHEMBL1071905	Inhibition of p38 alpha	B	Cc1ccc(C(=O)NCC(N)=O)cc1-c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL603640	=	IC50	nM	46.5	CHEMBL260	Homo sapiens	IC50	nM	46.5
	3082912	CHEMBL1071905	Inhibition of p38 alpha	B	Cc1ccc(C(=O)NCCO)cc1-c1nnc2ccc(Sc3ccc(F)cc3F)cn12.Cl		CHEMBL607089	=	IC50	nM	20.5	CHEMBL260	Homo sapiens	IC50	nM	20.5
	3082913	CHEMBL1071905	Inhibition of p38 alpha	B	COC(=O)c1ccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)cc1.Cl		CHEMBL594387	=	IC50	nM	322.0	CHEMBL260	Homo sapiens	IC50	nM	322.0
	3082914	CHEMBL1071905	Inhibition of p38 alpha	B	Cl.O=C(O)c1ccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)cc1		CHEMBL593460	=	IC50	nM	1170.0	CHEMBL260	Homo sapiens	IC50	nM	1170.0
	3082915	CHEMBL1071905	Inhibition of p38 alpha	B	Cl.NC(=O)c1ccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)cc1		CHEMBL593014	=	IC50	nM	201.0	CHEMBL260	Homo sapiens	IC50	nM	201.0
	3082916	CHEMBL1071905	Inhibition of p38 alpha	B	CNC(=O)c1ccc(-c2nnc3ccc(Sc4ccc(F)cc4F)cn23)cc1.Cl		CHEMBL593219	=	IC50	nM	293.0	CHEMBL260	Homo sapiens	IC50	nM	293.0
	3082917	CHEMBL1071905	Inhibition of p38 alpha	B	Cl.Fc1ccc(Sc2ccc3nnc(C4CCNCC4)n3c2)c(F)c1		CHEMBL594602	=	IC50	nM	3770.0	CHEMBL260	Homo sapiens	IC50	nM	3770.0
	3082918	CHEMBL1071905	Inhibition of p38 alpha	B	CC(=O)OCC(=O)N1CCC(c2nnc3ccc(Sc4ccc(F)cc4F)cn23)CC1.Cl		CHEMBL604053	=	IC50	nM	367.0	CHEMBL260	Homo sapiens	IC50	nM	367.0
	3082919	CHEMBL1071905	Inhibition of p38 alpha	B	Cl.O=C(CO)N1CCC(c2nnc3ccc(Sc4ccc(F)cc4F)cn23)CC1		CHEMBL596469	=	IC50	nM	212.0	CHEMBL260	Homo sapiens	IC50	nM	212.0
	3082920	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(Sc3ccc(Br)cc3C(F)(F)F)cn12.Cl		CHEMBL595339	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	3082921	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(Sc3ccc(F)cc3C(F)(F)F)cn12.Cl		CHEMBL594167	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	3082922	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(Sc3ccc(Cl)cc3Cl)cn12.Cl		CHEMBL608376	=	IC50	nM	8240.0	CHEMBL260	Homo sapiens	IC50	nM	8240.0
	3082923	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(Sc3ccc(F)cc3F)c(Cl)n12		CHEMBL594839	=	IC50	nM	12.3	CHEMBL260	Homo sapiens	IC50	nM	12.3
	3082924	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2cc(Cl)c(Sc3ccc(F)cc3F)cn12		CHEMBL592979	=	IC50	nM	889.0	CHEMBL260	Homo sapiens	IC50	nM	889.0
	3082925	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2cc(Cl)c(Sc3ccc(F)cc3F)c(Cl)n12		CHEMBL608091	=	IC50	nM	3380.0	CHEMBL260	Homo sapiens	IC50	nM	3380.0
	3082926	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2cc(Cl)c(Sc3ccc(F)cc3F)c(Br)n12		CHEMBL609596	=	IC50	nM	6080.0	CHEMBL260	Homo sapiens	IC50	nM	6080.0
	3082927	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(C(=O)c3ccc(F)cc3F)cn12		CHEMBL595558	=	IC50	nM	1050.0	CHEMBL260	Homo sapiens	IC50	nM	1050.0
	3082928	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc([S+]([O-])c3ccc(F)cc3F)cn12		CHEMBL608674	=	IC50	nM	9680.0	CHEMBL260	Homo sapiens	IC50	nM	9680.0
	3082929	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(S(=O)(=O)c3ccc(F)cc3F)cn12		CHEMBL611648	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	3082930	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(C(=O)Nc3cc(F)cc(F)c3)cn12		CHEMBL596272	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	3082931	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)c1nnc2ccc(C(=O)Cc3cc(F)cc(F)c3)cn12		CHEMBL596492	=	IC50	nM	7370.0	CHEMBL260	Homo sapiens	IC50	nM	7370.0
	3082932	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)C1=NNC2C=CC(Cc3ccc(F)cc3F)=CN12		CHEMBL607557	=	IC50	nM	26.1	CHEMBL260	Homo sapiens	IC50	nM	26.1
	3082933	CHEMBL1071905	Inhibition of p38 alpha	B	CC(C)C1=NNC2C=CC(CCc3ccc(F)cc3F)=CN12		CHEMBL610487	=	IC50	nM	85.0	CHEMBL260	Homo sapiens	IC50	nM	85.0
	3089488	CHEMBL1067362	Inhibition of p38alpha	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	32000.0	CHEMBL260	Homo sapiens	IC50	nM	32000.0
	3094746	CHEMBL1069051	Inhibition of p38alpha at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	-3.0	CHEMBL260	Homo sapiens	INH	%	-3.0
	3094765	CHEMBL1069051	Inhibition of p38alpha at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	3094772	CHEMBL1069051	Inhibition of p38alpha at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	3094785	CHEMBL1069051	Inhibition of p38alpha at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	3098289	CHEMBL1067804	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	3098305	CHEMBL1067804	Inhibition of p38alpha	B	CC(c1ccc(F)cc1)N1C[C@@H](C)N(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)C[C@@H]1C		CHEMBL605134	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	3098306	CHEMBL1067804	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1C(c1ccc(F)cc1)c1ccc(F)cc1		CHEMBL600470	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	3098307	CHEMBL1067804	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1C(c1ccccc1)c1ccccc1		CHEMBL591217	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	3098308	CHEMBL1067804	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1C1CCc2ccccc21		CHEMBL600583	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	3098309	CHEMBL1067804	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1C(C#N)c1ccc(F)cc1		CHEMBL601452	=	IC50	nM	183.0	CHEMBL260	Homo sapiens	IC50	uM	0.183
	3098310	CHEMBL1067804	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1C(C)(C#N)c1ccc(F)cc1		CHEMBL601666	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	uM	0.047
	3098311	CHEMBL1067804	Inhibition of p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1c1n[nH]c2c(Cl)cccc12		CHEMBL605790	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	uM	0.048
	3099469	CHEMBL1070204	Inhibition of p38alpha MAPK	B	CCCNc1nnc(Sc2ncc([N+](=O)[O-])s2)s1		CHEMBL609039	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3099470	CHEMBL1070204	Inhibition of p38alpha MAPK	B	COCCNc1nnc(Sc2ncc([N+](=O)[O-])s2)s1		CHEMBL611079	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3099471	CHEMBL1070204	Inhibition of p38alpha MAPK	B	COc1ccc(CCNc2nnc(Sc3ncc([N+](=O)[O-])s3)s2)cc1OC		CHEMBL599111	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3099472	CHEMBL1070204	Inhibition of p38alpha MAPK	B	CCC(C)Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1		CHEMBL599518	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3102036	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	CN(C)C(=O)C(=O)c1c[nH]c2cc(Cl)c(C(=O)N3CCC(Cc4ccc(F)cc4)CC3)cc12		CHEMBL599799	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	3102037	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	COc1cc2[nH]cc(C(=O)C(=O)N(C)C)c2cc1C(=O)N1CCC(Cc2ccc(F)cc2)CC1		CHEMBL605978	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	3102038	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	COc1ccc(C(=O)C(=O)N(C)C)cc1C(=O)N1CCC(Cc2ccc(F)cc2)CC1		CHEMBL592777	=	IC50	nM	945.0	CHEMBL260	Homo sapiens	IC50	uM	0.945
	3102039	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	CN(C)C(=O)C(=O)c1ccc2c(c1)C=C(C(=O)N1CCC(Cc3ccc(F)cc3)CC1)C(C(F)(F)F)O2		CHEMBL590390	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3102040	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	CN(C)C(=O)C(=O)c1nn(C)c2cc(Cl)c(C(=O)N3CCC(Cc4ccc(F)cc4)CC3)cc12		CHEMBL601063	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	3102041	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	Cc1[nH]c2ccc(C(=O)C(=O)N(C)C)cc2c1C(=O)N1CCC(Cc2ccc(F)cc2)CC1		CHEMBL603682	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	3102042	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	COc1cc2occ(C(=O)C(=O)N(C)C)c2cc1C(=O)N1CCC(Cc2ccc(F)cc2)CC1		CHEMBL597428	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	3102043	CHEMBL1069380	Inhibition of human p38alpha after 60 mins	B	COc1nc2[nH]cc(C(=O)C(=O)N(C)C)c2cc1C(=O)N1CCC(Cc2ccc(F)cc2)CC1		CHEMBL597429	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
Not Active	3110706	CHEMBL1065863	Inhibition of p38alpha MAPK at 10 uM	B	O=[N+]([O-])c1ccc2c(c1)S(=O)(=O)N=S2c1ccc(Br)cc1		CHEMBL605161		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	3110831	CHEMBL1071100	Inhibition of p38alpha	B	Nc1nn(-c2cccc(-c3ccc4cc[nH]c4c3)c2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL597839	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3117838	CHEMBL1067575	Inhibition of human MAPK p38alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	3117839	CHEMBL1067575	Inhibition of human MAPK p38alpha	B	Fc1ccc(-c2ncn(CC3CC3)c2-c2ccncc2)cc1		CHEMBL96741	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	3117840	CHEMBL1067575	Inhibition of human MAPK p38alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	3117841	CHEMBL1067575	Inhibition of human MAPK p38alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CC2CC2)n1		CHEMBL590753	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	3117842	CHEMBL1067575	Inhibition of human MAPK p38alpha	B	O=C1CCc2ccccc2N1		CHEMBL388582	=	IC50	nM	0.74	CHEMBL260	Homo sapiens	IC50	nM	0.74
	3117843	CHEMBL1067575	Inhibition of human MAPK p38alpha	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
	3117846	CHEMBL1067575	Inhibition of human MAPK p38alpha	B	COc1ccc(/C(C)=N/OC(N)=O)cc1OC1CCCC1		CHEMBL590754	=	IC50	nM	960.0	CHEMBL260	Homo sapiens	IC50	nM	960.0
	3123990	CHEMBL1067549	Inhibition of p38alpha MAPK	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL597592	=	IC50	nM	152.0	CHEMBL260	Homo sapiens	IC50	uM	0.152
	3123991	CHEMBL1067549	Inhibition of p38alpha MAPK	B	O=C(Nc1cc(Oc2cccc3[nH]c(=O)[nH]c23)c(F)c(F)c1F)c1cccc(OC(F)(F)F)c1		CHEMBL602123	=	IC50	nM	608.0	CHEMBL260	Homo sapiens	IC50	uM	0.608
	3123992	CHEMBL1067549	Inhibition of p38alpha MAPK	B	CC(C)(C)c1cc(NC(=O)c2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL598626	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	3127411	CHEMBL1064451	Inhibition of p38alpha	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3127445	CHEMBL1064451	Inhibition of p38alpha	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3130790	CHEMBL1065103	Inhibition of p38a at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3132186	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	84.2	CHEMBL260	Homo sapiens	IC50	nM	84.2
	3132187	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(NC(=O)c2nc(C(F)(F)F)[nH]c2-c2ccccc2)cc1Nc1ccc2ncn(C)c(=O)c2c1		CHEMBL589415	=	IC50	nM	405.2	CHEMBL260	Homo sapiens	IC50	nM	405.2
	3132188	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(-c2[nH]c(C(F)(F)F)nc2C(=O)Nc2ccc(C)c(Nc3ccc4ncn(C)c(=O)c4c3)c2)cc1		CHEMBL605198	=	IC50	nM	1648.0	CHEMBL260	Homo sapiens	IC50	nM	1648.0
	3132189	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(NC(=O)c2nc(C(F)(F)F)[nH]c2-c2ccc(F)cc2)cc1Nc1ccc2ncn(C)c(=O)c2c1		CHEMBL590871	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	3132190	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(NC(=O)c2nc(C(F)(F)F)[nH]c2-c2ccc(F)c(Cl)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1		CHEMBL589602	=	IC50	nM	48.8	CHEMBL260	Homo sapiens	IC50	nM	48.8
	3132191	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1cc(-c2[nH]c(C(F)(F)F)nc2C(=O)Nc2ccc(C)c(Nc3ccc4ncn(C)c(=O)c4c3)c2)ccc1F		CHEMBL589603	=	IC50	nM	60.1	CHEMBL260	Homo sapiens	IC50	nM	60.1
	3132192	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(-c2[nH]c(C(F)(F)F)nc2C(=O)Nc2ccc(C)c(Nc3ccc4ncn(C)c(=O)c4c3)c2)cc1F		CHEMBL600047	=	IC50	nM	100.2	CHEMBL260	Homo sapiens	IC50	nM	100.2
	3132193	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	COc1cc(-c2[nH]c(C(F)(F)F)nc2C(=O)Nc2ccc(C)c(Nc3ccc4ncn(C)c(=O)c4c3)c2)cc(OC)c1OC		CHEMBL591673	=	IC50	nM	94.4	CHEMBL260	Homo sapiens	IC50	nM	94.4
	3132194	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(NC(=O)c2nc(C(F)(F)F)[nH]c2-c2cccc(C(F)(F)F)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1		CHEMBL591526	=	IC50	nM	105.2	CHEMBL260	Homo sapiens	IC50	nM	105.2
	3132195	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(NC(=O)c2nc(C(F)(F)F)[nH]c2-c2ccccc2C(F)(F)F)cc1Nc1ccc2ncn(C)c(=O)c2c1		CHEMBL591661	=	IC50	nM	468.4	CHEMBL260	Homo sapiens	IC50	nM	468.4
	3132196	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(NC(=O)c2nc(C(F)(F)F)[nH]c2-c2ccc(F)c(F)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1		CHEMBL591275	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	3132197	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(-c2[nH]c(C(C)(C)C)nc2C(=O)Nc2ccc(C)c(Nc3ccc4ncn(C)c(=O)c4c3)c2)cc1		CHEMBL591276	=	IC50	nM	96.3	CHEMBL260	Homo sapiens	IC50	nM	96.3
	3132198	CHEMBL1073514	Inhibition of human recombinant full length p38alpha assessed as MAPKAPK2 phosphorylation by [32P]ATP SDS-PAGE gel kinase assay	B	Cc1ccc(NC(=O)c2nc(-c3ccccc3)[nH]c2-c2ccccc2)cc1Nc1ccc2ncn(C)c(=O)c2c1		CHEMBL605404	=	IC50	nM	121.7	CHEMBL260	Homo sapiens	IC50	nM	121.7
	3132212	CHEMBL1073513	Inhibition of p38alpha	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	3191064	CHEMBL1102126	Inhibition of p38alpha at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	=	Inhibition	%	89.0	CHEMBL260	Homo sapiens	INH	%	89.0
	3201851	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cn1c(=O)cc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3F)c21		CHEMBL558448	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	3201852	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2ccccc2Cl)c1		CHEMBL1076741	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	3201855	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1nncc2c1cnn2-c1cccc(F)c1		CHEMBL1087386	=	IC50	nM	4.6	CHEMBL260	Homo sapiens	IC50	nM	4.6
	3201858	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2cccc(F)c2)c1		CHEMBL1088440	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	3201861	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2ccc(F)cc2)c1		CHEMBL1088441	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	nM	8.5
	3201864	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	CCCNC(=O)c1ccc(C)c(Nc2nncc3c2cnn3-c2ccc(F)cc2F)c1		CHEMBL1088442	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	3201867	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1nncc2c1cnn2-c1ccc(F)cc1F		CHEMBL1088443	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	3201870	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(F)c(Nc2nncc3c2cnn3-c2ccc(F)cc2F)c1		CHEMBL1088031	=	IC50	nM	43.0	CHEMBL260	Homo sapiens	IC50	nM	43.0
	3201873	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2ccc(F)cc2F)c1		CHEMBL1088032	=	IC50	nM	3.3	CHEMBL260	Homo sapiens	IC50	nM	3.3
	3201876	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1nncc2c1cnn2-c1ccc(F)cc1F		CHEMBL1088166	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	3201879	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(Cl)c(Oc2nncc3c2cnn3-c2ccc(F)cc2F)c1		CHEMBL1088167	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	3201882	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2cc(F)ccc2F)c1		CHEMBL1081990	=	IC50	nM	2.1	CHEMBL260	Homo sapiens	IC50	nM	2.1
	3201885	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1nncc2c1cnn2-c1c(F)cccc1F		CHEMBL1081991	=	IC50	nM	1.7	CHEMBL260	Homo sapiens	IC50	nM	1.7
	3201888	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2c(F)cccc2F)c1		CHEMBL1082158	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	3201891	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1nncc2c1cnn2-c1c(F)cccc1F		CHEMBL1082159	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	3201894	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1nnc(C)c2c1cnn2-c1ccc(F)cc1		CHEMBL1082182	=	IC50	nM	4.1	CHEMBL260	Homo sapiens	IC50	nM	4.1
	3201897	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1nnc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3)c12		CHEMBL1076560	=	IC50	nM	2.3	CHEMBL260	Homo sapiens	IC50	nM	2.3
	3201900	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1nnc(C)c2c1cnn2-c1ccc(F)cc1		CHEMBL1082183	=	IC50	nM	7.7	CHEMBL260	Homo sapiens	IC50	nM	7.7
	3201903	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1nnc(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL1080673	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	3201906	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1Nc1nnc(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL1082205	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	3201909	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1nnc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3ccc(F)cc3F)c12		CHEMBL1082206	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	3201912	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1Oc1nnc(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL1081037	=	IC50	nM	6.3	CHEMBL260	Homo sapiens	IC50	nM	6.3
	3201915	CHEMBL1102672	Inhibition of human recombinant p38alpha assessed as phosphorylated ATF2 after 1 hr by HTRF assay	B	Cc1nnc(Nc2cc(C(=O)NC3CC3)ccc2Cl)c2cnn(-c3c(F)cccc3F)c12		CHEMBL1081208	=	IC50	nM	1.7	CHEMBL260	Homo sapiens	IC50	nM	1.7
	3201941	CHEMBL1099700	Inhibition of p38alpha	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2c(F)cccc2F)c1		CHEMBL1082158	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	3213989	CHEMBL1116737	Inhibition of P38alpha at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	87.0	CHEMBL260	Homo sapiens	INH	%	87.0
	3219872	CHEMBL1113987	Inhibition of P38alpha	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	nM	50000.0
	3219873	CHEMBL1113987	Inhibition of P38alpha	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	nM	50000.0
	3220043	CHEMBL1116671	Inhibition of p38alpha	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	uM	0.069
	3223524	CHEMBL1101788	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccccc2)ccn1Cc1ccccc1		CHEMBL1095447	=	IC50	nM	680.0	CHEMBL260	Homo sapiens	IC50	uM	0.68
	3223526	CHEMBL1101788	Inhibition of p38alpha	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	3223528	CHEMBL1101788	Inhibition of p38alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	3223530	CHEMBL1101788	Inhibition of p38alpha	B	O=c1c(Cl)c(OCc2ccccc2)ccn1Cc1ccccc1		CHEMBL1078021	=	IC50	nM	900.0	CHEMBL260	Homo sapiens	IC50	uM	0.9
	3223532	CHEMBL1101788	Inhibition of p38alpha	B	O=c1c(I)c(OCc2ccccc2)ccn1Cc1ccccc1		CHEMBL1078022	=	IC50	nM	3100.0	CHEMBL260	Homo sapiens	IC50	uM	3.1
	3223534	CHEMBL1101788	Inhibition of p38alpha	B	O=c1cc(OCc2ccccc2)ccn1Cc1ccccc1		CHEMBL265448	=	IC50	nM	43000.0	CHEMBL260	Homo sapiens	IC50	uM	43.0
	3223536	CHEMBL1101788	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(Cl)cc2)ccn1Cc1ccc(F)cc1		CHEMBL1078023	=	IC50	nM	1900.0	CHEMBL260	Homo sapiens	IC50	uM	1.9
	3223538	CHEMBL1101788	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)cc2)ccn1Cc1cccc(F)c1		CHEMBL1078024	=	IC50	nM	620.0	CHEMBL260	Homo sapiens	IC50	uM	0.62
	3223540	CHEMBL1101788	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)cc2F)ccn1Cc1cccc(F)c1		CHEMBL1078301	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	3223542	CHEMBL1101788	Inhibition of p38alpha	B	C=Cc1c(OCc2ccccc2)ccn(Cc2ccccc2)c1=O		CHEMBL1077396	=	IC50	nM	72000.0	CHEMBL260	Homo sapiens	IC50	uM	72.0
	3223544	CHEMBL1101788	Inhibition of p38alpha	B	CCc1c(OCc2ccccc2)ccn(Cc2ccccc2)c1=O		CHEMBL1078302	=	IC50	nM	6100.0	CHEMBL260	Homo sapiens	IC50	uM	6.1
	3223546	CHEMBL1101788	Inhibition of p38alpha	B	Cc1c(OCc2ccccc2)ccn(Cc2ccccc2)c1=O		CHEMBL1078303	=	IC50	nM	5300.0	CHEMBL260	Homo sapiens	IC50	uM	5.3
	3223548	CHEMBL1101788	Inhibition of p38alpha	B	O=c1c(C(F)(F)F)c(OCc2ccccc2)ccn1Cc1cccc(F)c1		CHEMBL1078404	=	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3223550	CHEMBL1101788	Inhibition of p38alpha	B	N#Cc1c(OCc2ccc(F)cc2F)ccn(Cc2cccc(F)c2)c1=O		CHEMBL1078583	=	IC50	nM	9900.0	CHEMBL260	Homo sapiens	IC50	uM	9.9
	3223552	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccccc1C#N		CHEMBL1078584	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	3223554	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1cccc(C#N)c1		CHEMBL1078585	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	3223556	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(C#N)cc1		CHEMBL1078678	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	3223558	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccccc1C(N)=O		CHEMBL1077406	=	IC50	nM	2670.0	CHEMBL260	Homo sapiens	IC50	uM	2.67
	3223560	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1cccc(C(N)=O)c1		CHEMBL1077414	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	uM	0.27
	3223562	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(C(N)=O)cc1		CHEMBL1078859	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	3223564	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1cccc(C(=O)N(C)C)c1		CHEMBL1078961	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	3223566	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(C(=O)N(C)C)cc1		CHEMBL1078804	=	IC50	nM	66.0	CHEMBL260	Homo sapiens	IC50	uM	0.066
	3223568	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Cl)c(=O)n1Cc1ccc(C(=O)N(C)C)cc1		CHEMBL1079110	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	uM	0.079
	3223570	CHEMBL1101788	Inhibition of p38alpha	B	C/N=C/C(=O)c1cccc(Cn2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1079184	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	3223572	CHEMBL1101788	Inhibition of p38alpha	B	C/N=C/C(=O)c1ccc(Cn2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)cc1		CHEMBL1080218	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	3223574	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2)c(Br)c(=O)n1-c1ccccn1		CHEMBL1080219	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	3223576	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2)c(Br)c(=O)n1-c1cccnc1		CHEMBL1080220	=	IC50	nM	380.0	CHEMBL260	Homo sapiens	IC50	uM	0.38
	3223578	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2)c(Br)c(=O)n1-c1ccncc1		CHEMBL1081674	=	IC50	nM	390.0	CHEMBL260	Homo sapiens	IC50	uM	0.39
	3223580	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccnc1		CHEMBL1081675	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	3223582	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1ccncc1		CHEMBL1081676	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	3223584	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cnc(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)cn1		CHEMBL1081677	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	3223586	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	3223588	CHEMBL1101788	Inhibition of p38alpha	B	Cc1ncc(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)cn1		CHEMBL1080771	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	3223590	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccccc1CN		CHEMBL1079308	=	IC50	nM	1260.0	CHEMBL260	Homo sapiens	IC50	uM	1.26
	3223592	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1cccc(CN)c1		CHEMBL1079309	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	uM	0.065
	3223594	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN)cc1		CHEMBL1079310	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	3223596	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1cccc(CN(C)C)c1		CHEMBL1078101	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	uM	0.063
	3223598	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	3223600	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CNC(=O)CO)cc1		CHEMBL1078666	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	3223602	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Cl)c(=O)n1Cc1ccc(CNC(=O)CO)cc1		CHEMBL1078667	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	uM	0.055
	3223604	CHEMBL1101788	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1cccc(CNC(=O)CO)c1		CHEMBL1078594	=	IC50	nM	49.0	CHEMBL260	Homo sapiens	IC50	uM	0.049
	3224874	CHEMBL1100952	Inhibition of p38alpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	3225124	CHEMBL1100952	Inhibition of p38alpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	3226362	CHEMBL1101787	Activity at p38alpha	B	O=c1c(Br)c(OCc2ccccc2)ccn1Cc1ccccc1		CHEMBL1095447	=	Activity	uM	1.0	CHEMBL260	Homo sapiens	Activity	uM	1.0
	3228108	CHEMBL1114820	Inhibition of p38alpha	B	CN(C)Cc1ccc(-c2cnn3c(-c4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccnc23)cc1		CHEMBL1087397	=	IC50	nM	216.0	CHEMBL260	Homo sapiens	IC50	uM	0.216
	3229201	CHEMBL1108472	Inhibition of p38alpha by high throughput screening	B	O=C(NC1CCNCC1)c1cccc(-c2n[nH]c3cc(Nc4ccccc4Cl)ccc23)c1		CHEMBL194806	=	IC50	nM	3.981	CHEMBL260	Homo sapiens	pIC50		8.4
	3229202	CHEMBL1108472	Inhibition of p38alpha by high throughput screening	B	O=C(Nc1cc(-c2ccnc(Nc3ccccc3)c2)ccn1)C1CCOC1		CHEMBL203535	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
	3229213	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1OC)C(c1ccccc1)=NCC2		CHEMBL1086783	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229214	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1Cl)CCN=C2c1cccc(Cl)c1		CHEMBL1077116	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229215	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1Cl)CCN=C2c1cccc(F)c1		CHEMBL1082865	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229216	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1Cl)CCN=C2c1ccc(F)cc1		CHEMBL1082867	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229217	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1OC)C(c1ccc(Cl)c(Cl)c1)=NCC2		CHEMBL1086653	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229218	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1OC)C(c1ccc(Cl)cc1)=NCC2		CHEMBL1086784	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229219	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cccc(C2=NCCc3cc(OC)c(OC)cc32)c1		CHEMBL1086785	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229220	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	Clc1cccc(C2=NCCc3ccccc32)c1		CHEMBL1084663	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229221	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1cccc(F)c1)=NCC2		CHEMBL1084664	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229222	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1ccc(F)cc1)=NCC2		CHEMBL1082866	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229238	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1Cl)CCN=C2c1cccc(Br)c1		CHEMBL1077137	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229239	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1Cl)CCN=C2c1ccc2ccccc2c1		CHEMBL1087420	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229240	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1Cl)CCN=C2c1ccc(Cl)c(Cl)c1		CHEMBL1087544	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229241	CHEMBL1108474	Inhibition of histidine-tagged human recombinant p38alpha after 120 mins by TR-FRET assay	B	COc1cc2c(cc1Cl)CCN=C2c1ccccc1		CHEMBL1088632	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229242	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1cccc(Br)c1)=NCC2		CHEMBL1083185	=	IC50	nM	12589.25	CHEMBL260	Homo sapiens	pIC50		4.9
	3229243	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1ccc3ccccc3c1)=NCC2		CHEMBL1088053	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229244	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1ccc(Cl)c(Cl)c1)=NCC2		CHEMBL1087421	=	IC50	nM	7943.28	CHEMBL260	Homo sapiens	pIC50		5.1
	3229245	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1ccccc1)=NCC2		CHEMBL1077132	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229246	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1cccc(Cl)c1)=NCC2		CHEMBL1088633	=	IC50	nM	7943.28	CHEMBL260	Homo sapiens	pIC50		5.1
	3229247	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1cccc(C)c1)=NCC2		CHEMBL1088634	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229248	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(c1cccc(Cl)c1F)=NCC2		CHEMBL1077129	=	IC50	nM	12589.25	CHEMBL260	Homo sapiens	pIC50		4.9
	3229249	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	COc1cc2c(cc1Cl)C(Cc1ccccc1)=NCC2		CHEMBL1087694	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3229250	CHEMBL1108475	Inhibition of N-terminal GST-tagged p38alpha expressed in Escherichia coli by fluorescence anisotropy	B	CCC1=NCCc2cc(OC)c(Cl)cc21		CHEMBL1087810	<	IC50	nM	15848.93	CHEMBL260	Homo sapiens	pIC50		4.8
	3235149	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	O=C(c1ccc2ccccc2c1)N(Cc1ccc(F)cc1)c1ccncc1		CHEMBL1091737	=	IC50	nM	1260.0	CHEMBL260	Homo sapiens	IC50	uM	1.26
	3235150	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc2ccccc2c1)c1ccnc(N[C@@H](C)c2ccccc2)c1		CHEMBL1091253	=	IC50	nM	313.0	CHEMBL260	Homo sapiens	IC50	uM	0.313
	3235152	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc2ccccc2c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092974	=	IC50	nM	64.0	CHEMBL260	Homo sapiens	IC50	uM	0.064
	3235154	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc2c(c1)CCO2)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092975	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	3235156	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc2c(c1)OCO2)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092964	=	IC50	nM	164.0	CHEMBL260	Homo sapiens	IC50	uM	0.164
	3235158	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc2occc2c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1093219	=	IC50	nM	71.0	CHEMBL260	Homo sapiens	IC50	uM	0.071
	3235160	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cccc2c1OCC2)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1091259	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	3235162	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc2c(c1)CCC2)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1091260	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
	3235164	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc2c(c1)CCCC2)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092096	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	3235166	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1csc2ccccc12)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1093209	=	IC50	nM	188.0	CHEMBL260	Homo sapiens	IC50	uM	0.188
	3235168	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cn(C)c2ccccc12)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1091248	=	IC50	nM	154.0	CHEMBL260	Homo sapiens	IC50	uM	0.154
	3235170	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cc2ccccc2o1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1091249	=	IC50	nM	179.0	CHEMBL260	Homo sapiens	IC50	uM	0.179
	3235172	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccccc1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092970	=	IC50	nM	193.0	CHEMBL260	Homo sapiens	IC50	uM	0.193
	3235174	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccccc1Cl)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092971	=	IC50	nM	267.0	CHEMBL260	Homo sapiens	IC50	uM	0.267
	3235176	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cccc(Cl)c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092349	=	IC50	nM	81.0	CHEMBL260	Homo sapiens	IC50	uM	0.081
	3235178	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc(Cl)cc1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092350	=	IC50	nM	313.0	CHEMBL260	Homo sapiens	IC50	uM	0.313
	3235180	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cccc(C)c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092675	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	3235182	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc(C)c(C)c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092676	=	IC50	nM	91.0	CHEMBL260	Homo sapiens	IC50	uM	0.091
	3235184	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cccc(C)c1C)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092677	=	IC50	nM	81.0	CHEMBL260	Homo sapiens	IC50	uM	0.081
	3235186	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCc1cccc(C(=O)N(CC)c2ccnc(N[C@@H](C)c3ccccc3)n2)c1		CHEMBL1092693	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	uM	0.065
	3235188	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cccc(C2CC2)c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1092694	=	IC50	nM	104.0	CHEMBL260	Homo sapiens	IC50	uM	0.104
	3235190	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cccc(C(F)(F)F)c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1093317	=	IC50	nM	64.0	CHEMBL260	Homo sapiens	IC50	uM	0.064
	3235192	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1ccc(F)c(C)c1)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1090891	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	3235194	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCN(C(=O)c1cc(C)ccc1F)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1090892	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	uM	0.026
	3235196	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CC(C)CN(C(=O)c1ccc2c(c1)CCO2)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1090585	=	IC50	nM	462.0	CHEMBL260	Homo sapiens	IC50	uM	0.462
	3235198	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CC2CC2)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1090586	=	IC50	nM	165.0	CHEMBL260	Homo sapiens	IC50	uM	0.165
	3235200	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	COCCN(C(=O)c1ccc2c(c1)CCO2)c1ccnc(N[C@@H](C)c2ccccc2)n1		CHEMBL1090587	=	IC50	nM	345.0	CHEMBL260	Homo sapiens	IC50	uM	0.345
	3235202	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CC2CCOCC2)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1090588	=	IC50	nM	158.0	CHEMBL260	Homo sapiens	IC50	uM	0.158
	3235204	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CC2CCNCC2)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1090230	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	uM	0.054
	3235206	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CC2CCCNC2)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1090231	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3235207	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CC2CCCCN2)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1093580	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3235208	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CC2CCN(C(N)=O)CC2)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1090246	=	IC50	nM	711.0	CHEMBL260	Homo sapiens	IC50	uM	0.711
	3235210	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CC2CCN(S(N)(=O)=O)CC2)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1093546	=	IC50	nM	673.0	CHEMBL260	Homo sapiens	IC50	uM	0.673
	3235212	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CCCN)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1093547	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3235213	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CCCCN)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1093548	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	3235215	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CCCCO)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1093549	=	IC50	nM	96.0	CHEMBL260	Homo sapiens	IC50	uM	0.096
	3235217	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@H](Nc1nccc(N(CCCS(C)(=O)=O)C(=O)c2ccc3c(c2)CCO3)n1)c1ccccc1		CHEMBL1093833	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	uM	0.072
	3235219	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CC(C)Nc1nccc(N(CC2CCNCC2)C(=O)c2ccc3c(c2)CCO3)n1		CHEMBL1093834	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	3235222	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	O=C(c1ccc2c(c1)CCO2)N(CC1CCNCC1)c1ccnc(NC2CCC(O)CC2)n1		CHEMBL1091228	=	IC50	nM	360.0	CHEMBL260	Homo sapiens	IC50	uM	0.36
	3235225	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	NC1CCC(Nc2nccc(N(CC3CCNCC3)C(=O)c3ccc4c(c3)CCO4)n2)CC1		CHEMBL1091229	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	3235228	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	COC[C@H](C)Nc1nccc(N(CC2CCNCC2)C(=O)c2ccc3c(c2)CCO3)n1		CHEMBL1091287	=	IC50	nM	316.0	CHEMBL260	Homo sapiens	IC50	uM	0.316
	3235231	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CC(C)(CO)Nc1nccc(N(CC2CCNCC2)C(=O)c2ccc3c(c2)CCO3)n1		CHEMBL1091634	=	IC50	nM	3040.0	CHEMBL260	Homo sapiens	IC50	uM	3.04
	3235234	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CCC(COC)Nc1nccc(N(CC2CCNCC2)C(=O)c2ccc3c(c2)CCO3)n1		CHEMBL1091635	=	IC50	nM	530.0	CHEMBL260	Homo sapiens	IC50	uM	0.53
	3235237	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	O=C(c1ccc2c(c1)CCO2)N(CC1CCNCC1)c1ccnc(NC2CC2)n1		CHEMBL1091636	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	3235240	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	CC(C)Nc1nccc(N(CCCCN)C(=O)c2ccc3c(c2)CCO3)n1		CHEMBL1089655	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	3235243	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	NCCCCN(C(=O)c1ccc2c(c1)CCO2)c1ccnc(NC2CCC(O)CC2)n1		CHEMBL1091614	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	3235246	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	COC[C@H](C)Nc1nccc(N(CCCCN)C(=O)c2ccc3c(c2)CCO3)n1		CHEMBL1091615	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	3235249	CHEMBL1103558	Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting	B	C[C@@H](CO)Nc1nccc(N(CCCCN)C(=O)c2ccc3c(c2)CCO3)n1		CHEMBL1091288	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	uM	0.31
	3240596	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	COc1cc2[nH]cc(C(=O)C(=O)N(C)C)c2cc1C(=O)N1CCC(Cc2ccc(F)cc2)CC1		CHEMBL605978	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	3240597	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	O=C(c1ccc2ccccc2c1)N(Cc1ccc(F)cc1)c1ccncc1		CHEMBL1091737	=	IC50	nM	1260.0	CHEMBL260	Homo sapiens	IC50	uM	1.26
	3240598	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	C[C@H](Nc1nccc(-c2c(-c3cccc(C(F)(F)F)c3)nc(C3CCNCC3)n2C)n1)c1ccccc1		CHEMBL305178	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	3240599	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	C[C@H](Nc1cc(N(Cc2ccc(F)cc2)C(=O)c2ccc3ccccc3c2)ccn1)c1ccccc1		CHEMBL1093218	=	IC50	nM	345.0	CHEMBL260	Homo sapiens	IC50	uM	0.345
	3240600	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	C[C@@H](Nc1cc(N(Cc2ccc(F)cc2)C(=O)c2ccc3ccccc3c2)ccn1)c1ccccc1		CHEMBL1092961	=	IC50	nM	7800.0	CHEMBL260	Homo sapiens	IC50	uM	7.8
	3240601	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	O=C(c1ccc2ccccc2c1)N(Cc1ccc(F)cc1)c1ccnc(NCc2ccccc2)c1		CHEMBL1092962	=	IC50	nM	1220.0	CHEMBL260	Homo sapiens	IC50	uM	1.22
	3240602	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	Nc1cc(N(Cc2ccc(F)cc2)C(=O)c2ccc3ccccc3c2)ccn1		CHEMBL1092963	=	IC50	nM	5080.0	CHEMBL260	Homo sapiens	IC50	uM	5.08
	3240603	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	O=C(c1ccc2ccccc2c1)N(Cc1ccc(F)cc1)c1ccnc(NC2CCCCC2)c1		CHEMBL1091265	=	IC50	nM	1110.0	CHEMBL260	Homo sapiens	IC50	uM	1.11
	3240604	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	CC(C)Nc1cc(N(Cc2ccc(F)cc2)C(=O)c2ccc3ccccc3c2)ccn1		CHEMBL1092953	=	IC50	nM	671.0	CHEMBL260	Homo sapiens	IC50	uM	0.671
	3240605	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	C[C@H](Nc1cc(N(Cc2ccc(F)cc2)C(=O)c2ccccc2)ccn1)c1ccccc1		CHEMBL1092954	=	IC50	nM	589.0	CHEMBL260	Homo sapiens	IC50	uM	0.589
	3240606	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	CC(=O)N(Cc1ccc(F)cc1)c1ccnc(N[C@@H](C)c2ccccc2)c1		CHEMBL1092955	=	IC50	nM	408.0	CHEMBL260	Homo sapiens	IC50	uM	0.408
	3240607	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	CCN(C(=O)c1ccc2ccccc2c1)c1ccnc(N[C@@H](C)c2ccccc2)c1		CHEMBL1091253	=	IC50	nM	313.0	CHEMBL260	Homo sapiens	IC50	uM	0.313
	3240608	CHEMBL1107088	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate at 1 uM after 60 mins by scintillation counter	B	C[C@H](Nc1cc(NCc2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1093473	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3240609	CHEMBL1107088	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate at 1 uM after 60 mins by scintillation counter	B	O=C(c1ccc2ccccc2c1)N(Cc1ccncc1)c1ccc(F)cc1		CHEMBL1093474	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3240610	CHEMBL1107088	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate at 1 uM after 60 mins by scintillation counter	B	C[C@H](Nc1cc(CN(C(=O)c2ccc3ccccc3c2)c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1092347	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3240611	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	C[C@H](Nc1cc(N(Cc2ccc(F)cc2)S(=O)(=O)c2ccc3ccccc3c2)ccn1)c1ccccc1		CHEMBL1092348	=	IC50	nM	7540.0	CHEMBL260	Homo sapiens	IC50	uM	7.54
	3240612	CHEMBL1107087	Inhibition of p38alpha assessed as inhibition of gamma-32p-ATP incorporation into biotin peptide substrate after 60 mins by scintillation counter	B	C[C@H](Nc1cc(N(Cc2ccc(F)cc2)C(=O)N2CCC3C=CC=CC3C2)ccn1)c1ccccc1		CHEMBL1090584	=	IC50	nM	1110.0	CHEMBL260	Homo sapiens	IC50	uM	1.11
	3242223	CHEMBL1111609	Inhibition of p38alpha	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3244716	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Fc1ccc(-c2n[nH]c(C3CCCNC3)c2-c2ccncc2)cc1		CHEMBL1091552	=	IC50	nM	48.3	CHEMBL260	Homo sapiens	IC50	nM	48.3
	3244717	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCCC(c2[nH]nc(-c3ccc(F)cc3)c2-c2ccncc2)C1		CHEMBL1091560	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	nM	90.0
	3244718	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Fc1ccc(-c2n[nH]c(C3CCNCC3)c2-c2ccncc2)cc1		CHEMBL1091667	=	IC50	nM	25.3	CHEMBL260	Homo sapiens	IC50	nM	25.3
	3244719	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(F)cc3)c2-c2ccncc2)CC1		CHEMBL1091668	=	IC50	nM	54.7	CHEMBL260	Homo sapiens	IC50	nM	54.7
	3244721	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1092902	=	IC50	nM	31.6	CHEMBL260	Homo sapiens	IC50	nM	31.6
	3244722	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3cccc(Cl)c3)c2-c2ccncc2)CC1		CHEMBL1092903	=	IC50	nM	39.2	CHEMBL260	Homo sapiens	IC50	nM	39.2
	3244723	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(C(F)(F)F)cc3)c2-c2ccncc2)CC1		CHEMBL1090511	=	IC50	nM	40.5	CHEMBL260	Homo sapiens	IC50	nM	40.5
	3244724	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3cccc(C(F)(F)F)c3)c2-c2ccncc2)CC1		CHEMBL1090512	=	IC50	nM	26.5	CHEMBL260	Homo sapiens	IC50	nM	26.5
	3244725	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Cc1ccc(-c2n[nH]c(C3CCN(C)CC3)c2-c2ccncc2)cc1		CHEMBL1090836	=	IC50	nM	99.6	CHEMBL260	Homo sapiens	IC50	nM	99.6
	3244726	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Cc1cccc(-c2n[nH]c(C3CCN(C)CC3)c2-c2ccncc2)c1		CHEMBL1090837	=	IC50	nM	67.3	CHEMBL260	Homo sapiens	IC50	nM	67.3
	3244727	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	OCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1093456	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	3244728	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1089197	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	nM	70.0
	3244729	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1089198	=	IC50	nM	106.0	CHEMBL260	Homo sapiens	IC50	nM	106.0
	3244730	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	NS(=O)(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1089520	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	3244731	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CS(=O)(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1088897	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	nM	70.0
	3244732	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O=C(O)CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1092383	=	IC50	nM	126.0	CHEMBL260	Homo sapiens	IC50	nM	126.0
	3244733	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1091921	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	nM	68.0
	3244734	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1091922	=	IC50	nM	111.0	CHEMBL260	Homo sapiens	IC50	nM	111.0
	3244735	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1091923	=	IC50	nM	71.0	CHEMBL260	Homo sapiens	IC50	nM	71.0
	3244736	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN(C)CC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncc2)CC1		CHEMBL1092246	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	nM	80.0
	3244737	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1092722	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	3244738	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	OCCN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1093007	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	3244739	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(C)(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1092906	=	IC50	nM	184.0	CHEMBL260	Homo sapiens	IC50	nM	184.0
	3244740	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(C)(O)CN1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1092907	=	IC50	nM	88.0	CHEMBL260	Homo sapiens	IC50	nM	88.0
	3244741	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Clc1ccc(-c2n[nH]c(C3CCN(C4CCOC4)CC3)c2-c2ccncn2)cc1		CHEMBL1092001	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	3244742	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Clc1ccc(-c2n[nH]c(C3CCN(C4CCOCC4)CC3)c2-c2ccncn2)cc1		CHEMBL1092648	=	IC50	nM	205.0	CHEMBL260	Homo sapiens	IC50	nM	205.0
	3244743	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O[C@H]1CCC[C@@H]1N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1089172	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	3244744	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	Clc1ccc(-c2n[nH]c(C3CCN(Cc4ccncc4)CC3)c2-c2ccncn2)cc1		CHEMBL1093301	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	3244745	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1089173	=	IC50	nM	152.0	CHEMBL260	Homo sapiens	IC50	nM	152.0
	3244746	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1090173	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	3244747	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	COCC(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1090174	=	IC50	nM	94.0	CHEMBL260	Homo sapiens	IC50	nM	94.0
	3244748	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CN(C)C(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1091912	=	IC50	nM	88.0	CHEMBL260	Homo sapiens	IC50	nM	88.0
	3244749	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CS(=O)(=O)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1		CHEMBL1088914	=	IC50	nM	198.0	CHEMBL260	Homo sapiens	IC50	nM	198.0
	3244822	CHEMBL1107046	Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting	B	CC(=O)N1CCC(c2[nH]nc(-c3ccc(F)cc3)c2-c2ccncc2)CC1		CHEMBL1092901	=	IC50	nM	82.0	CHEMBL260	Homo sapiens	IC50	nM	82.0
	3246855	CHEMBL1103397	Inhibition of p38alpha	B	O=C(NCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1)c1ccccc1		CHEMBL199247	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	nM	46.0
	3246866	CHEMBL1103397	Inhibition of p38alpha	B	CCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3n2[C@H](CO)CC3)n1		CHEMBL198756	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	3246868	CHEMBL1103397	Inhibition of p38alpha	B	CCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3n2[C@H](Cc2ccc(OC)cc2)CC3)n1		CHEMBL1094013	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	nM	54.0
	3246877	CHEMBL1103397	Inhibition of p38alpha	B	c1ccc(Nc2ccc3c(-c4ccccc4)n[nH]c3c2)cc1		CHEMBL383177	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
	3246880	CHEMBL1103397	Inhibition of p38alpha	B	CN(C)CCCC(=O)Nc1cc(C(=O)O)cc(-c2n[nH]c3cc(Nc4ccccc4Cl)ccc23)c1		CHEMBL1092764	=	IC50	nM	903.0	CHEMBL260	Homo sapiens	IC50	nM	903.0
	3246883	CHEMBL1103397	Inhibition of p38alpha	B	O=C(Nc1cc(-c2ccnc(Nc3ccccc3)c2)ccn1)C1CCOC1		CHEMBL203535	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
	3251249	CHEMBL1107904	Inhibition of P38alpha	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	3251546	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccccc3C)c2n(C)c1=O		CHEMBL1089122	=	Ki	nM	1.9	CHEMBL260	Homo sapiens	Ki	nM	1.9
	3251547	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccccc3Cl)c2n(C)c1=O		CHEMBL1089456	=	Ki	nM	0.9	CHEMBL260	Homo sapiens	Ki	nM	0.9
	3251548	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ncccc3C(F)(F)F)c2n(C)c1=O		CHEMBL1089457	=	Ki	nM	2.3	CHEMBL260	Homo sapiens	Ki	nM	2.3
	3251549	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1091199	=	Ki	nM	2.3	CHEMBL260	Homo sapiens	Ki	nM	2.3
	3251550	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3cc(F)ccc3F)c2n(C)c1=O		CHEMBL1089534	=	Ki	nM	1.9	CHEMBL260	Homo sapiens	Ki	nM	1.9
	3251551	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	=	Ki	nM	1.4	CHEMBL260	Homo sapiens	Ki	nM	1.4
	3251552	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2cnn(-c3ccc(F)cc3F)c21		CHEMBL1089866	=	Ki	nM	0.6	CHEMBL260	Homo sapiens	Ki	nM	0.6
	3251553	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2c(C)nn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1091927	=	Ki	nM	8.0	CHEMBL260	Homo sapiens	Ki	nM	8.0
	3251554	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2Cl)cc2cnn(-c3c(F)cccc3F)c21		CHEMBL1091928	=	Ki	nM	1.1	CHEMBL260	Homo sapiens	Ki	nM	1.1
	3251555	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1091929	=	Ki	nM	0.8	CHEMBL260	Homo sapiens	Ki	nM	0.8
	3251556	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(N)=O)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1091930	=	Ki	nM	1.5	CHEMBL260	Homo sapiens	Ki	nM	1.5
	3251557	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2(C)CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1092011	=	Ki	nM	1.7	CHEMBL260	Homo sapiens	Ki	nM	1.7
	3251558	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1092012	=	Ki	nM	1.0	CHEMBL260	Homo sapiens	Ki	nM	1.0
	3251585	CHEMBL1103668	Binding affinity to p38alpha by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3F)nncc2c1		CHEMBL1088796	=	Kd	nM	0.05	CHEMBL260	Homo sapiens	Kd	nM	0.05
	3251586	CHEMBL1103668	Binding affinity to p38alpha by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1091199	=	Kd	nM	0.31	CHEMBL260	Homo sapiens	Kd	nM	0.31
	3251587	CHEMBL1103668	Binding affinity to p38alpha by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccccc3F)c2n(C)c1=O		CHEMBL1092013	=	Kd	nM	0.18	CHEMBL260	Homo sapiens	Kd	nM	0.18
	3251629	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)O)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1093461	=	Ki	nM	458.0	CHEMBL260	Homo sapiens	Ki	nM	458.0
	3251632	CHEMBL1103663	Inhibition of human recombinant p38alpha-mediated AFT2 phosphorylation after 1 hr by HTRF assay	B	CNc1noc2c(-c3cc4cnn(-c5c(F)cccc5F)c4n(C)c3=O)c(C)ccc12		CHEMBL1089513	=	Ki	nM	2.0	CHEMBL260	Homo sapiens	Ki	nM	2.0
	3251650	CHEMBL1104508	Inhibition of p38alpha at 1 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3251654	CHEMBL1103668	Binding affinity to p38alpha by scintillation proximity assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	=	Kd	nM	0.25	CHEMBL260	Homo sapiens	Kd	nM	0.25
Not Active	3253630	CHEMBL1114422	Inhibition of p38alpha at 10 uM	B	FC(F)(F)c1ccc(Nc2ccnc3nc(-c4ncccc4C(F)(F)F)ccc23)nc1		CHEMBL1089119		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	3260098	CHEMBL1108070	Inhibition of p38alpha at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	30.0	CHEMBL260	Homo sapiens	Activity	%	30.0
	3260510	CHEMBL1109845	Inhibition of P38alpha	B	O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1089082	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3260839	CHEMBL1111805	Binding affinity to p38alpha	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	Kd	nM	1.3	CHEMBL260	Homo sapiens	Kd	uM	0.0013
	3260848	CHEMBL1111805	Binding affinity to p38alpha	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	Kd	nM	0.48	CHEMBL260	Homo sapiens	Kd	uM	0.00048
	3260850	CHEMBL1111805	Binding affinity to p38alpha	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	=	Kd	nM	3.7	CHEMBL260	Homo sapiens	Kd	uM	0.0037
	3260857	CHEMBL1114528	Inhibition of human recombinant p38alpha by liquid scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	3260866	CHEMBL1114528	Inhibition of human recombinant p38alpha by liquid scintillation counting	B	CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)NCCN(C)C)cc21		CHEMBL1088750	=	IC50	nM	4.5	CHEMBL260	Homo sapiens	IC50	nM	4.5
	3260867	CHEMBL1114528	Inhibition of human recombinant p38alpha by liquid scintillation counting	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	3260869	CHEMBL1111805	Binding affinity to p38alpha	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	Ki	nM	5.8	CHEMBL260	Homo sapiens	Ki	nM	5.8
	3260870	CHEMBL1111805	Binding affinity to p38alpha	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Ki	nM	7.943	CHEMBL260	Homo sapiens	pKi		8.1
	3261375	CHEMBL1108070	Inhibition of p38alpha at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	63.0	CHEMBL260	Homo sapiens	Activity	%	63.0
	3261939	CHEMBL1114528	Inhibition of human recombinant p38alpha by liquid scintillation counting	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	3262016	CHEMBL1114551	Inhibition of MAPK14	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	3262278	CHEMBL1113462	Inhibition of P38alpha at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	3262279	CHEMBL1113462	Inhibition of P38alpha at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	3262280	CHEMBL1113462	Inhibition of P38alpha at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	3262281	CHEMBL1113462	Inhibition of P38alpha at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	3262282	CHEMBL1113462	Inhibition of P38alpha at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	3262283	CHEMBL1113462	Inhibition of P38alpha at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	3264378	CHEMBL1104647	Inhibition of p38alpha	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3271035	CHEMBL1104647	Inhibition of p38alpha	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	=	IC50	nM	28900.0	CHEMBL260	Homo sapiens	IC50	uM	28.9
Not Active	3272416	CHEMBL1108310	Inhibition of P38alpha	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272417	CHEMBL1108310	Inhibition of P38alpha	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272418	CHEMBL1108310	Inhibition of P38alpha	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272419	CHEMBL1108310	Inhibition of P38alpha	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272420	CHEMBL1108310	Inhibition of P38alpha	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272421	CHEMBL1108310	Inhibition of P38alpha	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272422	CHEMBL1108310	Inhibition of P38alpha	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272423	CHEMBL1108310	Inhibition of P38alpha	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272424	CHEMBL1108310	Inhibition of P38alpha	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3272425	CHEMBL1108310	Inhibition of P38alpha	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	3272426	CHEMBL1108310	Inhibition of P38alpha	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL260	Homo sapiens	INH	%	20.0
Not Active	3272427	CHEMBL1108310	Inhibition of P38alpha	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	3289177	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccccc2)ccn1Cc1ccccc1		CHEMBL1095447	=	IC50	nM	680.0	CHEMBL260	Homo sapiens	IC50	uM	0.68
	3289178	CHEMBL1110043	Inhibition of p38alpha	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	3289179	CHEMBL1110043	Inhibition of p38alpha	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	IC50	nM	5.8	CHEMBL260	Homo sapiens	IC50	uM	0.0058
	3289180	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccccc2)cnn1Cc1ccccc1		CHEMBL1094166	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3289181	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccccc2)cnn1-c1ccccc1		CHEMBL1094167	=	IC50	nM	24400.0	CHEMBL260	Homo sapiens	IC50	uM	24.4
	3289182	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)cc2F)cnn1-c1ccccc1		CHEMBL1094476	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	uM	2.7
	3289183	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccccc2)cnn1-c1c(Cl)cccc1Cl		CHEMBL1094983	=	IC50	nM	1390.0	CHEMBL260	Homo sapiens	IC50	uM	1.39
	3289184	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(NCc2ccccc2)cnn1-c1c(Cl)cccc1Cl		CHEMBL1095775	=	IC50	nM	5720.0	CHEMBL260	Homo sapiens	IC50	uM	5.72
	3289185	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCCc2ccccc2)cnn1-c1c(Cl)cccc1Cl		CHEMBL1096090	=	IC50	nM	3140.0	CHEMBL260	Homo sapiens	IC50	uM	3.14
	3289186	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(NCCc2ccccc2)cnn1-c1c(Cl)cccc1Cl		CHEMBL1096091	=	IC50	nM	3810.0	CHEMBL260	Homo sapiens	IC50	uM	3.81
	3289187	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)cc2)cnn1-c1c(Cl)cccc1Cl		CHEMBL1096092	=	IC50	nM	1320.0	CHEMBL260	Homo sapiens	IC50	uM	1.32
	3289188	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(NCc2ccc(F)cc2)cnn1-c1c(Cl)cccc1Cl		CHEMBL1095142	=	IC50	nM	12300.0	CHEMBL260	Homo sapiens	IC50	uM	12.3
	3289189	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)cc2F)cnn1-c1c(Cl)cccc1Cl		CHEMBL1096436	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	3289190	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2c(F)cc(F)cc2F)cnn1-c1c(Cl)cccc1Cl		CHEMBL1096437	=	IC50	nM	540.0	CHEMBL260	Homo sapiens	IC50	uM	0.54
	3289191	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)c(F)c2)cnn1-c1c(Cl)cccc1Cl		CHEMBL1095304	=	IC50	nM	2070.0	CHEMBL260	Homo sapiens	IC50	uM	2.07
	3289192	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)c(F)c2F)cnn1-c1c(Cl)cccc1Cl		CHEMBL1096438	=	IC50	nM	470.0	CHEMBL260	Homo sapiens	IC50	uM	0.47
	3289193	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(Cl)cc2F)cnn1-c1c(Cl)cccc1Cl		CHEMBL1098756	=	IC50	nM	1010.0	CHEMBL260	Homo sapiens	IC50	uM	1.01
	3289194	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)cc2F)cnn1-c1c(Cl)cncc1Cl		CHEMBL1098757	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	3289195	CHEMBL1110043	Inhibition of p38alpha	B	O=c1c(Br)c(OCc2ccc(F)cc2F)cnn1-c1c(F)cccc1F		CHEMBL1099098	=	IC50	nM	590.0	CHEMBL260	Homo sapiens	IC50	uM	0.59
	3289196	CHEMBL1110043	Inhibition of p38alpha	B	COC(=O)c1ccc(C)c(-n2ncc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1099099	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	3289197	CHEMBL1110043	Inhibition of p38alpha	B	CNC(=O)c1ccc(C)c(-n2ncc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1097021	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	3291468	CHEMBL1111967	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3304849	CHEMBL1120006	Inhibition of SAPK2A	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Ki	nM	10000.0	CHEMBL260	Homo sapiens	Ki	uM	10.0
	3306932	CHEMBL1118056	Inhibition of SAPK2A/P38 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	3316809	CHEMBL1120368	Inhibition of SAPK2A at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	25.0	CHEMBL260	Homo sapiens	INH	%	25.0
	3326161	CHEMBL1168767	Inhibition of p38alpha at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3329239	CHEMBL1166746	Inhibition of p38alpha	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	IC50	nM	540.0	CHEMBL260	Homo sapiens	IC50	uM	0.54
	3332061	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3333476	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3334881	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3336301	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3337598	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3338929	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3339183	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3340486	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3341843	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3343290	CHEMBL1166599	Inhibition of p38-alpha at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
Not Active	3352228	CHEMBL1175402	Inhibition of P38alpha at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3352229	CHEMBL1175402	Inhibition of P38alpha at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	3352230	CHEMBL1175402	Inhibition of P38alpha at 10 uM	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	3354860	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	3354861	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	3354862	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	3354863	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	3354864	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	3354865	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	-3.0	CHEMBL260	Homo sapiens	INH	%	-3.0
	3354866	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	3354867	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	-2.0	CHEMBL260	Homo sapiens	INH	%	-2.0
	3354868	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	3354869	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	3354870	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	3354943	CHEMBL1174000	Inhibition of p38alpha at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	3355401	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2ccco2)c1		CHEMBL1171204	=	IC50	nM	251.19	CHEMBL260	Homo sapiens	pIC50		6.6
	3355402	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(NCc1cccs1)c1cc(C(=O)c2c(Cl)cccc2Cl)c[nH]1		CHEMBL1171205	=	IC50	nM	794.33	CHEMBL260	Homo sapiens	pIC50		6.1
	3355403	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	COc1ccc(C(=O)c2c[nH]c(C(=O)NCc3cccs3)c2)cc1		CHEMBL1171206	<	IC50	nM	25118.86	CHEMBL260	Homo sapiens	pIC50		4.6
	3355404	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	COc1ccccc1CNC(=O)c1cc(C(=O)c2ccccc2C)c[nH]1		CHEMBL1170375	=	IC50	nM	316.23	CHEMBL260	Homo sapiens	pIC50		6.5
	3355405	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(NC1CCCC1)c1cc(C(=O)c2c(Cl)cccc2Cl)c[nH]1		CHEMBL1170586	=	IC50	nM	1995.26	CHEMBL260	Homo sapiens	pIC50		5.7
	3355406	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NN2CCN(Cc3ccccc3)CC2)c1		CHEMBL1169654	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	pIC50		5.0
	3355407	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2c(F)cccc2F)c1		CHEMBL1170113	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	pIC50		7.0
	3355408	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	Cc1cc(F)ccc1C(=O)c1c[nH]c(C(=O)NCc2c(F)cccc2F)c1		CHEMBL1171611	=	IC50	nM	251.19	CHEMBL260	Homo sapiens	pIC50		6.6
	3355409	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(NCc1c(F)cccc1F)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL1171612	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	3355410	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	CN1CCN(c2cccc(CNC(=O)c3cc(C(=O)c4ccccc4F)c[nH]3)c2)CC1		CHEMBL1171613	=	IC50	nM	12.59	CHEMBL260	Homo sapiens	pIC50		7.9
	3355411	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	CC(NC(=O)c1cc(C(=O)c2ccccc2F)c[nH]1)C(C)(C)C		CHEMBL1171396	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
	3355412	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(NCc1ccccc1O)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL1171397	=	IC50	nM	50.12	CHEMBL260	Homo sapiens	pIC50		7.3
	3355413	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(NCc1ccccc1O)c1cc(C(=O)c2ccc(C(F)(F)F)cc2F)c[nH]1		CHEMBL1170589	<	IC50	nM	25118.86	CHEMBL260	Homo sapiens	pIC50		4.6
	3355414	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(NCc1ccccc1O)c1cc(C(=O)c2csc3ccccc23)c[nH]1		CHEMBL1170590	=	IC50	nM	19952.62	CHEMBL260	Homo sapiens	pIC50		4.7
	3355415	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(NCc1ccccc1O)c1cc(C(=O)c2ccc(F)cc2F)c[nH]1		CHEMBL1170798	=	IC50	nM	31.62	CHEMBL260	Homo sapiens	pIC50		7.5
	3355416	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	CC(NC(=O)c1cc(C(=O)c2ccc(F)cc2F)c[nH]1)C(C)(C)O		CHEMBL1171789	=	IC50	nM	1258.93	CHEMBL260	Homo sapiens	pIC50		5.9
	3355417	CHEMBL1174571	Inhibition of human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli after 120 mins by TR-FRET assay	B	O=C(Nc1c(F)cccc1F)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL1170617	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	pIC50		6.0
	3355418	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2ccco2)c1		CHEMBL1171204	=	IC50	nM	630.96	CHEMBL260	Homo sapiens	pIC50		6.2
	3355419	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2c(F)cccc2F)c1		CHEMBL1170113	=	IC50	nM	3162.28	CHEMBL260	Homo sapiens	pIC50		5.5
	3355420	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	Cc1cc(F)ccc1C(=O)c1c[nH]c(C(=O)NCc2c(F)cccc2F)c1		CHEMBL1171611	=	IC50	nM	3981.07	CHEMBL260	Homo sapiens	pIC50		5.4
	3355421	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	O=C(NCc1c(F)cccc1F)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL1171612	=	IC50	nM	1584.89	CHEMBL260	Homo sapiens	pIC50		5.8
	3355422	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	CN1CCN(c2cccc(CNC(=O)c3cc(C(=O)c4ccccc4F)c[nH]3)c2)CC1		CHEMBL1171613	=	IC50	nM	1995.26	CHEMBL260	Homo sapiens	pIC50		5.7
	3355423	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	CC(NC(=O)c1cc(C(=O)c2ccccc2F)c[nH]1)C(C)(C)C		CHEMBL1171396	=	IC50	nM	158.49	CHEMBL260	Homo sapiens	pIC50		6.8
	3355424	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	O=C(NCc1ccccc1O)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL1171397	=	IC50	nM	794.33	CHEMBL260	Homo sapiens	pIC50		6.1
	3355425	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	O=C(NCc1ccccc1O)c1cc(C(=O)c2ccc(F)cc2F)c[nH]1		CHEMBL1170798	=	IC50	nM	1258.93	CHEMBL260	Homo sapiens	pIC50		5.9
	3355426	CHEMBL1174572	Inhibition of p38alpha assessed as HSP27 phosphorylation in IL-1-alpha-stimulated HLF cells	B	O=C(Nc1c(F)cccc1F)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL1170617	=	IC50	nM	1584.89	CHEMBL260	Homo sapiens	pIC50		5.8
	3355437	CHEMBL1174582	Binding affinity to human recombinant N-terminal 6-His-tagged p38alpha expressed in Escherichia coli at 10 uM assessed as binding remaining relative to control	B	Cc1ccccc1C(=O)c1c[nH]c(C(=O)NCc2ccco2)c1		CHEMBL1171204	=	Activity	%	0.7	CHEMBL260	Homo sapiens	Activity	%	0.7
	3358709	CHEMBL1174951	Inhibition of p38alpha at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3359151	CHEMBL1174951	Inhibition of p38alpha at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3368940	CHEMBL1177017	Inhibition of p38alpha	B	O=c1[nH]c(-c2ccc(F)cc2)c(-c2ccnc(N[C@H]3CC[C@H](O)CC3)c2)[nH]1		CHEMBL1172017	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	3368942	CHEMBL1177017	Inhibition of p38alpha	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c(=O)[nH]c2-c2ccc(F)cc2)ccn1		CHEMBL1173078	=	IC50	nM	49.0	CHEMBL260	Homo sapiens	IC50	uM	0.049
	3368944	CHEMBL1177017	Inhibition of p38alpha	B	C[C@@H](Nc1cc(-c2[nH]c(=O)[nH]c2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1173375	=	IC50	nM	324.0	CHEMBL260	Homo sapiens	IC50	uM	0.324
	3368946	CHEMBL1177017	Inhibition of p38alpha	B	O=c1[nH]c(-c2ccncc2)c(-c2ccc(F)cc2)[nH]1		CHEMBL1171464	=	IC50	nM	468.0	CHEMBL260	Homo sapiens	IC50	uM	0.468
	3368948	CHEMBL1177017	Inhibition of p38alpha	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	3381362	CHEMBL1211154	Inhibition of p38alpha	B	Fc1ccc(-c2[nH]cc(C3=C[C@@H]4CCCN4CC3)c2-c2ccncc2)cc1		CHEMBL1209288	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	3382326	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CN)c2)n1		CHEMBL1209212	=	IC50	nM	2850.0	CHEMBL260	Homo sapiens	IC50	uM	2.85
	3382327	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CN)c2)n1		CHEMBL1209213	=	IC50	nM	176.0	CHEMBL260	Homo sapiens	IC50	uM	0.176
	3382328	CHEMBL1211971	Inhibition of unactive p38alpha	B	COC(=O)NCC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209214	=	IC50	nM	176.0	CHEMBL260	Homo sapiens	IC50	uM	0.176
	3382329	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC=O)c2)n1		CHEMBL1209273	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	uM	0.068
	3382330	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(=O)NCC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209274	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	3382331	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC(=O)c3ccccc3)c2)n1		CHEMBL1209275	=	IC50	nM	169.0	CHEMBL260	Homo sapiens	IC50	uM	0.169
	3382332	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC(=O)c3cccnc3)c2)n1		CHEMBL1209276	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	uM	0.051
	3382333	CHEMBL1211971	Inhibition of unactive p38alpha	B	Cc1cc(C(=O)NCC(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)no1		CHEMBL1209342	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	3382334	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC(=O)c3ccco3)c2)n1		CHEMBL1209343	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	3382335	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(=O)NC(C)C(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209344	=	IC50	nM	168.0	CHEMBL260	Homo sapiens	IC50	uM	0.168
	3382336	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(=O)NC1(C(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)CCCC1		CHEMBL1209404	=	IC50	nM	715.0	CHEMBL260	Homo sapiens	IC50	uM	0.715
	3382337	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNS(C)(=O)=O)c2)n1		CHEMBL1209405	=	IC50	nM	108.0	CHEMBL260	Homo sapiens	IC50	uM	0.108
	3382338	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(=O)NCC(=O)N(C)Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209406	=	IC50	nM	211.0	CHEMBL260	Homo sapiens	IC50	uM	0.211
	3382339	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CN3CCCC3=O)c2)n1		CHEMBL1209407	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	uM	0.068
	3382340	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CN3CCOC3=O)c2)n1		CHEMBL1209481	=	IC50	nM	185.0	CHEMBL260	Homo sapiens	IC50	uM	0.185
	3382341	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)Cn3ccccc3=O)c2)n1		CHEMBL1209482	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	uM	0.016
	3382342	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)Cn3ccnc3)c2)n1		CHEMBL1209483	=	IC50	nM	231.0	CHEMBL260	Homo sapiens	IC50	uM	0.231
	3382343	CHEMBL1211971	Inhibition of unactive p38alpha	B	Cc1nccn1CC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209484	=	IC50	nM	132.0	CHEMBL260	Homo sapiens	IC50	uM	0.132
	3382344	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)Cn3cccn3)c2)n1		CHEMBL1209563	=	IC50	nM	48.8	CHEMBL260	Homo sapiens	IC50	uM	0.0488
	3382345	CHEMBL1211971	Inhibition of unactive p38alpha	B	Cc1ccn(CC(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)n1		CHEMBL1209564	=	IC50	nM	27.9	CHEMBL260	Homo sapiens	IC50	uM	0.0279
	3382346	CHEMBL1211971	Inhibition of unactive p38alpha	B	Cc1cc(C)n(CC(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)n1		CHEMBL1209565	=	IC50	nM	78.2	CHEMBL260	Homo sapiens	IC50	uM	0.0782
	3383059	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CCC(=O)O)c2)n1		CHEMBL1209566	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	uM	0.037
	3383060	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(CC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1)C(=O)O		CHEMBL1209636	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	3383061	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)C3C[C@H]3C(=O)O)c2)n1		CHEMBL1209637	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	3383062	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)C3CCCC[C@H]3C(=O)O)c2)n1		CHEMBL1209638	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	uM	0.057
	3383063	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)C3CC=CC[C@H]3C(=O)O)c2)n1		CHEMBL1209639	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	3383064	CHEMBL1211971	Inhibition of unactive p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(CNC(=O)CCC(=O)O)c2)n1		CHEMBL1209703	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	3383065	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CN)c2)n1		CHEMBL1209212	>	IC50	nM	16700.0	CHEMBL260	Homo sapiens	IC50	uM	16.7
	3383066	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CN)c2)n1		CHEMBL1209213	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	3383067	CHEMBL1211972	Inhibition of active p38alpha	B	COC(=O)NCC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209214	=	IC50	nM	287.0	CHEMBL260	Homo sapiens	IC50	uM	0.287
	3383068	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC=O)c2)n1		CHEMBL1209273	=	IC50	nM	332.0	CHEMBL260	Homo sapiens	IC50	uM	0.332
	3383069	CHEMBL1211972	Inhibition of active p38alpha	B	CC(=O)NCC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209274	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	3383070	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC(=O)c3ccccc3)c2)n1		CHEMBL1209275	=	IC50	nM	441.0	CHEMBL260	Homo sapiens	IC50	uM	0.441
	3383071	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC(=O)c3cccnc3)c2)n1		CHEMBL1209276	=	IC50	nM	205.0	CHEMBL260	Homo sapiens	IC50	uM	0.205
	3383072	CHEMBL1211972	Inhibition of active p38alpha	B	Cc1cc(C(=O)NCC(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)no1		CHEMBL1209342	=	IC50	nM	243.0	CHEMBL260	Homo sapiens	IC50	uM	0.243
	3383073	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNC(=O)c3ccco3)c2)n1		CHEMBL1209343	=	IC50	nM	88.0	CHEMBL260	Homo sapiens	IC50	uM	0.088
	3383074	CHEMBL1211972	Inhibition of active p38alpha	B	CC(=O)NC(C)C(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209344	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	3383075	CHEMBL1211972	Inhibition of active p38alpha	B	CC(=O)NC1(C(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)CCCC1		CHEMBL1209404	=	IC50	nM	4550.0	CHEMBL260	Homo sapiens	IC50	uM	4.55
	3383076	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CNS(C)(=O)=O)c2)n1		CHEMBL1209405	=	IC50	nM	649.0	CHEMBL260	Homo sapiens	IC50	uM	0.649
	3383077	CHEMBL1211972	Inhibition of active p38alpha	B	CC(=O)NCC(=O)N(C)Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209406	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	3383078	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CN3CCCC3=O)c2)n1		CHEMBL1209407	=	IC50	nM	296.0	CHEMBL260	Homo sapiens	IC50	uM	0.296
	3383079	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CN3CCOC3=O)c2)n1		CHEMBL1209481	=	IC50	nM	599.0	CHEMBL260	Homo sapiens	IC50	uM	0.599
	3383080	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)Cn3ccccc3=O)c2)n1		CHEMBL1209482	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	uM	0.063
	3383081	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)Cn3ccnc3)c2)n1		CHEMBL1209483	=	IC50	nM	536.0	CHEMBL260	Homo sapiens	IC50	uM	0.536
	3383082	CHEMBL1211972	Inhibition of active p38alpha	B	Cc1nccn1CC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1		CHEMBL1209484	=	IC50	nM	677.0	CHEMBL260	Homo sapiens	IC50	uM	0.677
	3383083	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)Cn3cccn3)c2)n1		CHEMBL1209563	=	IC50	nM	135.0	CHEMBL260	Homo sapiens	IC50	uM	0.135
	3383084	CHEMBL1211972	Inhibition of active p38alpha	B	Cc1ccn(CC(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)n1		CHEMBL1209564	=	IC50	nM	201.0	CHEMBL260	Homo sapiens	IC50	uM	0.201
	3383085	CHEMBL1211972	Inhibition of active p38alpha	B	Cc1cc(C)n(CC(=O)NCc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3ccccc3)c2)n1		CHEMBL1209565	=	IC50	nM	331.0	CHEMBL260	Homo sapiens	IC50	uM	0.331
	3383086	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)CCC(=O)O)c2)n1		CHEMBL1209566	=	IC50	nM	393.0	CHEMBL260	Homo sapiens	IC50	uM	0.393
	3383087	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(CC(=O)NCc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccccc2)c1)C(=O)O		CHEMBL1209636	=	IC50	nM	3680.0	CHEMBL260	Homo sapiens	IC50	uM	3.68
	3383088	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)C3C[C@H]3C(=O)O)c2)n1		CHEMBL1209637	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	uM	1.1
	3383089	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)C3CCCC[C@H]3C(=O)O)c2)n1		CHEMBL1209638	=	IC50	nM	3360.0	CHEMBL260	Homo sapiens	IC50	uM	3.36
	3383090	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(CNC(=O)C3CC=CC[C@H]3C(=O)O)c2)n1		CHEMBL1209639	=	IC50	nM	737.0	CHEMBL260	Homo sapiens	IC50	uM	0.737
	3383091	CHEMBL1211972	Inhibition of active p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(CNC(=O)CCC(=O)O)c2)n1		CHEMBL1209703	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	3383671	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	CC(C)(C)c1cccc(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL1209755	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	3383672	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	CC(C)(C)c1cc(C#N)cc(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL1209837	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	uM	0.033
	3383673	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	N#Cc1cc(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(N2CCOCC2)c1		CHEMBL1209838	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	uM	0.028
	3383674	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(C#N)cc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL1209839	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	uM	0.042
	3383675	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1ccc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL1209840	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	3383676	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(Cl)cc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL1208828	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	3383677	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208829	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	3383678	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1C(=O)NC1CC1		CHEMBL1208830	=	IC50	nM	71.0	CHEMBL260	Homo sapiens	IC50	uM	0.071
	3383679	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)/C(=N/O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208831	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	3383680	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)C(O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208832	=	IC50	nM	390.0	CHEMBL260	Homo sapiens	IC50	uM	0.39
	3383681	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)Cc2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208889	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	3383682	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(Nc3ccncn3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208890	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	uM	0.072
	3383683	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(Nc3ccncc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208891	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	3383684	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(C#N)cc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(Nc2ccncc2)c2ccccc12		CHEMBL1208952	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	uM	0.051
	3383685	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(Oc3ccnc(N4CCOCC4)n3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208954	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	3383686	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(C#N)cc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(-c2cccnc2)c2ccccc12		CHEMBL1208955	=	IC50	nM	78.0	CHEMBL260	Homo sapiens	IC50	uM	0.078
	3383687	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(C#N)cc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(-c2ccncc2)c2ccccc12		CHEMBL1208956	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	3383688	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(C#N)cc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(-c2ccc(F)nc2)c2ccccc12		CHEMBL1209012	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	3383689	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	COc1c(C#N)cc(C(C)(C)C)cc1NC(=O)C(=O)c1ccc(-c2ccnc(C)c2)c2ccccc12		CHEMBL1209013	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	3383690	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	3383691	CHEMBL1211566	Inhibition of p38 alpha activity by ELISA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	3383693	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	3383694	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	6000.0	CHEMBL260	Homo sapiens	IC50	uM	6.0
	3383695	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	CC(C)(C)c1cccc(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)c1		CHEMBL1209755	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	uM	0.31
	3383696	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208829	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	3383697	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1C(=O)NC1CC1		CHEMBL1208830	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	3383698	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	COc1c(NC(=O)Cc2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208889	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	3383699	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(Nc3ccncn3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208890	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	3383700	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(Nc3ccncc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208891	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	3383701	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	CNc1nccc(Nc2ccc(C(=O)C(=O)Nc3cc(C(C)(C)C)cc(NS(C)(=O)=O)c3OC)c3ccccc23)n1		CHEMBL1208953	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	uM	0.021
	3383702	CHEMBL1211568	Inhibition of phospho-p38 alpha activity by ELISA	B	COc1c(NC(=O)C(=O)c2ccc(Oc3ccnc(N4CCOCC4)n3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL1208954	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	3396647	CHEMBL1220468	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	Kd	nM	55.0	CHEMBL260	Homo sapiens	Kd	uM	0.055
	3396648	CHEMBL1220468	Binding affinity to p38alpha	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	495.0	CHEMBL260	Homo sapiens	Kd	uM	0.495
Not Active	3396649	CHEMBL1220468	Binding affinity to p38alpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Kd			CHEMBL260	Homo sapiens	Kd		
Not Active	3396650	CHEMBL1220468	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2c(Cl)cc(C(F)(F)F)cc2Cl)n1		CHEMBL584726		Kd			CHEMBL260	Homo sapiens	Kd		
	3396651	CHEMBL1220468	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc([N+](=O)[O-])c2)n1		CHEMBL578172	=	Kd	nM	8.0	CHEMBL260	Homo sapiens	Kd	uM	0.008
	3396652	CHEMBL1220468	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387	=	Kd	nM	12.0	CHEMBL260	Homo sapiens	Kd	uM	0.012
	3396653	CHEMBL1220468	Binding affinity to p38alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2cccc(N)c2)n1		CHEMBL87580	=	Kd	nM	197.0	CHEMBL260	Homo sapiens	Kd	uM	0.197
	3396655	CHEMBL1220611	Binding affinity to acrylodan-labelled p38 alpha assessed as binding half life at 2 uM	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	=	T1/2	hr	0.01211	CHEMBL260	Homo sapiens	t1/2	s	43.6
	3396961	CHEMBL1218393	Inhibition of p38alpha assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 4 hrs by radiometric assay	B	CONC(=O)c1ccc(C)c(Nc2nc(NCC3CCCC(CN)C3)nc(NC(C)C(C)(C)C)n2)c1		CHEMBL1213078	<=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3396962	CHEMBL1218393	Inhibition of p38alpha assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 4 hrs by radiometric assay	B	CONC(=O)c1ccc(C)c(Nc2nc(NCC3CCCC(CN)C3)nc(NC3CCCCC3)n2)c1		CHEMBL1213079	<=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3396963	CHEMBL1218393	Inhibition of p38alpha assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 4 hrs by radiometric assay	B	CONC(=O)c1ccc(C)c(Nc2nc(NCc3cccc(C)c3)nc(NC(C)C(C)(C)C)n2)c1		CHEMBL1213107	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	3396964	CHEMBL1218393	Inhibition of p38alpha assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 4 hrs by radiometric assay	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCNCC3)n2)c1		CHEMBL376506	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	3396972	CHEMBL1218395	Displacement of radioligand form p38alpha after 30 mins by luminescence assay	B	CCOc1nc(N[C@@H](Cc2ccc3c(c2)COC(C)(C)O3)C(=O)NC)nc(-n2cnc3cc(C(=O)N4CCCc5ccccc54)ccc32)n1		CHEMBL1213154	=	EC50	nM	2700.0	CHEMBL260	Homo sapiens	EC50	uM	2.7
	3396973	CHEMBL1218395	Displacement of radioligand form p38alpha after 30 mins by luminescence assay	B	CCOc1nc(N[C@@H](Cc2ccc3c(c2)COC(C)(C)O3)C(=O)NC)nc(-n2cnc3ccc(C(=O)N4CCCc5ccccc54)cc32)n1		CHEMBL1213155	<=	EC50	nM	8.0	CHEMBL260	Homo sapiens	EC50	uM	0.008
	3396974	CHEMBL1218395	Displacement of radioligand form p38alpha after 30 mins by luminescence assay	B	CNC(=O)[C@H](Cc1ccc2c(c1)COC(C)(C)O2)Nc1nc(O)nc(-n2cnc3cc(C(=O)N4CCCc5ccccc54)ccc32)n1		CHEMBL1213156	=	EC50	nM	5200.0	CHEMBL260	Homo sapiens	EC50	uM	5.2
	3396975	CHEMBL1218395	Displacement of radioligand form p38alpha after 30 mins by luminescence assay	B	CNC(=O)[C@H](Cc1ccc2c(c1)COC(C)(C)O2)Nc1nc(O)nc(-n2cnc3ccc(C(=O)N4CCCc5ccccc54)cc32)n1		CHEMBL1213157	<=	EC50	nM	7.0	CHEMBL260	Homo sapiens	EC50	uM	0.007
	3397806	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
	3397807	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	84.8	CHEMBL260	Homo sapiens	IC50	nM	84.8
	3397808	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	3397809	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)cc2)ccn1		CHEMBL1213922	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
	3397810	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	CN1CCN(Cc2ccc(C(=O)Nc3ccc(OCCN4CCOCC4)c4ccccc34)cc2)CC1		CHEMBL1213923	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
	3397811	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	Cc1ccc(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1213924	=	IC50	nM	18.4	CHEMBL260	Homo sapiens	IC50	nM	18.4
	3397812	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ccc(OCCN2CCOCC2)c2ccccc12		CHEMBL1213925	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	3397813	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL1213973	=	IC50	nM	189.3	CHEMBL260	Homo sapiens	IC50	nM	189.3
	3397814	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)cc2)ccn1		CHEMBL1213974	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	3397815	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(CN4CCN(C)CC4)cc3)cc2)ccn1		CHEMBL1213975	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
	3397816	CHEMBL1217288	Inhibition of human recombinant full-length N-terminal GST-tagged p38alpha expressed in Escherichia coli by radiometric kinase assay	B	O=C(Nc1ccc(OCCN2CCOCC2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL1213976	=	IC50	nM	105.5	CHEMBL260	Homo sapiens	IC50	nM	105.5
	3400040	CHEMBL1217237	Inhibition of human SAPK2a at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	3407714	CHEMBL1219770	Inhibition of MAPK14 at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	3407715	CHEMBL1219770	Inhibition of MAPK14 at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
Not Determined	3410600	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	CN(C)CCNC(=O)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL588573		IC50			CHEMBL260	Homo sapiens	IC50		
	3410601	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	O=C(NCCN1CCCC1)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL1222474	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3410602	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL1222565	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3410603	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1222990	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3410604	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCc4cccc(Cl)c4)nn23)cc1		CHEMBL1222992	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	3410605	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	CN(C)CCNC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223203	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
Not Determined	3410606	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	CCN(CC)CCNC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223204		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	3410607	CHEMBL1228249	Inhibition of recombinant p38alpha after 15 mins	B	CC(CN(C)C)NC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223207		IC50			CHEMBL260	Homo sapiens	IC50		
	3423139	CHEMBL1227388	Inhibition of p38alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.16	CHEMBL260	Homo sapiens	Kd	nM	0.16
	3430283	CHEMBL1248540	Binding affinity to p38alpha by radioligand displacement assay	B	O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1		CHEMBL1242923	>=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	Ki	nM	1000.0
	3430284	CHEMBL1248540	Binding affinity to p38alpha by radioligand displacement assay	B	CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1		CHEMBL1242950	>=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	Ki	nM	1000.0
	3434694	CHEMBL1246563	Inhibition of p38alpha at 5 uM	B	c1cc(-c2cc(C3CCNCC3)n[nH]2)ccn1		CHEMBL1241462	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	3439116	CHEMBL1247963	Inhibition of P38alpha by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977	=	IC50	nM	8000.0	CHEMBL260	Homo sapiens	IC50	nM	8000.0
	3443445	CHEMBL1244211	Inhibition of p38alpha at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	3443662	CHEMBL1244211	Inhibition of p38alpha at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	3444817	CHEMBL1244211	Inhibition of p38alpha at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	3445441	CHEMBL1244211	Inhibition of p38alpha at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	3445658	CHEMBL1244211	Inhibition of p38alpha at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	3445861	CHEMBL1244211	Inhibition of p38alpha at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	39.0	CHEMBL260	Homo sapiens	INH	%	39.0
	3446051	CHEMBL1244211	Inhibition of p38alpha at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	37.0	CHEMBL260	Homo sapiens	INH	%	37.0
Not Active	3446222	CHEMBL1244362	Inhibition of MAPK14	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		IC50			CHEMBL260	Homo sapiens	IC50		
	3446547	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	88.0	CHEMBL260	Homo sapiens	INH	%	88.0
	3446576	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	84.0	CHEMBL260	Homo sapiens	INH	%	84.0
	3446600	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Inhibition	%	93.0	CHEMBL260	Homo sapiens	INH	%	93.0
	3446625	CHEMBL1247633	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 20 uM	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Inhibition	%	138.0	CHEMBL260	Homo sapiens	INH	%	138.0
	3446652	CHEMBL1249545	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 50 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Inhibition	%	98.0	CHEMBL260	Homo sapiens	INH	%	98.0
	3446680	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Inhibition	%	86.0	CHEMBL260	Homo sapiens	INH	%	86.0
	3446685	CHEMBL1249809	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	3446706	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3446730	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	3446754	CHEMBL1249545	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 50 uM	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Inhibition	%	85.0	CHEMBL260	Homo sapiens	INH	%	85.0
	3446779	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	3446783	CHEMBL1249809	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	IC50	nM	55000.0	CHEMBL260	Homo sapiens	IC50	uM	55.0
	3446811	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	INH	%	75.0
	3446838	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	3446865	CHEMBL1247633	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 20 uM	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Inhibition	%	111.0	CHEMBL260	Homo sapiens	INH	%	111.0
	3446896	CHEMBL1247633	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 20 uM	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Inhibition	%	93.0	CHEMBL260	Homo sapiens	INH	%	93.0
	3447166	CHEMBL1249644	Inhibition of p38alpha kinase	B	COc1cc2ncnc(Nc3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3C)c2cc1OCCN1CCCC1		CHEMBL184659	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	3447180	CHEMBL1249644	Inhibition of p38alpha kinase	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	Kd	nM	1160.0	CHEMBL260	Homo sapiens	Kd	uM	1.16
	3447181	CHEMBL1249644	Inhibition of p38alpha kinase	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cc2ccncc2)cc1		CHEMBL288812	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	3447183	CHEMBL1249644	Inhibition of p38alpha kinase	B	O=C(Nc1ccc2ccn(CCc3ccncc3)c2c1)c1cc(F)cc(N2CCOCC2)c1		CHEMBL193264	=	IC50	nM	340.0	CHEMBL260	Homo sapiens	IC50	uM	0.34
	3447273	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Inhibition	%	94.0	CHEMBL260	Homo sapiens	INH	%	94.0
	3447307	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	99.0	CHEMBL260	Homo sapiens	INH	%	99.0
	3447322	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	Inhibition	%	104.0	CHEMBL260	Homo sapiens	INH	%	104.0
	3447346	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Inhibition	%	90.0	CHEMBL260	Homo sapiens	INH	%	90.0
	3447370	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O		CHEMBL291725	=	Inhibition	%	101.0	CHEMBL260	Homo sapiens	INH	%	101.0
	3447394	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	Inhibition	%	115.0	CHEMBL260	Homo sapiens	INH	%	115.0
	3447418	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21		CHEMBL421565	=	Inhibition	%	117.0	CHEMBL260	Homo sapiens	INH	%	117.0
	3447442	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Inhibition	%	92.0	CHEMBL260	Homo sapiens	INH	%	92.0
	3447466	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	3447490	CHEMBL1247609	Inhibition of Gst-tagged human SAPK2a/p38 expressed in Escherichia coli at 10 uM	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Inhibition	%	103.0	CHEMBL260	Homo sapiens	INH	%	103.0
	3447516	CHEMBL1249569	Inhibition of His-tagged human SAPK2a/p38 expressed in Escherichia coli at 1 uM	B	CC[C@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL1242366	=	Inhibition	%	92.0	CHEMBL260	Homo sapiens	INH	%	92.0
	3447698	CHEMBL1250003	Inhibition of p38alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	0.097	CHEMBL260	Homo sapiens	Ki	nM	0.097
	3448051	CHEMBL1249674	Inhibition of human SAPK2a activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	3448127	CHEMBL1249674	Inhibition of human SAPK2a activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	3448537	CHEMBL1244545	Binding affinity to p38-alpha	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	3449291	CHEMBL1244545	Binding affinity to p38-alpha	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	370.0	CHEMBL260	Homo sapiens	Kd	nM	370.0
	3449767	CHEMBL1244545	Binding affinity to p38-alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	3449945	CHEMBL1244545	Binding affinity to p38-alpha	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	3450374	CHEMBL1244545	Binding affinity to p38-alpha	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	3450826	CHEMBL1244545	Binding affinity to p38-alpha	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	3451085	CHEMBL1244545	Binding affinity to p38-alpha	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	uM	10.0
	3463279	CHEMBL1252482	Inhibition of MAPK14 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	3463536	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Nc2ccc(F)cc2)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1254074	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	3463537	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Nc2ccc(F)cc2F)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1254075	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	3463538	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Nc2ccc(F)cn2)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1254167	=	IC50	nM	328.0	CHEMBL260	Homo sapiens	IC50	nM	328.0
	3463539	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Nc2ncc(F)cc2F)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1254168	=	IC50	nM	111.0	CHEMBL260	Homo sapiens	IC50	nM	111.0
	3463540	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	CN(c1ccc(F)cc1)c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1253981	=	IC50	nM	299.0	CHEMBL260	Homo sapiens	IC50	nM	299.0
	3463541	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Oc2ccc(F)cc2)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1253980	=	IC50	nM	78.0	CHEMBL260	Homo sapiens	IC50	nM	78.0
	3463542	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1253894	=	IC50	nM	8.4	CHEMBL260	Homo sapiens	IC50	nM	8.4
	3463543	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Cc2ccc(F)cc2)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1253893	=	IC50	nM	55.8	CHEMBL260	Homo sapiens	IC50	nM	55.8
	3463544	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(Cc2ccc(F)cc2F)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1253813	=	IC50	nM	6.1	CHEMBL260	Homo sapiens	IC50	nM	6.1
	3463545	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1ccc(C(=O)O)cc1-c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1253812	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	3463546	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1ccc(C(N)=O)cc1-c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1255074	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	3463547	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	CNC(=O)c1ccc(C)c(-c2cc3cnnc(-c4ccc(F)cc4F)c3n(C)c2=O)c1		CHEMBL1255073	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	3463548	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1254989	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	3463549	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1ccc(C(=O)NC2(C)CC2)cc1-c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1254988	=	IC50	nM	3.1	CHEMBL260	Homo sapiens	IC50	nM	3.1
	3463550	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1254901	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	3463551	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2Cl)cc2cnnc(-c3ccc(F)cc3F)c21		CHEMBL1254900	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	3463552	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1cnc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1254572	=	IC50	nM	14.5	CHEMBL260	Homo sapiens	IC50	nM	14.5
	3463553	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1cnc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccccc3C)c2n(C)c1=O		CHEMBL1254647	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	3463554	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1cnc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccccc3Cl)c2n(C)c1=O		CHEMBL1254648	=	IC50	nM	2.1	CHEMBL260	Homo sapiens	IC50	nM	2.1
	3463555	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1cnc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccccc3C(F)(F)F)c2n(C)c1=O		CHEMBL1254731	=	IC50	nM	3.9	CHEMBL260	Homo sapiens	IC50	nM	3.9
	3463556	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1cnc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccc(F)cc3C)c2n(C)c1=O		CHEMBL1254732	=	IC50	nM	3.1	CHEMBL260	Homo sapiens	IC50	nM	3.1
	3463557	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1cnc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3ccc(C(F)(F)F)cc3F)c2n(C)c1=O		CHEMBL1254814	=	IC50	nM	2.9	CHEMBL260	Homo sapiens	IC50	nM	2.9
	3463558	CHEMBL1251348	Inhibition of p38alpha MAP kinase	B	Cc1cnc(C(=O)NC2CC2)cc1-c1cc2cnnc(-c3cc(F)ccc3Cl)c2n(C)c1=O		CHEMBL1254815	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	3463823	CHEMBL1252482	Inhibition of MAPK14 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	INH	%	17.0
	3464042	CHEMBL1252482	Inhibition of MAPK14 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	3466571	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL252128	=	IC50	nM	3.1	CHEMBL260	Homo sapiens	IC50	nM	3.1
	3466572	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)N[C@@H](C)c4ccccc4)c(C)c23)c1		CHEMBL252535	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	3466573	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NCC)c(C)c23)c1		CHEMBL1254181	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	3466574	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)N[C@@H](C)c4ccccc4)c(C)c23)c1		CHEMBL1254088	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	nM	65.0
	3466575	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC)ccc3C)c2c1C		CHEMBL1254087	=	IC50	nM	397.0	CHEMBL260	Homo sapiens	IC50	nM	397.0
	3466576	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCCNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NCCC)c(C)c23)c1		CHEMBL1254267	=	IC50	nM	166.0	CHEMBL260	Homo sapiens	IC50	nM	166.0
	3466577	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC(C)C)ccc3C)c2c1C		CHEMBL1254348	=	IC50	nM	259.0	CHEMBL260	Homo sapiens	IC50	nM	259.0
	3466578	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCCCNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)NCC)c(C)c23)c1		CHEMBL1254349	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	3466579	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NCCOC)ccc3C)c2c1C		CHEMBL1254427	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	3466580	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1254428	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	3466581	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CCC4)ccc3C)c2c1C		CHEMBL1254503	=	IC50	nM	222.0	CHEMBL260	Homo sapiens	IC50	nM	222.0
	3466582	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1254504	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	3466583	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1230065	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	3466584	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1254583	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	3466585	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL1254661	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	3466586	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CC[C@H](C)NC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1254662	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	3466587	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	COCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1254744	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	3466588	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)N[C@@H](CO)c3ccccc3)c(C)c12		CHEMBL1254745	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	3466589	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	Cc1ccc(C(=O)Nc2ccccc2)cc1Nc1ncnn2cc(C(=O)N[C@@H](C)c3ccccc3)c(C)c12		CHEMBL1254830	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	3466590	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)Nc4nccs4)ccc3C)c2c1C		CHEMBL1254831	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	nM	72.0
	3466591	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)Nc4ncc(C)s4)ccc3C)c2c1C		CHEMBL1254916	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	3466592	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)Nc4ncco4)ccc3C)c2c1C		CHEMBL1254917	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	3466593	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)Nc4ccon4)ccc3C)c2c1C		CHEMBL1255004	=	IC50	nM	7.1	CHEMBL260	Homo sapiens	IC50	nM	7.1
	3466594	CHEMBL1251166	Inhibition of bacterially expressed p38alpha pretreated for 10 mins measured after 45 mins	B	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)Nc4ccon4)ccc3C)c2c1C		CHEMBL1230070	=	IC50	nM	3.9	CHEMBL260	Homo sapiens	IC50	nM	3.9
	3499054	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccccc3F)nc(N)n2)s1		CHEMBL1257952	=	IC50	nM	225.0	CHEMBL260	Homo sapiens	IC50	nM	225.0
	3499055	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccccc3F)nc(C)n2)s1		CHEMBL1257953	=	IC50	nM	520.0	CHEMBL260	Homo sapiens	IC50	nM	520.0
	3499056	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccccc3F)nc(C3CC3)n2)s1		CHEMBL1257954	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	3499057	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2ccnc(-c3ccccc3F)n2)s1		CHEMBL1258064	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	nM	30000.0
	3499058	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2ccnc(C3CC3)n2)s1		CHEMBL1255811	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	3499059	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2ccnc(-c3ccccn3)n2)s1		CHEMBL1258065	=	IC50	nM	314.0	CHEMBL260	Homo sapiens	IC50	nM	314.0
	3499060	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccc(F)cc3)nc(-c3ccccn3)n2)s1		CHEMBL1258066	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	nM	52.0
	3499061	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccccc3F)nc(-c3ccccn3)n2)s1		CHEMBL1258181	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	nM	52.0
	3499062	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258182	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	3499063	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccccc3OCC)nc(-c3ccccn3)n2)s1		CHEMBL1258294	=	IC50	nM	859.0	CHEMBL260	Homo sapiens	IC50	nM	859.0
	3499064	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccc(F)cc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258295	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	3499065	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCCNc1ncc(-c2cc(-c3ccc(OCC)cc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258406	=	IC50	nM	3940.0	CHEMBL260	Homo sapiens	IC50	nM	3940.0
	3499066	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	Nc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258407	=	IC50	nM	114.0	CHEMBL260	Homo sapiens	IC50	nM	114.0
	3499067	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCNc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258514	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	3499068	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	Clc1ccccc1-c1cc(-c2cnc(NC3CC3)s2)nc(-c2ccccn2)n1		CHEMBL1258515	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	3499069	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	Clc1ccccc1-c1cc(-c2cnc(NC3CCC3)s2)nc(-c2ccccn2)n1		CHEMBL1258632	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	3499070	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258633	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	3499071	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC[C@H](C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258741	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	3499072	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC[C@@H](C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258742	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	3499073	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)ncn2)s1		CHEMBL1258861	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	nM	46.0
	3499074	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(N)n2)s1		CHEMBL1258862	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	3499075	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(N(C)C)n2)s1		CHEMBL1258863	=	IC50	nM	573.0	CHEMBL260	Homo sapiens	IC50	nM	573.0
	3499076	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(NCCN(C)C)n2)s1		CHEMBL1258976	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	3499077	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(NCCO)n2)s1		CHEMBL1258977	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	3499078	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(NCC(O)CO)n2)s1		CHEMBL1257244	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	3499079	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1257245	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3499080	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	3499081	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3CNC(=O)NC3CC3)nc(NCCN(C)C)n2)s1		CHEMBL1257366	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	3499153	CHEMBL1259897	Inhibition of p38alpha at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	3499154	CHEMBL1259851	Inhibition of bacterially expressed activated p38alpha pre-incubated 10 mins measured after 45 mins by scintillation counting	B	CC(C)Nc1ncc(-c2ccnc(-c3ccccc3Cl)n2)s1		CHEMBL1257475	=	IC50	nM	223.0	CHEMBL260	Homo sapiens	IC50	nM	223.0
	3504310	CHEMBL1260192	Inhibition of p38alpha	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	3513291	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCC#N		CHEMBL1257930	=	Ki	nM	252.0	CHEMBL260	Homo sapiens	Ki	uM	0.252
	3513292	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCc1ccncc1		CHEMBL1257813	=	Ki	nM	176.0	CHEMBL260	Homo sapiens	Ki	uM	0.176
	3513293	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	CCN(CCN)C(=O)c1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)ccc1C		CHEMBL1257691	=	Ki	nM	157.0	CHEMBL260	Homo sapiens	Ki	uM	0.157
	3513294	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCN1CCN(C)CC1		CHEMBL1256035	=	Ki	nM	140.0	CHEMBL260	Homo sapiens	Ki	uM	0.14
	3513295	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)N[C@@H]1CS(=O)(=O)C[C@H]1O		CHEMBL1257569	=	Ki	nM	112.0	CHEMBL260	Homo sapiens	Ki	uM	0.112
	3513296	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)N(CCCN)C1CCCCC1		CHEMBL1256034	=	Ki	nM	89.0	CHEMBL260	Homo sapiens	Ki	uM	0.089
	3513297	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	CCN(CC)CCNC(=O)c1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)ccc1C		CHEMBL1257450	=	Ki	nM	86.0	CHEMBL260	Homo sapiens	Ki	uM	0.086
	3513298	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(CN3C(=O)CNS3(=O)=O)c2)n1		CHEMBL1257218	=	Ki	nM	99.0	CHEMBL260	Homo sapiens	Ki	uM	0.099
	3513299	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	22.0	CHEMBL260	Homo sapiens	Ki	uM	0.022
	3513300	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	57.0	CHEMBL260	Homo sapiens	Ki	uM	0.057
	3513301	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCCO		CHEMBL1257931	=	Ki	nM	283.0	CHEMBL260	Homo sapiens	Ki	uM	0.283
	3513302	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCCN1CCOCC1		CHEMBL1256033	=	Ki	nM	291.0	CHEMBL260	Homo sapiens	Ki	uM	0.291
	3513303	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCCN1CCCC1		CHEMBL1258040	=	Ki	nM	301.0	CHEMBL260	Homo sapiens	Ki	uM	0.301
	3513304	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)N(CCCN)C(C)C		CHEMBL1258158	=	Ki	nM	312.0	CHEMBL260	Homo sapiens	Ki	uM	0.312
	3513305	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCc1ccncn1		CHEMBL1255614	=	Ki	nM	327.0	CHEMBL260	Homo sapiens	Ki	uM	0.327
	3513306	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	COCCCN1CCC(NC(=O)c2cc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3cccc4ccccc34)ccc2C)CC1		CHEMBL1256036	=	Ki	nM	336.0	CHEMBL260	Homo sapiens	Ki	uM	0.336
	3513307	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCNc1ccccc1		CHEMBL1256037	=	Ki	nM	433.0	CHEMBL260	Homo sapiens	Ki	uM	0.433
	3513308	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NC[C@@H](CO)C(C)C		CHEMBL1258273	=	Ki	nM	471.0	CHEMBL260	Homo sapiens	Ki	uM	0.471
	3513309	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)N(C)CCN		CHEMBL1258386	=	Ki	nM	715.0	CHEMBL260	Homo sapiens	Ki	uM	0.715
	3513310	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	CCN(CCN(C)C)C(=O)c1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)ccc1C		CHEMBL1258498	=	Ki	nM	735.0	CHEMBL260	Homo sapiens	Ki	uM	0.735
	3513311	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCC(CC(C)C)C(N)=O		CHEMBL1256038	=	Ki	nM	786.0	CHEMBL260	Homo sapiens	Ki	uM	0.786
	3513312	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NC1CCN(CCN2CCOCC2)CC1		CHEMBL1256039	=	Ki	nM	885.0	CHEMBL260	Homo sapiens	Ki	uM	0.885
	3513313	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	CCN(CCOC)C(=O)c1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)ccc1C		CHEMBL1258609	=	Ki	nM	1390.0	CHEMBL260	Homo sapiens	Ki	uM	1.39
	3513314	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCc1c[nH]c2ccccc12		CHEMBL1256040	=	Ki	nM	1400.0	CHEMBL260	Homo sapiens	Ki	uM	1.4
	3513315	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCc1ccc(N)cc1		CHEMBL1256041	=	Ki	nM	1450.0	CHEMBL260	Homo sapiens	Ki	uM	1.45
	3513316	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	COc1ccccc1CCNC(=O)c1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)ccc1C		CHEMBL1256042	>	Ki	nM	3900.0	CHEMBL260	Homo sapiens	Ki	uM	3.9
	3513317	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCCC1=CCCCC1		CHEMBL1258717	>	Ki	nM	3900.0	CHEMBL260	Homo sapiens	Ki	uM	3.9
	3513318	CHEMBL1261656	Binding affinity to full-length GST-tagged p38alpha after 2.5 hrs by TR-FRET competition binding assay	B	COc1ccc(CCNC(=O)c2cc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3cccc4ccccc34)ccc2C)cc1		CHEMBL1256043	>	Ki	nM	3900.0	CHEMBL260	Homo sapiens	Ki	uM	3.9
	3513319	CHEMBL1261723	Binding affinity to full-length GST-tagged p38alpha by surface plasmon resonance assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	4.1	CHEMBL260	Homo sapiens	Kd	nM	4.1
	3513320	CHEMBL1261723	Binding affinity to full-length GST-tagged p38alpha by surface plasmon resonance assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.098	CHEMBL260	Homo sapiens	Kd	nM	0.098
	3513321	CHEMBL1261723	Binding affinity to full-length GST-tagged p38alpha by surface plasmon resonance assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(CN3C(=O)CNS3(=O)=O)c2)n1		CHEMBL1257218	=	Kd	nM	564.0	CHEMBL260	Homo sapiens	Kd	nM	564.0
	3513322	CHEMBL1261723	Binding affinity to full-length GST-tagged p38alpha by surface plasmon resonance assay	B	CCN(CC)CCNC(=O)c1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)ccc1C		CHEMBL1257450	=	Kd	nM	14.0	CHEMBL260	Homo sapiens	Kd	nM	14.0
	3513323	CHEMBL1261723	Binding affinity to full-length GST-tagged p38alpha by surface plasmon resonance assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCc1ccncc1		CHEMBL1257813	=	Kd	nM	10.0	CHEMBL260	Homo sapiens	Kd	nM	10.0
	3513324	CHEMBL1261723	Binding affinity to full-length GST-tagged p38alpha by surface plasmon resonance assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)cc1C(=O)NCC#N		CHEMBL1257930	=	Kd	nM	55.0	CHEMBL260	Homo sapiens	Kd	nM	55.0
	3515473	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	Cn1[nH]c(=O)n(Cc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3cccc4ccccc34)c2)c1=O		CHEMBL1270655	=	IC50	nM	292.0	CHEMBL260	Homo sapiens	IC50	nM	292.0
	3515474	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC1(C)C(=O)NN(Cc2cccc(-n3nc(C(C)(C)C)cc3NC(=O)Nc3cccc4ccccc34)c2)C1=O		CHEMBL1269011	=	IC50	nM	384.0	CHEMBL260	Homo sapiens	IC50	nM	384.0
	3515475	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(CNS(=O)(=O)NC(=O)N3CCCC3)c2)n1		CHEMBL1270557	=	IC50	nM	1107.0	CHEMBL260	Homo sapiens	IC50	nM	1107.0
	3515476	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(CN3C(=O)CNS3(=O)=O)c2)n1		CHEMBL1257218	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	nM	57.0
	3515477	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(CCN)c2)n1		CHEMBL1269026	=	IC50	nM	508.0	CHEMBL260	Homo sapiens	IC50	nM	508.0
	3515478	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CNC(=O)CNC(=O)CNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1270855	=	IC50	nM	949.0	CHEMBL260	Homo sapiens	IC50	nM	949.0
	3515479	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)N3C(=O)OC[C@@H]3c3ccccc3)c2)n1		CHEMBL1269405	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	3515480	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(CC(=O)N3CCOCC3)c2)n1		CHEMBL1270956	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	3515481	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1270957	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	nM	68.0
	3515482	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccc(CN3CCS(=O)(=O)CC3)cc2)n1		CHEMBL1271061	=	IC50	nM	2450.0	CHEMBL260	Homo sapiens	IC50	nM	2450.0
	3515483	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(CN)cc2)n1		CHEMBL1271062	=	IC50	nM	1740.0	CHEMBL260	Homo sapiens	IC50	nM	1740.0
	3515484	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccc(CO)cc2)n1		CHEMBL1271167	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	3515485	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccc(CCC(=O)O)cc2)n1		CHEMBL1271168	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	3515486	CHEMBL1274707	Inhibition of p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2ccc(CC(=O)N3CCS(=O)(=O)CC3)cc2)n1		CHEMBL1271268	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	3515487	CHEMBL1274708	Binding affinity to unphosphorylated p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271269	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	3515488	CHEMBL1274708	Binding affinity to unphosphorylated p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271376	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	3515489	CHEMBL1274708	Binding affinity to unphosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1271377	=	IC50	nM	119.0	CHEMBL260	Homo sapiens	IC50	nM	119.0
	3515490	CHEMBL1274708	Binding affinity to unphosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3F)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269838	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	3515491	CHEMBL1274708	Binding affinity to unphosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3cccs3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269839	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
	3515492	CHEMBL1274708	Binding affinity to unphosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3ccsc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269946	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	3515493	CHEMBL1274708	Binding affinity to unphosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269947	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	3515494	CHEMBL1274709	Binding affinity to phosphorylated p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271269	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	3515495	CHEMBL1274709	Binding affinity to phosphorylated p38alpha by fluoroprobe binding assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271376	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	3515496	CHEMBL1274709	Binding affinity to phosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1271377	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	3515497	CHEMBL1274709	Binding affinity to phosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3F)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269838	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	3515498	CHEMBL1274709	Binding affinity to phosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3cccs3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269839	=	IC50	nM	66.0	CHEMBL260	Homo sapiens	IC50	nM	66.0
	3515499	CHEMBL1274709	Binding affinity to phosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(-c3ccsc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269946	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	3515500	CHEMBL1274709	Binding affinity to phosphorylated p38alpha by fluoroprobe binding assay	B	NC(=O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269947	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	3515501	CHEMBL1274710	Binding affinity to unphosphorylated p38alpha assessed as change in melting temperature	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271269	=	Delta Tm	degrees C	9.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.1
	3515502	CHEMBL1274710	Binding affinity to unphosphorylated p38alpha assessed as change in melting temperature	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271376	=	Delta Tm	degrees C	12.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.8
	3515503	CHEMBL1274710	Binding affinity to unphosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1271377	=	Delta Tm	degrees C	8.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.0
	3515504	CHEMBL1274710	Binding affinity to unphosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3F)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269838	=	Delta Tm	degrees C	8.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.8
	3515505	CHEMBL1274710	Binding affinity to unphosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3cccs3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269839	=	Delta Tm	degrees C	11.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	11.2
	3515506	CHEMBL1274710	Binding affinity to unphosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3ccsc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269946	=	Delta Tm	degrees C	11.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	11.6
	3515507	CHEMBL1274710	Binding affinity to unphosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269947	=	Delta Tm	degrees C	12.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.2
	3515508	CHEMBL1274711	Binding affinity to phosphorylated p38alpha assessed as change in melting temperature	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271269	=	Delta Tm	degrees C	8.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.6
	3515509	CHEMBL1274711	Binding affinity to phosphorylated p38alpha assessed as change in melting temperature	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Cl)c2Cl)n(-c2cccc(CC(N)=O)c2)n1		CHEMBL1271376	=	Delta Tm	degrees C	9.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.1
	3515510	CHEMBL1274711	Binding affinity to phosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1271377	=	Delta Tm	degrees C	5.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.4
	3515511	CHEMBL1274711	Binding affinity to phosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3ccccc3F)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269838	=	Delta Tm	degrees C	7.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.1
	3515512	CHEMBL1274711	Binding affinity to phosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3cccs3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269839	=	Delta Tm	degrees C	8.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.5
	3515513	CHEMBL1274711	Binding affinity to phosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(-c3ccsc3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269946	=	Delta Tm	degrees C	9.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.3
Not Determined	3515514	CHEMBL1274711	Binding affinity to phosphorylated p38alpha assessed as change in melting temperature	B	NC(=O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269947		deltaTm			CHEMBL260	Homo sapiens	deltaTm		
	3515517	CHEMBL1274712	Inhibition of p38alpha autophosphorylation	B	NC(=O)Cc1cccc(-n2nc(-c3cccs3)cc2NC(=O)Nc2cccc(Cl)c2Cl)c1		CHEMBL1269839	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	3520686	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL426183	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	3520687	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCO		CHEMBL373807	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	3520688	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCO		CHEMBL374531	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	3520689	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCCO		CHEMBL1272053	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	3520690	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CC(O)CO		CHEMBL1272104	=	IC50	nM	1490.0	CHEMBL260	Homo sapiens	IC50	uM	1.49
	3520691	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C(CO)CO		CHEMBL1272105	=	IC50	nM	6280.0	CHEMBL260	Homo sapiens	IC50	uM	6.28
	3520692	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C(CCO)CCO		CHEMBL1272159	=	IC50	nM	6140.0	CHEMBL260	Homo sapiens	IC50	uM	6.14
	3520693	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCC(=O)O		CHEMBL1272160	=	IC50	nM	2260.0	CHEMBL260	Homo sapiens	IC50	uM	2.26
	3520694	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCOC(=O)CCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL1272214	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	uM	0.44
	3520695	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	COC(=O)CCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL1272215	=	IC50	nM	330.0	CHEMBL260	Homo sapiens	IC50	uM	0.33
	3520696	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCC(=O)O		CHEMBL1272268	=	IC50	nM	1620.0	CHEMBL260	Homo sapiens	IC50	uM	1.62
	3520697	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCCC(=O)O		CHEMBL1272269	=	IC50	nM	770.0	CHEMBL260	Homo sapiens	IC50	uM	0.77
	3520698	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCC(=O)N1CCCC1		CHEMBL1272315	=	IC50	nM	1140.0	CHEMBL260	Homo sapiens	IC50	uM	1.14
	3520699	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCN(CC)C(=O)CCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL1272316	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	3520700	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCC(=O)N1CCCCC1		CHEMBL1271499	=	IC50	nM	2240.0	CHEMBL260	Homo sapiens	IC50	uM	2.24
	3520701	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCC(=O)N1CCOCC1		CHEMBL1271500	=	IC50	nM	1570.0	CHEMBL260	Homo sapiens	IC50	uM	1.57
	3520702	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCN(CC)C(=O)Cn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL1271552	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	3520703	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CC(=O)N1CCOCC1		CHEMBL1271553	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	3520704	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C1CCOCC1		CHEMBL1271609	=	IC50	nM	780.0	CHEMBL260	Homo sapiens	IC50	uM	0.78
	3520705	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1[C@H]1CC[C@H](O)CC1		CHEMBL1271610	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	3520706	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C1CCCCC1		CHEMBL1271660	=	IC50	nM	790.0	CHEMBL260	Homo sapiens	IC50	uM	0.79
	3520707	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C1CC1		CHEMBL1271661	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	3520708	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCC(CC)n1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1		CHEMBL1271713	=	IC50	nM	570.0	CHEMBL260	Homo sapiens	IC50	uM	0.57
	3520709	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCl		CHEMBL1271714	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	3520710	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCCl		CHEMBL1271774	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	3520711	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCCCl		CHEMBL1271775	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	3520712	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCBr		CHEMBL1271830	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	3520713	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCF		CHEMBL1271831	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	3520714	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CCCI		CHEMBL1271889	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	3520715	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	C=CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SC)n2CCOC)ccn1		CHEMBL1271890	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	3520716	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SC)n2CCOC)ccn1		CHEMBL1269040	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	3520717	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)CC(F)(F)F)c1		CHEMBL1271943	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	3520718	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)c2cccs2)c1		CHEMBL1271998	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	3520719	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL1271999	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	3520720	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)/C=C/c2ccc(OC)cc2OC)c1		CHEMBL1272054	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	3520721	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)/C=C/c2ccc(OC)cc2)c1		CHEMBL1272055	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	uM	0.075
	3520722	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1		CHEMBL1272106	=	IC50	nM	93.0	CHEMBL260	Homo sapiens	IC50	uM	0.093
	3520723	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)/C=C/c3c(Cl)cccc3Cl)c2)n1C		CHEMBL1272107	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	3520724	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3c(-c4ccc(F)cc4)nc(SC)n3C)ccn2)c(OC)c1		CHEMBL1272161	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	3520725	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3c(-c4ccc(F)cc4)nc(SC)n3C)ccn2)cc1		CHEMBL1272162	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	3520726	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)n1C		CHEMBL1272216	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	3520727	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(Cl)cc3)c2)n1C		CHEMBL1272217	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	3520728	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)n1C		CHEMBL1272270	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	3520729	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCCC3)c2)n1C		CHEMBL1272271	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	3520730	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)/C=C/c3ccc(C)cc3)c2)[nH]1		CHEMBL1272317	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	uM	0.032
	3520731	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc1		CHEMBL1272318	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	3520732	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)/C=C/c3c(Cl)cccc3Cl)c2)[nH]1		CHEMBL1271501	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	3520733	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)/C(F)=C/c3ccccc3)c2)[nH]1		CHEMBL1271502	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	3520734	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1271554	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	3520735	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(C)c(F)c3)c2)[nH]1		CHEMBL1271555	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	3520736	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)COc3ccc(Cl)cc3)c2)[nH]1		CHEMBL1271611	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	3520737	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)COc3ccc(Cl)cc3Cl)c2)[nH]1		CHEMBL1271612	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	3520738	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)COc3cccc(Cl)c3Cl)c2)[nH]1		CHEMBL1271662	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	3520739	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3cc4ccccc4o3)c2)[nH]1		CHEMBL1271663	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	uM	0.053
	3520740	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3=Cc4ccccc4OC3)c2)[nH]1		CHEMBL1271715	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	3520741	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C(C)c3ccc(CC(C)C)cc3)c2)[nH]1		CHEMBL1271716	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	uM	0.09
	3520742	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CCc3ccc(C(C)(C)C)cc3)c2)[nH]1		CHEMBL1271776	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	3520743	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccco3)c2)[nH]1		CHEMBL1271777	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	3520744	CHEMBL1273209	Inhibition of p38alpha by immunosorbent based assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(-c4ccccc4)cc3)c2)[nH]1		CHEMBL1271832	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	3525162	CHEMBL1274109	Inhibition of p38alpha at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	92.0	CHEMBL260	Homo sapiens	INH	%	92.0
	3525192	CHEMBL1274109	Inhibition of p38alpha at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	Inhibition	%	96.0	CHEMBL260	Homo sapiens	INH	%	96.0
	3525222	CHEMBL1274109	Inhibition of p38alpha at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	91.0	CHEMBL260	Homo sapiens	INH	%	91.0
	3525252	CHEMBL1274109	Inhibition of p38alpha at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	Inhibition	%	110.0	CHEMBL260	Homo sapiens	INH	%	110.0
	3525282	CHEMBL1274109	Inhibition of p38alpha at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	121.0	CHEMBL260	Homo sapiens	INH	%	121.0
	3525312	CHEMBL1274109	Inhibition of p38alpha at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	85.0	CHEMBL260	Homo sapiens	INH	%	85.0
	3526972	CHEMBL1275093	Inhibition of P38alpha	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
Not Determined	3527784	CHEMBL1274489	Inhibition of p38alpha	B	O=S(=O)(Nc1ccnc(NCCc2ccccc2)n1)c1ccc(Cl)cc1		CHEMBL1270522		IC50			CHEMBL260	Homo sapiens	IC50		
	3527785	CHEMBL1274489	Inhibition of p38alpha	B	O=S(=O)(Nc1nc(NCCc2ccccc2)nc2c1CN(Cc1ccccc1)CC2)c1ccc2ccccc2c1		CHEMBL1271447	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	uM	11.0
	3527786	CHEMBL1274489	Inhibition of p38alpha	B	Cc1c(Cl)cccc1S(=O)(=O)Nc1nc(NCCc2ccccc2)nc2c1CN(Cc1ccccc1)CC2		CHEMBL1270331	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	uM	11.0
	3556138	CHEMBL1285877	Inhibition of MAPK14	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	IC50	nM	145.0	CHEMBL260	Homo sapiens	IC50	nM	145.0
	3556145	CHEMBL1285599	Inhibition of MAPK14 at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	81.0	CHEMBL260	Homo sapiens	INH	%	81.0
	3590776	CHEMBL1292148	Inhibition of human p38-alpha	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL260	Homo sapiens	Ki	uM	1000.0
	3590825	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2)c1		CHEMBL410668	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	3590826	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CNC(=O)c1ccc(C)c(NC(=O)c2cnn(-c3ccccc3)c2N)c1		CHEMBL1290288	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	3590827	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCNC(=O)c1ccc(C)c(NC(=O)c2cnn(-c3ccccc3)c2N)c1		CHEMBL1290289	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	3590828	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1290404	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	3590829	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	Cc1ccc(C(=O)Nc2ccnn2C)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1290405	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	3590830	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCn1nccc1NC(=O)c1ccc(C)c(NC(=O)c2cnn(-c3ccccc3)c2N)c1		CHEMBL1290514	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	3590831	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1234931	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	3590832	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccn2)c1N		CHEMBL1290626	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3590833	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCn1nccc1NC(=O)c1ccc(C)c(NC(=O)c2cnn(-c3ccccc3F)c2N)c1		CHEMBL1290627	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	3590834	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	Cc1ccc(C(=O)Nc2ccnn2C)cc1NC(=O)c1cnn(-c2ccccc2F)c1N		CHEMBL1290745	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	3590835	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N		CHEMBL1290746	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3590836	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCn1nccc1NC(=O)c1ccc(C)c(NC(=O)c2cnn(-c3ccc(F)cc3)c2N)c1		CHEMBL1289077	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3590837	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccc(F)cc2)c1N		CHEMBL1289078	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3590838	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCCCn1ncc(C(=O)Nc2cc(C(=O)Nc3ccnn3C)ccc2C)c1N		CHEMBL1287825	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	3590839	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCCCn1ncc(C(=O)Nc2cc(C(=O)Nc3ccon3)ccc2C)c1N		CHEMBL1289197	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	3590840	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CNc1c(C(=O)Nc2cc(C(=O)Nc3ccon3)ccc2C)cnn1-c1ccccc1		CHEMBL1289308	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	3590841	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCNC(=O)c1ccc(C)c(NC(=O)c2cnn(-c3ccccc3)c2NCC)c1		CHEMBL1289309	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	3590842	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCNc1c(C(=O)Nc2cc(C(=O)Nc3ccon3)ccc2C)cnn1-c1ccccn1		CHEMBL1289426	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	3590843	CHEMBL1292159	Inhibition of human recombinant p38alpha	B	CCNc1c(C(=O)Nc2cc(C(=O)Nc3ccon3)ccc2C)cnn1-c1ccccc1C		CHEMBL1289427	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	3601437	CHEMBL1292411	Inhibition of p38-alpha	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	3603136	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1nc[nH]n1		CHEMBL1288128	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603138	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COC(=O)c1sccc1NC(=O)Cc1cccc2cnccc12		CHEMBL1288215	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603140	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COC(=O)c1n[nH]cc1NC(=O)Cc1cccc2ccccc12		CHEMBL1287886	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603142	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COc1ccc(CC(=O)Nc2ccsc2-c2n[nH]c(C(F)(F)F)n2)cc1		CHEMBL1288038	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603144	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COc1ccc(CC(=O)Nc2ccsc2-c2n[nH]c(N)n2)cc1		CHEMBL1288039	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603146	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COc1ccc(CC(=O)Nc2ccsc2-c2cn(C)cn2)cc1		CHEMBL1288067	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603148	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COc1ccc(CC(=O)Nc2ccsc2-c2c[nH]c(C)n2)cc1		CHEMBL1288069	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603150	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COc1ccc(CC(=O)Nc2ccsc2-c2cnccn2)cc1		CHEMBL1288098	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603152	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2cnccc12)Nc1ccsc1-c1cscn1		CHEMBL1288100	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603154	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COC(=O)c1ncsc1NC(=O)Cc1cccc2cnccc12		CHEMBL1288127	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603156	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cn1ncnc1-c1ncsc1NC(=O)Cc1cccc2cnccc12		CHEMBL1288129	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603158	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cnccn1		CHEMBL1288159	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	3603160	CHEMBL1291192	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5120104	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	5120241	CHEMBL1646645	Inhibition of human SAPK2a at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	71.0	CHEMBL260	Homo sapiens	INH	%	71.0
	5120362	CHEMBL1646646	Inhibition of human SAPK2a T106M mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	104.0	CHEMBL260	Homo sapiens	INH	%	104.0
	5120847	CHEMBL1646932	Inhibition of MAPK14 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	5121188	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	C[C@H](Nc1cc(-c2n[nH]c(=O)n2-c2ccc3ccccc3c2)ccn1)c1ccccc1		CHEMBL1644628	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	5121216	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644617	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121217	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121218	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121219	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121220	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644621	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121221	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644622	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121222	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644623	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121223	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(Nc3ccccc3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644624	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121224	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(Nc3ccccn3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644625	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121225	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(Nc3cccnc3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644626	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121226	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(Nc3nccs3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644627	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121227	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	CC(=O)Nc1cc(-c2n[nH]c(=O)n2-c2ccc3ccccc3c2)ccn1		CHEMBL1644629	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121228	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Nc1cc(-c2n[nH]c(=O)n2-c2ccc3ccccc3c2)ccn1)C1CC1		CHEMBL1644630	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121229	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Nc1cc(-c2n[nH]c(=O)n2-c2ccc3ccccc3c2)ccn1)c1ccccc1		CHEMBL1644631	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121230	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2cc(F)ccc2c1		CHEMBL1644632	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121231	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Nc1ccc2cc(-n3c(-c4ccnc(NC5CCOCC5)c4)n[nH]c3=O)ccc2c1		CHEMBL1644633	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121232	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2cc(Br)ccc2c1		CHEMBL1644634	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121233	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2cccc(F)c2c1		CHEMBL1644635	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121234	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Nc1cccc2ccc(-n3c(-c4ccnc(NC5CCOCC5)c4)n[nH]c3=O)cc12		CHEMBL1644636	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121235	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1n(CC2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644638	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121236	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121237	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1n(C2CCOC2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644640	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121238	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1n(-c2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644641	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121239	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121240	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121241	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=c1n(C2CCNCC2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644643	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5121242	CHEMBL1648829	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COC(=O)N1CCC(n2nc(-c3ccnc(NC4CCOCC4)c3)n(-c3ccc4ccccc4c3)c2=O)CC1		CHEMBL1644646	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5133712	CHEMBL1648530	Inhibition of p38alpha assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	81.0	CHEMBL260	Homo sapiens	Activity	%	81.0
	5133807	CHEMBL1648530	Inhibition of p38alpha assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	71.0	CHEMBL260	Homo sapiens	Activity	%	71.0
	5133864	CHEMBL1648530	Inhibition of p38alpha assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	58.0	CHEMBL260	Homo sapiens	Activity	%	58.0
	5140499	CHEMBL1646788	Inhibition of MAPK14 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	5152496	CHEMBL1656541	Inhibition of p38alpha by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	5152521	CHEMBL1656541	Inhibition of p38alpha by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	5171440	CHEMBL1664298	Inhibition of p38alpha after 1 hr by ELISA	B	COc1c(O)cc([C@H]2Oc3cc(O)cc(O)c3C[C@H]2O)cc1O		CHEMBL485460	=	IC50	nM	39160.0	CHEMBL260	Homo sapiens	IC50	uM	39.16
	5171441	CHEMBL1664298	Inhibition of p38alpha after 1 hr by ELISA	B	O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1		CHEMBL297453	=	IC50	nM	2210.0	CHEMBL260	Homo sapiens	IC50	uM	2.21
	5171442	CHEMBL1664298	Inhibition of p38alpha after 1 hr by ELISA	B	O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1		CHEMBL36327	=	IC50	nM	1470.0	CHEMBL260	Homo sapiens	IC50	uM	1.47
	5171443	CHEMBL1664298	Inhibition of p38alpha after 1 hr by ELISA	B	COc1cc([C@H]2CC(=O)Oc3cc(O)c4c(c32)O[C@H](c2cc(O)c(OC)c(O)c2)[C@@H](O)C4)ccc1O		CHEMBL1651277	=	IC50	nM	50800.0	CHEMBL260	Homo sapiens	IC50	uM	50.8
	5191337	CHEMBL1663970	Inhibition of p38alpha MAPK at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	5191338	CHEMBL1663970	Inhibition of p38alpha MAPK at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
Not Active	5239589	CHEMBL1686875	Inhibition of p38alpha up to 10 uM	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	5243765	CHEMBL1685869	Inhibition of SAPK2a at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	89.0	CHEMBL260	Homo sapiens	INH	%	89.0
	5243873	CHEMBL1686085	Inhibition of SAPK2a at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	97.0	CHEMBL260	Homo sapiens	INH	%	97.0
	5243986	CHEMBL1685869	Inhibition of SAPK2a at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	105.0	CHEMBL260	Homo sapiens	INH	%	105.0
	5244094	CHEMBL1686085	Inhibition of SAPK2a at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	99.0	CHEMBL260	Homo sapiens	INH	%	99.0
	5244967	CHEMBL1685869	Inhibition of SAPK2a at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	98.0	CHEMBL260	Homo sapiens	INH	%	98.0
	5245075	CHEMBL1686085	Inhibition of SAPK2a at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	5245226	CHEMBL1685869	Inhibition of SAPK2a at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	106.0	CHEMBL260	Homo sapiens	INH	%	106.0
	5246056	CHEMBL1686085	Inhibition of SAPK2a at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	92.0	CHEMBL260	Homo sapiens	INH	%	92.0
	5249356	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	COC(=O)c1sccc1NC(=O)Cc1cccs1		CHEMBL1288895	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249357	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cc1n[nH]c(-c2c(C)csc2NC(=O)Cc2ccc(-c3ccncc3)cc2)n1		CHEMBL1682007	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	5249358	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cc1n[nH]c(-c2c(C)csc2NC(=O)Cc2ccc(OCCCN3CCCCC3)cc2)n1		CHEMBL1682008	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	5249359	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cc1n[nH]c(-c2c(C)csc2NC(=O)Cc2cccc3nccnc23)n1		CHEMBL1682009	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	5249360	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cc1n[nH]c(-c2c(C)csc2NC(=O)Cc2cccc3ncccc23)n1		CHEMBL1682010	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249361	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cc1csc(NC(=O)Cc2cccc3ncccc23)c1-c1ncn[nH]1		CHEMBL1682011	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249362	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cc1n[nH]c(-c2c(C)csc2NC(=O)CN2C(=O)CCc3ccccc32)n1		CHEMBL1682012	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249363	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	Cc1csc(NC(=O)CN2C(=O)CCc3ccccc32)c1-c1ncn[nH]1		CHEMBL1614820	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249364	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(CN1C(=O)CCc2ccccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1682013	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	5249365	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(CN1C(=O)CCc2ccccc21)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682014	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249366	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	N#Cc1csc(NC(=O)CN2C(=O)CCc3ccccc32)c1-c1ncn[nH]1		CHEMBL1682015	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249367	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2cnccc12)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1682016	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249368	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249369	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	N#Cc1csc(NC(=O)Cc2cccc3cnccc23)c1-c1ncn[nH]1		CHEMBL1682018	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249370	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2ncccc12)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1682019	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249371	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	O=C(Cc1cccc2ncccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682020	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5249372	CHEMBL1686761	Inhibition of recombinant p38alpha after 60 mins by TR-FRET assay	B	N#Cc1csc(NC(=O)Cc2cccc3ncccc23)c1-c1ncn[nH]1		CHEMBL1682021	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	5310435	CHEMBL1693595	Inhibition of p38alpha	B	CN(C)Cc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688860	=	IC50	nM	91.0	CHEMBL260	Homo sapiens	IC50	nM	91.0
	5310436	CHEMBL1693595	Inhibition of p38alpha	B	CC(C)(N)c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1		CHEMBL1688861	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	6167662	CHEMBL1769203	Inhibition of P38alpha	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL260	Homo sapiens	Ki	uM	1.0
	6168876	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766440	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168877	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766441	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168878	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccnc2ccc(-c3cn(CC(=O)Nc4ccccc4)nc3-c3cccc(C)n3)cc12		CHEMBL1766442	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168879	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccnc2ccc(-c3cn(CC(=O)Nc4cccc(C#N)c4)nc3-c3cccc(C)n3)cc12		CHEMBL1766443	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168880	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766444	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168881	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1766445	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168882	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1766446	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168883	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccnc2ccc(-c3cnn(CC(=O)Nc4ccccc4)c3-c3cccc(C)n3)cc12		CHEMBL1766447	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168884	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccnc2ccc(-c3cnn(CC(=O)Nc4cccc(C#N)c4)c3-c3cccc(C)n3)cc12		CHEMBL1766448	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168885	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2c(-c3ccc4ncccc4c3)cnn2CC(=O)Nc2cccc(C(N)=O)c2)n1		CHEMBL1766449	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168886	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766450	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168887	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766451	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168888	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccnc2ccc(-c3cn(CCC(=O)Nc4cccc(C#N)c4)nc3-c3cccc(C)n3)cc12		CHEMBL1766452	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168889	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766453	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168890	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766454	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168891	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CCC(=S)Nc3ccccc3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766455	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6168892	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nn(CCC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncccc3c2)n1		CHEMBL1766456	=	IC50	nM	630.0	CHEMBL260	Homo sapiens	IC50	uM	0.63
	6168893	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	594.0	CHEMBL260	Homo sapiens	IC50	uM	0.594
	6168894	CHEMBL1768524	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	6172865	CHEMBL1769105	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein at 10 uM after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	>	Inhibition	%	85.0	CHEMBL260	Homo sapiens	INH	%	85.0
	6172890	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	6172891	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CO)CO)nc21		CHEMBL1766577	=	IC50	nM	158.0	CHEMBL260	Homo sapiens	IC50	nM	158.0
	6172892	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	6172893	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCS(C)(=O)=O)nc21		CHEMBL1766578	=	IC50	nM	223.0	CHEMBL260	Homo sapiens	IC50	nM	223.0
	6172894	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766490	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	6172895	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	C[C@H](CS(C)(=O)=O)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232769	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	6172896	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccccc2)cc2cnc(NC3CCOCC3)nc21		CHEMBL1232773	=	IC50	nM	106.0	CHEMBL260	Homo sapiens	IC50	nM	106.0
	6172897	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	C[C@@H](CS(C)(=O)=O)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1230610	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	6172898	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766491	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	6172899	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CC(=O)N1CCC(Nc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL1766579	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	6172900	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2cccc(F)c2)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766492	=	IC50	nM	594.0	CHEMBL260	Homo sapiens	IC50	nM	594.0
	6172901	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N[C@H]3CC[C@H](O)CC3)nc21		CHEMBL1766580	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	6172902	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccccc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766493	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	6172903	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCS(=O)(=O)CC3)nc21		CHEMBL1766581	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	6172904	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Sc2ccccc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766494	=	IC50	nM	111.0	CHEMBL260	Homo sapiens	IC50	nM	111.0
	6172905	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	C[C@@H](Cn1ncnn1)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232784	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	6172906	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Cc2ccccc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766495	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	6172907	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	C[C@H](Cn1ncnn1)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1230351	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	6172908	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Cc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766496	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	6172909	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	O=c1[nH]c2nc(NC3CCOCC3)ncc2cc1Oc1ccc(F)cc1F		CHEMBL1766497	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	6172910	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CCn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766498	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	6172911	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	O=c1c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc2n1C1CC1		CHEMBL1766499	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	6172912	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	O=c1c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc2n1CCCO		CHEMBL1766500	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	6172913	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CS(=O)(=O)CCn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766501	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	6172914	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CS(=O)(=O)CCCn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766502	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	6172915	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	O=c1c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc2n1C1CCS(=O)(=O)CC1		CHEMBL1766503	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	6172916	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CC(C)(O)Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766504	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	6172917	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	O=c1c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc2n1C[C@H](O)CO		CHEMBL1766505	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	6172918	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	N#CCn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766506	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	6172919	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CS(=O)(=O)N1CCC(n2c(=O)c(Oc3ccc(F)cc3F)cc3cnc(NC4CCOCC4)nc32)CC1		CHEMBL1766572	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	6172920	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1766573	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	nM	260.0
	6172921	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	CC(C)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232772	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	6172922	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(N[C@H]3CCOC3)nc21		CHEMBL1766574	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	6172923	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCC(C)(C)O)nc21		CHEMBL1766575	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
	6172924	CHEMBL1769102	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(C)(C)CO)nc21		CHEMBL1766576	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	6172927	CHEMBL1769104	Inhibition of p38alpha	B	CCN(CC)CCOc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2c(Cl)cccc2Cl)C3)cc1		CHEMBL1234002	=	Kd	nM	10.0	CHEMBL260	Homo sapiens	Kd	nM	10.0
	6172928	CHEMBL1769104	Inhibition of p38alpha	B	O=C1Nc2nc(N[C@H]3CC[C@H](O)CC3)ncc2CN1c1ccccc1Cl		CHEMBL1235713	=	Kd	nM	32.0	CHEMBL260	Homo sapiens	Kd	nM	32.0
	6172929	CHEMBL1769105	Inhibition of human recombinant p38alpha assessed as incorporation of 33P from gamma-[33P]ATP into myelin basic protein at 10 uM after 30 mins by scintillation counting	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	>	Inhibition	%	85.0	CHEMBL260	Homo sapiens	INH	%	85.0
	6173434	CHEMBL1768212	Inhibition of MAPK14 at 25 uM by direct TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	6173482	CHEMBL1768227	Inhibition of MAPK14 at 25 uM by TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	6173716	CHEMBL1769104	Inhibition of p38alpha	B	Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL1766490	=	Kd	nM	0.3	CHEMBL260	Homo sapiens	Kd	nM	0.3
	6173717	CHEMBL1769104	Inhibition of p38alpha	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	Kd	nM	0.2	CHEMBL260	Homo sapiens	Kd	nM	0.2
	6173718	CHEMBL1769104	Inhibition of p38alpha	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	=	Kd	nM	1.3	CHEMBL260	Homo sapiens	Kd	nM	1.3
	6193712	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773439	=	Ratio IC50		1.98	CHEMBL260	Homo sapiens	Ratio IC50		1.98
	6193713	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL482086	=	Ratio IC50		7.24	CHEMBL260	Homo sapiens	Ratio IC50		7.24
	6193714	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773499	=	Ratio IC50		3.13	CHEMBL260	Homo sapiens	Ratio IC50		3.13
	6193715	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773438	=	Ratio IC50		4.24	CHEMBL260	Homo sapiens	Ratio IC50		4.24
	6193716	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773437	=	Ratio IC50		4.92	CHEMBL260	Homo sapiens	Ratio IC50		4.92
	6193717	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c(SC(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773436	=	Ratio IC50		19.42	CHEMBL260	Homo sapiens	Ratio IC50		19.42
	6193718	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773435	=	Ratio IC50		2.29	CHEMBL260	Homo sapiens	Ratio IC50		2.29
	6193719	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773434	=	Ratio IC50		3.62	CHEMBL260	Homo sapiens	Ratio IC50		3.62
	6193720	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773433	=	Ratio IC50		2.62	CHEMBL260	Homo sapiens	Ratio IC50		2.62
	6193721	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C)c2)[nH]1		CHEMBL1773432	=	Ratio IC50		12.0	CHEMBL260	Homo sapiens	Ratio IC50		12.0
	6193925	CHEMBL1777662	Inhibition of p38alpha at 10 uM	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	2.7	CHEMBL260	Homo sapiens	INH	%	2.7
	6193936	CHEMBL1777662	Inhibition of p38alpha at 10 uM	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	6193946	CHEMBL1776536	Inhibition of p38alpha at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	6194361	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773431	=	Ratio IC50		0.23	CHEMBL260	Homo sapiens	Ratio IC50		0.23
	6194362	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773430	=	Ratio IC50		0.27	CHEMBL260	Homo sapiens	Ratio IC50		0.27
	6194363	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773429	=	Ratio IC50		0.31	CHEMBL260	Homo sapiens	Ratio IC50		0.31
	6194364	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1271554	=	Ratio IC50		0.66	CHEMBL260	Homo sapiens	Ratio IC50		0.66
	6194365	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[C@H](Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773521	=	IC50	nM	5520.0	CHEMBL260	Homo sapiens	IC50	uM	5.52
	6194366	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[C@H](Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773520	=	IC50	nM	10020.0	CHEMBL260	Homo sapiens	IC50	uM	10.02
	6194367	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[C@H](Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773519	=	IC50	nM	6280.0	CHEMBL260	Homo sapiens	IC50	uM	6.28
	6194368	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)c3ccccc3)c2)[nH]1		CHEMBL321415	=	IC50	nM	1930.0	CHEMBL260	Homo sapiens	IC50	uM	1.93
	6194369	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773515	=	IC50	nM	750.0	CHEMBL260	Homo sapiens	IC50	uM	0.75
	6194370	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773514	=	IC50	nM	900.0	CHEMBL260	Homo sapiens	IC50	uM	0.9
	6194371	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773513	=	IC50	nM	1340.0	CHEMBL260	Homo sapiens	IC50	uM	1.34
	6194372	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)C(C)C)c2)[nH]1		CHEMBL1773512	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	6194373	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773511	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	6194374	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773510	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	6194375	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773509	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	6194376	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)C(C)C)c2)[nH]1		CHEMBL1773508	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	6194377	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773507	=	IC50	nM	830.0	CHEMBL260	Homo sapiens	IC50	uM	0.83
	6194378	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773506	=	IC50	nM	790.0	CHEMBL260	Homo sapiens	IC50	uM	0.79
	6194379	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773505	=	IC50	nM	340.0	CHEMBL260	Homo sapiens	IC50	uM	0.34
	6194380	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL480962	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	6194381	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773504	=	IC50	nM	340.0	CHEMBL260	Homo sapiens	IC50	uM	0.34
	6194382	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773503	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	6194383	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773421	=	IC50	nM	1080.0	CHEMBL260	Homo sapiens	IC50	uM	1.08
	6194384	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773502	=	IC50	nM	650.0	CHEMBL260	Homo sapiens	IC50	uM	0.65
	6194385	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773501	=	IC50	nM	590.0	CHEMBL260	Homo sapiens	IC50	uM	0.59
	6194386	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773500	=	IC50	nM	550.0	CHEMBL260	Homo sapiens	IC50	uM	0.55
	6194387	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773439	=	IC50	nM	620.0	CHEMBL260	Homo sapiens	IC50	uM	0.62
	6194388	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL482086	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	6194389	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773499	=	IC50	nM	610.0	CHEMBL260	Homo sapiens	IC50	uM	0.61
	6194390	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773438	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	6194391	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773437	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	6194392	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c(SC(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773436	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	6194393	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773435	=	IC50	nM	840.0	CHEMBL260	Homo sapiens	IC50	uM	0.84
	6194394	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773434	=	IC50	nM	530.0	CHEMBL260	Homo sapiens	IC50	uM	0.53
	6194395	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773433	=	IC50	nM	470.0	CHEMBL260	Homo sapiens	IC50	uM	0.47
	6194396	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C)c2)[nH]1		CHEMBL1773432	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	6194397	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773431	=	IC50	nM	7530.0	CHEMBL260	Homo sapiens	IC50	uM	7.53
	6194398	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773430	=	IC50	nM	6410.0	CHEMBL260	Homo sapiens	IC50	uM	6.41
	6194399	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773429	=	IC50	nM	5550.0	CHEMBL260	Homo sapiens	IC50	uM	5.55
	6194400	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1271554	=	IC50	nM	2980.0	CHEMBL260	Homo sapiens	IC50	uM	2.98
	6194401	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@H](Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773521	=	Ratio IC50		0.62	CHEMBL260	Homo sapiens	Ratio IC50		0.62
	6194402	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@H](Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773520	=	Ratio IC50		1.12	CHEMBL260	Homo sapiens	Ratio IC50		1.12
	6194403	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@H](Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773519	=	Ratio IC50		0.53	CHEMBL260	Homo sapiens	Ratio IC50		0.53
	6194404	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)c3ccccc3)c2)[nH]1		CHEMBL321415	=	Ratio IC50		1.0	CHEMBL260	Homo sapiens	Ratio IC50		1.0
	6194405	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@@H](Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773518	=	Ratio IC50		0.42	CHEMBL260	Homo sapiens	Ratio IC50		0.42
	6194406	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@@H](Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773517	=	Ratio IC50		0.49	CHEMBL260	Homo sapiens	Ratio IC50		0.49
	6194407	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@@H](Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773516	=	Ratio IC50		0.28	CHEMBL260	Homo sapiens	Ratio IC50		0.28
	6194408	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)c3ccccc3)c2)[nH]1		CHEMBL109331	=	Ratio IC50		1.2	CHEMBL260	Homo sapiens	Ratio IC50		1.2
	6194409	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773515	=	Ratio IC50		1.44	CHEMBL260	Homo sapiens	Ratio IC50		1.44
	6194410	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773514	=	Ratio IC50		2.32	CHEMBL260	Homo sapiens	Ratio IC50		2.32
	6194411	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773513	=	Ratio IC50		1.18	CHEMBL260	Homo sapiens	Ratio IC50		1.18
	6194412	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)C(C)C)c2)[nH]1		CHEMBL1773512	=	Ratio IC50		1.8	CHEMBL260	Homo sapiens	Ratio IC50		1.8
	6194413	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773511	=	Ratio IC50		2.15	CHEMBL260	Homo sapiens	Ratio IC50		2.15
	6194414	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773510	=	Ratio IC50		3.05	CHEMBL260	Homo sapiens	Ratio IC50		3.05
	6194415	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773509	=	Ratio IC50		3.41	CHEMBL260	Homo sapiens	Ratio IC50		3.41
	6194416	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)C(C)C)c2)[nH]1		CHEMBL1773508	=	Ratio IC50		1.81	CHEMBL260	Homo sapiens	Ratio IC50		1.81
	6194417	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773507	=	Ratio IC50		1.38	CHEMBL260	Homo sapiens	Ratio IC50		1.38
	6194418	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773506	=	Ratio IC50		4.45	CHEMBL260	Homo sapiens	Ratio IC50		4.45
	6194419	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773505	=	Ratio IC50		4.67	CHEMBL260	Homo sapiens	Ratio IC50		4.67
	6194420	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL480962	=	Ratio IC50		9.8	CHEMBL260	Homo sapiens	Ratio IC50		9.8
	6194421	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773504	=	Ratio IC50		1.62	CHEMBL260	Homo sapiens	Ratio IC50		1.62
	6194422	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773503	=	Ratio IC50		3.09	CHEMBL260	Homo sapiens	Ratio IC50		3.09
	6194423	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773421	=	Ratio IC50		2.17	CHEMBL260	Homo sapiens	Ratio IC50		2.17
	6194424	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773502	=	Ratio IC50		4.17	CHEMBL260	Homo sapiens	Ratio IC50		4.17
	6194425	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773501	=	Ratio IC50		1.48	CHEMBL260	Homo sapiens	Ratio IC50		1.48
	6194426	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773500	=	Ratio IC50		2.55	CHEMBL260	Homo sapiens	Ratio IC50		2.55
	6194427	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773439	=	Ratio IC50		1.68	CHEMBL260	Homo sapiens	Ratio IC50		1.68
	6194428	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL482086	=	Ratio IC50		2.89	CHEMBL260	Homo sapiens	Ratio IC50		2.89
	6194429	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773499	=	Ratio IC50		6.17	CHEMBL260	Homo sapiens	Ratio IC50		6.17
	6194430	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773438	=	Ratio IC50		9.25	CHEMBL260	Homo sapiens	Ratio IC50		9.25
	6194431	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773437	=	Ratio IC50		5.0	CHEMBL260	Homo sapiens	Ratio IC50		5.0
	6194432	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c(SC(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773436	=	Ratio IC50		3.75	CHEMBL260	Homo sapiens	Ratio IC50		3.75
	6194433	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773435	=	Ratio IC50		2.54	CHEMBL260	Homo sapiens	Ratio IC50		2.54
	6194434	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773434	=	Ratio IC50		5.08	CHEMBL260	Homo sapiens	Ratio IC50		5.08
	6194435	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773433	=	Ratio IC50		7.5	CHEMBL260	Homo sapiens	Ratio IC50		7.5
	6194436	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C)c2)[nH]1		CHEMBL1773432	=	Ratio IC50		18.0	CHEMBL260	Homo sapiens	Ratio IC50		18.0
	6194437	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773431	=	Ratio IC50		0.55	CHEMBL260	Homo sapiens	Ratio IC50		0.55
	6194438	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773430	=	Ratio IC50		1.0	CHEMBL260	Homo sapiens	Ratio IC50		1.0
	6194439	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773429	=	Ratio IC50		1.16	CHEMBL260	Homo sapiens	Ratio IC50		1.16
	6194440	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1271554	=	Ratio IC50		3.44	CHEMBL260	Homo sapiens	Ratio IC50		3.44
	6194441	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(=O)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773428	=	Ratio IC50		0.45	CHEMBL260	Homo sapiens	Ratio IC50		0.45
	6194442	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(=O)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773427	=	Ratio IC50		0.55	CHEMBL260	Homo sapiens	Ratio IC50		0.55
	6194443	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(=O)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773426	=	Ratio IC50		0.1	CHEMBL260	Homo sapiens	Ratio IC50		0.1
	6194444	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)[nH]1		CHEMBL1773425	=	Ratio IC50		2.11	CHEMBL260	Homo sapiens	Ratio IC50		2.11
	6194445	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@+](C)[O-])n2C)ccn1		CHEMBL1773424	=	Ratio IC50		0.028	CHEMBL260	Homo sapiens	Ratio IC50		0.028
	6194446	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@@+](C)[O-])n2C)ccn1		CHEMBL1773423	=	Ratio IC50		0.035	CHEMBL260	Homo sapiens	Ratio IC50		0.035
	6194447	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	Ratio IC50		0.042	CHEMBL260	Homo sapiens	Ratio IC50		0.042
	6194448	CHEMBL1776379	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL432798	=	Ratio IC50		0.28	CHEMBL260	Homo sapiens	Ratio IC50		0.28
	6194449	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[C@H](Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773521	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
	6194450	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[C@H](Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773520	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	6194451	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[C@H](Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773519	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	uM	0.095
	6194452	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)c3ccccc3)c2)[nH]1		CHEMBL321415	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	6194453	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[C@@H](Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773518	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	6194454	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[C@@H](Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773517	=	IC50	nM	168.0	CHEMBL260	Homo sapiens	IC50	uM	0.168
	6194455	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[C@@H](Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773516	=	IC50	nM	207.0	CHEMBL260	Homo sapiens	IC50	uM	0.207
	6194456	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)c3ccccc3)c2)[nH]1		CHEMBL109331	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	uM	0.065
	6194457	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773515	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	6194458	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773514	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	uM	0.031
	6194459	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773513	=	IC50	nM	61.0	CHEMBL260	Homo sapiens	IC50	uM	0.061
	6194460	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)C(C)C)c2)[nH]1		CHEMBL1773512	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	6194461	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773511	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	6194462	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773510	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	6194463	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773509	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	6194464	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773507	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	6194465	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773421	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	6194466	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773502	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	6194467	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773501	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	6194468	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773500	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	6194469	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773439	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	6194470	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL482086	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	6194471	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773435	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	6194472	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773434	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	6194473	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773431	=	IC50	nM	141.0	CHEMBL260	Homo sapiens	IC50	uM	0.141
	6194474	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773430	=	IC50	nM	77.0	CHEMBL260	Homo sapiens	IC50	uM	0.077
	6194475	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1773429	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	uM	0.069
	6194476	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773428	=	IC50	nM	197.0	CHEMBL260	Homo sapiens	IC50	uM	0.197
	6194477	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773427	=	IC50	nM	161.0	CHEMBL260	Homo sapiens	IC50	uM	0.161
	6194478	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773426	=	IC50	nM	403.0	CHEMBL260	Homo sapiens	IC50	uM	0.403
	6194479	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)[nH]1		CHEMBL1773425	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	uM	0.037
	6194480	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@+](C)[O-])n2C)ccn1		CHEMBL1773424	=	IC50	nM	1265.0	CHEMBL260	Homo sapiens	IC50	uM	1.265
	6194481	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@@+](C)[O-])n2C)ccn1		CHEMBL1773423	=	IC50	nM	1030.0	CHEMBL260	Homo sapiens	IC50	uM	1.03
	6194482	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	IC50	nM	1072.0	CHEMBL260	Homo sapiens	IC50	uM	1.072
	6194483	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL432798	=	IC50	nM	188.0	CHEMBL260	Homo sapiens	IC50	uM	0.188
	6194484	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)C(C)C)c2)[nH]1		CHEMBL1773508	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	uM	0.026
	6194485	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773506	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	6194486	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773505	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	6194487	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL480962	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	6194488	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773504	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	uM	0.021
	6194489	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773503	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	6194490	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773499	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	6194491	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S@+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773438	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	6194492	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S+]([O-])C(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773437	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	6194493	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c(SC(C)C)nc2-c2ccc(F)cc2)ccn1		CHEMBL1773436	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	6194494	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CC(C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773433	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	6194495	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)C)c2)[nH]1		CHEMBL1773432	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	6194496	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1271554	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
Not Determined	6194497	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[C@@H](Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773518		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194498	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[C@@H](Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773517		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194499	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[C@@H](Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773516		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194500	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)c3ccccc3)c2)[nH]1		CHEMBL109331		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194501	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773428		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194502	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773427		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194503	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773426		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194504	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)[nH]1		CHEMBL1773425		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194505	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@+](C)[O-])n2C)ccn1		CHEMBL1773424		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194506	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@@+](C)[O-])n2C)ccn1		CHEMBL1773423		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194507	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	6194508	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL432798		IC50			CHEMBL260	Homo sapiens	IC50		
	6194509	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773500	=	Ratio IC50		3.09	CHEMBL260	Homo sapiens	Ratio IC50		3.09
	6194510	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773501	=	Ratio IC50		2.08	CHEMBL260	Homo sapiens	Ratio IC50		2.08
	6194511	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773502	=	Ratio IC50		2.86	CHEMBL260	Homo sapiens	Ratio IC50		2.86
	6194512	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773421	=	Ratio IC50		1.72	CHEMBL260	Homo sapiens	Ratio IC50		1.72
	6194513	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773503	=	Ratio IC50		7.64	CHEMBL260	Homo sapiens	Ratio IC50		7.64
	6194514	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)[nH]1		CHEMBL1773504	=	Ratio IC50		5.62	CHEMBL260	Homo sapiens	Ratio IC50		5.62
	6194515	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL480962	=	Ratio IC50		10.67	CHEMBL260	Homo sapiens	Ratio IC50		10.67
	6194516	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773505	=	Ratio IC50		3.62	CHEMBL260	Homo sapiens	Ratio IC50		3.62
	6194517	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773506	=	Ratio IC50		2.15	CHEMBL260	Homo sapiens	Ratio IC50		2.15
	6194518	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[S@+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)[nH]1		CHEMBL1773507	=	Ratio IC50		2.05	CHEMBL260	Homo sapiens	Ratio IC50		2.05
	6194519	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)C(C)C)c2)[nH]1		CHEMBL1773508	=	Ratio IC50		31.2	CHEMBL260	Homo sapiens	Ratio IC50		31.2
	6194520	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773509	=	Ratio IC50		10.4	CHEMBL260	Homo sapiens	Ratio IC50		10.4
	6194521	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773510	=	Ratio IC50		8.5	CHEMBL260	Homo sapiens	Ratio IC50		8.5
	6194522	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773511	=	Ratio IC50		6.8	CHEMBL260	Homo sapiens	Ratio IC50		6.8
	6194523	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@H](C)C(C)C)c2)[nH]1		CHEMBL1773512	=	Ratio IC50		8.67	CHEMBL260	Homo sapiens	Ratio IC50		8.67
	6194524	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773513	=	Ratio IC50		0.92	CHEMBL260	Homo sapiens	Ratio IC50		0.92
	6194525	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773514	=	Ratio IC50		1.72	CHEMBL260	Homo sapiens	Ratio IC50		1.72
	6194526	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CC(C)[C@@H](C)Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1		CHEMBL1773515	=	Ratio IC50		2.07	CHEMBL260	Homo sapiens	Ratio IC50		2.07
	6194527	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(N[C@@H](C)c3ccccc3)c2)[nH]1		CHEMBL321415	=	Ratio IC50		0.88	CHEMBL260	Homo sapiens	Ratio IC50		0.88
	6194528	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@H](Nc1cc(-c2[nH]c([S+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773519	=	Ratio IC50		0.25	CHEMBL260	Homo sapiens	Ratio IC50		0.25
	6194529	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@H](Nc1cc(-c2[nH]c([S@@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773520	=	Ratio IC50		0.16	CHEMBL260	Homo sapiens	Ratio IC50		0.16
	6194530	CHEMBL1776381	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay relative to SB203580	B	C[C@H](Nc1cc(-c2[nH]c([S@+](C)[O-])nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL1773521	=	Ratio IC50		0.28	CHEMBL260	Homo sapiens	Ratio IC50		0.28
	6194531	CHEMBL1776378	Inhibition of p38 alpha MAPK in human whole blood assessed as phosphorylation of ATF-2 by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	6194532	CHEMBL1776380	Inhibition of p38 alpha MAPK in human whole blood assessed as suppression of LPS-induced TNF-alpha release by immunosorbent non-radioactive enzyme assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	1230.0	CHEMBL260	Homo sapiens	IC50	uM	1.23
	6194947	CHEMBL1775260	Inhibition of p38alpha	B	NS(=O)(=O)N1CCC(Nc2nccc(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)n2)CC1		CHEMBL1773329	=	IC50	nM	4700.0	CHEMBL260	Homo sapiens	IC50	uM	4.7
	6194948	CHEMBL1775260	Inhibition of p38alpha	B	O=S(=O)(c1ccc(-c2ccnc(NC3CCNCC3)n2)cc1)N1CCNCC1		CHEMBL1773334	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	6198137	CHEMBL1776203	Inhibition of P38alpha assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	6208255	CHEMBL1781129	Inhibition of p38alpha	B	C[C@H](CS(C)(=O)=O)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232769	=	Kd	nM	1.2	CHEMBL260	Homo sapiens	Kd	nM	1.2
	6208256	CHEMBL1781129	Inhibition of p38alpha	B	C[C@H](CS(C)(=O)=O)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1236810	=	Kd	nM	1.0	CHEMBL260	Homo sapiens	Kd	nM	1.0
	6208264	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	C[C@H](CS(C)(=O)=O)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1236810	=	IC50	nM	109.0	CHEMBL260	Homo sapiens	IC50	uM	0.109
	6208265	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	C[C@@H](CS(C)(=O)=O)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1232785	=	IC50	nM	2340.0	CHEMBL260	Homo sapiens	IC50	uM	2.34
	6208266	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	O=S1(=O)CCC(Nc2n[nH]c3nc(Oc4ccc(F)cc4F)ncc23)C1		CHEMBL1778188	=	IC50	nM	795.0	CHEMBL260	Homo sapiens	IC50	uM	0.795
	6208267	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	CC(=O)N1CCC(Nc2n[nH]c3nc(Oc4ccc(F)cc4F)ncc23)CC1		CHEMBL1778187	=	IC50	nM	690.0	CHEMBL260	Homo sapiens	IC50	uM	0.69
	6208268	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	CS(=O)(=O)CCNc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1778186	=	IC50	nM	10400.0	CHEMBL260	Homo sapiens	IC50	uM	10.4
	6208269	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	O=S1(=O)CCC(Nc2n[nH]c3nc(Oc4ccc(F)cc4F)ncc23)CC1		CHEMBL1778185	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	6208270	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	CC(CS(C)(=O)=O)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1778184	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
	6208271	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	CS(=O)(=O)N1CCC(Nc2n[nH]c3nc(Oc4ccc(F)cc4F)ncc23)CC1		CHEMBL1778106	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	6208272	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	Fc1ccc(Oc2ncc3c(NC4CCOCC4)n[nH]c3n2)c(F)c1		CHEMBL1230350	=	IC50	nM	218.0	CHEMBL260	Homo sapiens	IC50	uM	0.218
	6208273	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	CC(C)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1778105	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	6208274	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	CCS(=O)(=O)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1778104	=	IC50	nM	3580.0	CHEMBL260	Homo sapiens	IC50	uM	3.58
	6208275	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	O=S(=O)(Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12)c1ccccc1		CHEMBL1778103	=	IC50	nM	257.0	CHEMBL260	Homo sapiens	IC50	uM	0.257
	6208276	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	O=C(Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12)C1CCC1		CHEMBL1778102	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	6208277	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	O=C(Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12)C1CCCCC1		CHEMBL1778101	=	IC50	nM	84.0	CHEMBL260	Homo sapiens	IC50	uM	0.084
	6208278	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	O=C(Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12)C1CCCC1		CHEMBL1778100	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	uM	0.42
	6208279	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	CC(C)C(=O)Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1778099	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	6208280	CHEMBL1781010	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into myelin basic protein	B	Nc1n[nH]c2nc(Oc3ccc(F)cc3F)ncc12		CHEMBL1778098	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6208301	CHEMBL1781144	Inhibition of p38alpha at 10 uM	B	C[C@H](CS(C)(=O)=O)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232769	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	6218524	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c(C)c1		CHEMBL13850	=	IC50	nM	6.026	CHEMBL260	Homo sapiens	pIC50		8.22
	6218525	CHEMBL1785239	Inhibition of p38alpha	B	Oc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL273432	=	IC50	nM	6.607	CHEMBL260	Homo sapiens	pIC50		8.18
	6218526	CHEMBL1785239	Inhibition of p38alpha	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	IC50	nM	7.413	CHEMBL260	Homo sapiens	pIC50		8.13
	6218527	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(C)c(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL276576	=	IC50	nM	10.72	CHEMBL260	Homo sapiens	pIC50		7.97
	6218528	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3F)n2)cc1		CHEMBL14329	=	IC50	nM	12.88	CHEMBL260	Homo sapiens	pIC50		7.89
	6218529	CHEMBL1785239	Inhibition of p38alpha	B	Oc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14763	=	IC50	nM	14.13	CHEMBL260	Homo sapiens	pIC50		7.85
	6218530	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL13836	=	IC50	nM	15.14	CHEMBL260	Homo sapiens	pIC50		7.82
	6218531	CHEMBL1785239	Inhibition of p38alpha	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C		CHEMBL14212	=	IC50	nM	15.14	CHEMBL260	Homo sapiens	pIC50		7.82
	6218532	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14682	=	IC50	nM	19.05	CHEMBL260	Homo sapiens	pIC50		7.72
	6218533	CHEMBL1785239	Inhibition of p38alpha	B	COc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14300	=	IC50	nM	19.95	CHEMBL260	Homo sapiens	pIC50		7.7
	6218534	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1C		CHEMBL13880	=	IC50	nM	21.88	CHEMBL260	Homo sapiens	pIC50		7.66
	6218535	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	IC50	nM	22.91	CHEMBL260	Homo sapiens	pIC50		7.64
	6218536	CHEMBL1785239	Inhibition of p38alpha	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	6218537	CHEMBL1785239	Inhibition of p38alpha	B	Cc1cccc(C)c1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL277521	=	IC50	nM	34.67	CHEMBL260	Homo sapiens	pIC50		7.46
	6218538	CHEMBL1785239	Inhibition of p38alpha	B	CC(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL417079	=	IC50	nM	40.74	CHEMBL260	Homo sapiens	pIC50		7.39
	6218539	CHEMBL1785239	Inhibition of p38alpha	B	Cc1cc(C)cc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL417255	=	IC50	nM	40.74	CHEMBL260	Homo sapiens	pIC50		7.39
	6218540	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL268946	=	IC50	nM	56.23	CHEMBL260	Homo sapiens	pIC50		7.25
	6218541	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(-c4ccccc4)cc3)n2)cc1		CHEMBL14187	=	IC50	nM	60.26	CHEMBL260	Homo sapiens	pIC50		7.22
	6218542	CHEMBL1785239	Inhibition of p38alpha	B	CNC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14697	=	IC50	nM	75.86	CHEMBL260	Homo sapiens	pIC50		7.12
	6218543	CHEMBL1785239	Inhibition of p38alpha	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	IC50	nM	79.43	CHEMBL260	Homo sapiens	pIC50		7.1
	6218544	CHEMBL1785239	Inhibition of p38alpha	B	O=C(O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14233	=	IC50	nM	81.28	CHEMBL260	Homo sapiens	pIC50		7.09
	6218545	CHEMBL1785239	Inhibition of p38alpha	B	CCOC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL1784928	=	IC50	nM	85.11	CHEMBL260	Homo sapiens	pIC50		7.07
	6218546	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	IC50	nM	89.13	CHEMBL260	Homo sapiens	pIC50		7.05
	6218547	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	IC50	nM	95.5	CHEMBL260	Homo sapiens	pIC50		7.02
	6218548	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	IC50	nM	114.82	CHEMBL260	Homo sapiens	pIC50		6.94
	6218549	CHEMBL1785239	Inhibition of p38alpha	B	O=C(O)Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL273525	=	IC50	nM	120.23	CHEMBL260	Homo sapiens	pIC50		6.92
	6218550	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	IC50	nM	128.82	CHEMBL260	Homo sapiens	pIC50		6.89
	6218551	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	IC50	nM	131.83	CHEMBL260	Homo sapiens	pIC50		6.88
	6218552	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	IC50	nM	134.9	CHEMBL260	Homo sapiens	pIC50		6.87
	6218553	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	IC50	nM	151.36	CHEMBL260	Homo sapiens	pIC50		6.82
	6218554	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)c(Cl)c3)n2)cc1		CHEMBL275271	=	IC50	nM	165.96	CHEMBL260	Homo sapiens	pIC50		6.78
	6218555	CHEMBL1785239	Inhibition of p38alpha	B	O=C(O)CCCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13950	=	IC50	nM	173.78	CHEMBL260	Homo sapiens	pIC50		6.76
	6218556	CHEMBL1785239	Inhibition of p38alpha	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	IC50	nM	177.83	CHEMBL260	Homo sapiens	pIC50		6.75
	6218557	CHEMBL1785239	Inhibition of p38alpha	B	CC(C)NC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL276094	=	IC50	nM	190.55	CHEMBL260	Homo sapiens	pIC50		6.72
	6218558	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	IC50	nM	208.93	CHEMBL260	Homo sapiens	pIC50		6.68
	6218559	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(C(F)(F)F)cc3)n2)cc1		CHEMBL264227	=	IC50	nM	213.8	CHEMBL260	Homo sapiens	pIC50		6.67
	6218560	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	IC50	nM	302.0	CHEMBL260	Homo sapiens	pIC50		6.52
	6218561	CHEMBL1785239	Inhibition of p38alpha	B	CN(C)C(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14170	=	IC50	nM	309.03	CHEMBL260	Homo sapiens	pIC50		6.51
	6218562	CHEMBL1785239	Inhibition of p38alpha	B	O=C(Oc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1)c1ccccc1		CHEMBL1785005	=	IC50	nM	316.23	CHEMBL260	Homo sapiens	pIC50		6.5
	6218563	CHEMBL1785239	Inhibition of p38alpha	B	O=C(NN1CCNCC1)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL13830	=	IC50	nM	407.38	CHEMBL260	Homo sapiens	pIC50		6.39
	6218564	CHEMBL1785239	Inhibition of p38alpha	B	O=C(Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1)NN1CCNCC1		CHEMBL1785006	=	IC50	nM	457.09	CHEMBL260	Homo sapiens	pIC50		6.34
	6218565	CHEMBL1785239	Inhibition of p38alpha	B	O=C(NN1CCCCC1)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14252	=	IC50	nM	602.56	CHEMBL260	Homo sapiens	pIC50		6.22
	6218566	CHEMBL1785239	Inhibition of p38alpha	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	IC50	nM	645.65	CHEMBL260	Homo sapiens	pIC50		6.19
	6218567	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	IC50	nM	19.05	CHEMBL260	Homo sapiens	pIC50		7.72
	6218568	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c(C)c1		CHEMBL13850	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	6218569	CHEMBL1785239	Inhibition of p38alpha	B	Oc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL273432	=	IC50	nM	6.6	CHEMBL260	Homo sapiens	IC50	nM	6.6
	6218570	CHEMBL1785239	Inhibition of p38alpha	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	IC50	nM	7.4	CHEMBL260	Homo sapiens	IC50	nM	7.4
	6218571	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(C)c(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL276576	=	IC50	nM	10.7	CHEMBL260	Homo sapiens	IC50	nM	10.7
	6218572	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3F)n2)cc1		CHEMBL14329	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	6218573	CHEMBL1785239	Inhibition of p38alpha	B	Oc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14763	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	6218574	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL13836	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	6218575	CHEMBL1785239	Inhibition of p38alpha	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C		CHEMBL14212	=	IC50	nM	15.2	CHEMBL260	Homo sapiens	IC50	nM	15.2
	6218576	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14682	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	6218577	CHEMBL1785239	Inhibition of p38alpha	B	COc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14300	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	6218578	CHEMBL1785239	Inhibition of p38alpha	B	Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1C		CHEMBL13880	=	IC50	nM	21.6	CHEMBL260	Homo sapiens	IC50	nM	21.6
	6218579	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	6218580	CHEMBL1785239	Inhibition of p38alpha	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	6218581	CHEMBL1785239	Inhibition of p38alpha	B	Cc1cccc(C)c1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL277521	=	IC50	nM	34.3	CHEMBL260	Homo sapiens	IC50	nM	34.3
	6218582	CHEMBL1785239	Inhibition of p38alpha	B	CC(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL417079	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	6218583	CHEMBL1785239	Inhibition of p38alpha	B	Cc1cc(C)cc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL417255	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	6218584	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL268946	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
	6218585	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(-c4ccccc4)cc3)n2)cc1		CHEMBL14187	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	nM	60.0
	6218586	CHEMBL1785239	Inhibition of p38alpha	B	CNC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14697	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	nM	75.0
	6218587	CHEMBL1785239	Inhibition of p38alpha	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	6218588	CHEMBL1785239	Inhibition of p38alpha	B	O=C(O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL14233	=	IC50	nM	82.0	CHEMBL260	Homo sapiens	IC50	nM	82.0
	6218589	CHEMBL1785239	Inhibition of p38alpha	B	CCOC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL1784928	=	IC50	nM	85.4	CHEMBL260	Homo sapiens	IC50	nM	85.4
	6218590	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	IC50	nM	89.7	CHEMBL260	Homo sapiens	IC50	nM	89.7
	6218591	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	nM	95.0
	6218592	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	IC50	nM	114.0	CHEMBL260	Homo sapiens	IC50	nM	114.0
	6218593	CHEMBL1785239	Inhibition of p38alpha	B	O=C(O)Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL273525	=	IC50	nM	119.0	CHEMBL260	Homo sapiens	IC50	nM	119.0
	6218594	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	6218595	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	IC50	nM	132.0	CHEMBL260	Homo sapiens	IC50	nM	132.0
	6218596	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	IC50	nM	134.0	CHEMBL260	Homo sapiens	IC50	nM	134.0
	6218597	CHEMBL1785239	Inhibition of p38alpha	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	IC50	nM	151.0	CHEMBL260	Homo sapiens	IC50	nM	151.0
	6218598	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)c(Cl)c3)n2)cc1		CHEMBL275271	=	IC50	nM	165.0	CHEMBL260	Homo sapiens	IC50	nM	165.0
	6218599	CHEMBL1785239	Inhibition of p38alpha	B	O=C(O)CCCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13950	=	IC50	nM	174.0	CHEMBL260	Homo sapiens	IC50	nM	174.0
	6218600	CHEMBL1785239	Inhibition of p38alpha	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	IC50	nM	177.0	CHEMBL260	Homo sapiens	IC50	nM	177.0
	6218601	CHEMBL1785239	Inhibition of p38alpha	B	CC(C)NC(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL276094	=	IC50	nM	189.0	CHEMBL260	Homo sapiens	IC50	nM	189.0
	6218602	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	IC50	nM	209.0	CHEMBL260	Homo sapiens	IC50	nM	209.0
	6218603	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(C(F)(F)F)cc3)n2)cc1		CHEMBL264227	=	IC50	nM	215.0	CHEMBL260	Homo sapiens	IC50	nM	215.0
	6218604	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	nM	300.0
	6218605	CHEMBL1785239	Inhibition of p38alpha	B	CN(C)C(=O)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14170	=	IC50	nM	312.0	CHEMBL260	Homo sapiens	IC50	nM	312.0
	6218606	CHEMBL1785239	Inhibition of p38alpha	B	O=C(Oc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1)c1ccccc1		CHEMBL1785005	=	IC50	nM	317.0	CHEMBL260	Homo sapiens	IC50	nM	317.0
	6218607	CHEMBL1785239	Inhibition of p38alpha	B	O=C(NN1CCNCC1)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL13830	=	IC50	nM	406.0	CHEMBL260	Homo sapiens	IC50	nM	406.0
	6218608	CHEMBL1785239	Inhibition of p38alpha	B	O=C(Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1)NN1CCNCC1		CHEMBL1785006	=	IC50	nM	453.0	CHEMBL260	Homo sapiens	IC50	nM	453.0
	6218609	CHEMBL1785239	Inhibition of p38alpha	B	O=C(NN1CCCCC1)c1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL14252	=	IC50	nM	599.0	CHEMBL260	Homo sapiens	IC50	nM	599.0
	6218610	CHEMBL1785239	Inhibition of p38alpha	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	IC50	nM	650.0	CHEMBL260	Homo sapiens	IC50	nM	650.0
	6218611	CHEMBL1785239	Inhibition of p38alpha	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	IC50	nM	19.2	CHEMBL260	Homo sapiens	IC50	nM	19.2
	6230204	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Ki	nM	12.59	CHEMBL260	Homo sapiens	pKi		7.9
	6230205	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
	6230206	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	IC50	nM	1584.89	CHEMBL260	Homo sapiens	pIC50		5.8
	6230208	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784164	=	Ki	nM	3.981	CHEMBL260	Homo sapiens	pKi		8.4
	6230209	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784164	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	pIC50		7.0
	6230210	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784164	=	IC50	nM	251.19	CHEMBL260	Homo sapiens	pIC50		6.6
	6230212	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(Cl)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784165	=	Ki	nM	12.59	CHEMBL260	Homo sapiens	pKi		7.9
	6230213	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(Cl)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784165	=	IC50	nM	158.49	CHEMBL260	Homo sapiens	pIC50		6.8
	6230214	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(Cl)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784165	=	IC50	nM	1258.93	CHEMBL260	Homo sapiens	pIC50		5.9
	6230216	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1cc(C(=O)NC2CC2)cc(-c2ccc(C(=O)NCC3CC3)cc2)c1C		CHEMBL1784166	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	pKi		7.0
Not Determined	6230217	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1cc(C(=O)NC2CC2)cc(-c2ccc(C(=O)NCC3CC3)cc2)c1C		CHEMBL1784166		pIC50			CHEMBL260	Homo sapiens	pIC50		
Not Determined	6230218	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1cc(C(=O)NC2CC2)cc(-c2ccc(C(=O)NCC3CC3)cc2)c1C		CHEMBL1784166		pIC50			CHEMBL260	Homo sapiens	pIC50		
	6230220	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1cc(F)c(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784167	=	Ki	nM	125.89	CHEMBL260	Homo sapiens	pKi		6.9
Not Determined	6230221	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1cc(F)c(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784167		pIC50			CHEMBL260	Homo sapiens	pIC50		
Not Determined	6230222	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1cc(F)c(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1784167		pIC50			CHEMBL260	Homo sapiens	pIC50		
	6230224	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CCCO2)cc1		CHEMBL1784168	=	Ki	nM	15.85	CHEMBL260	Homo sapiens	pKi		7.8
	6230225	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CCCO2)cc1		CHEMBL1784168	=	IC50	nM	316.23	CHEMBL260	Homo sapiens	pIC50		6.5
	6230227	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1nc(CNC(=O)c2ccc(-c3cc(C(=O)NC4CC4)cc(F)c3C)cc2)cs1		CHEMBL1784169	=	Ki	nM	10.0	CHEMBL260	Homo sapiens	pKi		8.0
	6230228	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1nc(CNC(=O)c2ccc(-c3cc(C(=O)NC4CC4)cc(F)c3C)cc2)cs1		CHEMBL1784169	=	IC50	nM	79.43	CHEMBL260	Homo sapiens	pIC50		7.1
	6230230	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	COCCNC(=O)c1ccc(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc1		CHEMBL1784170	=	Ki	nM	12.59	CHEMBL260	Homo sapiens	pKi		7.9
	6230231	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	COCCNC(=O)c1ccc(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc1		CHEMBL1784170	=	IC50	nM	316.23	CHEMBL260	Homo sapiens	pIC50		6.5
	6230233	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)O)cc1		CHEMBL1784171	=	Ki	nM	10.0	CHEMBL260	Homo sapiens	pKi		8.0
	6230234	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)O)cc1		CHEMBL1784171	=	IC50	nM	79.43	CHEMBL260	Homo sapiens	pIC50		7.1
	6230236	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1784172	=	Ki	nM	7.943	CHEMBL260	Homo sapiens	pKi		8.1
	6230238	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1784172	=	IC50	nM	125.89	CHEMBL260	Homo sapiens	pIC50		6.9
	6230239	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1784172	=	IC50	nM	79.43	CHEMBL260	Homo sapiens	pIC50		7.1
	6230242	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)C)cn1		CHEMBL1784173	=	Ki	nM	7.943	CHEMBL260	Homo sapiens	pKi		8.1
	6230244	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)C)cn1		CHEMBL1784173	=	IC50	nM	158.49	CHEMBL260	Homo sapiens	pIC50		6.8
	6230245	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)C)cn1		CHEMBL1784173	=	IC50	nM	50.12	CHEMBL260	Homo sapiens	pIC50		7.3
	6230248	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)C)cn1		CHEMBL1784174	=	Ki	nM	7.943	CHEMBL260	Homo sapiens	pKi		8.1
	6230250	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)C)cn1		CHEMBL1784174	=	IC50	nM	63.1	CHEMBL260	Homo sapiens	pIC50		7.2
	6230251	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)C)cn1		CHEMBL1784174	=	IC50	nM	19.95	CHEMBL260	Homo sapiens	pIC50		7.7
	6230254	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)C)cn1		CHEMBL1784175	=	Ki	nM	7.943	CHEMBL260	Homo sapiens	pKi		8.1
Not Determined	6230256	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)C)cn1		CHEMBL1784175		pIC50			CHEMBL260	Homo sapiens	pIC50		
	6230257	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)C)cn1		CHEMBL1784175	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	6230260	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Ki	nM	7.943	CHEMBL260	Homo sapiens	pKi		8.1
	6230262	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	pIC50		7.0
	6230263	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	6230266	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)(C)C)cn1		CHEMBL1784176	=	Ki	nM	12.59	CHEMBL260	Homo sapiens	pKi		7.9
	6230268	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)(C)C)cn1		CHEMBL1784176	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	6230269	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@H](C)C(C)(C)C)cn1		CHEMBL1784176	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	6230272	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)(C)C)cn1		CHEMBL1784177	=	Ki	nM	6.31	CHEMBL260	Homo sapiens	pKi		8.2
Not Determined	6230274	CHEMBL1787754	Inhibition of p38alpha-dependent TNFalpha production in human PBMC preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)(C)C)cn1		CHEMBL1784177		pIC50			CHEMBL260	Homo sapiens	pIC50		
	6230275	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)N[C@@H](C)C(C)(C)C)cn1		CHEMBL1784177	=	IC50	nM	6.31	CHEMBL260	Homo sapiens	pIC50		8.2
	6230278	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1232887	=	Ki	nM	25.12	CHEMBL260	Homo sapiens	pKi		7.6
	6230279	CHEMBL1787755	Inhibition of p38alpha-dependent TNFalpha production in human whole blood preincubated for 1 hr before LPS challenge by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1232887	=	IC50	nM	316.23	CHEMBL260	Homo sapiens	pIC50		6.5
	6230298	CHEMBL1786932	Competitive inhibition of p38alpha catalytic activity using ATP	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Ki	nM	63.1	CHEMBL260	Homo sapiens	pKi		7.2
	6230348	CHEMBL1787752	Inhibition of GST-tagged p38alpha by fluorescence polarization method	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)nc1		CHEMBL1782167	=	Ki	nM	794.33	CHEMBL260	Homo sapiens	pKi		6.1
	6261882	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	6261883	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	=	Ki	nM	193.0	CHEMBL260	Homo sapiens	Ki	nM	193.0
	6261884	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCC(N)=O)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1795681	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	6261885	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC[C@@H](O)CO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1795682	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	6261886	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC[C@H](C)CO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1795683	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	6261887	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)N[C@H](C)C(N)=O)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1795684	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	6261888	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Br)c1=O		CHEMBL1795687	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	nM	60.0
	6261889	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(C)c1=O		CHEMBL1795685	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	6261890	CHEMBL1798415	Inhibition of p38alpha kinase	B	CCc1c(OCc2ccc(F)cc2F)ncn(-c2cc(C(=O)NCCO)ccc2C)c1=O		CHEMBL1795686	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	6261891	CHEMBL1798415	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(SCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1795688	=	IC50	nM	193.0	CHEMBL260	Homo sapiens	IC50	nM	193.0
	6261937	CHEMBL1798599	Inhibition of p38alpha kinase-dependent HSP-27 phosphorylation in human U937 cells	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	IC50	nM	1.05	CHEMBL260	Homo sapiens	IC50	nM	1.05
	6261938	CHEMBL1798599	Inhibition of p38alpha kinase-dependent HSP-27 phosphorylation in human U937 cells	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	6261943	CHEMBL1798602	Inhibition of p38alpha kinase in human monocytes	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	IC50	nM	17.4	CHEMBL260	Homo sapiens	IC50	nM	17.4
	6261944	CHEMBL1798602	Inhibition of p38alpha kinase in human monocytes	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	=	IC50	nM	16.9	CHEMBL260	Homo sapiens	IC50	nM	16.9
	6262788	CHEMBL1798415	Inhibition of p38alpha kinase	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	Ki	nM	2.9	CHEMBL260	Homo sapiens	Ki	nM	2.9
	6265563	CHEMBL1798272	Inhibition of p38 alpha at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL260	Homo sapiens	INH	%	65.0
	6265667	CHEMBL1798272	Inhibition of p38 alpha at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL260	Homo sapiens	INH	%	65.0
	6266789	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cccc1F		CHEMBL1797123	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	6266790	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Cl)c(=O)n1-c1c(F)cccc1F		CHEMBL1797124	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	6266791	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccccc2)c(Br)c(=O)n1-c1c(Cl)cccc1Cl		CHEMBL1797125	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	6266792	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2)c(Br)c(=O)n1-c1c(Cl)cccc1Cl		CHEMBL1797201	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	6266793	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(Cl)cccc1Cl		CHEMBL1797202	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	6266794	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cccc(C)c1-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O		CHEMBL1797203	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	6266795	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cc(N2CCN(C)CC2)cc1F		CHEMBL1797204	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	6267401	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Cl)c(=O)n1-c1c(F)cc(N2CCN(C)CC2)cc1F		CHEMBL1797205	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	6267402	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cc(N(C)C)cc1F		CHEMBL1797206	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	6267403	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cc(O)cc1F		CHEMBL1797207	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	6267404	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cc(OCCO)cc1F		CHEMBL1797208	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	uM	0.007
	6267405	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cc(OCC(N)=O)cc1F		CHEMBL1797209	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	6267406	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	O=c1c(Br)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797210	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	6267407	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	6267408	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	CN(C)Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cccc1F		CHEMBL1797212	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	6267409	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	CN(C)Cc1cc(OCc2ccc(F)cc2F)c(Cl)c(=O)n1-c1c(F)cccc1F		CHEMBL1797213	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	6267410	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	O=c1c(Br)c(OCc2ccc(F)cc2F)cc(CN2CCOCC2)n1-c1c(F)cccc1F		CHEMBL1797214	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	6267411	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1ccc(CN)cc1		CHEMBL1797215	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	uM	0.051
	6267412	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(CN)c1		CHEMBL1797216	=	IC50	nM	681.0	CHEMBL260	Homo sapiens	IC50	uM	0.681
	6267413	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1ccc(CNC(=O)CO)cc1		CHEMBL1797217	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	6267414	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(CNC(=O)CO)c1		CHEMBL1797218	=	IC50	nM	175.0	CHEMBL260	Homo sapiens	IC50	uM	0.175
	6267415	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1ccc(CNC(=O)CN)cc1		CHEMBL1797219	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	6267416	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(CNC(=O)CN)c1		CHEMBL1797220	=	IC50	nM	261.0	CHEMBL260	Homo sapiens	IC50	uM	0.261
	6267417	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1ccc(CNC(N)=O)cc1		CHEMBL1797221	=	IC50	nM	142.0	CHEMBL260	Homo sapiens	IC50	uM	0.142
	6267418	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(CNC(N)=O)c1		CHEMBL1797222	=	IC50	nM	251.0	CHEMBL260	Homo sapiens	IC50	uM	0.251
	6267419	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1ccc(C(N)=O)cc1		CHEMBL1797223	=	IC50	nM	122.0	CHEMBL260	Homo sapiens	IC50	uM	0.122
	6267420	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	6267421	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	CNC(=O)c1ccc(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)cc1		CHEMBL1797225	=	IC50	nM	126.0	CHEMBL260	Homo sapiens	IC50	uM	0.126
	6267422	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	CNC(=O)c1cccc(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1797226	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	6267423	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1ccc(C(=O)N(C)C)cc1		CHEMBL1797227	=	IC50	nM	746.0	CHEMBL260	Homo sapiens	IC50	uM	0.746
	6267424	CHEMBL1798818	Inhibition of p38alpha assessed as phosphorylation of fluorescently-labelled MK2 using Hsp27 peptide as substrate after 60 mins by fluorescence assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(=O)N(C)C)c1		CHEMBL1797228	=	IC50	nM	102.0	CHEMBL260	Homo sapiens	IC50	uM	0.102
Active	6267543	CHEMBL1799044	Inhibition of p38alpha at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	6267544	CHEMBL1799044	Inhibition of p38alpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	6270766	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	6270767	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	IC50	nM	2.5	CHEMBL260	Homo sapiens	IC50	nM	2.5
	6270768	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	IC50	nM	2.3	CHEMBL260	Homo sapiens	IC50	nM	2.3
	6270769	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	IC50	nM	247.0	CHEMBL260	Homo sapiens	IC50	nM	247.0
	6270770	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	Cc1ccc(C(N)=O)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O		CHEMBL1802632	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	6270771	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	Cc1ccc(C(=O)N(C)C)cc1-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O		CHEMBL1802633	=	IC50	nM	9.5	CHEMBL260	Homo sapiens	IC50	nM	9.5
	6270772	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c(C)c1		CHEMBL1802634	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	6270773	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1cccc(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1C		CHEMBL1802635	=	IC50	nM	48.5	CHEMBL260	Homo sapiens	IC50	nM	48.5
	6270797	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(F)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1802636	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	nM	8.5
	6270798	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(Cl)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1802637	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	6270799	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(OC)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1802638	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	6270800	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(C(=O)O)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1802639	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	6270801	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(CO)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1802640	=	IC50	nM	325.0	CHEMBL260	Homo sapiens	IC50	nM	325.0
	6270802	CHEMBL1805307	Inhibition of p38alpha assessed as phosphorylation FITC-labeled Hsp27 after 60 mins by fluorescence based cascade assay	B	CNC(=O)c1ccc(C)c(-n2c(CO)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1802641	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	6274412	CHEMBL1806004	Inhibition of p38alpha MAPK assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	98.0	CHEMBL260	Homo sapiens	Activity	%	98.0
	6282581	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)Nc2nc[nH]n2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800223	=	IC50	nM	1166.0	CHEMBL260	Homo sapiens	IC50	nM	1166.0
	6282582	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800222	=	IC50	nM	0.22	CHEMBL260	Homo sapiens	IC50	nM	0.22
	6282583	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)Nc2ccccn2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800221	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	6282584	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800220	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	6282585	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NCC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800921	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	6282586	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NC(C)(C)C)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800920	=	IC50	nM	275.0	CHEMBL260	Homo sapiens	IC50	nM	275.0
	6282587	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800919	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	6282588	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	CNC(=O)c1ccc(C)c(-c2ccc3c(c2)NC(=O)C32CCCC2)c1		CHEMBL1800918	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	6282589	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(N)=O)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800917	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	6282590	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800916	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	6282591	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	O=C(NC1CC1)c1cccc(-c2cc3c(cc2Cl)C2(CCCC2)C(=O)N3)c1		CHEMBL1800915	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	6282592	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	O=C(NC1CC1)c1cccc(-c2ccc3c(c2)NC(=O)C32CCCC2)c1		CHEMBL1800914	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	6282593	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	O=C(NC1CC1)c1ccc(Cl)c(-c2ccc3c(c2)NC(=O)C32CCCC2)c1		CHEMBL1800913	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	6282594	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCCC1		CHEMBL1825143	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	6282595	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800911	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	6282596	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC1		CHEMBL1800910	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	6282597	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C2(C)C		CHEMBL1800909	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	6282598	CHEMBL1804666	Inhibition of human p38alpha by FRET assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	nM	55.0
	6299695	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)O)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807441	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	6299696	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(CO)c(C)c12		CHEMBL1807452	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	6299704	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807447	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	6299705	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	COC(=O)NC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccccc4)c(C)c23)c1		CHEMBL1807448	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	6299706	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	6299707	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccco3)c(C)c12		CHEMBL1807591	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	6299708	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CCOC(=O)Nc1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccccc4)c(C)c23)c1		CHEMBL1807439	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	6299709	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(N)=O)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807442	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	6299710	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1cccc(C(=O)c2cn3ncnc(Nc4cc(C(=O)NC5CC5)ccc4C)c3c2C)n1		CHEMBL1807463	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	6299711	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccc[nH]3)c(C)c12		CHEMBL1807587	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	6299712	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3cc[nH]c3)c(C)c12		CHEMBL1807588	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	6299713	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CCNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccccc4)c(C)c23)c1		CHEMBL1807444	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	6299714	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3c[nH]c4ccccc34)c(C)c12		CHEMBL1807592	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	6299715	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CC#CC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1807455	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	6299716	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccccc4C)c(C)c23)c1		CHEMBL1807456	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	6299717	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccccc4)c(C)c23)c1		CHEMBL1807443	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	6299718	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4cccc(OC)c4)c(C)c23)c1		CHEMBL1807458	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	6299719	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3cnc4ccccc4n3)c(C)c12		CHEMBL1807586	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	6299720	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccn(C)c3)c(C)c12		CHEMBL1807590	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	6299721	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CCCC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1807454	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	6299722	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3cccnc3)c(C)c12		CHEMBL1807465	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	6299725	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC(C)C)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807445	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	6299727	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccc5c(c4)OCO5)c(C)c23)c1		CHEMBL1807461	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	6299728	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4cccc(F)c4)c(C)c23)c1		CHEMBL1807459	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	6299729	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccn3)c(C)c12		CHEMBL1807464	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	6299731	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3cccn3C)c(C)c12		CHEMBL1807589	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	6299732	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807440	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	6299733	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4cccc(C)n4)c(C)c23)c1		CHEMBL1807462	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	nM	51.0
	6299734	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3cc4ccccc4n3C)c(C)c12		CHEMBL1807593	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	nM	52.0
	6299735	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C=O)c(C)c12		CHEMBL1807453	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	nM	55.0
	6299736	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3cn(C)c4ccccc34)c(C)c12		CHEMBL1807594	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	nM	55.0
	6299738	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccccc4OC)c(C)c23)c1		CHEMBL1807457	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	nM	59.0
	6299741	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)Nc2cc(F)cc(N3CCOCC3)c2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807449	=	IC50	nM	88.0	CHEMBL260	Homo sapiens	IC50	nM	88.0
	6299747	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	CNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccc(F)cc4)c(C)c23)c1		CHEMBL1807460	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	nM	140.0
	6300713	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	COCCNC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)c4ccccc4)c(C)c23)c1		CHEMBL1807451	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	nM	230.0
	6300715	CHEMBL1811277	Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli using myelin basic protein as substrate after 45 mins	B	Cc1ccc(C(=O)NCCO)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807450	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	nM	240.0
	6317761	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	-7.0	CHEMBL260	Homo sapiens	INH	%	-7.0
	6317762	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	6317763	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	INH	%	17.0
	6317764	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	6317765	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	6317766	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	6317767	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	6317768	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	6317769	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	6317770	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	6317771	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	6317772	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	6317773	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	6317774	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	-3.0	CHEMBL260	Homo sapiens	INH	%	-3.0
	6317775	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	6317776	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	6317777	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	6317778	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	6317779	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	6317780	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	6317781	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	-1.0	CHEMBL260	Homo sapiens	INH	%	-1.0
	6317782	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	-1.0	CHEMBL260	Homo sapiens	INH	%	-1.0
	6317783	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	6317784	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	6317785	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	6317786	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	6317787	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	6317788	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	6317789	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	6317790	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	6317791	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	6317792	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	6317793	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	6317794	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	26.0	CHEMBL260	Homo sapiens	INH	%	26.0
	6317795	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	79.0	CHEMBL260	Homo sapiens	INH	%	79.0
	6317796	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	79.0	CHEMBL260	Homo sapiens	INH	%	79.0
	6317797	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	32.0	CHEMBL260	Homo sapiens	INH	%	32.0
	6317798	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	68.0	CHEMBL260	Homo sapiens	INH	%	68.0
	6317799	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	38.0	CHEMBL260	Homo sapiens	INH	%	38.0
	6317800	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	85.0	CHEMBL260	Homo sapiens	INH	%	85.0
	6317801	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	6317802	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	6317803	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	78.0	CHEMBL260	Homo sapiens	INH	%	78.0
	6317804	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	6317805	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	6317806	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	6317807	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	55.0	CHEMBL260	Homo sapiens	INH	%	55.0
	6317808	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	6317809	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	-5.0	CHEMBL260	Homo sapiens	INH	%	-5.0
	6317810	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	-1.0	CHEMBL260	Homo sapiens	INH	%	-1.0
	6317811	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	6317812	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	6317813	CHEMBL1815738	Inhibition of p38alpha at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	6318859	CHEMBL1815752	Inhibition of p38alpha by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	IC50	nM	8700.0	CHEMBL260	Homo sapiens	IC50	uM	8.7
	6325320	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	INH	%	24.0
	6325349	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	34.0	CHEMBL260	Homo sapiens	INH	%	34.0
	6325362	CHEMBL1820099	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells by TR-FRET assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	>	IC50	nM	667000.0	CHEMBL260	Homo sapiens	IC50	uM	667.0
	6325381	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	6325413	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	INH	%	14.0
	6325445	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	76.0	CHEMBL260	Homo sapiens	INH	%	76.0
	6325474	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	6325503	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	INH	%	14.0
	6325532	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	6325875	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	61.0	CHEMBL260	Homo sapiens	INH	%	61.0
	6325905	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	42.0	CHEMBL260	Homo sapiens	INH	%	42.0
	6325935	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	99.0	CHEMBL260	Homo sapiens	INH	%	99.0
	6325964	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	96.0	CHEMBL260	Homo sapiens	INH	%	96.0
	6325993	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	64.0	CHEMBL260	Homo sapiens	INH	%	64.0
	6326022	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	79.0	CHEMBL260	Homo sapiens	INH	%	79.0
	6326051	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	53.0	CHEMBL260	Homo sapiens	INH	%	53.0
	6326080	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	42.0	CHEMBL260	Homo sapiens	INH	%	42.0
	6326109	CHEMBL1819997	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells at 667 uM by TR-FRET assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	25.0	CHEMBL260	Homo sapiens	INH	%	25.0
	6326125	CHEMBL1820099	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells by TR-FRET assay	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL97550	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	6326131	CHEMBL1820099	Inhibition of p38alpha expressed in Escherichia coli or baculovirus-infected insect cells by TR-FRET assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	<	IC50	nM	630957.34	CHEMBL260	Homo sapiens	pIC50		3.2
	6340947	CHEMBL1827271	Activity of p38-alpha kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	6350181	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCSCC1		CHEMBL1825149	=	IC50	nM	0.08	CHEMBL260	Homo sapiens	IC50	nM	0.08
	6350182	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825148	=	IC50	nM	0.09	CHEMBL260	Homo sapiens	IC50	nM	0.09
	6350183	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825147	=	IC50	nM	1.65	CHEMBL260	Homo sapiens	IC50	nM	1.65
	6350184	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)[C@]21CC[C@@H](O)CC1		CHEMBL1825151	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	6350185	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCN(S(C)(=O)=O)CC1		CHEMBL1825146	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	6350186	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1825154	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	6350187	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)[C@]21CC[C@H](O)CC1		CHEMBL1825152	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	6350188	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2c(cn1)C1(CCCC1)C(=O)N2		CHEMBL1825157	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	6350189	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C21CCCC1		CHEMBL1825158	=	IC50	nM	1.8	CHEMBL260	Homo sapiens	IC50	nM	1.8
	6350190	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1825153	=	IC50	nM	1.8	CHEMBL260	Homo sapiens	IC50	nM	1.8
	6350191	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1825160	=	IC50	nM	2.3	CHEMBL260	Homo sapiens	IC50	nM	2.3
	6350192	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(n1)NC(=O)C21CCCC1		CHEMBL1825156	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
	6350193	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCN(C)CC1		CHEMBL1825145	=	IC50	nM	5.2	CHEMBL260	Homo sapiens	IC50	nM	5.2
	6350194	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ncc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1825155	=	IC50	nM	7.4	CHEMBL260	Homo sapiens	IC50	nM	7.4
	6350195	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCS(=O)(=O)CC1		CHEMBL1825150	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
	6350196	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825159	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	6350197	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C2(C)C		CHEMBL1825161	=	IC50	nM	62.0	CHEMBL260	Homo sapiens	IC50	nM	62.0
	6350198	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ncc2c(n1)NC(=O)C21CCCC1		CHEMBL1825162	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	nM	72.0
	6350199	CHEMBL1825474	Inhibition of human p38alpha using biotinylated ATF2 substrate by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C2(CCO)CCO		CHEMBL1825144	=	IC50	nM	4570.0	CHEMBL260	Homo sapiens	IC50	nM	4570.0
	6350200	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825148	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	6350201	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)[C@]21CC[C@@H](O)CC1		CHEMBL1825151	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	6350202	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCN(C)CC1		CHEMBL1825145	=	IC50	nM	9.6	CHEMBL260	Homo sapiens	IC50	nM	9.6
	6350203	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1825154	=	IC50	nM	4.9	CHEMBL260	Homo sapiens	IC50	nM	4.9
	6350204	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825147	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	6350205	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800911	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	6350206	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCN(S(C)(=O)=O)CC1		CHEMBL1825146	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	6350207	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1825153	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	6350208	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCSCC1		CHEMBL1825149	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	6350209	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)[C@]21CC[C@H](O)CC1		CHEMBL1825152	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	6350210	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCCC1		CHEMBL1825143	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	6350211	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCS(=O)(=O)CC1		CHEMBL1825150	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	nM	75.0
	6350212	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2c(cn1)C1(CCCC1)C(=O)N2		CHEMBL1825157	=	IC50	nM	64.0	CHEMBL260	Homo sapiens	IC50	nM	64.0
	6350213	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1825160	=	IC50	nM	188.0	CHEMBL260	Homo sapiens	IC50	nM	188.0
	6350214	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C21CCCC1		CHEMBL1825158	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	nM	69.0
	6350215	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ncc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1825155	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	nM	150.0
	6350216	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825159	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	nM	86.0
	6350217	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(n1)NC(=O)C21CCCC1		CHEMBL1825156	=	IC50	nM	128.0	CHEMBL260	Homo sapiens	IC50	nM	128.0
	6350218	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C2(C)C		CHEMBL1825161	=	IC50	nM	544.0	CHEMBL260	Homo sapiens	IC50	nM	544.0
Not Determined	6350219	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C2(CCO)CCO		CHEMBL1825144		IC50			CHEMBL260	Homo sapiens	IC50		
	6350220	CHEMBL1825475	Inhibition of p38alpha in human whole blood assessed as reduction in TNF-alpha production by ELISA	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ncc2c(n1)NC(=O)C21CCCC1		CHEMBL1825162	=	IC50	nM	1097.0	CHEMBL260	Homo sapiens	IC50	nM	1097.0
	6352128	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824226	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352129	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824227	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352130	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824432	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352131	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824433	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352132	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1824434	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352133	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nc(C)c(C)nc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL1824435	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352134	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nccnc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1824436	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352135	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2c(-c3ccc4nc(C)c(C)nc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL1824437	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352136	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824438	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352137	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CCC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824439	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352138	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824440	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352139	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824441	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352140	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824442	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352141	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824443	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352142	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nccnc3c2)n1		CHEMBL1824444	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352143	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3nc(C)c(C)nc3c2)n1		CHEMBL1824445	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	6352144	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1.Cl		CHEMBL1824446	=	IC50	nM	594.0	CHEMBL260	Homo sapiens	IC50	uM	0.594
	6352145	CHEMBL1827918	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radiometric kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	6352250	CHEMBL1825898	Inhibition of p38alpha MAPK assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	6352783	CHEMBL1825682	Inhibition of recombinant p38alpha Thr69/71 of ATF-2 as substrate preincubated for 15 mins measured after 60 mins by TR-FRET assay	B	O=C(CN1C(=O)CCc2ncccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822138	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	6352784	CHEMBL1825682	Inhibition of recombinant p38alpha Thr69/71 of ATF-2 as substrate preincubated for 15 mins measured after 60 mins by TR-FRET assay	B	O=C(Cn1c(=O)ccc2cc(F)c(F)cc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822145	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	6352785	CHEMBL1825682	Inhibition of recombinant p38alpha Thr69/71 of ATF-2 as substrate preincubated for 15 mins measured after 60 mins by TR-FRET assay	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	6352786	CHEMBL1825682	Inhibition of recombinant p38alpha Thr69/71 of ATF-2 as substrate preincubated for 15 mins measured after 60 mins by TR-FRET assay	B	N#Cc1ccc2c(ccc(=O)n2CC(=O)Nc2scc(Br)c2-c2ncn[nH]2)c1		CHEMBL1822151	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
Not Active	6353508	CHEMBL1825797	Inhibition of p38alpha using ATF2 substrate upto 100 uM by TR-FRET assay	B	CC(C)C[C@@H](NC(=O)CNC(=O)CNC(=O)CCCNC(=O)c1ccc(-c2n[nH]c3ccccc23)cc1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)[C@H](C)O)[C@H](C)O		CHEMBL1822314		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	6384539	CHEMBL1837586	Inhibition of human p38alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	6384540	CHEMBL1837586	Inhibition of human p38alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	6384541	CHEMBL1837586	Inhibition of human p38alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	6384542	CHEMBL1837586	Inhibition of human p38alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	6384543	CHEMBL1837586	Inhibition of human p38alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	6386357	CHEMBL1839858	Inhibition of recombinant p38alpha	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	7567119	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7567578	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7568049	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7568517	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	67.0	CHEMBL260	Homo sapiens	Kd	nM	67.0
	7568949	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7569092	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7569552	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7570024	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7570487	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7570914	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7571068	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7571525	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7572001	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7573049	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7573506	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	27.0	CHEMBL260	Homo sapiens	Kd	nM	27.0
	7573982	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7574009	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7574417	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7575027	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7575488	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7575982	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7576390	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7577001	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	1300.0	CHEMBL260	Homo sapiens	Kd	nM	1300.0
	7577496	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7577966	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7578371	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7579391	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	320.0	CHEMBL260	Homo sapiens	Kd	nM	320.0
	7579865	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7580334	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7580737	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7580925	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7581310	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.45	CHEMBL260	Homo sapiens	Kd	nM	0.45
	7581755	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7582226	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7582690	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7583090	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7583271	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7583668	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7584113	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7584584	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7585046	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7585450	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	2.8	CHEMBL260	Homo sapiens	Kd	nM	2.8
	7585601	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7586009	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7586455	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7586926	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7587380	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7587562	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7587981	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7588434	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7588905	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7589527	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7589951	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7590418	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7590901	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	12.0	CHEMBL260	Homo sapiens	Kd	nM	12.0
	7591500	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7591922	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7592425	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7592878	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7593467	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	73.0	CHEMBL260	Homo sapiens	Kd	nM	73.0
	7593902	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7593932	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7594405	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7594857	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7595435	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7595911	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7596382	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	460.0	CHEMBL260	Homo sapiens	Kd	nM	460.0
	7596829	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	370.0	CHEMBL260	Homo sapiens	Kd	nM	370.0
	7597418	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7597891	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7598361	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
	7598803	CHEMBL1908411	Binding constant for p38-alpha kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7598990	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL515914		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7598991	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL515914		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599136	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1		CHEMBL1200558		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599137	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1		CHEMBL1200558		Ki			CHEMBL260	Homo sapiens	Ki		
	7599273	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1		CHEMBL388590	=	IC50	nM	1235.0	CHEMBL260	Homo sapiens	IC50	uM	1.235
Note: corresponding IC50 reported as Active	7599274	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1		CHEMBL388590		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599999	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1458880		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600117	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCOC(N)=O.[Cl-]		CHEMBL14		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600118	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCOC(N)=O.[Cl-]		CHEMBL14		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600931	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600932	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601040	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCNC(=O)c1ccccc1		CHEMBL1231530		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601041	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCNC(=O)c1ccccc1		CHEMBL1231530		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601127	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Brc1c(NC2=NCCN2)ccc2nccnc12		CHEMBL844		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601128	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Brc1c(NC2=NCCN2)ccc2nccnc12		CHEMBL844		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601235	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl		CHEMBL1200396		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601236	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl		CHEMBL1200396		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601335	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1458880		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601605	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C		CHEMBL211501		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601606	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C		CHEMBL211501		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601804	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN		CHEMBL3084803		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601805	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN		CHEMBL3084803		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601924	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O		CHEMBL1095699		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601925	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O		CHEMBL1095699		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602067	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC(CC(=O)O)c1ccc(Cl)cc1		CHEMBL701		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602068	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC(CC(=O)O)c1ccc(Cl)cc1		CHEMBL701		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602183	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]		CHEMBL221753		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602184	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]		CHEMBL221753		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602934	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1		CHEMBL319244		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602935	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1		CHEMBL319244		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603857	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL415690		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603858	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL415690		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603971	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O		CHEMBL264374		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603972	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O		CHEMBL264374		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604055	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1		CHEMBL1077		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604056	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1		CHEMBL1077		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604162	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1		CHEMBL894		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604163	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1		CHEMBL894		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604518	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1c2ccccc2C=Cc2ccccc21		CHEMBL108		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604519	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1c2ccccc2C=Cc2ccccc21		CHEMBL108		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604531	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(=O)n(-c2ccccc2)n1C		CHEMBL277474		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604532	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(=O)n(-c2ccccc2)n1C		CHEMBL277474		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604727	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1		CHEMBL24		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604728	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1		CHEMBL24		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604852	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21		CHEMBL1598608		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604853	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21		CHEMBL1598608		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604996	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1		CHEMBL1201346		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604997	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1		CHEMBL1201346		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605097	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34		CHEMBL31184		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605098	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34		CHEMBL31184		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605840	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL113		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605841	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL113		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606763	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL135		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606764	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL135		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606882	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC		CHEMBL402794		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606883	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC		CHEMBL402794		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606966	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1		CHEMBL253376		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606967	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1		CHEMBL253376		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607071	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1		CHEMBL49		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607072	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1		CHEMBL49		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607434	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)n1ccn(C)c1=S		CHEMBL508102		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607435	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)n1ccn(C)c1=S		CHEMBL508102		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607445	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O		CHEMBL1256017		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607446	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O		CHEMBL1256017		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607639	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O		CHEMBL1487		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607640	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O		CHEMBL1487		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607767	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12		CHEMBL1542		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607768	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12		CHEMBL1542		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607910	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1		CHEMBL521589		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607911	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1		CHEMBL521589		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608009	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2c(c1)c1cccc3ccc4cccc2c4c31		CHEMBL1371125		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608010	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2c(c1)c1cccc3ccc4cccc2c4c31		CHEMBL1371125		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608759	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1		CHEMBL65		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608760	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1		CHEMBL65		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609536	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL282575		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609537	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL282575		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609665	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1		CHEMBL942		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609666	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1		CHEMBL942		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609749	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C(Br)C(=O)NC(N)=O		CHEMBL1515611		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609750	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C(Br)C(=O)NC(N)=O		CHEMBL1515611		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609848	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)OCCCCOS(C)(=O)=O		CHEMBL820		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609849	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)OCCCCOS(C)(=O)=O		CHEMBL820		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610098	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3		CHEMBL566534		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610099	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3		CHEMBL566534		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610294	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+]		CHEMBL499815		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610295	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+]		CHEMBL499815		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610422	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL564201		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610423	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL564201		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610561	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL270299		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610562	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL270299		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610664	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)c1ccc(N)cc1		CHEMBL278172		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610665	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)c1ccc(N)cc1		CHEMBL278172		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611403	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL1016		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611404	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL1016		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611557	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4		CHEMBL567597		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612187	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12		CHEMBL26260		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612188	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12		CHEMBL26260		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612317	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL418971		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612318	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL418971		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612408	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Brc1ccccc1		CHEMBL16068		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612409	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Brc1ccccc1		CHEMBL16068		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612515	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCOC(=O)c1ccc(N)cc1		CHEMBL127516		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612516	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCOC(=O)c1ccc(N)cc1		CHEMBL127516		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612761	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O		CHEMBL87285		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612762	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O		CHEMBL87285		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612891	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4		CHEMBL567597		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613086	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2		CHEMBL517712		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613087	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2		CHEMBL517712		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613227	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL529		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613228	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL529		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613364	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL1586		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613365	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL1586		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613469	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1ccccc1		CHEMBL541		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613470	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1ccccc1		CHEMBL541		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614221	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1		CHEMBL48449		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614222	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1		CHEMBL48449		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614501	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1O[C@H]([C@@H](O)CO)C(O)=C1O		CHEMBL196		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615143	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCc1ccccn1		CHEMBL24441		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615144	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCc1ccccn1		CHEMBL24441		Ki			CHEMBL260	Homo sapiens	Ki		
	7615257	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O		CHEMBL290106	=	IC50	nM	318.0	CHEMBL260	Homo sapiens	IC50	uM	0.318
Note: corresponding IC50 reported as Active	7615258	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O		CHEMBL290106		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615359	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL493		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615360	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL493		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615478	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12		CHEMBL990		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615479	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12		CHEMBL990		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615733	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C(=O)N2CCCC2=O)cc1		CHEMBL36994		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615734	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C(=O)N2CCCC2=O)cc1		CHEMBL36994		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615863	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1O[C@H]([C@@H](O)CO)C(O)=C1O		CHEMBL196		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616046	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1366		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616047	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1366		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616192	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1537		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616193	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1537		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616329	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O		CHEMBL838		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616330	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O		CHEMBL838		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616417	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2sc(SSc3nc4ccccc4s3)nc2c1		CHEMBL508112		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616418	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2sc(SSc3nc4ccccc4s3)nc2c1		CHEMBL508112		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617179	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O		CHEMBL294199		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617180	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O		CHEMBL294199		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617458	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Oc1ccccc1C(=O)O		CHEMBL25		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617459	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Oc1ccccc1C(=O)O		CHEMBL25		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618100	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL632		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618101	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL632		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618201	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]		CHEMBL4649901		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618202	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]		CHEMBL4649901		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618293	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1370		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618294	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1370		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618405	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12		CHEMBL1255834		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618406	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12		CHEMBL1255834		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618669	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1		CHEMBL712		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618670	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1		CHEMBL712		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619006	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL1489		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619007	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL1489		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619152	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O		CHEMBL158		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619153	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O		CHEMBL158		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619289	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1		CHEMBL340978		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619290	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1		CHEMBL340978		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619350	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2		CHEMBL1201203		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619351	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2		CHEMBL1201203		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620136	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1560		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620137	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1560		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620390	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1		CHEMBL296419		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620391	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1		CHEMBL296419		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620976	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCc1ccccc1		CHEMBL720		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620977	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCc1ccccc1		CHEMBL720		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621085	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O		CHEMBL1201207		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621086	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O		CHEMBL1201207		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621184	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1		CHEMBL357995		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621185	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1		CHEMBL357995		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621291	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1		CHEMBL188921		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621292	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1		CHEMBL188921		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621394	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1476898		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621395	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1476898		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621661	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1		CHEMBL423192		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621662	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1		CHEMBL423192		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621913	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc2c3c(cccc13)C(=O)NC2=O		CHEMBL338790		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621914	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc2c3c(cccc13)C(=O)NC2=O		CHEMBL338790		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622002	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc(CC(=O)O)ccc2c1		CHEMBL1105		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622003	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc(CC(=O)O)ccc2c1		CHEMBL1105		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622116	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1nnc(S(N)(=O)=O)s1		CHEMBL20		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622117	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1nnc(S(N)(=O)=O)s1		CHEMBL20		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622236	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O		CHEMBL1601669		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622237	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O		CHEMBL1601669		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622325	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622326	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622636	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(CCC(C)C)C(=O)N=C(O)NC1=O		CHEMBL267894		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622637	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(CCC(C)C)C(=O)N=C(O)NC1=O		CHEMBL267894		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622735	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1		CHEMBL461727		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622736	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1		CHEMBL461727		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624054	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN		CHEMBL1370561		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624055	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN		CHEMBL1370561		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624445	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1		CHEMBL63560		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624446	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1		CHEMBL63560		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624532	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc(Cn2ccnc2)cc1		CHEMBL14192		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624533	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc(Cn2ccnc2)cc1		CHEMBL14192		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624620	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2		CHEMBL30327		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624621	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2		CHEMBL30327		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624862	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1ccc(F)cc1)C(=O)O		CHEMBL1235242		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624863	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1ccc(F)cc1)C(=O)O		CHEMBL1235242		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624948	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c2ccccc2c2ccccc12		CHEMBL45245		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624949	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c2ccccc2c2ccccc12		CHEMBL45245		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625063	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC		CHEMBL502620		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625064	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC		CHEMBL502620		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625184	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1ncnc2[nH][nH]cc1-2		CHEMBL1467		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625185	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1ncnc2[nH][nH]cc1-2		CHEMBL1467		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625273	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)c1nc(N(C)C)nc(N(C)C)n1		CHEMBL1455		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625274	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)c1nc(N(C)C)nc(N(C)C)n1		CHEMBL1455		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625559	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2		CHEMBL1113		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625560	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2		CHEMBL1113		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627013	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1		CHEMBL376180		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627014	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1		CHEMBL376180		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627157	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1		CHEMBL1399		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627158	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1		CHEMBL1399		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627384	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1onc(O)c1CC(N)C(=O)O		CHEMBL13378		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627385	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1onc(O)c1CC(N)C(=O)O		CHEMBL13378		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627465	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	S=C=Nc1cccc2ccccc12		CHEMBL1381098		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627466	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	S=C=Nc1cccc2ccccc12		CHEMBL1381098		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627562	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1cccc(O)c1		CHEMBL9419		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627563	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1cccc(O)c1		CHEMBL9419		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627806	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cn[nH]c1		CHEMBL1308		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627807	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cn[nH]c1		CHEMBL1308		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627887	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL3215298		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627888	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL3215298		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628005	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1		CHEMBL2103747		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628006	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1		CHEMBL2103747		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628127	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCO		CHEMBL234926		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628128	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCO		CHEMBL234926		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628215	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC12CC3CC(CC(C3)C1)C2		CHEMBL660		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628216	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC12CC3CC(CC(C3)C1)C2		CHEMBL660		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628494	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1082		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628495	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1082		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629811	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(C(=O)O)c(O)c1		CHEMBL1169		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629812	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(C(=O)O)c(O)c1		CHEMBL1169		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630042	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12		CHEMBL117405		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630043	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12		CHEMBL117405		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630126	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(Cl)Cl		CHEMBL156455		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630127	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(Cl)Cl		CHEMBL156455		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630224	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1cccc(N)c1		CHEMBL81977		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630225	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1cccc(N)c1		CHEMBL81977		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630469	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCCc1ccc(O)cc1		CHEMBL153062		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630470	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCCc1ccc(O)cc1		CHEMBL153062		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630557	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1566		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630558	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1566		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630674	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(O)c2ncn(COCCO)c2n1		CHEMBL184		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630675	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(O)c2ncn(COCCO)c2n1		CHEMBL184		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630795	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O		CHEMBL1110		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630796	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O		CHEMBL1110		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630887	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1		CHEMBL153479		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630888	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1		CHEMBL153479		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631035	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL267345		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631036	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL267345		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632235	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCNCCSP(=O)(O)O		CHEMBL1006		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632236	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCNCCSP(=O)(O)O		CHEMBL1006		Ki			CHEMBL260	Homo sapiens	Ki		
	7632578	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1		CHEMBL1909048	=	IC50	nM	833.0	CHEMBL260	Homo sapiens	IC50	uM	0.833
Note: corresponding IC50 reported as Active	7632579	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1		CHEMBL1909048		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632667	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(Nc1ccccc1)Nc1ccccc1		CHEMBL77675		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632668	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(Nc1ccccc1)Nc1ccccc1		CHEMBL77675		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632765	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3		CHEMBL40583		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632766	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3		CHEMBL40583		Ki			CHEMBL260	Homo sapiens	Ki		
	7632995	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCc1ccc(O)cc1		CHEMBL195437	=	IC50	nM	15016.0	CHEMBL260	Homo sapiens	IC50	uM	15.016
Note: corresponding IC50 reported as Active	7632996	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCc1ccc(O)cc1		CHEMBL195437		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633110	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1		CHEMBL642		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633111	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1		CHEMBL642		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633228	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2		CHEMBL1697694		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633229	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2		CHEMBL1697694		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633346	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL1230813		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633347	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL1230813		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633720	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1		CHEMBL633		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633721	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1		CHEMBL633		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633752	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633753	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174		Ki			CHEMBL260	Homo sapiens	Ki		
	7634269	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O		CHEMBL291338	=	IC50	nM	2176.0	CHEMBL260	Homo sapiens	IC50	uM	2.176
Note: corresponding IC50 reported as Active	7634270	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O		CHEMBL291338		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634944	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O		CHEMBL177		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634945	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O		CHEMBL177		Ki			CHEMBL260	Homo sapiens	Ki		
	7635307	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1		CHEMBL437002	=	IC50	nM	537.0	CHEMBL260	Homo sapiens	IC50	uM	0.537
Note: corresponding IC50 reported as Active	7635308	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1		CHEMBL437002		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635397	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1c2ccccc2CCc2ccccc21		CHEMBL41543		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635398	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1c2ccccc2CCc2ccccc21		CHEMBL41543		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635711	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(Cc2ccc(N)cc2)cc1		CHEMBL85728		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635712	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(Cc2ccc(N)cc2)cc1		CHEMBL85728		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635825	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL93645		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635826	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL93645		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635944	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O		CHEMBL2105617		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635945	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O		CHEMBL2105617		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636046	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1403281		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636047	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1403281		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636396	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1		CHEMBL1365675		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636397	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1		CHEMBL1365675		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636444	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21		CHEMBL1566249		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636445	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21		CHEMBL1566249		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637006	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O		CHEMBL1544		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637007	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O		CHEMBL1544		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637675	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N		CHEMBL945		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637676	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N		CHEMBL945		Ki			CHEMBL260	Homo sapiens	Ki		
	7638150	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909049	=	IC50	nM	746.0	CHEMBL260	Homo sapiens	IC50	uM	0.746
Note: corresponding IC50 reported as Active	7638151	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909049		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638244	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1395		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638245	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1395		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638562	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F		CHEMBL917		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638563	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F		CHEMBL917		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638675	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL189171		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638676	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL189171		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638794	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1		CHEMBL1483		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638795	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1		CHEMBL1483		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638885	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12		CHEMBL283196		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638886	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12		CHEMBL283196		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639220	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCC=C1c2ccccc2CCc2ccccc21		CHEMBL629		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639221	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCC=C1c2ccccc2CCc2ccccc21		CHEMBL629		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639305	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1		CHEMBL116		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639306	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1		CHEMBL116		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639823	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCCc1cccs1		CHEMBL1230333		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639824	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCCc1cccs1		CHEMBL1230333		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640491	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCCCC(=O)O		CHEMBL1046		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640492	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCCCC(=O)O		CHEMBL1046		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640813	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL426123		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640814	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL426123		Ki			CHEMBL260	Homo sapiens	Ki		
	7640900	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909050	=	IC50	nM	329.0	CHEMBL260	Homo sapiens	IC50	uM	0.329
Note: corresponding IC50 reported as Active	7640901	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909050		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640994	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2		CHEMBL311469		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640995	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2		CHEMBL311469		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641319	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Sc1ncnc2nc[nH]c12		CHEMBL1425		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641320	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Sc1ncnc2nc[nH]c12		CHEMBL1425		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641432	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641433	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641552	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL870		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641553	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL870		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641641	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2		CHEMBL47		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641642	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2		CHEMBL47		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641951	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl		CHEMBL1491		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641952	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl		CHEMBL1491		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642041	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642042	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856		Ki			CHEMBL260	Homo sapiens	Ki		
	7642690	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1		CHEMBL1909051	=	IC50	nM	715.0	CHEMBL260	Homo sapiens	IC50	uM	0.715
Note: corresponding IC50 reported as Active	7642691	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1		CHEMBL1909051		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643363	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O		CHEMBL488		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643364	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O		CHEMBL488		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643743	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL558551		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643744	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL558551		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643829	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nn1nnc2ccccc21		CHEMBL101168		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643830	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nn1nnc2ccccc21		CHEMBL101168		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643916	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL577294		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643917	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL577294		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644419	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL989		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644420	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL989		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644481	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1		CHEMBL563		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644482	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1		CHEMBL563		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644621	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644622	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644757	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644758	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644864	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1		CHEMBL472		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644865	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1		CHEMBL472		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644998	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL583		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644999	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL583		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645588	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O		CHEMBL1752		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645589	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O		CHEMBL1752		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646178	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1		CHEMBL672		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646179	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1		CHEMBL672		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646319	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F		CHEMBL106		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646320	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F		CHEMBL106		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647311	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1cc(Cl)c(OCC#CI)cc1Cl		CHEMBL1289		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647312	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1cc(Cl)c(OCC#CI)cc1Cl		CHEMBL1289		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647423	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL389621		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647424	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL389621		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647547	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cn1cnc2c(N)nc3ccccc3c21		CHEMBL1282		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647548	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cn1cnc2c(N)nc3ccccc3c21		CHEMBL1282		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647888	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1902981		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647889	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1902981		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647955	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C		CHEMBL2220427		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647956	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C		CHEMBL2220427		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648066	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL241694		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648067	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL241694		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648197	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC12CCC(CC1)C(C)(C)O2		CHEMBL485259		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648198	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC12CCC(CC1)C(C)(C)O2		CHEMBL485259		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648691	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C		CHEMBL1501		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648692	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C		CHEMBL1501		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648756	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1		CHEMBL806		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648757	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1		CHEMBL806		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648898	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]		CHEMBL1200993		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648899	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]		CHEMBL1200993		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649031	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL3039597		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649032	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL3039597		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649147	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC(=O)O		CHEMBL773		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649148	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC(=O)O		CHEMBL773		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649281	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O		CHEMBL562		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649282	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O		CHEMBL562		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649705	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=P1(NCCCl)OCCCN1CCCl		CHEMBL1024		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649706	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=P1(NCCCl)OCCCN1CCCl		CHEMBL1024		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649824	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL305660		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649825	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL305660		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650482	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1cccc(Oc2ccccc2)c1		CHEMBL1297		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650483	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1cccc(Oc2ccccc2)c1		CHEMBL1297		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650624	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1[nH]c(=O)ncc1F		CHEMBL1463		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650625	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1[nH]c(=O)ncc1F		CHEMBL1463		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651630	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4		CHEMBL433257		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651631	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4		CHEMBL433257		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651739	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12		CHEMBL1535		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651740	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12		CHEMBL1535		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652092	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL808		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652093	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL808		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652197	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC[C@H](O)c1ccc(O)c(O)c1		CHEMBL679		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652198	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC[C@H](O)c1ccc(O)c(O)c1		CHEMBL679		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652277	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL768		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652278	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL768		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652386	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(C)CC(=O)NC1=O		CHEMBL696		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652387	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(C)CC(=O)NC1=O		CHEMBL696		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652517	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCc1ccc(O)c(OC)c1		CHEMBL42710		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652518	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCc1ccc(O)c(OC)c1		CHEMBL42710		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653007	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		CHEMBL177756		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653008	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		CHEMBL177756		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653067	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21		CHEMBL2220442		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653068	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21		CHEMBL2220442		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653211	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL407030		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653212	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL407030		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653314	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]		CHEMBL64894		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653315	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]		CHEMBL64894		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653457	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CO		CHEMBL252557		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653458	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CO		CHEMBL252557		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653591	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1OCC(O)CO		CHEMBL980		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653592	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1OCC(O)CO		CHEMBL980		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654031	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654032	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654791	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654792	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654934	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1568		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654935	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1568		Ki			CHEMBL260	Homo sapiens	Ki		
	7655910	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl		CHEMBL496	=	IC50	nM	87.6	CHEMBL260	Homo sapiens	IC50	uM	0.0876
Note: corresponding IC50 reported as Active	7655911	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl		CHEMBL496		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656039	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1062		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656040	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1062		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656350	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=NN(c2ccccc2)C(=O)C1		CHEMBL290916		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656351	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=NN(c2ccccc2)C(=O)C1		CHEMBL290916		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656471	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1		CHEMBL417		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656472	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1		CHEMBL417		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656549	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O		CHEMBL193482		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656550	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O		CHEMBL193482		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656663	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCO		CHEMBL457299		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656664	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCO		CHEMBL457299		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656796	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O		CHEMBL880		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656797	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O		CHEMBL880		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657287	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200600		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657288	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200600		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657350	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)P(=O)(O)O		CHEMBL666		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657351	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)P(=O)(O)O		CHEMBL666		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657494	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(O)c2ncn(COC(CO)CO)c2n1		CHEMBL182		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657495	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(O)c2ncn(COC(CO)CO)c2n1		CHEMBL182		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657590	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)=CCC/C(C)=C/CO		CHEMBL25719		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657591	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)=CCC/C(C)=C/CO		CHEMBL25719		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657733	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C		CHEMBL441687		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657734	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C		CHEMBL441687		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657856	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)N/N=C/c1c(Cl)cccc1Cl		CHEMBL420		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657857	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)N/N=C/c1c(Cl)cccc1Cl		CHEMBL420		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658335	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O		CHEMBL1130		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658336	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O		CHEMBL1130		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659041	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL914		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659042	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL914		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659182	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1201010		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659183	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1201010		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660143	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2		CHEMBL1319362		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660144	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2		CHEMBL1319362		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660276	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)NO		CHEMBL467		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660277	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)NO		CHEMBL467		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660578	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21		CHEMBL50588		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660579	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21		CHEMBL50588		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660704	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C		CHEMBL1536		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660705	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C		CHEMBL1536		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660778	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O		CHEMBL1405		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660779	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O		CHEMBL1405		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660894	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200623		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660895	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200623		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661032	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1		CHEMBL902		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661033	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1		CHEMBL902		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661523	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]cc(F)c(=O)[nH]1		CHEMBL185		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661524	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]cc(F)c(=O)[nH]1		CHEMBL185		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661587	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1		CHEMBL1103		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661588	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1		CHEMBL1103		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661731	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL31		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661732	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL31		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661827	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1		CHEMBL427216		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661828	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1		CHEMBL427216		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661970	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CNCP(=O)(O)O		CHEMBL95764		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661971	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CNCP(=O)(O)O		CHEMBL95764		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662088	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(N)=NCCN1CCCCCCC1		CHEMBL765		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662089	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(N)=NCCN1CCCCCCC1		CHEMBL765		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662574	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O		CHEMBL1527608		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662575	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O		CHEMBL1527608		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663277	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C		CHEMBL710		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663278	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C		CHEMBL710		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663418	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2		CHEMBL407		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663419	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2		CHEMBL407		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664396	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2		CHEMBL1255901		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664397	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2		CHEMBL1255901		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664527	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cc1ccc(C(C)C(=O)O)cc1		CHEMBL521		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664528	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cc1ccc(C(C)C(=O)O)cc1		CHEMBL521		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664831	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL578		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664832	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL578		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664946	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1385840		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664947	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1385840		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665035	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl		CHEMBL456		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665036	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl		CHEMBL456		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665146	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200624		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665147	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200624		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665287	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)Cc1ccc(-c2ccccc2)cc1		CHEMBL413965		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665288	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)Cc1ccc(-c2ccccc2)cc1		CHEMBL413965		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665672	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CHEMBL30008		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665673	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CHEMBL30008		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665789	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL41		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665790	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL41		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665867	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl		CHEMBL35		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665868	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl		CHEMBL35		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666011	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666012	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666107	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O		CHEMBL1481		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666108	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O		CHEMBL1481		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666250	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL306043		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666251	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL306043		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666364	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl		CHEMBL862		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666365	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl		CHEMBL862		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666862	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666863	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667563	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O		CHEMBL1493		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667564	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O		CHEMBL1493		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668712	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNc1nncc2ccccc12		CHEMBL276832		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668713	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNc1nncc2ccccc12		CHEMBL276832		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668844	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O		CHEMBL1117		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668845	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O		CHEMBL1117		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669150	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21		CHEMBL826		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669151	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21		CHEMBL826		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669248	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL119443		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669249	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL119443		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669355	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](CO)NCCN[C@@H](CC)CO		CHEMBL44884		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669356	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](CO)NCCN[C@@H](CC)CO		CHEMBL44884		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669465	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL871		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669466	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL871		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669601	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl		CHEMBL1480		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669602	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl		CHEMBL1480		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669962	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1512		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669963	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1512		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670054	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL726		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670055	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL726		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670190	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC1(CC(=O)O)CCCCC1		CHEMBL940		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670191	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCC1(CC(=O)O)CCCCC1		CHEMBL940		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670334	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1		CHEMBL457		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670335	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1		CHEMBL457		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670429	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1		CHEMBL1073		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670430	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1		CHEMBL1073		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670566	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1201469		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670567	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1201469		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670669	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1		CHEMBL434063		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670670	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1		CHEMBL434063		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671171	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21		CHEMBL1433		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671172	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21		CHEMBL1433		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671882	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1		CHEMBL6273		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671883	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1		CHEMBL6273		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672984	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NN		CHEMBL1237174		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672985	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NN		CHEMBL1237174		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673112	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O		CHEMBL252556		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673113	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O		CHEMBL252556		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673432	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1		CHEMBL15511		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673433	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1		CHEMBL15511		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673506	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL442		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673507	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL442		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673638	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCO		CHEMBL545		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673639	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCO		CHEMBL545		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673750	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3		CHEMBL622		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673751	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3		CHEMBL622		Ki			CHEMBL260	Homo sapiens	Ki		
	7673887	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1		CHEMBL37161	=	IC50	nM	3188.0	CHEMBL260	Homo sapiens	IC50	uM	3.188
Note: corresponding IC50 reported as Active	7673888	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1		CHEMBL37161		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674253	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1		CHEMBL1614641		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674254	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1		CHEMBL1614641		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674315	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1201012		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674316	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1201012		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674454	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1200431		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674455	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1200431		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674599	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O		CHEMBL34139		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674600	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O		CHEMBL34139		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674695	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O		CHEMBL1372		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674696	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O		CHEMBL1372		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674828	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2		CHEMBL289469		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674829	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2		CHEMBL289469		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674926	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1		CHEMBL1200845		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674927	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1		CHEMBL1200845		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7675432	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1		CHEMBL1108		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7675433	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1		CHEMBL1108		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676170	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1		CHEMBL1454946		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676171	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1		CHEMBL1454946		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677195	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1		CHEMBL54		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677196	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1		CHEMBL54		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677285	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O		CHEMBL435		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677286	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O		CHEMBL435		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677413	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I		CHEMBL788		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677414	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I		CHEMBL788		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677719	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1		CHEMBL56337		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677720	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1		CHEMBL56337		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677783	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL532		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677784	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL532		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677901	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C		CHEMBL691		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677902	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C		CHEMBL691		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678028	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O		CHEMBL44657		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678029	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O		CHEMBL44657		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678230	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1		CHEMBL452		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678231	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1		CHEMBL452		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678933	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1		CHEMBL1201353		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678934	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1		CHEMBL1201353		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679063	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COP(=O)(OC)OC=C(Cl)Cl		CHEMBL167911		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679064	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COP(=O)(OC)OC=C(Cl)Cl		CHEMBL167911		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679123	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O		CHEMBL898		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679124	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O		CHEMBL898		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679577	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12		CHEMBL723		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679578	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12		CHEMBL723		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679690	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]		CHEMBL334255		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679691	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]		CHEMBL334255		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679769	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1		CHEMBL498		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679770	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1		CHEMBL498		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679914	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1200528		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679915	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1200528		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680552	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909056		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680553	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909056		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680689	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1		CHEMBL428880		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680690	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1		CHEMBL428880		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680770	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL139835		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680771	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL139835		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680884	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1		CHEMBL157548		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680885	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1		CHEMBL157548		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681503	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCOC(c1ccccc1)c1ccccc1		CHEMBL657		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681504	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCOC(c1ccccc1)c1ccccc1		CHEMBL657		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682304	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL8		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682305	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL8		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682369	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1		CHEMBL1626		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682370	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1		CHEMBL1626		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682558	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1cccc(Cl)c1N=C1NCCN1		CHEMBL134		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682559	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1cccc(Cl)c1N=C1NCCN1		CHEMBL134		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683249	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1		CHEMBL248702		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683250	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1		CHEMBL248702		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683385	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL139		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683386	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL139		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683445	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C		CHEMBL404811		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683446	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C		CHEMBL404811		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683686	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O		CHEMBL1754		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683687	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O		CHEMBL1754		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683894	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccccc1O		CHEMBL280998		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683895	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccccc1O		CHEMBL280998		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683991	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1		CHEMBL515		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683992	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1		CHEMBL515		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684071	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL404520		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684072	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL404520		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684215	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C2CCCCC2)n(O)c(=O)c1		CHEMBL1413		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684216	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C2CCCCC2)n(O)c(=O)c1		CHEMBL1413		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684850	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C		CHEMBL47244		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684851	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C		CHEMBL47244		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684988	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C/C(=O)N(CC)c1ccccc1C		CHEMBL1200709		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684989	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C/C(=O)N(CC)c1ccccc1C		CHEMBL1200709		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685065	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)nc(NC2CC2)n1		CHEMBL1231107		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685066	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)nc(NC2CC2)n1		CHEMBL1231107		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685174	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1		CHEMBL1201216		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685175	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1		CHEMBL1201216		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685775	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1		CHEMBL936		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685776	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1		CHEMBL936		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686575	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC		CHEMBL1729		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686576	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC		CHEMBL1729		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686654	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1		CHEMBL49080		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686655	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1		CHEMBL49080		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686843	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1		CHEMBL1771		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686844	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1		CHEMBL1771		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687531	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1		CHEMBL175		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687532	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1		CHEMBL175		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687668	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O		CHEMBL1466		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687669	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O		CHEMBL1466		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687730	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL254219		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687731	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL254219		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687961	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC		CHEMBL707		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687962	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC		CHEMBL707		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688185	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21		CHEMBL1201195		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688186	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21		CHEMBL1201195		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688282	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl		CHEMBL130		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688283	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl		CHEMBL130		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688361	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl		CHEMBL1055		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688362	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl		CHEMBL1055		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688486	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1		CHEMBL7002		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688487	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1		CHEMBL7002		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689127	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2		CHEMBL107		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689128	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2		CHEMBL107		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689265	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1		CHEMBL1480987		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689266	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1		CHEMBL1480987		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689342	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689343	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689446	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL178		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689447	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL178		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690034	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1		CHEMBL932		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690035	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1		CHEMBL932		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690211	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCC=C1c2ccccc2COc2ccccc21		CHEMBL1628227		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690212	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCC=C1c2ccccc2COc2ccccc21		CHEMBL1628227		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690750	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1		CHEMBL34431		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690751	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1		CHEMBL34431		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690827	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL11359		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690828	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL11359		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690917	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1753		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690918	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1753		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691102	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)c1ccccc1Cl		CHEMBL1902627		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691103	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)c1ccccc1Cl		CHEMBL1902627		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691801	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL75435		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691802	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL75435		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691935	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1		CHEMBL1123		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691936	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1		CHEMBL1123		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692012	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL1751		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692013	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL1751		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692351	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClC(Cl)(Cl)Cl		CHEMBL44814		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692352	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClC(Cl)(Cl)Cl		CHEMBL44814		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692456	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1		CHEMBL1730		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692457	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1		CHEMBL1730		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692550	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1		CHEMBL451		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692551	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1		CHEMBL451		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692631	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c2cc(Cl)ccc2o1		CHEMBL1371		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692632	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c2cc(Cl)ccc2o1		CHEMBL1371		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693409	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O		CHEMBL2221249		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693410	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O		CHEMBL2221249		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693544	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL648		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693545	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL648		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693644	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2		CHEMBL504760		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693645	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2		CHEMBL504760		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693748	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(O)c(=O)ccn1C		CHEMBL70927		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693749	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(O)c(=O)ccn1C		CHEMBL70927		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694341	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]		CHEMBL487894		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694342	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]		CHEMBL487894		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695054	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1		CHEMBL799		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695055	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1		CHEMBL799		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695117	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21		CHEMBL549		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695118	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21		CHEMBL549		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695221	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1159650		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695222	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1159650		Ki			CHEMBL260	Homo sapiens	Ki		
	7695400	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O		CHEMBL12131	=	IC50	nM	656.0	CHEMBL260	Homo sapiens	IC50	uM	0.656
Note: corresponding IC50 reported as Active	7695401	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O		CHEMBL12131		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696115	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3		CHEMBL52440		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696116	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3		CHEMBL52440		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696232	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1		CHEMBL1460		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696233	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1		CHEMBL1460		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696298	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O		CHEMBL1255837		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696299	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O		CHEMBL1255837		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696685	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1351		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696686	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1351		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696777	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696778	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696885	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL110691		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696886	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL110691		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696972	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL1042		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696973	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL1042		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697760	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909057		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697761	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909057		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697880	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697881	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697982	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]		CHEMBL1687		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697983	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]		CHEMBL1687		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698086	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCCN1c2ccccc2CCc2ccccc21		CHEMBL72		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698087	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCCN1c2ccccc2CCc2ccccc21		CHEMBL72		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698657	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)C(=S)SSC(=S)N(CC)CC		CHEMBL964		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698658	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)C(=S)SSC(=S)N(CC)CC		CHEMBL964		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699388	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN/C(=N/CCSCc1nc[nH]c1C)NC#N		CHEMBL30		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699389	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN/C(=N/CCSCc1nc[nH]c1C)NC#N		CHEMBL30		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699446	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CC(O)(CC(=O)O)C(=O)O		CHEMBL1261		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699447	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CC(O)(CC(=O)O)C(=O)O		CHEMBL1261		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699548	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1		CHEMBL565		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699549	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1		CHEMBL565		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699674	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1		CHEMBL104		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699675	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1		CHEMBL104		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700458	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I		CHEMBL1201220		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700459	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I		CHEMBL1201220		Ki			CHEMBL260	Homo sapiens	Ki		
	7700574	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41		CHEMBL1873703	=	IC50	nM	43193.0	CHEMBL260	Homo sapiens	IC50	uM	43.193
Note: corresponding IC50 reported as Active	7700575	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41		CHEMBL1873703		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700619	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL1732		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700620	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL1732		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701011	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909054		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701012	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909054		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701099	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1		CHEMBL1727		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701100	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1		CHEMBL1727		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701205	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClC(Cl)Cl		CHEMBL44618		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701206	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClC(Cl)Cl		CHEMBL44618		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701292	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O		CHEMBL205596		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701293	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O		CHEMBL205596		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702041	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL1499		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702042	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL1499		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702162	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=P1(N(CCCl)CCCl)NCCCO1		CHEMBL88		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702163	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=P1(N(CCCl)CCCl)NCCCO1		CHEMBL88		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702264	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)/N=N/c1[nH]cnc1C(N)=O		CHEMBL476		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702265	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)/N=N/c1[nH]cnc1C(N)=O		CHEMBL476		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702349	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1		CHEMBL1172		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702350	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1		CHEMBL1172		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702942	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1		CHEMBL926		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702943	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1		CHEMBL926		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703747	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O		CHEMBL510139		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703748	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O		CHEMBL510139		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703849	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(Cl)cc1)C(=O)O		CHEMBL683		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703850	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(Cl)cc1)C(=O)O		CHEMBL683		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703969	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12		CHEMBL891		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703970	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12		CHEMBL891		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704754	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21		CHEMBL12		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704755	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21		CHEMBL12		Ki			CHEMBL260	Homo sapiens	Ki		
	7704838	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL411	=	IC50	nM	32903.0	CHEMBL260	Homo sapiens	IC50	uM	32.903
Note: corresponding IC50 reported as Active	7704839	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL411		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704923	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1		CHEMBL23		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704924	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1		CHEMBL23		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705313	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O		CHEMBL460499		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705314	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O		CHEMBL460499		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705402	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1		CHEMBL1477		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705403	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1		CHEMBL1477		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705508	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(O)cc(C)c1Cl		CHEMBL398440		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705509	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(O)cc(C)c1Cl		CHEMBL398440		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705605	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO		CHEMBL1567463		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705606	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO		CHEMBL1567463		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705722	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C/C=C/c1ccccc1		CHEMBL293492		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705723	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C/C=C/c1ccccc1		CHEMBL293492		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706269	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1		CHEMBL42		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706270	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1		CHEMBL42		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706401	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C		CHEMBL1650		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706402	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C		CHEMBL1650		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706521	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		CHEMBL160		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706522	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		CHEMBL160		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706624	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O		CHEMBL1554		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706625	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O		CHEMBL1554		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706701	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO		CHEMBL1766		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706702	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO		CHEMBL1766		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707215	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O		CHEMBL1200406		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707216	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O		CHEMBL1200406		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707268	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O		CHEMBL3545252		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707269	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O		CHEMBL3545252		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708038	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL43064		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708039	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL43064		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708124	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708125	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708202	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1		CHEMBL954		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708203	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1		CHEMBL954		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709183	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1		CHEMBL181		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709184	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1		CHEMBL181		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709244	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200545		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709245	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200545		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709726	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=NN(CCCl)C(=O)NCCCl		CHEMBL513		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709727	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=NN(CCCl)C(=O)NCCCl		CHEMBL513		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709815	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1		CHEMBL502896		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709816	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1		CHEMBL502896		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709882	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21		CHEMBL71		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709883	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21		CHEMBL71		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710027	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCO.[Cl-]		CHEMBL282468		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710028	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCO.[Cl-]		CHEMBL282468		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710516	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21		CHEMBL415		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710517	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21		CHEMBL415		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710662	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909055		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710663	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909055		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710798	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1ccc2ccccc2o1		CHEMBL6466		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710799	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1ccc2ccccc2o1		CHEMBL6466		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710897	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1		CHEMBL516		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710898	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1		CHEMBL516		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711016	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1479		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711017	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1479		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711121	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL384467		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711122	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL384467		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711631	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[S+](C)[O-]		CHEMBL504		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711632	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[S+](C)[O-]		CHEMBL504		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711672	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1		CHEMBL219916		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711673	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1		CHEMBL219916		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712436	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O		CHEMBL557555		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712437	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O		CHEMBL557555		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712526	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1741		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712527	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1741		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712810	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC		CHEMBL19224		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712811	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC		CHEMBL19224		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712935	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(C)C1(O)OC(=O)C=C1OC		CHEMBL495778		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712936	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(C)C1(O)OC(=O)C=C1OC		CHEMBL495778		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713019	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOc1ccc(NC(C)=O)cc1		CHEMBL16073		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713020	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOc1ccc(NC(C)=O)cc1		CHEMBL16073		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713873	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)CO		CHEMBL286398		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713874	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)CO		CHEMBL286398		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713952	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12		CHEMBL7568		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713953	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12		CHEMBL7568		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715393	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1		CHEMBL16		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715394	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1		CHEMBL16		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715490	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)CN1CCCC1=O		CHEMBL36715		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715491	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)CN1CCCC1=O		CHEMBL36715		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715632	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCOc1ccc(OCCCN2CCOCC2)cc1		CHEMBL1198		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715633	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCOc1ccc(OCCCN2CCOCC2)cc1		CHEMBL1198		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715751	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(NC(C)CCCN)c2ncccc2c1		CHEMBL506		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715752	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(NC(C)CCCN)c2ncccc2c1		CHEMBL506		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715851	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C		CHEMBL103		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715852	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C		CHEMBL103		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716297	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]		CHEMBL54126		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716298	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]		CHEMBL54126		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716423	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O		CHEMBL485549		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716424	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O		CHEMBL485549		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716542	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1		CHEMBL3183075		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716543	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1		CHEMBL3183075		Ki			CHEMBL260	Homo sapiens	Ki		
	7716621	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909071	=	IC50	nM	186.8	CHEMBL260	Homo sapiens	IC50	uM	0.1868
Note: corresponding IC50 reported as Active	7716622	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909071		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716717	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1C(OCCN(C)C)c1ccccc1		CHEMBL900		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716718	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1C(OCCN(C)C)c1ccccc1		CHEMBL900		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716935	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1		CHEMBL762		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716936	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1		CHEMBL762		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717068	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]		CHEMBL458019		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717069	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]		CHEMBL458019		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717194	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL29		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717195	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL29		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717273	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNCCc1ccccc1		CHEMBL1089		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717274	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNCCc1ccccc1		CHEMBL1089		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718134	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCc1cc(=O)[nH]c(=S)[nH]1		CHEMBL1518		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718135	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCc1cc(=O)[nH]c(=S)[nH]1		CHEMBL1518		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718970	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL222863		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718971	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL222863		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719651	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C		CHEMBL94		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719652	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C		CHEMBL94		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719749	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C		CHEMBL295416		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719750	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C		CHEMBL295416		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719889	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21		CHEMBL1144		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719890	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21		CHEMBL1144		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720011	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(c2ccccc2)C(=O)NCNC1=O		CHEMBL856		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720012	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(c2ccccc2)C(=O)NCNC1=O		CHEMBL856		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720107	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1		CHEMBL316561		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720108	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1		CHEMBL316561		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720349	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O		CHEMBL1592		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720350	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O		CHEMBL1592		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720562	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O		CHEMBL1572		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720563	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O		CHEMBL1572		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720685	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1		CHEMBL56367		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720686	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1		CHEMBL56367		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720804	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1		CHEMBL9514		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720805	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1		CHEMBL9514		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720887	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL450895		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720888	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL450895		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721182	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL1200585		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721183	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL1200585		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721308	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721309	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721435	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		CHEMBL55		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721436	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		CHEMBL55		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721536	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1c2ccccc2C(=O)C1c1ccccc1		CHEMBL711		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721537	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1c2ccccc2C(=O)C1c1ccccc1		CHEMBL711		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722409	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL600325		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722410	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL600325		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723247	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL414804		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723248	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL414804		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723903	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O		CHEMBL1200656		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723904	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O		CHEMBL1200656		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724001	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21		CHEMBL311350		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724002	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21		CHEMBL311350		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724140	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1		CHEMBL976		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724141	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1		CHEMBL976		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724262	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1		CHEMBL897		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724263	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1		CHEMBL897		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724332	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCN1c2ccccc2Sc2ccccc21		CHEMBL564		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724333	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCCN1c2ccccc2Sc2ccccc21		CHEMBL564		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724614	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909075		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724615	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909075		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724829	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1		CHEMBL57		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724830	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1		CHEMBL57		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724949	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21		CHEMBL13341		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724950	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21		CHEMBL13341		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725064	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1162		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725065	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1162		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725153	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1N		CHEMBL1612004		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725154	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1N		CHEMBL1612004		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725449	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1cccc2cccnc12		CHEMBL310555		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725450	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1cccc2cccnc12		CHEMBL310555		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725565	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21		CHEMBL540445		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725566	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21		CHEMBL540445		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725688	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL628		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725689	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL628		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725797	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O		CHEMBL40		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725798	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O		CHEMBL40		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726590	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(CN1c2ccccc2Sc2ccccc21)N(C)C		CHEMBL643		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726678	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1		CHEMBL469912		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726679	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1		CHEMBL469912		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726724	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5		CHEMBL19019		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726725	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5		CHEMBL19019		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7727517	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1		CHEMBL1071		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728179	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)COc1cccc2[nH]ccc12		CHEMBL500		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728180	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)COc1cccc2[nH]ccc12		CHEMBL500		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728280	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O		CHEMBL527		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728281	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O		CHEMBL527		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728412	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC		CHEMBL2		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728413	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC		CHEMBL2		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728548	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1		CHEMBL608		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728549	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1		CHEMBL608		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728582	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(CN1c2ccccc2Sc2ccccc21)N(C)C		CHEMBL643		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729115	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cccnc1		CHEMBL573		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729116	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cccnc1		CHEMBL573		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729228	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1		CHEMBL1428		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729229	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1		CHEMBL1428		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729342	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1201146		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729343	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1201146		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729436	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1		CHEMBL3350037		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729437	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1		CHEMBL3350037		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729526	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1		CHEMBL1071		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729730	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12		CHEMBL1517		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729731	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12		CHEMBL1517		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729847	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21		CHEMBL267648		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729848	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21		CHEMBL267648		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729953	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL531		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729954	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL531		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730083	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccccc1		CHEMBL14060		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730084	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccccc1		CHEMBL14060		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730838	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1		CHEMBL631		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730839	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1		CHEMBL631		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730954	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1cnccn1		CHEMBL614		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730955	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1cnccn1		CHEMBL614		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730998	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL757		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730999	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL757		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732458	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1		CHEMBL595		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732459	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1		CHEMBL595		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732561	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC		CHEMBL61		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732562	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC		CHEMBL61		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732688	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL131		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732689	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL131		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732826	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCNC(=O)c1ccc(N)cc1		CHEMBL640		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732827	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCNC(=O)c1ccc(N)cc1		CHEMBL640		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733377	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1cccnc1		CHEMBL1140		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733378	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1cccnc1		CHEMBL1140		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733484	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]		CHEMBL1726		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733485	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]		CHEMBL1726		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733602	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21		CHEMBL9		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733603	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21		CHEMBL9		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733697	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL4		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733698	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL4		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733794	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1c2ccccc2CC(=O)c2ccccc21		CHEMBL1068		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733795	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1c2ccccc2CC(=O)c2ccccc21		CHEMBL1068		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733998	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733999	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734120	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC1=NC(=O)C(c2ccccc2)O1		CHEMBL1177		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734121	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC1=NC(=O)C(c2ccccc2)O1		CHEMBL1177		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734210	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1		CHEMBL75880		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734211	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1		CHEMBL75880		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734340	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2c(c1)Nc1ccccc1S2		CHEMBL828		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734341	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2c(c1)Nc1ccccc1S2		CHEMBL828		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735112	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N		CHEMBL1196		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735113	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N		CHEMBL1196		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735228	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1		CHEMBL511		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735229	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1		CHEMBL511		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735284	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1		CHEMBL154		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735285	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1		CHEMBL154		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736726	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL1909072		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736727	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL1909072		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736855	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL3559671		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736856	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL3559671		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736979	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL635		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736980	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL635		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737120	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOC(=O)c1ccc(N)cc1		CHEMBL569		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737121	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOC(=O)c1ccc(N)cc1		CHEMBL569		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737670	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC[C@H]1c1cccnc1		CHEMBL3		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737671	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC[C@H]1c1cccnc1		CHEMBL3		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737775	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1		CHEMBL13209		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737776	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1		CHEMBL13209		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737892	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC		CHEMBL2107797		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737893	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC		CHEMBL2107797		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737974	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1		CHEMBL715		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737975	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1		CHEMBL715		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738091	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1		CHEMBL42442		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738092	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1		CHEMBL42442		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738307	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(CO)C(O)C(=O)NCCCO		CHEMBL1371937		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738308	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(CO)C(O)C(=O)NCCCO		CHEMBL1371937		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738429	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1		CHEMBL1540		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738430	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1		CHEMBL1540		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738513	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL567		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738514	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL567		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738631	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1		CHEMBL597		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738632	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1		CHEMBL597		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739395	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)c1cccc(C(C)C)c1O		CHEMBL526		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739396	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)c1cccc(C(C)C)c1O		CHEMBL526		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739508	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1cccc(O)c1O		CHEMBL307145		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739509	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1cccc(O)c1O		CHEMBL307145		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739566	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL783		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739567	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL783		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7740389	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL1262		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7740390	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL1262		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7740931	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O		CHEMBL101		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741028	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O		CHEMBL702		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741029	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O		CHEMBL702		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741163	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL2108139		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741164	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL2108139		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741285	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1400945		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741286	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1400945		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741430	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNNCc1ccc(C(=O)NC(C)C)cc1		CHEMBL1321		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741431	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNNCc1ccc(C(=O)NC(C)C)cc1		CHEMBL1321		Ki			CHEMBL260	Homo sapiens	Ki		
	7741868	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C		CHEMBL584	=	IC50	nM	18224.0	CHEMBL260	Homo sapiens	IC50	uM	18.224
Note: corresponding IC50 reported as Active	7741869	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C		CHEMBL584		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741998	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]		CHEMBL193		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741999	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]		CHEMBL193		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742110	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1		CHEMBL475534		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742111	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1		CHEMBL475534		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742201	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742202	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742311	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1		CHEMBL1503		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742312	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1		CHEMBL1503		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742640	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC		CHEMBL1502		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742641	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC		CHEMBL1502		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742762	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(S)[C@@H](N)C(=O)O		CHEMBL1430		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742763	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(S)[C@@H](N)C(=O)O		CHEMBL1430		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742846	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)NC(=O)Cc1ccccc1		CHEMBL918		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742847	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)NC(=O)Cc1ccccc1		CHEMBL918		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742961	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O		CHEMBL101		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743732	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)COc1cccc2ccccc12		CHEMBL27		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743733	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)COc1cccc2ccccc12		CHEMBL27		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743844	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1		CHEMBL716		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743845	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1		CHEMBL716		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744703	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1		CHEMBL1231		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744704	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1		CHEMBL1231		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745265	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNc1ccccc1		CHEMBL456807		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745266	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNc1ccccc1		CHEMBL456807		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745368	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]		CHEMBL1909073		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745369	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]		CHEMBL1909073		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745510	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[n+]1ccccc1/C=N/O.[Cl-]		CHEMBL748		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745511	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[n+]1ccccc1/C=N/O.[Cl-]		CHEMBL748		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745630	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCNC(C)C(=O)Nc1ccccc1C		CHEMBL1194		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745631	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCNC(C)C(=O)Nc1ccccc1C		CHEMBL1194		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745755	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL728		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745756	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL728		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746208	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O		CHEMBL184618		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746209	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O		CHEMBL184618		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746335	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1		CHEMBL63323		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746336	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1		CHEMBL63323		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746453	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1		CHEMBL572		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746454	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1		CHEMBL572		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746532	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C		CHEMBL364713		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746533	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C		CHEMBL364713		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746644	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O		CHEMBL46		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746645	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O		CHEMBL46		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746814	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O		CHEMBL580		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746815	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O		CHEMBL580		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746923	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO		CHEMBL689		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746924	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO		CHEMBL689		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747747	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21		CHEMBL58		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747748	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21		CHEMBL58		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747850	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2		CHEMBL866		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747851	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2		CHEMBL866		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747981	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314		CHEMBL895		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747982	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314		CHEMBL895		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748607	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1		CHEMBL141		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748608	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1		CHEMBL141		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748742	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc([C@H]2CN3CCSC3=N2)cc1		CHEMBL1454		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748743	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc([C@H]2CN3CCSC3=N2)cc1		CHEMBL1454		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748872	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1447		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748873	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1447		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749300	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(Nc2ccccc2C(=O)O)c1C		CHEMBL686		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749301	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(Nc2ccccc2C(=O)O)c1C		CHEMBL686		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749413	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=S(=O)([O-])CCS.[Na+]		CHEMBL975		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749414	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=S(=O)([O-])CCS.[Na+]		CHEMBL975		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749497	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c2occc2cc2ccc(=O)oc12		CHEMBL416		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749498	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c2occc2cc2ccc(=O)oc12		CHEMBL416		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749607	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1		CHEMBL1065		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749608	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1		CHEMBL1065		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749740	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(C)c1OCC(C)N		CHEMBL558		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749741	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(C)c1OCC(C)N		CHEMBL558		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750304	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1		CHEMBL165790		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750305	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1		CHEMBL165790		Ki			CHEMBL260	Homo sapiens	Ki		
	7750440	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1		CHEMBL547	=	IC50	nM	2529.0	CHEMBL260	Homo sapiens	IC50	uM	2.529
Note: corresponding IC50 reported as Active	7750441	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1		CHEMBL547		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750524	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1		CHEMBL534		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750525	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1		CHEMBL534		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751109	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL191		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751110	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL191		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751194	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCCC12CCC(c3ccccc31)c1ccccc12		CHEMBL21731		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751195	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNCCCC12CCC(c3ccccc31)c1ccccc12		CHEMBL21731		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752051	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1		CHEMBL86304		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752052	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1		CHEMBL86304		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752152	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOCCC1=CCC2CC1C2(C)C		CHEMBL1630579		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752153	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCOCCC1=CCC2CC1C2(C)C		CHEMBL1630579		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752800	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O		CHEMBL2106399		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752801	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O		CHEMBL2106399		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752901	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1		CHEMBL741		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752902	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1		CHEMBL741		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753031	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O		CHEMBL1201237		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753032	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O		CHEMBL1201237		Ki			CHEMBL260	Homo sapiens	Ki		
	7753169	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909064	=	IC50	nM	60.6	CHEMBL260	Homo sapiens	IC50	uM	0.0606
Note: corresponding IC50 reported as Active	7753170	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909064		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753472	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909067		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753593	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1201139		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753594	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1201139		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753706	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C		CHEMBL1201151		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753707	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C		CHEMBL1201151		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753790	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-]		CHEMBL1201024		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753791	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-]		CHEMBL1201024		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753892	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC		CHEMBL86		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753893	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC		CHEMBL86		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754013	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN2c3ccccc3Cc3ccccc3C2C1		CHEMBL6437		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754014	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN2c3ccccc3Cc3ccccc3C2C1		CHEMBL6437		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754450	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5		CHEMBL1618305		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754451	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5		CHEMBL1618305		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754624	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NNC(=O)c1ccncc1		CHEMBL92401		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754625	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NNC(=O)c1ccncc1		CHEMBL92401		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754756	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O		CHEMBL64391		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754757	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O		CHEMBL64391		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755423	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL503		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755424	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL503		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755509	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909067		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756289	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL91		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756290	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL91		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756396	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1		CHEMBL1373		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756397	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1		CHEMBL1373		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756500	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)N=O		CHEMBL164290		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756501	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)N=O		CHEMBL164290		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757150	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS		CHEMBL1221512		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757151	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS		CHEMBL1221512		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757264	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1		CHEMBL480		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757265	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1		CHEMBL480		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757391	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C		CHEMBL1201193		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757392	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C		CHEMBL1201193		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757523	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1237		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757524	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1237		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757939	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2[nH]cc(CCNC(C)=O)c2c1		CHEMBL45		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757940	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2[nH]cc(CCNC(C)=O)c2c1		CHEMBL45		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758026	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21		CHEMBL19215		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758027	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21		CHEMBL19215		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758147	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COS(C)(=O)=O		CHEMBL313493		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758148	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COS(C)(=O)=O		CHEMBL313493		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758244	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C		CHEMBL878		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758245	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C		CHEMBL878		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758768	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5		CHEMBL80		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758769	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5		CHEMBL80		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758947	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1		CHEMBL1513		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758948	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1		CHEMBL1513		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759065	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL1200633		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759066	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL1200633		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759755	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1		CHEMBL19299		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759756	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1		CHEMBL19299		Ki			CHEMBL260	Homo sapiens	Ki		
	7759840	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909068	=	IC50	nM	2272.0	CHEMBL260	Homo sapiens	IC50	uM	2.272
Note: corresponding IC50 reported as Active	7759841	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909068		Ki			CHEMBL260	Homo sapiens	Ki		
	7760557	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C		CHEMBL1276308	=	IC50	nM	83061.0	CHEMBL260	Homo sapiens	IC50	uM	83.061
Note: corresponding IC50 reported as Active	7760558	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C		CHEMBL1276308		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760677	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccc(OCc2ccccc2)cc1		CHEMBL1388		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760678	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccc(OCc2ccccc2)cc1		CHEMBL1388		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760792	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C=O		CHEMBL268291		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760793	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C=O		CHEMBL268291		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761421	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@H]2CC[C@]1(C)C(=O)C2		CHEMBL2252949		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761422	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@H]2CC[C@]1(C)C(=O)C2		CHEMBL2252949		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761536	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909062		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761537	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909062		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761666	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)C[C@H](O)CC(=O)[O-]		CHEMBL1149		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761667	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)C[C@H](O)CC(=O)[O-]		CHEMBL1149		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761776	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL157138		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761777	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL157138		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762105	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909069		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762106	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909069		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762225	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1		CHEMBL599		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762226	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1		CHEMBL599		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762302	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=N)NC(=N)N		CHEMBL1431		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762303	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=N)NC(=N)N		CHEMBL1431		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762423	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)c1ccccc1O		CHEMBL108545		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762424	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)c1ccccc1O		CHEMBL108545		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762518	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL13		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762519	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL13		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763095	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1		CHEMBL406		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763096	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1		CHEMBL406		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763217	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC		CHEMBL481		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763218	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC		CHEMBL481		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763338	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL1384		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763339	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL1384		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763999	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764000	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764818	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1		CHEMBL189		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764819	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1		CHEMBL189		Ki			CHEMBL260	Homo sapiens	Ki		
	7764923	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1		CHEMBL787	=	IC50	nM	856.0	CHEMBL260	Homo sapiens	IC50	uM	0.856
Note: corresponding IC50 reported as Active	7764924	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1		CHEMBL787		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765051	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1		CHEMBL1333512		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765052	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1		CHEMBL1333512		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765685	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O		CHEMBL245416		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765686	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O		CHEMBL245416		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765799	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909063		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765800	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909063		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765930	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL1009		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765931	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL1009		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766035	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21		CHEMBL561		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766036	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21		CHEMBL561		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766362	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766363	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766485	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O		CHEMBL852		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766486	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O		CHEMBL852		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766551	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCN(Cc1cccs1)c1ccccn1		CHEMBL1411979		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766552	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)CCN(Cc1cccs1)c1ccccn1		CHEMBL1411979		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766690	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL459		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766691	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL459		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766790	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ncc([N+](=O)[O-])n1CCO		CHEMBL137		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766791	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ncc([N+](=O)[O-])n1CCO		CHEMBL137		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767361	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O		CHEMBL115		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767362	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O		CHEMBL115		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767485	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O		CHEMBL1712923		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767486	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O		CHEMBL1712923		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767604	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC1(c2ccccc2Cl)CCCCC1=O		CHEMBL742		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767605	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC1(c2ccccc2Cl)CCCCC1=O		CHEMBL742		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768270	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC		CHEMBL1909065		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768271	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC		CHEMBL1909065		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769105	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]		CHEMBL802		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769106	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]		CHEMBL802		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769197	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL60889		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769198	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL60889		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769331	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc(CCC(C)=O)ccc2c1		CHEMBL1070		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769332	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2cc(CCC(C)=O)ccc2c1		CHEMBL1070		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769965	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1		CHEMBL429		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769966	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1		CHEMBL429		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770086	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL960		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770087	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL960		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770219	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL33		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770220	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL33		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770324	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=NN(CCCl)C(=O)NC1CCCCC1		CHEMBL514		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770325	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=NN(CCCl)C(=O)NC1CCCCC1		CHEMBL514		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770643	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl		CHEMBL509		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770644	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl		CHEMBL509		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770759	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1		CHEMBL395110		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770760	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1		CHEMBL395110		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770840	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1cc[nH]c1=S		CHEMBL1515		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770841	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1cc[nH]c1=S		CHEMBL1515		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770969	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL1201356		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770970	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL1201356		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771081	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C(=O)c1cccnc1)c1cccnc1		CHEMBL934		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771082	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C(=O)c1cccnc1)c1cccnc1		CHEMBL934		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771644	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL6		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771645	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL6		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771771	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C\c1ccc(O)c(OC)c1		CHEMBL445206		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771772	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C/C=C\c1ccc(O)c(OC)c1		CHEMBL445206		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771875	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL157101		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771876	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL157101		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772559	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N		CHEMBL2105807		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772560	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N		CHEMBL2105807		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773380	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12		CHEMBL105		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773381	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12		CHEMBL105		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773466	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1nc(C)nc(Cl)c1NC1=NCCN1		CHEMBL19236		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773467	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1nc(C)nc(Cl)c1NC1=NCCN1		CHEMBL19236		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773603	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2		CHEMBL649		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773604	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2		CHEMBL649		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774215	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C		CHEMBL460291		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774216	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C		CHEMBL460291		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774347	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1		CHEMBL1444		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774348	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1		CHEMBL1444		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774477	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL267044		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774478	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL267044		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774575	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774576	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774912	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1390		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774913	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1390		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775015	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(C)c1NC(=O)C1CCCCN1C		CHEMBL1087		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775016	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(C)c1NC(=O)C1CCCCN1C		CHEMBL1087		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775100	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1OCC(O)COC(N)=O		CHEMBL1201117		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775101	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccccc1OCC(O)COC(N)=O		CHEMBL1201117		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775222	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)c1ccc(O)cc1		CHEMBL325372		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775223	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)c1ccc(O)cc1		CHEMBL325372		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775334	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@](N)(Cc1ccc(O)cc1)C(=O)O		CHEMBL1200862		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775335	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@](N)(Cc1ccc(O)cc1)C(=O)O		CHEMBL1200862		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775896	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1201631		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775897	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1201631		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776027	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNC(=O)c1ccncc1		CHEMBL64		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776028	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NNC(=O)c1ccncc1		CHEMBL64		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776122	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL571		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776123	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL571		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776790	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1200693		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776791	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1200693		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777605	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1		CHEMBL1670		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777606	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1		CHEMBL1670		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777697	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2		CHEMBL1456		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777698	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2		CHEMBL1456		Ki			CHEMBL260	Homo sapiens	Ki		
	7777834	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O		CHEMBL1909070	=	IC50	nM	3740.5	CHEMBL260	Homo sapiens	IC50	uM	3.7405
Note: corresponding IC50 reported as Active	7777835	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O		CHEMBL1909070		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778447	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)C(=O)O		CHEMBL1200559		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778448	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(O)C(=O)O		CHEMBL1200559		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778582	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O		CHEMBL1679		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778583	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O		CHEMBL1679		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778712	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CC(=O)Nc1c(C)cccc1C		CHEMBL79		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778713	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CC(=O)Nc1c(C)cccc1C		CHEMBL79		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778797	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1		CHEMBL998		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778798	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1		CHEMBL998		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779135	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL717		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779136	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL717		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779244	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12		CHEMBL127		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779245	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12		CHEMBL127		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779329	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1		CHEMBL34259		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779330	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1		CHEMBL34259		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779449	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12		CHEMBL650		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779450	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12		CHEMBL650		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779566	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL54440		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779567	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL54440		Ki			CHEMBL260	Homo sapiens	Ki		
	7780134	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1c(I)cc(I)c2cccnc12		CHEMBL86754	=	IC50	nM	364.0	CHEMBL260	Homo sapiens	IC50	uM	0.364
Note: corresponding IC50 reported as Active	7780135	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1c(I)cc(I)c2cccnc12		CHEMBL86754		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780269	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)c1ccc(O)c(O)c1		CHEMBL434		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780270	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)c1ccc(O)c(O)c1		CHEMBL434		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780367	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O		CHEMBL469		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780368	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O		CHEMBL469		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781408	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2		CHEMBL56564		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781522	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1		CHEMBL865		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781523	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1		CHEMBL865		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781637	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL159		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781638	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL159		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781826	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(COC(C)=O)OC(C)=O		CHEMBL1489254		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781827	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)OCC(COC(C)=O)OC(C)=O		CHEMBL1489254		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781955	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL422		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781956	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL422		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782069	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2		CHEMBL56564		Ki			CHEMBL260	Homo sapiens	Ki		
	7782547	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12		CHEMBL603	=	IC50	nM	353.0	CHEMBL260	Homo sapiens	IC50	uM	0.353
Note: corresponding IC50 reported as Active	7782548	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12		CHEMBL603		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783007	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12		CHEMBL428		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783008	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12		CHEMBL428		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783124	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]		CHEMBL2107687		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783125	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]		CHEMBL2107687		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783243	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL90555		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783244	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL90555		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783432	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO		CHEMBL1451		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783433	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO		CHEMBL1451		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783555	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1		CHEMBL1490		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783556	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1		CHEMBL1490		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784144	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1		CHEMBL1521		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784145	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1		CHEMBL1521		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784597	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC		CHEMBL1566956		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784598	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC		CHEMBL1566956		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784707	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC(CCC)C(=O)O		CHEMBL109		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784708	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCC(CCC)C(=O)O		CHEMBL109		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784828	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL238071		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784829	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL238071		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785013	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1504		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785014	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1504		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785135	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CN2CCNCC2)c(OC)c1OC		CHEMBL203266		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785136	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CN2CCNCC2)c(OC)c1OC		CHEMBL203266		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785723	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1		CHEMBL28079		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785724	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1		CHEMBL28079		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786306	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786307	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786417	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C		CHEMBL1069		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786418	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C		CHEMBL1069		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786537	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2		CHEMBL553025		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786538	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2		CHEMBL553025		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786743	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@H]1CC[C@H](C(=O)O)CC1		CHEMBL877		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786744	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@H]1CC[C@H](C(=O)O)CC1		CHEMBL877		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786853	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1		CHEMBL585		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786854	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1		CHEMBL585		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786978	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)OC(C)(C)C1=O		CHEMBL695		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786979	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(=O)OC(C)(C)C1=O		CHEMBL695		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787580	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL129		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787581	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL129		Ki			CHEMBL260	Homo sapiens	Ki		
	7788162	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2		CHEMBL141343	=	IC50	nM	5596.0	CHEMBL260	Homo sapiens	IC50	uM	5.596
Note: corresponding IC50 reported as Active	7788163	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2		CHEMBL141343		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788292	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O		CHEMBL262777		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788293	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O		CHEMBL262777		Ki			CHEMBL260	Homo sapiens	Ki		
	7788400	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	643.0	CHEMBL260	Homo sapiens	IC50	uM	0.643
Note: corresponding IC50 reported as Active	7788401	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788620	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC		CHEMBL415324		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788621	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC		CHEMBL415324		Ki			CHEMBL260	Homo sapiens	Ki		
	7788726	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O		CHEMBL24944	=	IC50	nM	715.0	CHEMBL260	Homo sapiens	IC50	uM	0.715
Note: corresponding IC50 reported as Active	7788727	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O		CHEMBL24944		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788857	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1		CHEMBL1475		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788858	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1		CHEMBL1475		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789450	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(c1cc2ccccc2s1)N(O)C(N)=O		CHEMBL93		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789451	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(c1cc2ccccc2s1)N(O)C(N)=O		CHEMBL93		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790015	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O		CHEMBL29292		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790016	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O		CHEMBL29292		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790149	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]		CHEMBL1200629		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790150	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]		CHEMBL1200629		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790255	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O		CHEMBL1464		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790256	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O		CHEMBL1464		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790473	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1386		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790474	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1386		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790587	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O		CHEMBL1054		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790588	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O		CHEMBL1054		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790713	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2		CHEMBL408		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790714	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2		CHEMBL408		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791304	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	[Cl-].[Cl-].[Zn+2]		CHEMBL1200679		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791305	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	[Cl-].[Cl-].[Zn+2]		CHEMBL1200679		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791876	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(N)=O		CHEMBL462547		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791877	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(N)=O		CHEMBL462547		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792009	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1		CHEMBL637		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792010	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1		CHEMBL637		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792116	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792117	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792317	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12		CHEMBL621		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792318	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12		CHEMBL621		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792446	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)C(Cl)(Cl)Cl		CHEMBL14053		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792447	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)C(Cl)(Cl)Cl		CHEMBL14053		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792569	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(CO)(CO)CO		CHEMBL1200391		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792570	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(CO)(CO)CO		CHEMBL1200391		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793175	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909083		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793176	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909083		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793747	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21		CHEMBL1349		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793748	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21		CHEMBL1349		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793871	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC		CHEMBL6966		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793872	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC		CHEMBL6966		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793984	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21		CHEMBL15245		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793985	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21		CHEMBL15245		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794058	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1		CHEMBL38		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794059	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1		CHEMBL38		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794189	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClCC(Cl)Cl		CHEMBL43882		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794190	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	ClCC(Cl)Cl		CHEMBL43882		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794303	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1		CHEMBL1200604		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794304	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1		CHEMBL1200604		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795349	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795350	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795411	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21		CHEMBL1908355		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795412	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21		CHEMBL1908355		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796854	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21		CHEMBL1393		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796855	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21		CHEMBL1393		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796989	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46		CHEMBL227934		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796990	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46		CHEMBL227934		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797106	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL446		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797107	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL446		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797244	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C		CHEMBL453		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797245	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C		CHEMBL453		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797717	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL1440		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797718	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL1440		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797845	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc2[nH]cnc2c(=S)[nH]1		CHEMBL727		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797846	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc2[nH]cnc2c(=S)[nH]1		CHEMBL727		Ki			CHEMBL260	Homo sapiens	Ki		
	7797915	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1		CHEMBL1630578	=	IC50	nM	7406.0	CHEMBL260	Homo sapiens	IC50	uM	7.406
Note: corresponding IC50 reported as Active	7797916	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1		CHEMBL1630578		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798056	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc(C2(O)CCCCC2CN(C)C)c1		CHEMBL1237044		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798057	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cccc(C2(O)CCCCC2CN(C)C)c1		CHEMBL1237044		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798269	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798270	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798399	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(N)C12CC3CC(CC(C3)C1)C2		CHEMBL959		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798400	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(N)C12CC3CC(CC(C3)C1)C2		CHEMBL959		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798506	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O		CHEMBL1321154		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798507	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O		CHEMBL1321154		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798621	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1ccccc1O		CHEMBL27577		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798622	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1ccccc1O		CHEMBL27577		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798737	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O		CHEMBL447		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798738	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O		CHEMBL447		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798835	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=[As][O-].[Na+]		CHEMBL1909078		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798836	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=[As][O-].[Na+]		CHEMBL1909078		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799576	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		CHEMBL269732		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799577	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		CHEMBL269732		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799638	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O		CHEMBL302795		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799639	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O		CHEMBL302795		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800181	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1		CHEMBL1148		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800182	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1		CHEMBL1148		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801107	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909079		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801108	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL1909079		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801242	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL403		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801243	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL403		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801365	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1		CHEMBL1191		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801366	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1		CHEMBL1191		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801502	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1		CHEMBL15770		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801503	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1		CHEMBL15770		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802003	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL468		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802004	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL468		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802105	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2		CHEMBL479		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802106	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2		CHEMBL479		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802212	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O		CHEMBL1747		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802213	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O		CHEMBL1747		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802561	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC		CHEMBL772		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802562	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC		CHEMBL772		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802696	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O		CHEMBL923		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802697	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O		CHEMBL923		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802801	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1214185		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802802	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1214185		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802918	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1ccccc1O		CHEMBL424		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802919	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1ccccc1O		CHEMBL424		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803028	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#CCN(C)[C@H](C)Cc1ccccc1		CHEMBL972		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803029	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#CCN(C)[C@H](C)Cc1ccccc1		CHEMBL972		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803131	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL136478		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803132	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL136478		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803868	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1		CHEMBL83		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803869	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1		CHEMBL83		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803985	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC		CHEMBL611		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803986	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC		CHEMBL611		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804514	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1		CHEMBL273348		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804515	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1		CHEMBL273348		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805459	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL27769		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805460	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL27769		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805578	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL1221		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805579	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL1221		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805724	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1		CHEMBL443		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805725	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1		CHEMBL443		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805852	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1		CHEMBL18797		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805853	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1		CHEMBL18797		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806340	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O		CHEMBL190		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806341	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O		CHEMBL190		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806419	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC		CHEMBL84158		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806420	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC		CHEMBL84158		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806529	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(C)c1NC(=O)C(C)N		CHEMBL1762		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806530	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(C)c1NC(=O)C(C)N		CHEMBL1762		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806869	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806870	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807001	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2		CHEMBL85		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807002	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2		CHEMBL85		Ki			CHEMBL260	Homo sapiens	Ki		
	7807121	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	uM	0.075
Note: corresponding IC50 reported as Active	7807122	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807247	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C		CHEMBL1208572		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807248	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C		CHEMBL1208572		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807354	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1CCC(NC(=O)N(CCCl)N=O)CC1		CHEMBL12948		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807355	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1CCC(NC(=O)N(CCCl)N=O)CC1		CHEMBL12948		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807461	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL179166		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807462	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL179166		Ki			CHEMBL260	Homo sapiens	Ki		
	7808140	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL506247	=	IC50	nM	375.0	CHEMBL260	Homo sapiens	IC50	uM	0.375
Note: corresponding IC50 reported as Active	7808141	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL506247		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808269	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12		CHEMBL822		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808270	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12		CHEMBL822		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808793	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NC[C@@H](O)COc1cccc2ccccc12		CHEMBL275742		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808794	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NC[C@@H](O)COc1cccc2ccccc12		CHEMBL275742		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809739	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL2079587		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809740	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL2079587		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809855	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1		CHEMBL1243		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809856	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1		CHEMBL1243		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810001	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(N)(=O)=O)cc1		CHEMBL21		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810002	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(N)(=O)=O)cc1		CHEMBL21		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810124	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1		CHEMBL488025		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810125	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1		CHEMBL488025		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810617	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2[nH]c(-c3cscn3)nc2c1		CHEMBL625		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810618	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	c1ccc2[nH]c(-c3cscn3)nc2c1		CHEMBL625		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810694	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C		CHEMBL2103774		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810695	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C		CHEMBL2103774		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810813	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1		CHEMBL817		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810814	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1		CHEMBL817		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811154	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811155	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811272	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1		CHEMBL163		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811273	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1		CHEMBL163		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811392	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NC[C@H](O)COc1cccc2ccccc12		CHEMBL452861		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811393	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NC[C@H](O)COc1cccc2ccccc12		CHEMBL452861		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811531	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(Oc1ccccc1C(=O)O)c1ccccc1O		CHEMBL154111		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811532	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(Oc1ccccc1C(=O)O)c1ccccc1O		CHEMBL154111		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811620	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21		CHEMBL809		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811621	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21		CHEMBL809		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811753	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1		CHEMBL471		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811754	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1		CHEMBL471		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812386	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1		CHEMBL588119		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812430	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL404		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812431	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL404		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812556	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)c1cc(O)cc(O)c1		CHEMBL1760		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812557	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)c1cc(O)cc(O)c1		CHEMBL1760		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813086	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1		CHEMBL427526		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813087	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1		CHEMBL427526		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814023	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL991		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814024	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL991		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814139	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL439		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814140	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL439		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814284	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1		CHEMBL1109		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814285	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1		CHEMBL1109		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814387	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1		CHEMBL588119		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814918	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1		CHEMBL1236282		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814919	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1		CHEMBL1236282		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814985	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccccc1CN1CCc2sccc2C1		CHEMBL833		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814986	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Clc1ccccc1CN1CCc2sccc2C1		CHEMBL833		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815108	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1		CHEMBL1020		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815109	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1		CHEMBL1020		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815453	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O		CHEMBL444633		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815454	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O		CHEMBL444633		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815564	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC		CHEMBL18701		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815565	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC		CHEMBL18701		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815680	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@H](CSC(=S)NCc1ccccc1)C(=O)O		CHEMBL1909076		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815681	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	N[C@H](CSC(=S)NCc1ccccc1)C(=O)O		CHEMBL1909076		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815815	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1		CHEMBL114		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815816	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1		CHEMBL114		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815903	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1		CHEMBL1419		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815904	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1		CHEMBL1419		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816045	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1		CHEMBL850		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816046	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1		CHEMBL850		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816652	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL26		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816653	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL26		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816710	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c(=O)n(C2CCCO2)cc1F		CHEMBL20883		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816711	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=c1[nH]c(=O)n(C2CCCO2)cc1F		CHEMBL20883		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816809	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL1306		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816810	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL1306		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817374	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C		CHEMBL1219		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817375	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C		CHEMBL1219		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818319	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O		CHEMBL372795		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818320	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O		CHEMBL372795		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818435	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1		CHEMBL62193		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818436	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1		CHEMBL62193		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818580	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O		CHEMBL421		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818581	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O		CHEMBL421		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819074	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL17157		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819075	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL17157		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819190	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL508338		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819191	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B			CHEMBL508338		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819264	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl		CHEMBL267744		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819265	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl		CHEMBL267744		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819390	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1		CHEMBL83668		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819391	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1		CHEMBL83668		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819747	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL374478		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819748	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL374478		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819857	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1		CHEMBL122		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819858	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1		CHEMBL122		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819974	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O		CHEMBL1200748		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819975	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O		CHEMBL1200748		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820101	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL37858		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820102	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL37858		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820184	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12		CHEMBL192		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820185	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12		CHEMBL192		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820326	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1		CHEMBL412873		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820327	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1		CHEMBL412873		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820933	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1		CHEMBL128		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820934	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1		CHEMBL128		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820991	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O		CHEMBL2367892		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820992	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O		CHEMBL2367892		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821610	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12		CHEMBL81		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821611	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12		CHEMBL81		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822584	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1651906		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822585	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1651906		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822699	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC		CHEMBL1539		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822700	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC		CHEMBL1539		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822839	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL437		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822840	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL437		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823320	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL386630		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823321	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL386630		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823443	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=N)S		CHEMBL38737		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823444	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(=N)S		CHEMBL38737		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823516	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1		CHEMBL499		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823517	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1		CHEMBL499		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823640	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1076211		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823641	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1076211		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823859	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21		CHEMBL1168		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823860	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21		CHEMBL1168		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823986	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL1660		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823987	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL1660		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824095	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1		CHEMBL121		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824096	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1		CHEMBL121		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824210	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCc1ccc2c(c1)OCO2		CHEMBL242273		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824211	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=CCc1ccc2c(c1)OCO2		CHEMBL242273		Ki			CHEMBL260	Homo sapiens	Ki		
	7824330	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	159.0	CHEMBL260	Homo sapiens	IC50	uM	0.159
Note: corresponding IC50 reported as Active	7824331	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824427	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL1064		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824428	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL1064		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824570	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12		CHEMBL1167		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824571	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12		CHEMBL1167		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825174	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]		CHEMBL983		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825175	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]		CHEMBL983		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825235	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1		CHEMBL277100		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825236	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1		CHEMBL277100		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826806	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]		CHEMBL1909080		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826807	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]		CHEMBL1909080		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826921	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL438		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826922	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL438		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827061	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1		CHEMBL832		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827062	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1		CHEMBL832		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827544	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCNc1ccc(C(=O)OCCN(C)C)cc1		CHEMBL698		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827545	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCCCNc1ccc(C(=O)OCCN(C)C)cc1		CHEMBL698		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827670	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCCC[C@@H]1CCSS1		CHEMBL134342		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827671	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	O=C(O)CCCC[C@@H]1CCSS1		CHEMBL134342		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827742	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C		CHEMBL1220		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827743	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C		CHEMBL1220		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827865	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1		CHEMBL84		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827866	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1		CHEMBL84		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828085	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1		CHEMBL1790041		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828086	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1		CHEMBL1790041		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828211	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL744		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828212	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL744		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828319	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1		CHEMBL429023		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828320	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1		CHEMBL429023		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828435	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1		CHEMBL714		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828436	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1		CHEMBL714		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828550	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ncc([N+](=O)[O-])n1CC(C)O		CHEMBL498847		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828551	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	Cc1ncc([N+](=O)[O-])n1CC(C)O		CHEMBL498847		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828647	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL221886		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828648	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL221886		Ki			CHEMBL260	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828785	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1		CHEMBL70586		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828786	CHEMBL1909201	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	B	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1		CHEMBL70586		Ki			CHEMBL260	Homo sapiens	Ki		
	7848072	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800911	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	7848073	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCCC3)c2)o1		CHEMBL1911190	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	7848074	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCCC3)c2)no1		CHEMBL1911191	=	IC50	nM	583.0	CHEMBL260	Homo sapiens	IC50	nM	583.0
	7848075	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1noc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCCC3)c2)n1		CHEMBL1911192	=	IC50	nM	741.0	CHEMBL260	Homo sapiens	IC50	nM	741.0
	7848076	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCCC3)c2)[nH]1		CHEMBL1911193	=	IC50	nM	7.4	CHEMBL260	Homo sapiens	IC50	nM	7.4
	7848077	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCOCC3)c2)[nH]1		CHEMBL1911194	=	IC50	nM	7.6	CHEMBL260	Homo sapiens	IC50	nM	7.6
	7848078	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1cnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCOCC3)c2)[nH]1		CHEMBL1911195	=	IC50	nM	173.0	CHEMBL260	Homo sapiens	IC50	nM	173.0
	7848079	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ncc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCOCC3)c2)[nH]1		CHEMBL1911196	=	IC50	nM	880.0	CHEMBL260	Homo sapiens	IC50	nM	880.0
	7848080	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc(-c2ncn[nH]2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1911197	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	7848081	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc(-c2nnc(C3CC3)[nH]2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1911198	=	IC50	nM	135.0	CHEMBL260	Homo sapiens	IC50	nM	135.0
	7848082	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCC3)c2)[nH]1		CHEMBL1909657	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	7848083	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C4(C)C)c2)[nH]1		CHEMBL1911331	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	nM	87.0
	7848084	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCC(F)(F)CC3)c2)[nH]1		CHEMBL1911332	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	7848085	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCN(S(C)(=O)=O)CC3)c2)[nH]1		CHEMBL1911333	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
	7848086	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(NC3CC3)noc2c1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1911334	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	7848087	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	O=C1Nc2cc(-c3cccc4c(NC5CC5)noc34)ccc2C12CCCC2		CHEMBL1911335	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	7848088	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	O=C1Nc2cc(-c3cccc4c(NC5CC5)noc34)c(Cl)cc2C12CCCC2		CHEMBL1911336	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	7848089	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(NC3CC3)noc2c1-c1ccc2c(c1)NC(=O)C2(C)C		CHEMBL1911337	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	7848090	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(NC3CC3)noc2c1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1911338	=	IC50	nM	0.16	CHEMBL260	Homo sapiens	IC50	nM	0.16
	7848091	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(NC3CC3)noc2c1-c1ccc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1911339	=	IC50	nM	0.06	CHEMBL260	Homo sapiens	IC50	nM	0.06
	7848092	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(N)noc2c1-c1ccc2c(c1)NC(=O)C2(C)C		CHEMBL1911340	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	7848093	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(N)noc2c1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1911341	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	7848094	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(N)noc2c1-c1ccc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1911342	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	7848095	CHEMBL1913342	Inhibition of human p38alpha using biotinylated ATF2 as substrate preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccn2c(N)nnc2c1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1911344	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	7850034	CHEMBL1913341	Inhibition of human p38alpha using biotinylated ATF2 as substrate at 60 uM preincubated for 1 hr measured after 1 hr by FRET assay	B	Cc1ccc2c(N)n[nH]c2c1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1911343	=	Inhibition	%	60.0	CHEMBL260	Homo sapiens	INH	%	60.0
	7931109	CHEMBL1919404	Inhibition of MAPK14 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	7939472	CHEMBL1918088	Inhibition of p38alpha MAP kinase	B	O=C1CCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL564912	=	IC50	nM	0.74	CHEMBL260	Homo sapiens	IC50	nM	0.74
	7939473	CHEMBL1918088	Inhibition of p38alpha MAP kinase	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	7939478	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	Cc1ccccc1-c1nccc2c(-c3ccc(F)cc3F)ccnc12		CHEMBL1916343	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	7939479	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	Cc1ccccc1-c1c2nccc(-c3ccc(F)cc3F)c2cc[n+]1[O-]		CHEMBL1916344	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	nM	68.0
	7939480	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	COc1ccccc1-c1c2nccc(-c3ccc(F)cc3F)c2cc[n+]1[O-]		CHEMBL1914478	=	IC50	nM	144.0	CHEMBL260	Homo sapiens	IC50	nM	144.0
	7939481	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3F)ccnc2c1-c1ccccc1Cl		CHEMBL1916345	=	IC50	nM	195.0	CHEMBL260	Homo sapiens	IC50	nM	195.0
	7939482	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3F)ccnc2c1-c1ccccc1F		CHEMBL1916346	=	IC50	nM	333.0	CHEMBL260	Homo sapiens	IC50	nM	333.0
	7939483	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	Cc1cccc(C)c1-c1c2nccc(-c3ccc(F)cc3F)c2cc[n+]1[O-]		CHEMBL1916347	=	IC50	nM	148.0	CHEMBL260	Homo sapiens	IC50	nM	148.0
	7939484	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	COc1cccc(OC)c1-c1c2nccc(-c3ccc(F)cc3F)c2cc[n+]1[O-]		CHEMBL1916348	=	IC50	nM	141.0	CHEMBL260	Homo sapiens	IC50	nM	141.0
	7939485	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3F)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916349	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	7939486	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3F)ccnc2c1-c1c(F)cccc1F		CHEMBL1916350	=	IC50	nM	66.0	CHEMBL260	Homo sapiens	IC50	nM	66.0
	7939487	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	Cc1cc(O)ccc1-c1c2nccc(-c3ccc(F)cc3F)c2cc[n+]1[O-]		CHEMBL1916351	=	IC50	nM	90.0	CHEMBL260	Homo sapiens	IC50	nM	90.0
	7939488	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	Cc1cc(OCCN2CCOCC2)ccc1-c1c2nccc(-c3ccc(F)cc3F)c2cc[n+]1[O-]		CHEMBL1916352	=	IC50	nM	422.0	CHEMBL260	Homo sapiens	IC50	nM	422.0
	7939489	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	COCCNC(=O)c1ccc(-c2c3nccc(-c4ccc(F)cc4F)c3cc[n+]2[O-])c(C)c1		CHEMBL1916353	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	nM	1400.0
	7939490	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	Cc1cc(NS(C)(=O)=O)ccc1-c1c2nccc(-c3ccc(F)cc3F)c2cc[n+]1[O-]		CHEMBL1916354	=	IC50	nM	81.0	CHEMBL260	Homo sapiens	IC50	nM	81.0
	7939491	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	COc1ccccc1-c1ccnc2c(-c3c(F)cccc3F)[n+]([O-])ccc12		CHEMBL1916355	=	IC50	nM	77.0	CHEMBL260	Homo sapiens	IC50	nM	77.0
	7939492	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3cccc(C(F)(F)F)c3)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916356	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	7939493	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(C(F)(F)F)cc3)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916357	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	7939494	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccccc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916358	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	nM	37.0
	7939495	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	7939496	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)nc2c1-c1c(Cl)cccc1Cl		CHEMBL1738839	=	IC50	nM	0.82	CHEMBL260	Homo sapiens	IC50	nM	0.82
	7939497	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)cc(C3CCNCC3)nc2c1-c1c(Cl)cccc1Cl		CHEMBL1916360	=	IC50	nM	0.49	CHEMBL260	Homo sapiens	IC50	nM	0.49
	7939498	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	CN1CCC(c2cc(-c3ccc(F)cc3Cl)c3cc[n+]([O-])c(-c4c(Cl)cccc4Cl)c3n2)CC1		CHEMBL1916361	=	IC50	nM	0.72	CHEMBL260	Homo sapiens	IC50	nM	0.72
	7939499	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	CC(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3cc[n+]([O-])c(-c4c(Cl)cccc4Cl)c3n2)CC1		CHEMBL1916519	=	IC50	nM	0.59	CHEMBL260	Homo sapiens	IC50	nM	0.59
	7939500	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3cc[n+]([O-])c(-c4c(Cl)cccc4Cl)c3n2)CC1		CHEMBL1916520	=	IC50	nM	0.53	CHEMBL260	Homo sapiens	IC50	nM	0.53
	7939501	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)cc(-c3ccncc3)nc2c1-c1c(Cl)cccc1Cl		CHEMBL1916521	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	7939502	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)cc(-c3cccnc3)nc2c1-c1c(Cl)cccc1Cl		CHEMBL1916522	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	7939503	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccccc3Cl)cc(C3CCNCC3)nc2c1-c1c(F)cccc1F		CHEMBL1916523	=	IC50	nM	0.27	CHEMBL260	Homo sapiens	IC50	nM	0.27
	7939504	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	CC(=O)N1CCC(c2cc(-c3ccccc3Cl)c3cc[n+]([O-])c(-c4c(F)cccc4F)c3n2)CC1		CHEMBL1916524	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	7939505	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccc(F)cc3F)cc(NC3CCNCC3)nc2c1-c1c(F)cccc1F		CHEMBL1916525	=	IC50	nM	0.28	CHEMBL260	Homo sapiens	IC50	nM	0.28
	7939506	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccccc3Cl)cc(N3CCOCC3)nc2c1-c1c(F)cccc1F		CHEMBL1916526	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	7939507	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccccc3Cl)cc(N3CCNCC3)nc2c1-c1c(Cl)cccc1Cl		CHEMBL1916527	=	IC50	nM	0.26	CHEMBL260	Homo sapiens	IC50	nM	0.26
	7939508	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccccc3Cl)cc(NC3CCNCC3)nc2c1-c1c(Cl)cccc1Cl		CHEMBL1916528	=	IC50	nM	0.13	CHEMBL260	Homo sapiens	IC50	nM	0.13
	7939509	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	CN1C(C)(C)CC(Nc2cc(-c3ccccc3Cl)c3cc[n+]([O-])c(-c4c(Cl)cccc4Cl)c3n2)CC1(C)C		CHEMBL1916529	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	7939510	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	[O-][n+]1ccc2c(-c3ccccc3Cl)cc(OC3CCNCC3)nc2c1-c1c(Cl)cccc1Cl		CHEMBL1916530	=	IC50	nM	0.46	CHEMBL260	Homo sapiens	IC50	nM	0.46
	7939511	CHEMBL1918093	Inhibition of human p38alpha MAP kinase after 1 hr by FRET analysis	B	CCOCCOc1cc(-c2ccccc2Cl)c2cc[n+]([O-])c(-c3c(Cl)cccc3Cl)c2n1		CHEMBL1916531	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	7939959	CHEMBL1919729	Inhibition of human SAPK2a	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	7943746	CHEMBL1919766	Inhibition of p38alpha	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	14.3	CHEMBL260	Homo sapiens	IC50	nM	14.3
	7943787	CHEMBL1921555	Inhibition of p38alpha at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	7956240	CHEMBL1925199	Inhibition of N-terminus flag-tagged p38alpha expressed in baculovirus infected insect cells using [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	7959577	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCS(=O)(=O)CC2)c(NC(=O)Nc2cccc3ccccc23)s1		CHEMBL1929195	=	IC50	nM	76.0	CHEMBL260	Homo sapiens	IC50	uM	0.076
	7959578	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCS(=O)(=O)CC2)c(NC(=O)Nc2ccc3ccccc3c2)s1		CHEMBL1929196	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	7959579	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCS(=O)(=O)CC2)c(NC(=O)Nc2ccc(Cl)cc2)s1		CHEMBL1929197	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	7959580	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(CN2CCS(=O)(=O)CC2)c(NC(=O)Nc2cccc3ccccc23)s1		CHEMBL1929198	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	7959581	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(CN2CCS(=O)(=O)CC2)c(NC(=O)Nc2ccc3ccccc3c2)s1		CHEMBL1929199	=	IC50	nM	900.0	CHEMBL260	Homo sapiens	IC50	uM	0.9
	7959582	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(CN2CCS(=O)(=O)CC2)c(NC(=O)Nc2ccc(Cl)cc2)s1		CHEMBL1929200	=	IC50	nM	1700.0	CHEMBL260	Homo sapiens	IC50	uM	1.7
	7959583	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)c(C(=O)N2CCS(=O)(=O)CC2)s1		CHEMBL1929201	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	7959584	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)c(C(=O)N2CCS(=O)(=O)CC2)s1		CHEMBL1929202	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	7959585	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)c(C(=O)N2CCS(=O)(=O)CC2)s1		CHEMBL1929203	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	7959586	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)c(CN2CCS(=O)(=O)CC2)s1		CHEMBL1929204	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	7959587	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)c(CN2CCS(=O)(=O)CC2)s1		CHEMBL1929205	=	IC50	nM	5700.0	CHEMBL260	Homo sapiens	IC50	uM	5.7
	7959588	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)c(CN2CCS(=O)(=O)CC2)s1		CHEMBL1929206	=	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	uM	16.0
	7959589	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)c(N2CCS(=O)(=O)CC2)s1		CHEMBL1929207	=	IC50	nM	520.0	CHEMBL260	Homo sapiens	IC50	uM	0.52
	7959590	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)c(N2CCS(=O)(=O)CC2)s1		CHEMBL1929208	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	uM	2.0
	7959591	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(CC(=O)N2CCS(=O)(=O)CC2)n1		CHEMBL1929209	=	IC50	nM	6400.0	CHEMBL260	Homo sapiens	IC50	uM	6.4
	7959592	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(CC(=O)N2CCS(=O)(=O)CC2)n1		CHEMBL1929210	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	7959593	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(C(=O)N2CCS(=O)(=O)CC2)n1		CHEMBL1929211	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	uM	3.5
	7959594	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(C(=O)N2CCS(=O)(=O)CC2)n1		CHEMBL1929212	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	7959595	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CC[S+]([O-])CC2)c(NC(=O)Nc2cccc3ccccc23)s1		CHEMBL1929213	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	7959596	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCSCC2)c(NC(=O)Nc2cccc3ccccc23)s1		CHEMBL1929214	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	uM	2.0
	7959597	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2cccc3ccccc23)s1		CHEMBL1929215	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	7959598	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2ccc3ccccc3c2)s1		CHEMBL1929216	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	7959599	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2ccc(Cl)cc2)s1		CHEMBL1929217	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	7959600	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNS(=O)(=O)CC2)c(NC(=O)Nc2cccc3ccccc23)s1		CHEMBL1929218	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	7959601	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNS(=O)(=O)CC2)c(NC(=O)Nc2ccc3ccccc3c2)s1		CHEMBL1929219	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	7959602	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNS(=O)(=O)CC2)c(NC(=O)Nc2ccc(Cl)cc2)s1		CHEMBL1929220	=	IC50	nM	83.0	CHEMBL260	Homo sapiens	IC50	uM	0.083
	7959603	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)C2)c(NC(=O)Nc2cccc3ccccc23)s1		CHEMBL1929221	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	7959604	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)C2)c(NC(=O)Nc2ccc3ccccc3c2)s1		CHEMBL1929222	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	7959605	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)C2)c(NC(=O)Nc2ccc(Cl)cc2)s1		CHEMBL1929223	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	uM	0.086
	7959606	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2ccc(C#N)c3ccccc23)s1		CHEMBL1929224	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	7959607	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2cccc(Cl)c2)s1		CHEMBL1929225	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	uM	0.042
	7959608	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2cccc(Cl)c2Cl)s1		CHEMBL1926710	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	7959609	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2ccc(Cl)c(Cl)c2)s1		CHEMBL1929226	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	7959610	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2ccc3c(c2)OCO3)s1		CHEMBL1929227	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	7959611	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	Cc1cccc(NC(=O)Nc2sc(C(C)(C)C)cc2C(=O)N2CCNC(=O)CC2)c1		CHEMBL1929228	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	7959612	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2ccc(C#N)cc2Cl)s1		CHEMBL1929229	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	7959613	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCNC(=O)CC2)c(NC(=O)Nc2ccc(F)c(Cl)c2Cl)s1		CHEMBL1929230	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	7959614	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	COCCOCCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929231	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	7959615	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	COCCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929232	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	7959616	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCC(=O)N(CC(N)=O)CC2)c(NC(=O)Nc2cccc(Cl)c2Cl)s1		CHEMBL1929233	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	7959617	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC1(C)OCC(CN2CCN(C(=O)c3cc(C(C)(C)C)sc3NC(=O)Nc3cccc(Cl)c3Cl)CCC2=O)O1		CHEMBL1929234	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	uM	0.031
	7959618	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCC(=O)N(CCC(N)=O)CC2)c(NC(=O)Nc2cccc(Cl)c2Cl)s1		CHEMBL1929235	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	7959619	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CC(C)(C)c1cc(C(=O)N2CCC(=O)N(Cc3nn[nH]n3)CC2)c(NC(=O)Nc2cccc(Cl)c2Cl)s1		CHEMBL1929236	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	7959620	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929237	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	7959621	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	7959622	CHEMBL1932272	Inhibition of p38alpha assessed as [33P]gamma-ATP incorporation into GST-ATF2 substrate preincubated for 20 mins before substrate addition measured after 70 mins by liquid scintillation counter	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2ccc(F)c(Cl)c2Cl)CCC1=O		CHEMBL1929239	=	IC50	nM	73.0	CHEMBL260	Homo sapiens	IC50	uM	0.073
	7960787	CHEMBL1932540	Inhibition of p38alpha assessed as residual activity at 1 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	Activity	%	18.0	CHEMBL260	Homo sapiens	Activity	%	18.0
	7960788	CHEMBL1932541	Inhibition of p38alpha assessed as residual activity at 10 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928541	=	Activity	%	9.0	CHEMBL260	Homo sapiens	Activity	%	9.0
	7960996	CHEMBL1932621	Inhibition of p38alpha assessed as residual activity at 1 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	Activity	%	59.0	CHEMBL260	Homo sapiens	Activity	%	59.0
	7960997	CHEMBL1932622	Inhibition of p38alpha assessed as residual activity at 10 uM	B	Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(CCO)/N=C/c1cnn2ccc(C#N)cc12		CHEMBL1928561	=	Activity	%	13.0	CHEMBL260	Homo sapiens	Activity	%	13.0
	7961075	CHEMBL1931519	Inhibition of P38alpha	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	7961076	CHEMBL1931519	Inhibition of P38alpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	7969767	CHEMBL1929686	Inhibition of p38alpha MAPK assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	54.0	CHEMBL260	Homo sapiens	Activity	%	54.0
	7970444	CHEMBL1929915	Inhibition of p38alpha at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O	Outside typical range	CHEMBL1929247	=	Inhibition	%	-13.0	CHEMBL260	Homo sapiens	INH	%	-13.0
	7984695	CHEMBL1936529	Inhibition of P38alpha	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	7984696	CHEMBL1936529	Inhibition of P38alpha	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	7992202	CHEMBL1935876	Inhibition of MAPK14 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	-3.0	CHEMBL260	Homo sapiens	INH	%	-3.0
Active	7996820	CHEMBL1941729	Inhibition of p38alpha at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	7996821	CHEMBL1941729	Inhibition of p38alpha at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	7996822	CHEMBL1941729	Inhibition of p38alpha at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	7996823	CHEMBL1941729	Inhibition of p38alpha at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	8003412	CHEMBL1944414	Inhibition of human P38alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	8003413	CHEMBL1944414	Inhibition of human P38alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	8003414	CHEMBL1944414	Inhibition of human P38alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	8003415	CHEMBL1944414	Inhibition of human P38alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	8006763	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	7.5	CHEMBL260	Homo sapiens	Kd	nM	7.5
	8006764	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	NC(COCc1ccccc1)c1csc(NC(=O)Nc2ccc(Cl)c(F)c2)n1		CHEMBL1940496	=	Kd	nM	13400.0	CHEMBL260	Homo sapiens	Kd	nM	13400.0
	8006765	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1738946	=	Kd	nM	990.0	CHEMBL260	Homo sapiens	Kd	nM	990.0
	8006766	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	CC(C)(C)c1cc(NC(=O)Nc2nccs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738942	=	Kd	nM	196.0	CHEMBL260	Homo sapiens	Kd	nM	196.0
	8006767	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	CCOC(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1940499	=	Kd	nM	675.0	CHEMBL260	Homo sapiens	Kd	nM	675.0
	8006768	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)cc1		CHEMBL1738944	=	Kd	nM	382.0	CHEMBL260	Homo sapiens	Kd	nM	382.0
	8006769	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccc(F)cc3)cs2)cc1		CHEMBL1940500	=	Kd	nM	303.0	CHEMBL260	Homo sapiens	Kd	nM	303.0
	8006770	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3ccncc3)cs2)cc1		CHEMBL1738943	=	Kd	nM	586.0	CHEMBL260	Homo sapiens	Kd	nM	586.0
	8006771	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3cccnc3)cs2)cc1		CHEMBL1940501	=	Kd	nM	1656.0	CHEMBL260	Homo sapiens	Kd	nM	1656.0
	8006772	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	O=C(O)Cc1cccc(-n2nc(C3CC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)c1		CHEMBL1940502	=	Kd	nM	14700.0	CHEMBL260	Homo sapiens	Kd	nM	14700.0
	8006773	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738945	=	Kd	nM	287.0	CHEMBL260	Homo sapiens	Kd	nM	287.0
	8006774	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	CC(C)(C)c1cc(NC(=O)Nc2nc(CCOCc3ccccc3)cs2)n(-c2cccc(CC(=O)O)c2)n1		CHEMBL1940503	=	Kd	nM	920.0	CHEMBL260	Homo sapiens	Kd	nM	920.0
	8006775	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	O=C(O)Cc1cccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)c1		CHEMBL1940504	=	Kd	nM	580.0	CHEMBL260	Homo sapiens	Kd	nM	580.0
	8006776	CHEMBL1943082	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 after 5 hrs by fluorescence analysis	B	O=C(O)Cc1ccc(-n2nc(C3CCCC3)cc2NC(=O)Nc2nc(CCOCc3ccccc3)cs2)cc1		CHEMBL1940505	=	Kd	nM	901.0	CHEMBL260	Homo sapiens	Kd	nM	901.0
	8006777	CHEMBL1943083	Inhibition of N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 using GST-tagged ATF2 as substrate after 90 mins by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	8006778	CHEMBL1943083	Inhibition of N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 using GST-tagged ATF2 as substrate after 90 mins by HTRF assay	B	CC(C)(C)c1cc(NC(=O)Nc2nccs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738942	=	IC50	nM	135.0	CHEMBL260	Homo sapiens	IC50	nM	135.0
	8006779	CHEMBL1943083	Inhibition of N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 using GST-tagged ATF2 as substrate after 90 mins by HTRF assay	B	CCOC(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1940499	=	IC50	nM	639.0	CHEMBL260	Homo sapiens	IC50	nM	639.0
	8006780	CHEMBL1943083	Inhibition of N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 using GST-tagged ATF2 as substrate after 90 mins by HTRF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nc(CCOCc3cccnc3)cs2)cc1		CHEMBL1940501	=	IC50	nM	3641.0	CHEMBL260	Homo sapiens	IC50	nM	3641.0
	8006781	CHEMBL1943084	Inhibition of p38alpha-mediated MK2 phosphorylation in anisomysin-stimulated human HeLa cells after 2 hrs by immunoblot analysis	B	CCOC(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1940499	=	IC50	nM	6000.0	CHEMBL260	Homo sapiens	IC50	uM	6.0
Not Active	8006783	CHEMBL1943086	Binding affinity to N-terminus His-tagged human p38alpha expressed in Escherichia coli BL21 DE3 at 1 nM to 10 uM after 5 hrs by fluorescence analysis	B	O=C(Nc1nc(CCOCc2ccccc2)cs1)c1cc(F)cc(N2CCOCC2)c1		CHEMBL1940498		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	8006784	CHEMBL1943087	Inhibition of p38alpha-mediated MK2 phosphorylation in anisomysin-stimulated human HeLa cells at 0.5 to 50 uM after 2 hrs by immunoblot analysis	B	CC(C)(C)c1cc(NC(=O)Nc2nccs2)n(-c2ccc(CC(=O)O)cc2)n1		CHEMBL1738942		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Dose-dependent effect	8006785	CHEMBL1943084	Inhibition of p38alpha-mediated MK2 phosphorylation in anisomysin-stimulated human HeLa cells after 2 hrs by immunoblot analysis	B	CCOC(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2nccs2)cc1		CHEMBL1940499		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	8010524	CHEMBL1942361	Inhibition of MAPK14 at 10 uM	B	CCNC(=O)NCc1ccccc1Sc1ccc2nnc(C(C)C)n2c1		CHEMBL1938764		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	8010527	CHEMBL1942361	Inhibition of MAPK14 at 10 uM	B	CC(C)c1nnc2ccc(Sc3ccccc3CNC(=O)Nc3cc(C(C)(C)C)nn3-c3ccccc3)cn12		CHEMBL1938736		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	8010534	CHEMBL1942361	Inhibition of MAPK14 at 10 uM	B	CSC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(C(C)C)n3c2)n(-c2cccc(O)c2)n1		CHEMBL1938741		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	8010554	CHEMBL1944479	Binding affinity to p38alpha MAPK by surface plasmon resonance method	B	CC(C)c1nnc2ccc(Sc3ccccc3CNC(=O)Nc3cc(C(C)(C)C)nn3-c3ccccc3)cn12		CHEMBL1938736	=	Kd	nM	0.4	CHEMBL260	Homo sapiens	Kd	nM	0.4
	8010555	CHEMBL1944479	Binding affinity to p38alpha MAPK by surface plasmon resonance method	B	CCNC(=O)NCc1ccccc1Sc1ccc2nnc(C(C)C)n2c1		CHEMBL1938764	=	Kd	nM	3.3	CHEMBL260	Homo sapiens	Kd	nM	3.3
	8010556	CHEMBL1944479	Binding affinity to p38alpha MAPK by surface plasmon resonance method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1.0	CHEMBL260	Homo sapiens	Kd	nM	1.0
	8010637	CHEMBL1942369	Binding affinity to human p38alpha MAPK by surface plasmon resonance method	B	CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1	Outside typical range	CHEMBL1938400	=	Kd	nM	0.001	CHEMBL260	Homo sapiens	Kd	nM	0.001
	8010639	CHEMBL1942510	Binding affinity to p38alpha MAPK assessed as half life by surface plasmon resonance method	B	CC(C)c1nnc2ccc(Sc3ccccc3CNC(=O)Nc3cc(C(C)(C)C)nn3-c3ccccc3)cn12		CHEMBL1938736	=	T1/2	hr	4.81	CHEMBL260	Homo sapiens	t1/2	hr	4.81
	8010641	CHEMBL1942510	Binding affinity to p38alpha MAPK assessed as half life by surface plasmon resonance method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	T1/2	hr	3.85	CHEMBL260	Homo sapiens	t1/2	hr	3.85
	8010664	CHEMBL1942510	Binding affinity to p38alpha MAPK assessed as half life by surface plasmon resonance method	B	CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1		CHEMBL1938400	=	T1/2	hr	80.0	CHEMBL260	Homo sapiens	t1/2	hr	80.0
	8010665	CHEMBL1942510	Binding affinity to p38alpha MAPK assessed as half life by surface plasmon resonance method	B	CCNC(=O)NCc1ccccc1Sc1ccc2nnc(C(C)C)n2c1		CHEMBL1938764	=	T1/2	hr	0.01	CHEMBL260	Homo sapiens	t1/2	hr	0.01
	8013116	CHEMBL1948135	Inhibition of p38alpha using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	8018852	CHEMBL1948956	Inhibition of p38alpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	8018853	CHEMBL1948956	Inhibition of p38alpha assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	8018854	CHEMBL1948956	Inhibition of p38alpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	75.0	CHEMBL260	Homo sapiens	Activity	%	75.0
	8020304	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3F)n2n(C)c1=O		CHEMBL1945715	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	8020305	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3Cl)n2n(C)c1=O		CHEMBL1945716	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	8020306	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(C)cccc3F)n2n(C)c1=O		CHEMBL1945717	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	8020307	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3cc(F)ccc3Cl)n2n(C)c1=O		CHEMBL1945718	=	IC50	nM	6.3	CHEMBL260	Homo sapiens	IC50	nM	6.3
	8020308	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3ccc(F)cc3F)n2n(C)c1=O		CHEMBL1945719	=	IC50	nM	16.9	CHEMBL260	Homo sapiens	IC50	nM	16.9
	8020309	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3F)n2n(C)c1=O		CHEMBL1945720	=	IC50	nM	4.1	CHEMBL260	Homo sapiens	IC50	nM	4.1
	8020310	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3Cl)n2n(C)c1=O		CHEMBL1945721	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	8020311	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	Cc1cccc(F)c1-c1nnc2cc(-c3cc(C(=O)NC4CC4)cc(F)c3C)c(=O)n(C)n12		CHEMBL1944649	=	IC50	nM	2.8	CHEMBL260	Homo sapiens	IC50	nM	2.8
	8020312	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3F)n21		CHEMBL1945722	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	8020313	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945723	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	8020314	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(C)cccc3F)n21		CHEMBL1945724	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	8020315	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(F)cccc3F)n21		CHEMBL1945725	=	IC50	nM	1.9	CHEMBL260	Homo sapiens	IC50	nM	1.9
	8020316	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945726	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	8020317	CHEMBL1948783	Inhibition of human recombinant P38alpha assessed as inhibition of GST-tagged ATF2 phosphorylation after 1 hr by HTRF assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(C)cccc3F)n21		CHEMBL1945839	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	8020318	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3F)n2n(C)c1=O		CHEMBL1945715	=	IC50	nM	21.4	CHEMBL260	Homo sapiens	IC50	nM	21.4
	8020319	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3Cl)n2n(C)c1=O		CHEMBL1945716	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	nM	8.5
	8020320	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(C)cccc3F)n2n(C)c1=O		CHEMBL1945717	=	IC50	nM	11.3	CHEMBL260	Homo sapiens	IC50	nM	11.3
	8020321	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3cc(F)ccc3Cl)n2n(C)c1=O		CHEMBL1945718	=	IC50	nM	51.7	CHEMBL260	Homo sapiens	IC50	nM	51.7
	8020322	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3ccc(F)cc3F)n2n(C)c1=O		CHEMBL1945719	=	IC50	nM	112.0	CHEMBL260	Homo sapiens	IC50	nM	112.0
	8020323	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3F)n2n(C)c1=O		CHEMBL1945720	=	IC50	nM	7.2	CHEMBL260	Homo sapiens	IC50	nM	7.2
	8020324	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3Cl)n2n(C)c1=O		CHEMBL1945721	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	8020325	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	Cc1cccc(F)c1-c1nnc2cc(-c3cc(C(=O)NC4CC4)cc(F)c3C)c(=O)n(C)n12		CHEMBL1944649	=	IC50	nM	12.3	CHEMBL260	Homo sapiens	IC50	nM	12.3
	8020326	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3F)n21		CHEMBL1945722	=	IC50	nM	4.8	CHEMBL260	Homo sapiens	IC50	nM	4.8
	8020327	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945723	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	8020328	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(C)cccc3F)n21		CHEMBL1945724	=	IC50	nM	14.1	CHEMBL260	Homo sapiens	IC50	nM	14.1
	8020329	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(F)cccc3F)n21		CHEMBL1945725	=	IC50	nM	3.9	CHEMBL260	Homo sapiens	IC50	nM	3.9
	8020330	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945726	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	8020331	CHEMBL1948784	Inhibition of P38alpha in human whole blood assessed as inhibition of TNF-alpha-induced IL-8 production incubated for 1 hr prior to TNFalpha challenge measured after 16 to 18 hrs by ECL based antibody sandwich assay	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(C)cccc3F)n21		CHEMBL1945839	=	IC50	nM	3.4	CHEMBL260	Homo sapiens	IC50	nM	3.4
	8020332	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3F)n2n(C)c1=O		CHEMBL1945720	=	IC50	nM	18.5	CHEMBL260	Homo sapiens	IC50	nM	18.5
	8020333	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1cc2nnc(-c3c(F)cccc3Cl)n2n(C)c1=O		CHEMBL1945721	=	IC50	nM	9.8	CHEMBL260	Homo sapiens	IC50	nM	9.8
	8020334	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	Cc1cccc(F)c1-c1nnc2cc(-c3cc(C(=O)NC4CC4)cc(F)c3C)c(=O)n(C)n12		CHEMBL1944649	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	8020335	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3F)n21		CHEMBL1945722	=	IC50	nM	7.8	CHEMBL260	Homo sapiens	IC50	nM	7.8
	8020336	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945723	=	IC50	nM	4.9	CHEMBL260	Homo sapiens	IC50	nM	4.9
	8020337	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(C)cccc3F)n21		CHEMBL1945724	=	IC50	nM	15.8	CHEMBL260	Homo sapiens	IC50	nM	15.8
	8020338	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(F)cccc3F)n21		CHEMBL1945725	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	8020339	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945726	=	IC50	nM	6.9	CHEMBL260	Homo sapiens	IC50	nM	6.9
	8020340	CHEMBL1948782	Inhibition of P38alpha in human whole blood assessed as inhibition of LPS-induced MK2 phosphorylation incubated for 30 mins prior to LPS challenge measured after 45 mins by flow cytometry	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)cc(F)c2C)cc2nnc(-c3c(C)cccc3F)n21		CHEMBL1945839	=	IC50	nM	13.6	CHEMBL260	Homo sapiens	IC50	nM	13.6
	8020342	CHEMBL1948786	Binding affinity to human recombinant P38alpha at 10 uM relative to control	B	CCn1c(=O)c(-c2cc(C(=O)NC3CC3)ccc2C)cc2nnc(-c3c(F)cccc3Cl)n21		CHEMBL1945723	=	Activity	%	0.0	CHEMBL260	Homo sapiens	Activity	%	0.0
	8020369	CHEMBL1948797	Inhibition of P38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	=	IC50	nM	2.3	CHEMBL260	Homo sapiens	IC50	nM	2.3
	8020370	CHEMBL1948797	Inhibition of P38alpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccn2c(-c3c(F)cccc3F)nnc2c1		CHEMBL1945591	=	IC50	nM	2.5	CHEMBL260	Homo sapiens	IC50	nM	2.5
	8024457	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4)n(C4CCCC4)c3n2)cc1		CHEMBL1946324	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	8024458	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n(C4CCCC4)c3n2)cc1		CHEMBL1946325	>	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	8024459	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4Cl)n(C4CCCC4)c3n2)cc1		CHEMBL1946326	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	8024460	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCCC4)c3n2)cc1		CHEMBL1946327	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	8024461	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4c(F)cccc4F)n(C4CCCC4)c3n2)cc1		CHEMBL1946328	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	uM	3.5
	8024462	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CNc1ncc2nc(Nc3ccccc3F)n(C3CCCC3)c2n1		CHEMBL1946329	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	8024463	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CCNc1ncc2nc(Nc3ccccc3F)n(C3CCCC3)c2n1		CHEMBL1946330	=	IC50	nM	2600.0	CHEMBL260	Homo sapiens	IC50	uM	2.6
	8024464	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)Nc1ncc2nc(Nc3ccccc3F)n(C3CCCC3)c2n1		CHEMBL1946331	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	8024465	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	Fc1ccccc1Nc1nc2cnc(NC3CCCCC3)nc2n1C1CCCC1		CHEMBL1946332	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	8024466	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccccc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1946333	=	IC50	nM	510.0	CHEMBL260	Homo sapiens	IC50	uM	0.51
	8024467	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	N[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccccc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1946334	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	8024468	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CCn1c(Nc2ccccc2F)nc2cnc(Nc3ccc(OC)cc3)nc21		CHEMBL1946335	=	IC50	nM	9300.0	CHEMBL260	Homo sapiens	IC50	uM	9.3
	8024469	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n(C(C)C)c3n2)cc1		CHEMBL1946336	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	uM	2.1
	8024470	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n(C4CCCCC4)c3n2)cc1		CHEMBL1946337	>	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	8024471	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n(-c4ccccc4)c3n2)cc1		CHEMBL1946338	>	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	8024472	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n([C@H]4CC[C@H](N)CC4)c3n2)cc1		CHEMBL1946339	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	8024473	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n([C@H]4CC[C@@H](O)CC4)c3n2)cc1		CHEMBL1946340	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	8024474	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n(C4CCOCC4)c3n2)cc1		CHEMBL1946341	=	IC50	nM	2800.0	CHEMBL260	Homo sapiens	IC50	uM	2.8
	8024475	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	COc1ccc(Nc2ncc3nc(Nc4ccccc4F)n([C@H]4CC[C@@H](C(N)=O)CC4)c3n2)cc1		CHEMBL1946495	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	8024476	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	N[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cccc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1946646	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	8024477	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	N[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1946647	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	8024478	CHEMBL1947749	Inhibition of p38alpha using MBP and [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	N[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1946837	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	8029603	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	N[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1946837	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	8029606	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1950294	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	uM	0.56
	8029609	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCOCC4)c3n2)CC1		CHEMBL1950295	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	uM	2.7
	8030214	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	Fc1ccc(Nc2nc3cnc(C4CCOCC4)nc3n2C2CCCC2)c(F)c1		CHEMBL1950296	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	8030215	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CC(C)(O)[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCCC4)c3n2)CC1		CHEMBL1950297	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	8030216	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CC(C)(O)[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCOCC4)c3n2)CC1		CHEMBL1950298	=	IC50	nM	980.0	CHEMBL260	Homo sapiens	IC50	uM	0.98
	8030217	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CCO[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCOCC4)c3n2)CC1		CHEMBL1950299	>	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	8030218	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CS(=O)(=O)N[C@H]1CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCOCC4)c3n2)CC1		CHEMBL1950300	=	IC50	nM	860.0	CHEMBL260	Homo sapiens	IC50	uM	0.86
	8030219	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	C[C@]1(O)CC[C@H](Nc2ncc3nc(Nc4ccc(F)cc4F)n(C4CCOCC4)c3n2)CC1		CHEMBL1950301	>	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	8030220	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CC(C)(O)[C@H]1CC[C@@H](c2ncc3nc(Nc4ccc(F)cc4F)n(C4CCOCC4)c3n2)C1		CHEMBL1950302	>	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	8030235	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@@H]4CCOC4)c3n2)CC1		CHEMBL1950303	>	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	8030240	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CNC(=O)[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950304	=	IC50	nM	4200.0	CHEMBL260	Homo sapiens	IC50	uM	4.2
	8030245	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	=	IC50	nM	3400.0	CHEMBL260	Homo sapiens	IC50	uM	3.4
	8030318	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CC(C)Nc1ncc2nc(Nc3c(F)cccc3F)n([C@H]3CC[C@@H](O)CC3)c2n1		CHEMBL1950290	=	IC50	nM	910.0	CHEMBL260	Homo sapiens	IC50	uM	0.91
	8030319	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CC(C)Nc1ncc2nc(Nc3c(F)cc(F)cc3F)n([C@H]3CC[C@@H](C(N)=O)CC3)c2n1		CHEMBL1950291	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	8030320	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CC(C)Nc1ncc2nc(Nc3c(F)cc(F)cc3F)n([C@H]3CC[C@@H](C(=O)NC4CC4)CC3)c2n1		CHEMBL1950292	=	IC50	nM	6200.0	CHEMBL260	Homo sapiens	IC50	uM	6.2
	8030321	CHEMBL1952894	Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting	B	CC(C)Nc1ncc2nc(Nc3c(F)cc(F)cc3F)n([C@H]3CC[C@@H](C(=O)N4CCOCC4)CC3)c2n1		CHEMBL1950293	=	IC50	nM	6400.0	CHEMBL260	Homo sapiens	IC50	uM	6.4
	8037536	CHEMBL1954391	Inhibition of p38alpha	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	nM	190.0
	8047145	CHEMBL1958974	Inhibition of p38-alpha at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	8051011	CHEMBL1961067	Inhibition of recombinant p38alpha at 10 uM after 90 mins fluorescence assay	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL1957675	=	Inhibition	%	57.0	CHEMBL260	Homo sapiens	INH	%	57.0
	8059818	CHEMBL1958781	Inhibition of MAPK p38alpha assessed as activity remaining at 50 uM relative to control	B	Nc1nc(Nc2ccccc2)sc1C(=O)c1ccccc1		CHEMBL561114	=	Activity	%	8.1	CHEMBL260	Homo sapiens	Activity	%	8.1
	8059819	CHEMBL1958781	Inhibition of MAPK p38alpha assessed as activity remaining at 50 uM relative to control	B	Cn1cc(/C=C2/C(=O)NC(=O)N(CCc3ccccc3)C2=O)c2ccccc21		CHEMBL1956879	=	Activity	%	32.0	CHEMBL260	Homo sapiens	Activity	%	32.0
	8059820	CHEMBL1958781	Inhibition of MAPK p38alpha assessed as activity remaining at 50 uM relative to control	B	Cc1cccc(-c2nc(Nc3ccc(C(=O)O)cc3)c3ccccc3n2)c1		CHEMBL1956880	=	Activity	%	34.0	CHEMBL260	Homo sapiens	Activity	%	34.0
	8059821	CHEMBL1958781	Inhibition of MAPK p38alpha assessed as activity remaining at 50 uM relative to control	B	CCn1cc(/C=C2/Oc3c(ccc(O)c3CN3CCOCC3)C2=O)c2ccccc21		CHEMBL1956881	=	Activity	%	37.0	CHEMBL260	Homo sapiens	Activity	%	37.0
	8059822	CHEMBL1958781	Inhibition of MAPK p38alpha assessed as activity remaining at 50 uM relative to control	B	O=C1c2ccccc2C(=O)N1CCc1nc2c3c(-c4ccco4)c(-c4ccco4)oc3ncn2n1		CHEMBL1956882	=	Activity	%	39.0	CHEMBL260	Homo sapiens	Activity	%	39.0
	8059823	CHEMBL1958781	Inhibition of MAPK p38alpha assessed as activity remaining at 50 uM relative to control	B	NC(=O)c1ccc(Nc2nnc(-c3ccc(O)cc3)c3ccccc23)cc1		CHEMBL1524400	=	Activity	%	41.0	CHEMBL260	Homo sapiens	Activity	%	41.0
	8059824	CHEMBL1958782	Inhibition of MAPK p38alpha	B	Nc1nc(Nc2ccccc2)sc1C(=O)c1ccccc1		CHEMBL561114	=	IC50	nM	720.0	CHEMBL260	Homo sapiens	IC50	uM	0.72
	8059825	CHEMBL1958782	Inhibition of MAPK p38alpha	B	Cn1cc(/C=C2/C(=O)NC(=O)N(CCc3ccccc3)C2=O)c2ccccc21		CHEMBL1956879	=	IC50	nM	17100.0	CHEMBL260	Homo sapiens	IC50	uM	17.1
	8059826	CHEMBL1958782	Inhibition of MAPK p38alpha	B	Cc1cccc(-c2nc(Nc3ccc(C(=O)O)cc3)c3ccccc3n2)c1		CHEMBL1956880	=	IC50	nM	20400.0	CHEMBL260	Homo sapiens	IC50	uM	20.4
	8059827	CHEMBL1958782	Inhibition of MAPK p38alpha	B	CCn1cc(/C=C2/Oc3c(ccc(O)c3CN3CCOCC3)C2=O)c2ccccc21		CHEMBL1956881	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	8059828	CHEMBL1958782	Inhibition of MAPK p38alpha	B	O=C1c2ccccc2C(=O)N1CCc1nc2c3c(-c4ccco4)c(-c4ccco4)oc3ncn2n1		CHEMBL1956882	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	8059829	CHEMBL1958782	Inhibition of MAPK p38alpha	B	NC(=O)c1ccc(Nc2nnc(-c3ccc(O)cc3)c3ccccc23)cc1		CHEMBL1524400	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	8061310	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	41.04	CHEMBL260	Homo sapiens	Inhibition	%	41.04
	8061487	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.5	CHEMBL260	Homo sapiens	Inhibition	%	-2.5
	8061818	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	90.79	CHEMBL260	Homo sapiens	Inhibition	%	90.79
	8062009	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.62	CHEMBL260	Homo sapiens	Inhibition	%	3.62
	8062349	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.4	CHEMBL260	Homo sapiens	Inhibition	%	3.4
	8062511	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	Inhibition	%	13.0
	8062735	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.12	CHEMBL260	Homo sapiens	Inhibition	%	2.12
	8062833	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.78	CHEMBL260	Homo sapiens	Inhibition	%	3.78
	8063189	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	77.11	CHEMBL260	Homo sapiens	Inhibition	%	77.11
	8063356	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.58	CHEMBL260	Homo sapiens	Inhibition	%	4.58
	8063688	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	7.26	CHEMBL260	Homo sapiens	Inhibition	%	7.26
	8063870	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	7.85	CHEMBL260	Homo sapiens	Inhibition	%	7.85
	8064094	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	29.97	CHEMBL260	Homo sapiens	Inhibition	%	29.97
	8064209	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.34	CHEMBL260	Homo sapiens	Inhibition	%	6.34
	8064419	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.64	CHEMBL260	Homo sapiens	Inhibition	%	5.64
	8064643	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.87	CHEMBL260	Homo sapiens	Inhibition	%	2.87
	8064781	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.31	CHEMBL260	Homo sapiens	Inhibition	%	4.31
	8064947	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	36.06	CHEMBL260	Homo sapiens	Inhibition	%	36.06
	8065171	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.32	CHEMBL260	Homo sapiens	Inhibition	%	1.32
	8065287	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	15.52	CHEMBL260	Homo sapiens	Inhibition	%	15.52
	8065686	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	73.72	CHEMBL260	Homo sapiens	Inhibition	%	73.72
	8065801	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.32	CHEMBL260	Homo sapiens	Inhibition	%	-0.32
	8066025	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	8.29	CHEMBL260	Homo sapiens	Inhibition	%	8.29
	8066235	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.67	CHEMBL260	Homo sapiens	Inhibition	%	3.67
	8066371	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.01	CHEMBL260	Homo sapiens	Inhibition	%	5.01
	8066761	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.28	CHEMBL260	Homo sapiens	Inhibition	%	5.28
	8066885	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.25	CHEMBL260	Homo sapiens	Inhibition	%	7.25
	8067109	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	17.1	CHEMBL260	Homo sapiens	Inhibition	%	17.1
	8067284	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.23	CHEMBL260	Homo sapiens	Inhibition	%	3.23
	8067629	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	41.41	CHEMBL260	Homo sapiens	Inhibition	%	41.41
	8067839	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC	Outside typical range	CHEMBL365072	=	Inhibition	%	-20.35	CHEMBL260	Homo sapiens	Inhibition	%	-20.35
	8067974	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.59	CHEMBL260	Homo sapiens	Inhibition	%	2.59
	8068198	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	10.26	CHEMBL260	Homo sapiens	Inhibition	%	10.26
	8068362	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.24	CHEMBL260	Homo sapiens	Inhibition	%	2.24
	8068711	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.55	CHEMBL260	Homo sapiens	Inhibition	%	-0.55
	8068885	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	8.81	CHEMBL260	Homo sapiens	Inhibition	%	8.81
	8069234	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	81.18	CHEMBL260	Homo sapiens	Inhibition	%	81.18
	8069529	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.82	CHEMBL260	Homo sapiens	Inhibition	%	1.82
	8069690	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.69	CHEMBL260	Homo sapiens	Inhibition	%	3.69
	8070040	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.42	CHEMBL260	Homo sapiens	Inhibition	%	3.42
	8070212	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.72	CHEMBL260	Homo sapiens	Inhibition	%	1.72
	8070436	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	8.34	CHEMBL260	Homo sapiens	Inhibition	%	8.34
	8070561	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.48	CHEMBL260	Homo sapiens	Inhibition	%	5.48
	8070859	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	14.27	CHEMBL260	Homo sapiens	Inhibition	%	14.27
	8071016	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-2.89	CHEMBL260	Homo sapiens	Inhibition	%	-2.89
	8071240	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.98	CHEMBL260	Homo sapiens	Inhibition	%	3.98
	8071366	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.51	CHEMBL260	Homo sapiens	Inhibition	%	2.51
	8071763	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.53	CHEMBL260	Homo sapiens	Inhibition	%	2.53
	8071888	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	15.79	CHEMBL260	Homo sapiens	Inhibition	%	15.79
	8072202	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.37	CHEMBL260	Homo sapiens	Inhibition	%	2.37
	8072583	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.53	CHEMBL260	Homo sapiens	Inhibition	%	1.53
	8072708	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	11.98	CHEMBL260	Homo sapiens	Inhibition	%	11.98
	8072932	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	7.43	CHEMBL260	Homo sapiens	Inhibition	%	7.43
	8073099	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.49	CHEMBL260	Homo sapiens	Inhibition	%	6.49
	8073224	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	18.87	CHEMBL260	Homo sapiens	Inhibition	%	18.87
	8073448	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	63.66	CHEMBL260	Homo sapiens	Inhibition	%	63.66
	8073567	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.29	CHEMBL260	Homo sapiens	Inhibition	%	1.29
	8073800	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	5.26	CHEMBL260	Homo sapiens	Inhibition	%	5.26
	8074024	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.68	CHEMBL260	Homo sapiens	Inhibition	%	0.68
	8074176	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	6.62	CHEMBL260	Homo sapiens	Inhibition	%	6.62
	8074530	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.82	CHEMBL260	Homo sapiens	Inhibition	%	1.82
	8074687	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	30.67	CHEMBL260	Homo sapiens	Inhibition	%	30.67
	8075038	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.44	CHEMBL260	Homo sapiens	Inhibition	%	1.44
	8075149	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	5.27	CHEMBL260	Homo sapiens	Inhibition	%	5.27
	8075373	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	7.39	CHEMBL260	Homo sapiens	Inhibition	%	7.39
	8075610	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.47	CHEMBL260	Homo sapiens	Inhibition	%	-0.47
	8075751	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.44	CHEMBL260	Homo sapiens	Inhibition	%	1.44
	8076117	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-5.71	CHEMBL260	Homo sapiens	Inhibition	%	-5.71
	8076265	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	73.81	CHEMBL260	Homo sapiens	Inhibition	%	73.81
	8076623	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.03	CHEMBL260	Homo sapiens	Inhibition	%	2.03
	8076949	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	48.03	CHEMBL260	Homo sapiens	Inhibition	%	48.03
	8077196	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.44	CHEMBL260	Homo sapiens	Inhibition	%	1.44
	8077324	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.72	CHEMBL260	Homo sapiens	Inhibition	%	4.72
	8077548	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	9.1	CHEMBL260	Homo sapiens	Inhibition	%	9.1
	8077699	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.3	CHEMBL260	Homo sapiens	Inhibition	%	0.3
	8077842	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.09	CHEMBL260	Homo sapiens	Inhibition	%	4.09
	8078066	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	13.14	CHEMBL260	Homo sapiens	Inhibition	%	13.14
	8078205	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.03	CHEMBL260	Homo sapiens	Inhibition	%	-1.03
	8078531	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	25.39	CHEMBL260	Homo sapiens	Inhibition	%	25.39
	8078781	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.33	CHEMBL260	Homo sapiens	Inhibition	%	1.33
	8079121	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	43.16	CHEMBL260	Homo sapiens	Inhibition	%	43.16
	8079279	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.66	CHEMBL260	Homo sapiens	Inhibition	%	2.66
	8079645	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.59	CHEMBL260	Homo sapiens	Inhibition	%	1.59
	8079784	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.41	CHEMBL260	Homo sapiens	Inhibition	%	-2.41
	8080113	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	73.68	CHEMBL260	Homo sapiens	Inhibition	%	73.68
	8080365	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.94	CHEMBL260	Homo sapiens	Inhibition	%	-0.94
	8080704	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	5.87	CHEMBL260	Homo sapiens	Inhibition	%	5.87
	8080868	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.54	CHEMBL260	Homo sapiens	Inhibition	%	3.54
	8081092	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	66.76	CHEMBL260	Homo sapiens	Inhibition	%	66.76
	8081227	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	8.77	CHEMBL260	Homo sapiens	Inhibition	%	8.77
	8081371	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.69	CHEMBL260	Homo sapiens	Inhibition	%	1.69
	8081595	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	11.71	CHEMBL260	Homo sapiens	Inhibition	%	11.71
	8081698	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.38	CHEMBL260	Homo sapiens	Inhibition	%	1.38
	8081950	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.21	CHEMBL260	Homo sapiens	Inhibition	%	-2.21
	8082174	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.43	CHEMBL260	Homo sapiens	Inhibition	%	-0.43
	8082287	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	10.15	CHEMBL260	Homo sapiens	Inhibition	%	10.15
	8082684	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	87.86	CHEMBL260	Homo sapiens	Inhibition	%	87.86
	8082807	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	12.35	CHEMBL260	Homo sapiens	Inhibition	%	12.35
	8083187	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.52	CHEMBL260	Homo sapiens	Inhibition	%	1.52
	8083286	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	8.66	CHEMBL260	Homo sapiens	Inhibition	%	8.66
	8083510	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.33	CHEMBL260	Homo sapiens	Inhibition	%	-1.33
	8083764	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-3.77	CHEMBL260	Homo sapiens	Inhibition	%	-3.77
	8083874	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	49.7	CHEMBL260	Homo sapiens	Inhibition	%	49.7
	8084098	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	83.04	CHEMBL260	Homo sapiens	Inhibition	%	83.04
	8084283	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.75	CHEMBL260	Homo sapiens	Inhibition	%	0.75
	8084401	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	57.58	CHEMBL260	Homo sapiens	Inhibition	%	57.58
	8084625	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	5.84	CHEMBL260	Homo sapiens	Inhibition	%	5.84
	8084786	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	7.84	CHEMBL260	Homo sapiens	Inhibition	%	7.84
	8085108	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	6.14	CHEMBL260	Homo sapiens	Inhibition	%	6.14
	8085364	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.19	CHEMBL260	Homo sapiens	Inhibition	%	-2.19
	8085696	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	84.13	CHEMBL260	Homo sapiens	Inhibition	%	84.13
	8085885	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	12.27	CHEMBL260	Homo sapiens	Inhibition	%	12.27
	8086224	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	8.31	CHEMBL260	Homo sapiens	Inhibition	%	8.31
	8086386	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.69	CHEMBL260	Homo sapiens	Inhibition	%	1.69
	8086709	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.59	CHEMBL260	Homo sapiens	Inhibition	%	2.59
	8086920	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	6.41	CHEMBL260	Homo sapiens	Inhibition	%	6.41
	8087302	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	20.11	CHEMBL260	Homo sapiens	Inhibition	%	20.11
	8087416	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	8.09	CHEMBL260	Homo sapiens	Inhibition	%	8.09
	8087640	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	10.44	CHEMBL260	Homo sapiens	Inhibition	%	10.44
	8087778	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.88	CHEMBL260	Homo sapiens	Inhibition	%	11.88
	8088144	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	20.52	CHEMBL260	Homo sapiens	Inhibition	%	20.52
	8088292	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.19	CHEMBL260	Homo sapiens	Inhibition	%	1.19
	8088644	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.72	CHEMBL260	Homo sapiens	Inhibition	%	6.72
	8088961	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.34	CHEMBL260	Homo sapiens	Inhibition	%	4.34
	8089089	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.2	CHEMBL260	Homo sapiens	Inhibition	%	0.2
	8089461	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.04	CHEMBL260	Homo sapiens	Inhibition	%	0.04
	8089805	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	7.68	CHEMBL260	Homo sapiens	Inhibition	%	7.68
	8089985	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	47.16	CHEMBL260	Homo sapiens	Inhibition	%	47.16
	8090150	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.02	CHEMBL260	Homo sapiens	Inhibition	%	5.02
	8090374	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.81	CHEMBL260	Homo sapiens	Inhibition	%	6.81
	8090541	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.9	CHEMBL260	Homo sapiens	Inhibition	%	3.9
	8090680	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.48	CHEMBL260	Homo sapiens	Inhibition	%	1.48
	8090904	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	4.8	CHEMBL260	Homo sapiens	Inhibition	%	4.8
	8091109	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.73	CHEMBL260	Homo sapiens	Inhibition	%	4.73
	8091246	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	8.04	CHEMBL260	Homo sapiens	Inhibition	%	8.04
	8091470	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.64	CHEMBL260	Homo sapiens	Inhibition	%	4.64
	8091625	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	62.9	CHEMBL260	Homo sapiens	Inhibition	%	62.9
	8091965	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	Inhibition	%	11.0
	8092102	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	80.63	CHEMBL260	Homo sapiens	Inhibition	%	80.63
	8092326	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	86.49	CHEMBL260	Homo sapiens	Inhibition	%	86.49
	8092477	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.29	CHEMBL260	Homo sapiens	Inhibition	%	7.29
	8092625	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.84	CHEMBL260	Homo sapiens	Inhibition	%	0.84
	8092849	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.93	CHEMBL260	Homo sapiens	Inhibition	%	0.93
	8092978	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.39	CHEMBL260	Homo sapiens	Inhibition	%	7.39
	8093290	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	64.43	CHEMBL260	Homo sapiens	Inhibition	%	64.43
	8093430	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.85	CHEMBL260	Homo sapiens	Inhibition	%	3.85
	8093654	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.93	CHEMBL260	Homo sapiens	Inhibition	%	1.93
	8093793	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.72	CHEMBL260	Homo sapiens	Inhibition	%	1.72
	8094137	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	12.18	CHEMBL260	Homo sapiens	Inhibition	%	12.18
	8094317	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.46	CHEMBL260	Homo sapiens	Inhibition	%	1.46
	8094716	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.36	CHEMBL260	Homo sapiens	Inhibition	%	4.36
	8094872	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.71	CHEMBL260	Homo sapiens	Inhibition	%	3.71
	8095236	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	13.57	CHEMBL260	Homo sapiens	Inhibition	%	13.57
	8095439	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.34	CHEMBL260	Homo sapiens	Inhibition	%	7.34
	8095804	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.87	CHEMBL260	Homo sapiens	Inhibition	%	7.87
	8095952	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.33	CHEMBL260	Homo sapiens	Inhibition	%	4.33
	8096293	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	37.75	CHEMBL260	Homo sapiens	Inhibition	%	37.75
	8096656	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	16.93	CHEMBL260	Homo sapiens	Inhibition	%	16.93
	8096812	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.32	CHEMBL260	Homo sapiens	Inhibition	%	8.32
	8097183	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.59	CHEMBL260	Homo sapiens	Inhibition	%	1.59
	8097270	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.3	CHEMBL260	Homo sapiens	Inhibition	%	6.3
	8097490	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	91.05	CHEMBL260	Homo sapiens	Inhibition	%	91.05
	8097864	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.14	CHEMBL260	Homo sapiens	Inhibition	%	1.14
	8097997	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.1	CHEMBL260	Homo sapiens	Inhibition	%	-1.1
	8098221	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.12	CHEMBL260	Homo sapiens	Inhibition	%	1.12
	8098341	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.67	CHEMBL260	Homo sapiens	Inhibition	%	1.67
	8098521	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.43	CHEMBL260	Homo sapiens	Inhibition	%	1.43
	8098745	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.18	CHEMBL260	Homo sapiens	Inhibition	%	2.18
	8098930	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	8.96	CHEMBL260	Homo sapiens	Inhibition	%	8.96
	8099074	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.52	CHEMBL260	Homo sapiens	Inhibition	%	3.52
	8099298	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.25	CHEMBL260	Homo sapiens	Inhibition	%	5.25
	8099440	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.86	CHEMBL260	Homo sapiens	Inhibition	%	4.86
	8099634	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	75.38	CHEMBL260	Homo sapiens	Inhibition	%	75.38
	8099858	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	84.17	CHEMBL260	Homo sapiens	Inhibition	%	84.17
	8100005	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.95	CHEMBL260	Homo sapiens	Inhibition	%	6.95
	8100151	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.94	CHEMBL260	Homo sapiens	Inhibition	%	3.94
	8100375	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.88	CHEMBL260	Homo sapiens	Inhibition	%	2.88
	8100491	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	70.95	CHEMBL260	Homo sapiens	Inhibition	%	70.95
	8100855	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	20.83	CHEMBL260	Homo sapiens	Inhibition	%	20.83
	8101015	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	7.77	CHEMBL260	Homo sapiens	Inhibition	%	7.77
	8101381	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-3.46	CHEMBL260	Homo sapiens	Inhibition	%	-3.46
	8101566	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.99	CHEMBL260	Homo sapiens	Inhibition	%	6.99
	8101819	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	7.04	CHEMBL260	Homo sapiens	Inhibition	%	7.04
	8102043	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	13.32	CHEMBL260	Homo sapiens	Inhibition	%	13.32
	8102198	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	4.23	CHEMBL260	Homo sapiens	Inhibition	%	4.23
	8102553	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.78	CHEMBL260	Homo sapiens	Inhibition	%	1.78
	8102673	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	8.88	CHEMBL260	Homo sapiens	Inhibition	%	8.88
	8103075	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.81	CHEMBL260	Homo sapiens	Inhibition	%	2.81
	8103271	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.73	CHEMBL260	Homo sapiens	Inhibition	%	4.73
	8103633	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.29	CHEMBL260	Homo sapiens	Inhibition	%	2.29
	8103783	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.85	CHEMBL260	Homo sapiens	Inhibition	%	3.85
	8104192	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	7.99	CHEMBL260	Homo sapiens	Inhibition	%	7.99
	8104340	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.02	CHEMBL260	Homo sapiens	Inhibition	%	9.02
	8104710	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.83	CHEMBL260	Homo sapiens	Inhibition	%	2.83
	8104824	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	28.83	CHEMBL260	Homo sapiens	Inhibition	%	28.83
	8105048	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	74.18	CHEMBL260	Homo sapiens	Inhibition	%	74.18
	8105188	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	68.02	CHEMBL260	Homo sapiens	Inhibition	%	68.02
	8105354	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	9.51	CHEMBL260	Homo sapiens	Inhibition	%	9.51
	8105578	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	9.29	CHEMBL260	Homo sapiens	Inhibition	%	9.29
	8105716	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-4.25	CHEMBL260	Homo sapiens	Inhibition	%	-4.25
	8105996	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.3	CHEMBL260	Homo sapiens	Inhibition	%	3.3
	8106385	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	17.84	CHEMBL260	Homo sapiens	Inhibition	%	17.84
	8106541	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	2.87	CHEMBL260	Homo sapiens	Inhibition	%	2.87
	8106894	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.27	CHEMBL260	Homo sapiens	Inhibition	%	1.27
	8107015	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.81	CHEMBL260	Homo sapiens	Inhibition	%	0.81
	8107239	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.53	CHEMBL260	Homo sapiens	Inhibition	%	1.53
	8107411	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.34	CHEMBL260	Homo sapiens	Inhibition	%	1.34
	8107612	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	7.11	CHEMBL260	Homo sapiens	Inhibition	%	7.11
	8107971	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.5	CHEMBL260	Homo sapiens	Inhibition	%	2.5
	8108129	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.47	CHEMBL260	Homo sapiens	Inhibition	%	5.47
	8108353	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.08	CHEMBL260	Homo sapiens	Inhibition	%	5.08
	8108528	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	12.02	CHEMBL260	Homo sapiens	Inhibition	%	12.02
	8108675	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.8	CHEMBL260	Homo sapiens	Inhibition	%	5.8
	8108899	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.58	CHEMBL260	Homo sapiens	Inhibition	%	6.58
	8109041	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.07	CHEMBL260	Homo sapiens	Inhibition	%	0.07
	8109379	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	87.17	CHEMBL260	Homo sapiens	Inhibition	%	87.17
	8109509	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	89.01	CHEMBL260	Homo sapiens	Inhibition	%	89.01
	8109904	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	10.65	CHEMBL260	Homo sapiens	Inhibition	%	10.65
	8110036	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	6.3	CHEMBL260	Homo sapiens	Inhibition	%	6.3
	8110260	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.68	CHEMBL260	Homo sapiens	Inhibition	%	5.68
	8110315	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.63	CHEMBL260	Homo sapiens	Inhibition	%	5.63
	8110539	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.36	CHEMBL260	Homo sapiens	Inhibition	%	5.36
	8110705	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	67.75	CHEMBL260	Homo sapiens	Inhibition	%	67.75
	8110863	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.31	CHEMBL260	Homo sapiens	Inhibition	%	2.31
	8111087	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-5.03	CHEMBL260	Homo sapiens	Inhibition	%	-5.03
	8111210	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.41	CHEMBL260	Homo sapiens	Inhibition	%	2.41
	8111561	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.34	CHEMBL260	Homo sapiens	Inhibition	%	0.34
	8111727	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.04	CHEMBL260	Homo sapiens	Inhibition	%	4.04
	8111932	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.91	CHEMBL260	Homo sapiens	Inhibition	%	5.91
	8112156	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.59	CHEMBL260	Homo sapiens	Inhibition	%	6.59
	8112293	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.46	CHEMBL260	Homo sapiens	Inhibition	%	1.46
	8112685	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	13.94	CHEMBL260	Homo sapiens	Inhibition	%	13.94
	8112857	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.69	CHEMBL260	Homo sapiens	Inhibition	%	2.69
	8113233	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	6.16	CHEMBL260	Homo sapiens	Inhibition	%	6.16
	8113369	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.7	CHEMBL260	Homo sapiens	Inhibition	%	0.7
	8113717	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	94.95	CHEMBL260	Homo sapiens	Inhibition	%	94.95
	8113833	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	62.8	CHEMBL260	Homo sapiens	Inhibition	%	62.8
	8114057	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	89.56	CHEMBL260	Homo sapiens	Inhibition	%	89.56
	8114233	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	11.87	CHEMBL260	Homo sapiens	Inhibition	%	11.87
	8114589	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.31	CHEMBL260	Homo sapiens	Inhibition	%	7.31
	8114865	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	17.35	CHEMBL260	Homo sapiens	Inhibition	%	17.35
	8115031	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	8.71	CHEMBL260	Homo sapiens	Inhibition	%	8.71
	8115420	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.35	CHEMBL260	Homo sapiens	Inhibition	%	-0.35
	8115540	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.05	CHEMBL260	Homo sapiens	Inhibition	%	3.05
	8115897	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.75	CHEMBL260	Homo sapiens	Inhibition	%	0.75
	8116056	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.1	CHEMBL260	Homo sapiens	Inhibition	%	2.1
	8116280	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.84	CHEMBL260	Homo sapiens	Inhibition	%	1.84
	8116483	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	8.8	CHEMBL260	Homo sapiens	Inhibition	%	8.8
	8116617	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.91	CHEMBL260	Homo sapiens	Inhibition	%	0.91
	8116841	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.75	CHEMBL260	Homo sapiens	Inhibition	%	0.75
	8117013	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	55.87	CHEMBL260	Homo sapiens	Inhibition	%	55.87
	8117184	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.9	CHEMBL260	Homo sapiens	Inhibition	%	0.9
	8117566	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	7.38	CHEMBL260	Homo sapiens	Inhibition	%	7.38
	8117696	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.17	CHEMBL260	Homo sapiens	Inhibition	%	-0.17
	8117920	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.25	CHEMBL260	Homo sapiens	Inhibition	%	3.25
	8118058	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	48.22	CHEMBL260	Homo sapiens	Inhibition	%	48.22
	8118398	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.26	CHEMBL260	Homo sapiens	Inhibition	%	8.26
	8118570	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	13.95	CHEMBL260	Homo sapiens	Inhibition	%	13.95
	8118930	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.29	CHEMBL260	Homo sapiens	Inhibition	%	6.29
	8119201	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.35	CHEMBL260	Homo sapiens	Inhibition	%	1.35
	8119360	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	36.63	CHEMBL260	Homo sapiens	Inhibition	%	36.63
	8119751	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.8	CHEMBL260	Homo sapiens	Inhibition	%	-1.8
	8119870	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.36	CHEMBL260	Homo sapiens	Inhibition	%	2.36
	8120094	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.56	CHEMBL260	Homo sapiens	Inhibition	%	5.56
	8120233	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.33	CHEMBL260	Homo sapiens	Inhibition	%	3.33
	8120617	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.21	CHEMBL260	Homo sapiens	Inhibition	%	0.21
	8120818	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	11.34	CHEMBL260	Homo sapiens	Inhibition	%	11.34
	8121170	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.04	CHEMBL260	Homo sapiens	Inhibition	%	-0.04
	8121342	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.54	CHEMBL260	Homo sapiens	Inhibition	%	4.54
	8121509	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.13	CHEMBL260	Homo sapiens	Inhibition	%	1.13
	8121733	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.21	CHEMBL260	Homo sapiens	Inhibition	%	0.21
	8121896	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	8.45	CHEMBL260	Homo sapiens	Inhibition	%	8.45
	8122241	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-2.42	CHEMBL260	Homo sapiens	Inhibition	%	-2.42
	8122379	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	84.39	CHEMBL260	Homo sapiens	Inhibition	%	84.39
	8122723	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	10.28	CHEMBL260	Homo sapiens	Inhibition	%	10.28
	8122890	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	65.73	CHEMBL260	Homo sapiens	Inhibition	%	65.73
	8123114	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	80.16	CHEMBL260	Homo sapiens	Inhibition	%	80.16
	8123256	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	9.41	CHEMBL260	Homo sapiens	Inhibition	%	9.41
	8123534	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	5.59	CHEMBL260	Homo sapiens	Inhibition	%	5.59
	8123684	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.51	CHEMBL260	Homo sapiens	Inhibition	%	4.51
	8123908	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	10.69	CHEMBL260	Homo sapiens	Inhibition	%	10.69
	8124075	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.63	CHEMBL260	Homo sapiens	Inhibition	%	2.63
	8124418	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	5.7	CHEMBL260	Homo sapiens	Inhibition	%	5.7
	8124557	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	23.2	CHEMBL260	Homo sapiens	Inhibition	%	23.2
	8124781	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.42	CHEMBL260	Homo sapiens	Inhibition	%	2.42
	8124946	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.45	CHEMBL260	Homo sapiens	Inhibition	%	0.45
	8125147	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	87.43	CHEMBL260	Homo sapiens	Inhibition	%	87.43
	8125501	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.2	CHEMBL260	Homo sapiens	Inhibition	%	-0.2
	8125669	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.37	CHEMBL260	Homo sapiens	Inhibition	%	2.37
	8126057	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.33	CHEMBL260	Homo sapiens	Inhibition	%	-0.33
	8126221	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	23.07	CHEMBL260	Homo sapiens	Inhibition	%	23.07
	8126560	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	20.34	CHEMBL260	Homo sapiens	Inhibition	%	20.34
	8126696	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	18.56	CHEMBL260	Homo sapiens	Inhibition	%	18.56
	8126920	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	23.38	CHEMBL260	Homo sapiens	Inhibition	%	23.38
	8127042	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	79.6	CHEMBL260	Homo sapiens	Inhibition	%	79.6
	8127433	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	13.44	CHEMBL260	Homo sapiens	Inhibition	%	13.44
	8127575	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	9.56	CHEMBL260	Homo sapiens	Inhibition	%	9.56
	8127863	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.66	CHEMBL260	Homo sapiens	Inhibition	%	0.66
	8128239	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.83	CHEMBL260	Homo sapiens	Inhibition	%	5.83
	8128406	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.98	CHEMBL260	Homo sapiens	Inhibition	%	-0.98
	8128749	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	9.35	CHEMBL260	Homo sapiens	Inhibition	%	9.35
	8129110	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	6.98	CHEMBL260	Homo sapiens	Inhibition	%	6.98
	8129281	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.58	CHEMBL260	Homo sapiens	Inhibition	%	-0.58
	8129470	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	91.51	CHEMBL260	Homo sapiens	Inhibition	%	91.51
	8129694	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.65	CHEMBL260	Homo sapiens	Inhibition	%	3.65
	8129833	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.37	CHEMBL260	Homo sapiens	Inhibition	%	-1.37
	8129994	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	6.27	CHEMBL260	Homo sapiens	Inhibition	%	6.27
	8130218	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	5.78	CHEMBL260	Homo sapiens	Inhibition	%	5.78
	8130390	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.72	CHEMBL260	Homo sapiens	Inhibition	%	-0.72
	8130550	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	6.95	CHEMBL260	Homo sapiens	Inhibition	%	6.95
	8130774	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	13.08	CHEMBL260	Homo sapiens	Inhibition	%	13.08
	8130890	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	28.67	CHEMBL260	Homo sapiens	Inhibition	%	28.67
	8131253	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	80.69	CHEMBL260	Homo sapiens	Inhibition	%	80.69
	8131373	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	94.99	CHEMBL260	Homo sapiens	Inhibition	%	94.99
	8131597	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	59.32	CHEMBL260	Homo sapiens	Inhibition	%	59.32
	8131764	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	14.89	CHEMBL260	Homo sapiens	Inhibition	%	14.89
	8131905	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	16.08	CHEMBL260	Homo sapiens	Inhibition	%	16.08
	8132129	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	43.38	CHEMBL260	Homo sapiens	Inhibition	%	43.38
	8132191	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.12	CHEMBL260	Homo sapiens	Inhibition	%	4.12
	8132415	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.82	CHEMBL260	Homo sapiens	Inhibition	%	-0.82
	8132562	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	7.03	CHEMBL260	Homo sapiens	Inhibition	%	7.03
	8132730	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-6.55	CHEMBL260	Homo sapiens	Inhibition	%	-6.55
	8132954	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.16	CHEMBL260	Homo sapiens	Inhibition	%	-0.16
	8133075	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.58	CHEMBL260	Homo sapiens	Inhibition	%	2.58
	8133437	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.3	CHEMBL260	Homo sapiens	Inhibition	%	1.3
	8133609	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.13	CHEMBL260	Homo sapiens	Inhibition	%	0.13
	8134013	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.32	CHEMBL260	Homo sapiens	Inhibition	%	4.32
	8134161	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.46	CHEMBL260	Homo sapiens	Inhibition	%	-1.46
	8134545	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	50.44	CHEMBL260	Homo sapiens	Inhibition	%	50.44
	8134729	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-4.68	CHEMBL260	Homo sapiens	Inhibition	%	-4.68
	8135113	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.59	CHEMBL260	Homo sapiens	Inhibition	%	7.59
	8135228	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	71.31	CHEMBL260	Homo sapiens	Inhibition	%	71.31
	8135452	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.55	CHEMBL260	Homo sapiens	Inhibition	%	5.55
	8135593	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	84.25	CHEMBL260	Homo sapiens	Inhibition	%	84.25
	8135938	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	91.49	CHEMBL260	Homo sapiens	Inhibition	%	91.49
	8136106	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.18	CHEMBL260	Homo sapiens	Inhibition	%	5.18
	8136474	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	77.27	CHEMBL260	Homo sapiens	Inhibition	%	77.27
	8136764	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.91	CHEMBL260	Homo sapiens	Inhibition	%	3.91
	8136899	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.46	CHEMBL260	Homo sapiens	Inhibition	%	1.46
	8137286	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.81	CHEMBL260	Homo sapiens	Inhibition	%	1.81
	8137406	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.97	CHEMBL260	Homo sapiens	Inhibition	%	7.97
	8137630	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.86	CHEMBL260	Homo sapiens	Inhibition	%	1.86
	8137778	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.76	CHEMBL260	Homo sapiens	Inhibition	%	1.76
	8137944	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.85	CHEMBL260	Homo sapiens	Inhibition	%	-1.85
	8138168	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.18	CHEMBL260	Homo sapiens	Inhibition	%	-1.18
	8138347	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.2	CHEMBL260	Homo sapiens	Inhibition	%	4.2
	8138495	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.41	CHEMBL260	Homo sapiens	Inhibition	%	0.41
	8138719	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.4	CHEMBL260	Homo sapiens	Inhibition	%	1.4
	8138877	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	79.16	CHEMBL260	Homo sapiens	Inhibition	%	79.16
	8139062	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.23	CHEMBL260	Homo sapiens	Inhibition	%	-2.23
	8139286	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.09	CHEMBL260	Homo sapiens	Inhibition	%	5.09
	8139445	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	12.86	CHEMBL260	Homo sapiens	Inhibition	%	12.86
	8139783	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.96	CHEMBL260	Homo sapiens	Inhibition	%	2.96
	8139924	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	15.87	CHEMBL260	Homo sapiens	Inhibition	%	15.87
	8140271	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	31.37	CHEMBL260	Homo sapiens	Inhibition	%	31.37
	8140430	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.34	CHEMBL260	Homo sapiens	Inhibition	%	5.34
	8140654	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.95	CHEMBL260	Homo sapiens	Inhibition	%	4.95
	8140797	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	83.7	CHEMBL260	Homo sapiens	Inhibition	%	83.7
	8141099	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.41	CHEMBL260	Homo sapiens	Inhibition	%	3.41
	8141229	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.94	CHEMBL260	Homo sapiens	Inhibition	%	4.94
	8141453	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.96	CHEMBL260	Homo sapiens	Inhibition	%	1.96
	8141613	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	7.62	CHEMBL260	Homo sapiens	Inhibition	%	7.62
	8141956	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.55	CHEMBL260	Homo sapiens	Inhibition	%	7.55
	8142117	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	68.94	CHEMBL260	Homo sapiens	Inhibition	%	68.94
	8142509	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.1	CHEMBL260	Homo sapiens	Inhibition	%	-2.1
	8142685	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.19	CHEMBL260	Homo sapiens	Inhibition	%	3.19
	8143058	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	39.45	CHEMBL260	Homo sapiens	Inhibition	%	39.45
	8143213	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	7.8	CHEMBL260	Homo sapiens	Inhibition	%	7.8
	8143624	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	8.57	CHEMBL260	Homo sapiens	Inhibition	%	8.57
	8143783	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	37.48	CHEMBL260	Homo sapiens	Inhibition	%	37.48
	8144121	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	6.51	CHEMBL260	Homo sapiens	Inhibition	%	6.51
	8144260	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	14.93	CHEMBL260	Homo sapiens	Inhibition	%	14.93
	8144484	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	89.25	CHEMBL260	Homo sapiens	Inhibition	%	89.25
	8144614	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	75.62	CHEMBL260	Homo sapiens	Inhibition	%	75.62
	8144991	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.5	CHEMBL260	Homo sapiens	Inhibition	%	4.5
	8145128	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	16.06	CHEMBL260	Homo sapiens	Inhibition	%	16.06
	8145441	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.7	CHEMBL260	Homo sapiens	Inhibition	%	3.7
	8145789	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	5.5	CHEMBL260	Homo sapiens	Inhibition	%	5.5
	8145950	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.39	CHEMBL260	Homo sapiens	Inhibition	%	2.39
	8146294	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	5.88	CHEMBL260	Homo sapiens	Inhibition	%	5.88
	8146454	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	86.99	CHEMBL260	Homo sapiens	Inhibition	%	86.99
	8146678	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2	Outside typical range	CHEMBL456252	=	Inhibition	%	-20.56	CHEMBL260	Homo sapiens	Inhibition	%	-20.56
	8146845	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.86	CHEMBL260	Homo sapiens	Inhibition	%	1.86
	8147014	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.12	CHEMBL260	Homo sapiens	Inhibition	%	4.12
	8147380	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.54	CHEMBL260	Homo sapiens	Inhibition	%	3.54
	8147533	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	8.07	CHEMBL260	Homo sapiens	Inhibition	%	8.07
	8147757	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	15.03	CHEMBL260	Homo sapiens	Inhibition	%	15.03
	8147944	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.88	CHEMBL260	Homo sapiens	Inhibition	%	5.88
	8148102	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	73.51	CHEMBL260	Homo sapiens	Inhibition	%	73.51
	8148326	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.09	CHEMBL260	Homo sapiens	Inhibition	%	9.09
	8148440	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.46	CHEMBL260	Homo sapiens	Inhibition	%	5.46
	8148803	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	92.76	CHEMBL260	Homo sapiens	Inhibition	%	92.76
	8148941	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	52.72	CHEMBL260	Homo sapiens	Inhibition	%	52.72
	8149324	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.64	CHEMBL260	Homo sapiens	Inhibition	%	4.64
	8149458	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	14.04	CHEMBL260	Homo sapiens	Inhibition	%	14.04
	8149682	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.83	CHEMBL260	Homo sapiens	Inhibition	%	7.83
	8149780	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.47	CHEMBL260	Homo sapiens	Inhibition	%	3.47
	8150129	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	4.66	CHEMBL260	Homo sapiens	Inhibition	%	4.66
	8150289	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.34	CHEMBL260	Homo sapiens	Inhibition	%	3.34
	8150513	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.67	CHEMBL260	Homo sapiens	Inhibition	%	-0.67
	8150633	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	39.29	CHEMBL260	Homo sapiens	Inhibition	%	39.29
	8151022	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2	Outside typical range	CHEMBL456252	=	Inhibition	%	-18.03	CHEMBL260	Homo sapiens	Inhibition	%	-18.03
	8151185	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	3.93	CHEMBL260	Homo sapiens	Inhibition	%	3.93
	8151362	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	10.53	CHEMBL260	Homo sapiens	Inhibition	%	10.53
	8151586	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.19	CHEMBL260	Homo sapiens	Inhibition	%	4.19
	8151724	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.79	CHEMBL260	Homo sapiens	Inhibition	%	1.79
	8152102	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	57.81	CHEMBL260	Homo sapiens	Inhibition	%	57.81
	8152290	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.6	CHEMBL260	Homo sapiens	Inhibition	%	7.6
	8152672	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	11.76	CHEMBL260	Homo sapiens	Inhibition	%	11.76
	8152786	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	5.92	CHEMBL260	Homo sapiens	Inhibition	%	5.92
	8153149	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.45	CHEMBL260	Homo sapiens	Inhibition	%	11.45
	8153286	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	85.35	CHEMBL260	Homo sapiens	Inhibition	%	85.35
	8153510	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	14.47	CHEMBL260	Homo sapiens	Inhibition	%	14.47
	8153667	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.94	CHEMBL260	Homo sapiens	Inhibition	%	3.94
	8154024	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.55	CHEMBL260	Homo sapiens	Inhibition	%	6.55
	8154121	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.16	CHEMBL260	Homo sapiens	Inhibition	%	3.16
	8154345	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.01	CHEMBL260	Homo sapiens	Inhibition	%	1.01
	8154471	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	39.35	CHEMBL260	Homo sapiens	Inhibition	%	39.35
	8154854	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.2	CHEMBL260	Homo sapiens	Inhibition	%	3.2
	8154974	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	65.45	CHEMBL260	Homo sapiens	Inhibition	%	65.45
	8155198	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	79.18	CHEMBL260	Homo sapiens	Inhibition	%	79.18
	8155374	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	7.89	CHEMBL260	Homo sapiens	Inhibition	%	7.89
	8155535	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	52.82	CHEMBL260	Homo sapiens	Inhibition	%	52.82
	8155937	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	7.08	CHEMBL260	Homo sapiens	Inhibition	%	7.08
	8156075	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.75	CHEMBL260	Homo sapiens	Inhibition	%	3.75
	8156511	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.56	CHEMBL260	Homo sapiens	Inhibition	%	3.56
	8156661	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	5.09	CHEMBL260	Homo sapiens	Inhibition	%	5.09
	8157028	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	9.04	CHEMBL260	Homo sapiens	Inhibition	%	9.04
	8157148	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.31	CHEMBL260	Homo sapiens	Inhibition	%	1.31
	8157372	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.28	CHEMBL260	Homo sapiens	Inhibition	%	5.28
	8157513	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.25	CHEMBL260	Homo sapiens	Inhibition	%	1.25
	8157867	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.25	CHEMBL260	Homo sapiens	Inhibition	%	5.25
	8158028	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.45	CHEMBL260	Homo sapiens	Inhibition	%	4.45
	8158278	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	17.26	CHEMBL260	Homo sapiens	Inhibition	%	17.26
	8158660	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	79.62	CHEMBL260	Homo sapiens	Inhibition	%	79.62
	8158829	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.76	CHEMBL260	Homo sapiens	Inhibition	%	1.76
	8159188	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.55	CHEMBL260	Homo sapiens	Inhibition	%	3.55
	8159532	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.13	CHEMBL260	Homo sapiens	Inhibition	%	1.13
	8159663	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	9.21	CHEMBL260	Homo sapiens	Inhibition	%	9.21
	8160028	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	13.36	CHEMBL260	Homo sapiens	Inhibition	%	13.36
	8160165	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.67	CHEMBL260	Homo sapiens	Inhibition	%	5.67
	8160389	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	9.2	CHEMBL260	Homo sapiens	Inhibition	%	9.2
	8160539	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	70.78	CHEMBL260	Homo sapiens	Inhibition	%	70.78
	8160833	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.38	CHEMBL260	Homo sapiens	Inhibition	%	6.38
	8160983	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.79	CHEMBL260	Homo sapiens	Inhibition	%	0.79
	8161207	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.83	CHEMBL260	Homo sapiens	Inhibition	%	5.83
	8161350	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.07	CHEMBL260	Homo sapiens	Inhibition	%	7.07
	8161699	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.48	CHEMBL260	Homo sapiens	Inhibition	%	2.48
	8161837	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.99	CHEMBL260	Homo sapiens	Inhibition	%	6.99
	8162191	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	13.59	CHEMBL260	Homo sapiens	Inhibition	%	13.59
	8162351	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	8.14	CHEMBL260	Homo sapiens	Inhibition	%	8.14
	8162575	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	51.84	CHEMBL260	Homo sapiens	Inhibition	%	51.84
	8162604	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-0.78	CHEMBL260	Homo sapiens	Inhibition	%	-0.78
	8162828	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	10.69	CHEMBL260	Homo sapiens	Inhibition	%	10.69
	8162976	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.49	CHEMBL260	Homo sapiens	Inhibition	%	5.49
	8163145	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	8.79	CHEMBL260	Homo sapiens	Inhibition	%	8.79
	8163369	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.97	CHEMBL260	Homo sapiens	Inhibition	%	2.97
	8163503	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.34	CHEMBL260	Homo sapiens	Inhibition	%	7.34
	8163850	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	10.88	CHEMBL260	Homo sapiens	Inhibition	%	10.88
	8163984	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	13.89	CHEMBL260	Homo sapiens	Inhibition	%	13.89
	8164208	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	17.15	CHEMBL260	Homo sapiens	Inhibition	%	17.15
	8164348	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	64.48	CHEMBL260	Homo sapiens	Inhibition	%	64.48
	8164727	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	3.74	CHEMBL260	Homo sapiens	Inhibition	%	3.74
	8164871	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	92.52	CHEMBL260	Homo sapiens	Inhibition	%	92.52
	8165165	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.75	CHEMBL260	Homo sapiens	Inhibition	%	4.75
	8165530	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.4	CHEMBL260	Homo sapiens	Inhibition	%	2.4
	8165673	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	13.31	CHEMBL260	Homo sapiens	Inhibition	%	13.31
	8166023	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.36	CHEMBL260	Homo sapiens	Inhibition	%	4.36
	8166161	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.56	CHEMBL260	Homo sapiens	Inhibition	%	1.56
	8166385	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	7.1	CHEMBL260	Homo sapiens	Inhibition	%	7.1
	8166515	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	34.89	CHEMBL260	Homo sapiens	Inhibition	%	34.89
	8166840	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	10.03	CHEMBL260	Homo sapiens	Inhibition	%	10.03
	8167152	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.01	CHEMBL260	Homo sapiens	Inhibition	%	2.01
	8167293	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	18.74	CHEMBL260	Homo sapiens	Inhibition	%	18.74
	8167681	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.23	CHEMBL260	Homo sapiens	Inhibition	%	5.23
	8167814	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.24	CHEMBL260	Homo sapiens	Inhibition	%	5.24
	8168038	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	8.37	CHEMBL260	Homo sapiens	Inhibition	%	8.37
	8168162	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.74	CHEMBL260	Homo sapiens	Inhibition	%	2.74
	8168527	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	74.94	CHEMBL260	Homo sapiens	Inhibition	%	74.94
	8168663	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	77.63	CHEMBL260	Homo sapiens	Inhibition	%	77.63
	8169051	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	14.63	CHEMBL260	Homo sapiens	Inhibition	%	14.63
	8169193	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.35	CHEMBL260	Homo sapiens	Inhibition	%	2.35
	8169417	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	7.21	CHEMBL260	Homo sapiens	Inhibition	%	7.21
	8169497	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.76	CHEMBL260	Homo sapiens	Inhibition	%	8.76
	8169855	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.09	CHEMBL260	Homo sapiens	Inhibition	%	5.09
	8170000	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.48	CHEMBL260	Homo sapiens	Inhibition	%	2.48
	8170224	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	11.01	CHEMBL260	Homo sapiens	Inhibition	%	11.01
	8170349	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.09	CHEMBL260	Homo sapiens	Inhibition	%	3.09
	8170713	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.04	CHEMBL260	Homo sapiens	Inhibition	%	-0.04
	8170848	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	71.12	CHEMBL260	Homo sapiens	Inhibition	%	71.12
	8171269	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	4.78	CHEMBL260	Homo sapiens	Inhibition	%	4.78
	8171486	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.87	CHEMBL260	Homo sapiens	Inhibition	%	5.87
	8171627	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.03	CHEMBL260	Homo sapiens	Inhibition	%	4.03
	8171851	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	10.69	CHEMBL260	Homo sapiens	Inhibition	%	10.69
	8172004	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.34	CHEMBL260	Homo sapiens	Inhibition	%	-0.34
	8172360	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	11.55	CHEMBL260	Homo sapiens	Inhibition	%	11.55
	8172488	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	6.99	CHEMBL260	Homo sapiens	Inhibition	%	6.99
	8172854	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	86.38	CHEMBL260	Homo sapiens	Inhibition	%	86.38
	8172990	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	6.37	CHEMBL260	Homo sapiens	Inhibition	%	6.37
	8173214	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	9.34	CHEMBL260	Homo sapiens	Inhibition	%	9.34
	8173379	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.43	CHEMBL260	Homo sapiens	Inhibition	%	9.43
	8173744	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.87	CHEMBL260	Homo sapiens	Inhibition	%	5.87
	8173831	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.71	CHEMBL260	Homo sapiens	Inhibition	%	5.71
	8174055	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.13	CHEMBL260	Homo sapiens	Inhibition	%	8.13
	8174187	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.5	CHEMBL260	Homo sapiens	Inhibition	%	1.5
	8174559	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.13	CHEMBL260	Homo sapiens	Inhibition	%	1.13
	8174681	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.54	CHEMBL260	Homo sapiens	Inhibition	%	5.54
	8174905	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.94	CHEMBL260	Homo sapiens	Inhibition	%	1.94
	8175048	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.69	CHEMBL260	Homo sapiens	Inhibition	%	5.69
	8175184	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-1.86	CHEMBL260	Homo sapiens	Inhibition	%	-1.86
	8175408	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	28.16	CHEMBL260	Homo sapiens	Inhibition	%	28.16
	8175664	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.86	CHEMBL260	Homo sapiens	Inhibition	%	6.86
	8175827	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.32	CHEMBL260	Homo sapiens	Inhibition	%	4.32
	8176204	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.72	CHEMBL260	Homo sapiens	Inhibition	%	4.72
	8176353	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	5.39	CHEMBL260	Homo sapiens	Inhibition	%	5.39
	8176709	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	11.49	CHEMBL260	Homo sapiens	Inhibition	%	11.49
	8176839	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	9.4	CHEMBL260	Homo sapiens	Inhibition	%	9.4
	8177063	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	36.76	CHEMBL260	Homo sapiens	Inhibition	%	36.76
	8177205	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	8.41	CHEMBL260	Homo sapiens	Inhibition	%	8.41
	8177567	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.65	CHEMBL260	Homo sapiens	Inhibition	%	4.65
	8177731	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	16.39	CHEMBL260	Homo sapiens	Inhibition	%	16.39
	8178095	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	7.67	CHEMBL260	Homo sapiens	Inhibition	%	7.67
	8178407	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.35	CHEMBL260	Homo sapiens	Inhibition	%	1.35
	8178534	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.57	CHEMBL260	Homo sapiens	Inhibition	%	5.57
	8178758	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.2	CHEMBL260	Homo sapiens	Inhibition	%	2.2
	8178907	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	13.88	CHEMBL260	Homo sapiens	Inhibition	%	13.88
	8179254	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.4	CHEMBL260	Homo sapiens	Inhibition	%	5.4
	8179398	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.35	CHEMBL260	Homo sapiens	Inhibition	%	6.35
	8179759	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	10.36	CHEMBL260	Homo sapiens	Inhibition	%	10.36
	8180016	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.08	CHEMBL260	Homo sapiens	Inhibition	%	2.08
	8180170	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	19.72	CHEMBL260	Homo sapiens	Inhibition	%	19.72
	8180394	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.24	CHEMBL260	Homo sapiens	Inhibition	%	1.24
	8180550	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.01	CHEMBL260	Homo sapiens	Inhibition	%	10.01
	8180698	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.18	CHEMBL260	Homo sapiens	Inhibition	%	1.18
	8180922	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.39	CHEMBL260	Homo sapiens	Inhibition	%	2.39
	8181055	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	13.99	CHEMBL260	Homo sapiens	Inhibition	%	13.99
	8181410	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.61	CHEMBL260	Homo sapiens	Inhibition	%	2.61
	8181550	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	12.63	CHEMBL260	Homo sapiens	Inhibition	%	12.63
	8181774	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.83	CHEMBL260	Homo sapiens	Inhibition	%	4.83
	8181913	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.77	CHEMBL260	Homo sapiens	Inhibition	%	10.77
	8182076	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	23.59	CHEMBL260	Homo sapiens	Inhibition	%	23.59
	8182300	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	76.36	CHEMBL260	Homo sapiens	Inhibition	%	76.36
	8182440	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.53	CHEMBL260	Homo sapiens	Inhibition	%	1.53
	8182756	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	Inhibition	%	7.0
	8183102	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	7.4	CHEMBL260	Homo sapiens	Inhibition	%	7.4
	8183251	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.78	CHEMBL260	Homo sapiens	Inhibition	%	4.78
	8183604	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	17.05	CHEMBL260	Homo sapiens	Inhibition	%	17.05
	8183746	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.05	CHEMBL260	Homo sapiens	Inhibition	%	6.05
	8183970	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.03	CHEMBL260	Homo sapiens	Inhibition	%	0.03
	8184106	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.25	CHEMBL260	Homo sapiens	Inhibition	%	4.25
	8184372	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.41	CHEMBL260	Homo sapiens	Inhibition	%	5.41
	8184743	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.89	CHEMBL260	Homo sapiens	Inhibition	%	4.89
	8184900	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	71.97	CHEMBL260	Homo sapiens	Inhibition	%	71.97
	8185273	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.05	CHEMBL260	Homo sapiens	Inhibition	%	1.05
	8185404	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	58.8	CHEMBL260	Homo sapiens	Inhibition	%	58.8
	8185628	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.36	CHEMBL260	Homo sapiens	Inhibition	%	3.36
	8185759	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	3.43	CHEMBL260	Homo sapiens	Inhibition	%	3.43
	8186122	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	11.15	CHEMBL260	Homo sapiens	Inhibition	%	11.15
	8186263	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	32.95	CHEMBL260	Homo sapiens	Inhibition	%	32.95
	8186651	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.41	CHEMBL260	Homo sapiens	Inhibition	%	3.41
	8186790	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	8.46	CHEMBL260	Homo sapiens	Inhibition	%	8.46
	8187014	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.66	CHEMBL260	Homo sapiens	Inhibition	%	2.66
	8187112	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.9	CHEMBL260	Homo sapiens	Inhibition	%	4.9
	8187460	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.92	CHEMBL260	Homo sapiens	Inhibition	%	2.92
	8187608	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	7.73	CHEMBL260	Homo sapiens	Inhibition	%	7.73
	8187832	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.92	CHEMBL260	Homo sapiens	Inhibition	%	3.92
	8187961	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	67.47	CHEMBL260	Homo sapiens	Inhibition	%	67.47
	8188328	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.11	CHEMBL260	Homo sapiens	Inhibition	%	4.11
	8188463	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-3.8	CHEMBL260	Homo sapiens	Inhibition	%	-3.8
	8188737	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.49	CHEMBL260	Homo sapiens	Inhibition	%	3.49
	8189109	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.82	CHEMBL260	Homo sapiens	Inhibition	%	1.82
	8189265	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	92.81	CHEMBL260	Homo sapiens	Inhibition	%	92.81
	8189489	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.96	CHEMBL260	Homo sapiens	Inhibition	%	7.96
	8189638	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.7	CHEMBL260	Homo sapiens	Inhibition	%	-0.7
	8189994	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	13.89	CHEMBL260	Homo sapiens	Inhibition	%	13.89
	8190126	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.73	CHEMBL260	Homo sapiens	Inhibition	%	2.73
	8190490	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.9	CHEMBL260	Homo sapiens	Inhibition	%	6.9
	8190627	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	80.95	CHEMBL260	Homo sapiens	Inhibition	%	80.95
	8190851	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	66.28	CHEMBL260	Homo sapiens	Inhibition	%	66.28
	8191015	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	12.19	CHEMBL260	Homo sapiens	Inhibition	%	12.19
	8191377	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	7.04	CHEMBL260	Homo sapiens	Inhibition	%	7.04
	8191473	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	6.5	CHEMBL260	Homo sapiens	Inhibition	%	6.5
	8191697	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	6.91	CHEMBL260	Homo sapiens	Inhibition	%	6.91
	8191819	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	8.4	CHEMBL260	Homo sapiens	Inhibition	%	8.4
	8192192	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	8.94	CHEMBL260	Homo sapiens	Inhibition	%	8.94
	8192321	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	19.41	CHEMBL260	Homo sapiens	Inhibition	%	19.41
	8192689	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.76	CHEMBL260	Homo sapiens	Inhibition	%	3.76
	8192825	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.7	CHEMBL260	Homo sapiens	Inhibition	%	4.7
	8193049	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	8.65	CHEMBL260	Homo sapiens	Inhibition	%	8.65
	8193097	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.59	CHEMBL260	Homo sapiens	Inhibition	%	8.59
	8193321	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	6.13	CHEMBL260	Homo sapiens	Inhibition	%	6.13
	8193466	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.92	CHEMBL260	Homo sapiens	Inhibition	%	3.92
	8193847	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	13.48	CHEMBL260	Homo sapiens	Inhibition	%	13.48
	8193996	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.24	CHEMBL260	Homo sapiens	Inhibition	%	1.24
	8194351	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.71	CHEMBL260	Homo sapiens	Inhibition	%	5.71
	8194482	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	11.27	CHEMBL260	Homo sapiens	Inhibition	%	11.27
	8194706	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.97	CHEMBL260	Homo sapiens	Inhibition	%	3.97
	8194849	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	14.95	CHEMBL260	Homo sapiens	Inhibition	%	14.95
	8195206	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	86.34	CHEMBL260	Homo sapiens	Inhibition	%	86.34
	8195370	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.28	CHEMBL260	Homo sapiens	Inhibition	%	2.28
	8195733	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.43	CHEMBL260	Homo sapiens	Inhibition	%	4.43
	8196055	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	7.75	CHEMBL260	Homo sapiens	Inhibition	%	7.75
	8196172	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.98	CHEMBL260	Homo sapiens	Inhibition	%	6.98
	8196546	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	70.99	CHEMBL260	Homo sapiens	Inhibition	%	70.99
	8196674	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	66.58	CHEMBL260	Homo sapiens	Inhibition	%	66.58
	8196898	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	16.86	CHEMBL260	Homo sapiens	Inhibition	%	16.86
	8197039	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.09	CHEMBL260	Homo sapiens	Inhibition	%	6.09
	8197400	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.85	CHEMBL260	Homo sapiens	Inhibition	%	2.85
	8197675	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	8.6	CHEMBL260	Homo sapiens	Inhibition	%	8.6
	8197815	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.7	CHEMBL260	Homo sapiens	Inhibition	%	2.7
	8198196	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	19.76	CHEMBL260	Homo sapiens	Inhibition	%	19.76
	8198334	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.47	CHEMBL260	Homo sapiens	Inhibition	%	-3.47
	8198558	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.14	CHEMBL260	Homo sapiens	Inhibition	%	5.14
	8198688	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	22.07	CHEMBL260	Homo sapiens	Inhibition	%	22.07
	8199043	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.43	CHEMBL260	Homo sapiens	Inhibition	%	8.43
	8199191	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.65	CHEMBL260	Homo sapiens	Inhibition	%	6.65
	8199549	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.33	CHEMBL260	Homo sapiens	Inhibition	%	6.33
	8199712	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.71	CHEMBL260	Homo sapiens	Inhibition	%	6.71
	8199936	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.49	CHEMBL260	Homo sapiens	Inhibition	%	5.49
	8200074	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	14.93	CHEMBL260	Homo sapiens	Inhibition	%	14.93
	8200402	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	46.49	CHEMBL260	Homo sapiens	Inhibition	%	46.49
	8200517	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.36	CHEMBL260	Homo sapiens	Inhibition	%	6.36
	8200741	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.26	CHEMBL260	Homo sapiens	Inhibition	%	7.26
	8200891	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	88.54	CHEMBL260	Homo sapiens	Inhibition	%	88.54
	8201245	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	12.33	CHEMBL260	Homo sapiens	Inhibition	%	12.33
	8201380	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	7.07	CHEMBL260	Homo sapiens	Inhibition	%	7.07
	8201737	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	8.81	CHEMBL260	Homo sapiens	Inhibition	%	8.81
	8202016	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.28	CHEMBL260	Homo sapiens	Inhibition	%	4.28
	8202156	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	18.45	CHEMBL260	Homo sapiens	Inhibition	%	18.45
	8202380	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.75	CHEMBL260	Homo sapiens	Inhibition	%	1.75
	8202547	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	67.42	CHEMBL260	Homo sapiens	Inhibition	%	67.42
	8202896	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	37.03	CHEMBL260	Homo sapiens	Inhibition	%	37.03
	8203026	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.29	CHEMBL260	Homo sapiens	Inhibition	%	5.29
	8203381	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.68	CHEMBL260	Homo sapiens	Inhibition	%	2.68
	8203527	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	9.66	CHEMBL260	Homo sapiens	Inhibition	%	9.66
	8203751	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.91	CHEMBL260	Homo sapiens	Inhibition	%	1.91
	8203885	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	11.6	CHEMBL260	Homo sapiens	Inhibition	%	11.6
	8204275	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	6.26	CHEMBL260	Homo sapiens	Inhibition	%	6.26
	8204412	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	13.86	CHEMBL260	Homo sapiens	Inhibition	%	13.86
	8204741	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	82.75	CHEMBL260	Homo sapiens	Inhibition	%	82.75
	8205080	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	6.91	CHEMBL260	Homo sapiens	Inhibition	%	6.91
	8205229	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.66	CHEMBL260	Homo sapiens	Inhibition	%	6.66
	8205589	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	-6.67	CHEMBL260	Homo sapiens	Inhibition	%	-6.67
	8205728	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	8.35	CHEMBL260	Homo sapiens	Inhibition	%	8.35
	8205952	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	29.67	CHEMBL260	Homo sapiens	Inhibition	%	29.67
	8206084	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	8.45	CHEMBL260	Homo sapiens	Inhibition	%	8.45
	8206360	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	11.81	CHEMBL260	Homo sapiens	Inhibition	%	11.81
	8206727	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.33	CHEMBL260	Homo sapiens	Inhibition	%	-0.33
	8206907	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.93	CHEMBL260	Homo sapiens	Inhibition	%	5.93
	8207257	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	8.73	CHEMBL260	Homo sapiens	Inhibition	%	8.73
	8207387	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.65	CHEMBL260	Homo sapiens	Inhibition	%	8.65
	8207611	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.42	CHEMBL260	Homo sapiens	Inhibition	%	6.42
	8207743	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	17.05	CHEMBL260	Homo sapiens	Inhibition	%	17.05
	8208112	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	8.35	CHEMBL260	Homo sapiens	Inhibition	%	8.35
	8208244	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.92	CHEMBL260	Homo sapiens	Inhibition	%	7.92
	8208468	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	37.18	CHEMBL260	Homo sapiens	Inhibition	%	37.18
	8208634	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.64	CHEMBL260	Homo sapiens	Inhibition	%	3.64
	8208767	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	58.78	CHEMBL260	Homo sapiens	Inhibition	%	58.78
	8208991	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	9.91	CHEMBL260	Homo sapiens	Inhibition	%	9.91
	8209096	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	5.17	CHEMBL260	Homo sapiens	Inhibition	%	5.17
	8209436	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-0.64	CHEMBL260	Homo sapiens	Inhibition	%	-0.64
	8209586	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	16.55	CHEMBL260	Homo sapiens	Inhibition	%	16.55
	8209810	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	7.62	CHEMBL260	Homo sapiens	Inhibition	%	7.62
	8209946	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.06	CHEMBL260	Homo sapiens	Inhibition	%	6.06
	8210311	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	74.33	CHEMBL260	Homo sapiens	Inhibition	%	74.33
	8210447	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.19	CHEMBL260	Homo sapiens	Inhibition	%	-3.19
	8210706	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	9.97	CHEMBL260	Homo sapiens	Inhibition	%	9.97
	8210930	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	54.25	CHEMBL260	Homo sapiens	Inhibition	%	54.25
	8211074	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.39	CHEMBL260	Homo sapiens	Inhibition	%	2.39
	8211244	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	12.86	CHEMBL260	Homo sapiens	Inhibition	%	12.86
	8211468	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.28	CHEMBL260	Homo sapiens	Inhibition	%	5.28
	8211591	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	50.05	CHEMBL260	Homo sapiens	Inhibition	%	50.05
	8211944	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	Inhibition	%	16.0
	8212076	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.47	CHEMBL260	Homo sapiens	Inhibition	%	2.47
	8212300	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.87	CHEMBL260	Homo sapiens	Inhibition	%	8.87
	8212441	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.02	CHEMBL260	Homo sapiens	Inhibition	%	3.02
	8212798	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.85	CHEMBL260	Homo sapiens	Inhibition	%	4.85
	8212968	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.06	CHEMBL260	Homo sapiens	Inhibition	%	5.06
	8213321	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	9.15	CHEMBL260	Homo sapiens	Inhibition	%	9.15
	8213425	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	8.57	CHEMBL260	Homo sapiens	Inhibition	%	8.57
	8213649	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.32	CHEMBL260	Homo sapiens	Inhibition	%	0.32
	8213762	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	6.59	CHEMBL260	Homo sapiens	Inhibition	%	6.59
	8214133	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.94	CHEMBL260	Homo sapiens	Inhibition	%	5.94
	8214270	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.73	CHEMBL260	Homo sapiens	Inhibition	%	5.73
	8214494	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	6.35	CHEMBL260	Homo sapiens	Inhibition	%	6.35
	8214628	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.41	CHEMBL260	Homo sapiens	Inhibition	%	4.41
	8214780	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.26	CHEMBL260	Homo sapiens	Inhibition	%	0.26
	8215004	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.12	CHEMBL260	Homo sapiens	Inhibition	%	3.12
	8215255	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	21.18	CHEMBL260	Homo sapiens	Inhibition	%	21.18
	8215408	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	9.56	CHEMBL260	Homo sapiens	Inhibition	%	9.56
	8215796	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	8.23	CHEMBL260	Homo sapiens	Inhibition	%	8.23
	8215915	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.09	CHEMBL260	Homo sapiens	Inhibition	%	2.09
	8216258	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	8.95	CHEMBL260	Homo sapiens	Inhibition	%	8.95
	8216618	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.38	CHEMBL260	Homo sapiens	Inhibition	%	4.38
	8216756	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.71	CHEMBL260	Homo sapiens	Inhibition	%	7.71
	8217114	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	12.25	CHEMBL260	Homo sapiens	Inhibition	%	12.25
	8217288	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	5.45	CHEMBL260	Homo sapiens	Inhibition	%	5.45
	8217643	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.48	CHEMBL260	Homo sapiens	Inhibition	%	4.48
	8217968	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.58	CHEMBL260	Homo sapiens	Inhibition	%	-0.58
	8218083	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.87	CHEMBL260	Homo sapiens	Inhibition	%	3.87
	8218307	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	15.94	CHEMBL260	Homo sapiens	Inhibition	%	15.94
	8218434	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.36	CHEMBL260	Homo sapiens	Inhibition	%	2.36
	8218801	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.62	CHEMBL260	Homo sapiens	Inhibition	%	4.62
	8218932	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	27.97	CHEMBL260	Homo sapiens	Inhibition	%	27.97
	8219316	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	28.93	CHEMBL260	Homo sapiens	Inhibition	%	28.93
	8219566	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	64.92	CHEMBL260	Homo sapiens	Inhibition	%	64.92
	8219727	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.37	CHEMBL260	Homo sapiens	Inhibition	%	4.37
	8219951	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	13.44	CHEMBL260	Homo sapiens	Inhibition	%	13.44
	8220120	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.72	CHEMBL260	Homo sapiens	Inhibition	%	5.72
	8220249	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.88	CHEMBL260	Homo sapiens	Inhibition	%	9.88
	8220473	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.19	CHEMBL260	Homo sapiens	Inhibition	%	3.19
	8220587	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	10.27	CHEMBL260	Homo sapiens	Inhibition	%	10.27
	8220949	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.01	CHEMBL260	Homo sapiens	Inhibition	%	7.01
	8221085	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.52	CHEMBL260	Homo sapiens	Inhibition	%	3.52
	8221309	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.62	CHEMBL260	Homo sapiens	Inhibition	%	7.62
	8221442	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.33	CHEMBL260	Homo sapiens	Inhibition	%	6.33
	8221607	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	8.09	CHEMBL260	Homo sapiens	Inhibition	%	8.09
	8221831	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	72.53	CHEMBL260	Homo sapiens	Inhibition	%	72.53
	8221962	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	8.47	CHEMBL260	Homo sapiens	Inhibition	%	8.47
	8222284	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.16	CHEMBL260	Homo sapiens	Inhibition	%	2.16
	8222642	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.61	CHEMBL260	Homo sapiens	Inhibition	%	3.61
	8222760	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	11.79	CHEMBL260	Homo sapiens	Inhibition	%	11.79
	8223128	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	30.39	CHEMBL260	Homo sapiens	Inhibition	%	30.39
	8223257	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	11.12	CHEMBL260	Homo sapiens	Inhibition	%	11.12
	8223481	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	39.99	CHEMBL260	Homo sapiens	Inhibition	%	39.99
	8223642	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.58	CHEMBL260	Homo sapiens	Inhibition	%	0.58
	8223892	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	14.15	CHEMBL260	Homo sapiens	Inhibition	%	14.15
	8224278	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	38.26	CHEMBL260	Homo sapiens	Inhibition	%	38.26
	8224448	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	8.08	CHEMBL260	Homo sapiens	Inhibition	%	8.08
	8224807	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.41	CHEMBL260	Homo sapiens	Inhibition	%	8.41
	8224921	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-3.41	CHEMBL260	Homo sapiens	Inhibition	%	-3.41
	8225145	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.81	CHEMBL260	Homo sapiens	Inhibition	%	6.81
	8225279	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.9	CHEMBL260	Homo sapiens	Inhibition	%	4.9
	8225641	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.21	CHEMBL260	Homo sapiens	Inhibition	%	4.21
	8225776	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	9.12	CHEMBL260	Homo sapiens	Inhibition	%	9.12
	8226158	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	91.06	CHEMBL260	Homo sapiens	Inhibition	%	91.06
	8226283	CHEMBL1962058	GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.98	CHEMBL260	Homo sapiens	Inhibition	%	2.98
	8226507	CHEMBL1962059	GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	7.42	CHEMBL260	Homo sapiens	Inhibition	%	7.42
active	9544530	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	=	Ki	nM	316.23	CHEMBL260	Homo sapiens	pKi		6.5
inactive	9544531	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544532	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544533	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544534	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544535	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Ki	nM	5.012	CHEMBL260	Homo sapiens	pKi		8.3
active	9544536	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	50118.72	CHEMBL260	Homo sapiens	pKi		4.3
inactive	9544537	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544538	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544539	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544540	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544541	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544542	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
active	9544543	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(N)=O)cc2)n1		CHEMBL1998765	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
active	9544544	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	=	Ki	nM	125.89	CHEMBL260	Homo sapiens	pKi		6.9
inactive	9544545	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544546	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544547	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544548	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
inactive	9544549	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544550	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544551	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544552	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	=	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
active	9544553	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	50118.72	CHEMBL260	Homo sapiens	pKi		4.3
active	9544554	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
inactive	9544555	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544556	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
inactive	9544557	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544558	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544559	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	=	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
active	9544560	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)c2cc3ccccc3s2)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1968727	=	Ki	nM	794.33	CHEMBL260	Homo sapiens	pKi		6.1
active	9544561	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
inactive	9544562	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544563	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	c1ccc(-c2ncc3ccccn23)cc1		CHEMBL1380050	=	Ki	nM	50118.72	CHEMBL260	Homo sapiens	pKi		4.3
inactive	9544564	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544565	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544566	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544567	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
active	9544568	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	1584.89	CHEMBL260	Homo sapiens	pKi		5.8
inactive	9544569	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9544570	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9544571	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	79.43	CHEMBL260	Homo sapiens	pKi		7.1
inactive	9548465	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548466	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	31.62	CHEMBL260	Homo sapiens	pKi		7.5
inactive	9548467	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548468	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	=	Ki	nM	3.162	CHEMBL260	Homo sapiens	pKi		8.5
active	9548469	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
active	9548470	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)CC(NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1)C(N)=O		CHEMBL1965469	=	Ki	nM	794.33	CHEMBL260	Homo sapiens	pKi		6.1
inactive	9548471	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548472	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548473	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548474	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548475	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548476	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548477	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548478	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548479	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548480	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548481	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548482	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548483	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548484	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1995.26	CHEMBL260	Homo sapiens	pKi		5.7
active	9548485	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	=	Ki	nM	251.19	CHEMBL260	Homo sapiens	pKi		6.6
inactive	9548486	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548487	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
inactive	9548488	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548489	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	=	Ki	nM	794.33	CHEMBL260	Homo sapiens	pKi		6.1
inactive	9548490	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548491	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548492	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548493	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548494	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548495	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548496	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548497	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548498	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548499	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2002660	=	Ki	nM	398.11	CHEMBL260	Homo sapiens	pKi		6.4
inactive	9548500	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548501	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548502	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548503	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	=	Ki	nM	1.585	CHEMBL260	Homo sapiens	pKi		8.8
inactive	9548504	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548505	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548506	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548507	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548508	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548509	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548510	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1cccc(Br)c1c2=O		CHEMBL1976158	=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	pKi		6.0
inactive	9548511	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548512	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	=	Ki	nM	1995.26	CHEMBL260	Homo sapiens	pKi		5.7
inactive	9548513	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548514	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548515	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548516	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	50118.72	CHEMBL260	Homo sapiens	pKi		4.3
active	9548517	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	501.19	CHEMBL260	Homo sapiens	pKi		6.3
inactive	9548518	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548519	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548520	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
inactive	9548521	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548522	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548523	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
active	9548524	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	=	Ki	nM	0.5012	CHEMBL260	Homo sapiens	pKi		9.3
active	9548525	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
active	9548526	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548527	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	pKi		7.0
active	9548528	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(=O)[nH]c2[nH]nc(-c3cccc(C(F)(F)F)c3)c12		CHEMBL1991377	=	Ki	nM	398.11	CHEMBL260	Homo sapiens	pKi		6.4
active	9548529	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
active	9548530	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	pKi		7.0
inactive	9548531	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548532	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548533	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	501.19	CHEMBL260	Homo sapiens	pKi		6.3
active	9548534	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
inactive	9548535	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548536	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
inactive	9548537	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
inactive	9548538	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548539	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548540	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548541	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	19.95	CHEMBL260	Homo sapiens	pKi		7.7
inactive	9548542	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548543	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	=	Ki	nM	251.19	CHEMBL260	Homo sapiens	pKi		6.6
active	9548544	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
active	9548545	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	10000.0	CHEMBL260	Homo sapiens	pKi		5.0
inactive	9548546	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548547	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548548	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548549	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	=	Ki	nM	398.11	CHEMBL260	Homo sapiens	pKi		6.4
inactive	9548550	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548551	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	199.53	CHEMBL260	Homo sapiens	pKi		6.7
inactive	9548552	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548553	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	15848.93	CHEMBL260	Homo sapiens	pKi		4.8
active	9548554	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	1995.26	CHEMBL260	Homo sapiens	pKi		5.7
inactive	9548555	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548556	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
inactive	9548557	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548558	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548559	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548560	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548561	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548562	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548563	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	10.0	CHEMBL260	Homo sapiens	pKi		8.0
inactive	9548564	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548565	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548566	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548567	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548568	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548569	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548570	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548571	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548572	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548573	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	501.19	CHEMBL260	Homo sapiens	pKi		6.3
inactive	9548574	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548575	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548576	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
active	9548577	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	1995.26	CHEMBL260	Homo sapiens	pKi		5.7
inactive	9548578	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548579	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548580	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	=	Ki	nM	1584.89	CHEMBL260	Homo sapiens	pKi		5.8
active	9548581	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	15.85	CHEMBL260	Homo sapiens	pKi		7.8
inactive	9548582	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548583	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548584	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)CC(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1992334	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
inactive	9548585	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548586	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548587	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	39810.72	CHEMBL260	Homo sapiens	pKi		4.4
inactive	9548588	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548589	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548590	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548591	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	12589.25	CHEMBL260	Homo sapiens	pKi		4.9
active	9548592	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
inactive	9548593	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548594	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548595	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548596	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	=	Ki	nM	0.1259	CHEMBL260	Homo sapiens	pKi		9.9
inactive	9548597	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548598	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	0.2512	CHEMBL260	Homo sapiens	pKi		9.6
active	9548599	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	1258.93	CHEMBL260	Homo sapiens	pKi		5.9
active	9548600	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	316.23	CHEMBL260	Homo sapiens	pKi		6.5
inactive	9548601	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548602	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548603	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncnc2nc3ccccc3n12		CHEMBL1983884	<	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
inactive	9548604	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548605	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548606	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548607	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ccc2cc(NCCc3ccccc3)cc(Nc3ncccn3)c2n1		CHEMBL550275	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
inactive	9548608	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548609	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	pKi		6.0
active	9548610	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(=O)n1ncc2cc(N)ccc21		CHEMBL1972454	=	Ki	nM	7943.28	CHEMBL260	Homo sapiens	pKi		5.1
active	9548611	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)CCCCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2001451	=	Ki	nM	794.33	CHEMBL260	Homo sapiens	pKi		6.1
inactive	9548612	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548613	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548614	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548615	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548616	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548617	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548618	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548619	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548620	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(SCC1CCC2CC1C2(C)C)C(N)=O		CHEMBL1966976	=	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
inactive	9548621	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548622	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548623	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548624	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548625	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548626	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548627	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
active	9548628	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548629	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548630	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	25118.86	CHEMBL260	Homo sapiens	pKi		4.6
active	9548631	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	=	Ki	nM	316.23	CHEMBL260	Homo sapiens	pKi		6.5
inactive	9548632	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CC)CCNc1ccc(O)c2ccccc12		CHEMBL576113	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548633	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
active	9548634	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)c2cc3ccccc3s2)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL1973324	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
inactive	9548635	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548636	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548637	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	19952.62	CHEMBL260	Homo sapiens	pKi		4.7
inactive	9548638	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548639	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	=	Ki	nM	316.23	CHEMBL260	Homo sapiens	pKi		6.5
inactive	9548640	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548641	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)NCCO)cc2)n1		CHEMBL2006149	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
active	9548642	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	316.23	CHEMBL260	Homo sapiens	pKi		6.5
active	9548643	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	pKi		6.0
inactive	9548644	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548645	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548646	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
active	9548647	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	199.53	CHEMBL260	Homo sapiens	pKi		6.7
active	9548648	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	=	Ki	nM	79.43	CHEMBL260	Homo sapiens	pKi		7.1
inactive	9548649	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548650	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548651	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548652	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548653	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	pKi		6.0
inactive	9548654	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548655	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548656	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548657	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548658	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548659	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	C(=Cc1ccc2nccn2n1)c1ccccc1		CHEMBL1988622	=	Ki	nM	100000.0	CHEMBL260	Homo sapiens	pKi		4.0
inactive	9548660	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548661	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548662	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	=	Ki	nM	501.19	CHEMBL260	Homo sapiens	pKi		6.3
inactive	9548663	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548664	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548665	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CCN(C)C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1992354	=	Ki	nM	794.33	CHEMBL260	Homo sapiens	pKi		6.1
active	9548666	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	=	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548667	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548668	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548669	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	=	Ki	nM	39810.72	CHEMBL260	Homo sapiens	pKi		4.4
inactive	9548670	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548671	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1258.93	CHEMBL260	Homo sapiens	pKi		5.9
inactive	9548672	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548673	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548674	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548675	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548676	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	39810.72	CHEMBL260	Homo sapiens	pKi		4.4
inactive	9548677	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548678	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548679	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCO)c2)n1		CHEMBL2007073	=	Ki	nM	398.11	CHEMBL260	Homo sapiens	pKi		6.4
active	9548680	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	7.943	CHEMBL260	Homo sapiens	pKi		8.1
inactive	9548681	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548682	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548683	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	3.162	CHEMBL260	Homo sapiens	pKi		8.5
inactive	9548684	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548685	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	=	Ki	nM	100000.0	CHEMBL260	Homo sapiens	pKi		4.0
active	9548686	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	pKi		6.0
inactive	9548687	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548688	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548689	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548690	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548691	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548692	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548693	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	25118.86	CHEMBL260	Homo sapiens	pKi		4.6
active	9548694	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	19952.62	CHEMBL260	Homo sapiens	pKi		4.7
inactive	9548695	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548696	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548697	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9548698	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	501.19	CHEMBL260	Homo sapiens	pKi		6.3
active	9548699	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
inactive	9548700	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548701	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548702	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9548703	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552602	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552603	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)N(CCN)CCO)c2)n1		CHEMBL1993634	=	Ki	nM	630.96	CHEMBL260	Homo sapiens	pKi		6.2
inactive	9552604	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552605	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552606	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552607	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552608	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552609	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	100000.0	CHEMBL260	Homo sapiens	pKi		4.0
inactive	9552610	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552611	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552612	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552613	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552614	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552615	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552616	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552617	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	79432.82	CHEMBL260	Homo sapiens	pKi		4.1
inactive	9552618	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552619	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552620	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	pKi		6.0
inactive	9552621	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552622	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552623	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	158.49	CHEMBL260	Homo sapiens	pKi		6.8
inactive	9552624	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552625	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	=	Ki	nM	316.23	CHEMBL260	Homo sapiens	pKi		6.5
active	9552626	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	=	Ki	nM	158.49	CHEMBL260	Homo sapiens	pKi		6.8
inactive	9552627	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552628	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	=	Ki	nM	251.19	CHEMBL260	Homo sapiens	pKi		6.6
inactive	9552629	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552630	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCOCC(C)Oc1cccc2[nH]nc(N)c12		CHEMBL2002736	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552631	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552632	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
active	9552633	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	=	Ki	nM	2511.89	CHEMBL260	Homo sapiens	pKi		5.6
active	9552634	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1258.93	CHEMBL260	Homo sapiens	pKi		5.9
active	9552635	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Ki	nM	5.012	CHEMBL260	Homo sapiens	pKi		8.3
inactive	9552636	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552637	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552638	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552639	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552640	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	501.19	CHEMBL260	Homo sapiens	pKi		6.3
inactive	9552641	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552642	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1000.0	CHEMBL260	Homo sapiens	pKi		6.0
inactive	9552643	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	<	Ki	nM	3162.28	CHEMBL260	Homo sapiens	pKi		5.5
active	9552644	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1258.93	CHEMBL260	Homo sapiens	pKi		5.9
inactive	9552645	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552646	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	398.11	CHEMBL260	Homo sapiens	pKi		6.4
inactive	9552647	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552648	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552649	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552650	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
inactive	9552651	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
active	9552652	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	794.33	CHEMBL260	Homo sapiens	pKi		6.1
inactive	9552653	CHEMBL1964117	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK14	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	3981.07	CHEMBL260	Homo sapiens	pKi		5.4
	10839428	CHEMBL2015413	Inhibition of p38alpha at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	10839593	CHEMBL2016305	Inhibition of p38alpha MAPK assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	88.0	CHEMBL260	Homo sapiens	Activity	%	88.0
	10839680	CHEMBL2015173	Inhibition of p38alpha MAPK assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	79.0	CHEMBL260	Homo sapiens	Activity	%	79.0
Not Active	10842738	CHEMBL2016351	Inhibition of p38alpha at 10 uM	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10842739	CHEMBL2016351	Inhibition of p38alpha at 10 uM	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10842740	CHEMBL2016351	Inhibition of p38alpha at 10 uM	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10842741	CHEMBL2016351	Inhibition of p38alpha at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10842742	CHEMBL2016351	Inhibition of p38alpha at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10842743	CHEMBL2016351	Inhibition of p38alpha at 10 uM	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844855	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Fc1ccc(-c2cn(-c3ccc(C(F)(F)F)cc3)nc2-c2ccncc2)cc1		CHEMBL2011305		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844856	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Fc1ccc(-c2cn(-c3c(Cl)cc(Cl)cc3Cl)nc2-c2ccncc2)cc1		CHEMBL2011304		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844857	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Nc1cc(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011303		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844858	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Nc1c(C(=O)O)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011302		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844859	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	NC(=O)c1c(-c2ccncc2)nn(-c2ccccc2)c1N		CHEMBL2011301		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844860	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	CCOC(=O)c1c(-c2ccncc2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1N		CHEMBL2011300		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844861	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	NC(=O)c1c(-c2ccncc2)nn(-c2c(Cl)cc(Cl)cc2Cl)c1N		CHEMBL2011299		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844862	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(C(F)(F)F)cc1		CHEMBL2011298		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844863	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	N#Cc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011297		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844864	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Cc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011296		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844865	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL2011295		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844866	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	COc1ccc(-n2nc(-c3ccncc3)c(-c3ccc(F)cc3)c2N)cc1		CHEMBL2011294		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844867	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL2011293		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844868	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccccc1		CHEMBL2011292		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	10844869	CHEMBL2015055	Inhibition of p38alpha MAP kinase	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011291		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	10867376	CHEMBL2027477	Inhibition of p38alpha kinase	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	10867378	CHEMBL2027477	Inhibition of p38alpha kinase	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccncc2)cc1		CHEMBL279416	=	Ki	nM	60.0	CHEMBL260	Homo sapiens	Ki	nM	60.0
	10867380	CHEMBL2027258	Inhibition of p38alpha in human whole blood assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	nM	150.0
	10867381	CHEMBL2027259	Inhibition of p38alpha in human whole blood assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	nM	180.0
	10867388	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(Cl)cc1Cl		CHEMBL2024347	=	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	10867389	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(Cl)cc1Cl		CHEMBL2024347	=	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867390	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(Cl)cc1Cl		CHEMBL2024347	=	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867391	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1		CHEMBL2024348	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
Not Determined	10867392	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1		CHEMBL2024348		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	10867393	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1		CHEMBL2024348		IC50			CHEMBL260	Homo sapiens	IC50		
	10867394	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Cc1ccccc1-c1c(=O)ncn2nc(Sc3ccccc3)ccc12		CHEMBL2024349	=	IC50	nM	4400.0	CHEMBL260	Homo sapiens	IC50	uM	4.4
	10867395	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Cc1ccccc1-c1c(=O)ncn2nc(Sc3ccccc3)ccc12		CHEMBL2024349	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	uM	3.5
	10867396	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Cc1ccccc1-c1c(=O)ncn2nc(Sc3ccccc3)ccc12		CHEMBL2024349	=	IC50	nM	9700.0	CHEMBL260	Homo sapiens	IC50	uM	9.7
	10867397	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	COc1ccccc1-c1c(=O)ncn2nc(Sc3ccccc3)ccc12		CHEMBL2024350	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	uM	12.0
	10867398	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	COc1ccccc1-c1c(=O)ncn2nc(Sc3ccccc3)ccc12		CHEMBL2024350	=	IC50	nM	2800.0	CHEMBL260	Homo sapiens	IC50	uM	2.8
	10867399	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	COc1ccccc1-c1c(=O)ncn2nc(Sc3ccccc3)ccc12		CHEMBL2024350	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867400	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1C(F)(F)F		CHEMBL2024351	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	uM	11.0
	10867401	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1C(F)(F)F		CHEMBL2024351	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	uM	2.1
	10867402	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1C(F)(F)F		CHEMBL2024351	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867403	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1Cl		CHEMBL2024352	=	IC50	nM	4100.0	CHEMBL260	Homo sapiens	IC50	uM	4.1
	10867404	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1Cl		CHEMBL2024352	=	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	10867405	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccccc1Cl		CHEMBL2024352	=	IC50	nM	19900.0	CHEMBL260	Homo sapiens	IC50	uM	19.9
	10867406	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(F)cc1		CHEMBL2024353	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867407	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(F)cc1		CHEMBL2024353	=	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	10867408	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(F)cc1		CHEMBL2024353	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867409	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	COc1ccc(-c2c(=O)ncn3nc(Sc4ccccc4)ccc23)cc1		CHEMBL2024526	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867410	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	COc1ccc(-c2c(=O)ncn3nc(Sc4ccccc4)ccc23)cc1		CHEMBL2024526	=	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867411	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	COc1ccc(-c2c(=O)ncn3nc(Sc4ccccc4)ccc23)cc1		CHEMBL2024526	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867412	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(Cl)c(Cl)c1		CHEMBL2024527	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867413	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(Cl)c(Cl)c1		CHEMBL2024527	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867414	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1ccc(Cl)c(Cl)c1		CHEMBL2024527	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	10867415	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(F)cccc1C(F)(F)F		CHEMBL2024528	=	IC50	nM	1700.0	CHEMBL260	Homo sapiens	IC50	uM	1.7
	10867416	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(F)cccc1C(F)(F)F		CHEMBL2024528	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	10867417	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(F)cccc1C(F)(F)F		CHEMBL2024528	=	IC50	nM	3100.0	CHEMBL260	Homo sapiens	IC50	uM	3.1
	10867418	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(F)cccc1F		CHEMBL2024529	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	uM	3.5
	10867419	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(F)cccc1F		CHEMBL2024529	=	IC50	nM	3700.0	CHEMBL260	Homo sapiens	IC50	uM	3.7
	10867420	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(F)cccc1F		CHEMBL2024529	=	IC50	nM	15300.0	CHEMBL260	Homo sapiens	IC50	uM	15.3
	10867421	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL113806	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	10867422	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL113806	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	10867423	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL113806	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	uM	0.46
	10867424	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)cc1		CHEMBL114121	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	10867425	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)cc1		CHEMBL114121	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	uM	0.37
	10867426	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)cc1		CHEMBL114121	=	IC50	nM	870.0	CHEMBL260	Homo sapiens	IC50	uM	0.87
	10867427	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccc(F)cc3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL326629	=	IC50	nM	123.0	CHEMBL260	Homo sapiens	IC50	uM	0.123
	10867428	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL326629	=	IC50	nM	99.0	CHEMBL260	Homo sapiens	IC50	uM	0.099
	10867429	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL326629	=	IC50	nM	293.0	CHEMBL260	Homo sapiens	IC50	uM	0.293
	10867430	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3cccc(F)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114962	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	10867431	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3cccc(F)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114962	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	uM	0.44
	10867432	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3cccc(F)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114962	=	IC50	nM	720.0	CHEMBL260	Homo sapiens	IC50	uM	0.72
	10867433	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3cccc(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114430	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	10867434	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3cccc(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114430	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	uM	0.35
	10867435	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3cccc(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114430	=	IC50	nM	900.0	CHEMBL260	Homo sapiens	IC50	uM	0.9
	10867436	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Cc1cccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c1		CHEMBL324089	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	10867437	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Cc1cccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c1		CHEMBL324089	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	10867438	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Cc1cccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c1		CHEMBL324089	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	10867439	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	CCc1ccccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL2024530	=	IC50	nM	750.0	CHEMBL260	Homo sapiens	IC50	uM	0.75
	10867440	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	CCc1ccccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL2024530	=	IC50	nM	980.0	CHEMBL260	Homo sapiens	IC50	uM	0.98
	10867441	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	CCc1ccccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL2024530	=	IC50	nM	2800.0	CHEMBL260	Homo sapiens	IC50	uM	2.8
	10867442	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Cc1ccccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL326089	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	10867443	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Cc1ccccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL326089	=	IC50	nM	330.0	CHEMBL260	Homo sapiens	IC50	uM	0.33
	10867444	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Cc1ccccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL326089	=	IC50	nM	3700.0	CHEMBL260	Homo sapiens	IC50	uM	3.7
	10867445	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccccc3O)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL117211	=	IC50	nM	360.0	CHEMBL260	Homo sapiens	IC50	uM	0.36
	10867446	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3O)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL117211	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	10867447	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccccc3O)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL117211	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	10867448	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccc(Cl)c(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114057	=	IC50	nM	800.0	CHEMBL260	Homo sapiens	IC50	uM	0.8
	10867449	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(Cl)c(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114057	=	IC50	nM	970.0	CHEMBL260	Homo sapiens	IC50	uM	0.97
	10867450	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(Cl)c(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL114057	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	10867451	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)cc1C		CHEMBL326944	=	IC50	nM	1900.0	CHEMBL260	Homo sapiens	IC50	uM	1.9
	10867452	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)cc1C		CHEMBL326944	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	uM	2.4
	10867453	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)cc1C		CHEMBL326944	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	uM	3.5
	10867454	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccc(F)c(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL431865	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	10867455	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)c(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL431865	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	10867456	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)c(Cl)c3)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL431865	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	10867457	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Nc1cc(F)ccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL324091	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	10867458	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Nc1cc(F)ccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL324091	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	10867459	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Nc1cc(F)ccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL324091	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	10867460	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccc(F)cc3Cl)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL420134	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	10867461	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3Cl)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL420134	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	uM	0.053
	10867462	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3Cl)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL420134	=	IC50	nM	275.0	CHEMBL260	Homo sapiens	IC50	uM	0.275
	10867463	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	10867464	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
	10867465	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	uM	0.051
	10867466	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Cc1cc(Cl)ccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL115491	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	10867467	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Cc1cc(Cl)ccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL115491	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	10867468	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Cc1cc(Cl)ccc1Sc1ccc2c(-c3c(Cl)cccc3Cl)c(=O)ncn2n1		CHEMBL115491	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	10867469	CHEMBL2027255	Inhibition of p38alpha kinase using KRELVEPLTPSGEAPNQALLR as substrate for 20 mins by lactate dehydrogenase-coupled spectrophotometric assay	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(C)c1		CHEMBL331361	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	10867470	CHEMBL2027256	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced IL1beta production after 16 to 18 hrs by ELISA	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(C)c1		CHEMBL331361	=	IC50	nM	690.0	CHEMBL260	Homo sapiens	IC50	uM	0.69
	10867471	CHEMBL2027257	Inhibition of p38alpha in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 16 to 18 hrs by ELISA	B	Cc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(C)c1		CHEMBL331361	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	10889032	CHEMBL2032483	Inhibition of p38alpha	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	10889059	CHEMBL2032483	Inhibition of p38alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	10894491	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL183630	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	10894492	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031219	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	10894493	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031220	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	nM	220.0
	10894494	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031221	=	IC50	nM	89.0	CHEMBL260	Homo sapiens	IC50	nM	89.0
	10894495	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031222	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	10894496	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031223	=	IC50	nM	1941.0	CHEMBL260	Homo sapiens	IC50	nM	1941.0
	10894497	CHEMBL2034460	Inhibition of p38alpha kinase	B	COc1ccccc1C(=O)Nc1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031224	=	IC50	nM	108.0	CHEMBL260	Homo sapiens	IC50	nM	108.0
	10894498	CHEMBL2034460	Inhibition of p38alpha kinase	B	COc1cccc(C(=O)Nc2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)c1		CHEMBL2031225	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	nM	65.0
	10894499	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(C#N)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031226	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	10894500	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031227	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	10894501	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031228	=	IC50	nM	708.0	CHEMBL260	Homo sapiens	IC50	nM	708.0
	10894502	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccccc2F)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031229	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	10894503	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(F)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031230	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	10894504	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)C2CCOCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031231	=	IC50	nM	484.0	CHEMBL260	Homo sapiens	IC50	nM	484.0
	10894505	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)C2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031232	=	IC50	nM	155.0	CHEMBL260	Homo sapiens	IC50	nM	155.0
	10894506	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)C2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031233	=	IC50	nM	108.0	CHEMBL260	Homo sapiens	IC50	nM	108.0
	10894507	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccnc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031234	=	IC50	nM	525.0	CHEMBL260	Homo sapiens	IC50	nM	525.0
	10894508	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031235	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	10894509	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cscn2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031236	=	IC50	nM	181.0	CHEMBL260	Homo sapiens	IC50	nM	181.0
	10894510	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031237	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	nM	26.0
	10894511	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2029367	>	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	nM	2200.0
	10894512	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031238	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	10894513	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031239	=	IC50	nM	1535.0	CHEMBL260	Homo sapiens	IC50	nM	1535.0
	10894514	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031240	=	IC50	nM	347.0	CHEMBL260	Homo sapiens	IC50	nM	347.0
	10894515	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031241	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	nM	72.0
	10894516	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1csc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)n1		CHEMBL2031242	=	IC50	nM	276.0	CHEMBL260	Homo sapiens	IC50	nM	276.0
	10894517	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1cnc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)s1		CHEMBL2031243	>	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	nM	2200.0
	10894518	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2nncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031460	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	10894519	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2ccon2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031461	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
	10894520	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031462	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	10894521	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC2CCCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031463	=	IC50	nM	692.0	CHEMBL260	Homo sapiens	IC50	nM	692.0
	10894522	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031464	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	nM	54.0
	10894523	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031465	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	10894524	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC(C)C)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031466	=	IC50	nM	156.0	CHEMBL260	Homo sapiens	IC50	nM	156.0
	10894525	CHEMBL2034460	Inhibition of p38alpha kinase	B	CCNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031467	=	IC50	nM	83.0	CHEMBL260	Homo sapiens	IC50	nM	83.0
	10894526	CHEMBL2034460	Inhibition of p38alpha kinase	B	CNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031468	=	IC50	nM	437.0	CHEMBL260	Homo sapiens	IC50	nM	437.0
	10894527	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031469	=	IC50	nM	261.0	CHEMBL260	Homo sapiens	IC50	nM	261.0
	10894528	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL183630	=	IC50	nM	15.85	CHEMBL260	Homo sapiens	pIC50		7.8
	10894529	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031219	=	IC50	nM	26.3	CHEMBL260	Homo sapiens	pIC50		7.58
	10894530	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031220	=	IC50	nM	218.78	CHEMBL260	Homo sapiens	pIC50		6.66
	10894531	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031221	=	IC50	nM	89.13	CHEMBL260	Homo sapiens	pIC50		7.05
	10894532	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031222	=	IC50	nM	15.14	CHEMBL260	Homo sapiens	pIC50		7.82
	10894533	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031223	=	IC50	nM	1949.84	CHEMBL260	Homo sapiens	pIC50		5.71
	10894534	CHEMBL2034460	Inhibition of p38alpha kinase	B	COc1ccccc1C(=O)Nc1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031224	=	IC50	nM	83.18	CHEMBL260	Homo sapiens	pIC50		7.08
	10894535	CHEMBL2034460	Inhibition of p38alpha kinase	B	COc1cccc(C(=O)Nc2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)c1		CHEMBL2031225	=	IC50	nM	64.57	CHEMBL260	Homo sapiens	pIC50		7.19
	10894536	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(C#N)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031226	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	10894537	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031227	=	IC50	nM	16.6	CHEMBL260	Homo sapiens	pIC50		7.78
	10894538	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031228	=	IC50	nM	707.95	CHEMBL260	Homo sapiens	pIC50		6.15
	10894539	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccccc2F)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031229	=	IC50	nM	14.13	CHEMBL260	Homo sapiens	pIC50		7.85
	10894540	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccc(F)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031230	=	IC50	nM	28.84	CHEMBL260	Homo sapiens	pIC50		7.54
	10894541	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)C2CCOCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031231	=	IC50	nM	478.63	CHEMBL260	Homo sapiens	pIC50		6.32
	10894542	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)C2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031232	=	IC50	nM	154.88	CHEMBL260	Homo sapiens	pIC50		6.81
	10894543	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)C2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031233	=	IC50	nM	107.15	CHEMBL260	Homo sapiens	pIC50		6.97
	10894544	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cccnc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031234	=	IC50	nM	524.81	CHEMBL260	Homo sapiens	pIC50		6.28
	10894545	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031235	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	10894546	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cscn2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031236	=	IC50	nM	181.97	CHEMBL260	Homo sapiens	pIC50		6.74
	10894547	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2cncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031237	=	IC50	nM	25.7	CHEMBL260	Homo sapiens	pIC50		7.59
	10894835	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2029367	<	IC50	nM	2238.72	CHEMBL260	Homo sapiens	pIC50		5.65
	10894836	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031238	=	IC50	nM	8.913	CHEMBL260	Homo sapiens	pIC50		8.05
	10894837	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031239	=	IC50	nM	1548.82	CHEMBL260	Homo sapiens	pIC50		5.81
	10894838	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031240	=	IC50	nM	346.74	CHEMBL260	Homo sapiens	pIC50		6.46
	10894839	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031241	=	IC50	nM	72.44	CHEMBL260	Homo sapiens	pIC50		7.14
	10894840	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1csc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)n1		CHEMBL2031242	=	IC50	nM	275.42	CHEMBL260	Homo sapiens	pIC50		6.56
	10894841	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1cnc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)s1		CHEMBL2031243	<	IC50	nM	2238.72	CHEMBL260	Homo sapiens	pIC50		5.65
	10894842	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2nncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031460	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
	10894843	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2ccon2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031461	=	IC50	nM	6.607	CHEMBL260	Homo sapiens	pIC50		8.18
	10894844	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)Nc2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031462	=	IC50	nM	11.48	CHEMBL260	Homo sapiens	pIC50		7.94
	10894845	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC2CCCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031463	=	IC50	nM	691.83	CHEMBL260	Homo sapiens	pIC50		6.16
	10894846	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031464	=	IC50	nM	53.7	CHEMBL260	Homo sapiens	pIC50		7.27
	10894847	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031465	=	IC50	nM	15.85	CHEMBL260	Homo sapiens	pIC50		7.8
	10894848	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NC(C)C)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031466	=	IC50	nM	154.88	CHEMBL260	Homo sapiens	pIC50		6.81
	10894849	CHEMBL2034460	Inhibition of p38alpha kinase	B	CCNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031467	=	IC50	nM	83.18	CHEMBL260	Homo sapiens	pIC50		7.08
	10894850	CHEMBL2034460	Inhibition of p38alpha kinase	B	CNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031468	=	IC50	nM	436.52	CHEMBL260	Homo sapiens	pIC50		6.36
	10894851	CHEMBL2034460	Inhibition of p38alpha kinase	B	Cc1ccc(C(=O)NCC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031469	=	IC50	nM	263.03	CHEMBL260	Homo sapiens	pIC50		6.58
	10894852	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL183630	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	10894853	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031219	=	IC50	nM	420.0	CHEMBL260	Homo sapiens	IC50	uM	0.42
	10894854	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031220	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	10894855	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031221	=	IC50	nM	900.0	CHEMBL260	Homo sapiens	IC50	uM	0.9
	10894856	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031222	=	IC50	nM	640.0	CHEMBL260	Homo sapiens	IC50	uM	0.64
	10894857	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031223	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	10894858	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	COc1ccccc1C(=O)Nc1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031224	=	IC50	nM	1800.0	CHEMBL260	Homo sapiens	IC50	uM	1.8
	10894859	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	COc1cccc(C(=O)Nc2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)c1		CHEMBL2031225	=	IC50	nM	3400.0	CHEMBL260	Homo sapiens	IC50	uM	3.4
	10894860	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(C#N)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031226	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	10894861	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031227	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	10894862	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031228	=	IC50	nM	9100.0	CHEMBL260	Homo sapiens	IC50	uM	9.1
	10894863	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccccc2F)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031229	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	10894864	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(F)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031230	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	10894865	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)C2CCOCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031231	=	IC50	nM	4200.0	CHEMBL260	Homo sapiens	IC50	uM	4.2
	10894866	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)C2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031232	=	IC50	nM	2900.0	CHEMBL260	Homo sapiens	IC50	uM	2.9
	10894867	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)C2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031233	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	10894868	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccnc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031234	=	IC50	nM	9000.0	CHEMBL260	Homo sapiens	IC50	uM	9.0
	10894869	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031235	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	10894870	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cscn2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031236	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	10894871	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031237	=	IC50	nM	730.0	CHEMBL260	Homo sapiens	IC50	uM	0.73
	10894872	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2029367	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	10894873	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031238	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	10894874	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031239	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	uM	12.0
	10894875	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031240	=	IC50	nM	5400.0	CHEMBL260	Homo sapiens	IC50	uM	5.4
	10894876	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031241	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	uM	0.35
	10894877	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1csc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)n1		CHEMBL2031242	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	uM	12.0
	10894878	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1cnc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)s1		CHEMBL2031243	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	10894879	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2nncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031460	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	uM	2.0
	10894880	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2ccon2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031461	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	10894881	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031462	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	uM	0.041
	10894882	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC2CCCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031463	=	IC50	nM	11000.0	CHEMBL260	Homo sapiens	IC50	uM	11.0
	10894883	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031464	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	uM	0.44
	10894884	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031465	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	10894885	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC(C)C)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031466	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	10894886	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	CCNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031467	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	10894887	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	CNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031468	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	10894888	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NCC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031469	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	10894889	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL183630	=	IC50	nM	1258.93	CHEMBL260	Homo sapiens	pIC50		5.9
	10894890	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031219	=	IC50	nM	416.87	CHEMBL260	Homo sapiens	pIC50		6.38
	10894891	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031220	=	IC50	nM	3019.95	CHEMBL260	Homo sapiens	pIC50		5.52
	10894892	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031221	=	IC50	nM	912.01	CHEMBL260	Homo sapiens	pIC50		6.04
	10894893	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031222	=	IC50	nM	645.65	CHEMBL260	Homo sapiens	pIC50		6.19
	10894894	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031223	<	IC50	nM	50118.72	CHEMBL260	Homo sapiens	pIC50		4.3
	10894895	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	COc1ccccc1C(=O)Nc1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031224	=	IC50	nM	1819.7	CHEMBL260	Homo sapiens	pIC50		5.74
	10894896	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	COc1cccc(C(=O)Nc2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)c1		CHEMBL2031225	=	IC50	nM	3890.45	CHEMBL260	Homo sapiens	pIC50		5.41
	10894897	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(C#N)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031226	=	IC50	nM	1412.54	CHEMBL260	Homo sapiens	pIC50		5.85
	10894898	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031227	=	IC50	nM	181.97	CHEMBL260	Homo sapiens	pIC50		6.74
	10894899	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031228	=	IC50	nM	9120.11	CHEMBL260	Homo sapiens	pIC50		5.04
	10894900	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccccc2F)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031229	=	IC50	nM	501.19	CHEMBL260	Homo sapiens	pIC50		6.3
	10894901	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccc(F)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031230	=	IC50	nM	1202.26	CHEMBL260	Homo sapiens	pIC50		5.92
	10894902	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)C2CCOCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031231	=	IC50	nM	4168.69	CHEMBL260	Homo sapiens	pIC50		5.38
	10894903	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)C2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031232	=	IC50	nM	2884.03	CHEMBL260	Homo sapiens	pIC50		5.54
	10894904	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)C2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031233	=	IC50	nM	1023.29	CHEMBL260	Homo sapiens	pIC50		5.99
	10894905	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cccnc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031234	=	IC50	nM	8912.51	CHEMBL260	Homo sapiens	pIC50		5.05
	10894906	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031235	=	IC50	nM	109.65	CHEMBL260	Homo sapiens	pIC50		6.96
	10894907	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cscn2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031236	=	IC50	nM	1288.25	CHEMBL260	Homo sapiens	pIC50		5.89
	10894908	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2cncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031237	=	IC50	nM	741.31	CHEMBL260	Homo sapiens	pIC50		6.13
	10894909	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2029367	<	IC50	nM	50118.72	CHEMBL260	Homo sapiens	pIC50		4.3
	10894910	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031238	=	IC50	nM	112.2	CHEMBL260	Homo sapiens	pIC50		6.95
	10894911	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031239	=	IC50	nM	12022.64	CHEMBL260	Homo sapiens	pIC50		4.92
	10894912	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031240	=	IC50	nM	5370.32	CHEMBL260	Homo sapiens	pIC50		5.27
	10894913	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031241	=	IC50	nM	354.81	CHEMBL260	Homo sapiens	pIC50		6.45
	10894914	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1csc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)n1		CHEMBL2031242	=	IC50	nM	12302.69	CHEMBL260	Homo sapiens	pIC50		4.91
	10894915	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1cnc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)s1		CHEMBL2031243	<	IC50	nM	50118.72	CHEMBL260	Homo sapiens	pIC50		4.3
	10894916	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2nncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031460	=	IC50	nM	1995.26	CHEMBL260	Homo sapiens	pIC50		5.7
	10894917	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2ccon2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031461	=	IC50	nM	11.22	CHEMBL260	Homo sapiens	pIC50		7.95
	10894918	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)Nc2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031462	=	IC50	nM	40.74	CHEMBL260	Homo sapiens	pIC50		7.39
	10894919	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC2CCCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031463	=	IC50	nM	10964.78	CHEMBL260	Homo sapiens	pIC50		4.96
	10894920	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031464	=	IC50	nM	436.52	CHEMBL260	Homo sapiens	pIC50		6.36
	10894921	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031465	=	IC50	nM	27.54	CHEMBL260	Homo sapiens	pIC50		7.56
	10894922	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NC(C)C)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031466	=	IC50	nM	1445.44	CHEMBL260	Homo sapiens	pIC50		5.84
	10894923	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	CCNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031467	=	IC50	nM	162.18	CHEMBL260	Homo sapiens	pIC50		6.79
	10894924	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	CNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031468	=	IC50	nM	1288.25	CHEMBL260	Homo sapiens	pIC50		5.89
	10894925	CHEMBL2034461	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood	B	Cc1ccc(C(=O)NCC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031469	=	IC50	nM	2290.87	CHEMBL260	Homo sapiens	pIC50		5.64
	10894980	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL183630	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	10894981	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031219	=	IC50	nM	123.03	CHEMBL260	Homo sapiens	pIC50		6.91
	10894982	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031220	=	IC50	nM	407.38	CHEMBL260	Homo sapiens	pIC50		6.39
	10894983	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031221	=	IC50	nM	190.55	CHEMBL260	Homo sapiens	pIC50		6.72
	10894984	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031222	=	IC50	nM	30.2	CHEMBL260	Homo sapiens	pIC50		7.52
	10894985	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccccc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031223	=	IC50	nM	3388.44	CHEMBL260	Homo sapiens	pIC50		5.47
	10894986	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	COc1ccccc1C(=O)Nc1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031224	=	IC50	nM	89.13	CHEMBL260	Homo sapiens	pIC50		7.05
	10894987	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	COc1cccc(C(=O)Nc2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)c1		CHEMBL2031225	=	IC50	nM	295.12	CHEMBL260	Homo sapiens	pIC50		6.53
	10894988	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2cccc(C#N)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031226	=	IC50	nM	239.88	CHEMBL260	Homo sapiens	pIC50		6.62
	10894989	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031227	=	IC50	nM	34.67	CHEMBL260	Homo sapiens	pIC50		7.46
	10894990	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccc(C#N)cc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031228	=	IC50	nM	1318.26	CHEMBL260	Homo sapiens	pIC50		5.88
	10894991	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccccc2F)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031229	=	IC50	nM	56.23	CHEMBL260	Homo sapiens	pIC50		7.25
	10894992	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2cccc(F)c2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031230	=	IC50	nM	53.7	CHEMBL260	Homo sapiens	pIC50		7.27
	10894993	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)C2CCOCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031231	=	IC50	nM	1202.26	CHEMBL260	Homo sapiens	pIC50		5.92
	10894994	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)C2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031232	=	IC50	nM	537.03	CHEMBL260	Homo sapiens	pIC50		6.27
	10894995	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)C2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031233	=	IC50	nM	213.8	CHEMBL260	Homo sapiens	pIC50		6.67
	10894996	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2cccnc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031234	=	IC50	nM	1348.96	CHEMBL260	Homo sapiens	pIC50		5.87
	10894997	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031235	=	IC50	nM	20.42	CHEMBL260	Homo sapiens	pIC50		7.69
	10894998	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2cscn2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031236	=	IC50	nM	218.78	CHEMBL260	Homo sapiens	pIC50		6.66
	10894999	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2cncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031237	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
	10895000	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2029367	=	IC50	nM	7413.1	CHEMBL260	Homo sapiens	pIC50		5.13
	10895001	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031238	=	IC50	nM	15.85	CHEMBL260	Homo sapiens	pIC50		7.8
	10895002	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(NC(=O)c2ccoc2)cc1-n1c(C)nc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031239	=	IC50	nM	1621.81	CHEMBL260	Homo sapiens	pIC50		5.79
	10895003	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)Nc2ccccc2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031240	=	IC50	nM	398.11	CHEMBL260	Homo sapiens	pIC50		6.4
	10895004	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)Nc2nccs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031241	=	IC50	nM	81.28	CHEMBL260	Homo sapiens	pIC50		7.09
	10895005	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1csc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)n1		CHEMBL2031242	=	IC50	nM	1258.93	CHEMBL260	Homo sapiens	pIC50		5.9
	10895006	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1cnc(NC(=O)c2ccc(C)c(-n3cnc4ccc(N5CCN(C)CC5)cc4c3=O)c2)s1		CHEMBL2031243	=	IC50	nM	5011.87	CHEMBL260	Homo sapiens	pIC50		5.3
	10895007	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)Nc2nncs2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031460	=	IC50	nM	346.74	CHEMBL260	Homo sapiens	pIC50		6.46
	10895008	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)Nc2ccon2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031461	=	IC50	nM	4.677	CHEMBL260	Homo sapiens	pIC50		8.33
	10895009	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)Nc2ccno2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031462	=	IC50	nM	8.128	CHEMBL260	Homo sapiens	pIC50		8.09
	10895010	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)NC2CCCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031463	=	IC50	nM	4570.88	CHEMBL260	Homo sapiens	pIC50		5.34
	10895011	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)NC2CCC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031464	=	IC50	nM	208.93	CHEMBL260	Homo sapiens	pIC50		6.68
	10895012	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031465	=	IC50	nM	17.38	CHEMBL260	Homo sapiens	pIC50		7.76
	10895013	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)NC(C)C)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031466	=	IC50	nM	794.33	CHEMBL260	Homo sapiens	pIC50		6.1
	10895014	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	CCNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031467	=	IC50	nM	107.15	CHEMBL260	Homo sapiens	pIC50		6.97
	10895015	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	CNC(=O)c1ccc(C)c(-n2cnc3ccc(N4CCN(C)CC4)cc3c2=O)c1		CHEMBL2031468	=	IC50	nM	660.69	CHEMBL260	Homo sapiens	pIC50		6.18
	10895016	CHEMBL2034480	Inhibition of p38alpha-mediated TNFalpha secretion in LPS-stimulated human whole blood assessed as IC50 equals to free drug concentration at human whole blood IC50	B	Cc1ccc(C(=O)NCC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031469	=	IC50	nM	1288.25	CHEMBL260	Homo sapiens	pIC50		5.89
	10923982	CHEMBL2044305	Inhibition of p38alpha at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	10925125	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)oc2ccccc12		CHEMBL2041956	=	IC50	nM	813.0	CHEMBL260	Homo sapiens	IC50	nM	813.0
	10925126	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(Cl)c2)oc2ccccc12		CHEMBL2041957	=	IC50	nM	1380.0	CHEMBL260	Homo sapiens	IC50	nM	1380.0
	10925127	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	10925128	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	CCCCNc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041959	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	10925129	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	COCCCNc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041960	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	nM	39.0
	10925130	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	CN(C)CCCNc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041961	=	IC50	nM	761.0	CHEMBL260	Homo sapiens	IC50	nM	761.0
	10925131	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	10925132	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCOCC3)c2)oc2ccccc12		CHEMBL2041963	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	10925133	CHEMBL2046097	Inhibition of p38alpha MAPK after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NCc3ccccc3)c2)oc2ccccc12		CHEMBL2042121	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	10926148	CHEMBL2046223	Inhibition of human SAPK2a assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	-3.0	CHEMBL260	Homo sapiens	Activity	%	-3.0
	10926149	CHEMBL2046223	Inhibition of human SAPK2a assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	-1.0	CHEMBL260	Homo sapiens	Activity	%	-1.0
Active	10926160	CHEMBL2045336	Inhibition of anisomycin-induced p38alpha MAPK signalling in human MCF7 cells assessed as inhibition of ATF2 activation at 0.5 uM after 30 mins by SDS PAGE analysis	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	10926161	CHEMBL2045337	Inhibition of anisomycin-induced p38alpha MAPK signalling in human MCF7 cells assessed as inhibition of HSP27 activation at 0.5 uM after 30 mins by SDS PAGE analysis	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	10926162	CHEMBL2045338	Inhibition of anisomycin-induced p38alpha MAPK signalling in human MCF7 cells assessed as inhibition of ATF2 activation at 10 uM after 30 mins by SDS PAGE analysis	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962		Imax			CHEMBL260	Homo sapiens	Imax		
Active	10926163	CHEMBL2045339	Inhibition of anisomycin-induced p38alpha MAPK signalling in human MCF7 cells assessed as inhibition of HSP27 activation at 10 uM after 30 mins by SDS PAGE analysis	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962		Imax			CHEMBL260	Homo sapiens	Imax		
Active	10926176	CHEMBL2045347	Inhibition of p38alpha phosphorylation in human MCF7 cells at 0.5 to 10 uM after 30 mins by SDS PAGE analysis	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	10949921	CHEMBL2049453	Inhibition of N-terminus FLAG-tagged p38alpha expressed in baculovirus expression system using [gamma-33P]-ATP measured after 60 mins by scintillation counting	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	10953255	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cc(F)cc(N3CCCC3)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL184712	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	10953256	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL184721	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	10953257	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1NC(=O)c1ccc(OCc2cscn2)cc1		CHEMBL183630	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	10953258	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(OC(C)C)cc1		CHEMBL365472	=	IC50	nM	166.0	CHEMBL260	Homo sapiens	IC50	uM	0.166
	10953259	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL366255	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	uM	0.051
	10953260	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2nc3ccccc3[nH]2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059859	=	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	10953261	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2c[nH]cn2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059860	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	10953262	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2nccn2C)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059861	=	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	10953263	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ncc(C)n2C)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059862	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	10953264	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ncc(C(F)(F)F)[nH]2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059863	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	uM	12.0
	10953265	CHEMBL2060772	Inhibition of p38alpha	B	Cc1cnc(-c2ccc(C)c(NC(=O)c3ccc(OCc4ccccn4)cc3)c2)[nH]1		CHEMBL2059864	=	IC50	nM	5900.0	CHEMBL260	Homo sapiens	IC50	uM	5.9
	10953266	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ncc[nH]2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059865	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	uM	2.7
	10953267	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2cn(C)cn2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059866	=	IC50	nM	19000.0	CHEMBL260	Homo sapiens	IC50	uM	19.0
	10953268	CHEMBL2060772	Inhibition of p38alpha	B	Cc1nc(-c2ccc(C)c(NC(=O)c3ccc(OCc4ccccn4)cc3)c2)c[nH]1		CHEMBL2059867	=	IC50	nM	36000.0	CHEMBL260	Homo sapiens	IC50	uM	36.0
	10953269	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2[nH]cnc2C)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059868	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	10953270	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2cn(C)c(C)n2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059869	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	10953271	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2c(C)nn(C)c2C)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059870	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	10953272	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2cc(C(F)(F)F)n[nH]2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059871	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	10953273	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ncc(CN3CCOCC3)s2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059872	=	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	10953274	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2nccs2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059873	=	IC50	nM	14000.0	CHEMBL260	Homo sapiens	IC50	uM	14.0
	10953275	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ccccn2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059875	=	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	10953276	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ccncc2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059876	=	IC50	nM	22000.0	CHEMBL260	Homo sapiens	IC50	uM	22.0
	10953277	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ccc(N)nn2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2057336	=	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	10953278	CHEMBL2060772	Inhibition of p38alpha	B	Cc1ccc(-c2ncnc3nc[nH]c23)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2057337	=	IC50	nM	3500.0	CHEMBL260	Homo sapiens	IC50	uM	3.5
Not Active	10953940	CHEMBL2060780	Inhibition of p38alpha at 50 uM by whole blood cell assay	B	Cc1ccc(-c2ncc[nH]2)cc1NC(=O)c1ccc(OCc2ccccn2)cc1		CHEMBL2059865		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	10960306	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	10960307	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2ccccc2O)cc1		CHEMBL2058043	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	10960308	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2ccccc2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058044	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	10960309	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2ccccc2Oc2ccnc(N3CCCCC3)n2)cc1		CHEMBL2058045	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	10960310	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2ccccc2Oc2ccnc(Cl)n2)cc1		CHEMBL2058046	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	10960311	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058047	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	10960312	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(Cl)ccc2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058048	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	10960313	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(C)ccc2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058049	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	10960314	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(C(F)(F)F)ccc2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058050	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	uM	0.035
	10960315	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)cc(F)c2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058051	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	10960316	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)cc(Cl)c2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058052	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	10960317	CHEMBL2061259	Inhibition of human recombinant P38alpha-mediated ATF2 phosphorylation after 1 hr	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)cc(C)c2Oc2ccnc(N3CCOCC3)n2)cc1		CHEMBL2058053	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	10978452	CHEMBL2066255	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ulight-CFFKNIVTPRTPPPSQGK amide as substrate assessed as residual activity at 1 uM after 60 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL260	Homo sapiens	Activity	%	80.0
Not Active	10986939	CHEMBL2072243	Inhibition of SAPK2a at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	10990845	CHEMBL2071840	Inhibition of MAPK p38alpha	B	CCOc1ccc(-c2cc(-c3cnc(NC(C)C)s3)nc(-c3ccccn3)n2)c(Cl)c1		CHEMBL2070489	=	IC50	nM	3940.0	CHEMBL260	Homo sapiens	IC50	nM	3940.0
	10990846	CHEMBL2071840	Inhibition of MAPK p38alpha	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258633	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	10990847	CHEMBL2071840	Inhibition of MAPK p38alpha	B	CCOc1ccc(-c2cc(-c3cnc(NC(C)C)s3)nc(-c3ccccc3F)n2)c(Cl)c1		CHEMBL2070490	=	IC50	nM	590.0	CHEMBL260	Homo sapiens	IC50	nM	590.0
	10990848	CHEMBL2071840	Inhibition of MAPK p38alpha	B	CCOc1ccc(-c2cc(-c3cnc(NC(C)C)s3)nc(-c3cnccn3)n2)c(Cl)c1		CHEMBL2070491	=	IC50	nM	1999.0	CHEMBL260	Homo sapiens	IC50	nM	1999.0
Not Active	10990933	CHEMBL2071858	Binding affinity to human p38alpha	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615		Activity			CHEMBL260	Homo sapiens	Activity		
	10991127	CHEMBL2072946	Inhibition of human p38alpha using myelin basic protein as substrate after 180 mins	B	COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070045	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	10991128	CHEMBL2072946	Inhibition of human p38alpha using myelin basic protein as substrate after 180 mins	B	COc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070047	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	10991129	CHEMBL2072946	Inhibition of human p38alpha using myelin basic protein as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070048	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	10991130	CHEMBL2072946	Inhibition of human p38alpha using myelin basic protein as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070050	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	10991131	CHEMBL2072946	Inhibition of human p38alpha using myelin basic protein as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2n1.Cl		CHEMBL2070051	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	10991132	CHEMBL2072946	Inhibition of human p38alpha using myelin basic protein as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(C4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070075	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	10991133	CHEMBL2072946	Inhibition of human p38alpha using myelin basic protein as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070081	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	10995984	CHEMBL2073529	Inhibition of MAPK p38alpha	B	NC(=O)c1ccc(Oc2ccc(/C=C3\SC(=S)N(c4ccc(OCCCN5CCCC5)cc4)C3=O)cc2)cc1		CHEMBL2070416	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	10995985	CHEMBL2073529	Inhibition of MAPK p38alpha	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5cccc(C(N)=O)c5)cc4)SC3=S)cc2)CC1		CHEMBL2070412	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	10995986	CHEMBL2073529	Inhibition of MAPK p38alpha	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(C(N)=O)cc5)cc4)SC3=S)cc2)CC1		CHEMBL2070413	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	11023336	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	nM	480.0
	11023337	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	594.0	CHEMBL260	Homo sapiens	IC50	nM	594.0
	11023338	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088224	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023339	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088223	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023340	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088222	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023341	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2sc(NCc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL2088221	=	IC50	nM	8820.0	CHEMBL260	Homo sapiens	IC50	nM	8820.0
	11023342	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(C(N)=O)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088220	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023343	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(C(N)=O)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088219	=	IC50	nM	6190.0	CHEMBL260	Homo sapiens	IC50	nM	6190.0
	11023344	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1cc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc(OC)c1		CHEMBL2088218	=	IC50	nM	7990.0	CHEMBL260	Homo sapiens	IC50	nM	7990.0
	11023345	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1OC		CHEMBL2088217	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023346	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1OC		CHEMBL2088216	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023347	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cc(C)cc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2088215	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023348	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(C)c3C)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088214	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023349	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cc(Cl)cc(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2088213	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023350	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(Cl)c(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087986	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023351	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(Cl)c3Cl)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087985	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023352	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cc(F)cc(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087984	=	IC50	nM	3820.0	CHEMBL260	Homo sapiens	IC50	nM	3820.0
	11023353	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(F)c(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087983	=	IC50	nM	3580.0	CHEMBL260	Homo sapiens	IC50	nM	3580.0
	11023354	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(F)c3F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087982	=	IC50	nM	7200.0	CHEMBL260	Homo sapiens	IC50	nM	7200.0
	11023355	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3OC(F)(F)F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087981	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023356	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3C)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087980	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023357	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3Cl)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087979	=	IC50	nM	5860.0	CHEMBL260	Homo sapiens	IC50	nM	5860.0
	11023358	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3F)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087978	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023359	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(C#N)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087977	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023360	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(OC(F)(F)F)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087976	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023361	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1		CHEMBL2087975	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023362	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1ccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)cc1		CHEMBL2087974	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023363	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(Cl)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087973	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023364	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccc(F)cc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087972	=	IC50	nM	9200.0	CHEMBL260	Homo sapiens	IC50	nM	9200.0
	11023365	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(C#N)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087971	=	IC50	nM	3780.0	CHEMBL260	Homo sapiens	IC50	nM	3780.0
	11023366	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(OC(F)(F)F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087970	=	IC50	nM	7390.0	CHEMBL260	Homo sapiens	IC50	nM	7390.0
	11023367	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	COc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2087969	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	11023368	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(CNc2nc(-c3cccc(C)n3)c(-c3ccc4ncnn4c3)s2)c1		CHEMBL2087968	=	IC50	nM	5370.0	CHEMBL260	Homo sapiens	IC50	nM	5370.0
	11023369	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(Cl)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087967	=	IC50	nM	3280.0	CHEMBL260	Homo sapiens	IC50	nM	3280.0
	11023370	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3cccc(F)c3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087966	=	IC50	nM	3530.0	CHEMBL260	Homo sapiens	IC50	nM	3530.0
	11023371	CHEMBL2091129	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as a substrate by radioisotopic protein kinase assay	B	Cc1cccc(-c2nc(NCc3ccccc3)sc2-c2ccc3ncnn3c2)n1		CHEMBL2087965	=	IC50	nM	5530.0	CHEMBL260	Homo sapiens	IC50	nM	5530.0
	12036438	CHEMBL2150409	Inhibition of N-terminal FLAG-tagged p38alpha expressed in baculovirus after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	12047285	CHEMBL2157310	Inhibition of p38alpha at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-1.6	CHEMBL260	Homo sapiens	INH	%	-1.6
	12047410	CHEMBL2157246	Inhibition of p38alpha at 1 uM by direct inhibition assay	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	6.4	CHEMBL260	Homo sapiens	INH	%	6.4
	12047420	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3N)cc1CC2		CHEMBL2152777	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047421	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2152778	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047422	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3N)cc1CC2		CHEMBL2152779	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047423	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3OC)cc1CC2		CHEMBL2152780	=	IC50	nM	380.0	CHEMBL260	Homo sapiens	IC50	uM	0.38
	12047424	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3Cl)cc1CC2		CHEMBL2152781	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	uM	0.56
	12047425	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3C(F)(F)F)cc1CC2		CHEMBL2152782	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	12047426	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3F)cc1CC2		CHEMBL2152783	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	12047427	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3)cc1CC2		CHEMBL2152784	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	12047428	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3Cl)cc1CC2		CHEMBL2152785	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047429	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3C)cc1CC2		CHEMBL2152786	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	12047430	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C(F)(F)F)cc3N)cc1CC2		CHEMBL2152787	=	IC50	nM	900.0	CHEMBL260	Homo sapiens	IC50	uM	0.9
	12047431	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C)c3)cc1CC2		CHEMBL2152788	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047432	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)cc(F)c3F)cc1CC2		CHEMBL2152789	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	12047433	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(F)c3F)cc1CC2		CHEMBL2152790	=	IC50	nM	3530.0	CHEMBL260	Homo sapiens	IC50	uM	3.53
	12047434	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(O)cc21		CHEMBL2152793	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047435	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccccc3Cl)cc2CCc2ccc(O)cc21		CHEMBL2152794	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	12047436	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3Cl)cc2CCc2ccc(O)cc21		CHEMBL2152795	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	uM	0.56
	12047437	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccccc3)cc2CCc2ccc(O)cc21		CHEMBL2152796	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	12047438	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=c1c2ccc(Nc3ccc(F)cc3F)cc2ccc2ccc(O)cc12		CHEMBL2152797	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	12047439	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152798	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	12047440	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL2152936	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047441	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152937	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	12047442	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@@H](O)CO)cc1C2=O		CHEMBL2152938	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	12047443	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	Nc1ccccc1Nc1ccc2c(=O)c3cc(OCCN4CCOCC4)ccc3ccc2c1		CHEMBL2152939	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	12047444	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12047445	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	12047446	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC3CCOCC3)cc21		CHEMBL2152942	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	12047447	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152943	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047448	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	12047449	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152945	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047450	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	12047451	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152947	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12047452	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCC[C@@H](O)CO)cc21		CHEMBL2152948	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12047453	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCN3CCOCC3)cc21		CHEMBL2152949	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12047454	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCN3CCOCC3)cc21		CHEMBL2152950	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	12047455	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(Oc3ccc(F)cc3F)cc1CC2		CHEMBL2152951	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	12047456	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Oc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152952	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047457	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Oc3ccc(F)cc3F)cc2CCc2ccc(OCCN3CCOCC3)cc21		CHEMBL2152953	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047458	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047459	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152954	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047460	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OCCO)ccc21		CHEMBL2152955	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047461	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OCCCO)ccc21		CHEMBL2152956	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	12047462	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152957	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047463	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@H](O)CO)ccc21		CHEMBL2152958	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	12047464	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152959	=	IC50	nM	360.0	CHEMBL260	Homo sapiens	IC50	uM	0.36
	12047465	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@@H](O)CO)ccc21		CHEMBL2152960	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	12047466	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OCCN3CCOCC3)ccc21		CHEMBL2152961	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047467	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1ccc2c(c1)CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152962	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	12047468	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152963	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047469	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	Nc1ccccc1Nc1ccc2c(c1)CCc1cc(OC[C@H](O)CO)ccc1C2=O		CHEMBL2152964	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	12047470	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1cccc2c1CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152965	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047471	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(O)cccc21		CHEMBL2152966	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047472	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c1cccc2C1CCOCC1		CHEMBL2152967	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	12047473	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152968	=	IC50	nM	440.0	CHEMBL260	Homo sapiens	IC50	uM	0.44
	12047474	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OC[C@H](O)CO)cccc21		CHEMBL2152969	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12047475	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21		CHEMBL2152970	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	12047476	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	COc1cccc2c1CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152971	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047477	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152972	=	IC50	nM	1040.0	CHEMBL260	Homo sapiens	IC50	uM	1.04
	12047478	CHEMBL2155531	Inhibition of p38alpha by immunosorbent based kinase assay	B	Nc1ccccc1Nc1ccc2c(c1)CCc1c(OC[C@H](O)CO)cccc1C2=O		CHEMBL2152973	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047479	CHEMBL2155532	Inhibition of p38alpha at 10 uM by immunosorbent based kinase assay	B	COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2		CHEMBL2152791	=	Inhibition	%	32.0	CHEMBL260	Homo sapiens	INH	%	32.0
	12047480	CHEMBL2155532	Inhibition of p38alpha at 10 uM by immunosorbent based kinase assay	B	COc1ccc2ccc3cc(Nc4ccc(F)cc4F)ccc3c(=O)c2c1		CHEMBL2152792	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	INH	%	21.0
	12047481	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3N)cc1CC2		CHEMBL2152777	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	12047482	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2152778	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	12047483	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3N)cc1CC2		CHEMBL2152779	=	IC50	nM	1900.0	CHEMBL260	Homo sapiens	IC50	uM	1.9
	12047484	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3OC)cc1CC2		CHEMBL2152780	=	IC50	nM	7600.0	CHEMBL260	Homo sapiens	IC50	uM	7.6
	12047485	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3Cl)cc1CC2		CHEMBL2152781	=	IC50	nM	4600.0	CHEMBL260	Homo sapiens	IC50	uM	4.6
	12047486	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3C(F)(F)F)cc1CC2		CHEMBL2152782	=	IC50	nM	33600.0	CHEMBL260	Homo sapiens	IC50	uM	33.6
	12047487	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3F)cc1CC2		CHEMBL2152783	=	IC50	nM	4900.0	CHEMBL260	Homo sapiens	IC50	uM	4.9
	12047488	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3)cc1CC2		CHEMBL2152784	=	IC50	nM	3200.0	CHEMBL260	Homo sapiens	IC50	uM	3.2
	12047489	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3Cl)cc1CC2		CHEMBL2152785	=	IC50	nM	5400.0	CHEMBL260	Homo sapiens	IC50	uM	5.4
	12047490	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3C)cc1CC2		CHEMBL2152786	=	IC50	nM	3900.0	CHEMBL260	Homo sapiens	IC50	uM	3.9
	12047491	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C(F)(F)F)cc3N)cc1CC2		CHEMBL2152787	=	IC50	nM	25500.0	CHEMBL260	Homo sapiens	IC50	uM	25.5
	12047492	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C)c3)cc1CC2		CHEMBL2152788	=	IC50	nM	1900.0	CHEMBL260	Homo sapiens	IC50	uM	1.9
	12047493	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)cc(F)c3F)cc1CC2		CHEMBL2152789	=	IC50	nM	4300.0	CHEMBL260	Homo sapiens	IC50	uM	4.3
	12047494	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(F)c3F)cc1CC2		CHEMBL2152790	=	IC50	nM	81000.0	CHEMBL260	Homo sapiens	IC50	uM	81.0
Not Determined	12047495	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2		CHEMBL2152791		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	12047496	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2ccc3cc(Nc4ccc(F)cc4F)ccc3c(=O)c2c1		CHEMBL2152792		IC50			CHEMBL260	Homo sapiens	IC50		
	12047497	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(O)cc21		CHEMBL2152793	=	IC50	nM	700.0	CHEMBL260	Homo sapiens	IC50	uM	0.7
	12047498	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccccc3Cl)cc2CCc2ccc(O)cc21		CHEMBL2152794	=	IC50	nM	7500.0	CHEMBL260	Homo sapiens	IC50	uM	7.5
	12047499	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3Cl)cc2CCc2ccc(O)cc21		CHEMBL2152795	=	IC50	nM	3800.0	CHEMBL260	Homo sapiens	IC50	uM	3.8
	12047500	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccccc3)cc2CCc2ccc(O)cc21		CHEMBL2152796	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	12047501	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=c1c2ccc(Nc3ccc(F)cc3F)cc2ccc2ccc(O)cc12		CHEMBL2152797	=	IC50	nM	26700.0	CHEMBL260	Homo sapiens	IC50	uM	26.7
	12047502	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152798	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	12047503	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL2152936	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047504	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152937	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	12047505	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@@H](O)CO)cc1C2=O		CHEMBL2152938	=	IC50	nM	170.0	CHEMBL260	Homo sapiens	IC50	uM	0.17
	12047506	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	Nc1ccccc1Nc1ccc2c(=O)c3cc(OCCN4CCOCC4)ccc3ccc2c1		CHEMBL2152939	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	12047507	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	12047508	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	12047509	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC3CCOCC3)cc21		CHEMBL2152942	=	IC50	nM	530.0	CHEMBL260	Homo sapiens	IC50	uM	0.53
	12047510	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152943	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	12047511	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12047512	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152945	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	12047513	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	uM	0.06
	12047514	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152947	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	12047515	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCC[C@@H](O)CO)cc21		CHEMBL2152948	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047516	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCN3CCOCC3)cc21		CHEMBL2152949	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047517	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCN3CCOCC3)cc21		CHEMBL2152950	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	uM	0.08
	12047518	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Oc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152952	=	IC50	nM	6700.0	CHEMBL260	Homo sapiens	IC50	uM	6.7
	12047519	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Oc3ccc(F)cc3F)cc2CCc2ccc(OCCN3CCOCC3)cc21		CHEMBL2152953	=	IC50	nM	4500.0	CHEMBL260	Homo sapiens	IC50	uM	4.5
	12047520	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	uM	2.0
	12047521	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152954	=	IC50	nM	10200.0	CHEMBL260	Homo sapiens	IC50	uM	10.2
	12047522	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OCCO)ccc21		CHEMBL2152955	=	IC50	nM	4700.0	CHEMBL260	Homo sapiens	IC50	uM	4.7
	12047523	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OCCCO)ccc21		CHEMBL2152956	=	IC50	nM	19500.0	CHEMBL260	Homo sapiens	IC50	uM	19.5
	12047524	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1	Outside typical range	CHEMBL2152957	=	IC50	nM	170000.0	CHEMBL260	Homo sapiens	IC50	uM	170.0
	12047525	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@H](O)CO)ccc21		CHEMBL2152958	=	IC50	nM	10400.0	CHEMBL260	Homo sapiens	IC50	uM	10.4
	12047526	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1	Outside typical range	CHEMBL2152959	=	IC50	nM	123000.0	CHEMBL260	Homo sapiens	IC50	uM	123.0
	12047527	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@@H](O)CO)ccc21		CHEMBL2152960	=	IC50	nM	5200.0	CHEMBL260	Homo sapiens	IC50	uM	5.2
	12047528	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OCCN3CCOCC3)ccc21		CHEMBL2152961	=	IC50	nM	40000.0	CHEMBL260	Homo sapiens	IC50	uM	40.0
	12047529	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1ccc2c(c1)CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152962	=	IC50	nM	12300.0	CHEMBL260	Homo sapiens	IC50	uM	12.3
	12047530	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152963	=	IC50	nM	93600.0	CHEMBL260	Homo sapiens	IC50	uM	93.6
	12047531	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	Nc1ccccc1Nc1ccc2c(c1)CCc1cc(OC[C@H](O)CO)ccc1C2=O		CHEMBL2152964	=	IC50	nM	6000.0	CHEMBL260	Homo sapiens	IC50	uM	6.0
	12047532	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1cccc2c1CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152965	=	IC50	nM	78700.0	CHEMBL260	Homo sapiens	IC50	uM	78.7
	12047533	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(O)cccc21		CHEMBL2152966	=	IC50	nM	37300.0	CHEMBL260	Homo sapiens	IC50	uM	37.3
	12047534	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c1cccc2C1CCOCC1		CHEMBL2152967	=	IC50	nM	87200.0	CHEMBL260	Homo sapiens	IC50	uM	87.2
	12047535	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OC[C@H](O)CO)cccc21		CHEMBL2152969	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	12047536	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21	Outside typical range	CHEMBL2152970	=	IC50	nM	200000.0	CHEMBL260	Homo sapiens	IC50	uM	200.0
	12047537	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	COc1cccc2c1CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152971	=	IC50	nM	52100.0	CHEMBL260	Homo sapiens	IC50	uM	52.1
	12047538	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccccc4N)ccc2C3=O)O1	Outside typical range	CHEMBL2152972	=	IC50	nM	158000.0	CHEMBL260	Homo sapiens	IC50	uM	158.0
	12047539	CHEMBL2155533	Inhibition of p38alpha-dependent TNFalpha production in human whole blood	B	Nc1ccccc1Nc1ccc2c(c1)CCc1c(OC[C@H](O)CO)cccc1C2=O		CHEMBL2152973	=	IC50	nM	78800.0	CHEMBL260	Homo sapiens	IC50	uM	78.8
	12047540	CHEMBL2155534	Inhibition of p38alpha-dependent TNFalpha production in human whole blood at 100 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152968	=	Inhibition	%	40.0	CHEMBL260	Homo sapiens	INH	%	40.0
	12051569	CHEMBL2154709	Inhibition of SAPK2a	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	=	IC50	nM	13.4	CHEMBL260	Homo sapiens	IC50	nM	13.4
	12051591	CHEMBL2154970	Inhibition of SAPK2a at 10 uM	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	>	Inhibition	%	30.0	CHEMBL260	Homo sapiens	INH	%	30.0
Not Determined	12053148	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	C[C@@H]1[C@H](c2ccc3c(c2)OCO3)O[C@@H](c2ccc3c(c2)OCO3)[C@@H]1C		CHEMBL1980140		IC50			CHEMBL260	Homo sapiens	IC50		
	12053149	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	C[C@@H]1[C@@H](c2ccc3c(c2)OCO3)O[C@H](c2ccc3c(c2)OCO3)[C@@H]1C	Outside typical range	CHEMBL2151191	=	IC50	nM	252000.0	CHEMBL260	Homo sapiens	IC50	uM	252.0
	12053150	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	N=C1NC2C(/N=N/c3ccc(Br)cc3)C(=N)NN2c2[nH][nH]c(=N)c21		CHEMBL2151192	=	IC50	nM	60000.0	CHEMBL260	Homo sapiens	IC50	uM	60.0
	12053151	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	COc1ccc(-c2nnc3sc4c5ccccc5ccc4n23)cc1		CHEMBL2151193	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
Not Active	12053152	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	NC(=S)N/N=C1\NC(=O)/C(=C/c2ccc3c(c2)OCO3)S1		CHEMBL1969923		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active	12053153	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	COc1cccc(C2c3cc4c(cc3OC(NCCO)C2C)OCO4)c1OC		CHEMBL1981814		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active	12053154	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	O=C(Nc1ncc([N+](=O)[O-])s1)c1cccc([N+](=O)[O-])c1		CHEMBL1492532		IC50			CHEMBL260	Homo sapiens	IC50		
	12053155	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	O=C(CC(C(=O)O)c1ccc2c(c1)OCO2)c1ccc2c(c1)OCO2	Outside typical range	CHEMBL2000337	=	IC50	nM	197000.0	CHEMBL260	Homo sapiens	IC50	uM	197.0
Not Active	12053156	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	O=C1OC(CN2CCOCC2)CN1/N=C/c1ccc([N+](=O)[O-])o1		CHEMBL1189513		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active	12053157	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	Cc1ccc(/N=N/c2c(=N)[nH]n3cc4c(nc23)CCCC4)cc1		CHEMBL2151285		IC50			CHEMBL260	Homo sapiens	IC50		
Not Active	12053158	CHEMBL2155146	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	COc1ccc(/N=N/c2c(=N)[nH]n3cc4c(nc23)CCC4)cc1		CHEMBL2151286		IC50			CHEMBL260	Homo sapiens	IC50		
	12053159	CHEMBL2155147	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate at saturating concentration preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	C[C@@H]1[C@@H](c2ccc3c(c2)OCO3)O[C@H](c2ccc3c(c2)OCO3)[C@@H]1C		CHEMBL2151191	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	12053160	CHEMBL2155147	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate at saturating concentration preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	N=C1NC2C(/N=N/c3ccc(Br)cc3)C(=N)NN2c2[nH][nH]c(=N)c21		CHEMBL2151192	=	Inhibition	%	57.0	CHEMBL260	Homo sapiens	INH	%	57.0
	12053161	CHEMBL2155147	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate at saturating concentration preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	COc1ccc(-c2nnc3sc4c5ccccc5ccc4n23)cc1		CHEMBL2151193	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	INH	%	24.0
	12053162	CHEMBL2155147	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate at saturating concentration preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting	B	O=C(CC(C(=O)O)c1ccc2c(c1)OCO2)c1ccc2c(c1)OCO2		CHEMBL2000337	=	Inhibition	%	25.0	CHEMBL260	Homo sapiens	INH	%	25.0
	12053163	CHEMBL2155148	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting in presence of 100 units/mL of catalase	B	Cn1nc(-c2ccc3c(c2)OCO3)nc2c(=O)n(C)c(=O)nc1-2		CHEMBL2151190	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	12053164	CHEMBL2155149	Inhibition of p38MAPKalpha using GST-ATF2 (1 to 115) as substrate at saturating concentration preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting in presence of 100 units/mL of catalase	B	Cn1nc(-c2ccc3c(c2)OCO3)nc2c(=O)n(C)c(=O)nc1-2		CHEMBL2151190	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	12060932	CHEMBL2157035	Binding affinity to P38alpha at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	12074703	CHEMBL2161424	Inhibition of SAPK2alpha at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	12094400	CHEMBL2166390	Inhibition of human p38alpha at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	12094411	CHEMBL2166178	Inhibition of P38alpha	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163999	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	12133447	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(C(=O)Nc2cccc(Nc3ccc4c(c3)OCc3ccccc3C4=O)c2)s1		CHEMBL2182066	=	IC50	nM	6800.0	CHEMBL260	Homo sapiens	IC50	uM	6.8
	12133448	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccccc1C2=O		CHEMBL2182090	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	12133449	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccccc2C3=O)ccc1F)c1ccsc1		CHEMBL2182089	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12133450	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)cc1NC(=O)c1ccsc1		CHEMBL2182088	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	12133451	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1)c1ccsc1		CHEMBL2182087	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12133452	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1)c1ccoc1		CHEMBL2182086	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12133453	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)CCCCC2=O		CHEMBL2182085	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12133454	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccsc1		CHEMBL2182084	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	12133455	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)CCCCC2=O		CHEMBL2182083	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	12133456	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1)c1ccsc1		CHEMBL2182082	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	12133457	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccoc1		CHEMBL2182081	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	uM	0.032
	12133458	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1)c1ccco1		CHEMBL2182080	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	12133459	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C1CCCCc2cc(Nc3cccc(NC(=O)C4CC4)c3)ccc21		CHEMBL2182079	=	IC50	nM	990.0	CHEMBL260	Homo sapiens	IC50	uM	0.99
	12133460	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(CCc1ccccc1)Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F		CHEMBL2182078	=	IC50	nM	4400.0	CHEMBL260	Homo sapiens	IC50	uM	4.4
	12133461	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Cc1ccccc1)Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F		CHEMBL2182076	=	IC50	nM	3300.0	CHEMBL260	Homo sapiens	IC50	uM	3.3
	12133462	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1ccsc1		CHEMBL2182074	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12133463	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1cccs1		CHEMBL2182073	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	12133464	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccccc2C3=O)ccc1F)c1ccoc1		CHEMBL2182072	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	12133465	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1ccoc1		CHEMBL2182071	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	12133466	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1ccco1		CHEMBL2182070	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	12133467	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C1c2ccccc2CCc2cc(Nc3cccc(NC(=O)C4CC4)c3)ccc21		CHEMBL2182069	=	IC50	nM	83.0	CHEMBL260	Homo sapiens	IC50	uM	0.083
	12133468	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(CCc1ccccc1)Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1		CHEMBL2177154	=	IC50	nM	4300.0	CHEMBL260	Homo sapiens	IC50	uM	4.3
	12133469	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Cc1ccccc1)Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1		CHEMBL2182068	=	IC50	nM	3100.0	CHEMBL260	Homo sapiens	IC50	uM	3.1
	12133470	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1)c1cccc(N2CCOCC2)c1		CHEMBL2182067	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	12133471	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1)c1cccc(F)c1		CHEMBL2177210	=	IC50	nM	180.0	CHEMBL260	Homo sapiens	IC50	uM	0.18
	12133472	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1cccc(C(=O)Nc2cccc(Nc3ccc4c(c3)OCc3ccccc3C4=O)c2)c1		CHEMBL2177209	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	12133473	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1)c1cccc(N2CCOCC2)c1		CHEMBL2177208	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	12133474	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1)c1cccc(C(F)(F)F)c1		CHEMBL2177207	=	IC50	nM	4800.0	CHEMBL260	Homo sapiens	IC50	uM	4.8
	12133475	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1)c1ccc(F)cc1		CHEMBL2177206	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	uM	0.13
	12133476	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1cccc(F)c1		CHEMBL2177205	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12133477	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1)c1cccc(F)c1		CHEMBL2177204	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	12133478	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	COc1ccc(C(=O)Nc2cccc(Nc3ccc4c(c3)CCCCC4=O)c2)cc1		CHEMBL2182110	=	IC50	nM	84.0	CHEMBL260	Homo sapiens	IC50	uM	0.084
	12133479	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	COc1cccc(C(=O)Nc2cccc(Nc3ccc4c(c3)CCCCC4=O)c2)c1		CHEMBL2182109	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	12133480	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	COc1ccccc1C(=O)Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1		CHEMBL2182108	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	12133481	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1cccc(C(=O)Nc2cccc(Nc3ccc4c(c3)CCCCC4=O)c2)c1		CHEMBL2182107	=	IC50	nM	850.0	CHEMBL260	Homo sapiens	IC50	uM	0.85
	12133482	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	CC(C)(C)c1ccc(C(=O)Nc2cc(Nc3ccc4c(c3)CCCCC4=O)ccc2F)cc1		CHEMBL2182106	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	uM	1.6
	12133483	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)cc2)cc1Nc1ccc2c(c1)CCCCC2=O		CHEMBL2182105	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	uM	2.7
	12135264	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(NC(=O)c2cccc(N3CCOCC3)c2)cc1Nc1ccc2c(c1)CCc1ccccc1C2=O		CHEMBL2182103	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	uM	0.042
	12135265	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1cccc(C(F)(F)F)c1		CHEMBL2182102	=	IC50	nM	970.0	CHEMBL260	Homo sapiens	IC50	uM	0.97
	12135266	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1ccc(F)cc1		CHEMBL2182101	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12135267	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1cccc(F)c1		CHEMBL2182100	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	12135268	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	COc1cccc(C(=O)Nc2cccc(Nc3ccc4c(c3)CCc3ccccc3C4=O)c2)c1		CHEMBL2182099	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	12135269	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1cccc(C(=O)Nc2cccc(Nc3ccc4c(c3)CCc3ccccc3C4=O)c2)c1		CHEMBL2182098	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	uM	0.35
	12135270	CHEMBL2184767	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2 at 10 uM	B	O=C(Cc1ccccc1)Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1		CHEMBL2182075	=	Inhibition	%	47.0	CHEMBL260	Homo sapiens	INH	%	47.0
	12135271	CHEMBL2184767	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2 at 10 uM	B	O=C(CCc1ccccc1)Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1		CHEMBL2182077	=	Inhibition	%	44.0	CHEMBL260	Homo sapiens	INH	%	44.0
	12135272	CHEMBL2184767	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2 at 10 uM	B	CC(C)(C)c1ccc(C(=O)Nc2cccc(Nc3ccc4c(c3)CCCCC4=O)c2)cc1		CHEMBL2182104	=	Inhibition	%	39.0	CHEMBL260	Homo sapiens	INH	%	39.0
	12135273	CHEMBL2184767	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2 at 10 uM	B	CC(C)(C)c1ccc(C(=O)Nc2cccc(Nc3ccc4c(c3)CCc3ccccc3C4=O)c2)cc1		CHEMBL2182097	=	Inhibition	%	43.0	CHEMBL260	Homo sapiens	INH	%	43.0
	12135279	CHEMBL2184767	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2 at 10 uM	B	O=C(NC1CC1)c1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1		CHEMBL2182096	=	Inhibition	%	26.0	CHEMBL260	Homo sapiens	INH	%	26.0
	12135280	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1ccccc1)c1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1		CHEMBL2182095	=	IC50	nM	3800.0	CHEMBL260	Homo sapiens	IC50	uM	3.8
	12135281	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1Nc1ccc2c(c1)CCCCC2=O		CHEMBL2182094	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	12135282	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	CC(C)(C)c1cccc(NC(=O)c2cccc(Nc3ccc4c(c3)CCCCC4=O)c2)c1		CHEMBL2182093	=	IC50	nM	4700.0	CHEMBL260	Homo sapiens	IC50	uM	4.7
	12135283	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(NC1CC1)c1cccc(Nc2ccc3c(c2)CCCCC3=O)c1		CHEMBL2182092	=	IC50	nM	4800.0	CHEMBL260	Homo sapiens	IC50	uM	4.8
	12135284	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1ccccc1)c1cccc(Nc2ccc3c(c2)CCCCC3=O)c1		CHEMBL2182091	=	IC50	nM	6200.0	CHEMBL260	Homo sapiens	IC50	uM	6.2
	12135285	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1Nc1ccc2c(c1)CCc1ccccc1C2=O		CHEMBL2177228	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	12135286	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	CC(C)(C)c1cccc(NC(=O)c2cccc(Nc3ccc4c(c3)CCc3ccccc3C4=O)c2)c1		CHEMBL2177227	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	uM	2.0
	12135287	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(NC1CC1)c1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1		CHEMBL2177226	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	12135288	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1ccccc1)c1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1		CHEMBL2177225	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	12135289	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	uM	0.037
	12135290	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccccc2C3=O)ccc1F)c1ccccc1		CHEMBL2177224	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12135291	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)cc1NC(=O)c1ccccc1		CHEMBL2177223	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	12135292	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1)c1ccccc1		CHEMBL2177222	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	12135293	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1ccc2c(c1)OCc1ccccc1C2=O		CHEMBL2177221	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	12135294	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)OCc2ccccc2C3=O)c1)c1ccccc1		CHEMBL2177220	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	uM	0.055
	12135295	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccccc1		CHEMBL2177219	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	uM	0.035
	12135296	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(Nc2ccc3c(c2)CCCCC3=O)cc1NC(=O)c1ccccc1		CHEMBL2177218	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	12135297	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)CCCCC3=O)c1)c1ccccc1		CHEMBL2177106	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	12135298	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1ccc2c(c1)CCCCC2=O		CHEMBL2177217	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	12135299	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCCCC3=O)c1)c1ccccc1		CHEMBL2177216	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	uM	0.037
	12135300	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccccc2C3=O)ccc1F)c1ccccc1		CHEMBL2177215	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	12135301	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)cc1NC(=O)c1ccccc1		CHEMBL2177214	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12135302	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1ccccc1		CHEMBL2177213	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	12135303	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1ccc2c(c1)CCc1ccccc1C2=O		CHEMBL2177212	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	uM	0.035
	12135304	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	O=C(Nc1cccc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c1)c1ccccc1		CHEMBL2177211	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	12135305	CHEMBL2184768	Inhibition of MAP kinase p38alpha assessed as phosphorylation of ATF-2	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccccc1C2=O		CHEMBL218962	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	12150568	CHEMBL2188505	Inhibition of human recombinant p38alpha by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
Active	12155963	CHEMBL2185157	Inhibition of MAPK14 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	12155964	CHEMBL2185157	Inhibition of MAPK14 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	Activity	%	8.9	CHEMBL260	Homo sapiens	Activity	%	8.9
	12155971	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	Ratio IC50		19.67	CHEMBL260	Homo sapiens	Ratio IC50		19.67
	12155972	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	CS(=O)(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179118	=	Ratio IC50		3.46	CHEMBL260	Homo sapiens	Ratio IC50		3.46
	12155973	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179117	=	Ratio IC50		4.75	CHEMBL260	Homo sapiens	Ratio IC50		4.75
	12155974	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179116	=	Ratio IC50		0.97	CHEMBL260	Homo sapiens	Ratio IC50		0.97
	12155975	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	COc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179121	=	Ratio IC50		0.67	CHEMBL260	Homo sapiens	Ratio IC50		0.67
	12155976	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	COc1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc(OC)c1OC		CHEMBL2179120	=	Ratio IC50		0.12	CHEMBL260	Homo sapiens	Ratio IC50		0.12
	12155977	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	COCn1c(-c2ccccc2)nc(-c2ccc(F)cc2)c1-c1ccnc2[nH]ccc12		CHEMBL2179126	=	Ratio IC50		0.18	CHEMBL260	Homo sapiens	Ratio IC50		0.18
	12155978	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	COCn1c(-c2ccccc2)nc(-c2ccc(F)cc2)c1-c1ncnc2[nH]cnc12		CHEMBL2179125	=	Ratio IC50		0.01	CHEMBL260	Homo sapiens	Ratio IC50		0.01
	12155979	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c(C4CCCCC4)cc23)cc1		CHEMBL2179115	=	Ratio IC50		2.07	CHEMBL260	Homo sapiens	Ratio IC50		2.07
	12155980	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c(Cc4ccccc4)cc23)cc1		CHEMBL2179129	=	Ratio IC50		0.07	CHEMBL260	Homo sapiens	Ratio IC50		0.07
	12155981	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c(-c4ccccc4)cc23)cc1		CHEMBL2179128	=	Ratio IC50		2.38	CHEMBL260	Homo sapiens	Ratio IC50		2.38
	12155982	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c4ccccc4c23)cc1		CHEMBL2179127	=	Ratio IC50		0.55	CHEMBL260	Homo sapiens	Ratio IC50		0.55
	12155983	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1		CHEMBL416169	=	Ratio IC50		0.33	CHEMBL260	Homo sapiens	Ratio IC50		0.33
	12155984	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]ccc23)cc1		CHEMBL2179124	=	Ratio IC50		0.47	CHEMBL260	Homo sapiens	Ratio IC50		0.47
	12155985	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ncnc3[nH]ccc23)cc1		CHEMBL2179123	=	Ratio IC50		0.03	CHEMBL260	Homo sapiens	Ratio IC50		0.03
	12155986	CHEMBL2185573	Ratio of SB203580 IC50 to compound IC50 for inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ncnc3[nH]cnc23)cc1		CHEMBL2179122	=	Ratio IC50		0.1	CHEMBL260	Homo sapiens	Ratio IC50		0.1
	12155987	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12155988	CHEMBL2185574	Inhibition of p38alpha MAPK	B	CS(=O)(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179118	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	12155989	CHEMBL2185574	Inhibition of p38alpha MAPK	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179117	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	12155990	CHEMBL2185574	Inhibition of p38alpha MAPK	B	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179116	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	12155991	CHEMBL2185574	Inhibition of p38alpha MAPK	B	COc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179121	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	12155992	CHEMBL2185574	Inhibition of p38alpha MAPK	B	COc1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc(OC)c1OC		CHEMBL2179120	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	12155993	CHEMBL2185574	Inhibition of p38alpha MAPK	B	COCn1c(-c2ccccc2)nc(-c2ccc(F)cc2)c1-c1ccnc2[nH]ccc12		CHEMBL2179126	=	IC50	nM	451.0	CHEMBL260	Homo sapiens	IC50	uM	0.451
	12155994	CHEMBL2185574	Inhibition of p38alpha MAPK	B	COCn1c(-c2ccccc2)nc(-c2ccc(F)cc2)c1-c1ncnc2[nH]cnc12		CHEMBL2179125	=	IC50	nM	2989.0	CHEMBL260	Homo sapiens	IC50	uM	2.989
	12155995	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c(C4CCCCC4)cc23)cc1		CHEMBL2179115	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	12155996	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c(Cc4ccccc4)cc23)cc1		CHEMBL2179129	=	IC50	nM	345.0	CHEMBL260	Homo sapiens	IC50	uM	0.345
	12155997	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c(-c4ccccc4)cc23)cc1		CHEMBL2179128	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	uM	0.016
	12155998	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c4ccccc4c23)cc1		CHEMBL2179127	=	IC50	nM	153.0	CHEMBL260	Homo sapiens	IC50	uM	0.153
	12155999	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2[nH]c(-c3ccccc3)nc2-c2ccncc2)cc1		CHEMBL416169	=	IC50	nM	154.0	CHEMBL260	Homo sapiens	IC50	uM	0.154
	12156000	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]ccc23)cc1		CHEMBL2179124	=	IC50	nM	108.0	CHEMBL260	Homo sapiens	IC50	uM	0.108
	12156001	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ncnc3[nH]ccc23)cc1		CHEMBL2179123	=	IC50	nM	2600.0	CHEMBL260	Homo sapiens	IC50	uM	2.6
	12156002	CHEMBL2185574	Inhibition of p38alpha MAPK	B	Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ncnc3[nH]cnc23)cc1		CHEMBL2179122	=	IC50	nM	740.0	CHEMBL260	Homo sapiens	IC50	uM	0.74
	12166111	CHEMBL2211585	Binding affinity to p38alpha at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL260	Homo sapiens	Activity	%	50.0
	12170764	CHEMBL2209891	Inhibition of p38a MAPK assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	12170895	CHEMBL2213454	Inhibition of p38a MAPK assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	12172308	CHEMBL2215423	Inhibition of p38-alpha assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	12175181	CHEMBL2210706	Inhibition of p38alpha	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	12183853	CHEMBL2211535	Inhibition of MAPK14	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL260	Homo sapiens	pIC50		5.0
	12194105	CHEMBL2214708	Inhibition of p38alpha	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1.Cl		CHEMBL2205637	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	12195596	CHEMBL2212375	Inhibition of human recombinant p38alpha expressed in Escherichia coli using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate assessed as residual activity at 1 uM after 60 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	99.4	CHEMBL260	Homo sapiens	Activity	%	99.4
Not Active	12196259	CHEMBL2209543	Inhibition of p38alpha at 1 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(-c3ccc4nccnc4c3)[nH]n2)cc1		CHEMBL2207441		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	12196260	CHEMBL2209543	Inhibition of p38alpha at 1 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(-c3ccc4ncccc4c3)[nH]n2)cc1		CHEMBL2207440		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	12197168	CHEMBL2209543	Inhibition of p38alpha at 1 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3cc(C(=O)N(C)CCc4ccccn4)[nH]c23)cc1		CHEMBL2207429		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	12197169	CHEMBL2209543	Inhibition of p38alpha at 1 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3cc(C(=O)N4CCCC4)[nH]c23)cc1		CHEMBL2207823		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	12263180	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL260	Homo sapiens	Residual Activity	%	107.0
	12263181	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	98.0	CHEMBL260	Homo sapiens	Residual Activity	%	98.0
	12263182	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	80.0	CHEMBL260	Homo sapiens	Residual Activity	%	80.0
	12263183	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12263184	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	83.0	CHEMBL260	Homo sapiens	Residual Activity	%	83.0
	12263185	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	83.0	CHEMBL260	Homo sapiens	Residual Activity	%	83.0
	12263186	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12263187	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	56.0	CHEMBL260	Homo sapiens	Residual Activity	%	56.0
	12263188	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	114.0	CHEMBL260	Homo sapiens	Residual Activity	%	114.0
	12263189	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	64.0	CHEMBL260	Homo sapiens	Residual Activity	%	64.0
	12263190	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12263191	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12263192	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12263193	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	41.0	CHEMBL260	Homo sapiens	Residual Activity	%	41.0
	12263194	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263195	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12263196	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	111.0	CHEMBL260	Homo sapiens	Residual Activity	%	111.0
	12263197	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	106.0	CHEMBL260	Homo sapiens	Residual Activity	%	106.0
	12263198	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263199	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	73.0	CHEMBL260	Homo sapiens	Residual Activity	%	73.0
	12263200	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12263201	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	57.0	CHEMBL260	Homo sapiens	Residual Activity	%	57.0
	12263202	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263203	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12263204	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12263205	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	57.0	CHEMBL260	Homo sapiens	Residual Activity	%	57.0
	12263206	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	75.0	CHEMBL260	Homo sapiens	Residual Activity	%	75.0
	12263207	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	51.0	CHEMBL260	Homo sapiens	Residual Activity	%	51.0
	12263208	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12263209	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	62.0	CHEMBL260	Homo sapiens	Residual Activity	%	62.0
	12263210	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	49.0	CHEMBL260	Homo sapiens	Residual Activity	%	49.0
	12263211	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	23.0	CHEMBL260	Homo sapiens	Residual Activity	%	23.0
	12263212	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	75.0	CHEMBL260	Homo sapiens	Residual Activity	%	75.0
	12263213	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	100.0	CHEMBL260	Homo sapiens	Residual Activity	%	100.0
	12263214	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12263215	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	81.0	CHEMBL260	Homo sapiens	Residual Activity	%	81.0
	12263216	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	69.0	CHEMBL260	Homo sapiens	Residual Activity	%	69.0
	12263217	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	72.0	CHEMBL260	Homo sapiens	Residual Activity	%	72.0
	12263218	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	49.0	CHEMBL260	Homo sapiens	Residual Activity	%	49.0
	12263219	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	86.0	CHEMBL260	Homo sapiens	Residual Activity	%	86.0
	12263220	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263221	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	110.0	CHEMBL260	Homo sapiens	Residual Activity	%	110.0
	12263222	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12263223	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263224	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12263225	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	77.0	CHEMBL260	Homo sapiens	Residual Activity	%	77.0
	12263226	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	80.0	CHEMBL260	Homo sapiens	Residual Activity	%	80.0
	12263227	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12263228	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	111.0	CHEMBL260	Homo sapiens	Residual Activity	%	111.0
	12263229	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	109.0	CHEMBL260	Homo sapiens	Residual Activity	%	109.0
	12263230	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	95.0	CHEMBL260	Homo sapiens	Residual Activity	%	95.0
	12263231	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	86.0	CHEMBL260	Homo sapiens	Residual Activity	%	86.0
	12263232	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	80.0	CHEMBL260	Homo sapiens	Residual Activity	%	80.0
	12263233	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	74.0	CHEMBL260	Homo sapiens	Residual Activity	%	74.0
	12263234	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	72.0	CHEMBL260	Homo sapiens	Residual Activity	%	72.0
	12263235	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	81.0	CHEMBL260	Homo sapiens	Residual Activity	%	81.0
	12263236	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	116.0	CHEMBL260	Homo sapiens	Residual Activity	%	116.0
	12263237	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL260	Homo sapiens	Residual Activity	%	97.0
	12263238	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263239	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263240	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	54.0	CHEMBL260	Homo sapiens	Residual Activity	%	54.0
	12263241	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	71.0	CHEMBL260	Homo sapiens	Residual Activity	%	71.0
	12263242	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12263243	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12263244	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	106.0	CHEMBL260	Homo sapiens	Residual Activity	%	106.0
	12263245	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	102.0	CHEMBL260	Homo sapiens	Residual Activity	%	102.0
	12263246	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	95.0	CHEMBL260	Homo sapiens	Residual Activity	%	95.0
	12263247	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	101.0	CHEMBL260	Homo sapiens	Residual Activity	%	101.0
	12263248	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12263249	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	75.0	CHEMBL260	Homo sapiens	Residual Activity	%	75.0
	12263250	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12263251	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12263252	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	109.0	CHEMBL260	Homo sapiens	Residual Activity	%	109.0
	12263253	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	102.0	CHEMBL260	Homo sapiens	Residual Activity	%	102.0
	12263254	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	95.0	CHEMBL260	Homo sapiens	Residual Activity	%	95.0
	12263255	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12263256	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	99.0	CHEMBL260	Homo sapiens	Residual Activity	%	99.0
	12263257	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12263258	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	92.0	CHEMBL260	Homo sapiens	Residual Activity	%	92.0
	12263259	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	81.0	CHEMBL260	Homo sapiens	Residual Activity	%	81.0
	12263260	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL260	Homo sapiens	Residual Activity	%	107.0
	12263261	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263262	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263263	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL260	Homo sapiens	Residual Activity	%	106.0
	12263264	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263265	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12263266	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	-1.0	CHEMBL260	Homo sapiens	Residual Activity	%	-1.0
	12263267	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	5.0	CHEMBL260	Homo sapiens	Residual Activity	%	5.0
	12263268	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	103.0	CHEMBL260	Homo sapiens	Residual Activity	%	103.0
	12263269	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12263270	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12263271	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12263272	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263273	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	98.0	CHEMBL260	Homo sapiens	Residual Activity	%	98.0
	12263274	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	3.0	CHEMBL260	Homo sapiens	Residual Activity	%	3.0
	12263275	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263276	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	105.0	CHEMBL260	Homo sapiens	Residual Activity	%	105.0
	12263277	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12263278	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	97.0	CHEMBL260	Homo sapiens	Residual Activity	%	97.0
	12263279	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263280	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263281	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	92.0	CHEMBL260	Homo sapiens	Residual Activity	%	92.0
	12263282	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	86.0	CHEMBL260	Homo sapiens	Residual Activity	%	86.0
	12263283	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263284	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	99.0	CHEMBL260	Homo sapiens	Residual Activity	%	99.0
	12263285	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263286	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12263287	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263288	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12263289	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263290	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	1.0	CHEMBL260	Homo sapiens	Residual Activity	%	1.0
	12263291	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	57.0	CHEMBL260	Homo sapiens	Residual Activity	%	57.0
	12263292	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	100.0	CHEMBL260	Homo sapiens	Residual Activity	%	100.0
	12263293	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12263294	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263295	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263296	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12263297	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12263298	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	2.0	CHEMBL260	Homo sapiens	Residual Activity	%	2.0
	12263299	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	16.0	CHEMBL260	Homo sapiens	Residual Activity	%	16.0
	12263300	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	100.0	CHEMBL260	Homo sapiens	Residual Activity	%	100.0
	12263301	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263302	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12263303	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263304	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263305	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12263306	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12263307	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12263308	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	99.0	CHEMBL260	Homo sapiens	Residual Activity	%	99.0
	12263309	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12263310	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	96.0	CHEMBL260	Homo sapiens	Residual Activity	%	96.0
	12263311	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12263312	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	96.0	CHEMBL260	Homo sapiens	Residual Activity	%	96.0
	12263313	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	86.0	CHEMBL260	Homo sapiens	Residual Activity	%	86.0
	12263314	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	54.0	CHEMBL260	Homo sapiens	Residual Activity	%	54.0
	12263315	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	97.0	CHEMBL260	Homo sapiens	Residual Activity	%	97.0
	12263316	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263317	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263318	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12263319	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12263320	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263321	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12263322	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL260	Homo sapiens	Residual Activity	%	95.0
	12263323	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	96.0	CHEMBL260	Homo sapiens	Residual Activity	%	96.0
	12263324	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	77.0	CHEMBL260	Homo sapiens	Residual Activity	%	77.0
	12263325	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	92.0	CHEMBL260	Homo sapiens	Residual Activity	%	92.0
	12263326	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12263327	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	76.0	CHEMBL260	Homo sapiens	Residual Activity	%	76.0
	12263328	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12263329	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12263330	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12263331	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	77.0	CHEMBL260	Homo sapiens	Residual Activity	%	77.0
	12263332	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	81.0	CHEMBL260	Homo sapiens	Residual Activity	%	81.0
	12263333	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12263334	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	80.0	CHEMBL260	Homo sapiens	Residual Activity	%	80.0
	12263335	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12263336	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	1.0	CHEMBL260	Homo sapiens	Residual Activity	%	1.0
	12263337	CHEMBL2219171	Millipore: Percentage of residual kinase activity of MAPK14 at 1uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12263338	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	112.0	CHEMBL260	Homo sapiens	Residual Activity	%	112.0
	12263339	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	73.0	CHEMBL260	Homo sapiens	Residual Activity	%	73.0
	12263340	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	40.0	CHEMBL260	Homo sapiens	Residual Activity	%	40.0
	12263341	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12263342	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	77.0	CHEMBL260	Homo sapiens	Residual Activity	%	77.0
	12263343	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL260	Homo sapiens	Residual Activity	%	103.0
	12263344	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	96.0	CHEMBL260	Homo sapiens	Residual Activity	%	96.0
	12263345	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	25.0	CHEMBL260	Homo sapiens	Residual Activity	%	25.0
	12263346	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	112.0	CHEMBL260	Homo sapiens	Residual Activity	%	112.0
	12263347	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	25.0	CHEMBL260	Homo sapiens	Residual Activity	%	25.0
	12263348	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	98.0	CHEMBL260	Homo sapiens	Residual Activity	%	98.0
	12263349	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	101.0	CHEMBL260	Homo sapiens	Residual Activity	%	101.0
	12263350	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	50.0	CHEMBL260	Homo sapiens	Residual Activity	%	50.0
	12263351	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	7.0	CHEMBL260	Homo sapiens	Residual Activity	%	7.0
	12263352	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12263353	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	102.0	CHEMBL260	Homo sapiens	Residual Activity	%	102.0
	12263354	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	73.0	CHEMBL260	Homo sapiens	Residual Activity	%	73.0
	12263355	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	115.0	CHEMBL260	Homo sapiens	Residual Activity	%	115.0
	12263356	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	100.0	CHEMBL260	Homo sapiens	Residual Activity	%	100.0
	12263357	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	69.0	CHEMBL260	Homo sapiens	Residual Activity	%	69.0
	12263358	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	81.0	CHEMBL260	Homo sapiens	Residual Activity	%	81.0
	12263359	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	23.0	CHEMBL260	Homo sapiens	Residual Activity	%	23.0
	12263360	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL260	Homo sapiens	Residual Activity	%	105.0
	12263361	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	66.0	CHEMBL260	Homo sapiens	Residual Activity	%	66.0
	12263362	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	97.0	CHEMBL260	Homo sapiens	Residual Activity	%	97.0
	12263363	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	13.0	CHEMBL260	Homo sapiens	Residual Activity	%	13.0
	12265006	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	73.0	CHEMBL260	Homo sapiens	Residual Activity	%	73.0
	12265007	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	14.0	CHEMBL260	Homo sapiens	Residual Activity	%	14.0
	12265008	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12265009	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12265010	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	15.0	CHEMBL260	Homo sapiens	Residual Activity	%	15.0
	12265011	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	5.0	CHEMBL260	Homo sapiens	Residual Activity	%	5.0
	12265012	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	113.0	CHEMBL260	Homo sapiens	Residual Activity	%	113.0
	12265013	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	92.0	CHEMBL260	Homo sapiens	Residual Activity	%	92.0
	12265014	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL260	Homo sapiens	Residual Activity	%	99.0
	12265015	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12265016	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	44.0	CHEMBL260	Homo sapiens	Residual Activity	%	44.0
	12265017	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	83.0	CHEMBL260	Homo sapiens	Residual Activity	%	83.0
	12265018	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	16.0	CHEMBL260	Homo sapiens	Residual Activity	%	16.0
	12265019	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12265020	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12265021	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	116.0	CHEMBL260	Homo sapiens	Residual Activity	%	116.0
	12265022	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12265023	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	67.0	CHEMBL260	Homo sapiens	Residual Activity	%	67.0
	12265024	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	68.0	CHEMBL260	Homo sapiens	Residual Activity	%	68.0
	12265025	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	54.0	CHEMBL260	Homo sapiens	Residual Activity	%	54.0
	12265026	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	62.0	CHEMBL260	Homo sapiens	Residual Activity	%	62.0
	12265027	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	98.0	CHEMBL260	Homo sapiens	Residual Activity	%	98.0
	12265028	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	112.0	CHEMBL260	Homo sapiens	Residual Activity	%	112.0
	12265029	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL260	Homo sapiens	Residual Activity	%	101.0
	12265030	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12265031	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	63.0	CHEMBL260	Homo sapiens	Residual Activity	%	63.0
	12265032	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	74.0	CHEMBL260	Homo sapiens	Residual Activity	%	74.0
	12265033	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	81.0	CHEMBL260	Homo sapiens	Residual Activity	%	81.0
	12265034	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	102.0	CHEMBL260	Homo sapiens	Residual Activity	%	102.0
	12265035	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL260	Homo sapiens	Residual Activity	%	102.0
	12265036	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	117.0	CHEMBL260	Homo sapiens	Residual Activity	%	117.0
	12265037	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	104.0	CHEMBL260	Homo sapiens	Residual Activity	%	104.0
	12265038	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12265039	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	95.0	CHEMBL260	Homo sapiens	Residual Activity	%	95.0
	12265040	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	10.0	CHEMBL260	Homo sapiens	Residual Activity	%	10.0
	12265041	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12265042	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	55.0	CHEMBL260	Homo sapiens	Residual Activity	%	55.0
	12265043	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	83.0	CHEMBL260	Homo sapiens	Residual Activity	%	83.0
	12265044	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	107.0	CHEMBL260	Homo sapiens	Residual Activity	%	107.0
	12265045	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	106.0	CHEMBL260	Homo sapiens	Residual Activity	%	106.0
	12265046	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	106.0	CHEMBL260	Homo sapiens	Residual Activity	%	106.0
	12265047	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	98.0	CHEMBL260	Homo sapiens	Residual Activity	%	98.0
	12265048	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12265049	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	80.0	CHEMBL260	Homo sapiens	Residual Activity	%	80.0
	12265050	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12265051	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	59.0	CHEMBL260	Homo sapiens	Residual Activity	%	59.0
	12265052	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	106.0	CHEMBL260	Homo sapiens	Residual Activity	%	106.0
	12265053	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	106.0	CHEMBL260	Homo sapiens	Residual Activity	%	106.0
	12265054	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12265055	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	95.0	CHEMBL260	Homo sapiens	Residual Activity	%	95.0
	12265056	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	109.0	CHEMBL260	Homo sapiens	Residual Activity	%	109.0
	12265057	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	52.0	CHEMBL260	Homo sapiens	Residual Activity	%	52.0
	12265058	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12265059	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12265060	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	109.0	CHEMBL260	Homo sapiens	Residual Activity	%	109.0
	12265061	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	86.0	CHEMBL260	Homo sapiens	Residual Activity	%	86.0
	12265062	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12265063	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	107.0	CHEMBL260	Homo sapiens	Residual Activity	%	107.0
	12265064	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	86.0	CHEMBL260	Homo sapiens	Residual Activity	%	86.0
	12265065	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	59.0	CHEMBL260	Homo sapiens	Residual Activity	%	59.0
	12265066	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	0.0	CHEMBL260	Homo sapiens	Residual Activity	%	0.0
	12265067	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	2.0	CHEMBL260	Homo sapiens	Residual Activity	%	2.0
	12265068	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	99.0	CHEMBL260	Homo sapiens	Residual Activity	%	99.0
	12265069	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12265070	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12265071	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	33.0	CHEMBL260	Homo sapiens	Residual Activity	%	33.0
	12265072	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	64.0	CHEMBL260	Homo sapiens	Residual Activity	%	64.0
	12265073	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12265074	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	0.0	CHEMBL260	Homo sapiens	Residual Activity	%	0.0
	12265075	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12265076	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	105.0	CHEMBL260	Homo sapiens	Residual Activity	%	105.0
	12265077	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL260	Homo sapiens	Residual Activity	%	97.0
	12265078	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	93.0	CHEMBL260	Homo sapiens	Residual Activity	%	93.0
	12265079	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12265080	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12265081	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	67.0	CHEMBL260	Homo sapiens	Residual Activity	%	67.0
	12265082	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12265083	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	105.0	CHEMBL260	Homo sapiens	Residual Activity	%	105.0
	12265084	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	100.0	CHEMBL260	Homo sapiens	Residual Activity	%	100.0
	12265085	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12265086	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	81.0	CHEMBL260	Homo sapiens	Residual Activity	%	81.0
	12265087	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12265088	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12265089	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12265090	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	2.0	CHEMBL260	Homo sapiens	Residual Activity	%	2.0
	12265091	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	14.0	CHEMBL260	Homo sapiens	Residual Activity	%	14.0
	12265092	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	98.0	CHEMBL260	Homo sapiens	Residual Activity	%	98.0
	12265093	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	45.0	CHEMBL260	Homo sapiens	Residual Activity	%	45.0
	12265094	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	84.0	CHEMBL260	Homo sapiens	Residual Activity	%	84.0
	12265095	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12265096	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	77.0	CHEMBL260	Homo sapiens	Residual Activity	%	77.0
	12265097	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	96.0	CHEMBL260	Homo sapiens	Residual Activity	%	96.0
	12265098	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	1.0	CHEMBL260	Homo sapiens	Residual Activity	%	1.0
	12265099	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	3.0	CHEMBL260	Homo sapiens	Residual Activity	%	3.0
	12265100	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	88.0	CHEMBL260	Homo sapiens	Residual Activity	%	88.0
	12265101	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	61.0	CHEMBL260	Homo sapiens	Residual Activity	%	61.0
	12265102	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	74.0	CHEMBL260	Homo sapiens	Residual Activity	%	74.0
	12265103	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	79.0	CHEMBL260	Homo sapiens	Residual Activity	%	79.0
	12265104	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	78.0	CHEMBL260	Homo sapiens	Residual Activity	%	78.0
	12265105	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	53.0	CHEMBL260	Homo sapiens	Residual Activity	%	53.0
	12265106	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	80.0	CHEMBL260	Homo sapiens	Residual Activity	%	80.0
	12265107	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	35.0	CHEMBL260	Homo sapiens	Residual Activity	%	35.0
	12265108	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	100.0	CHEMBL260	Homo sapiens	Residual Activity	%	100.0
	12265109	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	53.0	CHEMBL260	Homo sapiens	Residual Activity	%	53.0
	12265110	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12265111	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	87.0	CHEMBL260	Homo sapiens	Residual Activity	%	87.0
	12265112	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12265113	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL260	Homo sapiens	Residual Activity	%	92.0
	12265114	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	11.0	CHEMBL260	Homo sapiens	Residual Activity	%	11.0
	12265115	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	95.0	CHEMBL260	Homo sapiens	Residual Activity	%	95.0
	12265116	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	97.0	CHEMBL260	Homo sapiens	Residual Activity	%	97.0
	12265117	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	70.0	CHEMBL260	Homo sapiens	Residual Activity	%	70.0
	12265118	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	83.0	CHEMBL260	Homo sapiens	Residual Activity	%	83.0
	12265119	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12265120	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12265121	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12265122	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	94.0	CHEMBL260	Homo sapiens	Residual Activity	%	94.0
	12265123	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12265124	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	37.0	CHEMBL260	Homo sapiens	Residual Activity	%	37.0
	12265125	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	82.0	CHEMBL260	Homo sapiens	Residual Activity	%	82.0
	12265126	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12265127	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	41.0	CHEMBL260	Homo sapiens	Residual Activity	%	41.0
	12265128	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	47.0	CHEMBL260	Homo sapiens	Residual Activity	%	47.0
	12265129	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	57.0	CHEMBL260	Homo sapiens	Residual Activity	%	57.0
	12265130	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	85.0	CHEMBL260	Homo sapiens	Residual Activity	%	85.0
	12265131	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	90.0	CHEMBL260	Homo sapiens	Residual Activity	%	90.0
	12265132	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12265133	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	92.0	CHEMBL260	Homo sapiens	Residual Activity	%	92.0
	12265134	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL260	Homo sapiens	Residual Activity	%	102.0
	12265135	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	91.0	CHEMBL260	Homo sapiens	Residual Activity	%	91.0
	12265136	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	1.0	CHEMBL260	Homo sapiens	Residual Activity	%	1.0
	12265137	CHEMBL2219172	Millipore: Percentage of residual kinase activity of MAPK14 at 10uM relative to control. Control inhibitor: SB203580 at 100.0uM. Buffer: 25 mM Tris pH 7.5, 0.02 mM EGTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	89.0	CHEMBL260	Homo sapiens	Residual Activity	%	89.0
	12591815	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	CC(C)(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL316604	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	pIC50		9.699
	12591816	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(CC4CCC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL264627	=	IC50	nM	0.5998	CHEMBL260	Homo sapiens	pIC50		9.222
	12591817	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(C4CCC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL419140	=	IC50	nM	0.3999	CHEMBL260	Homo sapiens	pIC50		9.398
	12591818	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	CC(C1CC1)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL318934	=	IC50	nM	0.2999	CHEMBL260	Homo sapiens	pIC50		9.523
	12591819	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(CC4CC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL419134	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	pIC50		9.301
	12591820	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(C4CC4)CC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96565	=	IC50	nM	1.099	CHEMBL260	Homo sapiens	pIC50		8.959
	12591821	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	CC(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL328242	=	IC50	nM	0.5998	CHEMBL260	Homo sapiens	pIC50		9.222
	12591822	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	CCN1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL96345	=	IC50	nM	1.199	CHEMBL260	Homo sapiens	pIC50		8.921
	12591823	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	CN1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1		CHEMBL96653	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	pIC50		9.301
	12591824	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C(c1cc(-c2ccc(F)cc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL96225	=	IC50	nM	1.099	CHEMBL260	Homo sapiens	pIC50		8.959
	12591825	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C(c1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL327217	=	IC50	nM	2.399	CHEMBL260	Homo sapiens	pIC50		8.62
	12591826	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C(c1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1		CHEMBL94444	=	IC50	nM	1.5	CHEMBL260	Homo sapiens	pIC50		8.824
	12591827	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(CN3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327746	=	IC50	nM	0.13	CHEMBL260	Homo sapiens	pIC50		9.886
	12591828	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccccc3Cl)cc(CN3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL97227	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	pIC50		10.0
	12591829	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(NC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96432	=	IC50	nM	0.5998	CHEMBL260	Homo sapiens	pIC50		9.222
	12591830	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccccc3Cl)cc(NC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327987	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	pIC50		9.301
	12591831	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(OC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL327959	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	pIC50		10.0
	12591832	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccccc3Cl)cc(OC3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL94825	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	pIC50		9.699
	12591833	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL94417	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	pIC50		8.585
	12591834	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccccc3Cl)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96487	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	pIC50		8.854
	12591835	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL328614	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	pIC50		10.0
	12591836	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	pIC50		9.699
	12591837	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	O=C1NCc2c(-c3ccccc3Cl)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL96763	=	IC50	nM	0.8995	CHEMBL260	Homo sapiens	pIC50		9.046
	12591838	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COc1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL96632	=	IC50	nM	5.998	CHEMBL260	Homo sapiens	pIC50		8.222
	12591839	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COc1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL96091	=	IC50	nM	10.99	CHEMBL260	Homo sapiens	pIC50		7.959
	12591840	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COc1cc(-c2ccc(F)cc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94770	=	IC50	nM	2.999	CHEMBL260	Homo sapiens	pIC50		8.523
	12591841	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccc(F)cc2C)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94783	=	IC50	nM	10.99	CHEMBL260	Homo sapiens	pIC50		7.959
	12591842	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2c(F)cccc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL316337	=	IC50	nM	43.95	CHEMBL260	Homo sapiens	pIC50		7.357
	12591843	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccc(F)cc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94547	=	IC50	nM	6.998	CHEMBL260	Homo sapiens	pIC50		8.155
	12591844	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccc(C)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL97579	=	IC50	nM	43.95	CHEMBL260	Homo sapiens	pIC50		7.357
	12591845	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2cccc(C)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328274	=	IC50	nM	319.89	CHEMBL260	Homo sapiens	pIC50		6.495
	12591846	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccccc2C)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94377	=	IC50	nM	10.99	CHEMBL260	Homo sapiens	pIC50		7.959
	12591847	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccc(C(F)(F)F)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94719	=	IC50	nM	130.02	CHEMBL260	Homo sapiens	pIC50		6.886
	12591848	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2cccc(C(F)(F)F)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328752	=	IC50	nM	169.82	CHEMBL260	Homo sapiens	pIC50		6.77
	12591849	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccc(Cl)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL330358	=	IC50	nM	46.99	CHEMBL260	Homo sapiens	pIC50		7.328
	12591850	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2cccc(Cl)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421566	=	IC50	nM	66.99	CHEMBL260	Homo sapiens	pIC50		7.174
	12591851	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccccc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94556	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	pIC50		9.0
	12591852	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccc(F)cc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL328252	=	IC50	nM	21.98	CHEMBL260	Homo sapiens	pIC50		7.658
	12591853	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2cccc(F)c2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94852	=	IC50	nM	79.07	CHEMBL260	Homo sapiens	pIC50		7.102
	12591854	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccccc2F)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL94495	=	IC50	nM	6.998	CHEMBL260	Homo sapiens	pIC50		8.155
	12591855	CHEMBL3070436	Inhibition of p38alpha MAPK (unknown origin)	B	COC(=O)c1cc(-c2ccccc2)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2		CHEMBL421194	=	IC50	nM	29.99	CHEMBL260	Homo sapiens	pIC50		7.523
	12628453	CHEMBL2321176	Inhibition of P38alpha MAPK (unknown origin) at 10 uM	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
Not Active	12641790	CHEMBL2317224	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release at 1 uM by ELISA	B	CC(C)C[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)O		CHEMBL2316200		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	12641791	CHEMBL2317225	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release measuring residual activity at 10 uM by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(C(=O)N3CCOCC3)cc21		CHEMBL2316467	=	Activity	%	39.0	CHEMBL260	Homo sapiens	Activity	%	39.0
	12641792	CHEMBL2317230	Binding affinity to p38alpha MAP kinase (unknown origin) by FLiK assay	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@@H](O)CO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316486	=	Kd	nM	17.0	CHEMBL260	Homo sapiens	Kd	nM	17.0
	12641793	CHEMBL2317230	Binding affinity to p38alpha MAP kinase (unknown origin) by FLiK assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	12.0	CHEMBL260	Homo sapiens	Kd	nM	12.0
	12641794	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)CCc2ccc(OCCO)cc2C3=O)c1)c1ccccc1		CHEMBL2316488	=	IC50	nM	9000.0	CHEMBL260	Homo sapiens	IC50	uM	9.0
	12641795	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	C[C@@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C1CCCCC1		CHEMBL2316471	=	IC50	nM	7600.0	CHEMBL260	Homo sapiens	IC50	uM	7.6
	12641796	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316482	=	IC50	nM	4100.0	CHEMBL260	Homo sapiens	IC50	uM	4.1
	12641797	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316483	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	uM	2.4
	12641798	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CC(=O)Oc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316204	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	12641799	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)c(NC(=O)C4CCOC4)c3)cc2CCc2ccc(OCCO)cc21		CHEMBL2316487	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	12641800	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	Cc1cc(F)c(NC(=O)C2CCOC2)cc1Nc1ccc2c(c1)CCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL2316495	=	IC50	nM	570.0	CHEMBL260	Homo sapiens	IC50	uM	0.57
	12641801	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316468	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	12641802	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	COC(=O)[C@H](CC(C)C)NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316199	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	uM	0.46
	12641803	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)c(NC(=O)c5ccccc5)c4)cc2CC3)O1		CHEMBL2316484	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	12641804	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)c(NC(=O)c5cccs5)c4)cc2CC3)O1		CHEMBL2316492	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	12641805	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c(F)cc1F)c1ccccc1		CHEMBL2316208	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	12641806	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@@H](O)CO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316486	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	12641807	CHEMBL2317228	Inhibition of p38alpha MAP kinase (unknown origin) in presence of 300 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	273.0	CHEMBL260	Homo sapiens	IC50	uM	0.273
	12641808	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CCOC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316202	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	uM	0.27
	12641809	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316485	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	12641810	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(OCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316206	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	uM	0.24
	12641811	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CCCOC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316203	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	12641812	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)c(F)cc1F)c1ccccc1		CHEMBL2316497	=	IC50	nM	220.0	CHEMBL260	Homo sapiens	IC50	uM	0.22
	12641813	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(OCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316205	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	12641814	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316201	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	12641815	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C1c2ccc(Nc3cc(NC(=O)C4CCOC4)c(F)cc3F)cc2CCc2ccc(OCCN3CCOCC3)cc21		CHEMBL2316496	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	12641816	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccoc1		CHEMBL2316489	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	12641817	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	Cc1cc(F)c(NC(=O)C2CCOC2)cc1Nc1ccc2c(c1)CCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL2316495	=	IC50	nM	98.0	CHEMBL260	Homo sapiens	IC50	uM	0.098
	12641818	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CCOC(=O)CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316196	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	uM	0.095
	12641819	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1cccs1		CHEMBL2316491	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	uM	0.095
	12641820	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CC(C)C[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)O		CHEMBL2316200	=	IC50	nM	94.0	CHEMBL260	Homo sapiens	IC50	uM	0.094
	12641821	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	C[C@@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C1CCCCC1		CHEMBL2316471	=	IC50	nM	89.0	CHEMBL260	Homo sapiens	IC50	uM	0.089
	12641822	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(NCCF)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316472	=	IC50	nM	83.0	CHEMBL260	Homo sapiens	IC50	uM	0.083
	12641823	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CNC(=O)CC[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)NC		CHEMBL2316198	=	IC50	nM	64.0	CHEMBL260	Homo sapiens	IC50	uM	0.064
	12641824	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(NCCCl)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316473	=	IC50	nM	64.0	CHEMBL260	Homo sapiens	IC50	uM	0.064
	12641825	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	COCCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316475	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	uM	0.054
	12641826	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CS(=O)(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316476	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	12641827	CHEMBL2317229	Inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	uM	0.048
	12641828	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(C(=O)N3CCOCC3)cc21		CHEMBL2316467	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	12641829	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@H](O)CO)cc2C3=O)ccc1F)c1cccs1		CHEMBL2316493	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	uM	0.042
	12641830	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	12641831	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316470	=	IC50	nM	37.0	CHEMBL260	Homo sapiens	IC50	uM	0.037
	12641832	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CSCCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316474	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	12641833	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	Cc1cc(F)c(NC(=O)c2ccoc2)cc1Nc1ccc2c(c1)CCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL2316494	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	uM	0.032
	12641834	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	uM	0.031
	12641835	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316479	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	12641836	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316477	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	12641837	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CC(=O)Oc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316204	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	12641838	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CN1CCN(CCNC(=O)c2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)CC1		CHEMBL2316194	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	12641839	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316478	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	12641840	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)c(NC(=O)c5ccccc5)c4)cc2CC3)O1		CHEMBL2316484	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	12641841	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccsc1		CHEMBL2316490	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	uM	0.026
	12641842	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316482	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	uM	0.021
	12641843	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C1c2ccc(Nc3ccc(F)c(NC(=O)C4CCOC4)c3)cc2CCc2ccc(OCCO)cc21		CHEMBL2316487	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	12641844	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CN1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)CC1		CHEMBL2316195	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	12641845	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316469	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	12641846	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	COC(=O)CC[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)OC		CHEMBL2316197	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	12641847	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	CN(C)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316481	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	12641848	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(NC(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316480	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	12641849	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CNC(=O)CC[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)NC		CHEMBL2316198	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	12641850	CHEMBL2317231	Inhibition of p38alpha MAP kinase in whole blood (unknown origin) assessed as lipopolysaccharide-stimulated TNF-alpha release by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)c(F)cc1F)c1ccsc1		CHEMBL2316466	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	12641851	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C1c2ccc(Nc3cc(NC(=O)C4CCOC4)c(F)cc3F)cc2CCc2ccc(OCCN3CCOCC3)cc21		CHEMBL2316496	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	12641852	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316468	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011
	12641853	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CN1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)CC1		CHEMBL2316195	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12641854	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CN1CCN(CCNC(=O)c2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)CC1		CHEMBL2316194	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12641855	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316469	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	12641856	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(NC(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316480	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	12641857	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CCCOC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316203	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	12641858	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	COC(=O)[C@H](CC(C)C)NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316199	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	uM	0.007
	12641859	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@H](O)CO)cc2C3=O)ccc1F)c1cccs1		CHEMBL2316493	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	uM	0.007
	12641860	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CCOC(=O)CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316196	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	12641861	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	COC(=O)CC[C@H](NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2)C(=O)OC		CHEMBL2316197	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	12641862	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316478	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	12641863	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	COCCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316475	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	12641864	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)c(F)cc1F)c1ccsc1		CHEMBL2316466	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	uM	0.0005
	12641865	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	12641866	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccccc2C3=O)c(F)cc1F)c1ccccc1		CHEMBL2316208	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	12641867	CHEMBL2317228	Inhibition of p38alpha MAP kinase (unknown origin) in presence of 300 uM ATP	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@@H](O)CO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316486	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12641868	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CCOC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316202	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12641869	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CN(C)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316481	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12641870	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316477	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12641871	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CS(=O)(=O)CCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316476	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12641872	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(NCCCl)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316473	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12641873	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316470	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	12641874	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(OCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316205	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641875	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316201	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641876	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316479	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641877	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CSCCNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316474	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641878	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(NCCF)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316472	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641879	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)c(NC(=O)c5cccs5)c4)cc2CC3)O1		CHEMBL2316492	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641880	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)CCc2ccc(OCCO)cc2C3=O)c1)c1ccccc1		CHEMBL2316488	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641881	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316483	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	12641882	CHEMBL2317229	Inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@@H](O)CO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316486	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	12641883	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(OCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2316206	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	12641884	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)c(F)cc1F)c1ccccc1		CHEMBL2316497	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	12641885	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	Cc1cc(F)c(NC(=O)c2ccoc2)cc1Nc1ccc2c(c1)CCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL2316494	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	12641886	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccoc1		CHEMBL2316489	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	12641887	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@@H](O)CO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316486	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	12641888	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccccc1		CHEMBL2316485	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	12641889	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1cccs1		CHEMBL2316491	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	uM	0.0007
	12641890	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccsc1		CHEMBL2316490	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	uM	0.0003
	12641891	CHEMBL2317232	Inhibition of p38alpha MAP kinase (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	uM	0.0002
	12647903	CHEMBL2329071	Inhibition of p38alpha (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	12647904	CHEMBL2329071	Inhibition of p38alpha (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	12647905	CHEMBL2329071	Inhibition of p38alpha (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	12647906	CHEMBL2329071	Inhibition of p38alpha (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	-5.0	CHEMBL260	Homo sapiens	INH	%	-5.0
	12649588	CHEMBL2329528	Inhibition of p38alpha (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1	Outside typical range	CHEMBL2325894	=	Inhibition	%	-19.0	CHEMBL260	Homo sapiens	INH	%	-19.0
	12649589	CHEMBL2329528	Inhibition of p38alpha (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	-5.0	CHEMBL260	Homo sapiens	INH	%	-5.0
	12649590	CHEMBL2329528	Inhibition of p38alpha (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	12657184	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	4.55	CHEMBL260	Homo sapiens	INH	%	4.55
	12657185	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Cc1cccc(-n2nnc(Cc3ccccc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2325040	=	Inhibition	%	-1.94	CHEMBL260	Homo sapiens	INH	%	-1.94
	12657186	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Cc1ccc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)cc1		CHEMBL2325039	=	Inhibition	%	-5.07	CHEMBL260	Homo sapiens	INH	%	-5.07
	12657187	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Cc1cccc(-n2nnc(-c3cc(F)cc(F)c3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324835	=	Inhibition	%	40.4	CHEMBL260	Homo sapiens	INH	%	40.4
	12657188	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	COc1ccc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)cc1	Outside typical range	CHEMBL2324834	=	Inhibition	%	-27.7	CHEMBL260	Homo sapiens	INH	%	-27.7
	12657189	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	COc1ccccc1-c1nnn(-c2cccc(C)n2)c1-c1ccc2nccnc2c1		CHEMBL2324833	=	Inhibition	%	18.4	CHEMBL260	Homo sapiens	INH	%	18.4
	12657190	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Cc1cccc(-n2nnc(-c3ccc(F)cc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324832	=	Inhibition	%	30.9	CHEMBL260	Homo sapiens	INH	%	30.9
	12657191	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Cc1cccc(-n2nnc(-c3ccccc3)c2-c2ccc3nccnc3c2)n1		CHEMBL2324831	=	Inhibition	%	31.2	CHEMBL260	Homo sapiens	INH	%	31.2
	12657192	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	COc1cc(OC)cc(-c2nnn(-c3cccc(C)n3)c2-c2ccc3nccnc3c2)c1		CHEMBL2324830	=	Inhibition	%	-6.87	CHEMBL260	Homo sapiens	INH	%	-6.87
	12657193	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Cc1cccc(-n2nnc(CCCCO)c2-c2ccc3nccnc3c2)n1	Outside typical range	CHEMBL2324829	=	Inhibition	%	-11.2	CHEMBL260	Homo sapiens	INH	%	-11.2
	12657194	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	Cc1cccc(-n2nnc(CCC(C)C)c2-c2ccc3nccnc3c2)n1		CHEMBL2324828	=	Inhibition	%	-5.91	CHEMBL260	Homo sapiens	INH	%	-5.91
	12657195	CHEMBL2328425	Inhibition of human P38alpha/MAPK at 10 uM in presence of 10 microM ATP	B	CCCCc1nnn(-c2cccc(C)n2)c1-c1ccc2nccnc2c1		CHEMBL2321907	=	Inhibition	%	-2.52	CHEMBL260	Homo sapiens	INH	%	-2.52
	12657867	CHEMBL2330085	Inhibition of P38alpha (unknown origin)	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5cccnn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324926	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	12657880	CHEMBL2330085	Inhibition of P38alpha (unknown origin)	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5cnccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324925	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	12657893	CHEMBL2330085	Inhibition of P38alpha (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2nccn12		CHEMBL2324924	=	IC50	nM	43.0	CHEMBL260	Homo sapiens	IC50	nM	43.0
	12657906	CHEMBL2330085	Inhibition of P38alpha (unknown origin)	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cncc5nccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324923	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	12657937	CHEMBL2330178	Binding affinity to p38alpha (unknown origin)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	2.8	CHEMBL260	Homo sapiens	Kd	nM	2.8
	12672953	CHEMBL2339293	Inhibition of recombinant p38 MAPKalpha (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	82.0	CHEMBL260	Homo sapiens	Activity	%	82.0
	12672954	CHEMBL2339293	Inhibition of recombinant p38 MAPKalpha (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	87.0	CHEMBL260	Homo sapiens	Activity	%	87.0
	12680245	CHEMBL2343184	Inhibition of p38-alpha (unknown origin) at 100 uM	B	CCc1ccc2oc(-c3ccc(N)cc3Cl)cc(=O)c2c1		CHEMBL2334408	=	Inhibition	%	14.47	CHEMBL260	Homo sapiens	INH	%	14.47
	12680258	CHEMBL2343189	Inhibition of p38-alpha (unknown origin) at 50 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	105.85	CHEMBL260	Homo sapiens	INH	%	105.85
Not Determined	12680259	CHEMBL2343189	Inhibition of p38-alpha (unknown origin) at 50 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Determined	12680260	CHEMBL2343189	Inhibition of p38-alpha (unknown origin) at 50 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	12680261	CHEMBL2343189	Inhibition of p38-alpha (unknown origin) at 50 uM	B	CCc1ccc2oc(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3Cl)cc(=O)c2c1		CHEMBL2334412	=	Inhibition	%	13.51	CHEMBL260	Homo sapiens	INH	%	13.51
Not Active	12680262	CHEMBL2343189	Inhibition of p38-alpha (unknown origin) at 50 uM	B	Nc1ccc(-c2cc(=O)c3ccc(O)cc3o2)c(Cl)c1		CHEMBL2334407		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	12700051	CHEMBL2344114	Inhibition of recombinant MAPK14 (unknown origin) by FRET-based Z'-LYTE assay	B	CN1C/C(=C\c2ccccn2)C(=O)[C@@H](Cc2ccccn2)C1		CHEMBL2338335	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	12700063	CHEMBL2344114	Inhibition of recombinant MAPK14 (unknown origin) by FRET-based Z'-LYTE assay	B	CN1C/C(=C\c2ccccn2)C(=O)[C@H](Cc2ccccn2)C1		CHEMBL2338334	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	12700075	CHEMBL2344114	Inhibition of recombinant MAPK14 (unknown origin) by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CSC/C1=C\c1ccccn1		CHEMBL2036343	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	12700087	CHEMBL2344114	Inhibition of recombinant MAPK14 (unknown origin) by FRET-based Z'-LYTE assay	B	CN1C/C(=C\c2ccccn2)C(=O)/C(=C/c2ccccn2)C1		CHEMBL2338333	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	12700100	CHEMBL2344114	Inhibition of recombinant MAPK14 (unknown origin) by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	IC50	nM	35000.0	CHEMBL260	Homo sapiens	IC50	uM	35.0
	12700158	CHEMBL2342696	Inhibition of recombinant MAPK14 (unknown origin) at 5 uM by cascade reaction assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	104.0	CHEMBL260	Homo sapiens	INH	%	104.0
	12700162	CHEMBL2344114	Inhibition of recombinant MAPK14 (unknown origin) by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccc2F)CNC/C1=C\c1ccccc1F		CHEMBL379849	=	IC50	nM	92000.0	CHEMBL260	Homo sapiens	IC50	uM	92.0
	12705252	CHEMBL2345794	Inhibition of p38alpha (unknown origin)	B	CN1c2ccc(NCc3ccc(C(C)(C)C)cc3)cc2-c2c(cnn2C)S1(=O)=O		CHEMBL2333444	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	12705253	CHEMBL2345794	Inhibition of p38alpha (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2c(cnn2C)S(=O)(=O)N3C)cc1		CHEMBL2333435	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	12705254	CHEMBL2345794	Inhibition of p38alpha (unknown origin)	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	12705464	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	CN(C)c1nc([C@@H]2CNC[C@H]2c2ccccc2)nc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333879	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705465	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	COc1ccc([C@@H]2CN(C)C[C@H]2c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2333887	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705466	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	NCc1ccc(C(=O)NC(c2ccc(Cl)cc2)c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2333884	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705467	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	CN(C)CC(=O)NC(c1ccc(Cl)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333882	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705468	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	O=c1[nH]c([C@@H]2CNC[C@H]2c2ccc(Cl)cc2)nc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333898	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705469	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	COc1cc(-c2cn[nH]c2)cc2c(=O)[nH]c(C(N)c3cccc(Cl)c3)nc12		CHEMBL2333896	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705470	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	NC(c1cccc(Cl)c1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333894	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705471	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	COc1ccc(C[C@H](N)c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2333909	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705472	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	COc1cc(-c2cn[nH]c2)cc2c(=O)[nH]c([C@H](N)Cc3cccc(F)c3)nc12		CHEMBL2333908	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705473	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	N[C@H](Cc1ccc(F)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333906	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705474	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	N[C@@H](Cc1ccc(F)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333905	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705475	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	N[C@@H](Cc1ccc(Cl)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2334293	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705476	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	O=c1[nH]c([C@@H]2CNC[C@H]2c2ccccc2)nc2ccc(-c3cn[nH]c3)cc12		CHEMBL2334292	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12705477	CHEMBL2346253	Inhibition of p38alpha (unknown origin)	B	COc1ccc(C(N)c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2334288	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	12718778	CHEMBL2353274	Inhibition of p38alpha (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	12718800	CHEMBL2350683	Inhibition of p38alpha (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	12718823	CHEMBL2350707	Inhibition of p38alpha (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	27.0	CHEMBL260	Homo sapiens	INH	%	27.0
	12721807	CHEMBL2353793	Inhibition of P38alpha (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	12727626	CHEMBL2350832	Inhibition of p38alpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	84.0	CHEMBL260	Homo sapiens	Activity	%	84.0
	12728093	CHEMBL2351308	Inhibition of N-terminal FLAG-tagged p38alpha (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-33P]ATP addition measured after 60 mins by scintillation counting analysis	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	=	IC50	nM	1700.0	CHEMBL260	Homo sapiens	IC50	nM	1700.0
	12728910	CHEMBL2352809	Inhibition of p38alpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	12729878	CHEMBL2349782	Inhibition of P38a (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	84.0	CHEMBL260	Homo sapiens	Activity	%	84.0
	12730053	CHEMBL2350832	Inhibition of p38alpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	13281335	CHEMBL2378432	Inhibition of p38alpha (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	-3.0	CHEMBL260	Homo sapiens	INH	%	-3.0
	13281336	CHEMBL2378432	Inhibition of p38alpha (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	27.0	CHEMBL260	Homo sapiens	INH	%	27.0
	13281337	CHEMBL2378432	Inhibition of p38alpha (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	-6.0	CHEMBL260	Homo sapiens	INH	%	-6.0
	13281338	CHEMBL2378432	Inhibition of p38alpha (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	13281339	CHEMBL2378432	Inhibition of p38alpha (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	-7.0	CHEMBL260	Homo sapiens	INH	%	-7.0
	13281340	CHEMBL2378432	Inhibition of p38alpha (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	13321345	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	Cc1cccc(-c2nc(-c3ccc([S+](C)[O-])cc3)[nH]c2C2=CCOCC2)c1		CHEMBL2385553	=	IC50	nM	73.0	CHEMBL260	Homo sapiens	IC50	nM	73.0
	13321346	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(C3=CCOCC3)[nH]2)cc1		CHEMBL2385552	=	IC50	nM	454.0	CHEMBL260	Homo sapiens	IC50	nM	454.0
	13321347	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	Cc1cccc(-c2nc(-c3ccc([S+](C)[O-])cc3)[nH]c2-c2ccncc2)c1		CHEMBL2385551	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	13321348	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	Cc1cccc(-c2nc(-c3ccc4ccccc4c3F)[nH]c2-c2ccncc2)c1		CHEMBL2385557	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	13321349	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	Cc1cccc(-c2nc(-c3ccc(O)cc3)[nH]c2-c2ccncc2)c1		CHEMBL2385556	=	IC50	nM	8.4	CHEMBL260	Homo sapiens	IC50	nM	8.4
	13321350	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	Cc1cccc(-c2nc(-c3ccccc3F)[nH]c2-c2ccncc2)c1		CHEMBL2385555	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
	13321351	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	Cc1cccc(-c2nc(-c3c(F)cccc3F)[nH]c2-c2ccncc2)c1		CHEMBL2385554	=	IC50	nM	4.3	CHEMBL260	Homo sapiens	IC50	nM	4.3
	13321352	CHEMBL2389974	Inhibition of recombinant GST-tagged p38alpha MAP kinase (unknown origin)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	13327651	CHEMBL2389820	Inhibition of MAPK14 (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	13327652	CHEMBL2389820	Inhibition of MAPK14 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	51.0	CHEMBL260	Homo sapiens	INH	%	51.0
	13351582	CHEMBL2399771	Inhibition of human SAPK2A at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	-1.0	CHEMBL260	Homo sapiens	INH	%	-1.0
	13371649	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnc(-c2ccccc2Cl)s1		CHEMBL2401978	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	13371734	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL2401980	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	nM	46.0
	13371735	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccn2)s1		CHEMBL2401996	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	13371736	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2ccn(C)c2c1		CHEMBL2402003	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	13371737	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2ccn(C(C)C)c2c1		CHEMBL2402004	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	13371738	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2cc[nH]c2c1		CHEMBL2402002	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	13371740	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	CCOC(=O)n1ccc2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)cc21		CHEMBL2402005	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	13371742	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2)s1		CHEMBL2401986	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	13371743	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccnc2)s1		CHEMBL2401997	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	13371744	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccncc2)s1		CHEMBL2401998	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	13371747	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccc(Cl)c2)s1		CHEMBL2401982	=	IC50	nM	8.9	CHEMBL260	Homo sapiens	IC50	nM	8.9
	13371748	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(CN(C)C)cc2)s1		CHEMBL2401992	=	IC50	nM	8.6	CHEMBL260	Homo sapiens	IC50	nM	8.6
	13371749	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(F)cc2)s1		CHEMBL2401984	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	13371750	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(-c2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)s2)cn1		CHEMBL2402001	=	IC50	nM	7.7	CHEMBL260	Homo sapiens	IC50	nM	7.7
	13371751	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cncc(F)c2)s1		CHEMBL2401999	=	IC50	nM	7.7	CHEMBL260	Homo sapiens	IC50	nM	7.7
	13371754	CHEMBL2405969	Binding affinity to human p38alpha expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccnc2)s1		CHEMBL2401997	=	Ka	10'6/M/s	5.9	CHEMBL260	Homo sapiens	Ka	10'6/M/s	5.9
	13371755	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(CO)cc2)s1		CHEMBL2401991	=	IC50	nM	5.4	CHEMBL260	Homo sapiens	IC50	nM	5.4
	13371757	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C#N)cc2)s1		CHEMBL2401990	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	13371758	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983	=	IC50	nM	4.8	CHEMBL260	Homo sapiens	IC50	nM	4.8
	13371759	CHEMBL2405969	Binding affinity to human p38alpha expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cccnc2)s1		CHEMBL2401997	=	Kd	nM	4.1	CHEMBL260	Homo sapiens	Kd	nM	4.1
	13371760	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	COc1ccc(-c2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)s2)cc1		CHEMBL2401989	=	IC50	nM	4.1	CHEMBL260	Homo sapiens	IC50	nM	4.1
	13371761	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(O)cc2)s1		CHEMBL2401987	=	IC50	nM	4.1	CHEMBL260	Homo sapiens	IC50	nM	4.1
	13371763	CHEMBL2405974	Inhibition of p38alpha (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	13371764	CHEMBL2405974	Inhibition of p38alpha (unknown origin)	B	CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258202	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	13371766	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(N)cc2)s1		CHEMBL2401988	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	13371767	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	13371768	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258202	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	13371769	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(=O)N(C)C)cc2)s1		CHEMBL2401993	=	IC50	nM	3.8	CHEMBL260	Homo sapiens	IC50	nM	3.8
	13371770	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)s1		CHEMBL2401985	=	IC50	nM	3.8	CHEMBL260	Homo sapiens	IC50	nM	3.8
	13371771	CHEMBL2405969	Binding affinity to human p38alpha expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	Kd	nM	3.3	CHEMBL260	Homo sapiens	Kd	nM	3.3
	13371772	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2cnccc2N2CCOCC2)s1		CHEMBL2402000	=	IC50	nM	2.8	CHEMBL260	Homo sapiens	IC50	nM	2.8
	13371773	CHEMBL2405966	Inhibition of human p38alpha expressed in Escherichia coli at 1 uM relative to control	B	CCOC(=O)n1ccc2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)cc21		CHEMBL2402005	=	Inhibition	%	2.5	CHEMBL260	Homo sapiens	INH	%	2.5
	13371776	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(Cl)cc2)s1		CHEMBL2401981	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	13371780	CHEMBL2405969	Binding affinity to human p38alpha expressed in Escherichia coli by surface plasmon resonance analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ncccc2C(F)(F)F)c1C		CHEMBL2401979	=	Ka	10'6/M/s	1.0	CHEMBL260	Homo sapiens	Ka	10'6/M/s	1.0
	13371783	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(=O)N3CCCCC3)cc2)s1		CHEMBL2401995	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	13371785	CHEMBL2405966	Inhibition of human p38alpha expressed in Escherichia coli at 1 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(Cl)cc2)s1		CHEMBL2401981	=	Inhibition	%	0.6	CHEMBL260	Homo sapiens	INH	%	0.6
	13371788	CHEMBL2405979	Inhibition of human p38alpha expressed in Escherichia coli using MBP as substrate preincubated for 10 mins prior to substrate addition measured after 45 mins by microbeta scintillation counting analysis	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccc(C(=O)N3CCOCC3)cc2)s1		CHEMBL2401994	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	13375792	CHEMBL2404188	Inhibition of p38alpha (unknown origin) at 10 uM by direct inhibition assay relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	13375793	CHEMBL2404187	Inhibition of p38alpha (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	13389890	CHEMBL2410834	Inhibition of p38alpha (unknown origin)	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	13389931	CHEMBL2410834	Inhibition of p38alpha (unknown origin)	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)c2)n(C)n1		CHEMBL2409790	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	13389932	CHEMBL2410834	Inhibition of p38alpha (unknown origin)	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4n3)c2)n(C)n1		CHEMBL2409781	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	13389933	CHEMBL2410834	Inhibition of p38alpha (unknown origin)	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c2)n(C)n1		CHEMBL2409779	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	13389934	CHEMBL2410834	Inhibition of p38alpha (unknown origin)	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)c2)n(C)n1		CHEMBL2409775	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	13389935	CHEMBL2410834	Inhibition of p38alpha (unknown origin)	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c2)n(C)n1		CHEMBL2348996	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	13415142	CHEMBL2423377	Inhibition of MAPK14 (unknown origin) at 1 uM	B	Cn1cc(-c2ccncc2)c(-c2ccc(F)cc2)n1		CHEMBL2420700	=	Inhibition	%	55.0	CHEMBL260	Homo sapiens	INH	%	55.0
	13415289	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	13415290	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	13415291	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	INH	%	14.0
	13415292	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	13415293	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	INH	%	14.0
	13415294	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	INH	%	21.0
	13415295	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	13415296	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	13415297	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	13415298	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	13415299	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13415300	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	13415301	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	13415302	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	13415303	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	13415304	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	13415305	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13415306	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	13415307	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13415308	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	13415309	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	13415310	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	13415311	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	13415312	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13415313	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	13415314	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	13415315	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	13415316	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	13415317	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	13415318	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	13415319	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13415320	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	13415321	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	13415322	CHEMBL2424324	Inhibition of p38alpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	13418840	CHEMBL2422668	Inhibition of MAPK14 (unknown origin)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	398.11	CHEMBL260	Homo sapiens	pIC50		6.4
	13418841	CHEMBL2422668	Inhibition of MAPK14 (unknown origin)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	IC50	nM	25118.86	CHEMBL260	Homo sapiens	pIC50		4.6
	13434630	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434631	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434632	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434633	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434634	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434635	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434636	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434637	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434638	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434639	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434640	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13434641	CHEMBL2424426	Inhibition of p38alpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL260	Homo sapiens	INH	%	35.0
	13442328	CHEMBL2429496	Competitive binding affinity to p38-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	13442441	CHEMBL2429496	Competitive binding affinity to p38-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL260	Homo sapiens	INH	%	85.0
	13442481	CHEMBL2429173	Binding affinity to p38-alpha (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	8800.0	CHEMBL260	Homo sapiens	Kd	uM	8.8
	13445463	CHEMBL2429496	Competitive binding affinity to p38-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	13448518	CHEMBL2429496	Competitive binding affinity to p38-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	13448654	CHEMBL2429496	Competitive binding affinity to p38-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	13451449	CHEMBL2429496	Competitive binding affinity to p38-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	13453009	CHEMBL2429439	Inhibition of SAPK2-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-51.0	CHEMBL260	Homo sapiens	INH	%	-51.0
	13453057	CHEMBL2429439	Inhibition of SAPK2-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-74.0	CHEMBL260	Homo sapiens	INH	%	-74.0
	13453105	CHEMBL2429439	Inhibition of SAPK2-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-96.0	CHEMBL260	Homo sapiens	INH	%	-96.0
	13454634	CHEMBL2429496	Competitive binding affinity to p38-alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	13464302	CHEMBL2432950	Inhibition of human p38alpha MAPK in presence of 50 uM ATP	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	4154.0	CHEMBL260	Homo sapiens	IC50	uM	4.154
	13464305	CHEMBL2432950	Inhibition of human p38alpha MAPK in presence of 50 uM ATP	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	IC50	nM	2042.0	CHEMBL260	Homo sapiens	IC50	uM	2.042
Not Active	13464311	CHEMBL2432950	Inhibition of human p38alpha MAPK in presence of 50 uM ATP	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323		IC50			CHEMBL260	Homo sapiens	IC50		
	13465460	CHEMBL2434209	Inhibition of human p38alpha MAPK assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	84.0	CHEMBL260	Homo sapiens	Activity	%	84.0
	13465486	CHEMBL2434381	Inhibition of human p38alpha MAPK assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	13465511	CHEMBL2434033	Inhibition of human p38alpha MAPK assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	13465534	CHEMBL2434381	Inhibition of human p38alpha MAPK assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	38.0	CHEMBL260	Homo sapiens	Activity	%	38.0
Not Active	13475263	CHEMBL2438979	Inhibition of human wild type p38alpha at 1 uM by qPCR analysis	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	13475318	CHEMBL2439758	Inhibition of wild type human P38a by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	12050.0	CHEMBL260	Homo sapiens	IC50	nM	12050.0
	13507531	CHEMBL2443988	Inhibition of P38alpha (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	13507532	CHEMBL2443988	Inhibition of P38alpha (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	13507533	CHEMBL2443988	Inhibition of P38alpha (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	13507534	CHEMBL2443988	Inhibition of P38alpha (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
Not Active	13508504	CHEMBL2447379	Inhibition of p38alpha (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	13827062	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=c1c2ccccc2ccc2cc(Nc3ccc(F)cc3F)ccc12		CHEMBL515727	=	IC50	nM	4200.0	CHEMBL260	Homo sapiens	IC50	uM	4.2
	13827063	CHEMBL3090383	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 300 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	723.0	CHEMBL260	Homo sapiens	IC50	uM	0.723
	13827064	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	uM	0.048
	13827726	CHEMBL3090383	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 300 uM ATP	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL3087471	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	13827730	CHEMBL3090390	Competitive inhibition of p38alpha MAP kinase (unknown origin) at 10 uM in presence of 100 uM ATP	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL3087471	>	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	13827731	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)OCc2c(OCCN4CCOCC4)cccc2C3=O)c1)c1ccccc1		CHEMBL3087473	=	Inhibition	%	39.0	CHEMBL260	Homo sapiens	INH	%	39.0
	13827732	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2cc(OCCN4CCOCC4)ccc2C3=O)ccc1F)c1ccccc1		CHEMBL3087472	=	Inhibition	%	36.0	CHEMBL260	Homo sapiens	INH	%	36.0
	13827733	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccccc1		CHEMBL3086685	=	Inhibition	%	34.0	CHEMBL260	Homo sapiens	INH	%	34.0
	13827734	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	Cc1ccccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3087477	=	Inhibition	%	30.3	CHEMBL260	Homo sapiens	INH	%	30.3
	13827735	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OC[C@H](O)CO)cccc21		CHEMBL3086110	=	Inhibition	%	48.5	CHEMBL260	Homo sapiens	INH	%	48.5
	13827736	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	CC1(C)OC[C@H](COc2cccc3c2COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3086108	=	Inhibition	%	42.4	CHEMBL260	Homo sapiens	INH	%	42.4
	13827737	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	CC1(C)OC[C@@H](COc2cccc3c2COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3086107	=	Inhibition	%	48.6	CHEMBL260	Homo sapiens	INH	%	48.6
	13827738	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	Nc1cc(F)ccc1Nc1ccc2c(c1)OCc1c(OCCN3CCOCC3)cccc1C2=O		CHEMBL3087489	=	Inhibition	%	38.8	CHEMBL260	Homo sapiens	INH	%	38.8
	13827739	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OCCN3CCOCC3)cccc21		CHEMBL3087488	=	Inhibition	%	32.2	CHEMBL260	Homo sapiens	INH	%	32.2
	13827740	CHEMBL3090389	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release at 100 uM by ELISA	B	COc1cccc2c1COc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL3087485	=	Inhibition	%	44.7	CHEMBL260	Homo sapiens	INH	%	44.7
Not Determined	13827741	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	CC(=O)OCCOc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086681		IC50			CHEMBL260	Homo sapiens	IC50		
	13827742	CHEMBL3090390	Competitive inhibition of p38alpha MAP kinase (unknown origin) at 10 uM in presence of 100 uM ATP	B	O=C1c2cc(OCCC3CCCCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086678	=	Inhibition	%	41.3	CHEMBL260	Homo sapiens	INH	%	41.3
	13827743	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	uM	0.052
	13827744	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941	=	IC50	nM	191.0	CHEMBL260	Homo sapiens	IC50	uM	0.191
	13827745	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940	=	IC50	nM	583.0	CHEMBL260	Homo sapiens	IC50	uM	0.583
	13827746	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2152778	=	IC50	nM	1647.0	CHEMBL260	Homo sapiens	IC50	uM	1.647
	13827747	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(O)cc21		CHEMBL2152793	=	IC50	nM	1247.0	CHEMBL260	Homo sapiens	IC50	uM	1.247
	13827748	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccccc2CCc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL515407	=	IC50	nM	1907.0	CHEMBL260	Homo sapiens	IC50	uM	1.907
	13827749	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C(Nc1cccc(Nc2ccc3c(c2)OCc2c(OCCN4CCOCC4)cccc2C3=O)c1)c1ccoc1		CHEMBL3087474	=	IC50	nM	51380.0	CHEMBL260	Homo sapiens	IC50	uM	51.38
	13827750	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL3087471	=	IC50	nM	125.0	CHEMBL260	Homo sapiens	IC50	uM	0.125
	13827751	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H]3COC(C)(C)O3)cc1C2=O		CHEMBL3087470	=	IC50	nM	287.0	CHEMBL260	Homo sapiens	IC50	uM	0.287
	13827752	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL3087469	=	IC50	nM	148.0	CHEMBL260	Homo sapiens	IC50	uM	0.148
	13827753	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)c1)c1ccccc1		CHEMBL3086686	=	IC50	nM	1560.0	CHEMBL260	Homo sapiens	IC50	uM	1.56
Not Determined	13827754	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(NCCN3CCOCC3)ccc2COc2cc(Oc3ccc(F)cc3F)ccc21		CHEMBL3086684		IC50			CHEMBL260	Homo sapiens	IC50		
	13827755	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(NCCN3CCOCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086683	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	uM	1.1
Not Determined	13827756	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccc2c(c1)C(=O)c1ccc(Oc3ccc(F)cc3F)cc1OC2		CHEMBL3086682		IC50			CHEMBL260	Homo sapiens	IC50		
	13827757	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(OCCCO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086680	=	IC50	nM	631.0	CHEMBL260	Homo sapiens	IC50	uM	0.631
	13827758	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(OCCO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086679	=	IC50	nM	588.0	CHEMBL260	Homo sapiens	IC50	uM	0.588
	13827759	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(OCCC3CCCCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086678	=	IC50	nM	18570.0	CHEMBL260	Homo sapiens	IC50	uM	18.57
	13827760	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(OCCC3CCOCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086677	=	IC50	nM	364.0	CHEMBL260	Homo sapiens	IC50	uM	0.364
	13827761	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	CCN(CC)CCOc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086676	=	IC50	nM	1060.0	CHEMBL260	Homo sapiens	IC50	uM	1.06
	13827762	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(OC[C@H](O)CO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086675	=	IC50	nM	233.0	CHEMBL260	Homo sapiens	IC50	uM	0.233
	13827763	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(OC[C@@H](O)CO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086674	=	IC50	nM	591.0	CHEMBL260	Homo sapiens	IC50	uM	0.591
	13827764	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2OC3)O1		CHEMBL3087476	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	13827765	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2OC3)O1		CHEMBL3087475	=	IC50	nM	1440.0	CHEMBL260	Homo sapiens	IC50	uM	1.44
	13827766	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1cccc(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)c1		CHEMBL3086698	=	IC50	nM	684.0	CHEMBL260	Homo sapiens	IC50	uM	0.684
	13827767	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccccc1Nc1ccc2c(c1)OCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL3086697	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	13827768	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(OCCN3CCOCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086696	=	IC50	nM	429.0	CHEMBL260	Homo sapiens	IC50	uM	0.429
	13827769	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2cc(O)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086695	=	IC50	nM	1850.0	CHEMBL260	Homo sapiens	IC50	uM	1.85
	13827770	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086694	=	IC50	nM	4710.0	CHEMBL260	Homo sapiens	IC50	uM	4.71
	13827771	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)c(F)cc3F)cc1OC2		CHEMBL3086693	=	IC50	nM	7810.0	CHEMBL260	Homo sapiens	IC50	uM	7.81
	13827772	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3)cc1OC2		CHEMBL3086692	=	IC50	nM	5700.0	CHEMBL260	Homo sapiens	IC50	uM	5.7
	13827773	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3F)cc1OC2		CHEMBL3086691	=	IC50	nM	4540.0	CHEMBL260	Homo sapiens	IC50	uM	4.54
	13827774	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1cccc(Nc2ccc3c(c2)OCc2ccc(N)cc2C3=O)c1		CHEMBL3086690	=	IC50	nM	2430.0	CHEMBL260	Homo sapiens	IC50	uM	2.43
	13827775	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3N)cc1OC2		CHEMBL3086689	=	IC50	nM	683.0	CHEMBL260	Homo sapiens	IC50	uM	0.683
	13827776	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3N)cc1OC2		CHEMBL3086688	=	IC50	nM	1170.0	CHEMBL260	Homo sapiens	IC50	uM	1.17
	13827777	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086687	=	IC50	nM	1944.0	CHEMBL260	Homo sapiens	IC50	uM	1.944
	13827778	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(OCC[C@@H](O)CO)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3087484	=	IC50	nM	37940.0	CHEMBL260	Homo sapiens	IC50	uM	37.94
	13827779	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(OC[C@@H](O)CO)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3087483	=	IC50	nM	28190.0	CHEMBL260	Homo sapiens	IC50	uM	28.19
Not Determined	13827780	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3087482		IC50			CHEMBL260	Homo sapiens	IC50		
	13827781	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	CC1(C)OC[C@@H](COc2ccc3c(c2)COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3087481	=	IC50	nM	91190.0	CHEMBL260	Homo sapiens	IC50	uM	91.19
	13827782	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	CN(C)CCOc1ccc2c(c1)COc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL3087480	=	IC50	nM	38080.0	CHEMBL260	Homo sapiens	IC50	uM	38.08
Not Determined	13827783	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(OCCC3CCOCC3)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3087479		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	13827784	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Cc1cc(F)ccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3087478		IC50			CHEMBL260	Homo sapiens	IC50		
	13827785	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1cc(F)ccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3086702	=	IC50	nM	94800.0	CHEMBL260	Homo sapiens	IC50	uM	94.8
	13827786	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	Nc1ccccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3086701	=	IC50	nM	58730.0	CHEMBL260	Homo sapiens	IC50	uM	58.73
	13827787	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(OCCN3CCOCC3)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086700	=	IC50	nM	71790.0	CHEMBL260	Homo sapiens	IC50	uM	71.79
	13827788	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	COc1ccc2c(c1)COc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL3086699	=	IC50	nM	71790.0	CHEMBL260	Homo sapiens	IC50	uM	71.79
Not Determined	13827789	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	COc1ccc2c(c1)COc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL3086111		IC50			CHEMBL260	Homo sapiens	IC50		
	13827790	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OC[C@@H](O)CO)cccc21		CHEMBL3086109	=	IC50	nM	90410.0	CHEMBL260	Homo sapiens	IC50	uM	90.41
Not Determined	13827791	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OCCC3CCOCC3)cccc21		CHEMBL3087490		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	13827792	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	COc1cccc2c1COc1cc(Nc3ccc(F)cc3N)ccc1C2=O		CHEMBL3087487		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	13827793	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	COc1cccc2c1COc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL3087486		IC50			CHEMBL260	Homo sapiens	IC50		
	13827794	CHEMBL3090388	Inhibition of p38alpha MAP kinase in human whole blood assessed as inhibition of LPS-induced TNFalpha release by ELISA	B	O=C1c2ccccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL376855	=	IC50	nM	22000.0	CHEMBL260	Homo sapiens	IC50	uM	22.0
	13827795	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	13827796	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	13827797	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	13827798	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1CC2		CHEMBL2152778	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	13827799	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(O)cc21		CHEMBL2152793	=	IC50	nM	49.0	CHEMBL260	Homo sapiens	IC50	uM	0.049
	13827800	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccccc2CCc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL515407	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	uM	0.095
	13827801	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C(Nc1cccc(Nc2ccc3c(c2)OCc2c(OCCN4CCOCC4)cccc2C3=O)c1)c1ccoc1		CHEMBL3087474	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	13827802	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)OCc2c(OCCN4CCOCC4)cccc2C3=O)c1)c1ccccc1		CHEMBL3087473	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	uM	0.01
	13827803	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2cc(OCCN4CCOCC4)ccc2C3=O)ccc1F)c1ccccc1		CHEMBL3087472	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	13827804	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL3087471	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	uM	0.0016
	13827805	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OC[C@H]3COC(C)(C)O3)cc1C2=O		CHEMBL3087470	=	IC50	nM	1.8	CHEMBL260	Homo sapiens	IC50	uM	0.0018
	13827806	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL3087469	=	IC50	nM	1.7	CHEMBL260	Homo sapiens	IC50	uM	0.0017
	13827807	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C(Nc1ccc(F)c(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)c1)c1ccccc1		CHEMBL3086686	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	uM	0.003
	13827808	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccccc1		CHEMBL3086685	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	13827809	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(NCCN3CCOCC3)ccc2COc2cc(Oc3ccc(F)cc3F)ccc21		CHEMBL3086684	=	IC50	nM	819.0	CHEMBL260	Homo sapiens	IC50	uM	0.819
	13827810	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(NCCN3CCOCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086683	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	uM	0.028
	13827811	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccc2c(c1)C(=O)c1ccc(Oc3ccc(F)cc3F)cc1OC2		CHEMBL3086682	=	IC50	nM	763.0	CHEMBL260	Homo sapiens	IC50	uM	0.763
	13827812	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CC(=O)OCCOc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086681	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	13827813	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(OCCCO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086680	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	uM	0.008
	13827814	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(OCCO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086679	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	13827815	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(OCCC3CCOCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086677	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	uM	0.079
	13827816	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CCN(CC)CCOc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086676	=	IC50	nM	101.0	CHEMBL260	Homo sapiens	IC50	uM	0.101
	13827817	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(OC[C@H](O)CO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086675	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	13827818	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(OC[C@@H](O)CO)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086674	=	IC50	nM	61.0	CHEMBL260	Homo sapiens	IC50	uM	0.061
	13827819	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2OC3)O1		CHEMBL3087476	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	uM	0.048
	13827820	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CC1(C)OC[C@@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2OC3)O1		CHEMBL3087475	=	IC50	nM	207.0	CHEMBL260	Homo sapiens	IC50	uM	0.207
	13828119	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1cccc(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)c1		CHEMBL3086698	=	IC50	nM	146.0	CHEMBL260	Homo sapiens	IC50	uM	0.146
	13828120	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccccc1Nc1ccc2c(c1)OCc1ccc(OCCN3CCOCC3)cc1C2=O		CHEMBL3086697	=	IC50	nM	107.0	CHEMBL260	Homo sapiens	IC50	uM	0.107
	13828121	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(OCCN3CCOCC3)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086696	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	uM	0.021
	13828122	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2cc(O)ccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086695	=	IC50	nM	122.0	CHEMBL260	Homo sapiens	IC50	uM	0.122
	13828123	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086694	=	IC50	nM	115.0	CHEMBL260	Homo sapiens	IC50	uM	0.115
	13828124	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)c(F)cc3F)cc1OC2		CHEMBL3086693	=	IC50	nM	74.0	CHEMBL260	Homo sapiens	IC50	uM	0.074
	13828125	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3)cc1OC2		CHEMBL3086692	=	IC50	nM	103.0	CHEMBL260	Homo sapiens	IC50	uM	0.103
	13828126	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3F)cc1OC2		CHEMBL3086691	=	IC50	nM	111.0	CHEMBL260	Homo sapiens	IC50	uM	0.111
	13828127	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1cccc(Nc2ccc3c(c2)OCc2ccc(N)cc2C3=O)c1		CHEMBL3086690	=	IC50	nM	651.0	CHEMBL260	Homo sapiens	IC50	uM	0.651
	13828128	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3N)cc1OC2		CHEMBL3086689	=	IC50	nM	205.0	CHEMBL260	Homo sapiens	IC50	uM	0.205
	13828129	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3N)cc1OC2		CHEMBL3086688	=	IC50	nM	151.0	CHEMBL260	Homo sapiens	IC50	uM	0.151
	13828130	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3086687	=	IC50	nM	43.0	CHEMBL260	Homo sapiens	IC50	uM	0.043
	13828131	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(OCC[C@@H](O)CO)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3087484	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	uM	0.021
	13828132	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(OC[C@@H](O)CO)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3087483	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	uM	0.027
	13828133	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3087482	=	IC50	nM	516.0	CHEMBL260	Homo sapiens	IC50	uM	0.516
	13828134	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CC1(C)OC[C@@H](COc2ccc3c(c2)COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3087481	=	IC50	nM	665.0	CHEMBL260	Homo sapiens	IC50	uM	0.665
	13828135	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CN(C)CCOc1ccc2c(c1)COc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL3087480	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	uM	0.053
	13828136	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(OCCC3CCOCC3)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3087479	=	IC50	nM	557.0	CHEMBL260	Homo sapiens	IC50	uM	0.557
	13828137	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Cc1cc(F)ccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3087478	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	13828138	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Cc1ccccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3087477	=	IC50	nM	85.0	CHEMBL260	Homo sapiens	IC50	uM	0.085
	13828139	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1cc(F)ccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3086702	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	uM	0.041
	13828140	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1ccccc1Nc1ccc2c(c1)OCc1cc(OCCN3CCOCC3)ccc1C2=O		CHEMBL3086701	=	IC50	nM	147.0	CHEMBL260	Homo sapiens	IC50	uM	0.147
	13828141	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(OCCN3CCOCC3)cc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL3086700	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	uM	0.033
	13828142	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1ccc2c(c1)COc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL3086699	=	IC50	nM	132.0	CHEMBL260	Homo sapiens	IC50	uM	0.132
	13828143	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1ccc2c(c1)COc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL3086111	=	IC50	nM	218.0	CHEMBL260	Homo sapiens	IC50	uM	0.218
	13828144	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OC[C@H](O)CO)cccc21		CHEMBL3086110	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	uM	0.042
	13828145	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OC[C@@H](O)CO)cccc21		CHEMBL3086109	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	uM	0.025
	13828146	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CC1(C)OC[C@H](COc2cccc3c2COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3086108	=	IC50	nM	481.0	CHEMBL260	Homo sapiens	IC50	uM	0.481
	13828147	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	CC1(C)OC[C@@H](COc2cccc3c2COc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL3086107	=	IC50	nM	563.0	CHEMBL260	Homo sapiens	IC50	uM	0.563
	13828148	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OCCC3CCOCC3)cccc21		CHEMBL3087490	=	IC50	nM	571.0	CHEMBL260	Homo sapiens	IC50	uM	0.571
	13828149	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	Nc1cc(F)ccc1Nc1ccc2c(c1)OCc1c(OCCN3CCOCC3)cccc1C2=O		CHEMBL3087489	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	uM	0.072
	13828150	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2c(OCCN3CCOCC3)cccc21		CHEMBL3087488	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	13828151	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1cccc2c1COc1cc(Nc3ccc(F)cc3N)ccc1C2=O		CHEMBL3087487	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	uM	0.087
	13828152	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1cccc2c1COc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL3087486	=	IC50	nM	94.0	CHEMBL260	Homo sapiens	IC50	uM	0.094
	13828153	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1cccc2c1COc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL3087485	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	uM	0.063
	13828154	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccccc2COc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL376855	=	IC50	nM	239.0	CHEMBL260	Homo sapiens	IC50	uM	0.239
	13828155	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	COc1cccc2c1C(=O)c1ccc(Nc3ccc(F)cc3F)cc1OC2		CHEMBL3087468	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	13828156	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2cccc(OC[C@@H](O)CO)c21		CHEMBL3087467	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	13828157	CHEMBL3090387	Competitive inhibition of p38alpha MAP kinase (unknown origin) in presence of 100 uM ATP	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2OCc2cccc(OC[C@H](O)CO)c21		CHEMBL3087466	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	13859962	CHEMBL3101956	Ratio of pirfenidone IC50 for compound IC50 for p38alpha (unknown origin) up to 60 mins by ADP-Glo assay	B	Cc1ccc(=O)n(-c2ccc(OCCCN3CCCCC3)cc2)c1		CHEMBL3099788	=	Ratio IC50		40.0	CHEMBL260	Homo sapiens	Ratio IC50		40.0
	13859963	CHEMBL3101957	Inhibition of p38alpha (unknown origin) up to 60 mins by ADP-Glo assay	B	Cc1ccc(=O)n(-c2ccccc2)c1	Outside typical range	CHEMBL1256391	=	IC50	nM	165400.0	CHEMBL260	Homo sapiens	IC50	uM	165.4
	13859964	CHEMBL3101957	Inhibition of p38alpha (unknown origin) up to 60 mins by ADP-Glo assay	B	Cc1ccc(=O)n(-c2ccc(OCCCCCN3CCCCC3)cc2)c1		CHEMBL3099800	=	IC50	nM	16190.0	CHEMBL260	Homo sapiens	IC50	uM	16.19
	13859965	CHEMBL3101957	Inhibition of p38alpha (unknown origin) up to 60 mins by ADP-Glo assay	B	Cc1ccc(=O)n(-c2ccc(OCCCCN3CCCCC3)cc2)c1		CHEMBL3099794	=	IC50	nM	5210.0	CHEMBL260	Homo sapiens	IC50	uM	5.21
	13859966	CHEMBL3101957	Inhibition of p38alpha (unknown origin) up to 60 mins by ADP-Glo assay	B	Cc1ccc(=O)n(-c2ccc(OCCCN3CCCCC3)cc2)c1		CHEMBL3099788	=	IC50	nM	4070.0	CHEMBL260	Homo sapiens	IC50	uM	4.07
	13859967	CHEMBL3101957	Inhibition of p38alpha (unknown origin) up to 60 mins by ADP-Glo assay	B	Cc1ccc(=O)n(-c2ccc(OCCCN(C)C)cc2)c1		CHEMBL3099785	=	IC50	nM	14170.0	CHEMBL260	Homo sapiens	IC50	uM	14.17
	13859968	CHEMBL3101957	Inhibition of p38alpha (unknown origin) up to 60 mins by ADP-Glo assay	B	Cc1ccc(=O)n(-c2ccc(OCCN3CCCCC3)cc2)c1		CHEMBL3099806	=	IC50	nM	54310.0	CHEMBL260	Homo sapiens	IC50	uM	54.31
Not Active	13863510	CHEMBL3101988	Inhibition of MAPK14 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	13863511	CHEMBL3101988	Inhibition of MAPK14 (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	13866139	CHEMBL3100619	Inhibition of human MAPK14 at 10 uM relative to control	B	COc1ccc(CNC(=O)c2cc(-c3cc(Cl)cc(Cl)c3)cnc2-c2cccnc2)cc1OC	Outside typical range	CHEMBL3099899	=	Inhibition	%	-29.0	CHEMBL260	Homo sapiens	INH	%	-29.0
	13871749	CHEMBL3100785	Inhibition of human SAPK2alpha assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	111.0	CHEMBL260	Homo sapiens	Activity	%	111.0
	13893405	CHEMBL3111173	Inhibition of p38alpha (unknown origin)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)c(COc3cccnc3)c2)[nH]n1		CHEMBL191598	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	uM	0.35
	13893406	CHEMBL3111173	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Cl)c(COc2cccnc2)c1)c1cc(Cl)cc(N2CCOCC2)c1		CHEMBL3109731	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	uM	0.065
	13893407	CHEMBL3111173	Inhibition of p38alpha (unknown origin)	B	Nc1ncccc1OCc1ccccc1	Outside typical range	CHEMBL194009	=	IC50	nM	1300000.0	CHEMBL260	Homo sapiens	IC50	uM	1300.0
	13893408	CHEMBL3111173	Inhibition of p38alpha (unknown origin)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccccc2)c1		CHEMBL3109732	=	IC50	nM	196.0	CHEMBL260	Homo sapiens	IC50	uM	0.196
	13925299	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C[N+](C)(C)CCO.Cn1c(-c2cnnn2CC(=O)[O-])nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120992	=	IC50	nM	4200.0	CHEMBL260	Homo sapiens	IC50	uM	4.2
	13925300	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CCOC(=O)Cn1nncc1-c1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1C		CHEMBL3120991	=	IC50	nM	56000.0	CHEMBL260	Homo sapiens	IC50	uM	56.0
	13925301	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CC(=O)N3CCN(CCO)CC3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120990	=	IC50	nM	3800.0	CHEMBL260	Homo sapiens	IC50	uM	3.8
	13925302	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	O=C(c1ccc(-n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)o3)nn2)cc1)N1CCN(CCO)CC1		CHEMBL3120989	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	uM	2.4
	13925303	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CC(=O)NCCO)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120988	=	IC50	nM	890.0	CHEMBL260	Homo sapiens	IC50	uM	0.89
	13925304	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3cccc(C(=O)NCCCO)c3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120987	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	13925305	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cl.Cn1c(-c2cn([C@H]3CCNC[C@@H]3F)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120986	=	IC50	nM	96.0	CHEMBL260	Homo sapiens	IC50	uM	0.096
	13925306	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCP(=O)([O-])[O-])nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1.[Na+].[Na+]		CHEMBL3120985	=	IC50	nM	350.0	CHEMBL260	Homo sapiens	IC50	uM	0.35
	13925307	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCOP(=O)([O-])[O-])nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1.[Na+].[Na+]		CHEMBL3120984	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	13925308	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C[N+](C)(C)CCO.Cn1c(-c2cn(-c3cccc(C(=O)[O-])c3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120173	=	IC50	nM	91.0	CHEMBL260	Homo sapiens	IC50	uM	0.091
	13925309	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3cccc(C(=O)O)c3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120983	=	IC50	nM	185.0	CHEMBL260	Homo sapiens	IC50	uM	0.185
	13925310	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn([C@@H](CC(=O)[O-])C(=O)[O-])nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1.[Na+].[Na+]		CHEMBL3120982	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	13925311	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	O=C([O-])Cn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1.[Li+]		CHEMBL3120981	=	IC50	nM	3200.0	CHEMBL260	Homo sapiens	IC50	uM	3.2
	13925312	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CC(=O)[O-])nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1.[Li+]		CHEMBL3120980	=	IC50	nM	430.0	CHEMBL260	Homo sapiens	IC50	uM	0.43
	13925313	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CC(=O)O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120979	=	IC50	nM	740.0	CHEMBL260	Homo sapiens	IC50	uM	0.74
	13925314	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	O=C(O)[C@H]1OC(n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)o3)nn2)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL3120978	=	IC50	nM	1170.0	CHEMBL260	Homo sapiens	IC50	uM	1.17
	13925315	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(C3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120977	=	IC50	nM	590.0	CHEMBL260	Homo sapiens	IC50	uM	0.59
	13925316	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	O[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1Cn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1		CHEMBL3120976	=	IC50	nM	5730.0	CHEMBL260	Homo sapiens	IC50	uM	5.73
	13925317	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(C[C@H]3O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]3O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120975	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	13925318	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(C#CCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120974	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	uM	0.46
	13925319	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)o1		CHEMBL3120973	=	IC50	nM	1790.0	CHEMBL260	Homo sapiens	IC50	uM	1.79
	13925320	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1C		CHEMBL3120972	=	IC50	nM	730.0	CHEMBL260	Homo sapiens	IC50	uM	0.73
	13925321	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Fc1ccc(-c2ncoc2-c2ccncc2)cc1		CHEMBL366007	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	13925322	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120971	=	IC50	nM	430.0	CHEMBL260	Homo sapiens	IC50	uM	0.43
	13925323	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	uM	0.04
	13925324	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1)c1ccccc1		CHEMBL3120970	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	uM	0.006
	13925325	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)n2C)nn1)OCC		CHEMBL3120969	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	13925910	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(C(C)(C)C(=O)O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120968	=	IC50	nM	1490.0	CHEMBL260	Homo sapiens	IC50	uM	1.49
	13925911	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C[C@@H](C(=O)O)n1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1		CHEMBL3120967	=	IC50	nM	11400.0	CHEMBL260	Homo sapiens	IC50	uM	11.4
	13925912	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	C[C@@H](C(=O)O)n1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)n2C)nn1		CHEMBL3120966	=	IC50	nM	1440.0	CHEMBL260	Homo sapiens	IC50	uM	1.44
Not Determined	13925913	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CCOC(=O)Cn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1		CHEMBL3120965		IC50			CHEMBL260	Homo sapiens	IC50		
	13925914	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CCOC(=O)Cn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)n2C)nn1		CHEMBL3120964	=	IC50	nM	1870.0	CHEMBL260	Homo sapiens	IC50	uM	1.87
	13925915	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCO)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120963	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	13925916	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Fc1ccc(-c2nc(-c3cn(Cc4ccccc4)nn3)oc2-c2ccncc2)cc1	Outside typical range	CHEMBL3120962	=	IC50	nM	158000.0	CHEMBL260	Homo sapiens	IC50	uM	158.0
	13925917	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Fc1ccc(-c2nc(-c3c[nH]nn3)oc2-c2ccncc2)cc1		CHEMBL3120961	=	IC50	nM	380.0	CHEMBL260	Homo sapiens	IC50	uM	0.38
	13925918	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2c[nH]nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120960	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	13925919	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	OCCOCCOCCOCCOCCOCCOCCOCCn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1		CHEMBL3120959	=	IC50	nM	23500.0	CHEMBL260	Homo sapiens	IC50	uM	23.5
	13925920	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCOCCOCCOCCOCCOCCOCCOCCO)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3121009	=	IC50	nM	11600.0	CHEMBL260	Homo sapiens	IC50	uM	11.6
	13925921	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	OCCOCCOCCOCCn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1		CHEMBL3121008	=	IC50	nM	12500.0	CHEMBL260	Homo sapiens	IC50	uM	12.5
	13925922	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCOCCOCCOCCO)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3121007	=	IC50	nM	11200.0	CHEMBL260	Homo sapiens	IC50	uM	11.2
	13925923	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCOCCOCCOCCN)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3121006	=	IC50	nM	5180.0	CHEMBL260	Homo sapiens	IC50	uM	5.18
	13925924	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	OC[C@H]1OC(O)[C@H](n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)o3)nn2)[C@@H](O)[C@@H]1O		CHEMBL3121005	=	IC50	nM	1190.0	CHEMBL260	Homo sapiens	IC50	uM	1.19
	13925925	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn([C@H]3C(O)O[C@H](CO)[C@@H](O)[C@@H]3O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3121004	=	IC50	nM	710.0	CHEMBL260	Homo sapiens	IC50	uM	0.71
	13925926	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CC(=O)OC[C@H]1O[C@H](OC(C)=O)[C@H](n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)o3)nn2)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL3121003	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	13925927	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CC(=O)OC[C@H]1O[C@H](OC(C)=O)[C@H](n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)n3C)nn2)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL3121002	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	13925928	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cl.Oc1ccccc1-n1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1		CHEMBL3121001	=	IC50	nM	2170.0	CHEMBL260	Homo sapiens	IC50	uM	2.17
	13925929	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cl.Cn1c(-c2cn(-c3ccccc3O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3121000	=	IC50	nM	1590.0	CHEMBL260	Homo sapiens	IC50	uM	1.59
	13925930	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cl.O=C(O)c1ccccc1-n1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)nn1		CHEMBL3120999	=	IC50	nM	6510.0	CHEMBL260	Homo sapiens	IC50	uM	6.51
	13925931	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cl.Cn1c(-c2cn(-c3ccccc3C(=O)O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120998	=	IC50	nM	1530.0	CHEMBL260	Homo sapiens	IC50	uM	1.53
	13925932	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	COC(=O)c1cccc(-n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)n3C)nn2)c1		CHEMBL3120997	=	IC50	nM	990.0	CHEMBL260	Homo sapiens	IC50	uM	0.99
	13925933	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	O=C(O)c1ccc(-n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)o3)nn2)cc1		CHEMBL3120996	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	13925934	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3ccc(C(=O)O)cc3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120995	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	13925935	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CN(C)c1ccc(-n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)o3)nn2)cc1		CHEMBL3120994	=	IC50	nM	19500.0	CHEMBL260	Homo sapiens	IC50	uM	19.5
	13925936	CHEMBL3123036	Inhibition of p38a MAPK (unknown origin) by radiometric assay	B	CN(C)c1ccc(-n2cc(-c3nc(-c4ccc(F)cc4)c(-c4ccncc4)n3C)nn2)cc1		CHEMBL3120993	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	13948194	CHEMBL3132601	Inhibition of C-terminal FLAG-tagged p38 alpha (unknown origin) expressed in baculovirus system using MBP as substrate after 60 mins	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	nmol/L	600.0
	13953225	CHEMBL3130704	Inhibition of human SAPK2alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	111.0	CHEMBL260	Homo sapiens	Activity	%	111.0
	13953240	CHEMBL3130704	Inhibition of human SAPK2alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	107.0	CHEMBL260	Homo sapiens	Activity	%	107.0
	13953313	CHEMBL3130704	Inhibition of human SAPK2alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	13966022	CHEMBL3136510	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13973297	CHEMBL3136890	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	13974015	CHEMBL3136479	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	13974106	CHEMBL3135617	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	2.5	CHEMBL260	Homo sapiens	INH	%	2.5
	13974197	CHEMBL3137137	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13974288	CHEMBL3136373	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13975026	CHEMBL3135986	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	13975117	CHEMBL3135713	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	13975208	CHEMBL3135797	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	13975851	CHEMBL3135314	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	13975944	CHEMBL3136998	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	13976035	CHEMBL3135391	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	6.5	CHEMBL260	Homo sapiens	INH	%	6.5
	13976126	CHEMBL3136916	Inhibition of human truncated p38 alpha expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	14525761	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1ccccc1		CHEMBL3218958	=	IC50	nM	83.0	CHEMBL260	Homo sapiens	IC50	uM	0.083
	14525762	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	O=C(Cc1ccc(F)cc1)Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1		CHEMBL3218959	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	14525763	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	O=C(Cc1ccccc1)Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1		CHEMBL3218960	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	14525764	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1ccco1		CHEMBL3218961	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	14525765	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	Cc1ccc(C(=O)Nc2cc(-c3c(-c4ccc(F)cc4)nc4n3CCS4)ccn2)cc1F		CHEMBL3218962	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	uM	0.029
	14525766	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)C1CC1c1ccccc1		CHEMBL3218963	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	14525767	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1cc2ccccc2o1		CHEMBL3218964	=	IC50	nM	115.0	CHEMBL260	Homo sapiens	IC50	uM	0.115
	14525768	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1ccc(F)cc1		CHEMBL3218965	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	14525769	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)n1C		CHEMBL3218966	=	IC50	nM	337.0	CHEMBL260	Homo sapiens	IC50	uM	0.337
	14525770	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)n1C		CHEMBL1272216	=	IC50	nM	133.0	CHEMBL260	Homo sapiens	IC50	uM	0.133
	14525771	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccccc3)c2)n1C		CHEMBL3218967	=	IC50	nM	498.0	CHEMBL260	Homo sapiens	IC50	uM	0.498
	14525772	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccco3)c2)n1C		CHEMBL3218968	=	IC50	nM	173.0	CHEMBL260	Homo sapiens	IC50	uM	0.173
	14525773	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(C)c(F)c3)c2)n1C		CHEMBL3218969	=	IC50	nM	411.0	CHEMBL260	Homo sapiens	IC50	uM	0.411
	14525774	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3c3ccccc3)c2)n1C		CHEMBL3218970	=	IC50	nM	186.0	CHEMBL260	Homo sapiens	IC50	uM	0.186
	14525775	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3cc4ccccc4o3)c2)n1C		CHEMBL3218971	=	IC50	nM	430.0	CHEMBL260	Homo sapiens	IC50	uM	0.43
	14525776	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(F)cc3)c2)n1C		CHEMBL3218972	=	IC50	nM	396.0	CHEMBL260	Homo sapiens	IC50	uM	0.396
	14525777	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)[nH]1		CHEMBL3218973	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	14525778	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1271554	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	14525779	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccccc3)c2)[nH]1		CHEMBL3218974	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	14525780	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccco3)c2)[nH]1		CHEMBL1271777	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	14525781	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(C)c(F)c3)c2)[nH]1		CHEMBL1271555	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	14525782	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3c3ccccc3)c2)[nH]1		CHEMBL3219237	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	14525783	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3cc4ccccc4o3)c2)[nH]1		CHEMBL1271663	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	uM	0.053
	14525784	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(F)cc3)c2)[nH]1		CHEMBL3219238	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	14525785	CHEMBL3222289	Inhibition of p38-alpha MAPK (unknown origin) after 3 hrs	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	14525786	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1ccccc1		CHEMBL3218958	=	Ratio IC50		0.89	CHEMBL260	Homo sapiens	Ratio IC50		0.89
	14525787	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	O=C(Cc1ccc(F)cc1)Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1		CHEMBL3218959	=	Ratio IC50		1.93	CHEMBL260	Homo sapiens	Ratio IC50		1.93
	14525788	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	O=C(Cc1ccccc1)Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1		CHEMBL3218960	=	Ratio IC50		0.97	CHEMBL260	Homo sapiens	Ratio IC50		0.97
	14525789	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1ccco1		CHEMBL3218961	=	Ratio IC50		0.63	CHEMBL260	Homo sapiens	Ratio IC50		0.63
	14525790	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)Nc2cc(-c3c(-c4ccc(F)cc4)nc4n3CCS4)ccn2)cc1F		CHEMBL3218962	=	Ratio IC50		0.96	CHEMBL260	Homo sapiens	Ratio IC50		0.96
	14525791	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)C1CC1c1ccccc1		CHEMBL3218963	=	Ratio IC50		1.4	CHEMBL260	Homo sapiens	Ratio IC50		1.4
	14525792	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1cc2ccccc2o1		CHEMBL3218964	=	Ratio IC50		0.77	CHEMBL260	Homo sapiens	Ratio IC50		0.77
	14525793	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	O=C(Nc1cc(-c2c(-c3ccc(F)cc3)nc3n2CCS3)ccn1)c1ccc(F)cc1		CHEMBL3218965	=	Ratio IC50		1.44	CHEMBL260	Homo sapiens	Ratio IC50		1.44
	14525794	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)n1C		CHEMBL3218966	=	Ratio IC50		0.18	CHEMBL260	Homo sapiens	Ratio IC50		0.18
	14525795	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)n1C		CHEMBL1272216	=	Ratio IC50		0.24	CHEMBL260	Homo sapiens	Ratio IC50		0.24
	14525796	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccccc3)c2)n1C		CHEMBL3218967	=	Ratio IC50		0.05	CHEMBL260	Homo sapiens	Ratio IC50		0.05
	14525797	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccco3)c2)n1C		CHEMBL3218968	=	Ratio IC50		0.35	CHEMBL260	Homo sapiens	Ratio IC50		0.35
	14525798	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(C)c(F)c3)c2)n1C		CHEMBL3218969	=	Ratio IC50		0.1	CHEMBL260	Homo sapiens	Ratio IC50		0.1
	14525799	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3c3ccccc3)c2)n1C		CHEMBL3218970	=	Ratio IC50		0.22	CHEMBL260	Homo sapiens	Ratio IC50		0.22
	14525800	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3cc4ccccc4o3)c2)n1C		CHEMBL3218971	=	Ratio IC50		0.1	CHEMBL260	Homo sapiens	Ratio IC50		0.1
	14525801	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(F)cc3)c2)n1C		CHEMBL3218972	=	Ratio IC50		0.16	CHEMBL260	Homo sapiens	Ratio IC50		0.16
	14525802	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccccc3)c2)[nH]1		CHEMBL3218973	=	Ratio IC50		1.36	CHEMBL260	Homo sapiens	Ratio IC50		1.36
	14525803	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(F)cc3)c2)[nH]1		CHEMBL1271554	=	Ratio IC50		3.55	CHEMBL260	Homo sapiens	Ratio IC50		3.55
	14525804	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccccc3)c2)[nH]1		CHEMBL3218974	=	Ratio IC50		1.23	CHEMBL260	Homo sapiens	Ratio IC50		1.23
	14525805	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccco3)c2)[nH]1		CHEMBL1271777	=	Ratio IC50		1.46	CHEMBL260	Homo sapiens	Ratio IC50		1.46
	14525806	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(C)c(F)c3)c2)[nH]1		CHEMBL1271555	=	Ratio IC50		1.93	CHEMBL260	Homo sapiens	Ratio IC50		1.93
	14525807	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3c3ccccc3)c2)[nH]1		CHEMBL3219237	=	Ratio IC50		1.85	CHEMBL260	Homo sapiens	Ratio IC50		1.85
	14525808	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3cc4ccccc4o3)c2)[nH]1		CHEMBL1271663	=	Ratio IC50		0.7	CHEMBL260	Homo sapiens	Ratio IC50		0.7
	14525809	CHEMBL3222290	Ratio of SB203580 IC50 to compound IC50 for p38-alpha MAPK (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccc(F)cc3)c2)[nH]1		CHEMBL3219238	=	Ratio IC50		0.61	CHEMBL260	Homo sapiens	Ratio IC50		0.61
	14536277	CHEMBL3222415	Inhibition of p38 alpha MAP kinase (unknown origin)	B	Cc1ccoc1-c1cc(-c2ccc(Br)cc2)[nH]c(=N)c1C#N		CHEMBL3219382	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	14536278	CHEMBL3222415	Inhibition of p38 alpha MAP kinase (unknown origin)	B	N#Cc1c(-c2ccc(Cl)c(Cl)c2)cc(-c2ccc(Br)cc2)[nH]c1=N		CHEMBL3219383	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	14536279	CHEMBL3222415	Inhibition of p38 alpha MAP kinase (unknown origin)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	uM	0.035
	14544096	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CC(O)c1nc(-c2cccc(CO)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL3218362	=	IC50	nM	460.0	CHEMBL260	Homo sapiens	IC50	nM	460.0
	14544097	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CCc1nc(-c2cccc(CO)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL3218363	=	IC50	nM	310.0	CHEMBL260	Homo sapiens	IC50	nM	310.0
	14544098	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	Cc1cccc(-c2nc(C(C)O)sc2-c2ccnc(NC(=O)c3ccccc3)c2)c1		CHEMBL3218364	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	14544099	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CCc1nc(-c2cccc(C(=O)O)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL3218365	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	nM	1500.0
	14544100	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	IC50	nM	71.0	CHEMBL260	Homo sapiens	IC50	nM	71.0
Dose-dependent effect	14544101	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CC(O)c1nc(-c2cccc(CO)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL3218362		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Dose-dependent effect	14544102	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CCc1nc(-c2cccc(CO)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL3218363		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Dose-dependent effect	14544103	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	Cc1cccc(-c2nc(C(C)O)sc2-c2ccnc(NC(=O)c3ccccc3)c2)c1		CHEMBL3218364		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Dose-dependent effect	14544104	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CCc1nc(-c2cccc(C(=O)O)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL3218365		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Dose-dependent effect	14544105	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	14544106	CHEMBL3224105	Displacement of SKF86002 from recombinant human p38alpha by fluorescence-based assay	B	CC(O)c1nc(-c2cccc(C(=O)O)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL3218366		IC50			CHEMBL260	Homo sapiens	IC50		
	14551095	CHEMBL3226859	Inhibition of p38 MAP kinase alpha (unknown origin) after 1 hr by Z'-lyte assay	B	Nc1c(C(=O)c2ccc(F)cc2F)ccc(=O)n1-c1c(F)cccc1F		CHEMBL3220548	=	IC50	nM	1.86	CHEMBL260	Homo sapiens	IC50	nM	1.86
	14551096	CHEMBL3226859	Inhibition of p38 MAP kinase alpha (unknown origin) after 1 hr by Z'-lyte assay	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3220549	=	IC50	nM	273.0	CHEMBL260	Homo sapiens	IC50	nM	273.0
	14551097	CHEMBL3226859	Inhibition of p38 MAP kinase alpha (unknown origin) after 1 hr by Z'-lyte assay	B	Nc1c(C(=O)c2ccc(F)cc2F)ccc(=O)n1-c1c(F)cc(OCCC[C@H](N)C(=O)OC2CCCC2)cc1F		CHEMBL3220550	=	IC50	nM	6.5	CHEMBL260	Homo sapiens	IC50	nM	6.5
	14551098	CHEMBL3226859	Inhibition of p38 MAP kinase alpha (unknown origin) after 1 hr by Z'-lyte assay	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)O		CHEMBL3220551	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	14551099	CHEMBL3226859	Inhibition of p38 MAP kinase alpha (unknown origin) after 1 hr by Z'-lyte assay	B	Nc1c(C(=O)c2ccc(F)cc2F)ccc(=O)n1-c1c(F)cc(OCCC[C@H](N)C(=O)O)cc1F		CHEMBL3220552	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	14553637	CHEMBL3225777	Inhibition of P38alpha (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	110.3	CHEMBL260	Homo sapiens	Activity	%	110.3
	14585362	CHEMBL3240782	Inhibition of human p38alpha assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	103.0	CHEMBL260	Homo sapiens	Activity	%	103.0
	14648052	CHEMBL3265836	Inhibition of human p38alpha MAPK at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	14648053	CHEMBL3265836	Inhibition of human p38alpha MAPK at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	14657740	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261092	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14657741	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261091	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14657742	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261086	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14657743	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261085	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14657744	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261084	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14657745	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=O)c3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261083	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14657746	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261095	=	IC50	nM	5210.0	CHEMBL260	Homo sapiens	IC50	uM	5.21
	14657747	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261096	=	IC50	nM	5110.0	CHEMBL260	Homo sapiens	IC50	uM	5.11
	14657748	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261087	=	IC50	nM	3770.0	CHEMBL260	Homo sapiens	IC50	uM	3.77
	14657749	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261090	=	IC50	nM	2830.0	CHEMBL260	Homo sapiens	IC50	uM	2.83
	14657750	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261089	=	IC50	nM	1490.0	CHEMBL260	Homo sapiens	IC50	uM	1.49
	14657751	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(CNC(=S)c3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3261088	=	IC50	nM	1050.0	CHEMBL260	Homo sapiens	IC50	uM	1.05
	14657752	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	590.0	CHEMBL260	Homo sapiens	IC50	uM	0.59
	14657753	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	14657786	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261093	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14657787	CHEMBL3269342	Inhibition of recombinant human p38-alpha expressed in Escherichia coli using ATF2 as substrate by radioisotope-based assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C(N)=O)c3)cc2-c2ccc3ncnn3c2)n1		CHEMBL3261094	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659488	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(COc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260564	=	IC50	nM	4890.0	CHEMBL260	Homo sapiens	IC50	uM	4.89
	14659489	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CSc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260565	=	IC50	nM	6240.0	CHEMBL260	Homo sapiens	IC50	uM	6.24
	14659490	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260566	=	IC50	nM	2290.0	CHEMBL260	Homo sapiens	IC50	uM	2.29
	14659491	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	1720.0	CHEMBL260	Homo sapiens	IC50	uM	1.72
	14659492	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3Cl)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260568	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659493	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3Br)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260569	=	IC50	nM	1980.0	CHEMBL260	Homo sapiens	IC50	uM	1.98
	14659494	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260570	=	IC50	nM	1940.0	CHEMBL260	Homo sapiens	IC50	uM	1.94
	14659495	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CCc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260571	=	IC50	nM	1530.0	CHEMBL260	Homo sapiens	IC50	uM	1.53
	14659496	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260572	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	uM	1.1
	14659497	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260573	=	IC50	nM	3680.0	CHEMBL260	Homo sapiens	IC50	uM	3.68
	14659498	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3OC(F)(F)F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260574	=	IC50	nM	2560.0	CHEMBL260	Homo sapiens	IC50	uM	2.56
	14659499	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CSc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260575	=	IC50	nM	1300.0	CHEMBL260	Homo sapiens	IC50	uM	1.3
	14659500	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	C=Cc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260576	=	IC50	nM	2050.0	CHEMBL260	Homo sapiens	IC50	uM	2.05
	14659501	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C#N)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260577	=	IC50	nM	3640.0	CHEMBL260	Homo sapiens	IC50	uM	3.64
	14659502	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C(N)=O)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260578	=	IC50	nM	3940.0	CHEMBL260	Homo sapiens	IC50	uM	3.94
	14659503	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3NS(C)(=O)=O)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260579	=	IC50	nM	1630.0	CHEMBL260	Homo sapiens	IC50	uM	1.63
	14659504	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CC(=O)Nc1ccccc1NCc1nc(-c2ccc3ncnn3c2)c(-c2cccc(C)n2)[nH]1		CHEMBL3260580	=	IC50	nM	2830.0	CHEMBL260	Homo sapiens	IC50	uM	2.83
	14659505	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260581	=	IC50	nM	820.0	CHEMBL260	Homo sapiens	IC50	uM	0.82
	14659506	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(Cl)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260582	=	IC50	nM	730.0	CHEMBL260	Homo sapiens	IC50	uM	0.73
	14659507	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(Br)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260583	=	IC50	nM	870.0	CHEMBL260	Homo sapiens	IC50	uM	0.87
	14659508	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260584	=	IC50	nM	1310.0	CHEMBL260	Homo sapiens	IC50	uM	1.31
	14659509	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CCc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260585	=	IC50	nM	1180.0	CHEMBL260	Homo sapiens	IC50	uM	1.18
	14659510	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(C)C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260586	=	IC50	nM	1210.0	CHEMBL260	Homo sapiens	IC50	uM	1.21
	14659511	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260587	=	IC50	nM	2430.0	CHEMBL260	Homo sapiens	IC50	uM	2.43
	14659512	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(OC(F)(F)F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260588	=	IC50	nM	1860.0	CHEMBL260	Homo sapiens	IC50	uM	1.86
	14659513	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CSc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260589	=	IC50	nM	700.0	CHEMBL260	Homo sapiens	IC50	uM	0.7
	14659514	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	C=Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260590	=	IC50	nM	1460.0	CHEMBL260	Homo sapiens	IC50	uM	1.46
	14659515	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260591	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	14659516	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260592	=	IC50	nM	1540.0	CHEMBL260	Homo sapiens	IC50	uM	1.54
	14659517	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CC#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260593	=	IC50	nM	1410.0	CHEMBL260	Homo sapiens	IC50	uM	1.41
	14659518	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CC(=O)c1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260594	=	IC50	nM	1280.0	CHEMBL260	Homo sapiens	IC50	uM	1.28
	14659519	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COC(=O)c1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260595	=	IC50	nM	1390.0	CHEMBL260	Homo sapiens	IC50	uM	1.39
	14659520	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(NS(C)(=O)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260596	=	IC50	nM	2270.0	CHEMBL260	Homo sapiens	IC50	uM	2.27
	14659521	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CC(=O)Nc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260597	=	IC50	nM	3980.0	CHEMBL260	Homo sapiens	IC50	uM	3.98
	14659522	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260598	=	IC50	nM	3930.0	CHEMBL260	Homo sapiens	IC50	uM	3.93
	14659523	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(Cl)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260599	=	IC50	nM	9300.0	CHEMBL260	Homo sapiens	IC50	uM	9.3
	14659524	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(Br)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260600	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659525	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260601	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659526	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(C)C)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260602	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659527	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260603	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659528	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(OC(F)(F)F)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260604	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659529	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CSc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260605	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659530	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	C=Cc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260606	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659531	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C#N)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260607	=	IC50	nM	7810.0	CHEMBL260	Homo sapiens	IC50	uM	7.81
	14659532	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C(N)=O)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260608	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659533	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(CC#N)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260609	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659534	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CC(=O)c1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260610	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659535	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COC(=O)c1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260611	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659536	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(NS(C)(=O)=O)cc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260612	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659537	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	CC(=O)Nc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL3260613	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659538	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260614	=	IC50	nM	2540.0	CHEMBL260	Homo sapiens	IC50	uM	2.54
	14659539	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(Cl)c3Cl)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260615	=	IC50	nM	8640.0	CHEMBL260	Homo sapiens	IC50	uM	8.64
	14659540	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C)c3C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260616	=	IC50	nM	3490.0	CHEMBL260	Homo sapiens	IC50	uM	3.49
	14659541	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1OC		CHEMBL3260617	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659542	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3C#N)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260618	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659543	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)c(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260619	=	IC50	nM	1250.0	CHEMBL260	Homo sapiens	IC50	uM	1.25
	14659544	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(Cl)c(Cl)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260620	=	IC50	nM	3890.0	CHEMBL260	Homo sapiens	IC50	uM	3.89
	14659545	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccc(C)c(C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260621	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659546	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COc1ccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc1OC		CHEMBL3260622	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14659547	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(F)cc(F)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260623	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	14659548	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(Cl)cc(Cl)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260624	=	IC50	nM	1070.0	CHEMBL260	Homo sapiens	IC50	uM	1.07
	14659549	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cc(C)cc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL3260625	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	14659550	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	COc1cc(NCc2nc(-c3ccc4ncnn4c3)c(-c3cccc(C)n3)[nH]2)cc(OC)c1		CHEMBL3260626	=	IC50	nM	2850.0	CHEMBL260	Homo sapiens	IC50	uM	2.85
	14659551	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	590.0	CHEMBL260	Homo sapiens	IC50	uM	0.59
	14659552	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	14659553	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(N(C)C)ccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260627	=	IC50	nM	178.0	CHEMBL260	Homo sapiens	IC50	uM	0.178
	14659554	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(CN(C)C)ccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260628	=	IC50	nM	2480.0	CHEMBL260	Homo sapiens	IC50	uM	2.48
	14659555	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CN(C)C)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260629	=	IC50	nM	4110.0	CHEMBL260	Homo sapiens	IC50	uM	4.11
	14659556	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CN4CCCC4)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260630	=	IC50	nM	4100.0	CHEMBL260	Homo sapiens	IC50	uM	4.1
	14659557	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(CN4CCOCC4)c3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260631	=	IC50	nM	1710.0	CHEMBL260	Homo sapiens	IC50	uM	1.71
	14659558	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3CN(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260897	=	IC50	nM	699.0	CHEMBL260	Homo sapiens	IC50	uM	0.699
	14659559	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3CN3CCCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260898	=	IC50	nM	2420.0	CHEMBL260	Homo sapiens	IC50	uM	2.42
	14659560	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cccc(C#N)c3CN3CCOCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260899	=	IC50	nM	2230.0	CHEMBL260	Homo sapiens	IC50	uM	2.23
	14659561	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(N(C)C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260900	=	IC50	nM	393.0	CHEMBL260	Homo sapiens	IC50	uM	0.393
	14659562	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(CN(C)C)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260901	=	IC50	nM	844.0	CHEMBL260	Homo sapiens	IC50	uM	0.844
	14659563	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(CN4CCCC4)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260902	=	IC50	nM	2350.0	CHEMBL260	Homo sapiens	IC50	uM	2.35
	14659564	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)cc(CN4CCOCC4)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260903	=	IC50	nM	384.0	CHEMBL260	Homo sapiens	IC50	uM	0.384
	14659565	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3N(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260904	=	IC50	nM	142.0	CHEMBL260	Homo sapiens	IC50	uM	0.142
	14659566	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3CN(C)C)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260905	=	IC50	nM	259.0	CHEMBL260	Homo sapiens	IC50	uM	0.259
	14659567	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3CN3CCCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260906	=	IC50	nM	533.0	CHEMBL260	Homo sapiens	IC50	uM	0.533
	14659568	CHEMBL3268789	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3cc(C#N)ccc3CN3CCOCC3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260907	=	IC50	nM	422.0	CHEMBL260	Homo sapiens	IC50	uM	0.422
	14664263	CHEMBL3271247	Inhibition of p38-alpha (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	76.0	CHEMBL260	Homo sapiens	INH	%	76.0
	14664264	CHEMBL3271247	Inhibition of p38-alpha (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	14664265	CHEMBL3271247	Inhibition of p38-alpha (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	14668878	CHEMBL3269301	Inhibition of SAPK2a (unknown origin) assessed as residual activity at 1 uM	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1		CHEMBL3264257	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	14710324	CHEMBL3292197	Inhibition of human SAPK2alpha assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4ccccc4)c23)C1=O		CHEMBL3290628	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	14710325	CHEMBL3292197	Inhibition of human SAPK2alpha assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4cccc(OCCN5CCCCC5)c4)c23)C1=O.Cl		CHEMBL3290631	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
Active	14728309	CHEMBL3292433	Inhibition of P38-alpha MAPK (unknown origin) at 0.5 uM by [33P]-ATP filter binding assay	B	C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290142		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	14751799	CHEMBL3300949	Inhibition of P38alpha (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14751800	CHEMBL3300949	Inhibition of P38alpha (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	14983186	CHEMBL3385013	Inhibition of MAPK14 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	14984428	CHEMBL3384363	Inhibition of MAPK14 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	20.0	CHEMBL260	Homo sapiens	INH	%	20.0
	14999360	CHEMBL3368451	Inhibition of human p38alpha MAPK at 10 uM relative to control	B	CC(C)(C)C1=NN(c2ccc(Cl)cc2)C(c2ccc(O)cc2)C1		CHEMBL3323314	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	15008111	CHEMBL3369114	Inhibition of human SAPK2a at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1	Outside typical range	CHEMBL3330255	=	Inhibition	%	-12.0	CHEMBL260	Homo sapiens	INH	%	-12.0
	15008112	CHEMBL3369114	Inhibition of human SAPK2a at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	-2.0	CHEMBL260	Homo sapiens	INH	%	-2.0
	15008113	CHEMBL3369114	Inhibition of human SAPK2a at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1	Outside typical range	CHEMBL3330410	=	Inhibition	%	-28.0	CHEMBL260	Homo sapiens	INH	%	-28.0
	15009802	CHEMBL3363742	Inhibition of P38a/MAPK14 (unknown origin)	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	8.66	CHEMBL260	Homo sapiens	IC50	nM	8.66
	15014125	CHEMBL3361637	Inhibition of P38a/MAPK14 (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	94.3	CHEMBL260	Homo sapiens	INH	%	94.3
	15014130	CHEMBL3363742	Inhibition of P38a/MAPK14 (unknown origin)	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	IC50	nM	571.0	CHEMBL260	Homo sapiens	IC50	nM	571.0
Not Determined	15014174	CHEMBL3363742	Inhibition of P38a/MAPK14 (unknown origin)	B	O=C1Nc2ccc(I)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL72365		IC50			CHEMBL260	Homo sapiens	IC50		
	15019184	CHEMBL3364377	Inhibition of MAPK14 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	INH	%	17.0
	15036893	CHEMBL3381094	Inhibition of P38alpha (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15036894	CHEMBL3381094	Inhibition of P38alpha (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15036895	CHEMBL3381094	Inhibition of P38alpha (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15036896	CHEMBL3381094	Inhibition of P38alpha (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15036897	CHEMBL3381094	Inhibition of P38alpha (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15037303	CHEMBL3368570	Inhibition of p38alpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	96.0	CHEMBL260	Homo sapiens	INH	%	96.0
	15037304	CHEMBL3368570	Inhibition of p38alpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	15037305	CHEMBL3368570	Inhibition of p38alpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	94.0	CHEMBL260	Homo sapiens	INH	%	94.0
	15037306	CHEMBL3368570	Inhibition of p38alpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	15037307	CHEMBL3368570	Inhibition of p38alpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	93.0	CHEMBL260	Homo sapiens	INH	%	93.0
	15040634	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	15040635	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2c[nH]nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120960	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	15040636	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3ccc(C(=O)O)cc3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120995	=	IC50	nM	166.0	CHEMBL260	Homo sapiens	IC50	uM	0.166
	15040637	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3cccc(C(=O)O)c3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120983	=	IC50	nM	185.0	CHEMBL260	Homo sapiens	IC50	uM	0.185
	15040638	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCO)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120963	=	IC50	nM	783.0	CHEMBL260	Homo sapiens	IC50	uM	0.783
	15040639	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn([C@H]3[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]3O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3314270	=	IC50	nM	1020.0	CHEMBL260	Homo sapiens	IC50	uM	1.02
	15040640	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Cl.Cn1c(-c2cn([C@H]3CCNC[C@@H]3F)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120986	=	IC50	nM	96.0	CHEMBL260	Homo sapiens	IC50	uM	0.096
	15040641	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)n2C)nn1)OCC		CHEMBL3120969	=	IC50	nM	2480.0	CHEMBL260	Homo sapiens	IC50	uM	2.48
	15040642	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCP(=O)([O-])[O-])nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1.[Na+].[Na+]		CHEMBL3120985	=	IC50	nM	345.0	CHEMBL260	Homo sapiens	IC50	uM	0.345
	15040643	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1)c1ccccc1		CHEMBL3120970	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	uM	0.0085
	15040644	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1		CHEMBL3314271	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	15040645	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	C#Cc1ccn2c(-c3ccnc(SC)n3)c(-c3ccc(F)cc3)nc2n1		CHEMBL3314272	=	IC50	nM	2510.0	CHEMBL260	Homo sapiens	IC50	uM	2.51
	15040646	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(-c4cn(CC(=O)[O-])nn4)ccn23)n1.[Na+]		CHEMBL3314273	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	15040647	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2ccn3c(-c4ccnc(SC)n4)c(-c4ccc(F)cc4)nc3n2)nn1)OCC		CHEMBL3314274	=	IC50	nM	12000.0	CHEMBL260	Homo sapiens	IC50	10'-5M	1.2
	15040648	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(-c4cn(CCP(=O)([O-])[O-])nn4)ccn23)n1.[Na+].[Na+]		CHEMBL3314275	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	15040649	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	C#Cc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1		CHEMBL3314276	=	IC50	nM	9390.0	CHEMBL260	Homo sapiens	IC50	uM	9.39
	15040650	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4cn(CCO)nn4)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314277	=	IC50	nM	18600.0	CHEMBL260	Homo sapiens	IC50	uM	18.6
	15040651	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CCOC(=O)Cn1cc(-c2ccc(-c3nc(-c4ccc(F)cc4)c(-c4cc[nH]c(=O)c4)[nH]3)cc2)nn1		CHEMBL3314278	=	IC50	nM	32900.0	CHEMBL260	Homo sapiens	IC50	uM	32.9
	15040652	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2ccc(-c3nc(-c4ccc(F)cc4)c(-c4cc[nH]c(=O)c4)[nH]3)cc2)nn1)OCC		CHEMBL3314279	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	15040653	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4cn(CCP(=O)([O-])[O-])nn4)cc3)nc2-c2ccc(F)cc2)cc[nH]1.[Na+].[Na+]		CHEMBL3314280	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	15040654	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314281	=	IC50	nM	4960.0	CHEMBL260	Homo sapiens	IC50	uM	4.96
	15040655	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	O=C([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1.[Na+]		CHEMBL3313935	=	IC50	nM	2940.0	CHEMBL260	Homo sapiens	IC50	uM	2.94
	15040656	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	O=C([O-])c1cc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)ccc1O.[Na+]		CHEMBL3314282	=	IC50	nM	6810.0	CHEMBL260	Homo sapiens	IC50	uM	6.81
	15040657	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(C3CCNCC3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314283	=	IC50	nM	1140.0	CHEMBL260	Homo sapiens	IC50	uM	1.14
	15040658	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4nnn[n-]4)cc3)nc2-c2ccc(F)cc2)cc[nH]1.[K+]		CHEMBL3314284	=	IC50	nM	2530.0	CHEMBL260	Homo sapiens	IC50	uM	2.53
	15040659	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	CSc1nccc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)n1		CHEMBL3314285	=	IC50	nM	95.5	CHEMBL260	Homo sapiens	IC50	10'-8M	9.55
	15040660	CHEMBL3363471	Inhibition of p38alpha MAPK (unknown origin) by radiometric assay	B	C#Cc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc(SC)n3)[nH]2)cc1		CHEMBL3314286	=	IC50	nM	82100.0	CHEMBL260	Homo sapiens	IC50	10'-5M	8.21
Not Active	15040773	CHEMBL3363479	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of IL-6 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=c1cc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314281		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040774	CHEMBL3363479	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of IL-6 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=C([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1.[Na+]		CHEMBL3313935		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040775	CHEMBL3363479	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of IL-6 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=C([O-])c1cc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)ccc1O.[Na+]		CHEMBL3314282		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040776	CHEMBL3363479	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of IL-6 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=c1cc(-c2[nH]c(C3CCNCC3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314283		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040777	CHEMBL3363480	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of COX-2 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=c1cc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314281		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040778	CHEMBL3363480	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of COX-2 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=C([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1.[Na+]		CHEMBL3313935		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040779	CHEMBL3363480	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of COX-2 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=C([O-])c1cc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)ccc1O.[Na+]		CHEMBL3314282		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040780	CHEMBL3363480	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of COX-2 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=c1cc(-c2[nH]c(C3CCNCC3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314283		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040781	CHEMBL3363481	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of VCAM-1 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=c1cc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314281		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040782	CHEMBL3363481	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of VCAM-1 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=C([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1.[Na+]		CHEMBL3313935		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040783	CHEMBL3363481	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of VCAM-1 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=C([O-])c1cc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)ccc1O.[Na+]		CHEMBL3314282		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15040784	CHEMBL3363481	Inhibition of p38alpha MAPK in TNF-alpha-induced HUVEC assessed as downregulation of VCAM-1 mRNA expression at 10 uM incubated for 4 hrs by RT-PCR analysis	B	O=c1cc(-c2[nH]c(C3CCNCC3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314283		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	15040785	CHEMBL3363482	Inhibition of p38alpha MAPK (unknown origin)	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1)c1ccccc1		CHEMBL3120970	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	15049566	CHEMBL3369574	Binding affinity to p38alpha MAP kinase (unknown origin) by NMR analysis	B	CS(=O)(=O)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL280317	=	Kd	nM	11.0	CHEMBL260	Homo sapiens	Kd	nM	11.0
	15061123	CHEMBL3376306	Inhibition of p38alpha (unknown origin) at 1 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CNCCO1		CHEMBL3322987	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	15062479	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1233024	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
	15062480	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Fc1ccc(-c2n[nH]c(CCCc3ccccc3)c2-c2ccncc2)cc1		CHEMBL3310126	=	IC50	nM	0.95	CHEMBL260	Homo sapiens	IC50	nM	0.95
	15062481	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Nc1[nH]nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3310127	=	IC50	nM	97.4	CHEMBL260	Homo sapiens	IC50	nM	97.4
	15062482	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1)Nc1[nH]nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3310128	=	IC50	nM	16.5	CHEMBL260	Homo sapiens	IC50	nM	16.5
	15062483	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccncc2)c1N		CHEMBL3310129	=	IC50	nM	70.4	CHEMBL260	Homo sapiens	IC50	nM	70.4
	15062484	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Cn1nc(NC(=O)Cc2ccccc2)c(-c2ccncc2)c1-c1ccc(F)cc1		CHEMBL3310130	=	IC50	nM	5.72	CHEMBL260	Homo sapiens	IC50	nM	5.72
	15062485	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Nc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3310131	=	IC50	nM	105.0	CHEMBL260	Homo sapiens	IC50	nM	105.0
	15062486	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Fc1ccc(-c2nocc2-c2ccncc2)cc1		CHEMBL3310132	=	IC50	nM	871.0	CHEMBL260	Homo sapiens	IC50	nM	871.0
	15062487	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	CC(=O)Nc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3310133	=	IC50	nM	1310.0	CHEMBL260	Homo sapiens	IC50	nM	1310.0
	15062488	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Nc1onc(Nc2ccc(F)cc2)c1-c1ccncc1)c1ccccc1		CHEMBL3310134	=	IC50	nM	1210.0	CHEMBL260	Homo sapiens	IC50	nM	1210.0
	15062489	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1)Nc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3310135	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	15062490	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(CCc1ccccc1)Nc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3310136	=	IC50	nM	23.4	CHEMBL260	Homo sapiens	IC50	nM	23.4
	15062491	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(CCCc1ccccc1)Nc1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3310137	=	IC50	nM	271.0	CHEMBL260	Homo sapiens	IC50	nM	271.0
	15062492	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310138	=	IC50	nM	792.0	CHEMBL260	Homo sapiens	IC50	nM	792.0
	15062493	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310139	=	IC50	nM	45.6	CHEMBL260	Homo sapiens	IC50	nM	45.6
	15062494	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1F)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310140	=	IC50	nM	33.2	CHEMBL260	Homo sapiens	IC50	nM	33.2
	15062495	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310141	=	IC50	nM	6.88	CHEMBL260	Homo sapiens	IC50	nM	6.88
	15062496	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142	=	IC50	nM	10.9	CHEMBL260	Homo sapiens	IC50	nM	10.9
	15062497	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Cc1ccc(C)c(CC(=O)Nc2onc(-c3ccc(F)cc3)c2-c2ccncn2)c1		CHEMBL3310143	=	IC50	nM	8.43	CHEMBL260	Homo sapiens	IC50	nM	8.43
	15062498	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1)Nc1onc(-c2ccccc2Cl)c1-c1ccncn1		CHEMBL3310144	=	IC50	nM	141.0	CHEMBL260	Homo sapiens	IC50	nM	141.0
	15062499	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1Cl)Nc1onc(-c2ccc(Cl)cc2)c1-c1ccncn1		CHEMBL3310145	=	IC50	nM	10.8	CHEMBL260	Homo sapiens	IC50	nM	10.8
	15062500	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1Cl)Nc1onc(-c2ccc(F)cc2F)c1-c1ccncn1		CHEMBL3310146	=	IC50	nM	2.73	CHEMBL260	Homo sapiens	IC50	nM	2.73
	15062501	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1)Nc1onc(-c2c(F)cccc2F)c1-c1ccncn1		CHEMBL3310147	=	IC50	nM	294.0	CHEMBL260	Homo sapiens	IC50	nM	294.0
	15062502	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	O=C(Cc1ccccc1)Nc1onc(-c2c(Cl)cccc2Cl)c1-c1ccncn1		CHEMBL3310148	=	IC50	nM	1010.0	CHEMBL260	Homo sapiens	IC50	nM	1010.0
	15062503	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Cc1cccc(-c2noc(NC(=O)Cc3ccccc3Cl)c2-c2ccncn2)c1		CHEMBL3310149	=	IC50	nM	3.62	CHEMBL260	Homo sapiens	IC50	nM	3.62
	15062504	CHEMBL3370278	Inhibition of full length human p38alpha MAP kinase by Off-chip mobility shift assay	B	Cc1cc(-c2noc(NC(=O)Cc3ccccc3C)c2-c2ccncn2)ccc1F		CHEMBL3310276	=	IC50	nM	5.48	CHEMBL260	Homo sapiens	IC50	nM	5.48
	15072488	CHEMBL3379507	Inhibition of p38alpha (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
Not Active	15074245	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	Cc1ccc(NC(=O)c2ccc(F)c(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)c2)cn1		CHEMBL3355156		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074246	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	Cc1cc(NC(=O)c2cccc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)c2)ccn1		CHEMBL3355165		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074247	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	Cc1cc(NC(=O)c2cccc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)c2)cc(C)n1		CHEMBL3355166		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074248	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	Cc1ccc(CNC(=O)c2cccc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)c2)cn1		CHEMBL3355168		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074249	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	CN(C)CCn1cc(NC(=O)c2cccc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)c2)cn1		CHEMBL3352845		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074250	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	O=C(Nc1cnn(-c2cccc(C(=O)Nc3cnn(C4CCNCC4)c3)c2)c1)Nc1ccccc1Cl		CHEMBL3355177		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074251	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	O=C(Nc1cnn(-c2cccc(C(=O)Nc3cnn(C4CCNC4)c3)c2)c1)Nc1ccccc1Cl		CHEMBL3355178		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074252	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	CCN(CC)CCNC(=O)c1cccc(-n2cc(NC(=O)Nc3ccccc3Cl)cn2)c1		CHEMBL3355179		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15074253	CHEMBL3372271	Inhibition of p38alpha (unknown origin) up to 10 uM after 1 hr by homogeneous time-resolved fluorescence assay	B	O=C(Nc1cnn(-c2cccc(C(=O)NCC3CCNCC3)c2)c1)Nc1ccccc1Cl		CHEMBL3355181		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	15074404	CHEMBL3372842	Inhibition of p38alpha (unknown origin) after 1 hr by homogeneous time-resolved fluorescence assay	B	CC(C)n1cc(NC(=O)c2cccc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)c2)cn1		CHEMBL3355174	=	IC50	nM	3623.0	CHEMBL260	Homo sapiens	IC50	nM	3623.0
	15091078	CHEMBL3382224	Inhibition of human recombinant p38alpha kinase expressed Escherichia coli using Ulight-CFFKNIVTPRTPPPSQGK-amide substrate assessed as remaining enzyme activity at 1 uM after 60 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
Not Active	15107520	CHEMBL3375316	Inhibition of human MAPK1 assessed as enzyme activity at 10 uM	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccccc2)cc1		CHEMBL213805		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	15112140	CHEMBL3388152	Inhibition of p38alpha (unknown origin)	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	15126915	CHEMBL3367703	Inhibition of human SAPK2a assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	72.0	CHEMBL260	Homo sapiens	Activity	%	72.0
	15126974	CHEMBL3367703	Inhibition of human SAPK2a assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	59.0	CHEMBL260	Homo sapiens	Activity	%	59.0
	15127006	CHEMBL3367703	Inhibition of human SAPK2a assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	99.0	CHEMBL260	Homo sapiens	Activity	%	99.0
	15149232	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL3394097	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	15149233	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	COC(=O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL3394094	=	IC50	nM	297.0	CHEMBL260	Homo sapiens	IC50	uM	0.297
	15149234	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCC(=O)N(C)C)n2C)ccn1		CHEMBL3394095	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	15149235	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCC(=O)O)n2C)ccn1		CHEMBL3394096	=	IC50	nM	1666.0	CHEMBL260	Homo sapiens	IC50	uM	1.666
	15149236	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SCCC(=O)O)n2C)ccn1		CHEMBL3394098	=	IC50	nM	246.0	CHEMBL260	Homo sapiens	IC50	uM	0.246
	15149237	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	COC(Cn1c(SCCC(=O)O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394099	=	IC50	nM	1699.0	CHEMBL260	Homo sapiens	IC50	uM	1.699
	15149238	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C)ccn1		CHEMBL3394100	=	IC50	nM	191.0	CHEMBL260	Homo sapiens	IC50	uM	0.191
	15149239	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	COC(Cn1c(S/C=C\C(=O)O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394101	=	IC50	nM	335.0	CHEMBL260	Homo sapiens	IC50	uM	0.335
	15149240	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	=	IC50	nM	123.0	CHEMBL260	Homo sapiens	IC50	uM	0.123
	15149241	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCC2)ccn1		CHEMBL3394103	=	IC50	nM	211.0	CHEMBL260	Homo sapiens	IC50	uM	0.211
	15149242	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCC2)ccn1		CHEMBL3394104	=	IC50	nM	164.0	CHEMBL260	Homo sapiens	IC50	uM	0.164
	15149243	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	=	IC50	nM	165.0	CHEMBL260	Homo sapiens	IC50	uM	0.165
	15149244	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CC2)ccn1		CHEMBL3394106	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	15149245	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCCC2)ccn1		CHEMBL3394107	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	15149246	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	=	IC50	nM	223.0	CHEMBL260	Homo sapiens	IC50	uM	0.223
	15149247	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC(O)CO)ccn1		CHEMBL3394109	=	IC50	nM	723.0	CHEMBL260	Homo sapiens	IC50	uM	0.723
	15149248	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SC3CCC(C(=O)O)CC3O)n2C2CCCCC2)ccn1		CHEMBL3394110	=	IC50	nM	416.0	CHEMBL260	Homo sapiens	IC50	uM	0.416
	15149249	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SC3CCC(C(=O)O)CC3O)n2C)ccn1		CHEMBL3394111	=	IC50	nM	764.0	CHEMBL260	Homo sapiens	IC50	uM	0.764
	15149250	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	=	IC50	nM	135.0	CHEMBL260	Homo sapiens	IC50	uM	0.135
	15149251	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(SC3CCC(C(=O)O)CC3O)n2CC2CCCO2)ccn1		CHEMBL3394113	=	IC50	nM	612.0	CHEMBL260	Homo sapiens	IC50	uM	0.612
	15149252	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CCOC(=O)/C=C/Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C1CC1		CHEMBL3394114	=	IC50	nM	451.0	CHEMBL260	Homo sapiens	IC50	uM	0.451
	15149253	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CCOC(=O)/C=C/Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CC(OC)OC		CHEMBL3394115	=	IC50	nM	2184.0	CHEMBL260	Homo sapiens	IC50	uM	2.184
	15149254	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CCOC(=O)/C=C/Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1CC1CC1		CHEMBL3394116	=	IC50	nM	655.0	CHEMBL260	Homo sapiens	IC50	uM	0.655
	15149255	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C/C(=O)O)n2CC2CC2)ccn1		CHEMBL3394117	=	IC50	nM	208.0	CHEMBL260	Homo sapiens	IC50	uM	0.208
	15149256	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	=	IC50	nM	356.0	CHEMBL260	Homo sapiens	IC50	uM	0.356
	15149257	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	COC(Cn1c(SCC#N)nc(-c2ccc(F)cc2)c1-c1ccnc(F)c1)OC		CHEMBL3394093	=	IC50	nM	642.0	CHEMBL260	Homo sapiens	IC50	uM	0.642
	15149258	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	COC(Cn1c(SCC#N)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CC2)c1)OC		CHEMBL3394119	=	IC50	nM	153.0	CHEMBL260	Homo sapiens	IC50	uM	0.153
	15149855	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	COC(Cn1c(S/C=C\C(=O)O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CC2)c1)OC		CHEMBL3394120	=	IC50	nM	128.0	CHEMBL260	Homo sapiens	IC50	uM	0.128
	15149856	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CCC(C)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC(OC)OC)ccn1		CHEMBL3394121	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	uM	0.034
	15149857	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CCNC(=O)N1CCC(Nc2cc(-c3c(-c4ccc(F)cc4)nc(S/C=C\C(=O)O)n3C)ccn2)CC1		CHEMBL3394122	=	IC50	nM	146.0	CHEMBL260	Homo sapiens	IC50	uM	0.146
	15149858	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	O=C(O)/C=C\Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)n1CC1CC1		CHEMBL3394123	=	IC50	nM	354.0	CHEMBL260	Homo sapiens	IC50	uM	0.354
	15149859	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	O=C(O)/C=C/Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)n1CC1CC1		CHEMBL3394124	=	IC50	nM	181.0	CHEMBL260	Homo sapiens	IC50	uM	0.181
	15149860	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	O=C(O)/C=C\Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1		CHEMBL3394125	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	uM	0.036
	15149861	CHEMBL3395778	Inhibition of p38alpha (unknown origin) assessed as phosphorylation of ATF-2 by ELISA	B	CCOC(=O)/C=C\Sc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1		CHEMBL3394126	=	IC50	nM	146.0	CHEMBL260	Homo sapiens	IC50	uM	0.146
	15150103	CHEMBL3396175	Inhibition of p38a (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	15150104	CHEMBL3396175	Inhibition of p38a (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	15150105	CHEMBL3396175	Inhibition of p38a (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	15150106	CHEMBL3396175	Inhibition of p38a (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	15150107	CHEMBL3396175	Inhibition of p38a (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	15150569	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccc(Cl)cc1		CHEMBL3393304	=	IC50	nM	390.0	CHEMBL260	Homo sapiens	IC50	uM	0.39
	15150570	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(C(=O)O)ccc2C)cnn1-c1ccccc1		CHEMBL3393303	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	uM	0.086
	15150571	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(C)(=O)=O)ccc2C)cnn1-c1ccccc1		CHEMBL3393302	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	15150572	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(C(=O)OC)ccc2C)cnn1-c1ccccc1		CHEMBL3393301	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	15150573	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(OCc3ccccc3)ccc2C)cnn1-c1ccccc1		CHEMBL3393300	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	15150574	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(O)ccc2C)cnn1-c1ccccc1		CHEMBL3393299	<	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	15150575	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(C#N)ccc2C)cnn1-c1ccccc1		CHEMBL3393298	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	15150576	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(F)ccc2C)cnn1-c1ccccc1		CHEMBL3393297	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	uM	0.11
	15150577	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	IC50	nM	61.0	CHEMBL260	Homo sapiens	IC50	uM	0.061
	15150578	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncn2)cc1		CHEMBL3393063	=	IC50	nM	2800.0	CHEMBL260	Homo sapiens	IC50	uM	2.8
	15150579	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2cccnc2)cc1		CHEMBL3393295	=	IC50	nM	560.0	CHEMBL260	Homo sapiens	IC50	uM	0.56
	15150580	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccccc2)cc1		CHEMBL3393294	=	IC50	nM	450.0	CHEMBL260	Homo sapiens	IC50	uM	0.45
	15150581	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2Cl)cc1		CHEMBL3393293	=	IC50	nM	1700.0	CHEMBL260	Homo sapiens	IC50	uM	1.7
	15150582	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL3393292	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	uM	2.0
	15150583	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	15150584	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(F)cc2)cc1		CHEMBL3393291	=	IC50	nM	2100.0	CHEMBL260	Homo sapiens	IC50	uM	2.1
	15150585	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(Cl)cc2)cc1		CHEMBL3393290	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	uM	2.4
	15150586	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	Cc1ccc(Oc2ccc(C(=O)NCc3ccncc3)cc2)cc1		CHEMBL1427458	=	IC50	nM	4700.0	CHEMBL260	Homo sapiens	IC50	uM	4.7
	15150587	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2)cc1		CHEMBL1607077	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	15150588	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1cccnc1		CHEMBL3393305	=	IC50	nM	270.0	CHEMBL260	Homo sapiens	IC50	uM	0.27
	15150589	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1Cc1ccccc1		CHEMBL3393306	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	uM	0.053
	15150590	CHEMBL3396501	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46 to 400) as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1CC(C)C		CHEMBL3393307	=	IC50	nM	76.0	CHEMBL260	Homo sapiens	IC50	uM	0.076
	15150591	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2)cc1		CHEMBL1607077	=	IC50	nM	4000.0	CHEMBL260	Homo sapiens	IC50	uM	4.0
	15150592	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	Cc1ccc(Oc2ccc(C(=O)NCc3ccncc3)cc2)cc1		CHEMBL1427458	=	IC50	nM	22000.0	CHEMBL260	Homo sapiens	IC50	uM	22.0
	15150593	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(Cl)cc2)cc1		CHEMBL3393290	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150594	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(F)cc2)cc1		CHEMBL3393291	=	IC50	nM	2300.0	CHEMBL260	Homo sapiens	IC50	uM	2.3
	15150595	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	IC50	nM	21000.0	CHEMBL260	Homo sapiens	IC50	uM	21.0
	15150596	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL3393292	=	IC50	nM	5400.0	CHEMBL260	Homo sapiens	IC50	uM	5.4
	15150597	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2Cl)cc1		CHEMBL3393293	=	IC50	nM	1700.0	CHEMBL260	Homo sapiens	IC50	uM	1.7
	15150598	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccccc2)cc1		CHEMBL3393294	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	15150599	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2cccnc2)cc1		CHEMBL3393295	=	IC50	nM	15000.0	CHEMBL260	Homo sapiens	IC50	uM	15.0
	15150600	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncn2)cc1		CHEMBL3393063	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	15150601	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	IC50	nM	9700.0	CHEMBL260	Homo sapiens	IC50	uM	9.7
	15150602	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(F)ccc2C)cnn1-c1ccccc1		CHEMBL3393297	=	IC50	nM	2500.0	CHEMBL260	Homo sapiens	IC50	uM	2.5
	15150603	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(C#N)ccc2C)cnn1-c1ccccc1		CHEMBL3393298	=	IC50	nM	890.0	CHEMBL260	Homo sapiens	IC50	uM	0.89
	15150604	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(O)ccc2C)cnn1-c1ccccc1		CHEMBL3393299	<	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	15150605	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(OCc3ccccc3)ccc2C)cnn1-c1ccccc1		CHEMBL3393300	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	15150606	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(C(=O)OC)ccc2C)cnn1-c1ccccc1		CHEMBL3393301	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	15150607	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(C)(=O)=O)ccc2C)cnn1-c1ccccc1		CHEMBL3393302	=	IC50	nM	23000.0	CHEMBL260	Homo sapiens	IC50	uM	23.0
	15150608	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(C(=O)O)ccc2C)cnn1-c1ccccc1		CHEMBL3393303	=	IC50	nM	4200.0	CHEMBL260	Homo sapiens	IC50	uM	4.2
	15150609	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccc(Cl)cc1		CHEMBL3393304	=	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	15150610	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1cccnc1		CHEMBL3393305	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	15150611	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1Cc1ccccc1		CHEMBL3393306	=	IC50	nM	6300.0	CHEMBL260	Homo sapiens	IC50	uM	6.3
	15150612	CHEMBL3396502	Inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate assessed as inhibition of phosphorylation after 60 mins by ELISA in presence of ATP	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1CC(C)C		CHEMBL3393307	=	IC50	nM	5400.0	CHEMBL260	Homo sapiens	IC50	uM	5.4
	15150613	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2)cc1		CHEMBL1607077	=	Ratio IC50		1.7	CHEMBL260	Homo sapiens	Ratio IC50		1.7
	15150614	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	Cc1ccc(Oc2ccc(C(=O)NCc3ccncc3)cc2)cc1		CHEMBL1427458	=	Ratio IC50		4.7	CHEMBL260	Homo sapiens	Ratio IC50		4.7
	15150615	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(Cl)cc2)cc1		CHEMBL3393290	=	Ratio IC50		4.2	CHEMBL260	Homo sapiens	Ratio IC50		4.2
	15150616	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(F)cc2)cc1		CHEMBL3393291	=	Ratio IC50		1.1	CHEMBL260	Homo sapiens	Ratio IC50		1.1
	15150617	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	Ratio IC50		34.0	CHEMBL260	Homo sapiens	Ratio IC50		34.0
	15150618	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL3393292	=	Ratio IC50		2.7	CHEMBL260	Homo sapiens	Ratio IC50		2.7
	15150619	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2Cl)cc1		CHEMBL3393293	=	Ratio IC50		1.0	CHEMBL260	Homo sapiens	Ratio IC50		1.0
	15150620	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccccc2)cc1		CHEMBL3393294	>	Ratio IC50		220.0	CHEMBL260	Homo sapiens	Ratio IC50		220.0
	15150621	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2cccnc2)cc1		CHEMBL3393295	=	Ratio IC50		27.0	CHEMBL260	Homo sapiens	Ratio IC50		27.0
	15150622	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncn2)cc1		CHEMBL3393063	>	Ratio IC50		36.0	CHEMBL260	Homo sapiens	Ratio IC50		36.0
	15150623	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	Ratio IC50		160.0	CHEMBL260	Homo sapiens	Ratio IC50		160.0
	15150624	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(F)ccc2C)cnn1-c1ccccc1		CHEMBL3393297	=	Ratio IC50		23.0	CHEMBL260	Homo sapiens	Ratio IC50		23.0
	15150625	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(C#N)ccc2C)cnn1-c1ccccc1		CHEMBL3393298	=	Ratio IC50		60.0	CHEMBL260	Homo sapiens	Ratio IC50		60.0
	15150626	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(C(=O)OC)ccc2C)cnn1-c1ccccc1		CHEMBL3393301	=	Ratio IC50		1.0	CHEMBL260	Homo sapiens	Ratio IC50		1.0
	15150627	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(C)(=O)=O)ccc2C)cnn1-c1ccccc1		CHEMBL3393302	=	Ratio IC50		120.0	CHEMBL260	Homo sapiens	Ratio IC50		120.0
	15150628	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(C(=O)O)ccc2C)cnn1-c1ccccc1		CHEMBL3393303	=	Ratio IC50		49.0	CHEMBL260	Homo sapiens	Ratio IC50		49.0
	15150629	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccc(Cl)cc1		CHEMBL3393304	=	Ratio IC50		50.0	CHEMBL260	Homo sapiens	Ratio IC50		50.0
	15150630	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1cccnc1		CHEMBL3393305	>	Ratio IC50		110.0	CHEMBL260	Homo sapiens	Ratio IC50		110.0
	15150631	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1Cc1ccccc1		CHEMBL3393306	=	Ratio IC50		120.0	CHEMBL260	Homo sapiens	Ratio IC50		120.0
	15150632	CHEMBL3396503	Selectivity ratio of IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MSK1 as substrate to IC50 for human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1CC(C)C		CHEMBL3393307	=	Ratio IC50		72.0	CHEMBL260	Homo sapiens	Ratio IC50		72.0
	15150633	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2)cc1		CHEMBL1607077	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150634	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	Cc1ccc(Oc2ccc(C(=O)NCc3ccncc3)cc2)cc1		CHEMBL1427458	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150635	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(Cl)cc2)cc1		CHEMBL3393290	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150636	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	O=C(NCc1ccncc1)c1ccc(Oc2ccc(F)cc2)cc1		CHEMBL3393291	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150637	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150638	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL3393292	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150639	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	O=C(NCc1ccncc1)c1ccc(Oc2ccccc2Cl)cc1		CHEMBL3393293	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150640	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccccc2)cc1		CHEMBL3393294	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150641	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2cccnc2)cc1		CHEMBL3393295	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150642	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncn2)cc1		CHEMBL3393063	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150643	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150644	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(F)ccc2C)cnn1-c1ccccc1		CHEMBL3393297	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150645	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(C#N)ccc2C)cnn1-c1ccccc1		CHEMBL3393298	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150646	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(O)ccc2C)cnn1-c1ccccc1		CHEMBL3393299	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150647	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(OCc3ccccc3)ccc2C)cnn1-c1ccccc1		CHEMBL3393300	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150648	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(C(=O)OC)ccc2C)cnn1-c1ccccc1		CHEMBL3393301	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150649	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(S(C)(=O)=O)ccc2C)cnn1-c1ccccc1		CHEMBL3393302	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150650	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(C(=O)O)ccc2C)cnn1-c1ccccc1		CHEMBL3393303	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150651	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccc(Cl)cc1		CHEMBL3393304	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150652	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1cccnc1		CHEMBL3393305	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150653	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1Cc1ccccc1		CHEMBL3393306	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150654	CHEMBL3396504	Inhibition of p38-alpha (unknown origin) by p38alpha-MBP IoC assay	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1CC(C)C		CHEMBL3393307	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15150663	CHEMBL3396506	Inhibition of p38-alpha in human PBMC assessed as inhibition of LPS-induced TNF-alpha production incubated for 30 mins prior to LPS challenge measured after 7 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	IC50	nM	5400.0	CHEMBL260	Homo sapiens	IC50	uM	5.4
Not Determined	15150664	CHEMBL3396506	Inhibition of p38-alpha in human PBMC assessed as inhibition of LPS-induced TNF-alpha production incubated for 30 mins prior to LPS challenge measured after 7 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccccc2)cc1		CHEMBL3393294		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	15150665	CHEMBL3396506	Inhibition of p38-alpha in human PBMC assessed as inhibition of LPS-induced TNF-alpha production incubated for 30 mins prior to LPS challenge measured after 7 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2cccnc2)cc1		CHEMBL3393295		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	15150666	CHEMBL3396506	Inhibition of p38-alpha in human PBMC assessed as inhibition of LPS-induced TNF-alpha production incubated for 30 mins prior to LPS challenge measured after 7 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncn2)cc1		CHEMBL3393063		IC50			CHEMBL260	Homo sapiens	IC50		
	15150667	CHEMBL3396506	Inhibition of p38-alpha in human PBMC assessed as inhibition of LPS-induced TNF-alpha production incubated for 30 mins prior to LPS challenge measured after 7 hrs by ELISA	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
Not Determined	15150668	CHEMBL3396506	Inhibition of p38-alpha in human PBMC assessed as inhibition of LPS-induced TNF-alpha production incubated for 30 mins prior to LPS challenge measured after 7 hrs by ELISA	B	CCCc1c(C(=O)Nc2cc(C#N)ccc2C)cnn1-c1ccccc1		CHEMBL3393298		IC50			CHEMBL260	Homo sapiens	IC50		
	15150669	CHEMBL3396506	Inhibition of p38-alpha in human PBMC assessed as inhibition of LPS-induced TNF-alpha production incubated for 30 mins prior to LPS challenge measured after 7 hrs by ELISA	B	CCCc1c(C(=O)Nc2cc(C(=O)O)ccc2C)cnn1-c1ccccc1		CHEMBL3393303	=	IC50	nM	21000.0	CHEMBL260	Homo sapiens	IC50	uM	21.0
	15150670	CHEMBL3396507	Inhibition of p38-alpha in human TC28 cells assessed as inhibition of IL-1-induced PGE2 production incubated for 20 mins prior to IL-1 challenge measured after 24 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	IC50	nM	25000.0	CHEMBL260	Homo sapiens	IC50	uM	25.0
	15150671	CHEMBL3396507	Inhibition of p38-alpha in human TC28 cells assessed as inhibition of IL-1-induced PGE2 production incubated for 20 mins prior to IL-1 challenge measured after 24 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccccc2)cc1		CHEMBL3393294	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	15150672	CHEMBL3396507	Inhibition of p38-alpha in human TC28 cells assessed as inhibition of IL-1-induced PGE2 production incubated for 20 mins prior to IL-1 challenge measured after 24 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2cccnc2)cc1		CHEMBL3393295	=	IC50	nM	4700.0	CHEMBL260	Homo sapiens	IC50	uM	4.7
	15150673	CHEMBL3396507	Inhibition of p38-alpha in human TC28 cells assessed as inhibition of IL-1-induced PGE2 production incubated for 20 mins prior to IL-1 challenge measured after 24 hrs by ELISA	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncn2)cc1		CHEMBL3393063	=	IC50	nM	7100.0	CHEMBL260	Homo sapiens	IC50	uM	7.1
	15150674	CHEMBL3396507	Inhibition of p38-alpha in human TC28 cells assessed as inhibition of IL-1-induced PGE2 production incubated for 20 mins prior to IL-1 challenge measured after 24 hrs by ELISA	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	IC50	nM	970.0	CHEMBL260	Homo sapiens	IC50	uM	0.97
	15150675	CHEMBL3396507	Inhibition of p38-alpha in human TC28 cells assessed as inhibition of IL-1-induced PGE2 production incubated for 20 mins prior to IL-1 challenge measured after 24 hrs by ELISA	B	CCCc1c(C(=O)Nc2cc(C#N)ccc2C)cnn1-c1ccccc1		CHEMBL3393298	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
Not Determined	15150676	CHEMBL3396507	Inhibition of p38-alpha in human TC28 cells assessed as inhibition of IL-1-induced PGE2 production incubated for 20 mins prior to IL-1 challenge measured after 24 hrs by ELISA	B	CCCc1c(C(=O)Nc2cc(C(=O)O)ccc2C)cnn1-c1ccccc1		CHEMBL3393303		IC50			CHEMBL260	Homo sapiens	IC50		
	15150677	CHEMBL3396508	Inhibition of p38-alpha (unknown origin) at 10 uM	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	Inhibition	%	30.0	CHEMBL260	Homo sapiens	INH	%	30.0
	15150678	CHEMBL3396508	Inhibition of p38-alpha (unknown origin) at 10 uM	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	Inhibition	%	30.0	CHEMBL260	Homo sapiens	INH	%	30.0
	15150701	CHEMBL3396515	Competitive inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	Ki	nM	290.0	CHEMBL260	Homo sapiens	Ki	uM	0.29
	15150702	CHEMBL3396515	Competitive inhibition of human recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	Ki	nM	14.0	CHEMBL260	Homo sapiens	Ki	uM	0.014
	15150703	CHEMBL3396516	Displacement of 1-[7-[3-[4-(aminomethyl)-1-piperidyl]propoxy]-6-methoxy-quinazolin-4-yl]-3-(2-chloro-6-methylphenyl)urea from GST-tagged phosphorylated p38-alpha (unknown origin) at 20 uM by surface plasmon resonance based ISA method	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	Activity	%	17.0	CHEMBL260	Homo sapiens	Activity	%	17.0
	15150704	CHEMBL3396517	Displacement of 1-[7-[3-[4-(aminomethyl)-1-piperidyl]propoxy]-6-methoxy-quinazolin-4-yl]-3-(2-chloro-6-methylphenyl)urea from GST-tagged phosphorylated p38-alpha (unknown origin) by surface plasmon resonance based ISA method	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	>	Kd	nM	20000.0	CHEMBL260	Homo sapiens	Kd	uM	20.0
	15150705	CHEMBL3396517	Displacement of 1-[7-[3-[4-(aminomethyl)-1-piperidyl]propoxy]-6-methoxy-quinazolin-4-yl]-3-(2-chloro-6-methylphenyl)urea from GST-tagged phosphorylated p38-alpha (unknown origin) by surface plasmon resonance based ISA method	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	Kd	nM	15400.0	CHEMBL260	Homo sapiens	Kd	uM	15.4
	15150706	CHEMBL3396518	Ratio of Kd for GST-tagged phosphorylated p38-alpha (unknown origin) to IC50 for uman recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	Ratio		100.0	CHEMBL260	Homo sapiens	Ratio		100.0
	15150707	CHEMBL3396518	Ratio of Kd for GST-tagged phosphorylated p38-alpha (unknown origin) to IC50 for uman recombinant 5'-c-myc, His6-tagged p38-alpha using MK2 (46-400) as substrate	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	Ratio		250.0	CHEMBL260	Homo sapiens	Ratio		250.0
	15150708	CHEMBL3395580	Binding affinity to phosphorylated full length 2H,15N-labeled p38-alpha (unknown origin) expressed in Escherichia coli by 2D-NMR analysis	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293	=	Activity	uM	50.0	CHEMBL260	Homo sapiens	Activity	uM	50.0
Not Active	15150709	CHEMBL3395580	Binding affinity to phosphorylated full length 2H,15N-labeled p38-alpha (unknown origin) expressed in Escherichia coli by 2D-NMR analysis	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296		Activity			CHEMBL260	Homo sapiens	Activity		
Active	15150710	CHEMBL3395581	Binding affinity to phosphorylated full length 2H,15N-labeled p38-alpha (unknown origin)/MK2 complex expressed in Escherichia coli by 2D-NMR analysis	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293		Activity			CHEMBL260	Homo sapiens	Activity		
Active	15150711	CHEMBL3395581	Binding affinity to phosphorylated full length 2H,15N-labeled p38-alpha (unknown origin)/MK2 complex expressed in Escherichia coli by 2D-NMR analysis	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296		Activity			CHEMBL260	Homo sapiens	Activity		
Active	15150712	CHEMBL3395582	Binding affinity to full length 2H,15N-labeled p38-alpha (unknown origin)/MK2 complex expressed in Escherichia coli by 2D-NMR analysis	B	N#Cc1ccccc1Oc1ccc(C(=O)NCc2ccncc2)cc1		CHEMBL1796293		Activity			CHEMBL260	Homo sapiens	Activity		
Active	15150713	CHEMBL3395582	Binding affinity to full length 2H,15N-labeled p38-alpha (unknown origin)/MK2 complex expressed in Escherichia coli by 2D-NMR analysis	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296		Activity			CHEMBL260	Homo sapiens	Activity		
	15150717	CHEMBL3396517	Displacement of 1-[7-[3-[4-(aminomethyl)-1-piperidyl]propoxy]-6-methoxy-quinazolin-4-yl]-3-(2-chloro-6-methylphenyl)urea from GST-tagged phosphorylated p38-alpha (unknown origin) by surface plasmon resonance based ISA method	B	CCCc1c(C(=O)Nc2cc(S(=O)(=O)N(C)C)ccc2C)cnn1-c1ccccc1		CHEMBL3393296	=	logKd		1.19	CHEMBL260	Homo sapiens	logKd		1.19
	15191139	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	43.0	CHEMBL260	Homo sapiens	INH	%	43.0
	15191140	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	28.0	CHEMBL260	Homo sapiens	INH	%	28.0
	15191141	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	INH	%	21.0
	15191142	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	15191143	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	15191144	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	15191145	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	15192330	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	65.0	CHEMBL260	Homo sapiens	INH	%	65.0
	15192331	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	67.0	CHEMBL260	Homo sapiens	INH	%	67.0
	15192332	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	89.0	CHEMBL260	Homo sapiens	INH	%	89.0
	15192333	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	15192334	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	15192335	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	15192336	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	15192337	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	15192338	CHEMBL3413721	Inhibition of p38alpha (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
Not Active	15217639	CHEMBL3419837	Inhibition of SAPK2a (unknown origin) assessed as reduction in kinase activity at 10 uM using ATP	B	COCCCNC(=O)c1sc2ncnc(Nc3cc(C)cn(C)c3=O)c2c1C		CHEMBL3417204		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15217640	CHEMBL3419837	Inhibition of SAPK2a (unknown origin) assessed as reduction in kinase activity at 10 uM using ATP	B	COCCn1cc(C)cc(Nc2ncnc3sc(C(=O)O)c(C)c23)c1=O		CHEMBL3417199		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	15217641	CHEMBL3419837	Inhibition of SAPK2a (unknown origin) assessed as reduction in kinase activity at 10 uM using ATP	B	Cc1cc(Nc2ncnc3sc(C(=O)O)c(C)c23)c(=O)n(C)c1		CHEMBL3417198		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	15251806	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	15251991	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	63.0	CHEMBL260	Homo sapiens	Activity	%	63.0
	15252636	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	109.0	CHEMBL260	Homo sapiens	Activity	%	109.0
	15252738	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	107.0	CHEMBL260	Homo sapiens	Activity	%	107.0
	15252840	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	89.0	CHEMBL260	Homo sapiens	Activity	%	89.0
	15253514	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	109.0	CHEMBL260	Homo sapiens	Activity	%	109.0
	15253616	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	108.0	CHEMBL260	Homo sapiens	Activity	%	108.0
	15253718	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	15254384	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	15254486	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	15254588	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	15255278	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	15255381	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	15255483	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	15256215	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	99.0	CHEMBL260	Homo sapiens	Activity	%	99.0
	15256317	CHEMBL3428741	Inhibition of p38alpha MAPK(unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	15604080	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	37.4	CHEMBL260	Homo sapiens	IC50	nM	37.4
	15604081	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccc(Cl)cc4)cc3)N=C2c2ccccc2)cc1		CHEMBL3577645	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	15604082	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4cccc(Cl)c4)cc3)N=C2c2ccccc2)cc1		CHEMBL3577644	=	IC50	nM	4.5	CHEMBL260	Homo sapiens	IC50	nM	4.5
	15604083	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4Cl)cc3)N=C2c2ccccc2)cc1		CHEMBL3577643	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
	15604084	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(NC(=O)COc2ccc(/C=C3\N=C(c4ccccc4)N(c4ccc(OC)cc4)C3=O)cc2)cc1		CHEMBL3577642	=	IC50	nM	345.0	CHEMBL260	Homo sapiens	IC50	nM	345.0
	15604085	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4cccc(OC)c4)cc3)N=C2c2ccccc2)cc1		CHEMBL3577641	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	15604086	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4OC)cc3)N=C2c2ccccc2)cc1		CHEMBL3577640	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	15604087	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccc(C)cc4)cc3)N=C2c2ccccc2)cc1		CHEMBL3577639	=	IC50	nM	345.0	CHEMBL260	Homo sapiens	IC50	nM	345.0
	15604088	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4cccc(C)c4)cc3)N=C2c2ccccc2)cc1		CHEMBL3577638	=	IC50	nM	77.0	CHEMBL260	Homo sapiens	IC50	nM	77.0
	15604089	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4C)cc3)N=C2c2ccccc2)cc1		CHEMBL3577637	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
	15604090	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4)cc3)N=C2c2ccccc2)cc1		CHEMBL3577636	=	IC50	nM	354.0	CHEMBL260	Homo sapiens	IC50	nM	354.0
	15604091	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccc(Cl)cc4)cc3)N=C2c2ccccc2)c1		CHEMBL3577635	=	IC50	nM	4.6	CHEMBL260	Homo sapiens	IC50	nM	4.6
	15604092	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4cccc(Cl)c4)cc3)N=C2c2ccccc2)c1		CHEMBL3577634	=	IC50	nM	3.7	CHEMBL260	Homo sapiens	IC50	nM	3.7
	15604093	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4Cl)cc3)N=C2c2ccccc2)c1		CHEMBL3577633	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
	15604094	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1ccc(NC(=O)COc2ccc(/C=C3\N=C(c4ccccc4)N(c4cccc(OC)c4)C3=O)cc2)cc1		CHEMBL3577632	=	IC50	nM	4.3	CHEMBL260	Homo sapiens	IC50	nM	4.3
	15604095	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(NC(=O)COc2ccc(/C=C3\N=C(c4ccccc4)N(c4cccc(OC)c4)C3=O)cc2)c1		CHEMBL3577631	=	IC50	nM	6.5	CHEMBL260	Homo sapiens	IC50	nM	6.5
	15604096	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4OC)cc3)N=C2c2ccccc2)c1		CHEMBL3577567	=	IC50	nM	54.0	CHEMBL260	Homo sapiens	IC50	nM	54.0
	15604097	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccc(C)cc4)cc3)N=C2c2ccccc2)c1		CHEMBL3577566	=	IC50	nM	4.5	CHEMBL260	Homo sapiens	IC50	nM	4.5
	15604098	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4cccc(C)c4)cc3)N=C2c2ccccc2)c1		CHEMBL3577565	=	IC50	nM	87.0	CHEMBL260	Homo sapiens	IC50	nM	87.0
	15604099	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4C)cc3)N=C2c2ccccc2)c1		CHEMBL3577564	=	IC50	nM	66.0	CHEMBL260	Homo sapiens	IC50	nM	66.0
	15604100	CHEMBL3580221	Inhibition of p38alpha MAP kinase (unknown origin) using GFP-ATF2 as substrate after 1 hr by TR-FRET assay	B	COc1cccc(N2C(=O)/C(=C/c3ccc(OCC(=O)Nc4ccccc4)cc3)N=C2c2ccccc2)c1		CHEMBL3577563	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	15650163	CHEMBL3595483	Inhibition of human MAPK14 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	15685906	CHEMBL3608085	Inhibition of human P38alpha	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	15747322	CHEMBL3624073	Inhibition of MAPK1 (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	>	Activity	%	65.0	CHEMBL260	Homo sapiens	Activity	%	65.0
	15747330	CHEMBL3624081	Inhibition of Sapk2A (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	>	Activity	%	65.0	CHEMBL260	Homo sapiens	Activity	%	65.0
	15754255	CHEMBL3631180	Inhibition of p38alpha (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	14.6	CHEMBL260	Homo sapiens	INH	%	14.6
	15755906	CHEMBL3630849	Inhibition of p38-alpha (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	15756882	CHEMBL3630746	Inhibition of P38alpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	98.88	CHEMBL260	Homo sapiens	INH	%	98.88
	15757841	CHEMBL3630746	Inhibition of P38alpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	18.83	CHEMBL260	Homo sapiens	INH	%	18.83
	15758820	CHEMBL3630746	Inhibition of P38alpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	62.29	CHEMBL260	Homo sapiens	INH	%	62.29
	15766647	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634706	=	IC50	nM	209.0	CHEMBL260	Homo sapiens	IC50	nM	209.0
	15766648	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634705	=	IC50	nM	766.0	CHEMBL260	Homo sapiens	IC50	nM	766.0
	15766649	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634704	=	IC50	nM	399.0	CHEMBL260	Homo sapiens	IC50	nM	399.0
	15766665	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1ccc(F)c(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634707	=	IC50	nM	251.0	CHEMBL260	Homo sapiens	IC50	nM	251.0
	15766666	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	C=Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3nc(C)ccc3F)[nH]2)c1		CHEMBL3634708	=	IC50	nM	171.0	CHEMBL260	Homo sapiens	IC50	nM	171.0
	15766667	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cc(F)cc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634709	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	15766668	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cc(F)cc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3634710	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	15766669	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634711	=	IC50	nM	2040.0	CHEMBL260	Homo sapiens	IC50	nM	2040.0
	15766670	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634712	=	IC50	nM	3370.0	CHEMBL260	Homo sapiens	IC50	nM	3370.0
	15766671	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3cccc(C#N)c3)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634799	=	IC50	nM	1240.0	CHEMBL260	Homo sapiens	IC50	nM	1240.0
	15766672	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1nc(-c2[nH]c(CNc3cccc(C(N)=O)c3)nc2-c2ccc3ncnn3c2)ccc1F		CHEMBL3634800	=	IC50	nM	1480.0	CHEMBL260	Homo sapiens	IC50	nM	1480.0
	15766673	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	C=Cc1cccc(NCc2nc(-c3ccc4ncnn4c3)c(-c3ccc(F)c(C)n3)[nH]2)c1		CHEMBL3634801	=	IC50	nM	1810.0	CHEMBL260	Homo sapiens	IC50	nM	1810.0
	15766674	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	668.0	CHEMBL260	Homo sapiens	IC50	nM	668.0
	15766675	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	405.0	CHEMBL260	Homo sapiens	IC50	nM	405.0
	15766676	CHEMBL3635885	Inhibition of human recombinant p38alpha expressed in Escherichia coli using ATF2 as substrate by proprietary radioisotopic protein kinase assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	2180.0	CHEMBL260	Homo sapiens	IC50	nM	2180.0
Not Active	15774420	CHEMBL3636794	Inhibition of P38a (unknown origin) after 120 mins by HotSpot assay	B	CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1		CHEMBL3633929		IC50			CHEMBL260	Homo sapiens	IC50		
278461	16258906	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL1090975	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
278478	16259457	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)ccc1CO		CHEMBL3695590	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
278474	16260242	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ncccc23)cc1		CHEMBL3695571	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
278482	16260393	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695573	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
278465	16267680	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccccc2)n1		CHEMBL1214131	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
278462	16279514	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)n(-c2ccccc2)n1		CHEMBL1093756	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
278493	16280770	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CSc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695581	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
278463	16281378	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cc1		CHEMBL1090979	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
191805	16287253	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ncnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695595	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
278485	16291708	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695573	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
278486	16292498	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CNS(=O)(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695574	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
278483	16295248	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695594	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
278480	16298365	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(CO)nc2)n1		CHEMBL3695592	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
278484	16298382	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cn1		CHEMBL3695572	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
278473	16299960	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c(Cl)c2Cl)cc1		CHEMBL3695586	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
278459	16303295	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695568	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
278466	16307159	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL1214134	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
278469	16307928	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL3695582	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
278489	16308250	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C3(C)CC3)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695577	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
278481	16310298	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)s1		CHEMBL3695593	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
278487	16315002	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(Cl)cc2)n1		CHEMBL3695575	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
278490	16316767	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695578	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
278464	16326146	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ncccc23)n(-c2ccccc2)n1		CHEMBL3695570	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
278475	16327460	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ncnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL3695587	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
278460	16329243	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695569	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
278458	16331516	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
278492	16332032	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(Cl)c(Cl)c2)n1		CHEMBL3695580	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
278491	16332085	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL3695579	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
278467	16332294	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1nc2c(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c4ccccc34)ccnc2[nH]c1=O		CHEMBL1214132	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
278471	16339010	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CCn1c(=O)[nH]c2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OC)cc4)c4ccccc34)c21		CHEMBL3695584	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
278477	16339462	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(CO)cc2)n1		CHEMBL3695589	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
278468	16341887	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)c(C)nc34)c3ccccc23)cc1		CHEMBL1214135	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
278472	16342437	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C(C)C)c34)c3ccccc23)cc1		CHEMBL3695585	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
278470	16342502	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cc1		CHEMBL3695583	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
278488	16346213	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695576	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
278479	16355246	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c(Cl)c2Cl)n(-c2ccc(CO)cc2)n1		CHEMBL3695591	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
278476	16355819	CHEMBL3705477	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3695588	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	16376467	CHEMBL3734491	Inhibition of recombinant human P38alpha using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O	Outside typical range	CHEMBL3732044	=	Inhibition	%	-13.0	CHEMBL260	Homo sapiens	INH	%	-13.0
	16379673	CHEMBL3739153	Inhibition of p38alpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-1.8	CHEMBL260	Homo sapiens	INH	%	-1.8
	16379674	CHEMBL3739153	Inhibition of p38alpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	-1.0	CHEMBL260	Homo sapiens	INH	%	-1.0
	16388311	CHEMBL3737486	Inhibition of p38 alpha (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	16397539	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	16397540	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	16397541	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	16397542	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	16397543	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	16397544	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	22.0	CHEMBL260	Homo sapiens	INH	%	22.0
	16397545	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	16397546	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	16397547	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	INH	%	21.0
	16397548	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	16397549	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	16397550	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	16397551	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	16397552	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	16397553	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	16397554	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	16397555	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	32.0	CHEMBL260	Homo sapiens	INH	%	32.0
	16397556	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	INH	%	24.0
	16397557	CHEMBL3743123	Inhibition of p38a (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	21.0	CHEMBL260	Homo sapiens	INH	%	21.0
	16416036	CHEMBL3751414	Inhibition of p38alpha phosphorylation in human TNFalpha-stimulated U937 cells treated 1 hr before by ELISA	B	CNc1ccc(-c2ccncc2)nc1C(N)=O		CHEMBL3747095	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	uM	2.7
	16416047	CHEMBL3751414	Inhibition of p38alpha phosphorylation in human TNFalpha-stimulated U937 cells treated 1 hr before by ELISA	B	NC(=O)c1nc(-c2ccns2)c2ccccn12		CHEMBL3746157	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	uM	0.37
	16421952	CHEMBL3748469	Inhibition of P38alpha (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16425294	CHEMBL3751090	Inhibition of p38alpha (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	16426144	CHEMBL3750471	Inhibition of p38alpha (unknown origin) at 1 uM by direct binding assay	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1	Outside typical range	CHEMBL3746293	=	Inhibition	%	-109.7	CHEMBL260	Homo sapiens	INH	%	-109.7
	16431936	CHEMBL3748029	Inhibition of human P38alpha using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16451647	CHEMBL3761289	Inhibition of p38alpha (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	44.5	CHEMBL260	Homo sapiens	INH	%	44.5
	16451648	CHEMBL3761290	Inhibition of p38alpha (unknown origin) by direct binding assay at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	20.6	CHEMBL260	Homo sapiens	INH	%	20.6
	16451761	CHEMBL3761290	Inhibition of p38alpha (unknown origin) by direct binding assay at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	22.4	CHEMBL260	Homo sapiens	INH	%	22.4
	16458482	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	16458483	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	16458484	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	16458485	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	16458486	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	16458487	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	16458488	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	16458489	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	16458490	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1	Outside typical range	CHEMBL3758802	=	Inhibition	%	-16.0	CHEMBL260	Homo sapiens	INH	%	-16.0
	16458491	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	16458492	CHEMBL3761588	Inhibition of MAPK14 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	16466480	CHEMBL3767832	Inhibition of human MAPK14 at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	11.4	CHEMBL260	Homo sapiens	INH	%	11.4
	16474703	CHEMBL3767323	Inhibition of MAPK14 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	14.8	CHEMBL260	Homo sapiens	INH	%	14.8
Not Active	16484205	CHEMBL3773474	Inhibition of MAPK14/P38-alpha (unknown origin)	B	COc1ncc(C)cc1CC[C@@](O)(CC(=O)O)C(=O)O		CHEMBL3771118		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	16486365	CHEMBL3771599	Inhibition of human recombinant p38alpha assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	16495219	CHEMBL3777761	Inhibition of N-terminal His6-tagged recombinant human SAPK2A expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-4.0	CHEMBL260	Homo sapiens	Activity	%	-4.0
	16495220	CHEMBL3777762	Inhibition of N-terminal His6-tagged recombinant human SAPK2A T106M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-4.0	CHEMBL260	Homo sapiens	Activity	%	-4.0
	16496138	CHEMBL3777761	Inhibition of N-terminal His6-tagged recombinant human SAPK2A expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-13.0	CHEMBL260	Homo sapiens	Activity	%	-13.0
	16496139	CHEMBL3777762	Inhibition of N-terminal His6-tagged recombinant human SAPK2A T106M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-52.0	CHEMBL260	Homo sapiens	Activity	%	-52.0
Not Active	16496866	CHEMBL3776414	Inhibition of human p38a MAPK (1 to 360 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	16506493	CHEMBL3778657	Inhibition of full length recombinant human GST-tagged MAPK14 expressed in Escherichia coli at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	16506494	CHEMBL3778658	Inhibition of full length recombinant human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	16507172	CHEMBL3779005	Inhibition of recombinant p38alpha MAP kinase (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	16508928	CHEMBL3777761	Inhibition of N-terminal His6-tagged recombinant human SAPK2A expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	5.0	CHEMBL260	Homo sapiens	Activity	%	5.0
	16508929	CHEMBL3777762	Inhibition of N-terminal His6-tagged recombinant human SAPK2A T106M mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-1.0	CHEMBL260	Homo sapiens	Activity	%	-1.0
	16510440	CHEMBL3783999	Inhibition of full length recombinant GST-tagged human p38-alpha expressed in Escherichia coli	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	IC50	nM	62.0	CHEMBL260	Homo sapiens	IC50	nM	62.0
Active	16510588	CHEMBL3784573	Inhibition of P38-alpha phosphorylation in human K562 cells at 0.01 to 3 uM after 1 hr by immunoblotting method	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	16510589	CHEMBL3784574	Inhibition of P38-alpha phosphorylation in human KU812 cells at 0.01 to 3 uM after 1 hr by immunoblotting method	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	16510590	CHEMBL3784575	Inhibition of P38-alpha phosphorylation in human MEG01 cells at 0.01 to 3 uM after 1 hr by immunoblotting method	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	16510622	CHEMBL3784715	Binding affinity to P38-alpha (unknown origin)	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	27.0	CHEMBL260	Homo sapiens	Kd	nM	27.0
	16510623	CHEMBL3784715	Binding affinity to P38-alpha (unknown origin)	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	460.0	CHEMBL260	Homo sapiens	Kd	nM	460.0
	16510635	CHEMBL3784726	Inhibition of full length human wild type p38-alpha expressed in bacterial expression system assessed as residual activity at 1 uM relative to control	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	Activity	%	0.0	CHEMBL260	Homo sapiens	Activity	%	0.0
	16512939	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	16512940	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCn3ccnc3)c3ccccc23)cc1		CHEMBL336001	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	16512941	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccccn3)c3ccccc23)cc1		CHEMBL3781528	=	IC50	nM	167.0	CHEMBL260	Homo sapiens	IC50	nM	167.0
	16512942	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3cccnc3)c3ccccc23)cc1		CHEMBL343227	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	16512943	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccncc3)c3ccccc23)cc1		CHEMBL143134	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	16512944	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccnc(N)c3)c3ccccc23)cc1		CHEMBL3781587	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	nM	60.0
	16512945	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccncc3N)c3ccccc23)cc1		CHEMBL3780111	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	16512946	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781430	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	16512947	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1cnccc1CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc12		CHEMBL3780488	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	16512948	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cnccc1CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc12		CHEMBL3782036	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	16512949	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780154	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	16512950	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	CNC(=O)c1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780089	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
	16512951	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCCNC(=O)c1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780629	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	16512952	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1nccn1CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc12		CHEMBL3782009	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	16512953	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCCNC(=O)c1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780410	=	IC50	nM	123.0	CHEMBL260	Homo sapiens	IC50	nM	123.0
	16512954	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(C(=O)NCCN4CCOCC4)c3)c3ccccc23)cc1		CHEMBL3781413	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	16512955	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781532	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	16512956	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NS(C)(=O)=O)c3)c3ccccc23)cc1		CHEMBL3780714	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	16512957	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781102	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	16512958	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	CNC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781687	=	IC50	nM	6.0	CHEMBL260	Homo sapiens	IC50	nM	6.0
	16512959	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)c4ccccc4)c3)c3ccccc23)cc1		CHEMBL3780519	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	16512960	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)Cc4ccccc4)c3)c3ccccc23)cc1		CHEMBL3781473	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
	16512961	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)CN(C)C)c3)c3ccccc23)cc1		CHEMBL3781244	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	16512962	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)CN4CCOCC4)c3)c3ccccc23)cc1		CHEMBL3780667	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	16512963	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	CSCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781245	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	16512964	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)CS(C)(=O)=O)c3)c3ccccc23)cc1		CHEMBL3780832	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
	16512965	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695568	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	16512966	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)N(C)c1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780386	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	16512967	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(C(C)Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781982	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	nM	52.0
	16512968	CHEMBL3783189	Inhibition of human recombinant p38 alpha assessed as phosphorylation of MAPKAP-K2 preincubated for 2 hrs followed by FRET peptide and MAPKAP-K2 addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(C(C)(C)Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781999	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
Not Active	16514150	CHEMBL3782371	Inhibition of partial length human p38alpha expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	16535255	CHEMBL3791632	Inhibition of recombinant human N-terminal GST-tagged p38-alpha (9 to 352 residues) expressed in Escherichia coli using modified erktide as substrate at 0.05 to 50 uM after 1 hr by microfluidic assay	B	COc1ccc(/C=C/C(=O)NCCNC(=O)/C=C/c2ccc(OC)cc2OC)c(OC)c1		CHEMBL3787558		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	16540859	CHEMBL3790001	Inhibition of MAPK14 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16540860	CHEMBL3790001	Inhibition of MAPK14 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16540861	CHEMBL3790001	Inhibition of MAPK14 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	4800.0	CHEMBL260	Homo sapiens	IC50	uM	4.8
	16540862	CHEMBL3790001	Inhibition of MAPK14 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16540863	CHEMBL3790001	Inhibition of MAPK14 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16540864	CHEMBL3790001	Inhibition of MAPK14 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16559730	CHEMBL3794941	Inhibition of human N-terminal GST-tagged p38alpha (9 to 352 residues) expressed in Escherichia coli using fluorescence labelled modified Erktide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	6.9	CHEMBL260	Homo sapiens	INH	%	6.9
	16559731	CHEMBL3794941	Inhibition of human N-terminal GST-tagged p38alpha (9 to 352 residues) expressed in Escherichia coli using fluorescence labelled modified Erktide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	-1.8	CHEMBL260	Homo sapiens	INH	%	-1.8
	16559732	CHEMBL3794941	Inhibition of human N-terminal GST-tagged p38alpha (9 to 352 residues) expressed in Escherichia coli using fluorescence labelled modified Erktide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-2.6	CHEMBL260	Homo sapiens	INH	%	-2.6
	16565466	CHEMBL3802847	Inhibition of N-terminal FLAG-tagged p38alpha (unknown origin) expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	16578401	CHEMBL3802273	Inhibition of full length wild type human p38alpha expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	16580662	CHEMBL3803136	Inhibition of N-terminal FLAG-tagged p38alpha (unknown origin) expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	16580663	CHEMBL3803136	Inhibition of N-terminal FLAG-tagged p38alpha (unknown origin) expressed in baculovirus preincubated for 5 mins using myelin basic protein as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	16587036	CHEMBL3807734	Inhibition of P38alpha (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	16593595	CHEMBL3811553	Inhibition of GST-tagged full length human recombinant p38alpha expressed in Escherichia coli using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL260	Homo sapiens	INH	%	40.0
	16594864	CHEMBL3812873	Inhibition of full length human p38-alpha expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	16595527	CHEMBL3811143	Inhibition of full length recombinant human N-terminal GST-tagged p38alpha MAP kinase expressed in Escherichia coli assessed as residual activity at 300 uM in presence of radiolabelled ATP by radiometric assay relative to control	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL3809381	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	16595533	CHEMBL3811137	Inhibition of full length recombinant human N-terminal GST-tagged p38alpha MAP kinase expressed in Escherichia coli assessed as residual activity at 30 uM in presence of radiolabelled ATP by radiometric assay relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)CC		CHEMBL3808687	=	Activity	%	61.0	CHEMBL260	Homo sapiens	Activity	%	61.0
	16612705	CHEMBL3815730	Inhibition of SAPK2a (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-5.0	CHEMBL260	Homo sapiens	Activity	%	-5.0
	16612706	CHEMBL3815730	Inhibition of SAPK2a (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-10.0	CHEMBL260	Homo sapiens	Activity	%	-10.0
	16612707	CHEMBL3815730	Inhibition of SAPK2a (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-16.0	CHEMBL260	Homo sapiens	Activity	%	-16.0
	16612708	CHEMBL3815730	Inhibition of SAPK2a (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-22.0	CHEMBL260	Homo sapiens	Activity	%	-22.0
	16614568	CHEMBL3817599	Inhibition of human P38alpha at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	16618677	CHEMBL3816099	Inhibition of full length recombinant human GST-tagged p38alpha MAP kinase expressed in Escherichia coli at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	16618678	CHEMBL3816100	Inhibition of full length recombinant human GST-tagged p38alpha (direct) MAP kinase expressed in Escherichia coli at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	16621524	CHEMBL3820663	Inhibition of p38alpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	nM	30000.0
	16622231	CHEMBL3820663	Inhibition of p38alpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	10.5	CHEMBL260	Homo sapiens	IC50	nM	10.5
	16627576	CHEMBL3820505	Inhibition of full length recombinant human N-terminal His6-tagged SAPK2A expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-1.0	CHEMBL260	Homo sapiens	INH	%	-1.0
	16627577	CHEMBL3820505	Inhibition of full length recombinant human N-terminal His6-tagged SAPK2A expressed in Escherichia coli at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	16628514	CHEMBL3820630	Inhibition of human recombinant full-length p38alpha at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL260	Homo sapiens	INH	%	80.0
	16638324	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	nM	500.0
	16638325	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	CS(=O)(=O)c1ccc2nccc(Nc3ccc4[nH]nnc4c3)c2c1		CHEMBL3823809	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	16638326	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	CS(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1		CHEMBL3822791	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	16638327	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	CS(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3822754	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	16638328	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	Cc1ccc(O)cc1Nc1ccnc2ccccc12		CHEMBL3822573	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	16638329	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	Cc1ccc(O)cc1Nc1ccnc2ccc(-c3cccnc3)cc12		CHEMBL237345	=	IC50	nM	3740.0	CHEMBL260	Homo sapiens	IC50	nM	3740.0
	16638330	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	Cc1ccc(O)cc1Nc1ccnc2ccc(C(=O)NCC3CCOCC3)cc12		CHEMBL3824056	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	16638331	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	COc1ccc2nccc(Nc3cc(O)ccc3C)c2c1		CHEMBL3823527	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	16638332	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	Cc1ccc(O)cc1Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL3822938	=	IC50	nM	1080.0	CHEMBL260	Homo sapiens	IC50	nM	1080.0
	16638333	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	CC(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3822577	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	16638334	CHEMBL3825641	Inhibition of p38alpha (unknown origin)	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	IC50	nM	5119.0	CHEMBL260	Homo sapiens	IC50	nM	5119.0
	16642003	CHEMBL3826415	Inhibition of GST-tagged full-length human MAPK14 (direct) expressed in Escherichia coli at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	16654181	CHEMBL3830954	Inhibition of human p38alpha MAPK (1-360 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	69.0	CHEMBL260	Homo sapiens	Activity	%	69.0
	16737970	CHEMBL3856687	Inhibition of human SAPK2a assessed as remaining activity at 10 uM in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	16739415	CHEMBL3857064	Inhibition of GST tagged recombinant full length human p38 alpha expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	15.0	CHEMBL260	Homo sapiens	INH	%	15.0
	16739416	CHEMBL3857064	Inhibition of GST tagged recombinant full length human p38 alpha expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	16739417	CHEMBL3857064	Inhibition of GST tagged recombinant full length human p38 alpha expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	16761079	CHEMBL3862234	Inhibition of full length wild type human p38alpha expressed in bacterial system at 2 uM by ADP quest assay	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	16761080	CHEMBL3862233	Inhibition of p38alpha in human THP1 cells assessed as suppression of LPS-induced TNFalpha secretion preincubated for 30 mins followed by LPS challenge measured after 2 hrs	B	CNC(=O)[C@H](Cc1cccc(C(F)(F)F)c1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3913027	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	nM	46.0
	16761081	CHEMBL3862233	Inhibition of p38alpha in human THP1 cells assessed as suppression of LPS-induced TNFalpha secretion preincubated for 30 mins followed by LPS challenge measured after 2 hrs	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)[C@H]1CC[C@H](CNC(=O)c2cnn(-c3ccccc3)c2N)CC1		CHEMBL3926709	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	16761082	CHEMBL3862233	Inhibition of p38alpha in human THP1 cells assessed as suppression of LPS-induced TNFalpha secretion preincubated for 30 mins followed by LPS challenge measured after 2 hrs	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
Active	16775223	CHEMBL3864548	Activation of human recombinant full length GST-tagged MAPK14 expressed in Escherichia coli assessed as increase in MAPK14 phosphorylation at 10 to 10000 nM in presence of 500 uM of ATP by direct Z-LITE assay	B	O=C1C(c2ccncc2)=C(c2ccc(F)cc2)c2ccccc21		CHEMBL3946999		Activity			CHEMBL260	Homo sapiens	Activity		
	16775224	CHEMBL3864547	Activation of human recombinant full length GST-tagged MAPK14 expressed in Escherichia coli assessed as increase in MAPK14 phosphorylation at 10 uM in presence of 500 uM of ATP by direct Z-LITE assay relative to control	B	O=C1C(c2ccncc2)=C(c2ccc(F)cc2)c2ccccc21		CHEMBL3946999	=	Activity	%	40.0	CHEMBL260	Homo sapiens	Activity	%	40.0
	16775225	CHEMBL3864546	Inhibition of human recombinant full length GST-tagged MAPK14 phosphorylation expressed in Escherichia coli in presence of 100 uM of ATP by direct Z-LITE assay	B	O=C1C(c2ccc(F)cc2)=C(c2ccncc2)c2ccccc21		CHEMBL3976283	=	IC50	nM	899.0	CHEMBL260	Homo sapiens	IC50	uM	0.899
	16775226	CHEMBL3864546	Inhibition of human recombinant full length GST-tagged MAPK14 phosphorylation expressed in Escherichia coli in presence of 100 uM of ATP by direct Z-LITE assay	B	O=C1C(c2ccncc2)=C(c2ccc(F)cc2)c2ccccc21		CHEMBL3946999		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	16775227	CHEMBL3864545	Inhibition of human recombinant full length GST-tagged MAPK14 phosphorylation expressed in Escherichia coli in presence of 500 uM of ATP by direct Z-LITE assay	B	O=C1C(c2ccc(F)cc2)=C(c2ccncc2)c2ccccc21		CHEMBL3976283	=	IC50	nM	1350.0	CHEMBL260	Homo sapiens	IC50	uM	1.35
	16775228	CHEMBL3864545	Inhibition of human recombinant full length GST-tagged MAPK14 phosphorylation expressed in Escherichia coli in presence of 500 uM of ATP by direct Z-LITE assay	B	O=C1C(c2ccncc2)=C(c2ccc(F)cc2)c2ccccc21		CHEMBL3946999		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	16775229	CHEMBL3864549	Activation of human recombinant full length GST-tagged MAPK14 expressed in Escherichia coli assessed as increase in MAPK14 phosphorylation at 10 to 10000 nM in presence of 100 uM of ATP by direct Z-LITE assay	B	O=C1C(c2ccncc2)=C(c2ccc(F)cc2)c2ccccc21	Potential missing data	CHEMBL3946999		Activity			CHEMBL260	Homo sapiens	Activity		
	16837447	CHEMBL3876110	Inhibition of human recombinant full length GST-tagged MAPK14alpha expressed in Escherichia coli	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	16844161	CHEMBL3877197	Inhibition of p38alpha (unknown origin)	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	16844162	CHEMBL3877197	Inhibition of p38alpha (unknown origin)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	25.0	CHEMBL260	Homo sapiens	IC50	nM	25.0
	16888402	CHEMBL3881305	Inhibition of IL1-beta-induced p38alpha phosphorylation in human A549 cells pre-incubated for 30 mins before IL1-beta stimulation and measured after 7 to 8 hrs post IL1-beta stimulation by Bright-Glo luciferase reporter gene assay	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	=	IC50	nM	2200.0	CHEMBL260	Homo sapiens	IC50	uM	2.2
	16888403	CHEMBL3881305	Inhibition of IL1-beta-induced p38alpha phosphorylation in human A549 cells pre-incubated for 30 mins before IL1-beta stimulation and measured after 7 to 8 hrs post IL1-beta stimulation by Bright-Glo luciferase reporter gene assay	B	CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3927112	=	IC50	nM	17000.0	CHEMBL260	Homo sapiens	IC50	uM	17.0
	16888404	CHEMBL3881305	Inhibition of IL1-beta-induced p38alpha phosphorylation in human A549 cells pre-incubated for 30 mins before IL1-beta stimulation and measured after 7 to 8 hrs post IL1-beta stimulation by Bright-Glo luciferase reporter gene assay	B	COC(=O)NC[C@H](C)Nc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3962696	=	IC50	nM	690.0	CHEMBL260	Homo sapiens	IC50	uM	0.69
	16896857	CHEMBL3882366	Inhibition of human MAPK14 using myelin basic protein as substrate in presence of [gamma-33P]-ATP	B	Cc1ccc(N/C=C2\C(=O)CCc3c2oc2c(Cl)c(Cl)c(O)cc32)cc1		CHEMBL3920024		Inhibition	%		CHEMBL260	Homo sapiens	INH		
191810	17602108	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(C)cc3)nc2n1		CHEMBL3185338	=	IC50	nM	18100.0	CHEMBL260	Homo sapiens	IC50	nM	18100.0
191814	17602112	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cccc(O)c3)nc2n1		CHEMBL3695657	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
191818	17602116	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cccc(C)c3)nc2n1		CHEMBL3695658	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
191822	17602120	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccccc3C)nc2n1		CHEMBL3695659	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
191826	17602124	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(OP(=O)(O)O)c(OC)c3)nc2n1		CHEMBL3695660	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
191830	17602128	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cc(Cl)c(O)c(OC)c3)nc2n1		CHEMBL3695661	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
198620	17602132	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc4ccccc4c3)nc2n1		CHEMBL3695662	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
198624	17602136	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(O)c(OC)c3)nc2n1		CHEMBL3695663	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
254565	17637398	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1ccccc1-c1nncc2nc(Nc3ccc(F)cc3F)ccc12		CHEMBL3649483	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
254566	17637399	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1cc(S(C)(=O)=O)ccc1-c1nncc2nc(Nc3ccc(F)cc3F)ccc12		CHEMBL3649484	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
254567	17637400	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1ncccc1-c1nncc2nc(Nc3ccc(F)cc3F)ccc12		CHEMBL3649485	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
254568	17637401	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1cc(S(C)(=O)=O)ccc1-c1nncc2nc(Nc3ccc(F)cc3)ccc12		CHEMBL3649486	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
254569	17637402	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Fc1ccc(Nc2ccc3c(-c4ccc(F)cc4F)nncc3n2)c(F)c1		CHEMBL3649487	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
254570	17637403	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	O=C(c1cccc(-c2nncc3nc(Nc4ccc(F)cc4F)ccc23)c1)N1CCOCC1		CHEMBL3649488	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
254571	17637404	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cn1cc(-c2nncc3nc(Nc4ccc(F)cc4F)ccc23)cn1		CHEMBL3649489	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
254572	17637405	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Fc1ccc(Nc2ccc3c(-c4cn[nH]c4)nncc3n2)c(F)c1		CHEMBL3649490	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
254573	17637406	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1n[nH]c(C)c1-c1nncc2nc(Nc3ccc(F)cc3F)ccc12		CHEMBL3649491	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
254574	17637407	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1n[nH]cc1-c1nncc2nc(Nc3ccc(F)cc3F)ccc12		CHEMBL3649492	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
254575	17637408	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1noc(C)c1-c1nncc2nc(Nc3ccc(F)cc3F)ccc12		CHEMBL3649493	=	IC50	nM	7.1	CHEMBL260	Homo sapiens	IC50	nM	7.1
254576	17637409	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Fc1ccc(Nc2ccc3c(N4CCOCC4)nncc3n2)c(F)c1		CHEMBL3649494	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
254577	17637410	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1ccccc1-c1nncc2nc(Oc3ccc(F)cc3F)ccc12		CHEMBL3649495	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
254578	17637411	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1ccc(C(N)=O)cc1-c1nncc2nc(Oc3ccc(F)cc3F)ccc12		CHEMBL3649496	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
254579	17637412	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1cc(S(C)(=O)=O)ccc1-c1nncc2nc(Oc3ccc(F)cc3F)ccc12		CHEMBL3649497	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	nM	0.7
254580	17637413	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Fc1ccc(Oc2ccc3c(-c4cn[nH]c4)nncc3n2)c(F)c1		CHEMBL3649498	=	IC50	nM	5.1	CHEMBL260	Homo sapiens	IC50	nM	5.1
254581	17637414	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1ccccc1-c1nncc2nc(Oc3ccc(F)cc3)ccc12		CHEMBL3649499	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
254582	17637415	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1ccc(C(N)=O)cc1-c1nncc2nc(Oc3ccc(F)cc3)ccc12		CHEMBL3649500	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
254583	17637416	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1noc(C)c1-c1nncc2nc(Oc3ccc(F)cc3F)ccc12		CHEMBL3649501	=	IC50	nM	6.5	CHEMBL260	Homo sapiens	IC50	nM	6.5
254584	17637417	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1cc(F)ccc1Oc1ccc2c(-c3ccccc3C)nncc2n1		CHEMBL3649502	=	IC50	nM	168.0	CHEMBL260	Homo sapiens	IC50	nM	168.0
254585	17637418	CHEMBL3706342	Biological Assay: Kinase reaction buffer for p38alpha HTRF assays consists of 50 mM Tris-pH 7.5, 5 mM MgCl2, 0.1 mg/mL BSA, 100 uM Na3VO4 and 0.5 mM DTT. HTRF Detection Buffer:HTRF detection buffer contains 100 mM HEPES-pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and 10 mM EDTA. Serial Dilution of Compounds: Compounds were dissolved in 100% DMSO and serially diluted (3 fold, 10 point) in a polypropylene 96-well microtiter plate (drug plate). The final starting concentration of compounds in the p38alpha enzymatic assays was 1 uM. Columns 6 and 12 (HI controls and LO controls respectively) in the drug plate were reserved as controls and contained only DMSO.Kinase Reaction: The p38alpha kinase reactions were carried out in a polypropylene 96-well black round bottom assay plate in total volume of 30 uL kinase reaction buffer.	B	Cc1cc(F)ccc1Oc1ccc2c(-c3cc(C(N)=O)ccc3C)nncc2n1		CHEMBL3649503	=	IC50	nM	417.0	CHEMBL260	Homo sapiens	IC50	nM	417.0
255886	17638654	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800911	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
255887	17638655	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC1		CHEMBL1800910	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
255888	17638656	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800919	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
255889	17638657	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(N)=O)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800917	=	IC50	nM	8.5	CHEMBL260	Homo sapiens	IC50	nM	8.5
255890	17638658	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(N)=O)cc1-c1ccc2c(c1)NC(=O)C2(C)C		CHEMBL3701781	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	nM	80.0
255891	17638659	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800220	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
255892	17638660	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)Nc2ccccn2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800221	=	IC50	nM	6.3	CHEMBL260	Homo sapiens	IC50	nM	6.3
255893	17638661	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800222	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
255894	17638662	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800916	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
255895	17638663	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NCC2CC2)cc1-c1ccc2c(c1)NC(=O)C2(C)C		CHEMBL3701782	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
255896	17638664	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C2(C)C		CHEMBL3640006	=	IC50	nM	0.04	CHEMBL260	Homo sapiens	IC50	nM	0.04
255897	17638665	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825147	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
255898	17638666	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)Nc2ccon2)cc1-c1ccc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825148	=	IC50	nM	0.06	CHEMBL260	Homo sapiens	IC50	nM	0.06
255899	17638667	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCS(=O)(=O)CC1		CHEMBL1825150	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
255900	17638668	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCN(C)CC1		CHEMBL1825145	=	IC50	nM	5.2	CHEMBL260	Homo sapiens	IC50	nM	5.2
255901	17638669	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCN(S(C)(=O)=O)CC1		CHEMBL1825146	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
255902	17638670	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC(F)(F)CC1		CHEMBL1825153	=	IC50	nM	1.8	CHEMBL260	Homo sapiens	IC50	nM	1.8
255903	17638671	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC(O)CC1		CHEMBL3701783	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
255904	17638672	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC(C)(O)CC1		CHEMBL3701784	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
255905	17638673	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCC(N2CCOCC2)CC1		CHEMBL3701785	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
255906	17638674	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(n1)NC(=O)C21CCCC1		CHEMBL1825156	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
255907	17638675	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C2(C)C		CHEMBL1825161	=	IC50	nM	62.0	CHEMBL260	Homo sapiens	IC50	nM	62.0
255908	17638676	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cnc2c(c1)NC(=O)C21CCOCC1		CHEMBL1825159	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
255909	17638677	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2c(cn1)C1(CCCC1)C(=O)N2		CHEMBL1825157	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
255910	17638678	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ncc2c(n1)NC(=O)C21CCCC1		CHEMBL1825162	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	nM	72.0
255911	17638679	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCCC3)c2)[nH]1		CHEMBL1911193	=	IC50	nM	7.5	CHEMBL260	Homo sapiens	IC50	nM	7.5
255912	17638680	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCC3)c2)[nH]1		CHEMBL1909657	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
255913	17638681	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1ccc(-c2ncn[nH]2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1911197	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	nM	9.0
255914	17638682	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCOCC3)c2)[nH]1		CHEMBL1911194	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
255915	17638683	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2cc(F)c(C)c(-c3ccc4c(c3)NC(=O)C43CCOCC3)c2)[nH]1		CHEMBL3701786	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
255916	17638684	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCC(F)(F)CC3)c2)[nH]1		CHEMBL1911332	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
255917	17638685	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2cc(F)c(C)c(-c3ccc4c(c3)NC(=O)C43CCC(C)(O)CC3)c2)[nH]1		CHEMBL3701787	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
255918	17638686	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCN(S(C)(=O)=O)CC3)c2)[nH]1		CHEMBL1911333	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
255919	17638687	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCCC3)c2)o1		CHEMBL1911190	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
255920	17638688	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCC(F)(F)CC3)c2)o1		CHEMBL3701788	=	IC50	nM	5.6	CHEMBL260	Homo sapiens	IC50	nM	5.6
255921	17638689	CHEMBL3705800	Inhibition Assay: Enzymatic activity assay was performed in 96-well microtiter plates (Corning, catalog number #3686) using a total volume of 50 ul of an assay buffer composed of 50 mM HEPES pH 7.5, 10 mM MgCl2, 1.75 mM Na3VO4. Various concentrations of the test compound or vehicle controls were pre-incubated for one hour with 0.055 ug/ml of the human p38alfa (SAPKa) enzyme (obtained from University of Dundee). The reaction was started by addition of biotinylated ATF2 substrate and ATP in concentrations around their Km values (final concentration 0.62 uM and 60 uM respectively) and took place for one hour at 25 C. Addition of the detection reagents, streptavidin XL665 and anti-phosphoresidue antibody coupled to Europium cryptate, caused the juxtaposition of the cryptate and the XL665 fluorophore, resulting in fluorescence energy transfer (FRET). The FRET intensity depends on the amount of bounded cryptate antibody, which is proportional to the extent of substrate phosphorylation.	B	Cc1nnc(-c2ccc(C)c(-c3ccc4c(c3)NC(=O)C43CCC(O)CC3)c2)o1		CHEMBL3701789	=	IC50	nM	5.7	CHEMBL260	Homo sapiens	IC50	nM	5.7
276576	17658915	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(CO)cc(C(C)(C)C)cc1NC(=O)N[C@@H]1Cc2c(F)cccc2[C@@H]1O		CHEMBL3652531	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
276577	17658916	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(NC(=O)N[C@@H]2Cc3ccccc3[C@@H]2O)cc(C(C)(C)C)cc1[C@@H](O)C(F)(F)F		CHEMBL3652532	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
276578	17658917	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(NC(=O)N[C@@H]2Cc3ccccc3[C@@H]2O)cc(C(C)(C)C)cc1[C@@H](O)C(F)(F)F		CHEMBL3652532	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
276579	17658918	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(NC(=O)N[C@@H]2Cc3c(F)cccc3[C@@H]2O)cc(C(C)(C)C)cc1[C@@H](O)C(F)(F)F		CHEMBL3652533	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
276580	17658919	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1cccc2c1C[C@@H](NC(=O)Nc1cc(C(C)(C)C)cc([C@H](O)C(F)(F)F)c1OC)[C@H]2O		CHEMBL3652534	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
276581	17658920	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(NC(=O)N[C@@H]2Cc3c(F)cccc3[C@@H]2O)cc(N2CCOCC2)cc1[C@@H](O)C(F)(F)F		CHEMBL3652535	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
276582	17658921	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(NC(=O)N[C@@H]2Cc3ccccc3[C@@H]2O)cc(N2CCCC2)cc1[C@@H](O)C(F)(F)F		CHEMBL3652536	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	nM	51.0
276583	17658922	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(NC(=O)N[C@@H]2Cc3ccccc3[C@@H]2O)cc(C2(C)CCOCC2)cc1[C@@H](O)C(F)(F)F		CHEMBL3652537	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
276584	17658923	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	CCC(C)(C)c1cc(NC(=O)N[C@@H]2Cc3ccccc3[C@@H]2O)c(OC)c([C@@H](O)C(F)(F)F)c1		CHEMBL3652538	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
276585	17658924	CHEMBL3705568	Inhibition Assay: Using human p38 MAPK alpha , the p38 MAPK inhibitory activity of Compound (I) was studied by a method partially modified from the method described in Current Medicinal Chemistry (2004, No. 11, pp. 721-730).A solution of each test compound solution in 100% DMSO and a p38alpha /SAPK2a solution (Final Concentration: 1.5 nM) (Invitrogen) were added to a 384-well plate, and then the plate was incubated at room temperature in a dark place for 1 hour. Thereafter, ATP (Final Concentration: 100 uM), which is a phosphate donor, and biotinylated ATF2 (Final Concentration: 30 nM) (upstate), which is a substrate, were added, and the resulting mixture was allowed to react at room temperature in a dark place for 1 hour (the final concentration of DMSO was 0.25%). After the reaction, an anti-phosphorylated ATF2 antibody (Final Concentration: 1 nM) (Cell Signaling), anti-IgG acceptor beads (Final Concentration: 20 ug/mL) (PerkinElmer) and streptavidin donor beads.	B	COc1c(NC(=O)NC2Cc3ccccc3C2)cc(C(C)(C)C)cc1C(O)C(F)(F)F		CHEMBL3652539	=	IC50	nM	117.0	CHEMBL260	Homo sapiens	IC50	nM	117.0
277732	17660073	CHEMBL3705609	Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against p38MAPK (MAPK12: Invitrogen) are evaluated in a similar fashion to that described hereinabove. The enzyme (800 ng/mL, 2.5 L) is incubated with the test compound (2.5 L of either 4 g/mL, 0.4 g/mL, 0.04 g/mL, or 0.004 g/mL) for 2 hr at RT. The FRET peptide (8 M, 2.5 L) and appropriate ATP solution (2.5 L, 400 M) are then added to the enzymes/compound mixtures and the whole is incubated for 1 hr. Development reagent (protease, 5 L) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, Thermo Scientific).	B	C#Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)n2)cc(C(=O)NCCOCCOCCOC)c1		CHEMBL3681949	=	IC50	nM	224.0	CHEMBL260	Homo sapiens	IC50	nM	224.0
278734	17661079	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cccc(O)c3)nc2n1		CHEMBL3695657	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
278735	17661080	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	C=CCNC(=O)Nc1ccc2ncc(-c3ccc(O)cc3)nc2n1		CHEMBL3695615	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278736	17661081	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	C=CCNC(=S)Nc1ccc2ncc(-c3ccc(O)cc3)nc2n1		CHEMBL3695616	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278737	17661082	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(O)cc3)nc2n1		CHEMBL3695617	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278738	17661083	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CNC(=S)Nc1ccc2ncc(-c3ccc(N)cc3)nc2n1		CHEMBL3695618	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278739	17661084	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCN(C(C)=O)C(=O)Nc1ccc2ncc(-c3ccccc3)nc2n1		CHEMBL3695619	=	IC50	nM	495.0	CHEMBL260	Homo sapiens	IC50	nM	495.0
278740	17661085	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(N)cc3)nc2n1		CHEMBL3695620	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
278741	17661086	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(O)c(OC)c3)nc2n1		CHEMBL3695663	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278742	17661087	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	O=C(NCCCCO)Nc1ccc2ncc(-c3ccccc3)nc2n1		CHEMBL3695621	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278743	17661088	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	O=C(NCCCO)Nc1ccc2ncc(-c3ccccc3)nc2n1		CHEMBL3695622	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278744	17661089	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(OCCCN4CCOCC4)cc3)nc2n1		CHEMBL3695623	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278745	17661090	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=S)Nc1ccc2ncc(-c3ccc(O)cc3)nc2n1		CHEMBL3695624	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278746	17661091	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cccc(O)c3)nc2n1		CHEMBL3695657	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278747	17661092	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cccc(C(=O)O)c3)nc2n1		CHEMBL3695625	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278748	17661093	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(OC)c(OC)c3)nc2n1		CHEMBL3695626	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278749	17661094	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(N)c(OC)c3)nc2n1		CHEMBL3695627	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
278750	17661095	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cccc(C(N)=O)c3)nc2n1		CHEMBL3695628	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278751	17661096	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cc(Cl)c(O)c(OC)c3)nc2n1		CHEMBL3695661	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278752	17661097	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(OC)cc3)nc2n1		CHEMBL3695629	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278753	17661098	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(Cl)cc3)nc2n1		CHEMBL3695630	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278754	17661099	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cccnc3)nc2n1		CHEMBL3695631	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278755	17661100	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(CC)cc3)nc2n1		CHEMBL3695632	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278756	17661101	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(C)c(OC)c3)nc2n1		CHEMBL3695633	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278757	17661102	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(O)cc3)nc2n1		CHEMBL3695634	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278758	17661103	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(C)cn3)nc2n1		CHEMBL3695635	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278759	17661104	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccn(C)n3)nc2n1		CHEMBL3695636	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278760	17661105	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(F)cc3)nc2n1		CHEMBL3695637	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278761	17661106	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	COc1cc(-c2cnc3ccc(NC(=O)NCCCCO)nc3n2)ccc1O		CHEMBL3695638	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278762	17661107	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(O)cc3Cl)nc2n1		CHEMBL3695639	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
278763	17661108	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(Cl)cc3OC)nc2n1		CHEMBL3695640	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278764	17661109	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3c(C)n[nH]c3C)nc2n1		CHEMBL3695641	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278765	17661110	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cnn(C)c3)nc2n1		CHEMBL3695642	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278766	17661111	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(C#N)s3)nc2n1		CHEMBL3695643	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
278767	17661112	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(OC)c(Cl)c3)nc2n1		CHEMBL3695644	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278768	17661113	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cnc4ccccc4c3)nc2n1		CHEMBL3639945	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	nM	1400.0
278769	17661114	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cc(OC)cc(OC)c3)nc2n1		CHEMBL3695645	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278770	17661115	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cnccn3)nc2n1		CHEMBL3695646	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278771	17661116	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cccc(OC(C)C)c3)nc2n1		CHEMBL3695647	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278772	17661117	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3ccc(OS(=O)(=O)c4ccc(C)cc4)c(OC)c3)nc2n1		CHEMBL3695648	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278773	17661118	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccnc(Cl)c3)nc2n1		CHEMBL3695649	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278774	17661119	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cc(Cl)c(O)c(Cl)c3)nc2n1		CHEMBL3695650	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278775	17661120	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(-c3cc(Cl)c(O)c(Cl)c3)nc2n1		CHEMBL3695651	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278776	17661121	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(OC)c(OC)c3)nc2n1		CHEMBL3695652	>	IC50	nM	31600.0	CHEMBL260	Homo sapiens	IC50	nM	31600.0
278777	17661122	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(C)c(O)c3)nc2n1		CHEMBL3695653	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278778	17661123	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3cc(C(=O)O)cc(C(F)(F)F)c3)nc2n1		CHEMBL3695654	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278779	17661124	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(OC)nc3)nc2n1		CHEMBL3695655	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
278780	17661125	CHEMBL3887036	Cell-Free Kinase Assay: The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic assays. Recombinant human kinases such as, for example, Erk2, PI3Kalpha, -beta, -gamma, -delta, p38alpha, p38gamma, Jnk1, Jnk2 and others were used in this case, partly as full-length kinases, partly as shortened fragments, but at least consisting of the functional kinase domains. The commercial kinase proteins (Proqinase, Upstate) were used as recombinant fusion proteins with GST (glutathion-S-transferase) or His-Tag. Depending on the type of substrate, the various kinase reactions were quantified by means of suitable ALPHA beads (Perkin-Elmer). The substance testing is described in detail hereinafter for the Erk assay. Selected test results of the Erk2, PD3Kalpha, p38alpha and Jnk2 assays are given below.	B	CCNC(=O)Nc1ccc2ncc(Nc3ccc(C#N)cc3)nc2n1		CHEMBL3695656	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
304670	17685531	CHEMBL3706164	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). The inhibitory activities of test compounds against the p38 MAPKalpha isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPKalpha protein (80 ng/mL, 2.5 uL) was mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 & 0.04 ug/mL).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	=	IC50	nM	60.0	CHEMBL260	Homo sapiens	IC50	nM	60.0
304675	17685536	CHEMBL3706164	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). The inhibitory activities of test compounds against the p38 MAPKalpha isoform (MAPK14: Invitrogen), were evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPKalpha protein (80 ng/mL, 2.5 uL) was mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 & 0.04 ug/mL).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	=	Kd	nM	20.0	CHEMBL260	Homo sapiens	Kd	nM	20.0
359493	17735076	CHEMBL3887881	Enzyme Inhibition Assay: The enzyme inhibitory activity of compound was determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). Recombinant, phosphorylated p38 MAPK  (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at desired final concentrations and incubated for two hours at room temperature. The FRET peptide (2 M) and ATP (100 M) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific). The site-specific protease cleaves only non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation and low ratios, low phosphorylation levels. The percentage inhibition of each reaction was calculated relative to non-inhibited control, and the 50% inhibitory concentration (IC50 value) then calculated from the concentration-response curve.	B	COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695569	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
359494	17735077	CHEMBL3887881	Enzyme Inhibition Assay: The enzyme inhibitory activity of compound was determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). Recombinant, phosphorylated p38 MAPK  (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at desired final concentrations and incubated for two hours at room temperature. The FRET peptide (2 M) and ATP (100 M) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific). The site-specific protease cleaves only non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation and low ratios, low phosphorylation levels. The percentage inhibition of each reaction was calculated relative to non-inhibited control, and the 50% inhibitory concentration (IC50 value) then calculated from the concentration-response curve.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
363333	17738708	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695569	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
363334	17738709	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3897917	=	IC50	nM	187.0	CHEMBL260	Homo sapiens	IC50	nM	187.0
363335	17738710	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)cc1		CHEMBL3972567	=	IC50	nM	93.0	CHEMBL260	Homo sapiens	IC50	nM	93.0
363336	17738711	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)NCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3957923	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
363337	17738712	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)ncn5C)n3)c3ccccc23)cc1		CHEMBL3940079	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
363338	17738713	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5onc(N)c5c4)n3)c3ccccc23)cc1		CHEMBL3922109	=	IC50	nM	81.0	CHEMBL260	Homo sapiens	IC50	nM	81.0
363339	17738714	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cnc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3964537	=	IC50	nM	177.0	CHEMBL260	Homo sapiens	IC50	nM	177.0
363340	17738715	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3894106	=	IC50	nM	80.0	CHEMBL260	Homo sapiens	IC50	nM	80.0
363341	17738716	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C3CCOC3)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3921479	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
363342	17738717	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3943934	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
363343	17738718	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(CN5CCCC5=O)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3915981	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
363344	17738719	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCCO5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3933807	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	nM	39.0
363345	17738720	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3931027	=	IC50	nM	77.0	CHEMBL260	Homo sapiens	IC50	nM	77.0
363346	17738721	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cn1		CHEMBL3971588	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
363347	17738722	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3899497	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
363348	17738723	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3933021	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
363349	17738724	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5[nH]ccc45)n3)c3ccccc23)cc1		CHEMBL3928618	=	IC50	nM	101.0	CHEMBL260	Homo sapiens	IC50	nM	101.0
363350	17738725	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5cc[nH]c45)n3)c3ccccc23)cc1		CHEMBL3964270	=	IC50	nM	376.0	CHEMBL260	Homo sapiens	IC50	nM	376.0
363351	17738726	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(ccn5C)c4)n3)c3ccccc23)cc1		CHEMBL3955192	=	IC50	nM	1359.0	CHEMBL260	Homo sapiens	IC50	nM	1359.0
363352	17738727	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CC(=O)N5)n3)c3ccccc23)cc1		CHEMBL3946614	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
363353	17738728	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CC(=O)N5C)n3)c3ccccc23)cc1		CHEMBL3975927	=	IC50	nM	61.0	CHEMBL260	Homo sapiens	IC50	nM	61.0
363354	17738729	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5[nH]ncc45)n3)c3ccccc23)cc1		CHEMBL3943340	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
363355	17738730	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3935885	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
363356	17738731	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)cc1		CHEMBL3958297	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	nM	30.0
363357	17738732	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5cn[nH]c5c4)n3)c3ccccc23)cc1		CHEMBL3901815	=	IC50	nM	245.0	CHEMBL260	Homo sapiens	IC50	nM	245.0
363358	17738733	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5cn[nH]c45)n3)c3ccccc23)cc1		CHEMBL3978244	=	IC50	nM	523.0	CHEMBL260	Homo sapiens	IC50	nM	523.0
363359	17738734	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5C)c4)n3)c3ccccc23)cc1		CHEMBL3907109	=	IC50	nM	145.0	CHEMBL260	Homo sapiens	IC50	nM	145.0
363360	17738735	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3956405	=	IC50	nM	263.0	CHEMBL260	Homo sapiens	IC50	nM	263.0
363361	17738736	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(Cl)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3953685	>	IC50	nM	1520.0	CHEMBL260	Homo sapiens	IC50	nM	1520.0
363362	17738737	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)cc1		CHEMBL3962324	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	nM	57.0
363363	17738738	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]cnc5c4)n3)c3ccccc23)cc1		CHEMBL3919242	=	IC50	nM	89.0	CHEMBL260	Homo sapiens	IC50	nM	89.0
363364	17738739	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncn(C)c5c4)n3)c3ccccc23)cc1		CHEMBL3960029	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
363365	17738740	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cnc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3932522	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
363366	17738741	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCO5)n3)c3ccccc23)cc1		CHEMBL3921959	=	IC50	nM	369.0	CHEMBL260	Homo sapiens	IC50	nM	369.0
363367	17738742	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5scnc5c4)n3)c3ccccc23)cc1		CHEMBL3958914	=	IC50	nM	308.0	CHEMBL260	Homo sapiens	IC50	nM	308.0
363368	17738743	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncsc5c4)n3)c3ccccc23)cc1		CHEMBL3983442	=	IC50	nM	439.0	CHEMBL260	Homo sapiens	IC50	nM	439.0
363369	17738744	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nnc5c4)n3)c3ccccc23)cc1		CHEMBL3958384	=	IC50	nM	92.0	CHEMBL260	Homo sapiens	IC50	nM	92.0
363370	17738745	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3899975	=	IC50	nM	332.0	CHEMBL260	Homo sapiens	IC50	nM	332.0
363371	17738746	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3984472	=	IC50	nM	184.0	CHEMBL260	Homo sapiens	IC50	nM	184.0
363372	17738747	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)cc1		CHEMBL3912970	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
363373	17738748	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3926692	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	nM	68.0
363374	17738749	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5C)c4)n3)c3ccccc23)cc1		CHEMBL3935024	=	IC50	nM	128.0	CHEMBL260	Homo sapiens	IC50	nM	128.0
363375	17738750	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3967247	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
363376	17738751	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)cc1		CHEMBL3958953	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
363377	17738752	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(OCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3927937	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
363378	17738753	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(OCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3950258	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
363379	17738754	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N(C)C)c5c4)n3)c3ccccc23)cc1		CHEMBL3922538	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
363380	17738755	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N(C)C)c5c4)n3)c3ccccc23)cc1		CHEMBL3975188	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
363381	17738756	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)n(-c2cccc(CN3CCCC3=O)c2)n1		CHEMBL3949262	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	nM	70.0
363382	17738757	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(CN3CCCC3=O)c2)n1		CHEMBL3966684	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
363383	17738758	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3936935	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
363384	17738759	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3925985	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
363385	17738760	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3965728	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
363386	17738761	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3893816	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
363387	17738762	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3920935	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
363388	17738763	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)C)nn4-c4cccc(OCCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3915395	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
363389	17738764	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(OCCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3898242	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	nM	46.0
363390	17738765	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COCCOc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)c3)c3ccccc23)c1		CHEMBL3920172	=	IC50	nM	74.0	CHEMBL260	Homo sapiens	IC50	nM	74.0
363391	17738766	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN(C)C)cc4)c4ccccc34)ccn2)cc2cn[nH]c12		CHEMBL3892167	<	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
363392	17738767	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CCC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3958095	=	IC50	nM	98.0	CHEMBL260	Homo sapiens	IC50	nM	98.0
363393	17738768	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)COC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3938312	=	IC50	nM	94.0	CHEMBL260	Homo sapiens	IC50	nM	94.0
363394	17738769	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3898648	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
363395	17738770	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5(C)C)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3969828	=	IC50	nM	98.0	CHEMBL260	Homo sapiens	IC50	nM	98.0
363396	17738771	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)C(=O)NC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3890213	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
363397	17738772	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CS(=O)(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3914683	=	IC50	nM	67.0	CHEMBL260	Homo sapiens	IC50	nM	67.0
363398	17738773	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCO5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3976445	=	IC50	nM	239.0	CHEMBL260	Homo sapiens	IC50	nM	239.0
363399	17738774	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc2[nH]1		CHEMBL3905700	=	IC50	nM	335.0	CHEMBL260	Homo sapiens	IC50	nM	335.0
363400	17738775	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3936257	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
363401	17738776	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)cc4)c4ccccc34)ccn2)cc2cn[nH]c12		CHEMBL3900304	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
363402	17738777	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3891402	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
363403	17738778	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3919491	=	IC50	nM	33.0	CHEMBL260	Homo sapiens	IC50	nM	33.0
363404	17738779	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1n[nH]c2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc12		CHEMBL3980630	=	IC50	nM	269.0	CHEMBL260	Homo sapiens	IC50	nM	269.0
363405	17738780	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1n[nH]c2ccc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)cc12		CHEMBL3896872	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
363406	17738781	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)cc4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3960541	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	nM	69.0
363407	17738782	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3936603	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
363408	17738783	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1nc2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc2[nH]1		CHEMBL3924003	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
363409	17738784	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5oc(=O)[nH]c5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL4110557	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	nM	48.0
363410	17738785	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]c(=O)oc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3918561	=	IC50	nM	417.0	CHEMBL260	Homo sapiens	IC50	nM	417.0
363411	17738786	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5sncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3984798	=	IC50	nM	139.0	CHEMBL260	Homo sapiens	IC50	nM	139.0
363412	17738787	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5scnc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3909641	=	IC50	nM	149.0	CHEMBL260	Homo sapiens	IC50	nM	149.0
363413	17738788	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncsc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3979828	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	nM	86.0
363414	17738789	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nnc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3899391	=	IC50	nM	66.0	CHEMBL260	Homo sapiens	IC50	nM	66.0
363415	17738790	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cn1		CHEMBL3973916	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	nM	63.0
363416	17738791	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N6CCOCC6)c5c4)n3)c3ccccc23)cn1		CHEMBL3907174	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
363417	17738792	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3935126	<	IC50	nM	1.5	CHEMBL260	Homo sapiens	IC50	nM	1.5
363418	17738793	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3912657	=	IC50	nM	8.0	CHEMBL260	Homo sapiens	IC50	nM	8.0
363419	17738794	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3944099	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
363420	17738795	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(=O)n(CCO)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3921640	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
363421	17738796	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCN3CCOCC3)c2)n1		CHEMBL3949420	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
363422	17738797	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(=O)n(CCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3961674	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
363423	17738798	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3986904	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
363424	17738799	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)nc4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3972709	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
363425	17738800	CHEMBL3887918	p38 MAPK Enzyme Inhibition Assay: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen), are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK&dlpha; protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38&dlpha; inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added and the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL). The mixture is incubated for 1 hr at RT. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3901628	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
364063	17739256	CHEMBL3887940	Competitive Binding Assay (KINOMEscan): For the competitive binding assay, test compounds were screened at 10 uM against 70 diverse kinase targets for competitive binding using the KINOMEscan technology (Ambit Biosciences) (Karaman, et al. (2008) Nature biotechnology 26:127-132). 11-point Kd curves were determined for hits identified during the initial screen.	B	CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cccc(C(F)(F)F)c4)[nH]3)cc2)n1		CHEMBL3932957	>	Kd	nM	10000.0	CHEMBL260	Homo sapiens	Kd	nM	10000.0
365163	17740208	CHEMBL3887971	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activities of compounds disclosed herein were determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). Recombinant, phosphorylated p38 MAPK (MAPK12: Invitrogen) was diluted in HEPES buffer, mixed with the test compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 M) and ATP (100 M) were added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific). The site-specific protease cleaves non-phosphorylated peptide only and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) for which high ratios indicate high phosphorylation and low rat	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
365164	17740209	CHEMBL3887971	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activities of compounds disclosed herein were determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). Recombinant, phosphorylated p38 MAPK (MAPK12: Invitrogen) was diluted in HEPES buffer, mixed with the test compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 M) and ATP (100 M) were added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific). The site-specific protease cleaves non-phosphorylated peptide only and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) for which high ratios indicate high phosphorylation and low rat	B	CC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781102	=	IC50	nM	2.5	CHEMBL260	Homo sapiens	IC50	nM	2.5
365165	17740210	CHEMBL3887971	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activities of compounds disclosed herein were determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). Recombinant, phosphorylated p38 MAPK (MAPK12: Invitrogen) was diluted in HEPES buffer, mixed with the test compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 M) and ATP (100 M) were added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific). The site-specific protease cleaves non-phosphorylated peptide only and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) for which high ratios indicate high phosphorylation and low rat	B	CC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3972318	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
412037	17776752	CHEMBL3888680	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
412172	17776887	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3965304	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
412173	17776888	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3)ccc2=O)cc1)C(=O)OC(C)(C)C		CHEMBL3926484	=	IC50	nM	724.0	CHEMBL260	Homo sapiens	IC50	nM	724.0
412174	17776889	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)cc1)C(=O)OC(C)(C)C		CHEMBL3965984	=	IC50	nM	330.0	CHEMBL260	Homo sapiens	IC50	nM	330.0
412175	17776890	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCCCCOc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3911381	=	IC50	nM	73.0	CHEMBL260	Homo sapiens	IC50	nM	73.0
412176	17776891	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	NCC[C@H](NCCCOc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3981379	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412177	17776892	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCCCCOc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3901931	=	IC50	nM	81.0	CHEMBL260	Homo sapiens	IC50	nM	81.0
412178	17776893	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CCOC(=O)[C@H](CC(C)C)NCCCOc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3)ccc2=O)c(F)c1		CHEMBL3929874	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
412179	17776894	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	C[C@H](NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)cc1)C(=O)OC(C)(C)C		CHEMBL3907385	=	IC50	nM	58.0	CHEMBL260	Homo sapiens	IC50	nM	58.0
412180	17776895	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3910819	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
412181	17776896	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL4110632	=	IC50	nM	167.0	CHEMBL260	Homo sapiens	IC50	nM	167.0
412182	17776897	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3220549	=	IC50	nM	231.0	CHEMBL260	Homo sapiens	IC50	nM	231.0
412183	17776898	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3900690	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
412184	17776899	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	C[C@@H](O)C(NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)cc1)C(=O)OC1CCCC1		CHEMBL4108746	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	nM	68.0
412185	17776900	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3962988	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
412186	17776901	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Nc1c(C(=O)c2ccc(F)cc2F)ccc(=O)n1-c1c(F)cc(CCN[C@H](C(=O)OC2CCCC2)c2ccccc2)cc1F		CHEMBL3894052	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	nM	65.0
412187	17776902	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)(C)OC(=O)[C@@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)c1ccccc1		CHEMBL3932432	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
412188	17776903	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)(C)OC[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3907977	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	nM	57.0
412189	17776904	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)(C)OC[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3923469	=	IC50	nM	72.0	CHEMBL260	Homo sapiens	IC50	nM	72.0
412190	17776905	CHEMBL3888703	Ester Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Nc1c(C(=O)c2ccc(F)cc2F)ccc(=O)n1-c1c(F)cc(CCN[C@@H](C(=O)OC2CCCC2)c2ccccc2)cc1F		CHEMBL4107794	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
412191	17776906	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3965304	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412192	17776907	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3)ccc2=O)cc1)C(=O)OC(C)(C)C		CHEMBL3926484	=	IC50	nM	118.0	CHEMBL260	Homo sapiens	IC50	nM	118.0
412193	17776908	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)cc1)C(=O)OC(C)(C)C		CHEMBL3965984	=	IC50	nM	58.0	CHEMBL260	Homo sapiens	IC50	nM	58.0
412194	17776909	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCCCCOc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3911381	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
412195	17776910	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	NCC[C@H](NCCCOc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3981379	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
412196	17776911	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCCCCOc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3901931	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
412197	17776912	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	C[C@H](NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)cc1)C(=O)OC(C)(C)C		CHEMBL3907385	=	IC50	nM	58.0	CHEMBL260	Homo sapiens	IC50	nM	58.0
412198	17776913	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3910819	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412199	17776914	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL4110632	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
412200	17776915	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3220549	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412201	17776916	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	C[C@@H](O)C(NCCc1ccc(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)cc1)C(=O)OC1CCCC1		CHEMBL4108746	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
412202	17776917	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)C[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3962988	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412203	17776918	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Nc1c(C(=O)c2ccc(F)cc2F)ccc(=O)n1-c1c(F)cc(CCN[C@H](C(=O)OC2CCCC2)c2ccccc2)cc1F		CHEMBL3894052	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412204	17776919	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)(C)OC(=O)[C@@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)c1ccccc1		CHEMBL3932432	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412205	17776920	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)(C)OC[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC1CCCC1		CHEMBL3907977	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
412206	17776921	CHEMBL3888704	Acid Enzyme Assay: The ability of compounds to inhibit p38 MAP a Kinase activity was measured in an assay performed by Upstate (Dundee UK). In a final reaction volume of 25 L, p38 MAP Kinase a (5-10 mU) is incubated with 25 mM Tris pH 7.5, 0.002 mMEGTA, 0.33 mg/mL myelin basic protein, 10 mM MgAcetate and [g-33p-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 5 L of a 3% phosphoric acid solution. 10 L of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(C)(C)OC[C@H](NCCc1cc(F)c(-n2c(N)c(C(=O)c3ccc(F)cc3F)ccc2=O)c(F)c1)C(=O)OC(C)(C)C		CHEMBL3923469	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
445403	17805111	CHEMBL3889286	Enzyme Binding Assays (Kinomescan): Kinase enzyme binding activities of the compound disclosed herein may be determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays may be conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The percentage inhibition produced by incubation with a test compound may be calculated relative to the non-inhibited control.	B	COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)ccn2)ccc1C(=O)O		CHEMBL3915286	=	Kd	nM	2.8	CHEMBL260	Homo sapiens	Kd	nM	2.8
445405	17805113	CHEMBL3889288	Enzyme Inhibition Assay: Method 2: This method follows the same steps as Method 1 below, but utilises a higher concentration of the p38 MAPK protein (2.5 uL of 200 ng/mL protein instead of 2.5 uL of 80 ng/mL protein) for mixing with the test compound (tested at either 1 ug/mL, 0.1 ug/mL, 0.01 ug/mL or 0.001 ug/mL). Method 1: The inhibitory activities of test compounds against the p38 MAPK isoform (MAPK14: Invitrogen) are evaluated indirectly by determining the level of activation/phosphorylation of the down-stream molecule, MAPKAP-K2. The p38 MAPK protein (80 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL of either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL or 0.004 ug/mL) for 2 hr at RT. The mix solution (2.5 uL) of the p38 inactive target MAPKAP-K2 (Invitrogen, 600 ng/mL) and FRET peptide (8 uM; a phosphorylation target for MAPKAP-K2) is then added, then the kinase reaction is initiated by adding ATP (40 uM, 2.5 uL), and appropriate ATP solution (2.5 uL, 400 uM) are then added to the enzymes/compound mixtures and the whole is incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, Thermo Scientific).	B	COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)ccn2)ccc1C(=O)O		CHEMBL3915286	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
Inactive	17915199	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915200	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915201	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915202	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915203	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915204	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915205	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915206	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915207	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915208	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915209	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915210	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915211	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915212	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915213	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	705.0	CHEMBL260	Homo sapiens	Kd apparent	nM	705.0
Inactive	17915214	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915215	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915216	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915217	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915218	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	1111.0	CHEMBL260	Homo sapiens	Kd apparent	nM	1111.0
Inactive	17915219	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915220	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915221	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915222	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915223	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915224	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915225	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915226	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915227	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915228	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915229	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915230	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	8500.0	CHEMBL260	Homo sapiens	Kd apparent	nM	8500.0
Inactive	17915231	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915232	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915233	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915234	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915235	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915236	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915237	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915238	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915239	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	566.0	CHEMBL260	Homo sapiens	Kd apparent	nM	566.0
Inactive	17915240	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915241	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915242	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915243	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915244	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915245	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915246	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915247	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915248	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915249	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915250	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915251	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915252	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915253	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915254	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915255	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915256	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915257	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915258	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915259	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915260	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915261	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915262	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915263	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915264	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915265	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915266	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915267	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915268	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915269	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915270	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915271	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915272	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915273	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915274	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915275	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915276	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915277	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915278	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915279	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915280	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915281	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915282	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	42.0	CHEMBL260	Homo sapiens	Kd apparent	nM	42.0
Inactive	17915283	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915284	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915285	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915286	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915287	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915288	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915289	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	2763.0	CHEMBL260	Homo sapiens	Kd apparent	nM	2763.0
Inactive	17915290	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915291	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915292	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915293	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915294	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915295	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915296	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915297	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915298	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915299	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	735.0	CHEMBL260	Homo sapiens	Kd apparent	nM	735.0
Inactive	17915300	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915301	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915302	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	945.0	CHEMBL260	Homo sapiens	Kd apparent	nM	945.0
Inactive	17915303	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915304	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915305	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915306	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915307	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915308	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915309	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915310	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915311	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915312	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	217.0	CHEMBL260	Homo sapiens	Kd apparent	nM	217.0
Inactive	17915313	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915314	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915315	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915316	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915317	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915318	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915319	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915320	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915321	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915322	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915323	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915324	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915325	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915326	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915327	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	=	Kd	nM	7.0	CHEMBL260	Homo sapiens	Kd apparent	nM	7.0
Inactive	17915328	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915329	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915330	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915331	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915332	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	=	Kd	nM	9.0	CHEMBL260	Homo sapiens	Kd apparent	nM	9.0
Inactive	17915333	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915334	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915335	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915336	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915337	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915338	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915339	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915340	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915341	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915342	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915343	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915344	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915345	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915346	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915347	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915348	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915349	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915350	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915351	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915352	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915353	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915354	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915355	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915356	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915357	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915358	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915359	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915360	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915361	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915362	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915363	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915364	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915365	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915366	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915367	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915368	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915369	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915370	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	927.0	CHEMBL260	Homo sapiens	Kd apparent	nM	927.0
Active	17915371	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	Kd	nM	5.0	CHEMBL260	Homo sapiens	Kd apparent	nM	5.0
Active	17915372	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	1047.0	CHEMBL260	Homo sapiens	Kd apparent	nM	1047.0
Inactive	17915373	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915374	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915375	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915376	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915377	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915378	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915379	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	358.0	CHEMBL260	Homo sapiens	Kd apparent	nM	358.0
Inactive	17915380	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915381	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915382	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915383	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915384	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915385	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915386	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915387	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915388	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915389	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915390	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915391	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915392	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915393	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915394	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915395	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915396	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915397	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915398	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915399	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915400	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915401	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915402	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915403	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915404	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	Kd	nM	8.0	CHEMBL260	Homo sapiens	Kd apparent	nM	8.0
Inactive	17915405	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915406	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	154.0	CHEMBL260	Homo sapiens	Kd apparent	nM	154.0
Inactive	17915407	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915408	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915409	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915410	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915411	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915412	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915413	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915414	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915415	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	536.0	CHEMBL260	Homo sapiens	Kd apparent	nM	536.0
Inactive	17915416	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915417	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915418	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915419	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915420	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915421	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915422	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915423	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915424	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915425	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915426	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915427	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915428	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915429	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915430	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915431	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Active	17915432	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	=	Kd	nM	729.0	CHEMBL260	Homo sapiens	Kd apparent	nM	729.0
Inactive	17915433	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915434	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915435	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915436	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915437	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915438	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915439	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915440	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17915441	CHEMBL3991772	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL260	Homo sapiens	Kd apparent	nM	30000.0
	17964929	CHEMBL3995038	Inhibition of full length human p38alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	98.0	CHEMBL260	Homo sapiens	Activity	%	98.0
	17971060	CHEMBL3995863	Inhibition of human MAPK p38allpha at 10 uM using myelin basic protein as substrate in presence of [33P]ATP by Hotspot assay relative to control	B	COc1cc2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c(C)nc2cc1OC		CHEMBL4100501	=	Inhibition	%	56.42	CHEMBL260	Homo sapiens	INH	%	56.42
	17979260	CHEMBL3998066	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	74.0	CHEMBL260	Homo sapiens	INH	%	74.0
	17979277	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(C2=Nc3c(ncnc3S(=O)(=O)c3ccc(C)cc3)[S+]([O-])c3ccc(C)cc32)cc1		CHEMBL4059699	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	17979278	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(S(=O)(=O)c2ncnc3c2N=C(c2ccccc2)c2cc(C)ccc2[S+]3[O-])cc1		CHEMBL4068803	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	17979279	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc([S+]([O-])c2ncnc3c2N=C(c2cccnc2)c2cc(C)ccc2S3)cc1		CHEMBL4096104	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	17979280	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(C2=Nc3c(ncnc3[S+]([O-])c3ccc(Cl)cc3)Sc3ccc(Cl)cc32)cc1		CHEMBL4079605	=	Inhibition	%	99.0	CHEMBL260	Homo sapiens	INH	%	99.0
	17979281	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	[O-][S+](c1ccc(Cl)cc1)c1ncnc2c1N=C(c1ccccc1)c1cc(Cl)ccc1S2		CHEMBL4103859	=	Inhibition	%	98.0	CHEMBL260	Homo sapiens	INH	%	98.0
	17979282	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	c1ccc(Sc2ncnc3c2N=C(c2cccnc2)c2ccccc2S3)cc1		CHEMBL4098540	=	Inhibition	%	98.0	CHEMBL260	Homo sapiens	INH	%	98.0
	17979283	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc([S+]([O-])c2ncnc3c2N=C(c2ccccc2)c2cc(C)ccc2S3)cc1		CHEMBL4080519	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	17979284	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(C2=Nc3c(ncnc3[S+]([O-])c3ccc(C)cc3)Sc3ccc(C)cc32)cc1		CHEMBL4060148	=	Inhibition	%	88.0	CHEMBL260	Homo sapiens	INH	%	88.0
	17979285	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	CCCC1=Nc2c(ncnc2[S+]([O-])c2ccccc2)Sc2ccccc21		CHEMBL4088380	=	Inhibition	%	73.0	CHEMBL260	Homo sapiens	INH	%	73.0
	17979286	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	O=[N+]([O-])c1ccccc1C1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4083031	=	Inhibition	%	63.0	CHEMBL260	Homo sapiens	INH	%	63.0
	17979287	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	37.0	CHEMBL260	Homo sapiens	INH	%	37.0
	17979288	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	COc1ccc(Sc2ncnc3c2N=C(c2ccc(C)cc2)c2cc(OC)ccc2S3)cc1		CHEMBL4071618	=	Inhibition	%	30.0	CHEMBL260	Homo sapiens	INH	%	30.0
	17979289	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc2c(c1)C(Cc1ccccc1)=Nc1c(NC3CCCCC3)ncnc1S2		CHEMBL4092415	=	Inhibition	%	29.0	CHEMBL260	Homo sapiens	INH	%	29.0
	17979290	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc2c(c1)C(Cc1ccccc1)=Nc1c(NCc3ccccc3)ncnc1S2		CHEMBL4062989	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	17979291	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc2c(c1)C(c1cccnc1)=Nc1c(NCc3ccccc3)ncnc1S2		CHEMBL4084660	=	Inhibition	%	18.0	CHEMBL260	Homo sapiens	INH	%	18.0
	17979292	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	c1ccc(Sc2ncnc3c2N=C(c2ccccc2)c2ccccc2S3)cc1		CHEMBL4090001	=	Inhibition	%	18.0	CHEMBL260	Homo sapiens	INH	%	18.0
	17979293	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	CCCC1=Nc2c(Sc3ccc(C)cc3)ncnc2Sc2ccc(C)cc21		CHEMBL4061952	=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
	17979294	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(Sc2ncnc3c2N=C(c2ccccc2)c2cc(C)ccc2S3)cc1		CHEMBL4082146	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	17979295	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	CCCC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4100149	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	17979296	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(C2=Nc3c(NC4CCCCC4)ncnc3Sc3ccc(Cl)cc32)cc1		CHEMBL4085624	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	17979297	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	COc1ccc(Sc2ncnc3c2N=C(Cc2ccccc2)c2cc(OC)ccc2S3)cc1		CHEMBL4103556	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	17979298	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	c1ccc(CC2=Nc3c(Sc4ccccc4)ncnc3Sc3ccccc32)cc1		CHEMBL4067179	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	17979299	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Fc1ccc(C2=Nc3c(Sc4ccccc4)ncnc3Sc3ccccc32)cc1		CHEMBL4094629	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	17979300	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	CCCC1=Nc2c(NCc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4104801	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	17979301	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(Sc2ncnc3c2N=C(c2cccnc2)c2cc(C)ccc2S3)cc1		CHEMBL4086922	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	17979302	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(C2=Nc3c(Sc4ccc(Cl)cc4)ncnc3Sc3ccc(Cl)cc32)cc1		CHEMBL4097087	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	17979303	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc2c(c1)C(c1ccc(F)cc1)=Nc1c(N)ncnc1S2		CHEMBL4079066	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	17979304	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Clc1ccc(Sc2ncnc3c2N=C(c2ccccc2)c2cc(Cl)ccc2S3)cc1		CHEMBL4089377	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	17979305	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(Sc2ncnc3c2N=C(Cc2ccccc2)c2cc(C)ccc2S3)cc1		CHEMBL4068197	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	17979306	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(Sc2ncnc3c2N=C(c2ccc(F)cc2)c2cc(C)ccc2S3)cc1		CHEMBL4081500	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	17979307	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Clc1ccc(Sc2ncnc3c2N=C(Cc2ccccc2)c2cc(Cl)ccc2S3)cc1		CHEMBL4059533	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	17979308	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc(C2=Nc3c(NCc4ccccc4)ncnc3Sc3ccc(Cl)cc32)cc1		CHEMBL4071102	=	Inhibition	%	-2.0	CHEMBL260	Homo sapiens	INH	%	-2.0
	17979309	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	Cc1ccc2c(c1)C(c1ccc(F)cc1)=Nc1c(NCCO)ncnc1S2		CHEMBL4091925	=	Inhibition	%	-3.0	CHEMBL260	Homo sapiens	INH	%	-3.0
	17979310	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	CCCCNc1ncnc2c1N=C(c1ccccc1)c1cc(C)ccc1S2		CHEMBL4081653	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	17979311	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	c1ccc(C2=Nc3c(ncnc3N3CCCC3)Sc3ccccc32)cc1		CHEMBL4099658	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	17979312	CHEMBL3998041	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli at 10 uM using Ser/Thr04 peptide as substrate in presence of inactive MAPKAPK2 after 1 hr by FRET assay relative to control	B	CCCCNc1ncnc2c1N=C(c1ccccc1)c1cc(Cl)ccc1S2		CHEMBL4072485	=	Inhibition	%	-6.0	CHEMBL260	Homo sapiens	INH	%	-6.0
	17979313	CHEMBL3998040	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli by Z'-Lyte assay	B	Cc1ccc(C2=Nc3c(ncnc3S(=O)(=O)c3ccc(C)cc3)[S+]([O-])c3ccc(C)cc32)cc1		CHEMBL4059699	=	IC50	nM	42.7	CHEMBL260	Homo sapiens	IC50	nM	42.7
	17979314	CHEMBL3998040	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli by Z'-Lyte assay	B	[O-][S+](c1ccc(Cl)cc1)c1ncnc2c1N=C(c1ccccc1)c1cc(Cl)ccc1S2		CHEMBL4103859	=	IC50	nM	855.0	CHEMBL260	Homo sapiens	IC50	nM	855.0
	17979315	CHEMBL3998040	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli by Z'-Lyte assay	B	c1ccc(Sc2ncnc3c2N=C(c2cccnc2)c2ccccc2S3)cc1		CHEMBL4098540	=	IC50	nM	1250.0	CHEMBL260	Homo sapiens	IC50	nM	1250.0
	17979316	CHEMBL3998040	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli by Z'-Lyte assay	B	CCCC1=Nc2c(ncnc2[S+]([O-])c2ccccc2)Sc2ccccc21		CHEMBL4088380	=	IC50	nM	969.0	CHEMBL260	Homo sapiens	IC50	nM	969.0
	17979317	CHEMBL3998040	Inhibition of full length recombinant human GST-tagged p38alpha expressed in Escherichia coli by Z'-Lyte assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6600.0	CHEMBL260	Homo sapiens	IC50	nM	6600.0
Active	17979318	CHEMBL3998081	Inhibition of p38alpha phosphorylation in human U266 cells at 10 uM after 3 hrs by western blot analysis	B	Cc1ccc(C2=Nc3c(ncnc3S(=O)(=O)c3ccc(C)cc3)[S+]([O-])c3ccc(C)cc32)cc1		CHEMBL4059699		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Dose-dependent effect	17979319	CHEMBL3998082	Inhibition of p38alpha phosphorylation in human MM1S cells after 3 hrs by western blot analysis	B	Cc1ccc(C2=Nc3c(ncnc3S(=O)(=O)c3ccc(C)cc3)[S+]([O-])c3ccc(C)cc32)cc1		CHEMBL4059699		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18007181	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4-c4ccc(F)cc4)ccn3)cc2)c1		CHEMBL4062023	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	18007182	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4-c4ccc(F)cc4)ccn3)cc2)cc1		CHEMBL4082212	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	18007183	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CCC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4-c4ccc(F)cc4)ccn3)cc2)c1		CHEMBL4069805	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	18007184	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)c1		CHEMBL4077018	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	18007185	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CCC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)c1		CHEMBL4092482	=	IC50	nM	126.0	CHEMBL260	Homo sapiens	IC50	nM	126.0
	18007186	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(NC(=O)c4cccc(N)c4)cc3)c2)n1C		CHEMBL4104351	=	IC50	nM	149.0	CHEMBL260	Homo sapiens	IC50	nM	149.0
	18007187	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)c1C		CHEMBL4086457	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	18007188	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CCC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)c1C		CHEMBL4066691	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	18007189	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1cccc(C(=O)Nc2cccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)c2)c1		CHEMBL4094220	=	IC50	nM	217.0	CHEMBL260	Homo sapiens	IC50	nM	217.0
	18007190	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CCC(=O)Nc1cccc(C(=O)Nc2cccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)c2)c1		CHEMBL4077684	=	IC50	nM	241.0	CHEMBL260	Homo sapiens	IC50	nM	241.0
	18007191	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)cc1		CHEMBL4101953	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	18007192	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)cc1		CHEMBL4085536	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	18007193	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)c(C)c2)cc1		CHEMBL4063964	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	18007194	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)c(C)c2)cc1		CHEMBL4093282	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	18007195	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)c2)cc1		CHEMBL4072555	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	nM	26.0
	18007196	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1cccc(C(=O)Nc2cccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)c2)c1C		CHEMBL4071770	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	nM	100.0
	18007197	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)c(C)c2)c1		CHEMBL4092555	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	18007198	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1		CHEMBL4082278	=	IC50	nM	1952.0	CHEMBL260	Homo sapiens	IC50	nM	1952.0
	18007199	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)cc1		CHEMBL4100292	=	IC50	nM	5920.0	CHEMBL260	Homo sapiens	IC50	nM	5920.0
	18007200	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CCC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1		CHEMBL4101252	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	18007201	CHEMBL4003428	Inhibition of GST-His tagged human p38alpha expressed in Escherichia coli assessed as reduction in ATF2 phosphorylation measured after 60 mins by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccc(N)cc3)c2)[nH]1		CHEMBL4074524	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	nM	17.0
	18008355	CHEMBL4003708	Inhibition of P38alpha (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1		CHEMBL4062453	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	18012415	CHEMBL4004235	Inhibition of recombinant human N-terminal GST-tagged p38-alpha (9 to 352 residues) expressed in Escherichia coli expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	18034727	CHEMBL4008330	Binding affinity to full length human p38alpha (1 to 360 amino acid residues) expressed in bacterial expression system assessed as percent control number at 1 uM by KINOMEscan assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4066104	=	Activity	%	0.0	CHEMBL260	Homo sapiens	Activity	%	0.0
	18034737	CHEMBL4008338	Inhibition of full-length recombinant human GST-tagged p38alpha expressed in Escherichia coli by Z'-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4066104	=	IC50	nM	106.0	CHEMBL260	Homo sapiens	IC50	nM	106.0
	18034738	CHEMBL4008338	Inhibition of full-length recombinant human GST-tagged p38alpha expressed in Escherichia coli by Z'-LYTE assay	B	CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4087478	=	IC50	nM	89.0	CHEMBL260	Homo sapiens	IC50	nM	89.0
Not Active	18037182	CHEMBL4008909	Stabilization of MAPK p38alpha in human U251 cell lysate at 10 uM preincubated for 1 hr followed by incubation at 40 to 70 degreeC for 3 mins by cellular thermal shift assay	B	Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL4096575		Activity			CHEMBL260	Homo sapiens	Activity		
	18048606	CHEMBL4011059	Inhibition of TNFalpha-stimulated SAPK2a in human U937 cells assessed as residual activity at 10 uM in presence of ATP relative to control	B	S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4088718	=	Activity	%	78.0	CHEMBL260	Homo sapiens	Activity	%	78.0
	18052920	CHEMBL4011932	Inhibition of p38alpha (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-5.3	CHEMBL260	Homo sapiens	INH	%	-5.3
	18055843	CHEMBL4012266	Potency index, ratio of SB203580 IC50 to compound IC50 for p38alpha MAPK (unknown origin)	B	COc1c2ccoc2cc2oc(C)c(-c3cc(-c4ccc(F)cc4)c(C#N)c(=N)[nH]3)c(=O)c12		CHEMBL4092497	=	Ratio IC50		2.6	CHEMBL260	Homo sapiens	Ratio IC50		2.6
	18088782	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4061315	=	Kd	nM	4.4	CHEMBL260	Homo sapiens	Kd	nM	4.4
	18088783	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4092372	=	Kd	nM	1.3	CHEMBL260	Homo sapiens	Kd	nM	1.3
	18088784	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4069033	=	Kd	nM	7.8	CHEMBL260	Homo sapiens	Kd	nM	7.8
	18088785	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4082844	=	Kd	nM	7.3	CHEMBL260	Homo sapiens	Kd	nM	7.3
	18088786	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4090650	=	Kd	nM	2.2	CHEMBL260	Homo sapiens	Kd	nM	2.2
	18088787	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	Kd	nM	3.14	CHEMBL260	Homo sapiens	Kd	nM	3.14
	18088788	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4095093	=	Kd	nM	17.7	CHEMBL260	Homo sapiens	Kd	nM	17.7
	18088789	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.123	CHEMBL260	Homo sapiens	Kd	nM	0.123
	18088790	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	21.7	CHEMBL260	Homo sapiens	Kd	nM	21.7
	18088791	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	Kd	nM	2.5	CHEMBL260	Homo sapiens	Kd	nM	2.5
	18088792	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	Cc1cc(F)c(NC(=O)c2ccccc2)cc1Nc1ccc2c(c1)CCc1ccc(C(=O)NC[C@@H](O)CO)cc1C2=O	Non standard unit for type	CHEMBL4074237	=	K	10'6/M/s	1.1	CHEMBL260	Homo sapiens	K	10'6/M/s	1.1
	18088793	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)ccc3F)cc1CC2		CHEMBL4103539	=	Ka	10'5/M.s	5.32	CHEMBL260	Homo sapiens	Ka	10'5/M.s	5.32
	18088794	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4078249	=	Ka	10'5/M.s	8.32	CHEMBL260	Homo sapiens	Ka	10'5/M.s	8.32
	18088795	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4061315	=	Ka	10'4/M.s	6.15	CHEMBL260	Homo sapiens	Ka	10'4/M.s	6.15
	18088796	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4092372	=	Ka	10'5/M.s	5.82	CHEMBL260	Homo sapiens	Ka	10'5/M.s	5.82
	18088797	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4069033	=	Ka	10'6/M.s	4.11	CHEMBL260	Homo sapiens	Ka	10'6/M.s	4.11
	18088798	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	Non standard unit for type	CHEMBL103667	=	K	10'-5/s	5.16	CHEMBL260	Homo sapiens	K	10'-5/s	5.16
	18088799	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	Non standard unit for type	CHEMBL103667	=	K	10'3/M/s	4.3	CHEMBL260	Homo sapiens	K	10'3/M/s	4.3
	18088823	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	T1/2	hr	0.006944	CHEMBL260	Homo sapiens	t1/2	s	25.0
	18088824	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	Outside typical range	CHEMBL10	=	T1/2	hr	0.0008889	CHEMBL260	Homo sapiens	t1/2	s	3.2
	18088825	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	T1/2	hr	19.25	CHEMBL260	Homo sapiens	t1/2	s	69300.0
	18088826	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4095093	=	T1/2	hr	0.006111	CHEMBL260	Homo sapiens	t1/2	s	22.0
	18088827	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	T1/2	hr	0.05	CHEMBL260	Homo sapiens	t1/2	s	180.0
	18088828	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4090650	=	T1/2	hr	0.7889	CHEMBL260	Homo sapiens	t1/2	s	2840.0
	18088829	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4082844	=	T1/2	hr	0.01639	CHEMBL260	Homo sapiens	t1/2	s	59.0
	18088830	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4069033	=	T1/2	hr	0.006111	CHEMBL260	Homo sapiens	t1/2	s	22.0
	18088831	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4092372	=	T1/2	hr	0.2558	CHEMBL260	Homo sapiens	t1/2	s	921.0
	18088832	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4061315	=	T1/2	hr	0.705	CHEMBL260	Homo sapiens	t1/2	s	2538.0
	18088833	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4078249	=	T1/2	hr	0.09611	CHEMBL260	Homo sapiens	t1/2	s	346.0
	18088834	CHEMBL4019408	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation half life by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)ccc3F)cc1CC2		CHEMBL4103539	=	T1/2	hr	0.0925	CHEMBL260	Homo sapiens	t1/2	s	333.0
	18088835	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	TIME	hr	0.01	CHEMBL260	Homo sapiens	Time	s	36.0
	18088836	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	TIME	hr	0.001278	CHEMBL260	Homo sapiens	Time	s	4.6
	18088837	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	TIME	hr	27.78	CHEMBL260	Homo sapiens	Time	s	100000.0
	18088838	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4095093	=	TIME	hr	0.008889	CHEMBL260	Homo sapiens	Time	s	32.0
	18088839	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	TIME	hr	0.07194	CHEMBL260	Homo sapiens	Time	s	259.0
	18088840	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4090650	=	TIME	hr	1.139	CHEMBL260	Homo sapiens	Time	s	4099.0
	18088841	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4082844	=	TIME	hr	0.02389	CHEMBL260	Homo sapiens	Time	s	86.0
	18088842	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4069033	=	TIME	hr	0.008611	CHEMBL260	Homo sapiens	Time	s	31.0
	18088843	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4092372	=	TIME	hr	0.3692	CHEMBL260	Homo sapiens	Time	s	1329.0
	18088844	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4061315	=	TIME	hr	1.018	CHEMBL260	Homo sapiens	Time	s	3663.0
	18088845	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4078249	=	TIME	hr	0.1386	CHEMBL260	Homo sapiens	Time	s	499.0
	18088846	CHEMBL4019407	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as residence time by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)ccc3F)cc1CC2		CHEMBL4103539	=	TIME	hr	0.1333	CHEMBL260	Homo sapiens	Time	s	480.0
	18088847	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1	Non standard unit for type	CHEMBL1088751	=	Kd	10'-2/s	2.75	CHEMBL260	Homo sapiens	Kd	10'-2/s	2.75
	18088848	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	Non standard unit for type	CHEMBL10	=	Kd	10'-1/s	2.18	CHEMBL260	Homo sapiens	Kd	10'-1/s	2.18
	18088849	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	Non standard unit for type	CHEMBL103667	=	Kd	10'-5/s	1.0	CHEMBL260	Homo sapiens	Kd	10'-5/s	1.0
	18088850	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2	Non standard unit for type	CHEMBL4095093	=	Kd	10'-2/s	3.09	CHEMBL260	Homo sapiens	Kd	10'-2/s	3.09
	18088851	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2	Non standard unit for type	CHEMBL2316207	=	Kd	10'-3/s	3.86	CHEMBL260	Homo sapiens	Kd	10'-3/s	3.86
	18088852	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2	Non standard unit for type	CHEMBL4090650	=	Kd	10'-4/s	2.44	CHEMBL260	Homo sapiens	Kd	10'-4/s	2.44
	18088853	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2	Non standard unit for type	CHEMBL4082844	=	Kd	10'-2/s	1.17	CHEMBL260	Homo sapiens	Kd	10'-2/s	1.17
	18088854	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2	Non standard unit for type	CHEMBL4069033	=	Kd	10'-2/s	3.22	CHEMBL260	Homo sapiens	Kd	10'-2/s	3.22
	18088855	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2	Non standard unit for type	CHEMBL4092372	=	Kd	10'-4/s	7.53	CHEMBL260	Homo sapiens	Kd	10'-4/s	7.53
	18088856	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2	Non standard unit for type	CHEMBL4061315	=	Kd	10'-4/s	2.73	CHEMBL260	Homo sapiens	Kd	10'-4/s	2.73
	18088857	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2	Non standard unit for type	CHEMBL4078249	=	Kd	10'-3/s	2.0	CHEMBL260	Homo sapiens	Kd	10'-3/s	2.0
	18088858	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)ccc3F)cc1CC2	Non standard unit for type	CHEMBL4103539	=	Kd	10'-3/s	2.08	CHEMBL260	Homo sapiens	Kd	10'-3/s	2.08
	18088859	CHEMBL4019406	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as dissociation rate constant by SPR analysis	B	Cc1cc(F)c(NC(=O)c2ccccc2)cc1Nc1ccc2c(c1)CCc1ccc(C(=O)NC[C@@H](O)CO)cc1C2=O	Non standard unit for type	CHEMBL4074237	=	K	10'-2/s	1.29	CHEMBL260	Homo sapiens	K	10'-2/s	1.29
	18088860	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	=	Ka	10'7/M.s	1.08	CHEMBL260	Homo sapiens	Ka	10'7/M.s	1.08
	18088861	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ka	10'7/M.s	1.0	CHEMBL260	Homo sapiens	Ka	10'7/M.s	1.0
	18088862	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ka	10'4/M.s	1.21	CHEMBL260	Homo sapiens	Ka	10'4/M.s	1.21
	18088863	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4095093	=	Ka	10'6/M.s	1.75	CHEMBL260	Homo sapiens	Ka	10'6/M.s	1.75
	18088864	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	Ka	10'6/M.s	1.23	CHEMBL260	Homo sapiens	Ka	10'6/M.s	1.23
	18088865	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4090650	=	Ka	10'5/M.s	1.09	CHEMBL260	Homo sapiens	Ka	10'5/M.s	1.09
	18088866	CHEMBL4019405	Binding affinity to wild type biotin labelled human p38 alpha (9 to 352 residues) expressed in sf21 insect cells assessed as association rate constant by SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4082844	=	Ka	10'6/M.s	1.61	CHEMBL260	Homo sapiens	Ka	10'6/M.s	1.61
	18088867	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4078249	=	Kd	nM	2.4	CHEMBL260	Homo sapiens	Kd	nM	2.4
	18088868	CHEMBL4019403	Binding affinity to wild type human biotin labelled p38 alpha (9 to 352 residues) expressed in sf21 insect cells SPR analysis	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)ccc3F)cc1CC2		CHEMBL4103539	=	Kd	nM	3.9	CHEMBL260	Homo sapiens	Kd	nM	3.9
Not Determined	18088869	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(C(F)(F)F)cc4)c(F)cc3F)cc1CC2		CHEMBL4104440		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088870	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccc(OC)c4)c(F)cc3F)cc1CC2		CHEMBL4069496		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088871	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(OC)cc4)c(F)cc3F)cc1CC2		CHEMBL4096722		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088872	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccc(F)c4)c(F)cc3F)cc1CC2		CHEMBL4060815		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088873	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(F)cc4)c(F)cc3F)cc1CC2		CHEMBL4089021		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088874	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccc(Cl)c4)c(F)cc3F)cc1CC2		CHEMBL4100394		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088875	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(Cl)cc4)c(F)cc3F)cc1CC2		CHEMBL4073561		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088876	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4074639		IC50			CHEMBL260	Homo sapiens	IC50		
	18088877	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4095093	=	IC50	nM	463.8	CHEMBL260	Homo sapiens	IC50	nM	463.8
Not Determined	18088878	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4084905		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088879	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4102854		IC50			CHEMBL260	Homo sapiens	IC50		
	18088880	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4103781	=	IC50	nM	69.0	CHEMBL260	Homo sapiens	IC50	nM	69.0
	18088881	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4079527	=	IC50	nM	43.2	CHEMBL260	Homo sapiens	IC50	nM	43.2
	18088882	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4066023	=	IC50	nM	59.3	CHEMBL260	Homo sapiens	IC50	nM	59.3
	18088883	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4087408	=	IC50	nM	42.2	CHEMBL260	Homo sapiens	IC50	nM	42.2
	18088884	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4066347	=	IC50	nM	60.2	CHEMBL260	Homo sapiens	IC50	nM	60.2
	18088885	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4093914	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	nM	31.0
	18088886	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4077602	=	IC50	nM	36.6	CHEMBL260	Homo sapiens	IC50	nM	36.6
	18088887	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4101643	=	IC50	nM	90.5	CHEMBL260	Homo sapiens	IC50	nM	90.5
	18088888	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
Not Determined	18088889	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4075759		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088890	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(C(=O)NCC(O)CO)cc1C2=O		CHEMBL4068060		IC50			CHEMBL260	Homo sapiens	IC50		
	18088891	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(C(=O)NC(CO)CO)cc2C3=O)c(F)cc1F)c1ccsc1		CHEMBL4077106	=	IC50	nM	382.4	CHEMBL260	Homo sapiens	IC50	nM	382.4
Not Determined	18088892	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccsc4)c(F)cc3C)cc1OC2		CHEMBL4072910		IC50			CHEMBL260	Homo sapiens	IC50		
	18088893	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NC(CO)(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4071599	=	IC50	nM	107.3	CHEMBL260	Homo sapiens	IC50	nM	107.3
	18088894	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NC(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4066610	=	IC50	nM	294.9	CHEMBL260	Homo sapiens	IC50	nM	294.9
Not Determined	18088895	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4081874		IC50			CHEMBL260	Homo sapiens	IC50		
	18088896	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4103149	=	IC50	nM	137.8	CHEMBL260	Homo sapiens	IC50	nM	137.8
	18088897	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4076950	=	IC50	nM	151.5	CHEMBL260	Homo sapiens	IC50	nM	151.5
Not Determined	18088898	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4090650		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088899	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(C(=O)N4CCOCC4)cc2C3=O)ccc1F)c1cccs1		CHEMBL4067880		IC50			CHEMBL260	Homo sapiens	IC50		
	18088900	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4082844	=	IC50	nM	168.5	CHEMBL260	Homo sapiens	IC50	nM	168.5
Not Determined	18088901	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4077412		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088902	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4073776		IC50			CHEMBL260	Homo sapiens	IC50		
	18088903	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4069033	=	IC50	nM	192.1	CHEMBL260	Homo sapiens	IC50	nM	192.1
Not Determined	18088904	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4064695		IC50			CHEMBL260	Homo sapiens	IC50		
	18088905	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4092372	=	IC50	nM	34.7	CHEMBL260	Homo sapiens	IC50	nM	34.7
	18088906	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4066269	=	IC50	nM	81.8	CHEMBL260	Homo sapiens	IC50	nM	81.8
	18088907	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4082939	=	IC50	nM	95.8	CHEMBL260	Homo sapiens	IC50	nM	95.8
	18088908	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4061315	=	IC50	nM	43.0	CHEMBL260	Homo sapiens	IC50	nM	43.0
	18088909	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4083921	=	IC50	nM	182.3	CHEMBL260	Homo sapiens	IC50	nM	182.3
	18088910	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4078249	=	IC50	nM	35.7	CHEMBL260	Homo sapiens	IC50	nM	35.7
	18088911	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4076170	=	IC50	nM	94.3	CHEMBL260	Homo sapiens	IC50	nM	94.3
	18088912	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4071095	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	18088913	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)ccc3F)cc1CC2		CHEMBL4103539	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
Not Determined	18088914	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4075277		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088915	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NC(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1OC2		CHEMBL4102590		IC50			CHEMBL260	Homo sapiens	IC50		
	18088916	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1OC2		CHEMBL4072511	=	IC50	nM	1613.6	CHEMBL260	Homo sapiens	IC50	nM	1613.6
Not Determined	18088917	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1OC2		CHEMBL4076787		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088918	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4061811		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088919	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4103075		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088920	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4094105		IC50			CHEMBL260	Homo sapiens	IC50		
	18088921	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4061369	=	IC50	nM	25.1	CHEMBL260	Homo sapiens	IC50	nM	25.1
	18088922	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4088396	=	IC50	nM	47.2	CHEMBL260	Homo sapiens	IC50	nM	47.2
Not Determined	18088923	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4066327		IC50			CHEMBL260	Homo sapiens	IC50		
	18088924	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4102537	=	IC50	nM	69.1	CHEMBL260	Homo sapiens	IC50	nM	69.1
Not Determined	18088925	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)ccc3F)cc1CC2		CHEMBL4084589		IC50			CHEMBL260	Homo sapiens	IC50		
	18088926	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4079228	=	IC50	nM	690.6	CHEMBL260	Homo sapiens	IC50	nM	690.6
	18088927	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)ccc3C)cc1CC2		CHEMBL4103486	=	IC50	nM	161.8	CHEMBL260	Homo sapiens	IC50	nM	161.8
	18088928	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)ccc3F)cc1CC2		CHEMBL4087104	=	IC50	nM	304.8	CHEMBL260	Homo sapiens	IC50	nM	304.8
	18088929	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4065681	=	IC50	nM	193.2	CHEMBL260	Homo sapiens	IC50	nM	193.2
Not Determined	18088930	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cccc(C(=O)NC4CC4)c3F)cc1CC2		CHEMBL4059727		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088931	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC4CC4)ccc3F)cc1CC2		CHEMBL4088016		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088932	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C)c(C(=O)NC4CC4)c3)cc1CC2		CHEMBL4068387		IC50			CHEMBL260	Homo sapiens	IC50		
	18088933	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC4CC4)ccc3C)cc1CC2		CHEMBL4095732	=	IC50	nM	903.2	CHEMBL260	Homo sapiens	IC50	nM	903.2
Not Determined	18088934	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C(=O)NC(C)C)c3)cc1CC2		CHEMBL4105222		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088935	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC(C)C)ccc3F)cc1CC2		CHEMBL4080980		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088936	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC(C)C)ccc3C)cc1CC2		CHEMBL4075599		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	18088937	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)N(C)C(C)C)ccc3C)cc1CC2		CHEMBL4084426		IC50			CHEMBL260	Homo sapiens	IC50		
	18088938	CHEMBL4019404	Inhibition of P38 alpha MAPK in human whole blood assessed as reduction in TNF-alpha release after 10 mins by ELISA	B	Cc1cc(F)c(NC(=O)c2ccccc2)cc1Nc1ccc2c(c1)CCc1ccc(C(=O)NC[C@@H](O)CO)cc1C2=O		CHEMBL4074237	=	IC50	nM	0.28	CHEMBL260	Homo sapiens	IC50	nM	0.28
	18088939	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(C(F)(F)F)cc4)c(F)cc3F)cc1CC2		CHEMBL4104440	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	18088940	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccc(OC)c4)c(F)cc3F)cc1CC2		CHEMBL4069496	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	18088941	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(OC)cc4)c(F)cc3F)cc1CC2		CHEMBL4096722	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	18088942	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccc(F)c4)c(F)cc3F)cc1CC2		CHEMBL4060815	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	IC50	nM	0.1
	18088943	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(F)cc4)c(F)cc3F)cc1CC2		CHEMBL4089021	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	18088944	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccc(Cl)c4)c(F)cc3F)cc1CC2		CHEMBL4100394	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
	18088945	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccc(Cl)cc4)c(F)cc3F)cc1CC2		CHEMBL4073561	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	18088946	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4074639	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	18088947	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4095093	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	18088948	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1OC2		CHEMBL4084905	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	18088949	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4102854	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	nM	0.7
	18088950	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4103781	=	IC50	nM	1.2	CHEMBL260	Homo sapiens	IC50	nM	1.2
	18088951	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4079527	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	18088952	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4066023	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	18088953	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)cc1CC2		CHEMBL4087408	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	18088954	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4066347	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
	18088955	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4093914	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	18088956	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4077602	=	IC50	nM	0.5	CHEMBL260	Homo sapiens	IC50	nM	0.5
	18088957	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4101643	=	IC50	nM	0.3	CHEMBL260	Homo sapiens	IC50	nM	0.3
	18088958	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
	18088959	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4075759	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	18088960	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	Cc1cc(F)c(NC(=O)c2ccsc2)cc1Nc1ccc2c(c1)OCc1ccc(C(=O)NCC(O)CO)cc1C2=O		CHEMBL4068060	=	IC50	nM	13.1	CHEMBL260	Homo sapiens	IC50	nM	13.1
	18088961	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(C(=O)NC(CO)CO)cc2C3=O)c(F)cc1F)c1ccsc1		CHEMBL4077106	=	IC50	nM	6.5	CHEMBL260	Homo sapiens	IC50	nM	6.5
	18088962	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4ccsc4)c(F)cc3C)cc1OC2		CHEMBL4072910	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	18088963	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NC(CO)(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4071599	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	18088964	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NC(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4066610	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	18088965	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4081874	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	18088966	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4103149	=	IC50	nM	0.7	CHEMBL260	Homo sapiens	IC50	nM	0.7
	18088967	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4076950	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	18088968	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1OC2		CHEMBL4090650	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	18088969	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(C(=O)N4CCOCC4)cc2C3=O)ccc1F)c1cccs1		CHEMBL4067880	=	IC50	nM	32.9	CHEMBL260	Homo sapiens	IC50	nM	32.9
	18088970	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4082844	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	nM	2.0
	18088971	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4077412	=	IC50	nM	2.6	CHEMBL260	Homo sapiens	IC50	nM	2.6
	18088972	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4073776	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	18088973	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4069033	=	IC50	nM	1.6	CHEMBL260	Homo sapiens	IC50	nM	1.6
	18088974	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1OC2		CHEMBL4064695	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	18088975	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4092372	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	18088976	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4066269	=	IC50	nM	5.2	CHEMBL260	Homo sapiens	IC50	nM	5.2
	18088977	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4082939	=	IC50	nM	0.4	CHEMBL260	Homo sapiens	IC50	nM	0.4
	18088978	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4061315	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	18088979	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)c(F)cc3F)cc1CC2		CHEMBL4083921	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	18088980	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4078249	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	18088981	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4076170	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	18088982	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4071095	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	18088983	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)c4cccs4)ccc3F)cc1CC2		CHEMBL4103539	=	IC50	nM	0.6	CHEMBL260	Homo sapiens	IC50	nM	0.6
	18088984	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4075277	=	IC50	nM	1.1	CHEMBL260	Homo sapiens	IC50	nM	1.1
	18088985	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NC(CO)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1OC2		CHEMBL4102590	=	IC50	nM	34.9	CHEMBL260	Homo sapiens	IC50	nM	34.9
	18088986	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1OC2		CHEMBL4072511	=	IC50	nM	23.8	CHEMBL260	Homo sapiens	IC50	nM	23.8
	18088987	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	COC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1OC2		CHEMBL4076787	=	IC50	nM	17.6	CHEMBL260	Homo sapiens	IC50	nM	17.6
	18088988	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4061811	=	IC50	nM	4.2	CHEMBL260	Homo sapiens	IC50	nM	4.2
	18088989	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4103075	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	18088990	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4094105	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	18088991	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCO)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4061369	=	IC50	nM	5.4	CHEMBL260	Homo sapiens	IC50	nM	5.4
	18088992	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)c(F)cc3F)cc1CC2		CHEMBL4088396	=	IC50	nM	2.4	CHEMBL260	Homo sapiens	IC50	nM	2.4
	18088993	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCC(O)CO)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4066327	=	IC50	nM	6.7	CHEMBL260	Homo sapiens	IC50	nM	6.7
	18088994	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4102537	=	IC50	nM	4.8	CHEMBL260	Homo sapiens	IC50	nM	4.8
	18088995	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)ccc3F)cc1CC2		CHEMBL4084589	=	IC50	nM	5.3	CHEMBL260	Homo sapiens	IC50	nM	5.3
	18088996	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4079228	=	IC50	nM	13.1	CHEMBL260	Homo sapiens	IC50	nM	13.1
	18088997	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)ccc3C)cc1CC2		CHEMBL4103486	=	IC50	nM	19.3	CHEMBL260	Homo sapiens	IC50	nM	19.3
	18088998	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(NC(=O)C4CC4)ccc3F)cc1CC2		CHEMBL4087104	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	18088999	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)C4CC4)c3)cc1CC2		CHEMBL4065681	=	IC50	nM	4.7	CHEMBL260	Homo sapiens	IC50	nM	4.7
	18089000	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cccc(C(=O)NC4CC4)c3F)cc1CC2		CHEMBL4059727	=	IC50	nM	40.9	CHEMBL260	Homo sapiens	IC50	nM	40.9
	18089001	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC4CC4)ccc3F)cc1CC2		CHEMBL4088016	=	IC50	nM	32.5	CHEMBL260	Homo sapiens	IC50	nM	32.5
	18089002	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C)c(C(=O)NC4CC4)c3)cc1CC2		CHEMBL4068387	=	IC50	nM	129.3	CHEMBL260	Homo sapiens	IC50	nM	129.3
	18089003	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC4CC4)ccc3C)cc1CC2		CHEMBL4095732	=	IC50	nM	10.9	CHEMBL260	Homo sapiens	IC50	nM	10.9
	18089004	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C(=O)NC(C)C)c3)cc1CC2		CHEMBL4105222	=	IC50	nM	659.1	CHEMBL260	Homo sapiens	IC50	nM	659.1
	18089005	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC(C)C)ccc3F)cc1CC2		CHEMBL4080980	=	IC50	nM	374.4	CHEMBL260	Homo sapiens	IC50	nM	374.4
	18089006	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)NC(C)C)ccc3C)cc1CC2		CHEMBL4075599	=	IC50	nM	106.7	CHEMBL260	Homo sapiens	IC50	nM	106.7
	18089007	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	CNC(=O)c1ccc2c(c1)C(=O)c1ccc(Nc3cc(C(=O)N(C)C(C)C)ccc3C)cc1CC2		CHEMBL4084426	=	IC50	nM	2300.8	CHEMBL260	Homo sapiens	IC50	nM	2300.8
	18089008	CHEMBL4019402	Inhibition of P38 alpha MAPK (unknown origin) by ELISA	B	Cc1cc(F)c(NC(=O)c2ccccc2)cc1Nc1ccc2c(c1)CCc1ccc(C(=O)NC[C@@H](O)CO)cc1C2=O		CHEMBL4074237	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	18092312	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	Fc1cccc(Cl)c1CNc1nc(-c2ccco2)n[nH]1		CHEMBL1354522	=	IC50	nM	14445.0	CHEMBL260	Homo sapiens	IC50	uM	14.445
	18092313	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	Fc1cccc(Cl)c1CNc1nc(-c2ccccc2)n[nH]1		CHEMBL4103618	=	IC50	nM	27143.0	CHEMBL260	Homo sapiens	IC50	uM	27.143
	18092314	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	Oc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1		CHEMBL4079354	=	IC50	nM	9221.0	CHEMBL260	Homo sapiens	IC50	uM	9.221
	18092315	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	Nc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1		CHEMBL4100228	=	IC50	nM	8815.0	CHEMBL260	Homo sapiens	IC50	uM	8.815
	18092316	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	CNc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1		CHEMBL4073371	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	18092317	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	COc1ccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)cc1N		CHEMBL4064000	>	IC50	nM	50000.0	CHEMBL260	Homo sapiens	IC50	uM	50.0
	18092318	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	COc1ccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)cc1OC		CHEMBL4091764	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	18092319	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	C=CC(=O)Nc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1		CHEMBL4101977	=	IC50	nM	20517.0	CHEMBL260	Homo sapiens	IC50	uM	20.517
Dose-dependent effect	18092366	CHEMBL4020189	Inhibition of human N-terminal His-tagged p38alpha expressed in Escherichia coli BL21 DE3 using Ser/Thr-15 peptide as substrate after 60 mins by Z'-LYTE assay	B	Fc1cccc(Cl)c1CNc1nc(-c2ccco2)n[nH]1		CHEMBL1354522		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18114212	CHEMBL4025282	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
Not Active	18134440	CHEMBL4029541	Inhibition of p38alpha (unknown origin) at <1 uM using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma32P]ATP by scintillation counter method	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	18134470	CHEMBL4029541	Inhibition of p38alpha (unknown origin) at <1 uM using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma32P]ATP by scintillation counter method	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18135445	CHEMBL4029697	Inhibition of full length wild type human SAPK2alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1cscn1		CHEMBL4061891	=	Activity	%	109.0	CHEMBL260	Homo sapiens	Activity	%	109.0
	18135462	CHEMBL4029697	Inhibition of full length wild type human SAPK2alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1csc(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4075290	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	18135479	CHEMBL4029697	Inhibition of full length wild type human SAPK2alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)N2C(=O)C3Nc4cc(Cl)cc(Cl)c4C3C=C12		CHEMBL4096175	=	Activity	%	103.0	CHEMBL260	Homo sapiens	Activity	%	103.0
	18135496	CHEMBL4029697	Inhibition of full length wild type human SAPK2alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	N=C1NC(=O)/C(=C/c2csc(-c3ccc(C(F)(F)F)cc3)n2)S1		CHEMBL4064860	=	Activity	%	94.0	CHEMBL260	Homo sapiens	Activity	%	94.0
	18138864	CHEMBL4030398	Potency index, ratio of SB203580 IC50 to compound IC50 for P38 MAPKalpha in LPS-stimulated human whole blood assessed as decrease in TNFalpha level	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL432798	=	Ratio IC50		2.1	CHEMBL260	Homo sapiens	Ratio IC50		2.1
	18138865	CHEMBL4030397	Potency index, ratio of SB203580 IC50 to compound IC50 for P38 MAPKalpha in human LPS-stimulated whole blood assessed as decrease in IL-1beta level	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL432798	=	Ratio IC50		1.5	CHEMBL260	Homo sapiens	Ratio IC50		1.5
	18138866	CHEMBL4030396	Potency index, ratio of SB203580 IC50 to compound IC50 for P38 MAPKalpha (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)n1C		CHEMBL432798	=	Ratio IC50		2.35	CHEMBL260	Homo sapiens	Ratio IC50		2.35
	18138867	CHEMBL4030397	Potency index, ratio of SB203580 IC50 to compound IC50 for P38 MAPKalpha in human LPS-stimulated whole blood assessed as decrease in IL-1beta level	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1		CHEMBL321494	=	Ratio IC50		3.2	CHEMBL260	Homo sapiens	Ratio IC50		3.2
	18138868	CHEMBL4030396	Potency index, ratio of SB203580 IC50 to compound IC50 for P38 MAPKalpha (unknown origin)	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1		CHEMBL321494	=	Ratio IC50		5.8	CHEMBL260	Homo sapiens	Ratio IC50		5.8
	18138870	CHEMBL4030398	Potency index, ratio of SB203580 IC50 to compound IC50 for P38 MAPKalpha in LPS-stimulated human whole blood assessed as decrease in TNFalpha level	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1		CHEMBL321494	=	Ratio IC50		5.4	CHEMBL260	Homo sapiens	Ratio IC50		5.4
	18138919	CHEMBL4030427	Inhibition of p38alpha MAPK (unknown origin)	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@@+](C)[O-])n2C)ccn1		CHEMBL1773423	=	IC50	nM	129.0	CHEMBL260	Homo sapiens	IC50	nM	129.0
	18138920	CHEMBL4030428	Inhibition of p38alpha MAPK (unknown origin) at 1 uM relative to control	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S@+](C)[O-])n2C)ccn1		CHEMBL1773424	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	18138921	CHEMBL4030434	Inhibition of p38alpha MAPK (unknown origin) by beta-galactosidase enzyme complementation assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
Not Active	18138944	CHEMBL4030456	Inhibition of p38MAPK alpha (unknown origin) at 10 uM relative to control	B	Cn1c([S+](C)[O-])nc(-c2ccc(F)cc2)c1-c1ccnc(N)c1		CHEMBL4075428		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18138948	CHEMBL4030460	Inhibition of P38 MAPKalpha in LPS-stimulated human whole blood assessed as decrease in TNFalpha level	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	IC50	nM	710.0	CHEMBL260	Homo sapiens	IC50	uM	0.71
	18138949	CHEMBL4030460	Inhibition of P38 MAPKalpha in LPS-stimulated human whole blood assessed as decrease in TNFalpha level	B	Cn1c([S+](C)[O-])nc(-c2ccc(F)cc2)c1-c1ccnc(N)c1		CHEMBL4075428	=	IC50	nM	710.0	CHEMBL260	Homo sapiens	IC50	uM	0.71
Active	18139140	CHEMBL4030610	Binding affinity to p38alpha MAPK (unknown origin) by SPR assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422		Activity			CHEMBL260	Homo sapiens	Activity		
Active	18139141	CHEMBL4030610	Binding affinity to p38alpha MAPK (unknown origin) by SPR assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	18139146	CHEMBL4030612	Inhibition of MKK6-mediated p38alpha MAPK (unknown origin) phosphorylation up to 10 uM	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	18140421	CHEMBL4031014	Inhibition of human p38alpha MAPK at 30 uM	B	CCN(CC)c1ccc(NC(=O)c2c(-c3ccccc3)noc2C)cc1		CHEMBL361366		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18153053	CHEMBL4034435	Inhibition of p38alpha (unknown origin) labeling at conserved lysine2 at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	14.5	CHEMBL260	Homo sapiens	INH	%	14.5
	18153255	CHEMBL4034436	Inhibition of p38a protein kinase domain (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	15.7	CHEMBL260	Homo sapiens	INH	%	15.7
	18168199	CHEMBL4036883	Inhibition of full length wild type human p38alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 2 uM by KINOMEscan assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)C(N)CCCCn1cc(CCCCNC(=O)CCCCCn2nc(N)c3cc(-c4c(-c5ccccc5)nn5ccccc45)nnc32)nn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C		CHEMBL4079223	=	Activity	%	0.25	CHEMBL260	Homo sapiens	Activity	%	0.25
	18203806	CHEMBL4044093	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	98.0	CHEMBL260	Homo sapiens	Activity	%	98.0
	18211522	CHEMBL4045785	Inhibition of p38a (QELNKTIWEVPER) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	18211523	CHEMBL4045784	Inhibition of p38a conserved Lys2 (DLKPSNLAVNEDCELK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	33.9	CHEMBL260	Homo sapiens	INH	%	33.9
	18211929	CHEMBL4046025	Inhibition of p38a conserved Lys2 (DLKPSNLAVNEDCELK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	22.3	CHEMBL260	Homo sapiens	INH	%	22.3
	18211930	CHEMBL4046026	Inhibition of p38a (QELNKTIWEVPER) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	8.2	CHEMBL260	Homo sapiens	INH	%	8.2
	18212117	CHEMBL4046135	Inhibition of p38alpha (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL260	Homo sapiens	INH	%	20.0
	18218053	CHEMBL4047106	Inhibition of p38alpha (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2c(N=Cc3ccc4ccccc4c3)c(C#N)c3n2CCC3)cc1		CHEMBL4079032	=	Inhibition	%	28.0	CHEMBL260	Homo sapiens	INH	%	28.0
	18218054	CHEMBL4047106	Inhibition of p38alpha (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	INH	%	17.0
	18232140	CHEMBL4050363	Inhibition of human p38a MAPK assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	89.0	CHEMBL260	Homo sapiens	Activity	%	89.0
	18243151	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	OCCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1		CHEMBL4101719	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
Active	18243300	CHEMBL4052522	Inhibition of recombinant full-length human p38alpha MAPK (M1 to S360 residues) expressed in Escherichia coli at 1 uM in presence of [33-gamma]-ATP after 60 mins by scintillation counting method	B	C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4-c4ccc(F)cc4)c23)c1		CHEMBL4071827		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18243301	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	Oc1ccc(-c2nc(-c3ccco3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL4071494	=	IC50	nM	288.0	CHEMBL260	Homo sapiens	IC50	uM	0.288
	18243302	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	Oc1ccc(-c2nc(-c3ccccc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL4070454	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	uM	0.001
	18243303	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	Oc1cccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)c1		CHEMBL4097627	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	uM	0.007
	18243304	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	OCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1		CHEMBL4061829	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	18243305	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	OCCCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1		CHEMBL4089892	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	18243306	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	OCCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]ccc23)[nH]1		CHEMBL4088971	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	uM	0.012
	18243307	CHEMBL4052523	Inhibition of p38alpha MAPK (unknown origin) assessed as decrease in ATF2 phosphorylation at Thr69/71 at 1 uM after 1 hr by ELISA	B	C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4-c4ccc(F)cc4)c23)c1		CHEMBL4071827	=	IC50	nM	214.0	CHEMBL260	Homo sapiens	IC50	uM	0.214
	18253654	CHEMBL4055111	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	94.0	CHEMBL260	Homo sapiens	Activity	%	94.0
	18253655	CHEMBL4055111	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	18265842	CHEMBL4057292	Inhibition of p38a (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.7	CHEMBL260	Homo sapiens	INH	%	1.7
	18265843	CHEMBL4057293	Inhibition of SAPK2a T106M mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.3	CHEMBL260	Homo sapiens	INH	%	1.3
	18266038	CHEMBL4057488	Inhibition of p38a (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-1.7	CHEMBL260	Homo sapiens	INH	%	-1.7
	18266039	CHEMBL4057489	Inhibition of SAPK2a T106M mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.3	CHEMBL260	Homo sapiens	INH	%	-0.3
	18266197	CHEMBL4057647	Inhibition of p38a (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	5.7	CHEMBL260	Homo sapiens	INH	%	5.7
	18275163	CHEMBL4118433	Inhibition of p38a in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNLAVNEDCELK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-7.7	CHEMBL260	Homo sapiens	INH	%	-7.7
	18275164	CHEMBL4118433	Inhibition of p38a in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNLAVNEDCELK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-3.3	CHEMBL260	Homo sapiens	INH	%	-3.3
	18275165	CHEMBL4118433	Inhibition of p38a in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNLAVNEDCELK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-14.2	CHEMBL260	Homo sapiens	INH	%	-14.2
	18275166	CHEMBL4118434	Inhibition of p38a in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled QELNKTIWEVPER probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-95.0	CHEMBL260	Homo sapiens	INH	%	-95.0
	18275167	CHEMBL4118434	Inhibition of p38a in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled QELNKTIWEVPER probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	12.7	CHEMBL260	Homo sapiens	INH	%	12.7
	18275168	CHEMBL4118434	Inhibition of p38a in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled QELNKTIWEVPER probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	10.2	CHEMBL260	Homo sapiens	INH	%	10.2
	18282133	CHEMBL4120088	Inhibition of recombinant full length GST-tagged human p38alpha expressed in Escherichia coli at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	1.1	CHEMBL260	Homo sapiens	INH	%	1.1
	18282452	CHEMBL4120088	Inhibition of recombinant full length GST-tagged human p38alpha expressed in Escherichia coli at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	5.8	CHEMBL260	Homo sapiens	INH	%	5.8
	18282714	CHEMBL4120299	Inhibition of p38a (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.7	CHEMBL260	Homo sapiens	INH	%	1.7
	18282781	CHEMBL4120366	Inhibition of SAPK2a T106M mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.3	CHEMBL260	Homo sapiens	INH	%	1.3
	18282941	CHEMBL4120526	Inhibition of p38a (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	2.3	CHEMBL260	Homo sapiens	INH	%	2.3
	18283008	CHEMBL4120593	Inhibition of SAPK2a T106M mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	0.3	CHEMBL260	Homo sapiens	INH	%	0.3
	18283114	CHEMBL4120699	Inhibition of p38a (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	5.7	CHEMBL260	Homo sapiens	INH	%	5.7
	18283232	CHEMBL4120817	Inhibition of SAPK2a T106M mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.7	CHEMBL260	Homo sapiens	INH	%	0.7
	18290802	CHEMBL4122585	Inhibition of recombinant human p38 alpha using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate at 10 uM after 30 mins in presence of ATP by LANCE method relative to control	B	COc1ccc2c(N[C@@H](C)Cc3cc(C)[nH]n3)ncnc2c1OC		CHEMBL4128481	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	18300345	CHEMBL4124647	Inhibition of full length recombinant human N-terminal His6-tagged SAPK2a expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1		CHEMBL4126750	=	Activity	%	112.0	CHEMBL260	Homo sapiens	Activity	%	112.0
	18316977	CHEMBL4133297	Inhibition of p38alpha (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCOCC4)nc3C)n2)c(OC)c1		CHEMBL4174540	>	Activity	%	40.0	CHEMBL260	Homo sapiens	Activity	%	40.0
	18316978	CHEMBL4133297	Inhibition of p38alpha (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067	>	Activity	%	40.0	CHEMBL260	Homo sapiens	Activity	%	40.0
	18379250	CHEMBL4145358	Inhibition of wild-type human full length MAPK14 (M1 to S360 residues) expressed in bacterial expression system at 10 uM by ATP-site competition binding assay based KinomeScan assay relative to control	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4172550	>	Inhibition	%	90.0	CHEMBL260	Homo sapiens	INH	%	90.0
	18379933	CHEMBL4145834	Inhibition of MAPK14 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-4.49	CHEMBL260	Homo sapiens	INH	%	-4.49
	18379985	CHEMBL4145886	Inhibition of MAPK14 (unknown origin)	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	16.3	CHEMBL260	Homo sapiens	IC50	nM	16.3
	18398320	CHEMBL4149572	Inhibition of recombinant human N-terminal GST-tagged full length SAPK2alpha expressed in Escherichia coli at 10 uM	B	Cc1ccc(C(=O)c2c(N)c(C(N)=O)c3ccccn23)cc1		CHEMBL4165173	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	INH	%	75.0
	18431068	CHEMBL4155749	Inhibition of recombinant full length GST-tagged human p38alpha expressed in Escherichia coli at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	INH	%	17.0
	18434131	CHEMBL4156113	Inhibition of recombinant human full length His-tagged p38-alpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	18434213	CHEMBL4156113	Inhibition of recombinant human full length His-tagged p38-alpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	18434273	CHEMBL4156113	Inhibition of recombinant human full length His-tagged p38-alpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	18434345	CHEMBL4156113	Inhibition of recombinant human full length His-tagged p38-alpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	17.0	CHEMBL260	Homo sapiens	INH	%	17.0
	18440348	CHEMBL4157172	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	18443306	CHEMBL4157937	Inhibition of human p38alpha MAPK assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	18449733	CHEMBL4178035	Inhibition of human p38alpha at 1 uM relative to control	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	18449941	CHEMBL4178175	Inhibition of human p38alpha (1 to 360 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	9.0	CHEMBL260	Homo sapiens	Activity	%	9.0
	18449943	CHEMBL4178177	Inhibition of human p38alpha (1 to 360 residues) at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Inhibition	%	91.0	CHEMBL260	Homo sapiens	INH	%	91.0
	18450275	CHEMBL4178303	Inhibition of recombinant human full length N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-7.0	CHEMBL260	Homo sapiens	Activity	%	-7.0
	18450325	CHEMBL4178303	Inhibition of recombinant human full length N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	4.0	CHEMBL260	Homo sapiens	Activity	%	4.0
	18462184	CHEMBL4180871	Inhibition of human full length p38a MAPK assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	108.0	CHEMBL260	Homo sapiens	Activity	%	108.0
	18470586	CHEMBL4182580	Inhibition of human p38alpha at 10 uM by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	11.0	CHEMBL260	Homo sapiens	INH	%	11.0
	18470763	CHEMBL4182580	Inhibition of human p38alpha at 10 uM by ADP-Glo kinase assay	B	Cc1nc(N)c2ccn(C3CCN(C(=O)c4ccc(S(=O)(=O)F)cc4)CC3)c2n1		CHEMBL4206295	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	18470764	CHEMBL4182580	Inhibition of human p38alpha at 10 uM by ADP-Glo kinase assay	B	Nc1ncnc2c1ccn2C1CCN(C(=O)c2ccc(S(=O)(=O)F)cc2)CC1		CHEMBL4218073	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	18484304	CHEMBL4185951	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	18484788	CHEMBL4185951	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	18489539	CHEMBL4187280	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	18507611	CHEMBL4191181	Inhibition of recombinant full-length human SAPK2a T106M mutant at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18507612	CHEMBL4191180	Inhibition of recombinant full-length human SAPK2a at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-5.0	CHEMBL260	Homo sapiens	INH	%	-5.0
	18528114	CHEMBL4194784	Inhibition of human p38alpha assessed as reduction in [gamma32P]ATP incorporation in to peptide substrate after 40 mins by scintillation counting method	B	O=C(c1ccc2[nH]ccc2c1)N1CCN(Cc2ccccc2)CC1		CHEMBL320069	=	IC50	nM	3981.07	CHEMBL260	Homo sapiens	pIC50		5.4
	18528115	CHEMBL4194784	Inhibition of human p38alpha assessed as reduction in [gamma32P]ATP incorporation in to peptide substrate after 40 mins by scintillation counting method	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	pIC50		8.0
	18528116	CHEMBL4194783	Inhibition of p38alpha (unknown origin)	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277	=	IC50	nM	794.33	CHEMBL260	Homo sapiens	pIC50		6.1
	18528117	CHEMBL4194783	Inhibition of p38alpha (unknown origin)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	0.1	CHEMBL260	Homo sapiens	pIC50		10.0
	18558660	CHEMBL4201058	Inhibition of human p38alpha at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.9	CHEMBL260	Homo sapiens	INH	%	98.9
	18568999	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3ccc(C)[n+]([O-])c3)c2)ccc1F		CHEMBL4225133	=	IC50	nM	2.7	CHEMBL260	Homo sapiens	IC50	nM	2.7
	18569000	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(C(=O)Nc2cc(-c3c(-c4ccc(F)c(C)c4)nc4cccnn34)ccn2)ccn1		CHEMBL4225173	=	IC50	nM	4.4	CHEMBL260	Homo sapiens	IC50	nM	4.4
	18569001	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(-c3c(-c4ccc(F)c(C)c4)nc4cccnn34)ccn2)cn1		CHEMBL4227523	=	IC50	nM	1.8	CHEMBL260	Homo sapiens	IC50	nM	1.8
	18569002	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	IC50	nM	240.0	CHEMBL260	Homo sapiens	IC50	nM	240.0
	18569003	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cccc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3ccccc3)c2)c1		CHEMBL4226206	=	IC50	nM	73.0	CHEMBL260	Homo sapiens	IC50	nM	73.0
	18569004	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cccc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3ccccc3)n2)c1		CHEMBL4225809	=	IC50	nM	56.0	CHEMBL260	Homo sapiens	IC50	nM	56.0
	18569005	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	O=C(Nc1cc(-c2c(-c3cccc(Cl)c3)nc3cccnn23)ccn1)c1ccccc1		CHEMBL4226302	=	IC50	nM	34.0	CHEMBL260	Homo sapiens	IC50	nM	34.0
	18569006	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	O=C(Nc1cc(-c2c(-c3ccc(Cl)cc3)nc3cccnn23)ccn1)c1ccccc1		CHEMBL4225547	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	nM	290.0
	18569007	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3ccccc3)c2)ccc1F		CHEMBL4228109	=	IC50	nM	9.4	CHEMBL260	Homo sapiens	IC50	nM	9.4
	18569008	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3cccc(C(F)(F)F)c3)c2)ccc1F		CHEMBL4226320	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	18569009	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	O=C(Nc1cc(-c2c(-c3ccc(F)c(Cl)c3)nc3cccnn23)ccn1)c1cccc(C(F)(F)F)c1		CHEMBL4225487	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	nM	210.0
	18569010	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3ccccc3C)c2)ccc1F		CHEMBL4226464	=	IC50	nM	84.0	CHEMBL260	Homo sapiens	IC50	nM	84.0
	18569011	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cccc(C(=O)Nc2cc(-c3c(-c4ccc(F)c(C)c4)nc4cccnn34)ccn2)c1		CHEMBL4226563	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	nM	11.0
	18569012	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1ccc(C(=O)Nc2cc(-c3c(-c4ccc(F)c(C)c4)nc4cccnn34)ccn2)cc1		CHEMBL4227689	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	18569013	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3cccc(F)c3)c2)ccc1F		CHEMBL4227582	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	18569014	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3cccc(Cl)c3)c2)ccc1F		CHEMBL4225003	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	18569015	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3ccccn3)c2)ccc1F		CHEMBL4226784	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	18569016	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3cccnc3)c2)ccc1F		CHEMBL4229137	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	18569017	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3ccncc3)c2)ccc1F		CHEMBL4227050	=	IC50	nM	5.4	CHEMBL260	Homo sapiens	IC50	nM	5.4
	18569018	CHEMBL4220319	Inhibition of recombinant human FLAG-tagged p38alpha expressed in baculovirus expression system using GFP-ATF2 (19 to 96 residues) as substrate preincubated for 5 mins followed by ATP addition measured after 20 mins by TR-FRET assay	B	Cc1cc(-c2nc3cccnn3c2-c2ccnc(NC(=O)c3cc[n+]([O-])c(C)c3)c2)ccc1F		CHEMBL4224940	=	IC50	nM	5.4	CHEMBL260	Homo sapiens	IC50	nM	5.4
	18653481	CHEMBL4230163	Inhibition of P38-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	70.0	CHEMBL260	Homo sapiens	INH	%	70.0
	18653482	CHEMBL4230163	Inhibition of P38-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	15.0	CHEMBL260	Homo sapiens	INH	%	15.0
	18655384	CHEMBL4230851	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	99.0	CHEMBL260	Homo sapiens	Activity	%	99.0
	18663935	CHEMBL4232919	Inhibition of full length human p38alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	18664032	CHEMBL4233016	Binding affinity to full length human p38alpha (M1 to S360 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL260	Homo sapiens	Kd	uM	5.0
	18665441	CHEMBL4233367	Inhibition of P38alpha (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	18674796	CHEMBL4235400	Inhibition of p38alpha (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	4000.0	CHEMBL260	Homo sapiens	Ki	nM	4000.0
Not Determined	18674797	CHEMBL4235400	Inhibition of p38alpha (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL260	Homo sapiens	Ki		
	18674798	CHEMBL4235400	Inhibition of p38alpha (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	4000.0	CHEMBL260	Homo sapiens	Ki	nM	4000.0
	18694010	CHEMBL4253463	Inhibition of recombinant human full length GST-tagged p38alpha expressed in Escherichia coli at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18694092	CHEMBL4253545	Inhibition of recombinant human full length GST-tagged p38alpha expressed in Escherichia coli at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-8.0	CHEMBL260	Homo sapiens	INH	%	-8.0
	18697664	CHEMBL4254337	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	84.0	CHEMBL260	Homo sapiens	Activity	%	84.0
	18702487	CHEMBL4255120	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	18702552	CHEMBL4255120	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	18702596	CHEMBL4255120	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	18702648	CHEMBL4255120	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	18702692	CHEMBL4255120	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	18702735	CHEMBL4255120	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	18704915	CHEMBL4255737	Inhibition of human p38alpha using FAM-p38tide as substrate by IMAP assay	B	CC(=O)N[C@H]1CC[C@H](Nc2nccc(-c3c(-c4ccccc4)noc3C)n2)CC1		CHEMBL4286199	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	nM	26.0
	18708934	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	18708971	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	39.0	CHEMBL260	Homo sapiens	INH	%	39.0
	18708979	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18709024	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18709053	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18709082	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	25.0	CHEMBL260	Homo sapiens	INH	%	25.0
	18709111	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	18709158	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	8.0	CHEMBL260	Homo sapiens	INH	%	8.0
	18709188	CHEMBL4256680	Inhibition of P38alpha (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	18709217	CHEMBL4256654	Inhibition of P38alpha (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	18709259	CHEMBL4256680	Inhibition of P38alpha (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	6.0	CHEMBL260	Homo sapiens	INH	%	6.0
	18709292	CHEMBL4256680	Inhibition of P38alpha (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	36.0	CHEMBL260	Homo sapiens	INH	%	36.0
Not Active	18723838	CHEMBL4258712	Inhibition of human SAPK2a using myelin basic protein as substrate at 100 uM after 40 mins in presence of [gamma-33P-ATP] by scintillation counting analysis	B	CCOc1c(S(=O)(=O)NC2CC(C)(C)NC(C)(C)C2)ccc(Cl)c1Cl		CHEMBL1502722		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18725400	CHEMBL4259097	Inhibition of p38-alpha (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	18751173	CHEMBL4263882	Inhibition of P38-ALPHA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	18752103	CHEMBL4264440	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	98.0	CHEMBL260	Homo sapiens	Activity	%	98.0
	18761581	CHEMBL4266632	Inhibition of recombinant human full length N-terminal GST-tagged SAPK2alpha expressed in Escherichia coli at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	-5.0	CHEMBL260	Homo sapiens	INH	%	-5.0
	18761852	CHEMBL4266632	Inhibition of recombinant human full length N-terminal GST-tagged SAPK2alpha expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-6.0	CHEMBL260	Homo sapiens	INH	%	-6.0
	18762015	CHEMBL4266632	Inhibition of recombinant human full length N-terminal GST-tagged SAPK2alpha expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1	Outside typical range	CHEMBL4290222	=	Inhibition	%	-11.0	CHEMBL260	Homo sapiens	INH	%	-11.0
	18764398	CHEMBL4267051	Inhibition of human p38a MAPK at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL260	Homo sapiens	INH	%	70.0
	18764399	CHEMBL4267051	Inhibition of human p38a MAPK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL260	Homo sapiens	INH	%	70.0
	18764459	CHEMBL4267051	Inhibition of human p38a MAPK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	=	Inhibition	%	70.0	CHEMBL260	Homo sapiens	INH	%	70.0
	18782439	CHEMBL4270436	Inhibition of p38alpha (unknown origin)	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)F)n2)ccn1		CHEMBL4284170	<	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	18782440	CHEMBL4270436	Inhibition of p38alpha (unknown origin)	B	[2H]C([2H])([2H])Oc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4280731	<	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	18782819	CHEMBL4270685	Inhibition of p38alpha (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Activity	%	9.0	CHEMBL260	Homo sapiens	Activity	%	9.0
	18788770	CHEMBL4272251	Inhibition of N-terminal flag-tagged p38alpha (unknown origin) expressed in baculovirus expression system using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma-32P]ATP by topcount scintillation method	B	S=C(Nc1ccccc1)N1N=C(c2ccc(Br)cc2)CC1c1ccc2c(c1)OCCO2	Outside typical range	CHEMBL4290513	>	IC50	nM	200000.0	CHEMBL260	Homo sapiens	IC50	uM	200.0
	18788771	CHEMBL4272251	Inhibition of N-terminal flag-tagged p38alpha (unknown origin) expressed in baculovirus expression system using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma-32P]ATP by topcount scintillation method	B	COc1cccc(C2=NN(C(=S)Nc3ccccc3)C(c3ccc4c(c3)OCCO4)C2)c1	Outside typical range	CHEMBL4277125	>	IC50	nM	200000.0	CHEMBL260	Homo sapiens	IC50	uM	200.0
	18788772	CHEMBL4272251	Inhibition of N-terminal flag-tagged p38alpha (unknown origin) expressed in baculovirus expression system using MBP as substrate preincubated for 5 mins followed by substrate addition measured after 60 mins in presence of [gamma-32P]ATP by topcount scintillation method	B	S=C(Nc1ccccc1)N1N=C(c2ccc(OCc3ccccc3)cc2)CC1c1ccc2c(c1)OCCO2	Outside typical range	CHEMBL4294787	>	IC50	nM	200000.0	CHEMBL260	Homo sapiens	IC50	uM	200.0
	18789039	CHEMBL4272389	Inhibition of p38alpha (unknown origin)	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	=	IC50	nM	3400.0	CHEMBL260	Homo sapiens	IC50	nM	3400.0
Not Active	18847292	CHEMBL4304928	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18858104	CHEMBL4307950	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	18860163	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccccc2O)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4561980	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	uM	0.05
	18860164	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2cccc(O)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4514346	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	18860165	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(O)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4453072	=	IC50	nM	1851.0	CHEMBL260	Homo sapiens	IC50	uM	1.851
	18860166	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2cccs2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4576003	=	IC50	nM	48.0	CHEMBL260	Homo sapiens	IC50	uM	0.048
	18860167	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccco2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4460515	=	IC50	nM	987.0	CHEMBL260	Homo sapiens	IC50	uM	0.987
	18860168	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	COc1ccccc1-c1nc(C)[nH]c1-c1ccnc(NC(=O)C2CC2)c1		CHEMBL4586627	=	IC50	nM	504.0	CHEMBL260	Homo sapiens	IC50	uM	0.504
	18860169	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2cncnc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4456865	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860170	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc3ccccc3c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4435496	=	IC50	nM	81.0	CHEMBL260	Homo sapiens	IC50	uM	0.081
	18860171	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)c(F)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474740	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	18860172	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4584996	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860173	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4444424	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860174	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CCCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4575638	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860175	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CCCCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4475448	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860176	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc3c(c2)OCO3)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4518273	=	IC50	nM	30.0	CHEMBL260	Homo sapiens	IC50	uM	0.03
	18860177	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)c(C)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4457174	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	uM	0.007
	18860178	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CCn3cncn3)c2)[nH]1		CHEMBL4557420	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	uM	0.041
	18860179	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CCn3cnnn3)c2)[nH]1		CHEMBL4466208	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	uM	0.038
	18860180	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccccc2)c(-c2ccnc(NC(=O)CCn3cncn3)c2)[nH]1		CHEMBL4575716	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860181	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccccc2)c(-c2ccnc(NC(=O)CCn3cnnn3)c2)[nH]1		CHEMBL4517450	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860182	CHEMBL4308532	Inhibition of P38alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1ncc(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4456432	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860183	CHEMBL4308532	Inhibition of P38alpha MAPK (unknown origin) by ELISA	B	NC(=O)c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4452444	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	uM	0.019
	18860203	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	CCOC(=O)c1ncc(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4446123	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860204	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	CCOC(=O)c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4518634	=	IC50	nM	89.0	CHEMBL260	Homo sapiens	IC50	uM	0.089
	18860205	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	O=C(Nc1cc(-c2[nH]c(CO)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4451444	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	uM	0.016
	18860206	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	Cc1nc(C(N)=O)[nH]c1-c1ccnc(NC(=O)C2CC2)c1		CHEMBL4445449	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860207	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(C2CC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4483032	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860208	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(C2CCCCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4526183	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860209	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(-c2ccccc2O)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4475312	=	IC50	nM	158.0	CHEMBL260	Homo sapiens	IC50	uM	0.158
	18860210	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	COc1ccccc1-c1nc(C(N)=O)[nH]c1-c1ccnc(NC(=O)C2CC2)c1		CHEMBL4456961	=	IC50	nM	2350.0	CHEMBL260	Homo sapiens	IC50	uM	2.35
	18860211	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(-c2ccc(F)c(C(F)(F)F)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4461695	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	uM	0.016
	18860212	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	NC(=O)c1ncc(-c2cc(NC(=O)C3CC3)ncc2Br)[nH]1		CHEMBL4439815	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	18860213	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	CC(=O)Nc1cc(-c2[nH]c(C(N)=O)nc2-c2ccc(F)cc2)ccn1		CHEMBL4564217	=	IC50	nM	117.0	CHEMBL260	Homo sapiens	IC50	uM	0.117
	18860214	CHEMBL4308531	Inhibition of P38alpha MAPK (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(-c2cccc(OC(F)(F)F)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4529679	=	IC50	nM	2040.0	CHEMBL260	Homo sapiens	IC50	uM	2.04
	18864274	CHEMBL4309597	Inhibition of human p38alpha at 10 uM using myelin basic protein as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1		CHEMBL4436746	=	Inhibition	%	-5.41	CHEMBL260	Homo sapiens	INH	%	-5.41
	18871613	CHEMBL4310109	Binding affinity to human p38alpha (1 to 360 residues) expressed in bacterial expression system	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL4521096	=	Kd	nM	0.47	CHEMBL260	Homo sapiens	Kd	nM	0.47
Dose-dependent effect	18871615	CHEMBL4310111	Stabilization of p38alpha in human A549 cells after 1 hrs by CETSA	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL4521096		Activity			CHEMBL260	Homo sapiens	Activity		
Active	18871620	CHEMBL4310114	Inhibition of p38alpha in human MM1S cells assessed as reduction in MSK1 phosphorylation at T581 at 0.1 to 30 uM by Western blot analysis	B	Cc1ccc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1C		CHEMBL4452281		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	18871621	CHEMBL4310114	Inhibition of p38alpha in human MM1S cells assessed as reduction in MSK1 phosphorylation at T581 at 0.1 to 30 uM by Western blot analysis	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1		CHEMBL4521096		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	18871622	CHEMBL4310115	Inhibition of p38alpha in human MM1S cells assessed as reduction in MSK1 phosphorylation at T581 up to 10 uM by Western blot analysis	B	Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n1-2		CHEMBL1957266		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	18883527	CHEMBL4312764	Activity at human SAPK2a at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL260	Homo sapiens	Activity		
	18886091	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4518669	=	IC50	nM	12215.0	CHEMBL260	Homo sapiens	IC50	uM	12.215
	18886092	CHEMBL4313426	Inhibition of human p38alpha at 10 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	Inhibition	%	86.37	CHEMBL260	Homo sapiens	INH	%	86.37
	18886136	CHEMBL4313426	Inhibition of human p38alpha at 10 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	94.61	CHEMBL260	Homo sapiens	INH	%	94.61
	18886147	CHEMBL4313404	Inhibition of human p38alpha T106M mutant at 10 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	-4.1	CHEMBL260	Homo sapiens	INH	%	-4.1
	18886153	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4ccccc4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4443352	=	IC50	nM	4005.0	CHEMBL260	Homo sapiens	IC50	uM	4.005
	18886154	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4ccc(Cl)c(Cl)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4541128	=	IC50	nM	2830.0	CHEMBL260	Homo sapiens	IC50	uM	2.83
	18886155	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4457417	=	IC50	nM	8540.0	CHEMBL260	Homo sapiens	IC50	uM	8.54
	18886156	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	IC50	nM	307.0	CHEMBL260	Homo sapiens	IC50	uM	0.307
	18886157	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1ccccc1)Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1		CHEMBL4445444	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	18886158	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)Nc1ccc(Cl)c(Cl)c1		CHEMBL4448992	=	IC50	nM	14400.0	CHEMBL260	Homo sapiens	IC50	uM	14.4
	18886159	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL4551900	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	18886160	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4456757	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	18886161	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4526954	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	18886162	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4ccc(Cl)c(Cl)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4465956	=	IC50	nM	1290.0	CHEMBL260	Homo sapiens	IC50	uM	1.29
	18886163	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	uM	0.022
	18886164	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4545175	=	IC50	nM	6065.0	CHEMBL260	Homo sapiens	IC50	uM	6.065
	18886165	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4455458	=	IC50	nM	2330.0	CHEMBL260	Homo sapiens	IC50	uM	2.33
	18886166	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)c1ccc(Cl)c(Cl)c1		CHEMBL4570572	=	IC50	nM	14350.0	CHEMBL260	Homo sapiens	IC50	uM	14.35
	18886167	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL4516630	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	18886168	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL4561055	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	18886169	CHEMBL4313398	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(O)c(Cl)c3)n2)c1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4522978	>	IC50	nM	30000.0	CHEMBL260	Homo sapiens	IC50	uM	30.0
	18886176	CHEMBL4313396	Inhibition of recombinant Nanoluc-tagged p38alpha (unknown origin) expressed in HEK293 cells incubated for 2 to 3 mins by NanoBRET assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	EC50	nM	1940.0	CHEMBL260	Homo sapiens	EC50	uM	1.94
	18886177	CHEMBL4313396	Inhibition of recombinant Nanoluc-tagged p38alpha (unknown origin) expressed in HEK293 cells incubated for 2 to 3 mins by NanoBRET assay	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	EC50	nM	520.0	CHEMBL260	Homo sapiens	EC50	uM	0.52
	18886178	CHEMBL4313396	Inhibition of recombinant Nanoluc-tagged p38alpha (unknown origin) expressed in HEK293 cells incubated for 2 to 3 mins by NanoBRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	EC50	nM	470.0	CHEMBL260	Homo sapiens	EC50	uM	0.47
	18886179	CHEMBL4313396	Inhibition of recombinant Nanoluc-tagged p38alpha (unknown origin) expressed in HEK293 cells incubated for 2 to 3 mins by NanoBRET assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	EC50	nM	60.0	CHEMBL260	Homo sapiens	EC50	uM	0.06
	18886221	CHEMBL4313465	Inhibition of p38alpha (unknown origin)	B	COc1cccc(-c2nn(-c3ccccc3)cc2-c2ccncc2)c1		CHEMBL4518235	=	IC50	nM	515.0	CHEMBL260	Homo sapiens	IC50	nM	515.0
	18892709	CHEMBL4314540	Inhibition of recombinant full-length human SAPK2a assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	109.0	CHEMBL260	Homo sapiens	Activity	%	109.0
	18892710	CHEMBL4314539	Inhibition of recombinant full-length human SAPK2a T106M mutant assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.5	CHEMBL260	Homo sapiens	Activity	%	100.5
	18895036	CHEMBL4315518	Inhibition of recombinant human N-terminal GST-tagged full length p38alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	Activity	%	33.0	CHEMBL260	Homo sapiens	Activity	%	33.0
	18895038	CHEMBL4315520	Inhibition of recombinant human N-terminal GST-tagged full length PRKG1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	Activity	%	3.0	CHEMBL260	Homo sapiens	Activity	%	3.0
	18895055	CHEMBL4315518	Inhibition of recombinant human N-terminal GST-tagged full length p38alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	Activity	%	2.0	CHEMBL260	Homo sapiens	Activity	%	2.0
	18895057	CHEMBL4315520	Inhibition of recombinant human N-terminal GST-tagged full length PRKG1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	Activity	%	11.0	CHEMBL260	Homo sapiens	Activity	%	11.0
	18895074	CHEMBL4315518	Inhibition of recombinant human N-terminal GST-tagged full length p38alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	Activity	%	5.0	CHEMBL260	Homo sapiens	Activity	%	5.0
	18895076	CHEMBL4315520	Inhibition of recombinant human N-terminal GST-tagged full length PRKG1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	Activity	%	13.0	CHEMBL260	Homo sapiens	Activity	%	13.0
	18895093	CHEMBL4315518	Inhibition of recombinant human N-terminal GST-tagged full length p38alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	17.0	CHEMBL260	Homo sapiens	Activity	%	17.0
	18895095	CHEMBL4315520	Inhibition of recombinant human N-terminal GST-tagged full length PRKG1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	4.0	CHEMBL260	Homo sapiens	Activity	%	4.0
	18910087	CHEMBL4320881	Binding affinity to p38alpha (unknown origin)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	3162.28	CHEMBL260	Homo sapiens	pKd		5.5
	18923779	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CN(C)C(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4469162	=	Delta Tm	degrees C	1.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.0
	18923780	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4540969	=	Delta Tm	degrees C	5.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.6
	18923781	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4443551	=	Delta Tm	degrees C	10.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.9
	18923782	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC(C)(C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4440113	=	Delta Tm	degrees C	2.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.7
	18923783	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)NCc2ncc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4444997	=	Delta Tm	degrees C	9.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.8
	18923784	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4455632	=	Delta Tm	degrees C	3.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.6
	18923785	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4439959	=	Delta Tm	degrees C	8.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.6
	18923786	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4454896	=	Delta Tm	degrees C	0.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.6
	18923787	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC2CC2)cc1		CHEMBL4574781	=	Delta Tm	degrees C	2.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.9
	18923788	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964	=	Delta Tm	degrees C	13.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	13.0
	18923789	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC(C)(C)C(N)=O)cc1		CHEMBL4581578	=	Delta Tm	degrees C	1.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.2
	18923790	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1		CHEMBL4580635	=	Delta Tm	degrees C	4.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.1
	18923791	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(C(C)NC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4460945	=	Delta Tm	degrees C	2.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.5
	18923792	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4513917	=	Delta Tm	degrees C	2.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.8
	18923793	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CCCC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4522291	=	Delta Tm	degrees C	1.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.9
	18923794	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4459087	=	Delta Tm	degrees C	1.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.8
	18923795	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)C1(NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)CC1		CHEMBL4473924	=	Delta Tm	degrees C	2.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.6
	18923796	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4475072	=	Delta Tm	degrees C	1.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.5
	18923797	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4466149	=	Delta Tm	degrees C	1.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.1
	18923798	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	Delta Tm	degrees C	15.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	15.4
	18923799	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CCCNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4452908	=	Delta Tm	degrees C	6.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.8
	18923800	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cnn1-c1ccccc1		CHEMBL4536573	=	Delta Tm	degrees C	3.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.9
	18923801	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4436353	=	Delta Tm	degrees C	2.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.3
	18923802	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4471195	=	Delta Tm	degrees C	2.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.3
	18923803	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cc(-c2ccccc2)n[nH]1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4584086	=	Delta Tm	degrees C	0.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.5
	18923804	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cc(-c2ccccc2)n[nH]1		CHEMBL4549215	=	Delta Tm	degrees C	4.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.6
	18923805	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4572186	=	Delta Tm	degrees C	-0.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	-0.5
	18923806	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4561109	=	Delta Tm	degrees C	3.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.0
	18923807	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4462660	=	Delta Tm	degrees C	1.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.6
	18923808	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F		CHEMBL4465031	=	Delta Tm	degrees C	7.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.5
	18923809	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4541621	=	Delta Tm	degrees C	0.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.0
	18923810	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4568134	=	Delta Tm	degrees C	6.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.5
	18923811	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NC(C)c2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440391	=	Delta Tm	degrees C	6.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.7
	18923812	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2C)c1		CHEMBL4476320	=	Delta Tm	degrees C	14.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	14.8
	18923813	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)Nc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4591730	=	Delta Tm	degrees C	0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.1
	18923814	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ncc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4574467	=	Delta Tm	degrees C	12.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.2
	18923815	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(NC(=O)c1cnn(-c2ccccc2)c1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4438679	=	Delta Tm	degrees C	4.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.2
	18923816	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1		CHEMBL4473671	=	Delta Tm	degrees C	12.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.6
	18923817	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4582420	=	Delta Tm	degrees C	-0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	-0.1
	18923818	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4531946	=	Delta Tm	degrees C	9.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.8
	18923819	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4584521	=	Delta Tm	degrees C	0.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.3
	18923820	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4520933	=	Delta Tm	degrees C	0.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.6
	18923821	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4436254	=	Delta Tm	degrees C	1.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.4
	18923822	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4455243	=	Delta Tm	degrees C	0.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.2
	18923823	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4464108	=	Delta Tm	degrees C	0.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.4
	18923824	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4534601	=	Delta Tm	degrees C	0.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.0
	18923825	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4524960	=	Delta Tm	degrees C	0.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.3
	18923826	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4448307	=	Delta Tm	degrees C	0.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.0
	18923827	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cn1		CHEMBL4447850	=	Delta Tm	degrees C	3.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.0
	18923828	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc2)cn1		CHEMBL4545614	=	Delta Tm	degrees C	1.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.4
	18923829	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440440	=	Delta Tm	degrees C	3.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.6
	18923830	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC(C)(C)C(N)=O)cc2)cn1		CHEMBL4474175	=	Delta Tm	degrees C	0.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.5
	18923831	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	O=C(NCc1ccc(C(=O)NC2CC2)cc1)c1cnn(-c2ccccc2)c1		CHEMBL4441653	=	Delta Tm	degrees C	1.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.7
	18923832	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4591811	=	Delta Tm	degrees C	0.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.6
	18923833	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1		CHEMBL4587099	=	Delta Tm	degrees C	1.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.5
	18923834	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4524754	=	Delta Tm	degrees C	0.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.0
	18923835	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Nc1c(C(=O)Nc2ccc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4544936	=	Delta Tm	degrees C	1.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.4
	18923836	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)CC[C@H](NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4537345	=	Delta Tm	degrees C	0.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.8
	18923837	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4455604	=	Delta Tm	degrees C	1.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.1
	18923838	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CC(C)(NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4548688	=	Delta Tm	degrees C	0.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.9
	18923839	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1290404	=	Delta Tm	degrees C	14.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	14.8
	18923840	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(=O)N(C)C		CHEMBL4462513	=	Delta Tm	degrees C	1.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.3
	18923841	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CN(C)C(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4465838	=	Delta Tm	degrees C	9.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.6
	18923842	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)cc1		CHEMBL4441119	=	Delta Tm	degrees C	8.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.3
	18923843	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983	=	Delta Tm	degrees C	9.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.6
	18923844	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4552734	=	Delta Tm	degrees C	5.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.2
	18923845	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CNC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1		CHEMBL4449421	=	Delta Tm	degrees C	5.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.4
	18923846	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NCCCC(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4539759	=	Delta Tm	degrees C	-0.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	-0.4
	18923847	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NCCCC2CCCCC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4578152	=	Delta Tm	degrees C	5.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.0
	18923848	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NCC(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4447226	=	Delta Tm	degrees C	1.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.4
	18923849	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4537919	=	Delta Tm	degrees C	2.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.7
	18923850	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)NC2(C(N)=O)CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4457772	=	Delta Tm	degrees C	6.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.7
	18923851	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4536763	=	Delta Tm	degrees C	2.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.2
	18923852	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	CCCC[C@H](NC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1)C(N)=O		CHEMBL4556210	=	Delta Tm	degrees C	2.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.1
	18923853	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4530981	=	Delta Tm	degrees C	0.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.7
	18923854	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4462636	=	Delta Tm	degrees C	5.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.0
	18923855	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4449398	=	Delta Tm	degrees C	4.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.7
	18923856	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](C)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4588589	=	Delta Tm	degrees C	1.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.1
	18923857	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4437864	=	Delta Tm	degrees C	1.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.9
	18923858	CHEMBL4324172	Binding affinity to P38alpha MAPK (unknown origin) assessed as change in melting temperature at 10 uM by differential scanning fluorimetry	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(C)c(NC(=O)c3ccc(-c4ccccc4Cl)s3)c2)cc1		CHEMBL4445600	=	Delta Tm	degrees C	2.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.8
	18923939	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964	=	IC50	nM	39.0	CHEMBL260	Homo sapiens	IC50	uM	0.039
	18923940	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC(C)(C)C(N)=O)cc1		CHEMBL4581578	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923941	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1		CHEMBL4580635	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	18923942	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(C(C)NC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4460945	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923943	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1N)c1ccc(C(=O)NC2CC2)cc1		CHEMBL4574781	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	18923944	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4454896	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923945	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4439959	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	uM	0.045
	18923946	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4455632	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	uM	0.12
	18923947	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)NCc2ncc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4444997	=	IC50	nM	9.0	CHEMBL260	Homo sapiens	IC50	uM	0.009
	18923948	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC(C)(C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4440113	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	uM	0.044
	18923949	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4443551	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.014
	18923950	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4540969	=	IC50	nM	53.0	CHEMBL260	Homo sapiens	IC50	uM	0.053
	18923951	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1290404	=	IC50	nM	2.0	CHEMBL260	Homo sapiens	IC50	uM	0.002
	18923952	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4548688	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923953	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1		CHEMBL4455604	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923954	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2N)s1)C(N)=O		CHEMBL4537345	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923955	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)Nc2ccc(C(=O)NC3CC3)s2)cnn1-c1ccccc1		CHEMBL4544936	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923956	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4524754	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923957	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1		CHEMBL4587099	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923958	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2)cc1)C(N)=O		CHEMBL4591811	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923959	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	O=C(NCc1ccc(C(=O)NC2CC2)cc1)c1cnn(-c2ccccc2)c1		CHEMBL4441653	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923960	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC(C)(C)C(N)=O)cc2)cn1		CHEMBL4474175	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923961	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440440	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	18923962	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc2)cn1		CHEMBL4545614	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923963	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cn1		CHEMBL4447850	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	18923964	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4448307	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923965	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4524960	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923966	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1)C(N)=O		CHEMBL4534601	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923967	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4464108	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923968	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)(NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4455243	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923969	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4436254	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923970	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1)C(N)=O		CHEMBL4520933	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923971	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	O=C(NC1CC1)c1ccc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)cc1		CHEMBL4584521	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923972	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4531946	=	IC50	nM	31.0	CHEMBL260	Homo sapiens	IC50	uM	0.031
	18923973	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2)s1		CHEMBL4582420	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923974	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1		CHEMBL4473671	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013
	18923975	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4438679	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	18923976	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NCc2ncc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4574467	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	uM	0.026
	18923977	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)Nc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)s2)cn1		CHEMBL4591730	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923978	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2C)c1		CHEMBL4476320	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018
	18923979	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccccc1-n1cc(C(=O)NC(C)c2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(N)=O)cc2)cn1		CHEMBL4440391	=	IC50	nM	91.0	CHEMBL260	Homo sapiens	IC50	uM	0.091
	18923980	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4568134	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923981	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)s1		CHEMBL4541621	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923982	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F		CHEMBL4465031	=	IC50	nM	71.0	CHEMBL260	Homo sapiens	IC50	uM	0.071
	18923983	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cnn(-c2ccccc2)c1C(F)(F)F)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4462660	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923984	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1cnc(CNC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4561109	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923985	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(NC(=O)c2cc(-c3ccccc3)n[nH]2)s1		CHEMBL4572186	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923986	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1cc(-c2ccccc2)n[nH]1		CHEMBL4549215	=	IC50	nM	101.0	CHEMBL260	Homo sapiens	IC50	uM	0.101
	18923987	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(NC(=O)c1cc(-c2ccccc2)n[nH]1)c1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1		CHEMBL4584086	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923988	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4471195	=	IC50	nM	258.0	CHEMBL260	Homo sapiens	IC50	uM	0.258
	18923989	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4436353	=	IC50	nM	370.0	CHEMBL260	Homo sapiens	IC50	uM	0.37
	18923990	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)NCc2ccc(C(=O)NC3CC3)cc2)cnn1-c1ccccc1		CHEMBL4536573	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	18923991	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CCCNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4452908	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	uM	0.047
	18923992	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	18923993	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)CNC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4466149	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923994	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4475072	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18923995	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	NC(=O)C1(NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)CC1		CHEMBL4473924	=	IC50	nM	480.0	CHEMBL260	Homo sapiens	IC50	uM	0.48
	18923996	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4459087	=	IC50	nM	360.0	CHEMBL260	Homo sapiens	IC50	uM	0.36
	18923997	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CCCC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4522291	=	IC50	nM	280.0	CHEMBL260	Homo sapiens	IC50	uM	0.28
	18923998	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CC(C)CC[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(N)=O		CHEMBL4513917	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	uM	0.32
	18923999	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CN(C)C(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4469162	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924000	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	C[C@H](NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1)C(=O)N(C)C		CHEMBL4462513	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924001	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CN(C)C(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4465838	=	IC50	nM	88.0	CHEMBL260	Homo sapiens	IC50	uM	0.088
	18924002	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)cc1		CHEMBL4441119	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	uM	0.055
	18924003	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	uM	0.005
	18924004	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4552734	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	18924005	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CNC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1		CHEMBL4449421	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	uM	0.017
	18924006	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NCCCC(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4539759	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924007	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NCCCC2CCCCC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4578152	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924008	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NCC(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4447226	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924009	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4537919	=	IC50	nM	316.0	CHEMBL260	Homo sapiens	IC50	uM	0.316
	18924010	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)NC2(C(N)=O)CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4457772	=	IC50	nM	59.0	CHEMBL260	Homo sapiens	IC50	uM	0.059
	18924011	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4536763	=	IC50	nM	470.0	CHEMBL260	Homo sapiens	IC50	uM	0.47
	18924012	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	CCCC[C@H](NC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1)C(N)=O		CHEMBL4556210	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924013	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC(C)C)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4530981	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924014	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4462636	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	uM	0.015
	18924015	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4449398	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924016	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](C)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4588589	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924017	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(C(=O)N[C@@H](CCC2CCCCC2)C(=O)N(C)C)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4437864	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	18924018	CHEMBL4324174	Inhibition of recombinant human His-tagged P38 alpha MAPK (1 to 360 residues) expressed in Escherichia coli incubated for 60 mins by [gamma-33P]ATP based scintillation counting method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)c2ccc(C)c(NC(=O)c3ccc(-c4ccccc4Cl)s3)c2)cc1		CHEMBL4445600	>	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
Active	18924182	CHEMBL4324186	Inhibition of full-length human C-terminal NanoLuc-tagged P38 alpha MAPK expressed in human HEK293T cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	CNC(=O)c1ccc(C)c(NC(=O)c2ccc(-c3ccccc3Cl)s2)c1		CHEMBL4449421		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	18924183	CHEMBL4324186	Inhibition of full-length human C-terminal NanoLuc-tagged P38 alpha MAPK expressed in human HEK293T cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Cc1ccc(C(N)=O)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL4552734		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	18924184	CHEMBL4324186	Inhibition of full-length human C-terminal NanoLuc-tagged P38 alpha MAPK expressed in human HEK293T cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc(-c2ccccc2Cl)s1		CHEMBL2401983		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	18924188	CHEMBL4324177	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18924196	CHEMBL4324186	Inhibition of full-length human C-terminal NanoLuc-tagged P38 alpha MAPK expressed in human HEK293T cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	IC50	nM	3.7	CHEMBL260	Homo sapiens	IC50	uM	0.0037
	18924197	CHEMBL4324186	Inhibition of full-length human C-terminal NanoLuc-tagged P38 alpha MAPK expressed in human HEK293T cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775	=	IC50	nM	13000.0	CHEMBL260	Homo sapiens	IC50	uM	13.0
	18934086	CHEMBL4326618	Inhibition of human MAPK14 at 10 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1	Outside typical range	CHEMBL4476226	=	Inhibition	%	-34.8	CHEMBL260	Homo sapiens	INH	%	-34.8
	18934908	CHEMBL4326807	Inhibition of MAPK14 (unknown origin) after 22 mins by homogeneous time-resolved fluorescence assay	B	O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cc(C2CCC2)[nH]n1		CHEMBL4439395	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	18938161	CHEMBL4327807	Inhibition of human p38alpha assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.7	CHEMBL260	Homo sapiens	Activity	%	101.7
	18938162	CHEMBL4327807	Inhibition of human p38alpha assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	101.73	CHEMBL260	Homo sapiens	Activity	%	101.73
	18938652	CHEMBL4328171	Inhibition of human p38alpha assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Activity	%	65.0	CHEMBL260	Homo sapiens	Activity	%	65.0
Not Determined	18939034	CHEMBL4328535	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL260	Homo sapiens	IC50		
	18939035	CHEMBL4328535	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	17.0	CHEMBL260	Homo sapiens	IC50	10'-8M	1.7
	18950242	CHEMBL4331094	Inhibition of human p38alpha assessed as residual activity at 10 uM using MBP as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	98.37	CHEMBL260	Homo sapiens	Activity	%	98.37
	18953677	CHEMBL4331940	Inhibition of p38a MAPK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
	18953743	CHEMBL4331940	Inhibition of p38a MAPK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	18953854	CHEMBL4331940	Inhibition of p38a MAPK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18953946	CHEMBL4331999	Inhibition of p38a MAPK (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18954010	CHEMBL4331999	Inhibition of p38a MAPK (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18954077	CHEMBL4331940	Inhibition of p38a MAPK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	18958656	CHEMBL4333535	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	18964674	CHEMBL4335278	Inhibition of recombinant human full length SAPK2a assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	18964675	CHEMBL4335278	Inhibition of recombinant human full length SAPK2a assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	18964676	CHEMBL4335279	Inhibition of recombinant human full length SAPK2a T106M mutant assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	80.0	CHEMBL260	Homo sapiens	Activity	%	80.0
	18964677	CHEMBL4335279	Inhibition of recombinant human full length SAPK2a T106M mutant assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	18972093	CHEMBL4337103	Inhibition of recombinant human full length SAPK2a assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	105.0	CHEMBL260	Homo sapiens	Activity	%	105.0
	18972094	CHEMBL4337104	Inhibition of recombinant human full length SAPK2a T106M mutant assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	18972840	CHEMBL4337339	Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cc1ccc(NC(=O)C2CC2)cc1NC(=O)c1ccc2c(c1)CCO2		CHEMBL4450593	=	IC50	nM	1230.0	CHEMBL260	Homo sapiens	IC50	uM	1.23
	18972841	CHEMBL4337339	Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cc1ccc(C(=O)NCC(F)(F)F)cc1NC(=O)c1cccc(C(N)=O)c1		CHEMBL4463733	=	IC50	nM	28330.0	CHEMBL260	Homo sapiens	IC50	uM	28.33
	18972842	CHEMBL4337339	Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	CC(=O)Nc1ccc(Cl)c(NC(=O)c2sc3nc4n(c(=O)c3c2C)CCCCC4)c1		CHEMBL4585735	=	IC50	nM	2390.0	CHEMBL260	Homo sapiens	IC50	uM	2.39
	18972843	CHEMBL4337339	Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	CCC(=O)Nc1ccc(Cl)c(NC(=O)c2ccc3c(c2)OCO3)c1		CHEMBL4514029	=	IC50	nM	2240.0	CHEMBL260	Homo sapiens	IC50	uM	2.24
	18972844	CHEMBL4337339	Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	IC50	nM	70.0	CHEMBL260	Homo sapiens	IC50	uM	0.07
	18972857	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Ki	nM	12.0	CHEMBL260	Homo sapiens	Ki	nM	12.0
	18972858	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	Ki	nM	480.0	CHEMBL260	Homo sapiens	Ki	nM	480.0
	18972859	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Ki	nM	240.0	CHEMBL260	Homo sapiens	Ki	nM	240.0
	18972861	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NOC)ccc3C)c2c1C		CHEMBL252128	=	IC50	nM	3.1	CHEMBL260	Homo sapiens	IC50	nM	3.1
	18972862	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CONC(=O)c1ccc(C)c(Nc2ncnn3cc(C(=O)N[C@@H](C)c4ccccc4)c(C)c23)c1		CHEMBL252535	=	IC50	nM	2.2	CHEMBL260	Homo sapiens	IC50	nM	2.2
	18972863	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CCNC(=O)NCc1ccccc1Sc1ccc2nnc(C(C)C)n2c1		CHEMBL1938764	=	IC50	nM	58.0	CHEMBL260	Homo sapiens	IC50	nM	58.0
	18972864	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F		CHEMBL559401	=	IC50	nM	3.2	CHEMBL260	Homo sapiens	IC50	nM	3.2
	18972865	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2c(F)cccc2F)c1		CHEMBL1082158	=	IC50	nM	1.4	CHEMBL260	Homo sapiens	IC50	nM	1.4
	18972866	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	O=C(NC1CC1)c1ccc(Cl)c(Nc2nncc3c2cnn3-c2c(F)cccc2F)c1		CHEMBL1082158	=	Ki	nM	1.0	CHEMBL260	Homo sapiens	Ki	nM	1.0
	18972867	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CNC(=O)c1ccc(C)c(Nc2nncc3c2cnn3-c2ccccc2)c1		CHEMBL4535046	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	18972868	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1091199	=	Ki	nM	2.3	CHEMBL260	Homo sapiens	Ki	nM	2.3
	18972869	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C		CHEMBL1230065	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	18972870	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)Nc4ccon4)ccc3C)c2c1C		CHEMBL1230070	=	IC50	nM	3.9	CHEMBL260	Homo sapiens	IC50	nM	3.9
	18972871	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(c1)NC(=O)C21CCCC1		CHEMBL1800911	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	nM	1.3
	18972872	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	18972873	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	nM	1500.0
	18972874	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL273158	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	nM	3000.0
	18972875	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	IC50	nM	75.0	CHEMBL260	Homo sapiens	IC50	nM	75.0
	18972876	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1		CHEMBL522579	=	Ki	nM	10.0	CHEMBL260	Homo sapiens	Ki	nM	10.0
	18972877	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1232887	=	Ki	nM	9.0	CHEMBL260	Homo sapiens	Ki	nM	9.0
	18972878	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cn1		CHEMBL1232887	=	IC50	nM	316.2	CHEMBL260	Homo sapiens	IC50	nM	316.2
	18972879	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCNC)n1		CHEMBL4593539	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	18972880	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3C)nncc2c1		CHEMBL492265	=	IC50	nM	0.8	CHEMBL260	Homo sapiens	IC50	nM	0.8
	18972881	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(-c3ccccc3C)nncc2c1		CHEMBL492265	=	Ki	nM	0.4	CHEMBL260	Homo sapiens	Ki	nM	0.4
	18972882	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL494072	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	18972883	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnc(NC3CCOCC3)nc2n(C)c1=O		CHEMBL1232751	=	IC50	nM	0.9	CHEMBL260	Homo sapiens	IC50	nM	0.9
	18972884	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccccc1		CHEMBL2177219	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	nM	35.0
	18972885	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccccc1		CHEMBL3086685	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	18972886	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	O=C(Nc1cc(Nc2ccc3c(c2)CCc2ccc(OC[C@H](O)CO)cc2C3=O)ccc1F)c1ccccc1		CHEMBL4575052	=	IC50	nM	1.0	CHEMBL260	Homo sapiens	IC50	nM	1.0
	18972887	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1cnc(-c2ccccc2Cl)s1		CHEMBL2401978	=	IC50	nM	7.0	CHEMBL260	Homo sapiens	IC50	nM	7.0
	18972888	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1		CHEMBL258202	=	IC50	nM	3.5	CHEMBL260	Homo sapiens	IC50	nM	3.5
	18972889	CHEMBL4337359	Inhibition of P38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL1234931	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	18972890	CHEMBL4337360	Binding affinity to P38alpha MAPK (unknown origin) assessed as dissociation constant	B	CCNC(=O)NCc1ccccc1Sc1ccc2nnc(C(C)C)n2c1		CHEMBL1938764	=	Kd	nM	3.3	CHEMBL260	Homo sapiens	Kd	nM	3.3
	18972891	CHEMBL4337360	Binding affinity to P38alpha MAPK (unknown origin) assessed as dissociation constant	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3ccc(F)cc3F)c2n(C)c1=O		CHEMBL1091199	=	Kd	nM	0.3	CHEMBL260	Homo sapiens	Kd	nM	0.3
	18972892	CHEMBL4337360	Binding affinity to P38alpha MAPK (unknown origin) assessed as dissociation constant	B	O=C(Nc1cc(Nc2ccc3c(c2)OCc2ccc(OCCN4CCOCC4)cc2C3=O)ccc1F)c1ccccc1		CHEMBL3086685	=	Kd	nM	17.0	CHEMBL260	Homo sapiens	Kd	nM	17.0
	18972893	CHEMBL4337356	Inhibition of P38alpha MAPK in human PBMC assessed as reduction in LPS-induced TNF-alpha secretion at 0.2 uM after 4 hrs by ELISA relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	>	Inhibition	%	90.0	CHEMBL260	Homo sapiens	INH	%	90.0
	18972894	CHEMBL4337357	Inhibition of P38alpha MAPK in human PBMC assessed as reduction in LPS-induced TNFalpha secretion at 50 nM after 4 hrs by ELISA relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	Inhibition	%	40.0	CHEMBL260	Homo sapiens	INH	%	40.0
	18972896	CHEMBL4337339	Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	35.0	CHEMBL260	Homo sapiens	IC50	uM	0.035
	18989209	CHEMBL4340751	Inhibition of recombinant human full-length untagged p38-alpha (M1 to S360 residues) expressed in Escherichia coli cells using recombinant ATF2 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	88000.0	CHEMBL260	Homo sapiens	IC50	uM	88.0
Active	19008129	CHEMBL4344886	Binding affinity to p38alpha (unknown origin)	A	O=C(Nc1ccc(Oc2ccncc2)c2ccccc12)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4438939		Activity			CHEMBL260	Homo sapiens	Activity		
	19021596	CHEMBL4347819	Inhibition of recombinant human P38alpha at 20 nM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 30 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	19021597	CHEMBL4347820	Inhibition of recombinant human P38alpha at 200 nM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 30 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19030021	CHEMBL4349160	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine/threonine-04 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	19032203	CHEMBL4349796	Inhibition of recombinant human full length p38-alpha (M1 to S360) expressed in Escherichia coli at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-8.0	CHEMBL260	Homo sapiens	INH	%	-8.0
	19035318	CHEMBL4350414	Inhibition of human p38alpha assessed as residual activity at 10 uM using MBP as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	74.0	CHEMBL260	Homo sapiens	Activity	%	74.0
Not Active	19040151	CHEMBL4352052	Inhibition of recombinant full-length human SAPK2a at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	19040152	CHEMBL4352053	Inhibition of recombinant full-length human SAPK2a T106M mutant at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Active	19041214	CHEMBL4352475	Inhibition of human p38alpha at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	19043773	CHEMBL4353239	Inhibition of human P38a using myelin basic protein as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	110.26	CHEMBL260	Homo sapiens	INH	%	110.26
	19059728	CHEMBL4358029	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	28.0	CHEMBL260	Homo sapiens	Activity	%	28.0
	19070726	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4569982	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070727	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccc3nsnc3c2)n1		CHEMBL4530888	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070728	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4471215	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070729	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4474331	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070730	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4594036	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070731	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccc3nsnc3c2)n1		CHEMBL4461256	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070732	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070733	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4455044	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070734	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070735	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2cc3cnccc3s2)n1		CHEMBL4460586	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070736	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4520187	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070737	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4531718	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070738	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4570292	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070739	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4513885	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070740	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4518531	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070741	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4546065	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070742	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4453089	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070743	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4522374	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070744	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4556543	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070745	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4447273	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070746	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4450974	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070747	CHEMBL4361669	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli at 10 uM using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay relative to control	B	Cc1cccc(-c2c(-c3cc4cnccc4s3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4592042	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19070764	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4569982	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070765	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccc3nsnc3c2)n1		CHEMBL4530888	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070766	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4471215	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070767	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4474331	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070768	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4594036	=	IC50	nM	5800.0	CHEMBL260	Homo sapiens	IC50	uM	5.8
	19070769	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccc3nsnc3c2)n1		CHEMBL4461256	=	IC50	nM	3800.0	CHEMBL260	Homo sapiens	IC50	uM	3.8
	19070770	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4527908	=	IC50	nM	7040.0	CHEMBL260	Homo sapiens	IC50	uM	7.04
	19070771	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccc3nsnc3c2)n1		CHEMBL4455044	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070772	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2cc3cnccc3s2)n1		CHEMBL4576703	=	IC50	nM	8120.0	CHEMBL260	Homo sapiens	IC50	uM	8.12
	19070773	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2cc3cnccc3s2)n1		CHEMBL4460586	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070774	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4520187	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070775	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4531718	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070776	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4570292	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19070777	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2cc3cnccc3s2)n1		CHEMBL4513885	=	IC50	nM	9460.0	CHEMBL260	Homo sapiens	IC50	uM	9.46
	19070778	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	19070779	CHEMBL4361671	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by radiometric assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	2180.0	CHEMBL260	Homo sapiens	IC50	uM	2.18
	19072932	CHEMBL4362107	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.82	CHEMBL260	Homo sapiens	FC		0.82
	19072971	CHEMBL4362146	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.92	CHEMBL260	Homo sapiens	FC		0.92
	19073010	CHEMBL4362107	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.29	CHEMBL260	Homo sapiens	log2FC		-0.29
	19073049	CHEMBL4362146	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.12	CHEMBL260	Homo sapiens	log2FC		-0.12
	19073111	CHEMBL4362107	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		1.03	CHEMBL260	Homo sapiens	FC		1.03
	19073150	CHEMBL4362146	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		1.21	CHEMBL260	Homo sapiens	FC		1.21
	19073189	CHEMBL4362107	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		0.05	CHEMBL260	Homo sapiens	log2FC		0.05
	19073228	CHEMBL4362146	Effect on p38alpha at T180/Y182 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		0.28	CHEMBL260	Homo sapiens	log2FC		0.28
	19087838	CHEMBL4365093	Inhibition of human recombinant full length N-terminal GST tagged p38alpha expressed in baculovirus infected Sf9 cells using p38 peptide as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	Nc1n[nH]c2cc(-c3ccc(C(=O)NCCNC(=O)c4ccc(Cl)c(C(F)(F)F)c4)cc3)ccc12		CHEMBL4467809	=	IC50	nM	34500.0	CHEMBL260	Homo sapiens	IC50	uM	34.5
	19089958	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2ccccc2F)c[nH]1		CHEMBL4526143	=	IC50	nM	360.0	CHEMBL260	Homo sapiens	IC50	uM	0.36
	19089959	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(c1cccc(Cl)c1)c1c[nH]c(C(=O)NCc2ccncc2)c1		CHEMBL4578343	=	IC50	nM	6500.0	CHEMBL260	Homo sapiens	IC50	uM	6.5
	19089960	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2cccc(F)c2F)c[nH]1		CHEMBL4458451	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	uM	2.4
	19089961	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2c(F)cccc2F)c[nH]1		CHEMBL4449117	=	IC50	nM	580.0	CHEMBL260	Homo sapiens	IC50	uM	0.58
	19089962	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(NCc1ccncc1)c1cc(C(=O)c2c(Cl)cccc2Cl)c[nH]1		CHEMBL4452485	=	IC50	nM	12300.0	CHEMBL260	Homo sapiens	IC50	uM	12.3
	19089963	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2F)c[nH]1		CHEMBL4443724	=	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	19089964	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2F)c[nH]1		CHEMBL4515859	=	IC50	nM	35000.0	CHEMBL260	Homo sapiens	IC50	uM	35.0
	19089965	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2Cl)c[nH]1	Outside typical range	CHEMBL4557683	>	IC50	nM	120000.0	CHEMBL260	Homo sapiens	IC50	uM	120.0
	19089966	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Cl)c[nH]1		CHEMBL4453232	=	IC50	nM	93200.0	CHEMBL260	Homo sapiens	IC50	uM	93.2
	19089967	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(Nc1ccncc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1	Outside typical range	CHEMBL4527483	>	IC50	nM	120000.0	CHEMBL260	Homo sapiens	IC50	uM	120.0
	19089968	CHEMBL4365546	Inhibition of recombinant N-terminal GST-tagged full length human p38alpha expressed in Escherichia coli cells assessed as substrate phosphorylation using Ulight-MBP peptide as substrate incubated for 1 hr by LANCE assay	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1	Outside typical range	CHEMBL4436895	>	IC50	nM	120000.0	CHEMBL260	Homo sapiens	IC50	uM	120.0
	19090293	CHEMBL4365867	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	19092045	CHEMBL4366519	Inhibition of human p38alpha at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-14.71	CHEMBL260	Homo sapiens	INH	%	-14.71
	19100315	CHEMBL4368355	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1cc(C)cc(Nc2cccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1		CHEMBL4437764	=	Kd	nM	6500.0	CHEMBL260	Homo sapiens	Kd	nM	6500.0
	19100316	CHEMBL4368355	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1		CHEMBL4475135	=	Kd	nM	2.2	CHEMBL260	Homo sapiens	Kd	nM	2.2
	19100317	CHEMBL4368355	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1cc(C)cc(Oc2nccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1		CHEMBL4461170	=	Kd	nM	120.0	CHEMBL260	Homo sapiens	Kd	nM	120.0
	19100318	CHEMBL4368355	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1cc(C)cc(Oc2cccc(-c3c(-c4ccc(F)cc4)nnn3C3CCNCC3)n2)c1		CHEMBL4589422	=	Kd	nM	5000.0	CHEMBL260	Homo sapiens	Kd	nM	5000.0
	19100319	CHEMBL4368355	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1cc(C)cc(Oc2cccc(-c3c(C)nnn3C3CCN(C(=N)N)CC3)n2)c1	Outside typical range	CHEMBL4559894	>	Kd	nM	200000.0	CHEMBL260	Homo sapiens	Kd	uM	200.0
	19100320	CHEMBL4368355	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1cc(C)cc(Nc2cccc(-c3c(C)nnn3C3CCN(C(=N)N)CC3)n2)c1		CHEMBL4527581	>	Kd	nM	25000.0	CHEMBL260	Homo sapiens	Kd	uM	25.0
	19127668	CHEMBL4374257	Inhibition of p38 alpha (unknown origin) at 1 uM	B	N=C1C(=O)NC(=O)c2cc(-c3ccccc3)sc21		CHEMBL4445621	=	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	19140828	CHEMBL4376592	Inhibition of recombinant full length human GST-tagged MAPK14 expressed in Escherichia coli at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	19144838	CHEMBL4377854	Inhibition of recombinant full-length human SAPK2a at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	20.0	CHEMBL260	Homo sapiens	INH	%	20.0
	19144839	CHEMBL4377855	Inhibition of recombinant full-length human SAPK2a T106M mutant at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19146972	CHEMBL4378820	Inhibition of recombinant full-length human SAPK2a at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	19148031	CHEMBL4379427	Inhibition of recombinant human full length SAPK2a using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19148032	CHEMBL4379428	Inhibition of recombinant human full length SAPK2a T106M mutant using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19159556	CHEMBL4382660	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	19172310	CHEMBL4385134	Inhibition of p38alpha (unknown origin)	B	CS(=O)(=O)Nc1cc(-c2ccncc2)cnc1Cl		CHEMBL4474208	<	IC50	nM	10000.0	CHEMBL260	Homo sapiens	pIC50		5.0
	19181175	CHEMBL4387386	Inhibition of recombinant full length human GST-tagged p38alpha expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-15 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	-1.0	CHEMBL260	Homo sapiens	INH	%	-1.0
	19181400	CHEMBL4387386	Inhibition of recombinant full length human GST-tagged p38alpha expressed in Escherichia coli expression system at 0.1 uM using serine/threonine-15 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	3.0	CHEMBL260	Homo sapiens	INH	%	3.0
	19191451	CHEMBL4389379	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	19192042	CHEMBL4389856	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL260	Homo sapiens	INH	%	100.0
	19200298	CHEMBL4391482	Binding affinity to wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	19225316	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	COc1cc(CCC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc(OC)c1OC		CHEMBL4520113	=	IC50	nM	88.0	CHEMBL260	Homo sapiens	IC50	nM	88.0
	19225317	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)[nH]1		CHEMBL1773425	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	19225318	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474903	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	nM	24.0
	19225319	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCCC3)c2)[nH]1		CHEMBL4574237	=	IC50	nM	40.0	CHEMBL260	Homo sapiens	IC50	nM	40.0
	19225320	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	COc1cc(CC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc(OC)c1OC		CHEMBL4513323	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	nM	13.0
	19225321	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	COc1ccc(CCC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc1		CHEMBL4547931	=	IC50	nM	55.0	CHEMBL260	Homo sapiens	IC50	nM	55.0
	19225322	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	COc1cccc(CCC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1		CHEMBL4592870	=	IC50	nM	36.0	CHEMBL260	Homo sapiens	IC50	nM	36.0
	19225323	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(C(F)(F)F)cc3)c2)[nH]1		CHEMBL4555766	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	19225324	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CCc3ccc(C(F)(F)F)cc3)c2)[nH]1		CHEMBL4518955	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	19225325	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3(C(F)(F)F)CC3)c2)[nH]1		CHEMBL4454724	=	IC50	nM	184.0	CHEMBL260	Homo sapiens	IC50	nM	184.0
	19225326	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)[C@@H]3C[C@H]3c3ccccc3)c2)[nH]1		CHEMBL4442468	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	19225327	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CC3CC3)c2)[nH]1		CHEMBL4434855	=	IC50	nM	15.0	CHEMBL260	Homo sapiens	IC50	nM	15.0
	19225328	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCC3)c2)[nH]1		CHEMBL4561291	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	19225329	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC(=O)C3)c2)[nH]1		CHEMBL4458096	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	19225330	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)[C@H]3C[C@H](Cl)C3)c2)[nH]1		CHEMBL4435922	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	19225331	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)[C@H]3C[C@@H](Cl)C3)c2)[nH]1		CHEMBL4446355	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	19225332	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCC(=O)C3)c2)[nH]1		CHEMBL4571942	=	IC50	nM	21.0	CHEMBL260	Homo sapiens	IC50	nM	21.0
	19225333	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCCO3)c2)[nH]1		CHEMBL4441042	=	IC50	nM	28.0	CHEMBL260	Homo sapiens	IC50	nM	28.0
	19225334	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CN3CCCC3=O)c2)[nH]1		CHEMBL4566059	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	nM	23.0
	19225335	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccoc3)c2)[nH]1		CHEMBL4555253	=	IC50	nM	22.0	CHEMBL260	Homo sapiens	IC50	nM	22.0
	19225336	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccccn3)c2)[nH]1		CHEMBL4475119	=	IC50	nM	42.0	CHEMBL260	Homo sapiens	IC50	nM	42.0
	19225337	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CC3)c2)[nH]1		CHEMBL4446519	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	19225338	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)n1C		CHEMBL1272270	=	IC50	nM	222.0	CHEMBL260	Homo sapiens	IC50	nM	222.0
	19225339	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CSc1nc(-c2ccnc(NC(=O)C3CC3)c2)c(-c2ccc(F)cc2)n1C		CHEMBL4449296	=	IC50	nM	1603.0	CHEMBL260	Homo sapiens	IC50	nM	1603.0
	19225340	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	COc1cc(CCC(=O)Nc2cc(-c3[nH]c(SCc4ccccc4)nc3-c3ccc(F)cc3)ccn2)cc(OC)c1OC		CHEMBL4452736	=	IC50	nM	61.0	CHEMBL260	Homo sapiens	IC50	nM	61.0
	19225341	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CC(=O)Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1		CHEMBL4591390	=	IC50	nM	51.0	CHEMBL260	Homo sapiens	IC50	nM	51.0
	19225342	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4546015	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	19225343	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CCCC1		CHEMBL4437018	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	19225344	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1		CHEMBL4452170	=	IC50	nM	3.0	CHEMBL260	Homo sapiens	IC50	nM	3.0
	19225345	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4589431	=	IC50	nM	44.0	CHEMBL260	Homo sapiens	IC50	nM	44.0
	19225346	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCC3)c2)[nH]1		CHEMBL4449570	=	IC50	nM	29.0	CHEMBL260	Homo sapiens	IC50	nM	29.0
	19225347	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Nc1cc(-c2[nH]cnc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4457096	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	19225348	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	Cc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4455711	=	IC50	nM	19.0	CHEMBL260	Homo sapiens	IC50	nM	19.0
	19225349	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	19225350	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Nc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4568095	=	IC50	nM	27.0	CHEMBL260	Homo sapiens	IC50	nM	27.0
	19225351	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Nc1cc(-c2[nH]c(Cc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4476724	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	19225352	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Nc1cc(-c2[nH]c(CCc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4473730	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	19225353	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	O=C(Nc1cc(-c2[nH]c(-c3ccco3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4476843	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	nM	18.0
	19225354	CHEMBL4395914	Inhibition of human recombinant p38alpha MAPK upto 10000 nM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 30 mins by LANCE assay relative to control	B	Cc1ncc(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4582385	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	19225488	CHEMBL4395908	Inhibition of human recombinant SAPK2A at 1 uM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 30 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	93.63	CHEMBL260	Homo sapiens	INH	%	93.63
	19225494	CHEMBL4395839	Inhibition of p38alpha MAPK (unknown origin) using ATF-2 as substrate after 1 hr by ELISA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	nM	41.0
	19225504	CHEMBL4395917	Inhibition of human recombinant p38alpha MAPK using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 30 mins by LANCE assay relative to control	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	nM	65.0
	19230937	CHEMBL4397171	Inhibition of N-terminal FLAG-tagged p38alpha (unknown origin) expressed in baculovirus expression system at 100 nM using myelin basic protein as substrate preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 60 mins by topcount scintillation counting method relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	19242753	CHEMBL4400088	Inhibition of recombinant full length human SAPK2alpha assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	92.0	CHEMBL260	Homo sapiens	Activity	%	92.0
	19256339	CHEMBL4402903	Inhibition of wild-type human P38alpha MAPK expressed in Escherichia coli Rosetta cells	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	19256340	CHEMBL4402903	Inhibition of wild-type human P38alpha MAPK expressed in Escherichia coli Rosetta cells	B	CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)O[C@@H]1[C@H](OCC(C)C)C[C@@H](O)[C@H](O)[C@H]1O)OC		CHEMBL4445946	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	19256341	CHEMBL4402903	Inhibition of wild-type human P38alpha MAPK expressed in Escherichia coli Rosetta cells	B	CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)O[C@@H]1[C@H](OCC2CCCCC2)C[C@@H](O)[C@H](O)[C@H]1O)OC		CHEMBL4459106	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	19266542	CHEMBL4405492	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL260	Homo sapiens	INH	%	50.0
	19271880	CHEMBL4406948	Inhibition of p38alpha (unknown origin) using biotinylated maltose peptide as substrate after 60 mins	B	O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12		CHEMBL285527	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	uM	1.2
	19272038	CHEMBL4406983	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	23.0	CHEMBL260	Homo sapiens	Activity	%	23.0
	19274886	CHEMBL4407577	Inhibition of recombinant human full-length GST-tagged MAPK14 expressed in Escherichia coli at 25 uM using FRET-labeled Ser/Thr 15 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	INH	%	24.0
	19274887	CHEMBL4407577	Inhibition of recombinant human full-length GST-tagged MAPK14 expressed in Escherichia coli at 25 uM using FRET-labeled Ser/Thr 15 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	19274888	CHEMBL4407577	Inhibition of recombinant human full-length GST-tagged MAPK14 expressed in Escherichia coli at 25 uM using FRET-labeled Ser/Thr 15 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	5.0	CHEMBL260	Homo sapiens	INH	%	5.0
	19276123	CHEMBL4408126	Inhibition of recombinant human full length SAPK2a at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	19276124	CHEMBL4408127	Inhibition of recombinant human full length SAPK2a T106M mutant at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	60.0	CHEMBL260	Homo sapiens	INH	%	60.0
	19296349	CHEMBL4412525	Inhibition of MMAPK14 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4586372	=	Inhibition	%	82.0	CHEMBL260	Homo sapiens	INH	%	82.0
	19371157	CHEMBL4424909	Inhibition of human full-length N-terminal GST-tagged SAPK2a expressed in baculovirus infected Sf21 insect cells using MBP as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	19411447	CHEMBL4427718	Inhibition of MAPK14 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	uM	5.0
	19411503	CHEMBL4427662	Inhibition of MAPK14 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL260	Homo sapiens	INH	%	16.0
Active	19440513	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL87277		Activity			CHEMBL260	Homo sapiens	Activity		
	19440514	CHEMBL4431480	Inhibition of SKF-86002 binding to human inactive p38alpha after 60 mins by fluorescence assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	0.1	CHEMBL260	Homo sapiens	Kd	nM	0.1
Active	19440515	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccccc2)n1		CHEMBL85860		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440516	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4444555		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440517	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	Cc1ccccc1-n1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL4453392		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440518	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)c1		CHEMBL568875		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440519	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(F)cc2)n1		CHEMBL4536623		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440520	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccccc2F)n1		CHEMBL4456735		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440521	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4438989		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440522	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	COc1ccccc1-n1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cl)cc1		CHEMBL4454979		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440523	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(Cl)cc2)n1		CHEMBL4542069		Activity			CHEMBL260	Homo sapiens	Activity		
Active	19440524	CHEMBL4431479	Binding affinity to 15N-Phe-isotope-labeled p38alpha (unknown origin) in apo-state by 1H-15N TROSY-HSQC NMR spectroscopic analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccccc2Cl)n1		CHEMBL4466649		Activity			CHEMBL260	Homo sapiens	Activity		
	19453906	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4464656	=	IC50	nM	763.0	CHEMBL260	Homo sapiens	IC50	uM	0.763
	19453907	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3nsnc3c2)n1		CHEMBL4453060	=	IC50	nM	1170.0	CHEMBL260	Homo sapiens	IC50	uM	1.17
	19453908	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261	=	IC50	nM	148.0	CHEMBL260	Homo sapiens	IC50	uM	0.148
	19453909	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4588407	=	IC50	nM	831.0	CHEMBL260	Homo sapiens	IC50	uM	0.831
	19453910	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3nsnc3c2)n1		CHEMBL4534375	=	IC50	nM	899.0	CHEMBL260	Homo sapiens	IC50	uM	0.899
	19453911	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(NCc2nc(-c3ccc4nsnc4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4574187	=	IC50	nM	513.0	CHEMBL260	Homo sapiens	IC50	uM	0.513
	19453912	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1ccc(NCc2nc(-c3ccc4nsnc4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4553389	=	IC50	nM	7700.0	CHEMBL260	Homo sapiens	IC50	uM	7.7
	19453913	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2cc3cnccc3s2)n1		CHEMBL4447399	=	IC50	nM	4400.0	CHEMBL260	Homo sapiens	IC50	uM	4.4
	19453914	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2cc3cnccc3s2)n1		CHEMBL4516224	=	IC50	nM	6060.0	CHEMBL260	Homo sapiens	IC50	uM	6.06
	19453915	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2cc3cnccc3s2)n1		CHEMBL4576341	=	IC50	nM	1520.0	CHEMBL260	Homo sapiens	IC50	uM	1.52
	19453916	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2cc3cnccc3s2)n1		CHEMBL4533727	=	IC50	nM	4840.0	CHEMBL260	Homo sapiens	IC50	uM	4.84
	19453917	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2cc3cnccc3s2)n1		CHEMBL4474911	=	IC50	nM	2440.0	CHEMBL260	Homo sapiens	IC50	uM	2.44
	19453918	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(NCc2nc(-c3cc4cnccc4s3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4543738	=	IC50	nM	2220.0	CHEMBL260	Homo sapiens	IC50	uM	2.22
	19453919	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1ccc(NCc2nc(-c3cc4cnccc4s3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4519255	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	19453920	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	493.0	CHEMBL260	Homo sapiens	IC50	uM	0.493
	19453921	CHEMBL4434539	Inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	2950.0	CHEMBL260	Homo sapiens	IC50	uM	2.95
	19453956	CHEMBL4434542	Potency index, ratio of IC50 for LY-2157299 to IC50 for test compound for inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261	=	Ratio IC50		3.3	CHEMBL260	Homo sapiens	Ratio IC50		3.3
	19453957	CHEMBL4434534	Potency index, ratio of IC50 for EW-7197 to IC50 for test compound for inhibition of human recombinant untagged p38alpha expressed in Escherichia coli using ATF2 as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3nsnc3c2)n1		CHEMBL4519261	=	Ratio IC50		19.9	CHEMBL260	Homo sapiens	Ratio IC50		19.9
	19474700	CHEMBL4479389	Inhibition of P38alpha (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL260	Homo sapiens	pIC50		5.0
	19476598	CHEMBL4479746	Inhibition of full-length recombinant human GST-tagged MAPK14 alpha expressed in Escherichia coli by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	1200.0	CHEMBL260	Homo sapiens	IC50	nM	1200.0
	19476698	CHEMBL4479746	Inhibition of full-length recombinant human GST-tagged MAPK14 alpha expressed in Escherichia coli by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	36000.0	CHEMBL260	Homo sapiens	IC50	nM	36000.0
	19476798	CHEMBL4479746	Inhibition of full-length recombinant human GST-tagged MAPK14 alpha expressed in Escherichia coli by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	nM	1400.0
	19476898	CHEMBL4479746	Inhibition of full-length recombinant human GST-tagged MAPK14 alpha expressed in Escherichia coli by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	nM	100000.0
	20597984	CHEMBL4602784	Inhibition of human p38alpha	B	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1		CHEMBL4632881	=	Ki	nM	620.0	CHEMBL260	Homo sapiens	Ki	uM	0.62
	20597985	CHEMBL4602784	Inhibition of human p38alpha	B	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1		CHEMBL4632881	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	20597986	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccccc3)nn2)CC1		CHEMBL4639555	=	IC50	nM	600.0	CHEMBL260	Homo sapiens	IC50	uM	0.6
	20597987	CHEMBL4602784	Inhibition of human p38alpha	B	c1ccc(-c2nnc(N3CCNCC3)cc2-c2ccncc2)cc1		CHEMBL4639028	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	uM	0.15
	20597988	CHEMBL4602784	Inhibition of human p38alpha	B	CCN(CC)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4642101	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	20597989	CHEMBL4602784	Inhibition of human p38alpha	B	CCCN(C)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4648747	=	IC50	nM	390.0	CHEMBL260	Homo sapiens	IC50	uM	0.39
	20597990	CHEMBL4602784	Inhibition of human p38alpha	B	CN(C)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4645737	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	20597991	CHEMBL4602784	Inhibition of human p38alpha	B	CN(C)c1cc(-c2ccncc2)c(-c2cccc3ccccc23)nn1		CHEMBL4646628	=	IC50	nM	190.0	CHEMBL260	Homo sapiens	IC50	uM	0.19
	20597992	CHEMBL4602784	Inhibition of human p38alpha	B	CN(C)c1cc(-c2ccncc2)c(-c2cccc3ccccc23)nn1		CHEMBL4646628	=	Ki	nM	180.0	CHEMBL260	Homo sapiens	Ki	uM	0.18
	20597993	CHEMBL4602784	Inhibition of human p38alpha	B	CN(C)c1cc(-c2ccncc2)c(-c2ccc3ccccc3c2)nn1		CHEMBL4648060	=	Ki	nM	110.0	CHEMBL260	Homo sapiens	Ki	uM	0.11
	20597994	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1		CHEMBL4129018	=	Ki	nM	100.0	CHEMBL260	Homo sapiens	Ki	uM	0.1
	20597995	CHEMBL4602784	Inhibition of human p38alpha	B	CN(C)c1cc(-c2ccncc2)c(-c2ccc3ccccc3c2)nn1		CHEMBL4648060	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	uM	0.21
	20597996	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1		CHEMBL4129018	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	20597997	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4cc(F)ccc4c3)nn2)CC1		CHEMBL4643993	=	IC50	nM	920.0	CHEMBL260	Homo sapiens	IC50	uM	0.92
	20597998	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccc(F)cc4c3)nn2)CC1		CHEMBL4640881	=	IC50	nM	710.0	CHEMBL260	Homo sapiens	IC50	uM	0.71
	20597999	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4cccc(F)c4c3)nn2)CC1		CHEMBL4642456	=	IC50	nM	630.0	CHEMBL260	Homo sapiens	IC50	uM	0.63
	20598000	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4c(F)cccc4c3)nn2)CC1		CHEMBL4643060	=	IC50	nM	1590.0	CHEMBL260	Homo sapiens	IC50	uM	1.59
	20598001	CHEMBL4602784	Inhibition of human p38alpha	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4[nH]ccc4c3)nn2)CC1		CHEMBL4635980	=	IC50	nM	570.0	CHEMBL260	Homo sapiens	IC50	uM	0.57
	20598002	CHEMBL4602784	Inhibition of human p38alpha	B	c1ccc2cc(-c3nnc(N4CCNCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4647072	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	20598003	CHEMBL4602784	Inhibition of human p38alpha	B	c1ccc2cc(-c3nnc(N4CCCCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4635988	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	uM	0.25
	20598004	CHEMBL4602784	Inhibition of human p38alpha	B	c1ccc2cc(-c3nnc(N4CCCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4639995	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	uM	0.2
	20598005	CHEMBL4602784	Inhibition of human p38alpha	B	c1ccc2cc(-c3nnc(N4CCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4643246	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	20600324	CHEMBL4603426	Inhibition of recombinant full length human p38alpha expressed in Escherichia coli at 10 uM using MBP as substrate after 30 mins by radiometric scintillation analysis relative to control	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	20600581	CHEMBL4603533	Inhibition of recombinant full length GST-tagged human inactive MAPK14 expressed in Escherichia coli using Ser/Thr 04 as substrate after 1 hr in presence of ATP by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	20600582	CHEMBL4603534	Inhibition of recombinant full length GST-tagged human MAPK14 expressed in Escherichia coli using Ser/Thr 04 as substrate after 1 hr in presence of ATP by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	20601668	CHEMBL4603800	Inhibition of recombinant human GST-tagged full length MAPK14 expressed in Escherichia coli expression system using Ser/Thr15 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	4.0	CHEMBL260	Homo sapiens	INH	%	4.0
	20604077	CHEMBL4604470	Inhibition of human MAPK14 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	20604078	CHEMBL4604470	Inhibition of human MAPK14 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	20604079	CHEMBL4604470	Inhibition of human MAPK14 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	Inhibition	%	93.0	CHEMBL260	Homo sapiens	INH	%	93.0
	20604080	CHEMBL4604470	Inhibition of human MAPK14 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	20604081	CHEMBL4604470	Inhibition of human MAPK14 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	Inhibition	%	95.0	CHEMBL260	Homo sapiens	INH	%	95.0
	20604082	CHEMBL4604470	Inhibition of human MAPK14 expressed in Escherichia coli at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	Inhibition	%	84.0	CHEMBL260	Homo sapiens	INH	%	84.0
	20604113	CHEMBL4604476	Inhibition of human MAPK14 expressed in Escherichia coli after 1 hr by Z'-LYTE assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	20604114	CHEMBL4604476	Inhibition of human MAPK14 expressed in Escherichia coli after 1 hr by Z'-LYTE assay	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	IC50	nM	1320.0	CHEMBL260	Homo sapiens	IC50	uM	1.32
	20604115	CHEMBL4604476	Inhibition of human MAPK14 expressed in Escherichia coli after 1 hr by Z'-LYTE assay	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	IC50	nM	950.0	CHEMBL260	Homo sapiens	IC50	uM	0.95
	20604116	CHEMBL4604476	Inhibition of human MAPK14 expressed in Escherichia coli after 1 hr by Z'-LYTE assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	IC50	nM	1710.0	CHEMBL260	Homo sapiens	IC50	uM	1.71
	20604117	CHEMBL4604476	Inhibition of human MAPK14 expressed in Escherichia coli after 1 hr by Z'-LYTE assay	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	IC50	nM	870.0	CHEMBL260	Homo sapiens	IC50	uM	0.87
	20604118	CHEMBL4604476	Inhibition of human MAPK14 expressed in Escherichia coli after 1 hr by Z'-LYTE assay	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	IC50	nM	990.0	CHEMBL260	Homo sapiens	IC50	uM	0.99
	20646092	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649828	=	Activity	%	10.0	CHEMBL260	Homo sapiens	Activity	%	10.0
	20646093	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccnc3ccccc23)n1		CHEMBL4643959	=	Activity	%	6.0	CHEMBL260	Homo sapiens	Activity	%	6.0
	20646094	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4642941	=	Activity	%	4.0	CHEMBL260	Homo sapiens	Activity	%	4.0
	20646095	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4637341	=	Activity	%	6.0	CHEMBL260	Homo sapiens	Activity	%	6.0
	20646096	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4634662	=	Activity	%	24.0	CHEMBL260	Homo sapiens	Activity	%	24.0
	20646097	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4637339	=	Activity	%	50.0	CHEMBL260	Homo sapiens	Activity	%	50.0
	20646098	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4638814	=	Activity	%	31.0	CHEMBL260	Homo sapiens	Activity	%	31.0
	20646099	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc4ccccc34)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4644172	=	Activity	%	51.0	CHEMBL260	Homo sapiens	Activity	%	51.0
	20646100	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649639	=	Activity	%	3.0	CHEMBL260	Homo sapiens	Activity	%	3.0
	20646101	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc3ccccc23)n1		CHEMBL4638492	=	Activity	%	4.0	CHEMBL260	Homo sapiens	Activity	%	4.0
	20646102	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4638285	=	Activity	%	3.0	CHEMBL260	Homo sapiens	Activity	%	3.0
	20646103	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649719	=	Activity	%	3.0	CHEMBL260	Homo sapiens	Activity	%	3.0
	20646104	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4645374	=	Activity	%	11.0	CHEMBL260	Homo sapiens	Activity	%	11.0
	20646105	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3ccccc3F)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4638055	=	Activity	%	20.0	CHEMBL260	Homo sapiens	Activity	%	20.0
	20646106	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(F)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4648655	=	Activity	%	14.0	CHEMBL260	Homo sapiens	Activity	%	14.0
	20646107	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=O)Nc3cccc(C#N)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4633712	=	Activity	%	24.0	CHEMBL260	Homo sapiens	Activity	%	24.0
	20646108	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2ccccc2)n1		CHEMBL4639727	=	Activity	%	66.0	CHEMBL260	Homo sapiens	Activity	%	66.0
	20646109	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2ccccc2F)n1		CHEMBL4636902	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
	20646110	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2cccc(F)c2)n1		CHEMBL4648311	=	Activity	%	81.0	CHEMBL260	Homo sapiens	Activity	%	81.0
	20646111	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2c(-c3ccnc(-c4ccccc4)c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1		CHEMBL4645318	=	Activity	%	135.0	CHEMBL260	Homo sapiens	Activity	%	135.0
	20646112	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4648490	=	Activity	%	10.0	CHEMBL260	Homo sapiens	Activity	%	10.0
	20646113	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4640708	=	Activity	%	4.0	CHEMBL260	Homo sapiens	Activity	%	4.0
	20646114	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4644045	=	Activity	%	9.0	CHEMBL260	Homo sapiens	Activity	%	9.0
	20646115	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4635582	=	Activity	%	15.0	CHEMBL260	Homo sapiens	Activity	%	15.0
	20646116	CHEMBL4614185	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as residual activity at 10 uM (Rvb = 100 +/- 0.1%)	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Activity	%	4.0	CHEMBL260	Homo sapiens	Activity	%	4.0
	20646142	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649639	=	IC50	nM	74.0	CHEMBL260	Homo sapiens	IC50	uM	0.074
	20646143	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc3ccccc23)n1		CHEMBL4638492	=	IC50	nM	68.0	CHEMBL260	Homo sapiens	IC50	uM	0.068
	20646144	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4638285	=	IC50	nM	63.0	CHEMBL260	Homo sapiens	IC50	uM	0.063
	20646145	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc3ccccc23)n1		CHEMBL4649719	=	IC50	nM	104.0	CHEMBL260	Homo sapiens	IC50	uM	0.104
	20646146	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4648490	=	IC50	nM	536.0	CHEMBL260	Homo sapiens	IC50	uM	0.536
	20646147	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3ccccc3F)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4640708	=	IC50	nM	487.0	CHEMBL260	Homo sapiens	IC50	uM	0.487
	20646148	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(F)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4644045	=	IC50	nM	761.0	CHEMBL260	Homo sapiens	IC50	uM	0.761
	20646149	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn(CC(=S)Nc3cccc(C#N)c3)cc2-c2ccnc(-c3ccccc3)c2)n1		CHEMBL4635582	=	IC50	nM	1150.0	CHEMBL260	Homo sapiens	IC50	uM	1.15
	20646150	CHEMBL4614187	Inhibition of recombinant human p38alpha expressed in Escherichia coli	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	487.0	CHEMBL260	Homo sapiens	IC50	uM	0.487
	20660936	CHEMBL4618314	Inhibition of recombinant human full-length N-terminal GST-tagged p38alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by ADP-glo assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4640746	=	IC50	nM	19.7	CHEMBL260	Homo sapiens	IC50	nM	19.7
	20660937	CHEMBL4618314	Inhibition of recombinant human full-length N-terminal GST-tagged p38alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by ADP-glo assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4645084	=	IC50	nM	29.7	CHEMBL260	Homo sapiens	IC50	nM	29.7
	20660938	CHEMBL4618314	Inhibition of recombinant human full-length N-terminal GST-tagged p38alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by ADP-glo assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4642910	=	IC50	nM	16.0	CHEMBL260	Homo sapiens	IC50	nM	16.0
	20660939	CHEMBL4618314	Inhibition of recombinant human full-length N-terminal GST-tagged p38alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by ADP-glo assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4646557	=	IC50	nM	24.6	CHEMBL260	Homo sapiens	IC50	nM	24.6
	20660940	CHEMBL4618314	Inhibition of recombinant human full-length N-terminal GST-tagged p38alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by ADP-glo assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	20660941	CHEMBL4618314	Inhibition of recombinant human full-length N-terminal GST-tagged p38alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins by ADP-glo assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4648755	=	IC50	nM	12.0	CHEMBL260	Homo sapiens	IC50	nM	12.0
	20660942	CHEMBL4618315	Inhibition of NanoBRET kinase tracer K4 binding to full-length human C-terminal NanoLuc-tagged p38alpha MAPK expressed in HEK293T cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4640746	=	IC50	nM	6.3	CHEMBL260	Homo sapiens	IC50	nM	6.3
	20660943	CHEMBL4618315	Inhibition of NanoBRET kinase tracer K4 binding to full-length human C-terminal NanoLuc-tagged p38alpha MAPK expressed in HEK293T cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4645084	=	IC50	nM	15.5	CHEMBL260	Homo sapiens	IC50	nM	15.5
	20660944	CHEMBL4618315	Inhibition of NanoBRET kinase tracer K4 binding to full-length human C-terminal NanoLuc-tagged p38alpha MAPK expressed in HEK293T cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4642910	=	IC50	nM	30.4	CHEMBL260	Homo sapiens	IC50	nM	30.4
	20660945	CHEMBL4618315	Inhibition of NanoBRET kinase tracer K4 binding to full-length human C-terminal NanoLuc-tagged p38alpha MAPK expressed in HEK293T cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4646557	=	IC50	nM	4.9	CHEMBL260	Homo sapiens	IC50	nM	4.9
	20660946	CHEMBL4618315	Inhibition of NanoBRET kinase tracer K4 binding to full-length human C-terminal NanoLuc-tagged p38alpha MAPK expressed in HEK293T cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	IC50	nM	4.3	CHEMBL260	Homo sapiens	IC50	nM	4.3
Not Determined	20660947	CHEMBL4618315	Inhibition of NanoBRET kinase tracer K4 binding to full-length human C-terminal NanoLuc-tagged p38alpha MAPK expressed in HEK293T cells incubated for 2 hrs by NanoBRET NanoGlo substrate based NanoBRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4648755		IC50			CHEMBL260	Homo sapiens	IC50		
	20660948	CHEMBL4618316	Inhibition of p38alpha MAPK in human whole blood assessed as reduction in LPS-induced TNFalpha production preincubated for 2.5 hrs followed by LPS stimulation by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4640746	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	20660949	CHEMBL4618316	Inhibition of p38alpha MAPK in human whole blood assessed as reduction in LPS-induced TNFalpha production preincubated for 2.5 hrs followed by LPS stimulation by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4645084	=	IC50	nM	276.0	CHEMBL260	Homo sapiens	IC50	nM	276.0
	20660950	CHEMBL4618316	Inhibition of p38alpha MAPK in human whole blood assessed as reduction in LPS-induced TNFalpha production preincubated for 2.5 hrs followed by LPS stimulation by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4642910	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	nM	490.0
	20660951	CHEMBL4618316	Inhibition of p38alpha MAPK in human whole blood assessed as reduction in LPS-induced TNFalpha production preincubated for 2.5 hrs followed by LPS stimulation by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4646557	=	IC50	nM	101.0	CHEMBL260	Homo sapiens	IC50	nM	101.0
	20660952	CHEMBL4618316	Inhibition of p38alpha MAPK in human whole blood assessed as reduction in LPS-induced TNFalpha production preincubated for 2.5 hrs followed by LPS stimulation by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	20660953	CHEMBL4618316	Inhibition of p38alpha MAPK in human whole blood assessed as reduction in LPS-induced TNFalpha production preincubated for 2.5 hrs followed by LPS stimulation by ELISA	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4648755	=	IC50	nM	43.0	CHEMBL260	Homo sapiens	IC50	nM	43.0
	20660954	CHEMBL4618317	Inhibition of p38alpha MAPK (unknown origin) assessed as target residence time using ATF2 as substrate preincubated for 1 hr followed by jump dilution in presence of substrate and measured every 3 mins for 4 hrs by TR-FRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL4640746	=	TIME	hr	0.2306	CHEMBL260	Homo sapiens	Time	s	830.0
	20660955	CHEMBL4618317	Inhibition of p38alpha MAPK (unknown origin) assessed as target residence time using ATF2 as substrate preincubated for 1 hr followed by jump dilution in presence of substrate and measured every 3 mins for 4 hrs by TR-FRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4645084	=	TIME	hr	0.3725	CHEMBL260	Homo sapiens	Time	s	1341.0
	20660956	CHEMBL4618317	Inhibition of p38alpha MAPK (unknown origin) assessed as target residence time using ATF2 as substrate preincubated for 1 hr followed by jump dilution in presence of substrate and measured every 3 mins for 4 hrs by TR-FRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(/C=N/NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4642910	=	TIME	hr	0.2814	CHEMBL260	Homo sapiens	Time	s	1013.0
	20660957	CHEMBL4618317	Inhibition of p38alpha MAPK (unknown origin) assessed as target residence time using ATF2 as substrate preincubated for 1 hr followed by jump dilution in presence of substrate and measured every 3 mins for 4 hrs by TR-FRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccc[se]4)c3)cc1CC2		CHEMBL4646557	=	TIME	hr	0.4433	CHEMBL260	Homo sapiens	Time	s	1596.0
	20660958	CHEMBL4618317	Inhibition of p38alpha MAPK (unknown origin) assessed as target residence time using ATF2 as substrate preincubated for 1 hr followed by jump dilution in presence of substrate and measured every 3 mins for 4 hrs by TR-FRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207	=	TIME	hr	0.05111	CHEMBL260	Homo sapiens	Time	s	184.0
	20660959	CHEMBL4618317	Inhibition of p38alpha MAPK (unknown origin) assessed as target residence time using ATF2 as substrate preincubated for 1 hr followed by jump dilution in presence of substrate and measured every 3 mins for 4 hrs by TR-FRET assay	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4cccs4)c3)cc1CC2		CHEMBL4648755	=	TIME	hr	0.2072	CHEMBL260	Homo sapiens	Time	s	746.0
	20660960	CHEMBL4618317	Inhibition of p38alpha MAPK (unknown origin) assessed as target residence time using ATF2 as substrate preincubated for 1 hr followed by jump dilution in presence of substrate and measured every 3 mins for 4 hrs by TR-FRET assay	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944	=	TIME	hr	0.02444	CHEMBL260	Homo sapiens	Time	s	88.0
	22391797	CHEMBL4667005	Inhibition of recombinant human GST-tagged full length p38 alpha expressed in Escherichia coli expression system using Ser/Thr 15 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	-4.0	CHEMBL260	Homo sapiens	INH	%	-4.0
	22391798	CHEMBL4667005	Inhibition of recombinant human GST-tagged full length p38 alpha expressed in Escherichia coli expression system using Ser/Thr 15 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	7.0	CHEMBL260	Homo sapiens	INH	%	7.0
	22391799	CHEMBL4667005	Inhibition of recombinant human GST-tagged full length p38 alpha expressed in Escherichia coli expression system using Ser/Thr 15 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	2.0	CHEMBL260	Homo sapiens	INH	%	2.0
	22392197	CHEMBL4667292	Inhibition of recombinant human GST-tagged full length p38 alpha expressed in Escherichia coli expression system using Ser/Thr 15 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.5	CHEMBL260	Homo sapiens	INH	%	0.5
	22421636	CHEMBL4673638	Inhibition of human p38alpha MAPK (1 to 360 residues) at 10 uM incubated for 5 mins in presence of [gamma33P]ATP by scintillation counting analysis relative to control	B	O=C(Cc1ccc(F)c(F)c1)N1CCC(Nc2ncc3c(N4CCOCC4)n[nH]c3n2)CC1		CHEMBL4762609	>	Inhibition	%	40.0	CHEMBL260	Homo sapiens	INH	%	40.0
	22423383	CHEMBL4674267	Inhibition of human p38alpha using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	96.45	CHEMBL260	Homo sapiens	Activity	%	96.45
	22423384	CHEMBL4674267	Inhibition of human p38alpha using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	103.38	CHEMBL260	Homo sapiens	Activity	%	103.38
	22430546	CHEMBL4676207	Inhibition of MAPK14 (unknown origin)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788	=	IC50	nM	10700.0	CHEMBL260	Homo sapiens	IC50	uM	10.7
	22482662	CHEMBL4687868	Inhibition of human SAPK2a assessed as residual activity at 10 uM relative to control	A	CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1		CHEMBL4757567	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	22485830	CHEMBL4688578	Inhibition of p38MAPK alpha (unknown origin) by ATP competitive based analysis	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1		CHEMBL4747992	>	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	nM	300.0
	22488261	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(O)cc1		CHEMBL4788985	=	Inhibition	%	98.01	CHEMBL260	Homo sapiens	INH	%	98.01
	22488262	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1ccc(S(=O)(=O)NCCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(O)c3)ccn2)cc1		CHEMBL4799139	=	Inhibition	%	92.02	CHEMBL260	Homo sapiens	INH	%	92.02
	22488263	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL4762037	=	Inhibition	%	75.28	CHEMBL260	Homo sapiens	INH	%	75.28
	22488264	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(F)c1		CHEMBL4742980	=	Inhibition	%	91.0	CHEMBL260	Homo sapiens	INH	%	91.0
	22488265	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1c(Cl)cccc1Cl		CHEMBL4752353	=	Inhibition	%	81.0	CHEMBL260	Homo sapiens	INH	%	81.0
	22488266	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(Cl)c1		CHEMBL4747004	=	Inhibition	%	86.83	CHEMBL260	Homo sapiens	INH	%	86.83
	22488267	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(F)cc1		CHEMBL4788879	=	Inhibition	%	99.7	CHEMBL260	Homo sapiens	INH	%	99.7
	22488268	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Br)cc1		CHEMBL4752592	=	Inhibition	%	87.31	CHEMBL260	Homo sapiens	INH	%	87.31
	22488269	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Cl)cc1		CHEMBL4758017	=	Inhibition	%	87.98	CHEMBL260	Homo sapiens	INH	%	87.98
	22488270	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccccc1		CHEMBL4786728	=	Inhibition	%	99.8	CHEMBL260	Homo sapiens	INH	%	99.8
	22488271	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(O)cc1		CHEMBL4779114	=	Inhibition	%	99.01	CHEMBL260	Homo sapiens	INH	%	99.01
	22488272	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1ccc(S(=O)(=O)NCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(O)c3)ccn2)cc1		CHEMBL4759330	=	Inhibition	%	75.05	CHEMBL260	Homo sapiens	INH	%	75.05
	22488273	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL4749662	=	Inhibition	%	36.5	CHEMBL260	Homo sapiens	INH	%	36.5
	22488274	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(F)c1		CHEMBL4750074	=	Inhibition	%	59.63	CHEMBL260	Homo sapiens	INH	%	59.63
	22488275	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1c(Cl)cccc1Cl		CHEMBL4782604	=	Inhibition	%	38.34	CHEMBL260	Homo sapiens	INH	%	38.34
	22488276	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(Cl)c1		CHEMBL4760381	=	Inhibition	%	47.86	CHEMBL260	Homo sapiens	INH	%	47.86
	22488277	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(F)cc1		CHEMBL4752233	=	Inhibition	%	97.1	CHEMBL260	Homo sapiens	INH	%	97.1
	22488278	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Br)cc1		CHEMBL4740303	=	Inhibition	%	46.78	CHEMBL260	Homo sapiens	INH	%	46.78
	22488279	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Cl)cc1		CHEMBL4744500	=	Inhibition	%	46.6	CHEMBL260	Homo sapiens	INH	%	46.6
	22488280	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccccc1		CHEMBL4753120	=	Inhibition	%	99.7	CHEMBL260	Homo sapiens	INH	%	99.7
	22488281	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1ccc(S(=O)(=O)NCCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(OC)c3)ccn2)cc1		CHEMBL4791720	=	Inhibition	%	89.04	CHEMBL260	Homo sapiens	INH	%	89.04
	22488282	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2)c1		CHEMBL4750885	=	Inhibition	%	96.0	CHEMBL260	Homo sapiens	INH	%	96.0
	22488283	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc(F)c3)c2)c1		CHEMBL4784340	=	Inhibition	%	76.42	CHEMBL260	Homo sapiens	INH	%	76.42
	22488284	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3c(Cl)cccc3Cl)c2)c1		CHEMBL4780305	=	Inhibition	%	65.36	CHEMBL260	Homo sapiens	INH	%	65.36
	22488285	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc(Cl)c3)c2)c1		CHEMBL4784670	=	Inhibition	%	62.45	CHEMBL260	Homo sapiens	INH	%	62.45
	22488286	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(F)cc3)c2)c1		CHEMBL4793652	=	Inhibition	%	78.95	CHEMBL260	Homo sapiens	INH	%	78.95
	22488287	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Br)cc3)c2)c1		CHEMBL4742136	=	Inhibition	%	94.01	CHEMBL260	Homo sapiens	INH	%	94.01
	22488288	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1		CHEMBL4789392	=	Inhibition	%	67.72	CHEMBL260	Homo sapiens	INH	%	67.72
	22488289	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccccc3)c2)c1		CHEMBL4778441	=	Inhibition	%	88.61	CHEMBL260	Homo sapiens	INH	%	88.61
	22488290	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1ccc(S(=O)(=O)NCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(OC)c3)ccn2)cc1		CHEMBL4746239	=	Inhibition	%	61.08	CHEMBL260	Homo sapiens	INH	%	61.08
	22488291	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2)c1		CHEMBL4790581	=	Inhibition	%	90.11	CHEMBL260	Homo sapiens	INH	%	90.11
	22488292	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3cccc(F)c3)c2)c1		CHEMBL4794673	=	Inhibition	%	48.61	CHEMBL260	Homo sapiens	INH	%	48.61
	22488293	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3c(Cl)cccc3Cl)c2)c1		CHEMBL4782039	=	Inhibition	%	34.72	CHEMBL260	Homo sapiens	INH	%	34.72
	22488294	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3cccc(Cl)c3)c2)c1		CHEMBL4781595	=	Inhibition	%	36.31	CHEMBL260	Homo sapiens	INH	%	36.31
	22488295	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(F)cc3)c2)c1		CHEMBL4777802	=	Inhibition	%	50.01	CHEMBL260	Homo sapiens	INH	%	50.01
	22488296	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(Br)cc3)c2)c1		CHEMBL4741705	=	Inhibition	%	90.0	CHEMBL260	Homo sapiens	INH	%	90.0
	22488297	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1		CHEMBL4761222	=	Inhibition	%	35.27	CHEMBL260	Homo sapiens	INH	%	35.27
	22488298	CHEMBL4689219	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system at 10 uM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay relative to control	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccccc3)c2)c1		CHEMBL4785893	=	Inhibition	%	74.42	CHEMBL260	Homo sapiens	INH	%	74.42
	22488299	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(O)cc1		CHEMBL4788985	=	IC50	nM	124.0	CHEMBL260	Homo sapiens	IC50	nM	124.0
	22488300	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1ccc(S(=O)(=O)NCCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(O)c3)ccn2)cc1		CHEMBL4799139	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	22488301	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL4762037	=	IC50	nM	961.0	CHEMBL260	Homo sapiens	IC50	nM	961.0
	22488302	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(F)c1		CHEMBL4742980	=	IC50	nM	321.0	CHEMBL260	Homo sapiens	IC50	nM	321.0
	22488303	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1c(Cl)cccc1Cl		CHEMBL4752353	=	IC50	nM	8250.0	CHEMBL260	Homo sapiens	IC50	nM	8250.0
	22488304	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(Cl)c1		CHEMBL4747004	=	IC50	nM	101.0	CHEMBL260	Homo sapiens	IC50	nM	101.0
	22488305	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(F)cc1		CHEMBL4788879	=	IC50	nM	45.0	CHEMBL260	Homo sapiens	IC50	nM	45.0
	22488306	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Br)cc1		CHEMBL4752592	=	IC50	nM	99.0	CHEMBL260	Homo sapiens	IC50	nM	99.0
	22488307	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Cl)cc1		CHEMBL4758017	=	IC50	nM	120.0	CHEMBL260	Homo sapiens	IC50	nM	120.0
	22488308	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccccc1		CHEMBL4786728	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	22488309	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(O)cc1		CHEMBL4779114	=	IC50	nM	510.0	CHEMBL260	Homo sapiens	IC50	nM	510.0
	22488310	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1ccc(S(=O)(=O)NCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(O)c3)ccn2)cc1		CHEMBL4759330	=	IC50	nM	2160.0	CHEMBL260	Homo sapiens	IC50	nM	2160.0
	22488311	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(C(F)(F)F)cc1		CHEMBL4749662	=	IC50	nM	13210.0	CHEMBL260	Homo sapiens	IC50	nM	13210.0
	22488312	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(F)c1		CHEMBL4750074	=	IC50	nM	8950.0	CHEMBL260	Homo sapiens	IC50	nM	8950.0
	22488313	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1c(Cl)cccc1Cl		CHEMBL4782604	=	IC50	nM	14300.0	CHEMBL260	Homo sapiens	IC50	nM	14300.0
	22488314	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1cccc(Cl)c1		CHEMBL4760381	=	IC50	nM	10200.0	CHEMBL260	Homo sapiens	IC50	nM	10200.0
	22488315	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(F)cc1		CHEMBL4752233	=	IC50	nM	150.0	CHEMBL260	Homo sapiens	IC50	nM	150.0
	22488316	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Br)cc1		CHEMBL4740303	=	IC50	nM	12100.0	CHEMBL260	Homo sapiens	IC50	nM	12100.0
	22488317	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccc(Cl)cc1		CHEMBL4744500	=	IC50	nM	11900.0	CHEMBL260	Homo sapiens	IC50	nM	11900.0
	22488318	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	O=S(=O)(NCCNc1cc(-c2[nH]c(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)c1ccccc1		CHEMBL4753120	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	nM	95.0
	22488319	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1ccc(S(=O)(=O)NCCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(OC)c3)ccn2)cc1		CHEMBL4791720	=	IC50	nM	4120.0	CHEMBL260	Homo sapiens	IC50	nM	4120.0
	22488320	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2)c1		CHEMBL4750885	=	IC50	nM	980.0	CHEMBL260	Homo sapiens	IC50	nM	980.0
	22488321	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc(F)c3)c2)c1		CHEMBL4784340	=	IC50	nM	1150.0	CHEMBL260	Homo sapiens	IC50	nM	1150.0
	22488322	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3c(Cl)cccc3Cl)c2)c1		CHEMBL4780305	=	IC50	nM	6750.0	CHEMBL260	Homo sapiens	IC50	nM	6750.0
	22488323	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc(Cl)c3)c2)c1		CHEMBL4784670	=	IC50	nM	6910.0	CHEMBL260	Homo sapiens	IC50	nM	6910.0
	22488324	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(F)cc3)c2)c1		CHEMBL4793652	=	IC50	nM	3910.0	CHEMBL260	Homo sapiens	IC50	nM	3910.0
	22488325	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Br)cc3)c2)c1		CHEMBL4742136	=	IC50	nM	3520.0	CHEMBL260	Homo sapiens	IC50	nM	3520.0
	22488326	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1		CHEMBL4789392	=	IC50	nM	7850.0	CHEMBL260	Homo sapiens	IC50	nM	7850.0
	22488327	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccccc3)c2)c1		CHEMBL4778441	=	IC50	nM	4980.0	CHEMBL260	Homo sapiens	IC50	nM	4980.0
	22488328	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1ccc(S(=O)(=O)NCCNc2cc(-c3[nH]c(-c4ccccc4)nc3-c3cccc(OC)c3)ccn2)cc1		CHEMBL4746239	=	IC50	nM	8720.0	CHEMBL260	Homo sapiens	IC50	nM	8720.0
	22488329	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(C(F)(F)F)cc3)c2)c1		CHEMBL4790581	=	IC50	nM	1750.0	CHEMBL260	Homo sapiens	IC50	nM	1750.0
	22488330	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3cccc(F)c3)c2)c1		CHEMBL4794673	=	IC50	nM	2540.0	CHEMBL260	Homo sapiens	IC50	nM	2540.0
	22488331	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3c(Cl)cccc3Cl)c2)c1		CHEMBL4782039	=	IC50	nM	8250.0	CHEMBL260	Homo sapiens	IC50	nM	8250.0
	22488332	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3cccc(Cl)c3)c2)c1		CHEMBL4781595	=	IC50	nM	14500.0	CHEMBL260	Homo sapiens	IC50	nM	14500.0
	22488333	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(F)cc3)c2)c1		CHEMBL4777802	=	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	22488334	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(Br)cc3)c2)c1		CHEMBL4741705	=	IC50	nM	3250.0	CHEMBL260	Homo sapiens	IC50	nM	3250.0
	22488335	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1		CHEMBL4761222	=	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	nM	16000.0
	22488336	CHEMBL4689220	Inhibition of recombinant human GST-tagged full length p38a expressed in Escherichia coli expression system using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP by Z'LYTE assay	B	COc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCNS(=O)(=O)c3ccccc3)c2)c1		CHEMBL4785893	=	IC50	nM	7100.0	CHEMBL260	Homo sapiens	IC50	nM	7100.0
	22752741	CHEMBL4700193	Inhibition of human MAPK p38 alpha at 1 uM by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	Inhibition	%	9.0	CHEMBL260	Homo sapiens	INH	%	9.0
Not Determined	22752742	CHEMBL4700193	Inhibition of human MAPK p38 alpha at 1 uM by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	22781873	CHEMBL4707491	Inhibition of p38alpha MAPK (unknown origin) assessed as residual activity at 10 uM	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1ccccc1Br		CHEMBL4794773	=	Activity	%	19.0	CHEMBL260	Homo sapiens	Activity	%	19.0
	22781874	CHEMBL4707492	Inhibition of p38alpha MAPK (unknown origin) assessed as residual activity	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1ccccc1Br		CHEMBL4794773	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	22781875	CHEMBL4707492	Inhibition of p38alpha MAPK (unknown origin) assessed as residual activity	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1cccc2[nH]ccc12		CHEMBL4755877	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	22790988	CHEMBL4709493	Inhibition of P38alpha (unknown origin) assessed as residual activity at 0.1 uM preincubated for 20 min followed by [gamma33P]ATP addition and measured after 120 mins by Hotspot assay relative to control	B	Cc1cccn(-c2ccc(-c3ccc4c(C(=O)NCc5ccncc5)n[nH]c4c3)c(Cl)c2)c1=O		CHEMBL4758500	=	Activity	%	77.96	CHEMBL260	Homo sapiens	Activity	%	77.96
	22798828	CHEMBL4711072	Inhibition of P38alpha (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4789145	=	Inhibition	%	5.21	CHEMBL260	Homo sapiens	INH	%	5.21
	22801736	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Delta Tm	degrees C	19.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	19.8
	22801737	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2ccccc2)n1		CHEMBL312873	=	Delta Tm	degrees C	13.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	13.1
	22801738	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccccc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4790278	=	Delta Tm	degrees C	10.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.3
	22801739	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc3ccccc3c2)n(-c2ccccc2)n1		CHEMBL102547	=	Delta Tm	degrees C	5.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.3
	22801740	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4751695	=	Delta Tm	degrees C	4.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.7
	22801741	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)cc2)n(-c2ccccc2)n1		CHEMBL4741055	=	Delta Tm	degrees C	8.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.9
	22801742	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccccc2)n1		CHEMBL4762688	=	Delta Tm	degrees C	0.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.2
	22801743	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCc3ccccc3)cc2)n(-c2ccccc2)n1		CHEMBL4785824	=	Delta Tm	degrees C	1.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.5
	22801744	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1cc(C)cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4783603	=	Delta Tm	degrees C	4.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.8
	22801745	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(F)cc1NC(=O)Nc1cc(C(C)(C)C)nn1-c1ccccc1		CHEMBL4759399	=	Delta Tm	degrees C	9.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.6
	22801746	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(F)c(F)c2)n(-c2ccccc2)n1		CHEMBL4765042	=	Delta Tm	degrees C	10.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.2
	22801747	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)n(-c2ccccc2)n1		CHEMBL314023	=	Delta Tm	degrees C	10.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.6
	22801748	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(S(=O)(=O)NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL4750748	=	Delta Tm	degrees C	-0.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	-0.4
	22801749	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	COc1cccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)c1		CHEMBL4746299	=	Delta Tm	degrees C	8.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.6
	22801750	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Delta Tm	degrees C	10.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.6
	22801751	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1		CHEMBL4759890	=	Delta Tm	degrees C	0.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.3
	22801752	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4784705	=	Delta Tm	degrees C	1.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.4
	22801753	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4784725	=	Delta Tm	degrees C	0.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.2
	22801754	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4744374	=	Delta Tm	degrees C	0.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.3
	22801755	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(C(C)(C)C)n1		CHEMBL4742158	=	Delta Tm	degrees C	0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.1
	22801756	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4797231	=	Delta Tm	degrees C	0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.1
	22801757	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4787226	=	Delta Tm	degrees C	2.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.2
	22801758	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4777689	=	Delta Tm	degrees C	0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.1
	22801759	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccccc2)n1		CHEMBL4764223	=	Delta Tm	degrees C	7.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.1
	22801760	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cc(F)cc(F)c2)cc1		CHEMBL4741029	=	Delta Tm	degrees C	7.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.0
	22801761	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4754583	=	Delta Tm	degrees C	3.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.0
	22801762	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(F)cc2)n1		CHEMBL4780554	=	Delta Tm	degrees C	5.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.2
	22801763	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4798321	=	Delta Tm	degrees C	5.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.0
	22801764	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(C(C)(C)C)n1		CHEMBL4791471	=	Delta Tm	degrees C	0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.1
	22801765	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2cc(F)cc(F)c2)n(-c2ccc(Br)cc2)n1		CHEMBL4757882	=	Delta Tm	degrees C	1.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.6
	22801766	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Cn1nc(-c2ccccc2)cc1NC(=O)Nc1cc(F)cc(F)c1		CHEMBL4740104	=	Delta Tm	degrees C	0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.1
	22801767	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1cc(F)cc(F)c1)Nc1cc(-c2ccccc2)nn1-c1ccccc1		CHEMBL4789547	=	Delta Tm	degrees C	2.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.8
	22801768	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Delta Tm	degrees C	0.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.4
	22801769	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc([N+](=O)[O-])cc2)n1		CHEMBL4787113	=	Delta Tm	degrees C	1.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.3
	22801770	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(N)cc2)n1		CHEMBL4756419	=	Delta Tm	degrees C	10.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.4
	22801771	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4740208	=	Delta Tm	degrees C	0.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.9
	22801772	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(OC(F)(F)F)cc2)n1		CHEMBL4756465	=	Delta Tm	degrees C	0.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.9
	22801773	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(C#N)cc2)n1		CHEMBL4786417	=	Delta Tm	degrees C	3.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.6
	22801774	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL4757100	=	Delta Tm	degrees C	5.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.6
	22801775	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NC(=O)C3CC3)cc2)n1		CHEMBL4788823	=	Delta Tm	degrees C	2.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.4
	22801776	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccc(NS(C)(=O)=O)cc2)n1		CHEMBL4754044	=	Delta Tm	degrees C	6.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.7
	22801777	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)C(=O)Nc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4782612	=	Delta Tm	degrees C	1.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.5
	22801778	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc(OC(F)(F)F)cc1		CHEMBL4790434	=	Delta Tm	degrees C	0.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.3
	22801779	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	N#Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL4742987	=	Delta Tm	degrees C	0.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.2
	22801780	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C2CC2)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4755558	=	Delta Tm	degrees C	0.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.1
	22801781	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	O=C(Nc1ccc(Cl)cc1)Nc1cc(C(F)(F)F)nn1-c1ccc([N+](=O)[O-])cc1		CHEMBL4794564	=	Delta Tm	degrees C	0.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	0.9
	22801782	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964	=	Delta Tm	degrees C	12.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.9
	22801783	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4784528	=	Delta Tm	degrees C	15.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	15.0
	22801784	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Delta Tm	degrees C	16.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	16.4
	22801785	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4778587	=	Delta Tm	degrees C	13.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	13.7
	22801786	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4797026	=	Delta Tm	degrees C	11.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	11.3
	22801787	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCCCCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4777896	=	Delta Tm	degrees C	7.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.4
	22801788	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCCCCCCCCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4764492	=	Delta Tm	degrees C	4.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.6
	22801789	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCC(C)NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4798320	=	Delta Tm	degrees C	14.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	14.0
	22801790	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCC(CC)NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4789011	=	Delta Tm	degrees C	10.4	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.4
	22801791	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CCC(CO)NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4790863	=	Delta Tm	degrees C	12.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.7
	22801792	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4784037	=	Delta Tm	degrees C	8.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	8.6
	22801793	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4749084	=	Delta Tm	degrees C	9.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.8
	22801794	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCOCC3)cc2)cnn1-c1ccccc1		CHEMBL4796755	=	Delta Tm	degrees C	13.2	CHEMBL260	Homo sapiens	deltaTm	degrees C	13.2
	22801795	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCNCC3)cc2)cnn1-c1ccccc1		CHEMBL4792880	=	Delta Tm	degrees C	12.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.6
	22801796	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	CC(C)(C)OC(=O)N1CCN(C(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnn(-c4ccccc4)c3N)cc2)CC1		CHEMBL4788903	=	Delta Tm	degrees C	5.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.6
	22801797	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3ccc(F)cc3)cc2)cnn1-c1ccccc1		CHEMBL4740565	=	Delta Tm	degrees C	10.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	10.1
	22801798	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3ccc(Cl)cc3)cc2)cnn1-c1ccccc1		CHEMBL4744966	=	Delta Tm	degrees C	7.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.5
	22801799	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3ccc(Br)cc3)cc2)cnn1-c1ccccc1		CHEMBL4755890	=	Delta Tm	degrees C	6.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.8
	22801800	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3cc(F)cc(F)c3)cc2)cnn1-c1ccccc1		CHEMBL4793252	=	Delta Tm	degrees C	7.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.3
	22801801	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3cc(Cl)cc(Cl)c3)cc2)cnn1-c1ccccc1		CHEMBL4794691	=	Delta Tm	degrees C	1.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.9
	22801802	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3cc(Br)cc(Br)c3)cc2)cnn1-c1ccccc1		CHEMBL4794195	=	Delta Tm	degrees C	2.3	CHEMBL260	Homo sapiens	deltaTm	degrees C	2.3
	22801803	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccccc3)cc2)cnn1-c1ccccc1		CHEMBL4760071	=	Delta Tm	degrees C	7.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.8
	22801804	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccc(Cl)cc3)cc2)cnn1-c1ccccc1		CHEMBL4750197	=	Delta Tm	degrees C	3.5	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.5
	22801805	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCCc3ccc(Cl)cc3)cc2)cnn1-c1ccccc1		CHEMBL4764177	=	Delta Tm	degrees C	5.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	5.1
	22801806	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccncc3)cc2)cnn1-c1ccccc1		CHEMBL4745922	=	Delta Tm	degrees C	14.7	CHEMBL260	Homo sapiens	deltaTm	degrees C	14.7
	22801807	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3cccnc3)cc2)cnn1-c1ccccc1		CHEMBL4795752	=	Delta Tm	degrees C	13.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	13.9
	22801808	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccccn3)cc2)cnn1-c1ccccc1		CHEMBL4779203	=	Delta Tm	degrees C	12.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	12.6
	22801809	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3cccs3)cc2)cnn1-c1ccccc1		CHEMBL4746375	=	Delta Tm	degrees C	6.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.1
	22801810	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4ccc(Cl)cc4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4778098	=	Delta Tm	degrees C	4.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.8
	22801811	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4ccc(Br)cc4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4761242	=	Delta Tm	degrees C	3.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.1
	22801812	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4nc5ccccc5s4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4787756	=	Delta Tm	degrees C	3.6	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.6
	22801813	CHEMBL4711692	Inhibition of p38alpha (unknown origin) assessed as change in melting temperature at 10 uM by DSF assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4nc5ccccc5o4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4780033	=	Delta Tm	degrees C	6.0	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.0
	22802090	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	7.7	CHEMBL260	Homo sapiens	IC50	nM	7.7
	22802091	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL3939964	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	22802092	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4784528	=	IC50	nM	21.9	CHEMBL260	Homo sapiens	IC50	nM	21.9
	22802093	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	nM	14.0
	22802094	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4778587	=	IC50	nM	17.7	CHEMBL260	Homo sapiens	IC50	nM	17.7
	22802095	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4797026	=	IC50	nM	33.7	CHEMBL260	Homo sapiens	IC50	nM	33.7
	22802096	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCCCCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4777896	=	IC50	nM	9520.0	CHEMBL260	Homo sapiens	IC50	nM	9520.0
	22802097	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCCCCCCCCCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4764492	=	IC50	nM	2070.0	CHEMBL260	Homo sapiens	IC50	nM	2070.0
	22802098	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCC(C)NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4798320	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	nM	20.0
	22802099	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCC(CC)NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4789011	=	IC50	nM	37.6	CHEMBL260	Homo sapiens	IC50	nM	37.6
	22802100	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCC(CO)NC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4790863	=	IC50	nM	38.2	CHEMBL260	Homo sapiens	IC50	nM	38.2
	22802101	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CC(C)CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4784037	=	IC50	nM	93.7	CHEMBL260	Homo sapiens	IC50	nM	93.7
	22802102	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4749084	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	nM	47.0
	22802103	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCOCC3)cc2)cnn1-c1ccccc1		CHEMBL4796755	=	IC50	nM	44.8	CHEMBL260	Homo sapiens	IC50	nM	44.8
	22802104	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCNCC3)cc2)cnn1-c1ccccc1		CHEMBL4792880	=	IC50	nM	81.3	CHEMBL260	Homo sapiens	IC50	nM	81.3
	22802105	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3ccc(F)cc3)cc2)cnn1-c1ccccc1		CHEMBL4740565	=	IC50	nM	22.1	CHEMBL260	Homo sapiens	IC50	nM	22.1
	22802106	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3ccc(Cl)cc3)cc2)cnn1-c1ccccc1		CHEMBL4744966	=	IC50	nM	107.0	CHEMBL260	Homo sapiens	IC50	nM	107.0
	22802107	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3ccc(Br)cc3)cc2)cnn1-c1ccccc1		CHEMBL4755890	=	IC50	nM	94.4	CHEMBL260	Homo sapiens	IC50	nM	94.4
	22802108	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3cc(F)cc(F)c3)cc2)cnn1-c1ccccc1		CHEMBL4793252	=	IC50	nM	41.1	CHEMBL260	Homo sapiens	IC50	nM	41.1
	22802109	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3cc(Cl)cc(Cl)c3)cc2)cnn1-c1ccccc1		CHEMBL4794691	=	IC50	nM	1990.0	CHEMBL260	Homo sapiens	IC50	nM	1990.0
	22802110	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)Nc3cc(Br)cc(Br)c3)cc2)cnn1-c1ccccc1		CHEMBL4794195	=	IC50	nM	2830.0	CHEMBL260	Homo sapiens	IC50	nM	2830.0
	22802111	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccccc3)cc2)cnn1-c1ccccc1		CHEMBL4760071	=	IC50	nM	543.0	CHEMBL260	Homo sapiens	IC50	nM	543.0
	22802112	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccc(Cl)cc3)cc2)cnn1-c1ccccc1		CHEMBL4750197	=	IC50	nM	287.0	CHEMBL260	Homo sapiens	IC50	nM	287.0
	22802113	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCCc3ccc(Cl)cc3)cc2)cnn1-c1ccccc1		CHEMBL4764177	=	IC50	nM	144.0	CHEMBL260	Homo sapiens	IC50	nM	144.0
	22802114	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccncc3)cc2)cnn1-c1ccccc1		CHEMBL4745922	=	IC50	nM	21.7	CHEMBL260	Homo sapiens	IC50	nM	21.7
	22802115	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3cccnc3)cc2)cnn1-c1ccccc1		CHEMBL4795752	=	IC50	nM	32.9	CHEMBL260	Homo sapiens	IC50	nM	32.9
	22802116	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3ccccn3)cc2)cnn1-c1ccccc1		CHEMBL4779203	=	IC50	nM	25.2	CHEMBL260	Homo sapiens	IC50	nM	25.2
	22802117	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)NCc3cccs3)cc2)cnn1-c1ccccc1		CHEMBL4746375	=	IC50	nM	81.3	CHEMBL260	Homo sapiens	IC50	nM	81.3
	22802118	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4ccc(Cl)cc4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4778098	=	IC50	nM	1770.0	CHEMBL260	Homo sapiens	IC50	nM	1770.0
	22802119	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4ccc(Br)cc4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4761242	=	IC50	nM	2390.0	CHEMBL260	Homo sapiens	IC50	nM	2390.0
	22802120	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4nc5ccccc5s4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4787756	=	IC50	nM	1040.0	CHEMBL260	Homo sapiens	IC50	nM	1040.0
	22802121	CHEMBL4711699	Inhibition of C-terminal NanoLuc-fused full length human MAPK14 expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)N[C@@H](CCC3CCCCC3)C(=O)N3CCN(c4nc5ccccc5o4)CC3)cc2)cnn1-c1ccccc1		CHEMBL4780033	=	IC50	nM	462.0	CHEMBL260	Homo sapiens	IC50	nM	462.0
	22802125	CHEMBL4711703	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Activity	%	1.5	CHEMBL260	Homo sapiens	Activity	%	1.5
	22802136	CHEMBL4711714	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system by Kinomescan method	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	Kd	nM	6.3	CHEMBL260	Homo sapiens	Kd	uM	0.0063
	22802162	CHEMBL4711737	Inhibition of C-terminal NanoLuc-fused full length p38alpha (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	CCNC(=O)[C@H](CCC1CCCCC1)NC(=O)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2N)cc1		CHEMBL4756586	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.013999999999999999
	22809778	CHEMBL4713313	Inhibition of recombinant full length human SAPK2a assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	22820580	CHEMBL4716292	Inhibition of N-terminal GST-tagged recombinant full length human SAPK2a expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	91.0	CHEMBL260	Homo sapiens	Activity	%	91.0
	22820581	CHEMBL4716292	Inhibition of N-terminal GST-tagged recombinant full length human SAPK2a expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	101.0	CHEMBL260	Homo sapiens	Activity	%	101.0
	22836312	CHEMBL4718874	Inhibition of recombinant human GST-tagged full length MAPK14 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	13.0	CHEMBL260	Homo sapiens	INH	%	13.0
	22836313	CHEMBL4718874	Inhibition of recombinant human GST-tagged full length MAPK14 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	14.0	CHEMBL260	Homo sapiens	INH	%	14.0
	22836314	CHEMBL4718874	Inhibition of recombinant human GST-tagged full length MAPK14 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	20.0	CHEMBL260	Homo sapiens	INH	%	20.0
	22836315	CHEMBL4718874	Inhibition of recombinant human GST-tagged full length MAPK14 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	10.0	CHEMBL260	Homo sapiens	INH	%	10.0
	22836316	CHEMBL4718874	Inhibition of recombinant human GST-tagged full length MAPK14 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	24.0	CHEMBL260	Homo sapiens	INH	%	24.0
	22836317	CHEMBL4718874	Inhibition of recombinant human GST-tagged full length MAPK14 expressed in Escherichia coli expression system at 500 nM using Ser/Thr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	19.0	CHEMBL260	Homo sapiens	INH	%	19.0
	22843981	CHEMBL4720967	Inhibition of human p38alpha assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	90.39	CHEMBL260	Homo sapiens	Activity	%	90.39
	22844802	CHEMBL4721477	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.88	CHEMBL260	Homo sapiens	Activity	%	99.88
	22845470	CHEMBL4721751	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	9.06	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.06
	22845491	CHEMBL4721772	Binding affinity to MAPK14 (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	<	IC50	nM	10.0	CHEMBL260	Homo sapiens	IC50	nM	10.0
	22845511	CHEMBL4721792	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by isothermal NaLTSA assay	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Delta Tm	degrees C	1.17	CHEMBL260	Homo sapiens	deltaTm	degrees C	1.17
	22845512	CHEMBL4721792	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by isothermal NaLTSA assay	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Delta Tm	degrees C	3.43	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.43
	22845513	CHEMBL4721792	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by isothermal NaLTSA assay	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Delta Tm	degrees C	3.05	CHEMBL260	Homo sapiens	deltaTm	degrees C	3.05
	22845514	CHEMBL4721792	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by isothermal NaLTSA assay	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Delta Tm	degrees C	4.9	CHEMBL260	Homo sapiens	deltaTm	degrees C	4.9
	22845515	CHEMBL4721792	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by isothermal NaLTSA assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Delta Tm	degrees C	7.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	7.8
	22845516	CHEMBL4721792	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by isothermal NaLTSA assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Delta Tm	degrees C	6.8	CHEMBL260	Homo sapiens	deltaTm	degrees C	6.8
	22845517	CHEMBL4721792	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by isothermal NaLTSA assay	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	Delta Tm	degrees C	9.1	CHEMBL260	Homo sapiens	deltaTm	degrees C	9.1
Not Active	22845518	CHEMBL4721793	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by NaLTSA assay (Rvb = 50.2 degreeC)	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436		Tm			CHEMBL260	Homo sapiens	Tm		
	22845519	CHEMBL4721793	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by NaLTSA assay (Rvb = 50.2 degreeC)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Tm	degrees C	56.8	CHEMBL260	Homo sapiens	Tm	degrees C	56.8
	22845520	CHEMBL4721793	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as change in melting temperature at 50 uM by NaLTSA assay (Rvb = 50.2 degreeC)	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	Tm	degrees C	59.0	CHEMBL260	Homo sapiens	Tm	degrees C	59.0
	22845521	CHEMBL4721794	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as percentage of stability at 10 uM incubated for 3 mins by isothermal NaLTSA assay (Rvb = 32 +/- 2.1 %)	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	41.0	CHEMBL260	Homo sapiens	Activity	%	41.0
	22845522	CHEMBL4721794	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as percentage of stability at 10 uM incubated for 3 mins by isothermal NaLTSA assay (Rvb = 32 +/- 2.1 %)	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Activity	%	41.0	CHEMBL260	Homo sapiens	Activity	%	41.0
	22845523	CHEMBL4721794	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as percentage of stability at 10 uM incubated for 3 mins by isothermal NaLTSA assay (Rvb = 32 +/- 2.1 %)	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	41.0	CHEMBL260	Homo sapiens	Activity	%	41.0
	22845524	CHEMBL4721794	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as percentage of stability at 10 uM incubated for 3 mins by isothermal NaLTSA assay (Rvb = 32 +/- 2.1 %)	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	41.0	CHEMBL260	Homo sapiens	Activity	%	41.0
	22845525	CHEMBL4721794	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as percentage of stability at 10 uM incubated for 3 mins by isothermal NaLTSA assay (Rvb = 32 +/- 2.1 %)	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	79.0	CHEMBL260	Homo sapiens	Activity	%	79.0
	22845526	CHEMBL4721794	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as percentage of stability at 10 uM incubated for 3 mins by isothermal NaLTSA assay (Rvb = 32 +/- 2.1 %)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	75.0	CHEMBL260	Homo sapiens	Activity	%	75.0
	22845527	CHEMBL4721794	Binding affinity to Nluc-tagged MAPK14 (unknown origin) expressed in HeLa cells assessed as percentage of stability at 10 uM incubated for 3 mins by isothermal NaLTSA assay (Rvb = 32 +/- 2.1 %)	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	Activity	%	90.0	CHEMBL260	Homo sapiens	Activity	%	90.0
	22853408	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	-46.0	CHEMBL260	Homo sapiens	Activity	%	-46.0
	22853409	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Activity	%	17.0	CHEMBL260	Homo sapiens	Activity	%	17.0
	22853410	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CN1CCN(CCCOc2ccc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3c2)CC1		CHEMBL4749477	=	Activity	%	-4.0	CHEMBL260	Homo sapiens	Activity	%	-4.0
	22853411	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1)c1ccc(CNCCO)cc1		CHEMBL4782561	=	Activity	%	-5.0	CHEMBL260	Homo sapiens	Activity	%	-5.0
	22853412	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	Cc1cccc(Oc2ccc(Nc3ncnc4ccc(NC(=O)CNCCO)cc34)cc2Cl)c1		CHEMBL4753194	=	Activity	%	13.0	CHEMBL260	Homo sapiens	Activity	%	13.0
	22853413	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1		CHEMBL4777529	=	Activity	%	-14.0	CHEMBL260	Homo sapiens	Activity	%	-14.0
	22853414	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4757576	=	Activity	%	-1.0	CHEMBL260	Homo sapiens	Activity	%	-1.0
	22853415	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL3637894	=	Activity	%	19.0	CHEMBL260	Homo sapiens	Activity	%	19.0
	22853416	CHEMBL4724259	Effect on human recombinant N-terminal GST-tagged p38alpha expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CNCCO)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4783947	=	Activity	%	13.0	CHEMBL260	Homo sapiens	Activity	%	13.0
	22855113	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2cc(C(=O)NC3CNC3)cs2)c1)Nc1ccccc1Cl		CHEMBL4777114	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855114	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	Cc1sc(C(=O)N[C@@H]2CCOC2)cc1-n1cc(NC(=O)Nc2c(F)cccc2Cl)cn1		CHEMBL4749547	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855115	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	Cc1sc(C(=O)NC2COC2)cc1-n1cc(NC(=O)Nc2c(F)cccc2Cl)cn1		CHEMBL4784092	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855116	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NC3COC3)c2)c1)Nc1ccc(F)cc1Cl		CHEMBL4754908	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855117	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NC3COC3)c2)c1)Nc1c(F)cccc1Cl		CHEMBL4778645	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855118	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NCC3CCOCC3)c2)c1)Nc1ccccc1Cl		CHEMBL4744992	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855119	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CN1CCC[C@H]1CNC(=O)c1cc(-n2cc(NC(=O)Nc3ccccc3Cl)cn2)cs1		CHEMBL4798047	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855120	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NC[C@H]3CCOC3)c2)c1)Nc1ccccc1Cl		CHEMBL4755895	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855121	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CN1CC[C@H](CNC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)C1		CHEMBL4753218	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855122	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NCC3CCNCC3)c2)c1)Nc1ccccc1Cl		CHEMBL4788258	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855123	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CN1CCC(CNC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)CC1		CHEMBL4754031	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855124	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CC1(NC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)COC1		CHEMBL4758113	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855125	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NC3COC3)c2)c1)Nc1ccccc1Cl		CHEMBL4753641	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855126	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)N[C@@H]3CCOC3)c2)c1)Nc1ccccc1Cl		CHEMBL4753310	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855127	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NC3CCOCC3)c2)c1)Nc1ccccc1Cl		CHEMBL4762965	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855128	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CN1CCC(NC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)CC1		CHEMBL4759538	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855129	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CC(C)N1CC[C@H](NC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)C1		CHEMBL4784095	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855130	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CN1CC[C@H](NC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)C1		CHEMBL4754584	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855131	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	[2H]C([2H])([2H])N1CC[C@@H](NC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)C1		CHEMBL4799926	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855132	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CN1CC[C@@H](NC(=O)c2cc(-n3cc(NC(=O)Nc4ccccc4Cl)cn3)cs2)C1		CHEMBL4745961	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855133	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)N[C@@H]3CCNC3)c2)c1)Nc1ccccc1Cl		CHEMBL4758690	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855134	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NC3CC3)c2)c1)Nc1ccccc1Cl		CHEMBL4793809	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855135	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	CNC(=O)c1cc(-n2cc(NC(=O)Nc3ccccc3Cl)cn2)cs1		CHEMBL4757583	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22855136	CHEMBL4724645	Inhibition of P38alpha (unknown origin)	B	O=C(Nc1cnn(-c2csc(C(=O)NC3CNC3)c2)c1)Nc1ccccc1Cl		CHEMBL4783382	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	uM	20.0
	22874815	CHEMBL4725506	Inhibition of human p38alpha assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	-6.0	CHEMBL260	Homo sapiens	Activity	%	-6.0
	22874849	CHEMBL4725540	Inhibition of human p38alpha assessed as remaining enzyme activity at 0.1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	52.0	CHEMBL260	Homo sapiens	Activity	%	52.0
	22874875	CHEMBL4725566	Inhibition of human p38alpha assessed as remaining enzyme activity at 0.01 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	22875504	CHEMBL4725738	Inhibition of P38 alpha MAPK (unknown origin)	B	CC(=O)Nc1ccc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)cn1		CHEMBL4747276	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	nM	500.0
	22881402	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccncc1=O		CHEMBL4758388	=	IC50	nM	5011.87	CHEMBL260	Homo sapiens	pIC50		5.3
	22881403	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N)c1=O		CHEMBL4758465	=	IC50	nM	5011.87	CHEMBL260	Homo sapiens	pIC50		5.3
	22881404	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	CNc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4798384	=	IC50	nM	794.33	CHEMBL260	Homo sapiens	pIC50		6.1
	22881405	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NC2CC2)c1=O		CHEMBL4741003	=	IC50	nM	398.11	CHEMBL260	Homo sapiens	pIC50		6.4
	22881406	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(Nc2ccccc2)c1=O		CHEMBL4794174	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	pIC50		7.0
	22881407	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCc2ccccc2)c1=O		CHEMBL4741213	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	22881408	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N(C)Cc2ccccc2)c1=O		CHEMBL4780420	=	IC50	nM	251.19	CHEMBL260	Homo sapiens	pIC50		6.6
	22881409	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCC2CCCCC2)c1=O		CHEMBL4764210	=	IC50	nM	79.43	CHEMBL260	Homo sapiens	pIC50		7.1
	22881410	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCCc2ccccc2)c1=O		CHEMBL4751865	=	IC50	nM	50.12	CHEMBL260	Homo sapiens	pIC50		7.3
	22881411	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@H](C)c2ccccc2)c1=O		CHEMBL4754593	=	IC50	nM	15.85	CHEMBL260	Homo sapiens	pIC50		7.8
	22881412	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](C)c2ccccc2)c1=O		CHEMBL4756240	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
	22881413	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N2CCCC2c2ccccc2)c1=O		CHEMBL4757282	=	IC50	nM	10.0	CHEMBL260	Homo sapiens	pIC50		8.0
	22881414	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H]2CCCc3ccccc32)c1=O		CHEMBL4761548	=	IC50	nM	31.62	CHEMBL260	Homo sapiens	pIC50		7.5
	22881415	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	CC[C@@H](Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O)c1ccccc1		CHEMBL4779799	=	IC50	nM	1.259	CHEMBL260	Homo sapiens	pIC50		8.9
	22881416	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NC(C)(C)c2ccccc2)c1=O		CHEMBL4777646	=	IC50	nM	6.31	CHEMBL260	Homo sapiens	pIC50		8.2
	22881417	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	COc1ccccc1CNc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4791615	=	IC50	nM	12.59	CHEMBL260	Homo sapiens	pIC50		7.9
	22881418	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	COc1cccc(CNc2nccn(-c3cc(C(=O)NC4CC4)ccc3C)c2=O)c1		CHEMBL4789572	=	IC50	nM	63.1	CHEMBL260	Homo sapiens	pIC50		7.2
	22881419	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	COc1ccc(CNc2nccn(-c3cc(C(=O)NC4CC4)ccc3C)c2=O)cc1		CHEMBL4743808	=	IC50	nM	794.33	CHEMBL260	Homo sapiens	pIC50		6.1
	22881420	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CO)c1=O		CHEMBL4756277	=	IC50	nM	2.512	CHEMBL260	Homo sapiens	pIC50		8.6
	22881421	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN(C)C)c1=O		CHEMBL4747984	=	IC50	nM	1.585	CHEMBL260	Homo sapiens	pIC50		8.8
	22881422	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCCCC2)c1=O		CHEMBL4763279	=	IC50	nM	1.585	CHEMBL260	Homo sapiens	pIC50		8.8
	22881423	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCOCC2)c1=O		CHEMBL4790176	=	IC50	nM	1.259	CHEMBL260	Homo sapiens	pIC50		8.9
	22881424	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCNCC2)c1=O		CHEMBL4764056	=	IC50	nM	0.1995	CHEMBL260	Homo sapiens	pIC50		9.7
	22881425	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCN[C@H](C)C2)c1=O		CHEMBL4764499	=	IC50	nM	0.2512	CHEMBL260	Homo sapiens	pIC50		9.6
	22881426	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCN[C@@H](C)C2)c1=O		CHEMBL4750120	=	IC50	nM	0.631	CHEMBL260	Homo sapiens	pIC50		9.2
	22881427	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCN(C)CC2)c1=O		CHEMBL4757835	=	IC50	nM	1.995	CHEMBL260	Homo sapiens	pIC50		8.7
	22881428	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCc2ccccc2OCCN2CCCC2)c1=O		CHEMBL4759781	=	IC50	nM	31.62	CHEMBL260	Homo sapiens	pIC50		7.5
	22881429	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	CC[C@@H](Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O)c1ccccc1OCCN1CCCC1		CHEMBL4786381	=	IC50	nM	0.631	CHEMBL260	Homo sapiens	pIC50		9.2
	22881430	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NC(C)(C)c2ccccc2OCCN2CCCC2)c1=O		CHEMBL4760873	=	IC50	nM	0.3162	CHEMBL260	Homo sapiens	pIC50		9.5
	22881431	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	CNCCOc1ccccc1C(C)(C)Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4792347	=	IC50	nM	0.2512	CHEMBL260	Homo sapiens	pIC50		9.6
	22881432	CHEMBL4727214	Inhibition of p38alpha MAPK (unknown origin)	B	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031465	=	IC50	nM	19.95	CHEMBL260	Homo sapiens	pIC50		7.7
Not Determined	22881585	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccncc1=O		CHEMBL4758388		pIC50			CHEMBL260	Homo sapiens	pIC50		
Not Determined	22881586	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N)c1=O		CHEMBL4758465		pIC50			CHEMBL260	Homo sapiens	pIC50		
Not Determined	22881587	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	CNc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4798384		pIC50			CHEMBL260	Homo sapiens	pIC50		
Not Determined	22881588	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NC2CC2)c1=O		CHEMBL4741003		pIC50			CHEMBL260	Homo sapiens	pIC50		
Not Determined	22881589	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(Nc2ccccc2)c1=O		CHEMBL4794174		pIC50			CHEMBL260	Homo sapiens	pIC50		
	22881590	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCc2ccccc2)c1=O		CHEMBL4741213	=	IC50	nM	251.19	CHEMBL260	Homo sapiens	pIC50		6.6
Not Determined	22881591	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N(C)Cc2ccccc2)c1=O		CHEMBL4780420		pIC50			CHEMBL260	Homo sapiens	pIC50		
	22881592	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCC2CCCCC2)c1=O		CHEMBL4764210	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
Not Determined	22881593	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCCc2ccccc2)c1=O		CHEMBL4751865		pIC50			CHEMBL260	Homo sapiens	pIC50		
	22881594	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@H](C)c2ccccc2)c1=O		CHEMBL4754593	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	pIC50		7.0
Not Determined	22881595	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](C)c2ccccc2)c1=O		CHEMBL4756240		pIC50			CHEMBL260	Homo sapiens	pIC50		
	22881596	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N2CCCC2c2ccccc2)c1=O		CHEMBL4757282	=	IC50	nM	199.53	CHEMBL260	Homo sapiens	pIC50		6.7
Not Determined	22881597	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H]2CCCc3ccccc32)c1=O		CHEMBL4761548		pIC50			CHEMBL260	Homo sapiens	pIC50		
	22881598	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	CC[C@@H](Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O)c1ccccc1		CHEMBL4779799	=	IC50	nM	15.85	CHEMBL260	Homo sapiens	pIC50		7.8
	22881599	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NC(C)(C)c2ccccc2)c1=O		CHEMBL4777646	=	IC50	nM	39.81	CHEMBL260	Homo sapiens	pIC50		7.4
	22881600	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	COc1ccccc1CNc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4791615	=	IC50	nM	79.43	CHEMBL260	Homo sapiens	pIC50		7.1
	22881601	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	COc1cccc(CNc2nccn(-c3cc(C(=O)NC4CC4)ccc3C)c2=O)c1		CHEMBL4789572	=	IC50	nM	251.19	CHEMBL260	Homo sapiens	pIC50		6.6
Not Determined	22881602	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	COc1ccc(CNc2nccn(-c3cc(C(=O)NC4CC4)ccc3C)c2=O)cc1		CHEMBL4743808		pIC50			CHEMBL260	Homo sapiens	pIC50		
	22881603	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CO)c1=O		CHEMBL4756277	=	IC50	nM	79.43	CHEMBL260	Homo sapiens	pIC50		7.1
	22881604	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN(C)C)c1=O		CHEMBL4747984	=	IC50	nM	19.95	CHEMBL260	Homo sapiens	pIC50		7.7
	22881605	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCCCC2)c1=O		CHEMBL4763279	=	IC50	nM	3.981	CHEMBL260	Homo sapiens	pIC50		8.4
	22881606	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCOCC2)c1=O		CHEMBL4790176	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
	22881607	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCNCC2)c1=O		CHEMBL4764056	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	pIC50		7.0
	22881608	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCN[C@H](C)C2)c1=O		CHEMBL4764499	=	IC50	nM	39.81	CHEMBL260	Homo sapiens	pIC50		7.4
	22881609	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCN[C@@H](C)C2)c1=O		CHEMBL4750120	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	pIC50		7.0
	22881610	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(N[C@@H](c2ccccc2)[C@@H](C)CN2CCN(C)CC2)c1=O		CHEMBL4757835	=	IC50	nM	25.12	CHEMBL260	Homo sapiens	pIC50		7.6
Not Determined	22881611	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NCc2ccccc2OCCN2CCCC2)c1=O		CHEMBL4759781		pIC50			CHEMBL260	Homo sapiens	pIC50		
	22881612	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	CC[C@@H](Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O)c1ccccc1OCCN1CCCC1		CHEMBL4786381	=	IC50	nM	12.59	CHEMBL260	Homo sapiens	pIC50		7.9
	22881613	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1ccnc(NC(C)(C)c2ccccc2OCCN2CCCC2)c1=O		CHEMBL4760873	=	IC50	nM	6.31	CHEMBL260	Homo sapiens	pIC50		8.2
	22881614	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	CNCCOc1ccccc1C(C)(C)Nc1nccn(-c2cc(C(=O)NC3CC3)ccc2C)c1=O		CHEMBL4792347	=	IC50	nM	6.31	CHEMBL260	Homo sapiens	pIC50		8.2
	22881615	CHEMBL4727238	Inhibition of p38alpha in human PBMC assessed as increase in LPS-induced ATF2 phosphorylation stimulated with LPS for 35 mins followed by compound treatment measured after 1 hr in presence of ATP by Western blot analysis	B	Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O		CHEMBL2031465	=	IC50	nM	50.12	CHEMBL260	Homo sapiens	pIC50		7.3
Not Active	22889536	CHEMBL4729055	Inhibition of wild-type human full length p38-alpha (M1 to S360 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	22908785	CHEMBL4733717	Inhibition of p38alpha (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1		CHEMBL4749204	=	Inhibition	%	5.63	CHEMBL260	Homo sapiens	INH	%	5.63
	22929197	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccccc3)n2)ccc1F		CHEMBL4794565	=	Inhibition	%	83.51	CHEMBL260	Homo sapiens	INH	%	83.51
	22929198	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)n2)ccc1F		CHEMBL4746338	=	Inhibition	%	72.79	CHEMBL260	Homo sapiens	INH	%	72.79
	22929199	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Br)cc3)n2)ccc1F		CHEMBL4794906	=	Inhibition	%	73.37	CHEMBL260	Homo sapiens	INH	%	73.37
	22929200	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(F)cc3)n2)ccc1F		CHEMBL4779622	=	Inhibition	%	84.13	CHEMBL260	Homo sapiens	INH	%	84.13
	22929201	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(C(F)(F)F)cc3)n2)ccc1F		CHEMBL4779348	=	Inhibition	%	48.6	CHEMBL260	Homo sapiens	INH	%	48.6
	22929202	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc(F)c3)n2)ccc1F		CHEMBL4782899	=	Inhibition	%	82.67	CHEMBL260	Homo sapiens	INH	%	82.67
	22929203	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(C)cc3)n2)ccc1F		CHEMBL4760933	=	Inhibition	%	79.36	CHEMBL260	Homo sapiens	INH	%	79.36
	22929204	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(F)c(OC)c3)n2)cc1		CHEMBL4755041	=	Inhibition	%	88.54	CHEMBL260	Homo sapiens	INH	%	88.54
	22929205	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc4ccccc34)n2)ccc1F		CHEMBL4746539	=	Inhibition	%	44.4	CHEMBL260	Homo sapiens	INH	%	44.4
	22929206	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccccc3)n2)ccc1Cl		CHEMBL4748856	=	Inhibition	%	58.62	CHEMBL260	Homo sapiens	INH	%	58.62
	22929207	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Cl)cc3)n2)ccc1Cl		CHEMBL4744544	=	Inhibition	%	52.13	CHEMBL260	Homo sapiens	INH	%	52.13
	22929208	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(Br)cc3)n2)ccc1Cl		CHEMBL4786909	=	Inhibition	%	30.0	CHEMBL260	Homo sapiens	INH	%	30.0
	22929209	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(F)cc3)n2)ccc1Cl		CHEMBL4758198	=	Inhibition	%	62.07	CHEMBL260	Homo sapiens	INH	%	62.07
	22929210	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(C(F)(F)F)cc3)n2)ccc1Cl		CHEMBL4741479	=	Inhibition	%	18.87	CHEMBL260	Homo sapiens	INH	%	18.87
	22929211	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc(F)c3)n2)ccc1Cl		CHEMBL4797722	=	Inhibition	%	58.28	CHEMBL260	Homo sapiens	INH	%	58.28
	22929212	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3ccc(C)cc3)n2)ccc1Cl		CHEMBL4788069	=	Inhibition	%	50.43	CHEMBL260	Homo sapiens	INH	%	50.43
	22929213	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(Cl)c(OC)c3)n2)cc1		CHEMBL4790449	=	Inhibition	%	54.56	CHEMBL260	Homo sapiens	INH	%	54.56
	22929214	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc(NCCCNS(=O)(=O)c3cccc4ccccc34)n2)ccc1Cl		CHEMBL4791204	=	Inhibition	%	27.11	CHEMBL260	Homo sapiens	INH	%	27.11
	22929215	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1ccccc1		CHEMBL4758203	=	Inhibition	%	87.01	CHEMBL260	Homo sapiens	INH	%	87.01
	22929216	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1ccc(Cl)cc1		CHEMBL4756617	=	Inhibition	%	84.89	CHEMBL260	Homo sapiens	INH	%	84.89
	22929217	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1ccc(Br)cc1		CHEMBL4755378	=	Inhibition	%	84.79	CHEMBL260	Homo sapiens	INH	%	84.79
	22929218	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1ccc(F)cc1		CHEMBL4763545	=	Inhibition	%	91.43	CHEMBL260	Homo sapiens	INH	%	91.43
	22929219	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1ccc(C(F)(F)F)cc1		CHEMBL4749455	=	Inhibition	%	65.42	CHEMBL260	Homo sapiens	INH	%	65.42
	22929220	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1cccc(F)c1		CHEMBL4794140	=	Inhibition	%	90.45	CHEMBL260	Homo sapiens	INH	%	90.45
	22929221	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	Cc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(F)c(O)c3)n2)cc1		CHEMBL4779919	=	Inhibition	%	87.85	CHEMBL260	Homo sapiens	INH	%	87.85
	22929222	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(F)c(O)c3)n2)cc1		CHEMBL4793723	=	Inhibition	%	92.8	CHEMBL260	Homo sapiens	INH	%	92.8
	22929223	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1cccc2ccccc12		CHEMBL4761938	=	Inhibition	%	79.77	CHEMBL260	Homo sapiens	INH	%	79.77
	22929224	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1ccccc1		CHEMBL4797100	=	Inhibition	%	82.22	CHEMBL260	Homo sapiens	INH	%	82.22
	22929225	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1ccc(Cl)cc1		CHEMBL4758191	=	Inhibition	%	70.76	CHEMBL260	Homo sapiens	INH	%	70.76
	22929226	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1ccc(Br)cc1		CHEMBL4756408	=	Inhibition	%	73.74	CHEMBL260	Homo sapiens	INH	%	73.74
	22929227	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1ccc(F)cc1		CHEMBL4800295	=	Inhibition	%	85.53	CHEMBL260	Homo sapiens	INH	%	85.53
	22929228	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1ccc(C(F)(F)F)cc1		CHEMBL4759618	=	Inhibition	%	54.31	CHEMBL260	Homo sapiens	INH	%	54.31
	22929229	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1cccc(F)c1		CHEMBL4795144	=	Inhibition	%	78.56	CHEMBL260	Homo sapiens	INH	%	78.56
	22929230	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	Cc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(Cl)c(O)c3)n2)cc1		CHEMBL4763666	=	Inhibition	%	70.85	CHEMBL260	Homo sapiens	INH	%	70.85
	22929231	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	COc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(Cl)c(O)c3)n2)cc1		CHEMBL4741154	=	Inhibition	%	77.62	CHEMBL260	Homo sapiens	INH	%	77.62
	22929232	CHEMBL4738305	Inhibition of p38 alpha (unknown origin) at 10 uM using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay relative to control	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1cccc2ccccc12		CHEMBL4747070	=	Inhibition	%	51.09	CHEMBL260	Homo sapiens	INH	%	51.09
	22929245	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1ccccc1		CHEMBL4758203	=	IC50	nM	210.0	CHEMBL260	Homo sapiens	IC50	nM	210.0
	22929246	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1ccc(Br)cc1		CHEMBL4755378	=	IC50	nM	330.0	CHEMBL260	Homo sapiens	IC50	nM	330.0
	22929247	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)c(O)c2)n1)c1cccc(F)c1		CHEMBL4794140	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	nM	140.0
	22929248	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	Cc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(F)c(O)c3)n2)cc1		CHEMBL4779919	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	22929249	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	COc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(F)c(O)c3)n2)cc1		CHEMBL4793723	=	IC50	nM	85.0	CHEMBL260	Homo sapiens	IC50	nM	85.0
Not Determined	22929250	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1ccccc1		CHEMBL4797100		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	22929251	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1ccc(Br)cc1		CHEMBL4756408		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	22929252	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	O=S(=O)(NCCCNc1nccc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(Cl)c(O)c2)n1)c1cccc(F)c1		CHEMBL4795144		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	22929253	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	Cc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(Cl)c(O)c3)n2)cc1		CHEMBL4763666		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	22929254	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	COc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(Cl)c(O)c3)n2)cc1		CHEMBL4741154		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	22929255	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL260	Homo sapiens	IC50		
	22929256	CHEMBL4738307	Inhibition of p38 alpha (unknown origin) using Ser/Thr 15 as substrate incubated for 1 hr in presence of ATP by Z'-Lyte assay	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	4230.0	CHEMBL260	Homo sapiens	IC50	nM	4230.0
	22929309	CHEMBL4738315	Potency index, ratio of PP2 IC50 to compound IC50 for inhibition of P38 alpha (unknown origin)	B	COc1ccc(S(=O)(=O)NCCCNc2nccc(-c3[nH]c(-c4ccccc4)nc3-c3ccc(F)c(O)c3)n2)cc1		CHEMBL4793723	=	Ratio IC50		49.8	CHEMBL260	Homo sapiens	Ratio IC50		49.8
	22929314	CHEMBL4738319	Inhibition of p38 alpha (unknown origin)	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	22929315	CHEMBL4738319	Inhibition of p38 alpha (unknown origin)	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	IC50	nM	7.1	CHEMBL260	Homo sapiens	IC50	nM	7.1
	22929316	CHEMBL4738319	Inhibition of p38 alpha (unknown origin)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	nM	4.0
	22929317	CHEMBL4738319	Inhibition of p38 alpha (unknown origin)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	uM	0.5
	22929318	CHEMBL4738319	Inhibition of p38 alpha (unknown origin)	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	IC50	nM	89.0	CHEMBL260	Homo sapiens	IC50	nM	89.0
	22929319	CHEMBL4738319	Inhibition of p38 alpha (unknown origin)	B	COc1ncc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)cn1		CHEMBL4798964	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	22934013	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4779584	=	IC50	nM	20.0	CHEMBL260	Homo sapiens	IC50	uM	0.02
	22934014	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4748823	=	IC50	nM	13.0	CHEMBL260	Homo sapiens	IC50	uM	0.013000000000000001
	22934015	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4778963	=	IC50	nM	4.0	CHEMBL260	Homo sapiens	IC50	uM	0.004
	22934016	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4780141	=	IC50	nM	52.0	CHEMBL260	Homo sapiens	IC50	uM	0.052000000000000005
	22934017	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4747557	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	22934018	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(NCc2nc(-c3ccc4[nH]ncc4c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4759911	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	uM	0.032
	22934019	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1ccc(NCc2nc(-c3ccc4[nH]ncc4c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4798879	=	IC50	nM	329.0	CHEMBL260	Homo sapiens	IC50	uM	0.32899999999999996
	22934020	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4756404	=	IC50	nM	66.0	CHEMBL260	Homo sapiens	IC50	uM	0.066
	22934021	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4752915	=	IC50	nM	95.0	CHEMBL260	Homo sapiens	IC50	uM	0.095
	22934022	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4794179	=	IC50	nM	26.0	CHEMBL260	Homo sapiens	IC50	uM	0.026000000000000002
	22934023	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccc(F)cc3)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4784124	=	IC50	nM	112.0	CHEMBL260	Homo sapiens	IC50	uM	0.11199999999999999
	22934024	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3C)nc2-c2ccc3c(cnn3C)c2)n1		CHEMBL4780013	=	IC50	nM	71.0	CHEMBL260	Homo sapiens	IC50	uM	0.071
	22934025	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(NCc2nc(-c3ccc4c(cnn4C)c3)c(-c3cccc(C)n3)[nH]2)c1		CHEMBL4788508	=	IC50	nM	23.0	CHEMBL260	Homo sapiens	IC50	uM	0.023
	22934026	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1ccc(NCc2nc(-c3ccc4c(cnn4C)c3)c(-c3cccc(C)n3)[nH]2)cc1		CHEMBL4740767	=	IC50	nM	565.0	CHEMBL260	Homo sapiens	IC50	uM	0.565
	22934027	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	493.0	CHEMBL260	Homo sapiens	IC50	uM	0.493
	22934028	CHEMBL4739182	Inhibition of recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	2950.0	CHEMBL260	Homo sapiens	IC50	uM	2.95
	22934073	CHEMBL4739195	Potency index, ratio of LY-2157299 IC50 to test compound IC50 for recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4778963	=	Ratio IC50		123.3	CHEMBL260	Homo sapiens	Ratio IC50		123.3
	22934074	CHEMBL4739196	Potency index, ratio of EW-7197 IC50 to test compound IC50 for recombinant human p38alpha expressed in Escherichia coli assessed as incoporation of [33]Pi after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counter method	B	Cc1cccc(-c2[nH]c(CNc3cccc(F)c3)nc2-c2ccc3[nH]ncc3c2)n1		CHEMBL4778963	=	Ratio IC50		737.5	CHEMBL260	Homo sapiens	Ratio IC50		737.5
Not Active	22936050	CHEMBL4739747	Inhibition of human p38alpha at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	22943999	CHEMBL4742519	Inhibition of p38-alpha (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	88.0	CHEMBL260	Homo sapiens	Activity	%	88.0
	22949294	CHEMBL4765776	Inhibition of human p38-alpha assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	22949295	CHEMBL4765776	Inhibition of human p38-alpha assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	22949296	CHEMBL4765776	Inhibition of human p38-alpha assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	95.0	CHEMBL260	Homo sapiens	Activity	%	95.0
	22949297	CHEMBL4765776	Inhibition of human p38-alpha assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	102.0	CHEMBL260	Homo sapiens	Activity	%	102.0
	22949298	CHEMBL4765776	Inhibition of human p38-alpha assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	106.0	CHEMBL260	Homo sapiens	Activity	%	106.0
	22949299	CHEMBL4765776	Inhibition of human p38-alpha assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	107.0	CHEMBL260	Homo sapiens	Activity	%	107.0
	22949300	CHEMBL4765777	Inhibition of human p38-alpha assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	99.0	CHEMBL260	Homo sapiens	Activity	%	99.0
	22949301	CHEMBL4765777	Inhibition of human p38-alpha assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	96.0	CHEMBL260	Homo sapiens	Activity	%	96.0
	22949302	CHEMBL4765777	Inhibition of human p38-alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	97.0	CHEMBL260	Homo sapiens	Activity	%	97.0
	22949303	CHEMBL4765777	Inhibition of human p38-alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	22949304	CHEMBL4765777	Inhibition of human p38-alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	22949305	CHEMBL4765777	Inhibition of human p38-alpha assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	104.0	CHEMBL260	Homo sapiens	Activity	%	104.0
	22950613	CHEMBL4766180	Inhibition of human full length recombinant p38alpha using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	342.0	CHEMBL260	Homo sapiens	IC50	uM	0.342
	22952992	CHEMBL4766929	Inhibition of recombinant human full length SAPK2a assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	11.0	CHEMBL260	Homo sapiens	Activity	%	11.0
	22966815	CHEMBL4769706	Inhibition of p38alpha (unknown origin) using FAM-labelled peptide substrate	B	CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CC(F)(F)C3)ccn2)ccn1		CHEMBL4791815	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	nM	10000.0
	23120818	CHEMBL4804453	Inhibition of P38alpha in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-36300.0	CHEMBL260	Homo sapiens	IC50	uM	-36.3
	23120819	CHEMBL4804453	Inhibition of P38alpha in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-25800.0	CHEMBL260	Homo sapiens	IC50	uM	-25.8
	23120820	CHEMBL4804453	Inhibition of P38alpha in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	7400.0	CHEMBL260	Homo sapiens	IC50	uM	7.4
	23120821	CHEMBL4804453	Inhibition of P38alpha in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-24700.0	CHEMBL260	Homo sapiens	IC50	uM	-24.7
	23120822	CHEMBL4804453	Inhibition of P38alpha in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-44200.0	CHEMBL260	Homo sapiens	IC50	uM	-44.2
	23120823	CHEMBL4804453	Inhibition of P38alpha in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	75800.0	CHEMBL260	Homo sapiens	IC50	uM	75.8
	23121856	CHEMBL4804635	Inhibition of P38alpha in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	23121857	CHEMBL4804635	Inhibition of P38alpha in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	23121858	CHEMBL4804635	Inhibition of P38alpha in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	23121859	CHEMBL4804635	Inhibition of P38alpha in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	23121860	CHEMBL4804635	Inhibition of P38alpha in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL260	Homo sapiens	INH	%	0.0
	23121861	CHEMBL4804635	Inhibition of P38alpha in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	INH	%	75.0
	23122713	CHEMBL4805064	Inhibition of human p38-alpha assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	84.0	CHEMBL260	Homo sapiens	Activity	%	84.0
	23123408	CHEMBL4805652	Inhibition of human p38-alpha assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	23123865	CHEMBL4806109	Inhibition of DNA-tagged human p38-alpha assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL260	Homo sapiens	Activity	%	100.0
	23124906	CHEMBL4806669	Inhibition of human p38-alpha assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	23124907	CHEMBL4806669	Inhibition of human p38-alpha assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL260	Homo sapiens	Activity	%	99.0
	23127501	CHEMBL4807637	Inhibition of p38alpha (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	3.0	CHEMBL260	Homo sapiens	Activity	%	3.0
	23127502	CHEMBL4807637	Inhibition of p38alpha (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	38.0	CHEMBL260	Homo sapiens	Activity	%	38.0
	23127503	CHEMBL4807637	Inhibition of p38alpha (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	12.0	CHEMBL260	Homo sapiens	Activity	%	12.0
	23128389	CHEMBL4807938	Inhibition of p38alpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL260	Homo sapiens	Activity	%	25.0
	23128390	CHEMBL4807938	Inhibition of p38alpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	25.0	CHEMBL260	Homo sapiens	Activity	%	25.0
	23128391	CHEMBL4807938	Inhibition of p38alpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL260	Homo sapiens	Activity	%	25.0
	23128858	CHEMBL4808076	Inhibition of p38alpha (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	65.0	CHEMBL260	Homo sapiens	INH	%	65.0
	23128859	CHEMBL4808076	Inhibition of p38alpha (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	15.0	CHEMBL260	Homo sapiens	INH	%	15.0
	23128860	CHEMBL4808076	Inhibition of p38alpha (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	63.0	CHEMBL260	Homo sapiens	INH	%	63.0
	23128861	CHEMBL4808076	Inhibition of p38alpha (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	25.0	CHEMBL260	Homo sapiens	INH	%	25.0
	23208077	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC		CHEMBL4850724	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208078	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C		CHEMBL4861772	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208079	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O		CHEMBL4860774	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208080	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O		CHEMBL4858673	=	IC50	nM	9000.0	CHEMBL260	Homo sapiens	IC50	uM	9.0
	23208081	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL4870695	=	IC50	nM	2600.0	CHEMBL260	Homo sapiens	IC50	uM	2.6
	23208082	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4868525	=	IC50	nM	1.3	CHEMBL260	Homo sapiens	IC50	uM	0.0013
	23208083	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	11.0	CHEMBL260	Homo sapiens	IC50	uM	0.011000000000000001
	23208084	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4864686	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
	23208085	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4847239	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	23208086	CHEMBL4822083	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of ATP by ELISA based competitive binding potency assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)O		CHEMBL4852110	=	IC50	nM	290.0	CHEMBL260	Homo sapiens	IC50	uM	0.29
	23208087	CHEMBL4822084	Binding affinity to recombinant human N-terminal GST-tagged P38alpha MAPK expressed in Escherichia coli using ERKtide as substrate by mobility shift assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC		CHEMBL4850724	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208088	CHEMBL4822084	Binding affinity to recombinant human N-terminal GST-tagged P38alpha MAPK expressed in Escherichia coli using ERKtide as substrate by mobility shift assay	B	CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(C)C		CHEMBL4861772	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208089	CHEMBL4822084	Binding affinity to recombinant human N-terminal GST-tagged P38alpha MAPK expressed in Escherichia coli using ERKtide as substrate by mobility shift assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O		CHEMBL4860774	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208090	CHEMBL4822084	Binding affinity to recombinant human N-terminal GST-tagged P38alpha MAPK expressed in Escherichia coli using ERKtide as substrate by mobility shift assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O		CHEMBL4858673	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208091	CHEMBL4822084	Binding affinity to recombinant human N-terminal GST-tagged P38alpha MAPK expressed in Escherichia coli using ERKtide as substrate by mobility shift assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL4870695	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208092	CHEMBL4822084	Binding affinity to recombinant human N-terminal GST-tagged P38alpha MAPK expressed in Escherichia coli using ERKtide as substrate by mobility shift assay	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4868525	>	IC50	nM	100000.0	CHEMBL260	Homo sapiens	IC50	uM	100.0
	23208093	CHEMBL4822084	Binding affinity to recombinant human N-terminal GST-tagged P38alpha MAPK expressed in Escherichia coli using ERKtide as substrate by mobility shift assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	18.0	CHEMBL260	Homo sapiens	IC50	uM	0.018000000000000002
Active	23208094	CHEMBL4822085	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of increasing concentration of ATP by ELISA	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4868525		Activity			CHEMBL260	Homo sapiens	Activity		
Not Active	23208095	CHEMBL4822085	Binding affinity to P38alpha MAPK (unknown origin) using Smad3 as substrate incubated for 1 hr in presence of increasing concentration of ATP by ELISA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Activity			CHEMBL260	Homo sapiens	Activity		
	23208096	CHEMBL4822086	Binding affinity to P38alpha MAPK (unknown origin) using MBP as substrate incubated for 1 hr by ELISA	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4868525	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23208097	CHEMBL4822087	Binding affinity to P38alpha MAPK (unknown origin) using MAPKAPK2 as substrate incubated for 1 hr by ELISA	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4868525	>	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23209432	CHEMBL4822404	Inhibition of p38alphaMAPK (unknown origin)	B	COc1ccc(C2=N/C(=C/c3ccc(O)cc3)C(=O)N2c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL4872231	=	IC50	nM	140.0	CHEMBL260	Homo sapiens	IC50	uM	0.14
	23235839	CHEMBL4828039	Binding affinity to HiBiT-tagged MAPK14 (unknown origin) assessed as shift in melting/aggregation temperature at 10 uM by luminescence based BiTSA assay	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	Tm	degrees C	12.4	CHEMBL260	Homo sapiens	Tm	degrees C	12.4
	23235840	CHEMBL4828040	Binding affinity to MAPK14 (unknown origin) by fluorescence imaging/AlphaLISA based thermal shit assay	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	EC50	nM	10.0	CHEMBL260	Homo sapiens	EC50	nM	10.0
	23235841	CHEMBL4828041	Binding affinity to HiBiT-tagged MAPK14 (unknown origin) assessed as shift in melting/aggregation temperature by luminescence based BiTSA assay	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	EC50	nM	2.06	CHEMBL260	Homo sapiens	EC50	nM	2.06
	23235842	CHEMBL4828042	Binding affinity to MAPK14 (unknown origin) measured after 5 to 6 hrs incubation by AlphaLISA based thermal shit assay	B	Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL585902	=	EC50	nM	35.0	CHEMBL260	Homo sapiens	EC50	nM	35.0
	23250072	CHEMBL4830984	Inhibition of GST-tagged human full length recombinant p38 alpha expressed in Escherichia coli at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162	<	Inhibition	%	25.0	CHEMBL260	Homo sapiens	INH	%	25.0
Not Active	23250073	CHEMBL4830984	Inhibition of GST-tagged human full length recombinant p38 alpha expressed in Escherichia coli at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(C)=O)c2)n1		CHEMBL4856343		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	23250122	CHEMBL4831011	Inhibition of GST-tagged human full length recombinant p38 alpha expressed in Escherichia coli at 100 to 1000 nM by Z'-LYTE assay	B	C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(S(=O)(=O)F)cc3)CC2)n1		CHEMBL4855850		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	23256056	CHEMBL4832007	Inhibition of p38alpha (unknown origin) at 0.3 uM	B	O=C(Nc1cncc(OCC2CCN(Cc3ccc(F)cc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4873612		Inhibition	%		CHEMBL260	Homo sapiens	INH		
Not Active	23270427	CHEMBL4835221	Inhibition of p38alpha kinase (unknown origin) at 10 uM	B	C[C@H]1CN(C(=O)CC[C@@]2(C3CC3)NC(=O)NC2=O)CCN1c1cc(F)cc(F)c1		CHEMBL4650334		Inhibition	%		CHEMBL260	Homo sapiens	INH		
	23294131	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(Nc1cnn(-c2cccc(C(=O)Nc3cnn(C4CCNC4)c3)c2)c1)Nc1ccccc1Cl		CHEMBL3355178	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	nM	20000.0
	23294132	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(Nc1cnn(-c2csc(C(=O)NC3COC3)c2)c1)Nc1ccccc1Cl		CHEMBL4753641	>	IC50	nM	20000.0	CHEMBL260	Homo sapiens	IC50	nM	20000.0
	23294133	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(NC1COC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)ncc32)cs1		CHEMBL4872832	=	IC50	nM	86.0	CHEMBL260	Homo sapiens	IC50	uM	0.086
	23294134	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(NC1COC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)cnc32)cs1		CHEMBL4872493	=	IC50	nM	260.0	CHEMBL260	Homo sapiens	IC50	uM	0.26
	23294135	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(NC1COC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4847784	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
	23294136	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(N[C@H]1CCOC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4874575	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	23294137	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(NC1CCOCC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4867426	=	IC50	nM	47.0	CHEMBL260	Homo sapiens	IC50	uM	0.047
	23294138	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	[2H]C([2H])([2H])N1CC[C@H](NC(=O)c2cc(-n3ncc4cc(Nc5ccccc5Cl)c(F)cc43)cs2)C1		CHEMBL4847175	=	IC50	nM	300.0	CHEMBL260	Homo sapiens	IC50	uM	0.3
	23294139	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CC(=O)N1CC[C@H](NC(=O)c2cc(-n3ncc4cc(Nc5ccccc5Cl)c(F)cc43)cs2)C1		CHEMBL4862656	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	uM	0.065
	23294140	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CC(C)NC(=O)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4865870	=	IC50	nM	124.0	CHEMBL260	Homo sapiens	IC50	uM	0.124
	23294141	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(NCC(F)F)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4879188	=	IC50	nM	46.0	CHEMBL260	Homo sapiens	IC50	uM	0.046
	23294142	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	COCCNC(=O)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4876387	=	IC50	nM	41.0	CHEMBL260	Homo sapiens	IC50	uM	0.040999999999999995
	23294143	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	O=C(NC1CC1)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4861739	=	IC50	nM	14.0	CHEMBL260	Homo sapiens	IC50	uM	0.013999999999999999
	23294144	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1		CHEMBL4874134	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	uM	0.1
	23294145	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	[2H]C([2H])([2H])N1CC[C@H](NC(=O)c2cc(-n3ncc4cc(Nc5ccccc5Cl)ccc43)cs2)C1		CHEMBL4875508	=	IC50	nM	226.0	CHEMBL260	Homo sapiens	IC50	uM	0.226
	23294146	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CC(C)N1CC[C@@H](NC(=O)c2cc(-n3ncc4cc(Nc5ccccc5Cl)ccc43)cs2)C1		CHEMBL4869300	=	IC50	nM	325.0	CHEMBL260	Homo sapiens	IC50	uM	0.325
	23294147	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(OC)cc32)cs1		CHEMBL4853326	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	uM	0.16
	23294148	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4c(F)cccc4Cl)c(F)cc32)cs1		CHEMBL4874573	=	IC50	nM	24.0	CHEMBL260	Homo sapiens	IC50	uM	0.024
	23294149	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4c(F)cccc4OC)c(F)cc32)cs1		CHEMBL4875476	=	IC50	nM	65.0	CHEMBL260	Homo sapiens	IC50	uM	0.065
	23294150	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Oc4ccccc4Cl)ccc32)cs1		CHEMBL4864514	=	IC50	nM	286.0	CHEMBL260	Homo sapiens	IC50	uM	0.28600000000000003
	23294151	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4ccccc4Cl)cnc32)cs1		CHEMBL4851793	=	IC50	nM	481.0	CHEMBL260	Homo sapiens	IC50	uM	0.48100000000000004
	23294152	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4c(F)cccc4Cl)ncc32)cs1		CHEMBL4877727	=	IC50	nM	57.0	CHEMBL260	Homo sapiens	IC50	uM	0.057
	23294153	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4c(F)cccc4Cl)cnc32)cs1		CHEMBL4857979	=	IC50	nM	106.0	CHEMBL260	Homo sapiens	IC50	uM	0.106
	23294154	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4c(F)cccc4Cl)c(C)nc32)cs1		CHEMBL4859957	=	IC50	nM	380.0	CHEMBL260	Homo sapiens	IC50	uM	0.38
	23294155	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	CNC(=O)c1cc(-n2ncc3cc(Nc4cccc(OC)c4Cl)c(C)nc32)cs1		CHEMBL4853306	>	IC50	nM	10000.0	CHEMBL260	Homo sapiens	IC50	uM	10.0
	23294156	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	Cc1nc2c(cnn2-c2csc(C(=O)NC3COC3)c2)cc1Nc1cccc(F)c1Cl		CHEMBL4876785	=	IC50	nM	1420.0	CHEMBL260	Homo sapiens	IC50	uM	1.42
	23294157	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	Cc1nc2c(cnn2-c2csc(C(=O)NC3COC3)c2)cc1Nc1ccc(F)cc1Cl		CHEMBL4854405	=	IC50	nM	490.0	CHEMBL260	Homo sapiens	IC50	uM	0.49
	23294158	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	Cc1nc2c(cnn2-c2csc(C(=O)NC3COC3)c2)cc1Nc1cc(F)ccc1Cl		CHEMBL4863524	=	IC50	nM	2890.0	CHEMBL260	Homo sapiens	IC50	uM	2.89
	23294159	CHEMBL4840120	Inhibition of p38 alpha (unknown origin) using biotinylated FL-ATF-2 as substrate measured after 22 mins by homogeneous time-resolved fluorescence analysis	B	Cc1nc2c(cnn2-c2csc(C(=O)NC3COC3)c2)cc1Nc1c(F)cccc1Cl		CHEMBL4845770	=	IC50	nM	106.0	CHEMBL260	Homo sapiens	IC50	uM	0.106
	23294303	CHEMBL4840138	Inhibition of human p38alpha at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	Cc1nc2c(cnn2-c2csc(C(=O)NC3COC3)c2)cc1Nc1c(F)cccc1Cl		CHEMBL4845770	=	Inhibition	%	75.0	CHEMBL260	Homo sapiens	INH	%	75.0
	23294308	CHEMBL4840143	Inhibition of human p38alpha using MBP as substrate by [gamma-33P]-ATP assay	B	Cc1nc2c(cnn2-c2csc(C(=O)NC3COC3)c2)cc1Nc1c(F)cccc1Cl		CHEMBL4845770	=	IC50	nM	110.0	CHEMBL260	Homo sapiens	IC50	nM	110.0
	23295901	CHEMBL4840674	Binding affinity to p38 alpha MAPK (unknown origin) assessed as association constant by surface plasmon resonance imaging	B	CCOc1ccc(Oc2cc(S(=O)(=O)N(C)C)cnc2N2CCC(Oc3ccc(Cl)cc3)CC2)cc1		CHEMBL4861363	=	Ka	10^4/M/s	2.08	CHEMBL260	Homo sapiens	Ka	10^4/M/s	2.08
	23295902	CHEMBL4840675	Binding affinity to p38 alpha MAPK (unknown origin) assessed as dissociation constant by surface plasmon resonance imaging	B	CCOc1ccc(Oc2cc(S(=O)(=O)N(C)C)cnc2N2CCC(Oc3ccc(Cl)cc3)CC2)cc1	Non standard unit for type	CHEMBL4861363	=	Kd	10^-4/s	2.48	CHEMBL260	Homo sapiens	Kd	10^-4/s	2.48
	23295903	CHEMBL4840676	Binding affinity to p38 alpha MAPK (unknown origin) assessed as steady state affinity by surface plasmon resonance imaging	B	CCOc1ccc(Oc2cc(S(=O)(=O)N(C)C)cnc2N2CCC(Oc3ccc(Cl)cc3)CC2)cc1		CHEMBL4861363	=	Kd	nM	12.0	CHEMBL260	Homo sapiens	Kd	nM	12.0
	23299308	CHEMBL4841754	Inhibition of p38alpha (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	12.0	CHEMBL260	Homo sapiens	INH	%	12.0
	23299309	CHEMBL4841754	Inhibition of p38alpha (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	1.0	CHEMBL260	Homo sapiens	INH	%	1.0
	23299552	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	nM	320.0
	23299553	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2ccncc2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1233853	=	IC50	nM	200.0	CHEMBL260	Homo sapiens	IC50	nM	200.0
	23299554	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2ccncn2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4856623	=	IC50	nM	630.0	CHEMBL260	Homo sapiens	IC50	nM	630.0
	23299555	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2ccnc3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4870490	=	IC50	nM	100.0	CHEMBL260	Homo sapiens	IC50	nM	100.0
	23299556	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4857725	=	IC50	nM	1260.0	CHEMBL260	Homo sapiens	IC50	nM	1260.0
	23299557	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	COc1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c2c1		CHEMBL4868251	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	23299558	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4856992	=	IC50	nM	800.0	CHEMBL260	Homo sapiens	IC50	nM	800.0
	23299559	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	Cc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2ccccc2n1		CHEMBL4864978	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299560	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4852364	=	IC50	nM	32.0	CHEMBL260	Homo sapiens	IC50	nM	32.0
	23299561	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4869054	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	nM	500.0
	23299562	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1nccc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)n1		CHEMBL4861519	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	23299563	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4863580	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299564	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	Nc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4849349	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299565	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CN(C)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4850251	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	nM	2000.0
	23299566	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2cc(O)ncn2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4873277	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	23299567	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	COc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4876578	=	IC50	nM	1260.0	CHEMBL260	Homo sapiens	IC50	nM	1260.0
	23299568	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	Cc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4872243	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299569	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CCNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4864463	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	nM	320.0
	23299570	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CC(C)Nc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4873406	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	23299571	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CCCNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4877505	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	23299572	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CC(C)CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4865829	=	IC50	nM	250.0	CHEMBL260	Homo sapiens	IC50	nM	250.0
	23299573	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2cc(NCCO)ncn2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4871527	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299574	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	C[C@@H](O)CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4847826	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	nM	500.0
	23299575	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	C[C@H](O)CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4859309	=	IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	nM	320.0
	23299576	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CC(C)(O)CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4854957	=	IC50	nM	630.0	CHEMBL260	Homo sapiens	IC50	nM	630.0
	23299577	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1		CHEMBL4845883	=	IC50	nM	79.0	CHEMBL260	Homo sapiens	IC50	nM	79.0
	23299578	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(O)Cc1cccc(Nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ncn2)c1		CHEMBL4875220	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	23299579	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	O=C(Nc1ccc(Oc2cc(Nc3cccc(CN4CCCC4)c3)ncn2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4867760	=	IC50	nM	50.0	CHEMBL260	Homo sapiens	IC50	nM	50.0
	23299580	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3ccccc3)cc2)ncn1		CHEMBL4856147	>	IC50	nM	25000.0	CHEMBL260	Homo sapiens	IC50	nM	25000.0
	23299581	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C)c3)cc2)ncn1		CHEMBL4855081	>	IC50	nM	25000.0	CHEMBL260	Homo sapiens	IC50	nM	25000.0
	23299582	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(CF)c3)cc2)ncn1		CHEMBL4859818	=	IC50	nM	25000.0	CHEMBL260	Homo sapiens	IC50	nM	25000.0
	23299583	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)F)c3)cc2)ncn1		CHEMBL4867053	=	IC50	nM	6300.0	CHEMBL260	Homo sapiens	IC50	nM	6300.0
	23299584	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CCc1cccc(NC(=O)Nc2ccc(Oc3cc(NC)ncn3)cc2)c1		CHEMBL4870079	=	IC50	nM	16000.0	CHEMBL260	Homo sapiens	IC50	nM	16000.0
	23299585	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)F)c3)cc2)ncn1		CHEMBL4850964	=	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	23299586	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)(F)F)c3)cc2)ncn1		CHEMBL4868391	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299587	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)(C)C)c3)cc2)ncn1		CHEMBL4850780	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299588	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ncn1		CHEMBL4066096	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	nM	1000.0
	23299589	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c(F)c2)ncn1		CHEMBL4863203	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	nM	400.0
	23299590	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c(F)c2F)ncn1		CHEMBL4857556	=	IC50	nM	160.0	CHEMBL260	Homo sapiens	IC50	nM	160.0
	23299591	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2Cl)ncn1		CHEMBL4874491	=	IC50	nM	800.0	CHEMBL260	Homo sapiens	IC50	nM	800.0
	23299592	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)ncn1		CHEMBL4870768	=	IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
	23299593	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2c(C)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)ncn1		CHEMBL4875166	=	IC50	nM	130.0	CHEMBL260	Homo sapiens	IC50	nM	130.0
	23299594	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2C)ncn1		CHEMBL4859380	=	IC50	nM	630.0	CHEMBL260	Homo sapiens	IC50	nM	630.0
	23299595	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2c(C)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2C)ncn1		CHEMBL4868757	=	IC50	nM	6300.0	CHEMBL260	Homo sapiens	IC50	nM	6300.0
	23299596	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2cc(C)c(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2C)ncn1		CHEMBL4870044	=	IC50	nM	5000.0	CHEMBL260	Homo sapiens	IC50	nM	5000.0
	23299597	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2c(Cl)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2Cl)ncn1		CHEMBL4869303	=	IC50	nM	800.0	CHEMBL260	Homo sapiens	IC50	nM	800.0
	23299598	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2c(F)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ncn1		CHEMBL4865373	=	IC50	nM	500.0	CHEMBL260	Homo sapiens	IC50	nM	500.0
	23299599	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNc1cc(Oc2c(C)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2Cl)ncn1		CHEMBL4856606	=	IC50	nM	2000.0	CHEMBL260	Homo sapiens	IC50	nM	2000.0
	23299600	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CCc1cc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc(Cl)c1Oc1cc(NC)ncn1		CHEMBL4867552	=	IC50	nM	1600.0	CHEMBL260	Homo sapiens	IC50	nM	1600.0
	23299601	CHEMBL4841803	Inhibition of p38alpha (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	38.0	CHEMBL260	Homo sapiens	IC50	nM	38.0
	23310496	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1cccc2[nH]ccc12		CHEMBL4755877	=	Activity	%	59.0	CHEMBL260	Homo sapiens	Activity	%	59.0
	23310497	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1ccccc1Br		CHEMBL4794773	=	Activity	%	59.0	CHEMBL260	Homo sapiens	Activity	%	59.0
	23310498	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccc2F)cc1-c1cccc2[nH]ccc12		CHEMBL4864880	=	Activity	%	28.0	CHEMBL260	Homo sapiens	Activity	%	28.0
	23310499	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2cccc(F)c2)cc1-c1cccc2[nH]ccc12		CHEMBL4865770	=	Activity	%	47.0	CHEMBL260	Homo sapiens	Activity	%	47.0
	23310500	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccc(F)cc2)cc1-c1cccc2[nH]ccc12		CHEMBL4866866	=	Activity	%	39.0	CHEMBL260	Homo sapiens	Activity	%	39.0
	23310501	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	CCOC(=O)c1ccccc1Nc1c[nH]c(=O)c(-c2cccc3[nH]ccc23)c1		CHEMBL4869451	=	Activity	%	104.0	CHEMBL260	Homo sapiens	Activity	%	104.0
	23310502	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	CCOC(=O)c1cccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)c1		CHEMBL4858658	=	Activity	%	81.0	CHEMBL260	Homo sapiens	Activity	%	81.0
	23310503	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	CCOC(=O)c1ccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)cc1		CHEMBL4866061	=	Activity	%	86.0	CHEMBL260	Homo sapiens	Activity	%	86.0
	23310504	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	COc1ccccc1Nc1c[nH]c(=O)c(-c2cccc3[nH]ccc23)c1		CHEMBL4860173	=	Activity	%	50.0	CHEMBL260	Homo sapiens	Activity	%	50.0
	23310505	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	COc1cccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)c1		CHEMBL4865837	=	Activity	%	50.0	CHEMBL260	Homo sapiens	Activity	%	50.0
	23310506	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	COc1ccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)cc1		CHEMBL4850326	=	Activity	%	59.0	CHEMBL260	Homo sapiens	Activity	%	59.0
	23310507	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2cccc(O)c2)cc1-c1cccc2[nH]ccc12		CHEMBL4852390	=	Activity	%	34.0	CHEMBL260	Homo sapiens	Activity	%	34.0
	23310508	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccc2[N+](=O)[O-])cc1-c1cccc2[nH]ccc12		CHEMBL4854668	=	Activity	%	92.3	CHEMBL260	Homo sapiens	Activity	%	92.3
	23310509	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2cccc([N+](=O)[O-])c2)cc1-c1cccc2[nH]ccc12		CHEMBL4858085	=	Activity	%	73.9	CHEMBL260	Homo sapiens	Activity	%	73.9
	23310510	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccc([N+](=O)[O-])cc2)cc1-c1cccc2[nH]ccc12		CHEMBL4849364	=	Activity	%	93.0	CHEMBL260	Homo sapiens	Activity	%	93.0
	23310511	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	Cc1ccccc1Nc1c[nH]c(=O)c(-c2cccc3[nH]ccc23)c1		CHEMBL4863866	=	Activity	%	33.0	CHEMBL260	Homo sapiens	Activity	%	33.0
	23310512	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccn2)cc1-c1cccc2[nH]ccc12		CHEMBL4855647	=	Activity	%	70.0	CHEMBL260	Homo sapiens	Activity	%	70.0
	23310513	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2cccnc2)cc1-c1cccc2[nH]ccc12		CHEMBL4861405	=	Activity	%	64.0	CHEMBL260	Homo sapiens	Activity	%	64.0
	23310514	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccncc2)cc1-c1cccc2[nH]ccc12		CHEMBL4871272	=	Activity	%	67.0	CHEMBL260	Homo sapiens	Activity	%	67.0
	23310515	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccc2Br)cc1-c1cccc2[nH]ccc12		CHEMBL4866206	=	Activity	%	45.0	CHEMBL260	Homo sapiens	Activity	%	45.0
	23310516	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2cccc(Br)c2)cc1-c1cccc2[nH]ccc12		CHEMBL4869161	=	Activity	%	31.0	CHEMBL260	Homo sapiens	Activity	%	31.0
	23310517	CHEMBL4843971	Inhibition of p38 alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccc(Br)cc2)cc1-c1cccc2[nH]ccc12		CHEMBL4859534	=	Activity	%	43.0	CHEMBL260	Homo sapiens	Activity	%	43.0
	23310518	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1cccc2[nH]ccc12		CHEMBL4755877	=	IC50	nM	3000.0	CHEMBL260	Homo sapiens	IC50	uM	3.0
	23310519	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1ccccc1Br		CHEMBL4794773	=	IC50	nM	1500.0	CHEMBL260	Homo sapiens	IC50	uM	1.5
	23310520	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccccc2F)cc1-c1cccc2[nH]ccc12		CHEMBL4864880	=	IC50	nM	230.0	CHEMBL260	Homo sapiens	IC50	uM	0.23
	23310521	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2cccc(F)c2)cc1-c1cccc2[nH]ccc12		CHEMBL4865770	=	IC50	nM	1400.0	CHEMBL260	Homo sapiens	IC50	uM	1.4
	23310522	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccc(F)cc2)cc1-c1cccc2[nH]ccc12		CHEMBL4866866	=	IC50	nM	400.0	CHEMBL260	Homo sapiens	IC50	uM	0.4
Not Determined	23310523	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	CCOC(=O)c1ccccc1Nc1c[nH]c(=O)c(-c2cccc3[nH]ccc23)c1		CHEMBL4869451		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	23310524	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	CCOC(=O)c1cccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)c1		CHEMBL4858658		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	23310525	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	CCOC(=O)c1ccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)cc1		CHEMBL4866061		IC50			CHEMBL260	Homo sapiens	IC50		
	23310526	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	COc1ccccc1Nc1c[nH]c(=O)c(-c2cccc3[nH]ccc23)c1		CHEMBL4860173	=	IC50	nM	5200.0	CHEMBL260	Homo sapiens	IC50	uM	5.2
	23310527	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	COc1cccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)c1		CHEMBL4865837	=	IC50	nM	5500.0	CHEMBL260	Homo sapiens	IC50	uM	5.5
	23310528	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	COc1ccc(Nc2c[nH]c(=O)c(-c3cccc4[nH]ccc34)c2)cc1		CHEMBL4850326	=	IC50	nM	3700.0	CHEMBL260	Homo sapiens	IC50	uM	3.7
	23310529	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2cccc(O)c2)cc1-c1cccc2[nH]ccc12		CHEMBL4852390	=	IC50	nM	1000.0	CHEMBL260	Homo sapiens	IC50	uM	1.0
Not Determined	23310530	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccccc2[N+](=O)[O-])cc1-c1cccc2[nH]ccc12		CHEMBL4854668		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	23310531	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2cccc([N+](=O)[O-])c2)cc1-c1cccc2[nH]ccc12		CHEMBL4858085		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	23310532	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccc([N+](=O)[O-])cc2)cc1-c1cccc2[nH]ccc12		CHEMBL4849364		IC50			CHEMBL260	Homo sapiens	IC50		
	23310533	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	Cc1ccccc1Nc1c[nH]c(=O)c(-c2cccc3[nH]ccc23)c1		CHEMBL4863866	=	IC50	nM	1100.0	CHEMBL260	Homo sapiens	IC50	uM	1.1
Not Determined	23310534	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccccn2)cc1-c1cccc2[nH]ccc12		CHEMBL4855647		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	23310535	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2cccnc2)cc1-c1cccc2[nH]ccc12		CHEMBL4861405		IC50			CHEMBL260	Homo sapiens	IC50		
Not Determined	23310536	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccncc2)cc1-c1cccc2[nH]ccc12		CHEMBL4871272		IC50			CHEMBL260	Homo sapiens	IC50		
	23310537	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccccc2Br)cc1-c1cccc2[nH]ccc12		CHEMBL4866206	=	IC50	nM	2700.0	CHEMBL260	Homo sapiens	IC50	uM	2.7
	23310538	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2cccc(Br)c2)cc1-c1cccc2[nH]ccc12		CHEMBL4869161	=	IC50	nM	700.0	CHEMBL260	Homo sapiens	IC50	uM	0.7
	23310539	CHEMBL4843972	Inhibition of p38 alpha (unknown origin)	B	O=c1[nH]cc(Nc2ccc(Br)cc2)cc1-c1cccc2[nH]ccc12		CHEMBL4859534	=	IC50	nM	2400.0	CHEMBL260	Homo sapiens	IC50	uM	2.4
	23310540	CHEMBL4843973	Inhibition of p38 alpha (unknown origin) at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccc2)cc1-c1ccccc1Br		CHEMBL4794773	=	Inhibition	%	41.0	CHEMBL260	Homo sapiens	INH	%	41.0
	23310541	CHEMBL4843973	Inhibition of p38 alpha (unknown origin) at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccccc2F)cc1-c1cccc2[nH]ccc12		CHEMBL4864880	=	Inhibition	%	72.0	CHEMBL260	Homo sapiens	INH	%	72.0
	23310542	CHEMBL4843973	Inhibition of p38 alpha (unknown origin) at 1 uM relative to control	B	O=c1[nH]cc(Nc2ccncc2)cc1-c1cccc2[nH]ccc12		CHEMBL4871272	=	Inhibition	%	33.0	CHEMBL260	Homo sapiens	INH	%	33.0
Not Active	23317549	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23318017	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23318683	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23319167	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23319804	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23320279	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	81.3	CHEMBL260	Homo sapiens	% Control	%	81.3
Not Active	23320957	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	89.0	CHEMBL260	Homo sapiens	% Control	%	89.0
Not Active	23321425	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23322055	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	99.0	CHEMBL260	Homo sapiens	% Control	%	99.0
Not Active	23322523	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23323212	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	99.0	CHEMBL260	Homo sapiens	% Control	%	99.0
Not Active	23323680	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	90.0	CHEMBL260	Homo sapiens	% Control	%	90.0
Not Active	23324130	CHEMBL4880748	SAPK2a (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	3.0	CHEMBL260	Homo sapiens	% inhibition	%	3.0
Not Active	23324534	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23325169	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	85.0	CHEMBL260	Homo sapiens	% Control	%	85.0
Not Active	23325637	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	89.0	CHEMBL260	Homo sapiens	% Control	%	89.0
Not Active	23326284	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23326752	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23327050	CHEMBL4880887	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		Inhibition	%	50.0	CHEMBL260	Homo sapiens	% inhibition	%	50.0
	23327051	CHEMBL4880887	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1	Non standard unit for type	CHEMBL4537788		IC50	M	10.7	CHEMBL260	Homo sapiens	IC50	M	10.7
Not Active	23327452	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23327920	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23328507	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	91.0	CHEMBL260	Homo sapiens	% Control	%	91.0
Not Active	23328975	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23329519	CHEMBL4881226	SAPK2a(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	113.0	CHEMBL260	Homo sapiens	% residual kinase activity	%	113.0
Not Active	23329921	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	99.0	CHEMBL260	Homo sapiens	% Control	%	99.0
Not Active	23330389	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23331145	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23331613	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	79.0	CHEMBL260	Homo sapiens	% Control	%	79.0
Active	23332200	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	0.0	CHEMBL260	Homo sapiens	% Control	%	0.0
Not Active	23332666	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23333384	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23334023	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	87.0	CHEMBL260	Homo sapiens	% Control	%	87.0
Not Active	23334491	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23334962	CHEMBL4881582	SAPK2a (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	21.0	CHEMBL260	Homo sapiens	% inhibition	%	21.0
Not Active	23335470	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23335938	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23336565	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23337033	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23337410	CHEMBL4881781	P38ALPHA_CE Cerep selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	113.0	CHEMBL260	Homo sapiens	% Ctrl	%	113.0
Not Active	23337667	CHEMBL4882038	MAPK14 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	107.0	CHEMBL260	Homo sapiens	% Ctrl	%	107.0
Not Active	23337668	CHEMBL4882039	MAPK14P38A Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	100.0	CHEMBL260	Homo sapiens	% Ctrl	%	100.0
Not Active	23338114	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	90.0	CHEMBL260	Homo sapiens	% Control	%	90.0
Not Active	23338582	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23339194	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23339662	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	97.0	CHEMBL260	Homo sapiens	% Control	%	97.0
Not Active	23340299	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23340767	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23341424	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23341892	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23342508	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23342976	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	95.0	CHEMBL260	Homo sapiens	% Control	%	95.0
Active	23343268	CHEMBL4882453	MAPK14 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	6.0	CHEMBL260	Homo sapiens	% Ctrl	%	6.0
Not Active	23343606	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23344074	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23344712	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23345285	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23345753	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	94.0	CHEMBL260	Homo sapiens	% Control	%	94.0
Not Active	23346330	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23346798	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	97.0	CHEMBL260	Homo sapiens	% Control	%	97.0
Not Active	23347400	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23347890	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23348469	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23348937	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23349524	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23350142	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23350610	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	94.0	CHEMBL260	Homo sapiens	% Control	%	94.0
Not Active	23351215	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23351683	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23352119	CHEMBL4882808	MAPK14 (p38 alpha) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-6.516	CHEMBL260	Homo sapiens	% Inhibition	%	-6.5157
Not Active	23352120	CHEMBL4882809	MAPK14 (p38 alpha) Direct Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.111	CHEMBL260	Homo sapiens	% Inhibition	%	8.1115
Not Active	23352271	CHEMBL4880887	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	19.0	CHEMBL260	Homo sapiens	% inhibition	%	19.0
Not Active	23352707	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	95.0	CHEMBL260	Homo sapiens	% Control	%	95.0
Not Active	23353175	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23353493	CHEMBL4883004	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1	Outside typical range	CHEMBL1800685		Inhibition	%	-76.0	CHEMBL260	Homo sapiens	% inhibition	%	-76.0
	23353494	CHEMBL4883004	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1	Non standard unit for type	CHEMBL1800685		IC50	M	0.00294	CHEMBL260	Homo sapiens	IC50	M	0.00294
Not Active	23353495	CHEMBL4883004	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	-7.0	CHEMBL260	Homo sapiens	% inhibition	%	-7.0
Not Active	23353496	CHEMBL4883004	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	0.0	CHEMBL260	Homo sapiens	% inhibition	%	0.0
Not Active	23353497	CHEMBL4883004	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	9.0	CHEMBL260	Homo sapiens	% inhibition	%	9.0
Not Active	23353739	CHEMBL4882992	NanoBRET (SGC Frankfurt) (MAPK14)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1	Non standard unit for type	CHEMBL1800685	>	IC50	M	20.0	CHEMBL260	Homo sapiens	IC50	M	20.0
Not Active	23354057	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23354525	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23354823	CHEMBL4883004	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2	Outside typical range	CHEMBL2204538		Inhibition	%	-14.0	CHEMBL260	Homo sapiens	% inhibition	%	-14.0
Not Active	23355257	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23355725	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23356361	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23356829	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	99.0	CHEMBL260	Homo sapiens	% Control	%	99.0
Active	23357438	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	0.0	CHEMBL260	Homo sapiens	% Control	%	0.0
Not Active	23357761	CHEMBL4883153	p38alpha kinase (h) CEREP ligand profiling	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		Inhibition	%	1.0	CHEMBL260	Homo sapiens	% inhibition	%	1.0
Not Active	23358085	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23358553	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23359139	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	96.7	CHEMBL260	Homo sapiens	% Control	%	96.7
Not Active	23359737	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23360205	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23360790	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23361258	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23361831	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23362367	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	95.0	CHEMBL260	Homo sapiens	% Control	%	95.0
Not Active	23362835	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23363278	CHEMBL4883255	MAPK14 (p38 alpha) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	6.389	CHEMBL260	Homo sapiens	% inhibition	%	6.389
Not Active	23363279	CHEMBL4883255	MAPK14 (p38 alpha) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	4.88	CHEMBL260	Homo sapiens	% inhibition	%	4.8795
Not Active	23364477	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	83.0	CHEMBL260	Homo sapiens	% Control	%	83.0
Not Active	23364945	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	97.0	CHEMBL260	Homo sapiens	% Control	%	97.0
Not Active	23365684	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23366227	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Active	23366491	CHEMBL4883788	Biochemical assay: ELISA, cell free	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207		IC50	nM	0.2	CHEMBL260	Homo sapiens	IC50	nM	0.2
Active	23366492	CHEMBL4883789	NanoBRET (MAPK14)	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(NC(=O)c4ccccc4)c3)cc1CC2		CHEMBL2316207		IC50	nM	14.9	CHEMBL260	Homo sapiens	IC50	nM	14.9
Active	23366496	CHEMBL4883793	Radiometric activity assay, ProQinase (MAPK14)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
Active	23366498	CHEMBL4883789	NanoBRET (MAPK14)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		IC50	nM	3.7	CHEMBL260	Homo sapiens	IC50	nM	3.7
Active	23366502	CHEMBL4883795	Binding based DSF (Differencial Scanning Fluorimetry) assay	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1	Non standard unit for type	CHEMBL4436748		deltaTm	C	15.4	CHEMBL260	Homo sapiens	deltaTm	C	15.4
Not Active	23366509	CHEMBL4883789	NanoBRET (MAPK14)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1	Non standard unit for type	CHEMBL4531775		IC50	M	13.0	CHEMBL260	Homo sapiens	IC50	M	13.0
Slightly Active	23366817	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	24.0	CHEMBL260	Homo sapiens	% Control	%	24.0
Not Active	23367285	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23367677	CHEMBL4884030	p38-alpha ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	0.0	CHEMBL260	Homo sapiens	% Residual activity with Skepinone-L	%	0.0
Active	23367786	CHEMBL4883802	Biochemical assay: cell free ELISA	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		IC50	nM	5.0	CHEMBL260	Homo sapiens	IC50	nM	5.0
Active	23367787	CHEMBL4883789	NanoBRET (MAPK14)	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		IC50	nM	13.6	CHEMBL260	Homo sapiens	IC50	nM	13.6
Not Active	23367792	CHEMBL4883789	NanoBRET (MAPK14)	B	CN(C(=O)c1ccccc1)c1cc(N(C)c2ccc3c(c2)CCc2ccc(C(=O)NCCN4CCOCC4)cc2C3=O)ccc1F	Non standard unit for type	CHEMBL4586225		IC50	M	11.3	CHEMBL260	Homo sapiens	IC50	M	11.3
Not Active	23368163	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	79.0	CHEMBL260	Homo sapiens	% Control	%	79.0
Not Active	23368631	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23369230	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23369698	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23370236	CHEMBL4884475	SAPK2a(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	101.0	CHEMBL260	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23370666	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23371134	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	88.0	CHEMBL260	Homo sapiens	% Control	%	88.0
Active	23371628	CHEMBL4884589	Enzyme kinetic assay (Reaction Biology) (MAPK14)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		IC50	nM	6.2	CHEMBL260	Homo sapiens	IC50	nM	6.2
Active	23371632	CHEMBL4884593	NanoBRET (SGC-Frankfurt) (MAPK14)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		IC50	nM	125.0	CHEMBL260	Homo sapiens	IC50	nM	125.0
Not Active	23371642	CHEMBL4884593	NanoBRET (SGC-Frankfurt) (MAPK14)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1	Non standard unit for type	CHEMBL4568183		IC50	M	5.39	CHEMBL260	Homo sapiens	IC50	M	5.39
Not Active	23371943	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	77.0	CHEMBL260	Homo sapiens	% Control	%	77.0
Not Active	23372411	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
	23372799	CHEMBL4884764	p38alpha(MP14LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL260	Homo sapiens	pIC50		6.0
	23373208	CHEMBL4885055	p38alpha(MP14LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL260	Homo sapiens	pIC50		6.0
	23373567	CHEMBL4885344	p38alpha(MP14LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL260	Homo sapiens	pIC50		6.0
Not Active	23375135	CHEMBL4886120	p38_alpha(direct) Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	4.0	CHEMBL260	Homo sapiens	% Inhibition	%	4.0
Not Active	23375302	CHEMBL4886284	mitogen-activated protein kinase 14 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-4.0	CHEMBL260	Homo sapiens	% inhibition	%	-4.0
Not Active	23375838	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23376306	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	93.0	CHEMBL260	Homo sapiens	% Control	%	93.0
Not Active	23376883	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	94.0	CHEMBL260	Homo sapiens	% Control	%	94.0
Not Active	23377351	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	81.0	CHEMBL260	Homo sapiens	% Control	%	81.0
Not Active	23378211	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23378679	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23379380	CHEMBL4883004	Protein Serine/Threonine Kinase, MAPK14 (p38) Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		Inhibition	%	-3.0	CHEMBL260	Homo sapiens	% inhibition	%	-3.0
Not Active	23379846	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23380314	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	86.0	CHEMBL260	Homo sapiens	% Control	%	86.0
Not Active	23380677	CHEMBL4887028	p38 alpha kinase (h) CEREP ligand profiling	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		Inhibition	%	-1.0	CHEMBL260	Homo sapiens	% inhibition	%	-1.0
Not Active	23381008	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23381656	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23382124	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23382431	CHEMBL4887146	SAPK2A/p38 Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	1.0	CHEMBL260	Homo sapiens	% inhibition	%	1.0
Not Active	23382748	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL260	Homo sapiens	% Control	%	100.0
Not Active	23383216	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	92.0	CHEMBL260	Homo sapiens	% Control	%	92.0
Active	23383480	CHEMBL4882992	NanoBRET (SGC Frankfurt) (MAPK14)	B	N#CN1CC[C@H](C(=O)Nc2nc3c(s2)CN(C(=O)CN=[N+]=[N-])CC3)C1		CHEMBL4802050		IC50	nM	320.0	CHEMBL260	Homo sapiens	IC50	nM	320.0
Not Active	23383870	CHEMBL4887492	MAPK14 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	92.0	CHEMBL260	Homo sapiens	% Ctrl	%	92.0
Not Active	23383871	CHEMBL4887492	MAPK14 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	60.0	CHEMBL260	Homo sapiens	% Ctrl	%	60.0
Not Active	23383872	CHEMBL4887493	MAPK14P38A Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	89.0	CHEMBL260	Homo sapiens	% Ctrl	%	89.0
Not Active	23384069	CHEMBL4887667	SAPK2AP38 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	85.3	CHEMBL260	Homo sapiens	% Ctrl	%	85.3
Not Active	23384456	CHEMBL4888051	SAPK2a(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	2.76	CHEMBL260	Homo sapiens	% inhibition	%	2.76
Not Active	23384668	CHEMBL4888194	MAPK14 (p38 alpha) Direct SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	-1.0	CHEMBL260	Homo sapiens	% Inhibition	%	-1.0
Not Active	23385131	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	88.0	CHEMBL260	Homo sapiens	% Control	%	88.0
Not Active	23385598	CHEMBL4879855	KinomeScan assay: inhibition of p38-alpha	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	83.0	CHEMBL260	Homo sapiens	% Control	%	83.0
